{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true,
    "ExecuteTime": {
     "end_time": "2023-05-08T05:57:02.610502600Z",
     "start_time": "2023-05-08T05:56:33.319234200Z"
    }
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  error: subprocess-exited-with-error\n",
      "  \n",
      "  git clone --filter=blob:none --quiet https://github.com/Andalusia-Data-Science-Team/chatGPT-api 'C:\\Users\\omar.mounir\\AppData\\Local\\Temp\\pip-req-build-42xfo5jx' did not run successfully.\n",
      "  exit code: 128\n",
      "  \n",
      "  [1 lines of output]\n",
      "  fatal: unable to access 'https://github.com/Andalusia-Data-Science-Team/chatGPT-api/': Failed to connect to github.com port 443 after 21105 ms: Couldn't connect to server\n",
      "  [end of output]\n",
      "  \n",
      "  note: This error originates from a subprocess, and is likely not a problem with pip.\n",
      "error: subprocess-exited-with-error\n",
      "\n",
      "git clone --filter=blob:none --quiet https://github.com/Andalusia-Data-Science-Team/chatGPT-api 'C:\\Users\\omar.mounir\\AppData\\Local\\Temp\\pip-req-build-42xfo5jx' did not run successfully.\n",
      "exit code: 128\n",
      "\n",
      "See above for output.\n",
      "\n",
      "note: This error originates from a subprocess, and is likely not a problem with pip.\n",
      "\n",
      "[notice] A new release of pip available: 22.3.1 -> 23.1.2\n",
      "[notice] To update, run: python.exe -m pip install --upgrade pip\n",
      "\n",
      "[notice] A new release of pip available: 22.3.1 -> 23.1.2\n",
      "[notice] To update, run: python.exe -m pip install --upgrade pip\n"
     ]
    }
   ],
   "source": [
    "!pip install git+https://github.com/Andalusia-Data-Science-Team/chatGPT-api --quiet\n",
    "! pip install openai --quiet\n",
    "\n",
    "import utils\n",
    "import json\n",
    "import time\n",
    "import glob\n",
    "\n",
    "#from chatGPT_api import ChatGPT\n",
    "\n",
    "api_key= \"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\"\n",
    "#chat_gpt=ChatGPT(api_key)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "test_interactions_df = pd.read_csv('LabFoodInteraction_1150.csv')"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-08T05:57:10.847178200Z",
     "start_time": "2023-05-08T05:57:07.158797200Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "outputs": [
    {
     "data": {
      "text/plain": "[\"Positive direct antiglobulin (Coombs) test; false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution), falsely elevated serum or urine creatinine with Jaffé reaction assay.\\n\\n\",\n nan,\n 'May suppress the wheal and flare reactions to skin test antigens\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n 'See individual agents.\\n\\n',\n 'See individual agents.\\n\\n',\n nan,\n 'Increased creatinine ( Jaffé alkaline picrate reaction); increased serum methotrexate by dihydrofolate reductase method\\n\\n',\n 'Omeprazole may falsely elevate serum chromogranin A (CgA) levels due to decreased gastric acidity; may cause false-positive results in the diagnosis of a neuroendocrine tumor. Assess CgA levels at ≥14 days after treatment is completed; repeat level if initially elevated.\\n\\n',\n 'Crizanlizumab may interfere with automated platelet counts (platelet clumping), particularly when blood samples are collected in tubes containing ethylenediaminetetraacetic acid (EDTA); platelet count may be unevaluable or falsely decreased. Management: Collect blood samples in citrate-containing tubes, and run blood samples within 4 hours of sample collection. If necessary, estimate platelet count through peripheral blood smear.\\n\\n',\n 'IV formulation: Due to propylene glycol content, triglyceride assays dependent on glycerol oxidase may be falsely elevated.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'HbA1c: Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Concurrent caffeine or theophylline use may demonstrate a false-negative result with dipyridamole-thallium myocardial imaging.\\n\\n',\n nan,\n nan,\n nan,\n 'May result in false positive results with some commercial HIV nucleic acid tests.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n \"Interferes with urinary glucose determination using Clinitest®; positive Coombs' [direct]\\n\\n\",\n nan,\n nan,\n \"Positive Coombs' [direct]\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n \"Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution); false- negative may occur with ferricyanide test. Glucose oxidase or hexokinase-based methods should be used.\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May cause transient increase in serum ferritin, urine zinc (with renal disease), or bilirubin (with hepatic metabolic disorders)\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n nan,\n nan,\n nan,\n 'May interfere with urine detection of methadone and phencyclidine (false-positives); may cause false-positive serum TCA screen; may suppress the wheal and flare reactions to skin test antigens\\n\\n',\n 'May suppress the wheal and flare reactions to skin test antigens\\n\\n',\n nan,\n nan,\n nan,\n nan,\n '\\n\\nSerum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric gluconate administration. Serum ferritin levels may be falsely elevated for 5 days after ferric gluconate administration.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May interfere with urine detection of methadone and phencyclidine (false-positives); may cause false-positive serum TCA screen; may suppress the wheal and flare reactions to skin test antigens\\n\\n',\n 'May alter results of thyroid function tests that are dependent on iodine estimation and may affect results of radioiodine uptake studies; perform these studies prior to diagnostic tests with iodinated contrast media.\\n\\n',\n nan,\n nan,\n \"Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May interfere with urine detection of phencyclidine (false-positive).\\n\\n',\n nan,\n nan,\n \"Interferes with urinary glucose determination using Clinitest®; positive Coombs' [direct]\\n\\n\",\n nan,\n 'Contains blood group isohemagglutinins; passive transmission of antibodies to erythrocyte antigens may interfere with serological tests for red cell antibodies (eg, Coombs test).\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Serum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric gluconate administration. Serum ferritin levels may be falsely elevated for 5 days after ferric gluconate administration.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n \"Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution); false- negative may occur with ferricyanide test. Glucose oxidase or hexokinase-based methods should be used.\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n '\\n\\nFalse-negative urinary glucose determinations when using Clinistix® or Diastix®\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'The following values may be affected, in vitro, following hydroxocobalamin 5 g dose. Interference following hydroxocobalamin 10 g dose can be expected to last up to an additional 24 hours. Note: Extent and duration of interference dependent on analyzer used and patient variability (Shapeton 2019).\\n\\nFalsely elevated:\\n\\nBasophils, hemoglobin, MCH, and MCHC [duration: 12-16 hours]\\n\\nAlbumin, alkaline phosphatase, cholesterol, creatinine, glucose, total protein, and triglycerides [duration: 24 hours] Bilirubin [duration: up to 4 days]\\n\\nUrinalysis: Glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite [duration: 2-8 days]\\n\\nFalsely decreased: ALT and amylase [duration: 24 hours]\\n\\nUnpredictable:\\n\\nAST, CK, CKMB, LDH, phosphate, and uric acid [duration: 24 hours] PT (quick or INR) and aPTT [duration: 24-48 hours]\\n\\nUrine pH [duration: 2-8 days]\\n\\n\\n\\nMay also turn both the plasma and urine a pinkish color and interfere with colorimetric or spectrophotometric tests (Wong 2016); may cause hemodialysis machines to shut down due to false detection of a blood leak from the blood-like appearance of the solution.\\n\\n',\n nan,\n 'Blood glucose: Administration may result in falsely elevated blood glucose concentrations due to the presence of maltose in the botulism antitoxin, specifically when blood glucose is measured using glucose dehydrogenase pyrroloquinoline-quinone (GDH-PQQ) method.\\n\\n',\n nan,\n \"Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction, false-positive urinary proteins and steroids\\n\\n\",\n 'Serum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration.\\n\\n',\n 'Positive Coombs.\\n\\n',\n nan,\n nan,\n 'HbA1c: Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n \"T4-binding globulin (TBG): Factors that alter binding in serum (ATA/AACE [Garber 2012]):\\n\\nNote: T4 is ~99.97% protein bound. Factors that alter protein binding will affect serum total T4 levels; however, measurement of serum free T4 (the metabolically active moiety) has largely replaced serum total T4 for thyroid status assessment.\\n\\nConditions/states that increase TBG binding: Pregnancy, hepatitis, porphyria, neonatal state\\n\\nMedications that increase TBG binding: Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\\n\\nConditions/states that decrease TBG binding: Hepatic failure, nephrosis, severe illness.\\n\\nMedications that decrease TBG binding: Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\\n\\nThyroxine (T4) and triiodothyronine (T3): Serum binding inhibitors (ATA/AACE [Garber 2012]):\\n\\nMedications that inhibit T4 and T3 binding: Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\\n\\nThyroid gland hormone: Interference with production and secretion (ATA/AACE [Garber 2012]): Medications affecting iodine uptake: Amiodarone, iodinated contrast agents, iodine, ethionamide\\n\\nMedications affecting hormone production: Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil),\\n\\nMedications affecting secretion: Amiodarone, iodinated contrast agents, iodine, lithium\\n\\nMedications inducing thyroiditis: Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\\n\\nMedications potentially causing the development of Graves’: Alemtuzumab, interferon alpha, antiretroviral therapy Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’: Glucocorticoids\\n\\nHypothalamic-pituitary axis and TSH: Interference with secretion (ATA/AACE [Garber 2012]):\\n\\nMedications decreasing TSH secretion: Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\\n\\nMedications increasing TSH secretion: Amphetamine, interleukin 2, metoclopramide, ritonavir, St John's wort Medications potentially causing hypophysitis: Ipilimumab\\n\\n\",\n nan,\n nan,\n nan,\n 'Iodine-binding capacity of thyroid tissue may be reduced for up to 2 weeks following administration of contrast media; diagnostic tests using iodine-containing isotopes may be affected. Thyroid function tests that are independent of iodine estimation for results are not affected (eg, T3 resin uptake, thyroxine assays).\\n\\n',\n nan,\n 'May interfere with urine detection of amphetamines/methamphetamines (false-positive).\\n\\n',\n 'May interfere with tests for parathyroid function; may lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n nan,\n nan,\n nan,\n nan,\n \"T4-binding globulin (TBG): Factors that alter binding in serum (ATA/AACE [Garber 2012]):\\n\\nNote: T4 is ~99.97% protein bound. Factors that alter protein binding will affect serum total T4 levels; however, measurement of serum free T4 (the metabolically active moiety) has largely replaced serum total T4 for thyroid status assessment.\\n\\nConditions/states that increase TBG binding: Pregnancy, hepatitis, porphyria, neonatal state\\n\\nMedications that increase TBG binding: Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\\n\\nConditions/states that decrease TBG binding: Hepatic failure, nephrosis, severe illness\\n\\nMedications that decrease TBG binding: Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\\n\\nThyroxine (T4) and Triiodothyronine (T3): Serum binding inhibitors (ATA/AACE [Garber 2012]):\\n\\nMedications that inhibit T4 and T3 binding: Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\\n\\nThyroid gland hormone: Interference with production and secretion (ATA/AACE [Garber 2012]): Medications affecting iodine uptake: Amiodarone, iodinated contrast agents, iodine, ethionamide\\n\\nMedications affecting hormone production: Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\\n\\nMedications affecting secretion: Amiodarone, iodinated contrast agents, iodine, lithium\\n\\n\\n\\nMedications inducing thyroiditis: Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\\n\\nMedications potentially causing the development of Graves’: Alemtuzumab, interferon alpha, antiretroviral therapy Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’: Glucocorticoids\\n\\nHypothalamic-pituitary axis and TSH: Interference with secretion (ATA/AACE [Garber 2012]):\\n\\nMedications decreasing TSH secretion: Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\\n\\nMedications increasing TSH secretion: Amphetamine, interleukin 2, metoclopramide, ritonavir, St John's wort Medications potentially causing hypophysitis: Ipilimumab\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n 'Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\\n\\n',\n 'False-negative stool occult blood 48 to 72 hours after ascorbic acid ingestion.\\n\\nAscorbic acid may interfere with laboratory tests based on oxidation-reduction reactions (eg, blood and urine glucose testing, nitrite and bilirubin levels, leucocyte count). High-dose ascorbic acid has been associated with falsely-elevated glucose measurements by point of care glucometers. Use of plasma laboratory assays or an FDA-approved device that corrects for interferences are recommended (Hager 2019; Tran 2014; Vasudevan 2014). Alternatively, laboratory tests based on oxidation-reduction reactions should be delayed until 24 hours after dose.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Interferes with gastric secretion test. Transdermal system should be discontinued ≥10 days prior to testing.\\n\\n',\n nan,\n \"May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Fehling’s solution, or Clinitest®).\\n\\n\\n\\nSome penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Serum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration.\\n\\n',\n nan,\n 'Phenothiazines may cause false-positive or negative pregnancy tests.\\n\\n',\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May interfere with urine detection of methadone (false-positive) (Lichtenwalner 1998).\\n\\n',\n \"False-positive Coombs' test [direct]\\n\\n\",\n nan,\n 'Methyldopa interferes with the following laboratory tests: urinary uric acid (phosphotungstate method), serum creatinine (alkaline picrate method), AST (colorimetric method), and urinary catecholamines (falsely high levels)\\n\\nMay lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'Plasma glucose, uric acid, free fatty acids, total cholesterol, HDL, HDL/LDL ratio, and urinary free cortisol excretion may be increased by theophylline. Theophylline may decrease triiodothyronine.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Altered results of coagulation and fibrinolytic activity tests\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May suppress the wheal and flare reactions to skin test antigens\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'Ceftazidime: Positive direct Coomb. False-positive reaction for urine glucose with certain methods; use glucose tests based on enzymatic glucose oxidase reactions.\\n\\n',\n 'Transitory changes in serum iron have been observed. May interfere with colorimetric tests for serum calcium (apparent decrease); alternate testing method is recommended for 12-24 hours after administration.\\n\\n',\n nan,\n 'False-positive urinary catecholamines (fluorometric assay), 17-hydroxycorticosteroids and 17-ketosteroids\\n\\n',\n 'May cause false-positive serum TCA screen. May suppress the wheal and flare reactions to skin test antigens.\\n\\n',\n nan,\n \"Positive Coombs' test; may lead to false-positive aldosterone/renin ratio (Funder 2016)\\n\\n\",\n nan,\n nan,\n nan,\n 'May interfere with MR imaging; alterations may persist for ≤3 months following use, with peak alterations anticipated in the first 2 days following administration. If MR imaging is required within 3 months after administration, use T1- or proton density-weighted MR pulse sequences to decrease effect on imaging. Do not use T2-weighted sequence MR imaging prior to 4 weeks following administration.\\n\\n\\n\\nSerum iron and transferrin-bound iron may be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\\n\\n',\n 'Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\\n\\n\\n\\nPassively transferred antibodies may yield false-positive serologic testing results; may yield false-positive direct and indirect Coombs’ test.\\n\\n',\n 'Omeprazole may falsely elevate serum chromogranin A (CgA) levels. The increased CgA level may cause false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'May interfere with detection of urine protein (false positive) when pyrogallol red reagent is used. Use a laboratory test that does not contain pyrogallol red reagent or use urine free of casimersen (eg, urine obtained prior to infusion or ≥48 hours after infusion).\\n\\n\\n\\n',\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Increased amylase (S), increased BSP retention, increased CPK (IM injections)\\n\\n',\n nan,\n 'May interfere with the serum progesterone assay; interaction may be observed for up to 30 minutes after a 16 mg/kg dose of sugammadex.\\n\\n',\n nan,\n nan,\n 'May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n 'May cause false positive results for blood ethylene glycol concentrations. High mannitol concentrations may cause false low results for inorganic phosphorus blood concentrations if assay based on the conversion of phosphate (orthophosphate) to the phosphomolybdate complex is used.\\n\\n',\n 'Interferes with gastric secretion test. Transdermal system should be discontinued ≥10 days prior to testing.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May interfere with bone imaging studies; increased hematopoietic activity of the bone marrow may appear as transient positive bone imaging changes.\\n\\n',\n 'May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n \"May interfere with urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest); positive Coombs' test\\n\\n\",\n 'Increased glucose; decreased HDL; may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n nan,\n nan,\n \"Positive direct and indirect Coombs', false-positive urinary glucose test using glucose tests based on Benedict's copper reduction reaction, false- positive serum or urine creatinine with Jaffé reaction.\\n\\n\\n\\nSome penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\\n\\n\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n \"May interfere with urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest); positive Coombs' test\\n\\n\",\n 'See individual agents.\\n\\n',\n nan,\n \"May interfere with urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest); positive Coombs' test\\n\\n\",\n 'May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n nan,\n 'Altered results of coagulation and fibrinolytic activity tests\\n\\n',\n nan,\n nan,\n 'May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'Digoxin immune fab may interfere with digitalis immunoassay measurements, thereby resulting in clinically misleading total serum digoxin concentrations until all Fab fragments are eliminated from the body (may take several days to >1 week after administration). Digoxin serum samples should be obtained before digoxin immune fab administration, if possible.\\n\\n',\n 'May interfere with urine detection of phencyclidine (false-positive).\\n\\n',\n nan,\n 'May suppress the wheal and flare reactions to skin test antigens\\n\\n',\n nan,\n 'Acetaminophen may cause false-positive urinary 5-hydroxyindoleacetic acid.\\n\\n',\n 'May interfere with certain enzymatic methods used to detect opioids, depending on sensitivity and specificity of the test (refer to test manufacturer for details)\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May decrease response to skin tests\\n\\n',\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'Ascorbic acid in the urine can cause false-negative urine glucose determinations.\\n\\nBiotin can significantly interfere with certain lab tests and cause incorrect test results that may go undetected, possibly leading to inappropriate patient management or misdiagnosis (FDA Safety Communication 2017).\\n\\n',\n nan,\n nan,\n 'PT/INR, when measuring coumarin derivative activity, is not reliable within 5 hours following danaparoid administration.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n 'May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Methotrexate, pyrimethamine, and most antibiotics invalidate folic acid and vitamin B12 diagnostic blood assays\\n\\n',\n nan,\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n 'Urine specimen assay: Contrast agent instillation into the bladder may interfere with urine specimen assay; collect urine prior to or at least 2 days after contrast administration.\\n\\n',\n nan,\n \"Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\\n\\n\",\n nan,\n nan,\n 'Rapid plasma reagin (RPR) test: Smallpox vaccine may induce false-positive RPR test for syphilis; confirm positive RPR test using a more specific test (eg, FTA assay).\\n\\n\\n\\nTuberculin skin (PPD) and blood tests: Smallpox vaccine may diminish the diagnostic utility of tuberculin skin (PPD) and blood tests; avoid skin test for ≥1 month after vaccine to prevent false-negative results.\\n\\n',\n nan,\n nan,\n 'Bisphosphonates may interfere with diagnostic imaging agents such as technetium-99m-diphosphonate in bone scans. Some studies suggest that clodronate may not interfere with radiopharmaceutical bone imaging (Pecherstorfer 1993).\\n\\n',\n nan,\n nan,\n 'Falsely low serum concentrations may occur with the Lactobacillus casei assay method in patients on anti-infectives (eg, tetracycline)\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'See individual agents.\\n\\n',\n nan,\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n \"May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®); may inactivate aminoglycosides in vitro; false- positive urinary and serum proteins\\n\\n\",\n nan,\n nan,\n 'See individual agents.\\n\\n',\n \"Positive direct Coombs'. False-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution); use test based on enzymatic glucose oxidase. May cause false-positive serum or urine creatinine with Jaffé reaction\\n\\n\",\n nan,\n 'May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n nan,\n 'The use of estrogens and/or progestogens may alter the results of some laboratory tests (eg, coagulation factors, lipids, glucose tolerance, thyroxine-binding globulin, sex hormone–binding globulin, cortisol-binding globulin).\\n\\n',\n nan,\n nan,\n 'Bisphosphonates may interfere with diagnostic imaging agents such as technetium-99m-diphosphonate in bone scans.\\n\\n',\n nan,\n nan,\n \"False-positive Coombs' test [direct]\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n 'False-negative dexamethasone suppression test; may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n 'False-positives for phenylketonuria, amylase, uroporphyrins, urobilinogen. May cause false-positive pregnancy test. May interfere with urine detection of amphetamine/methamphetamine and methadone (false-positives).\\n\\n',\n nan,\n nan,\n nan,\n nan,\n \"May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®)\\n\\n\\n\\nSome penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\\n\\n\",\n 'Flucytosine causes markedly false elevations in serum creatinine values when the Ektachem® analyzer is used. The Jaffé reaction is recommended for determining serum creatinine.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n 'HbA1c: Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\\n\\n\\n\\n',\n nan,\n nan,\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n 'Decreased response to skin tests\\n\\n',\n nan,\n nan,\n nan,\n \"May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest); may inactivate aminoglycosides in vitro; false- positive urine and serum proteins; false-positive in uric acid, urinary steroids\\n\\n\",\n nan,\n nan,\n nan,\n 'TPMT phenotyping results may not be accurate following recent blood transfusions.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Serum renin concentrations and IgG concentrations may be increased. Serum cortisol concentrations may be decreased. May cause a false- negative insulin response to glucagon.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May cause interference with fluorescence test for urinary catecholamines (false elevations).\\n\\n',\n nan,\n nan,\n nan,\n 'Refer to individual agents.\\n\\n',\n 'See individual agents.\\n\\n',\n nan,\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Thyroid function tests (protein bound and radioactive iodine uptake studies) may be inaccurate for up to 16 days after administration; may cause false positive urine protein test using Multistix; may affect urine specific gravity\\n\\n',\n nan,\n nan,\n nan,\n 'Argatroban may elevate PT/INR levels in the absence of warfarin. If warfarin is started, initial PT/INR goals while on argatroban may require modification. The American College of Chest Physicians suggests monitoring chromogenic factor X assay when transitioning from argatroban to warfarin (Garcia, 2012) or overlapping administration of warfarin for a minimum of 5 days until INR is within target range; recheck INR after anticoagulant effect of argatroban has dissipated (Guyatt, 2012). Factor Xa levels <45% have been associated with INR values >2 after the effects of argatroban have been eliminated (Arpino, 2005).\\n\\n',\n nan,\n 'Patients who have received betibeglogene autotemcel are likely to test positive by polymerase chain reaction (PCR) assays for HIV due to integrated BB305 LVV proviral DNA, resulting in a false-positive test for HIV; patients who have received betibeglogene autotemcel should not be screened for HIV infection using a PCR-based assay.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'IV administration may produce falsely decreased serum and urine magnesium concentrations\\n\\n',\n nan,\n \"Positive Coombs' test, false-positive urinary proteins\\n\\nSome penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Reduced response to metyrapone test.\\n\\n',\n nan,\n 'When the anti-FXa activity assay is performed after administration of andexanet alfa, the FXa inhibitor may dissociate from andexanet alfa, resulting in falsely elevated anti-FXa activity, causing a substantial underestimation of the reversal activity.\\n\\n',\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n \"Positive direct Coombs', false-positive urinary glucose test using nonenzymatic methods, false-positive galactosemia tests.\\n\\n\",\n 'Can cause a false-positive amphetamine EMIT assay\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Iodide may alter thyroid function tests.\\n\\n',\n nan,\n nan,\n 'Plasma glucose, uric acid, free fatty acids, total cholesterol, HDL, HDL/LDL ratio, and urinary free cortisol excretion may be increased by theophylline. Theophylline may decrease triiodothyronine.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May interfere with urine detection of phencyclidine (false-positive) (Hull 2006).\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\\n\\n\\n\\nPassively transferred antibodies may yield false-positive serologic testing results; may yield false-positive direct and indirect Coombs’ test.\\n\\n',\n 'May interfere with AST, ALT, triglycerides, glucose, and LDH testing\\n\\n',\n 'May suppress the wheal and flare reactions to skin test antigens\\n\\n',\n nan,\n 'Spironolactone may interfere with digoxin radioimmunoassay.\\n\\n',\n nan,\n 'Methotrexate levels: For up to 48 hours following glucarpidase administration, the preferred method of measuring methotrexate concentrations is the chromatographic method. DAMPA, an inactive methotrexate metabolite with a half-life of ~9 hours, interferes with immunoassays and may result in the overestimation of the methotrexate concentration.\\n\\n',\n nan,\n 'False-positive urine catecholamines, metanephrine, normetanephrine, and vanillylmandelic acid (VMA) if measured by fluorometric or photometric methods (high performance liquid chromatographic [HPLC] assay with solid phase extraction should be used to determine levels of catecholamines); false-positive urine amphetamine if measured by thin-layer chromatography or radioenzymatic assay (gas chromatographic-mass spectrometer technique should be used); may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n \"Interferes with urinary glucose determination using Clinitest®; positive Coombs' [direct]\\n\\n\",\n nan,\n nan,\n 'May interfere with urine detection of phencyclidine (false-positives) (Marchei 2007). May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n nan,\n 'Iodine-binding capacity of thyroid tissue may be reduced for up to 2 weeks following administration of contrast media; diagnostic tests using iodine-containing isotopes may be affected. Thyroid function tests that are independent of iodine estimation for results are not affected (eg, T3 resin uptake, thyroxine assays).\\n\\n',\n 'Increased renin (S), increased aldosterone (S)\\n\\n',\n nan,\n nan,\n 'Patients who have received elivaldogene autotemcel are likely to test positive by polymerase chain reaction (PCR) assays for HIV due to lentiviral vector proviral DNA, resulting in a false-positive test for HIV; patients who have received elivaldogene autotemcel should not be screened for HIV infection using a PCR-based assay.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Daptomycin may cause false prolongation of the PT and increase of INR with certain recombinant thromboplastin reagents. This appears to be a dose-dependent phenomenon. If PT/INR is elevated, repeat PT/INR immediately prior to next daptomycin dose (eg, trough). If PT/INR remains elevated, repeat PT/INR using alternate reagents (if available) and evaluate for other causes of elevated PT/INR.\\n\\n',\n nan,\n 'Plasma glucose, uric acid, free fatty acids, total cholesterol, HDL, HDL/LDL ratio, and urinary free cortisol excretion may be increased by theophylline. Theophylline may decrease triiodothyronine.\\n\\n',\n nan,\n 'Can cause a false-positive amphetamine EMIT assay\\n\\n',\n 'Positive Coombs.\\n\\n',\n nan,\n nan,\n \"Positive Coombs' test (direct), false-positive urinary and serum proteins; may inactivate aminoglycosides in vitro\\n\\n\",\n nan,\n nan,\n 'False-negative stool occult blood 48 to 72 hours after ascorbic acid ingestion.\\n\\nAscorbic acid may interfere with laboratory tests based on oxidation-reduction reactions (eg, blood and urine glucose testing, nitrite and bilirubin levels, leucocyte count). High-dose ascorbic acid has been associated with falsely-elevated glucose measurements by point of care glucometers. Use of plasma laboratory assays or an FDA-approved device that corrects for interferences are recommended (Hager 2019; Tran 2014; Vasudevan 2014). Alternatively, laboratory tests based on oxidation-reduction reactions should be delayed until 24 hours after dose.\\n\\n',\n 'When using an in vitro activated partial thromboplastin time (aPTT)–based one-stage clotting assay (OSA) for determining factor IX activity, results can be affected both by the type of aPTT reagent and the reference standard used in the assay. The same assay and reagents are recommended to be used when monitoring factor IX activity over time if feasible (the use of different assays or reagents may affect test results). Factor IX activity test results are lower if measured with chromogenic substrate assay (CSA) compared to OSA. In a clinical study, post-dose factor IX activity showed the mean CSA to OSA factor IX activity ratio ranging from 0.41 to 0.55.\\n\\n',\n nan,\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n \"Interferes with urinary glucose determination using Clinitest®; positive Coombs' [direct]\\n\\n\",\n nan,\n 'Elotuzumab may be detected on both serum protein electrophoresis (SPEP) and serum immunofixation assays used for multiple myeloma endogenous M-protein monitoring, and may affect the determination of complete response and disease progression of some patients with IgG kappa myeloma protein. A small peak in the early gamma region on SPEP that is IgG kappa on serum immunofixation may potentially be attributed to elotuzumab (especially when endogenous myeloma protein is IgA, IgM, IgD, or lambda light chain restricted).\\n\\n',\n nan,\n 'Falsely high or low values of serum iron (if determined by complexometric methods) may occur for up to 24 hours following administration.\\n\\n',\n nan,\n 'Acetaminophen may cause false-positive urinary 5-hydroxyindoleacetic acid. Ibuprofen may interfere with urine detection of phencyclidine (false-positives) (Marchei 2007), and may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n nan,\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered. False-positive urine methadone screens have been reported in patients taking medications, including diphenhydramine, doxylamine, clomipramine, chlorpromazine, thioridazine, quetiapine, and verapamil.\\n\\n',\n 'Potential interference with rabbit antibody-based immunoassays and with cross-match or panel-reactive antibody cytotoxicity assays. Has not been shown to interfere with routine clinical laboratory tests which do not use immunoglobulins.\\n\\n',\n nan,\n 'Refer to individual agents.\\n\\n',\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May interfere with detection of urine protein (false positive) when pyrogallol red reagent is used. Use a laboratory test that does not contain pyrogallol red reagent or use urine free of viltolarsen (eg, urine obtained prior to infusion or ≥48 hours after infusion).\\n\\n',\n nan,\n 'Falsely-elevated serum phosphate may occur when using the PHOSm assay.\\n\\n',\n nan,\n \"\\n\\nFalse-positive for uric acid using the phosphotungstate method and for urobilinogen using the Ehrlich's reagent; large doses may interfere with the spectrophotometric determination of serum theophylline concentration\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May cause false-positive results for urinary protein with Albustix®, Labstix®, Albutest®, Bumintest®; interferes with HPLC theophylline assay and serum uric acid levels; may lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n 'May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n nan,\n 'May interfere with diagnostic serum tests that utilize antibodies.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Passively transferred antibodies may yield false-positive serologic testing results; may yield false-positive direct and indirect Coombs test.\\n\\n',\n nan,\n nan,\n 'Abatacept for IV infusion contains maltose; may result in falsely elevated blood glucose levels with dehydrogenase pyrroloquinolinequinone or glucose-dye-oxidoreductase testing methods on the day of infusion. Glucose monitoring methods which utilize glucose dehydrogenase nicotine adenine dinucleotide (GDH-NAD), glucose oxidase, or glucose hexokinase are recommended.\\n\\n',\n nan,\n 'See individual agents.\\n\\n',\n nan,\n nan,\n 'Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\\n\\n',\n nan,\n 'May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n \"False-positive or negative urinary glucose determination using Clinitest®; positive Coombs' [direct]; false-positive urinary and/or serum proteins by certain test methods\\n\\n\",\n nan,\n \"Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\\n\\n\",\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n \"Daratumumab binds to CD38 on red blood cells; daratumumab-based therapy may result in a positive indirect antiglobulin test (indirect Coombs test). Daratumumab-mediated Coombs test positivity may persist for up to 6 months after the last dose. In addition, daratumumab (bound to red blood cells) masks antibody detection to minor antigens in the patient's serum; ABO and Rh blood type determination are not affected. Notify blood transfusion centers and blood banks that a patient has received daratumumab/hyaluronidase. Type and screen patients prior to treatment initiation.\\n\\nDaratumumab (a human IgG kappa monoclonal antibody) may be detected on serum protein electrophoresis and immunofixation assays that monitor for endogenous M-protein. Interference with these assays by daratumumab-based therapy may affect the determination of complete response and disease progression in some patients with IgG kappa myeloma protein.\\n\\n\",\n nan,\n nan,\n 'Interferes with gastric secretion test. Transdermal system should be discontinued ≥10 days prior to testing.\\n\\n',\n \"T4-binding globulin (TBG): Factors that alter binding in serum (ATA/AACE [Garber 2012]):\\n\\nNote: T4 is ~99.97% protein bound. Factors that alter protein binding will affect serum total T4 levels; however, measurement of serum free T4 (the metabolically active moiety) has largely replaced serum total T4 for thyroid status assessment.\\n\\nConditions/states that increase TBG binding: Pregnancy, hepatitis, porphyria, neonatal state\\n\\nMedications that increase TBG binding: Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\\n\\nConditions/states that decrease TBG binding: Hepatic failure, nephrosis, severe illness\\n\\nMedications that decrease TBG binding: Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\\n\\nThyroxine (T4) and Triiodothyronine (T3): Serum binding inhibitors (ATA/AACE [Garber 2012]):\\n\\nMedications that inhibit T4 and T3 binding: Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\\n\\nThyroid gland hormone: Interference with production and secretion (ATA/AACE [Garber 2012]): Medications affecting iodine uptake: Amiodarone, iodinated contrast agents, iodine, ethionamide\\n\\n\\n\\nMedications affecting hormone production: Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\\n\\nMedications affecting secretion: Amiodarone, iodinated contrast agents, iodine, lithium\\n\\nMedications inducing thyroiditis: Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\\n\\nMedications potentially causing the development of Graves’: Alemtuzumab, interferon alpha, antiretroviral therapy Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’: Glucocorticoids\\n\\nHypothalamic-pituitary axis and TSH: Interference with secretion (ATA/AACE [Garber 2012]):\\n\\nMedications decreasing TSH secretion: Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\\n\\nMedications increasing TSH secretion: Amphetamine, interleukin 2, metoclopramide, ritonavir, St John's wort Medications potentially causing hypophysitis: Ipilimumab\\n\\n\",\n 'May cause a false-positive result for urine ketones (valproate partially eliminated as a keto-metabolite in the urine); may alter thyroid function tests\\n\\n',\n 'May result in false-positive urine dipstick tests (eg, urine protein, ketones, occult blood).\\n\\n',\n 'False-positives for phenylketonuria, pregnancy\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Potential interference with rabbit antibody-based immunoassays and with cross-match or panel-reactive antibody cytotoxicity assays. Has not been shown to interfere with routine clinical laboratory tests which do not use immunoglobulins.\\n\\n',\n nan,\n \"Positive Coombs'\\n\\n\",\n 'May cause false-positive serum TCA screen (Dasgupta 2007).\\n\\n',\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May interfere with the interpretation of any urine test that relies on a blue indicator (such as the dipstick for leucocyte esterase).\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Can cause a false-positive amphetamine EMIT assay\\n\\n',\n 'Urinary ketones: False-positive tests for urinary ketones may occur in patients receiving mesna with the use of nitroprusside-based urine tests, including dipstick tests.\\n\\nCPK activity: Mesna may interfere with enzymatic creatine kinase (CPK) activity tests which use a thiol compound (eg, N-acetylcysteine) for CPK reactivation; may result in a falsely low CPK level.\\n\\nAscorbic acid: Mesna may result in false-positive reactions in Tillman’s reagent-based urine screening tests for ascorbic acid.\\n\\n',\n \"May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution). Glucose tests based on enzymatic glucose oxidase reactions (eg, Clinistix) are recommended.\\n\\nAmpicillin may transiently interfere with plasma concentrations of total conjugated estriol, estriol-glucuronide, conjugated estrone and estradiol in pregnant women.\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Ocrelizumab interferes with the CD20 assay for B-cell counts; use the CD19+ assay to measure B-cell counts.\\n\\n',\n nan,\n 'In the presence of propranolol or suprapharmacologic concentrations of lidocaine or meprobamate, tests which depend on fluorescence to measure procainamide/N-acetyl procainamide concentrations may be affected.\\n\\n',\n nan,\n nan,\n 'May cause falsely elevated values of serum bilirubin and falsely decreased values of serum calcium. Residual iron dextran may remain in reticuloendothelial cells; may affect accuracy of examination of bone marrow iron stores. Bone scans with 99m Tc-labeled bone seeking agents may show reduced bony uptake, marked renal activity, and excess blood pooling and soft tissue accumulation following IV iron dextran infusion or with high serum ferritin levels. Following IM iron dextran, bone scans with 99m Tc-diphosphonate may show dense activity in the buttocks.\\n\\n',\n \"May interfere with urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest); positive Coombs' test\\n\\n\",\n 'Iodine-binding capacity of thyroid tissue may be reduced for up to 2 weeks following administration of contrast media; diagnostic tests using iodine-containing isotopes may be affected. Thyroid function tests that are independent of iodine estimation for results are not affected (eg, T3 resin uptake, thyroxine assays).\\n\\n',\n nan,\n 'PT/INR levels may become elevated in the absence of warfarin. If warfarin is initiated, initial PT/INR goals while on bivalirudin may require modification.\\n\\n',\n nan,\n nan,\n nan,\n 'May cause interference with fluorescence test for urinary catecholamines (false elevations)\\n\\n',\n \"Artificially prolongs coagulation tests (binds to and prevents action of phospholipid reagents), including activated clotting time (ACT; ≤24 hours), aPTT (≤120 hours), prothrombin time (≤12 hours) and international normalized ratio (≤12 hours), silica clot time (SCT; ≤18 hours), dilute Russell's viper venom time (DRVVT; ≤72 hours), and D-dimer (≤72 hours). For patients requiring aPTT monitoring within 120 hours of a dose, consider a nonphospholipid-dependent coagulation test (eg, Factor Xa [chromogenic] assay) or an alternative anticoagulant not requiring aPTT monitoring. Positive indirect and direct antiglobulin tests have occurred in patients receiving oritavancin; positive indirect antiglobulin tests may interfere with cross-matching prior to blood transfusions.\\n\\n\",\n nan,\n 'Acetaminophen may cause false-positive urinary 5-hydroxyindoleacetic acid. Ibuprofen may interfere with urine detection of phencyclidine (false-positives) (Marchei 2007), and may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n nan,\n 'Moxetumomab pasudotox may interfere with detection of cellular CD22; CD19+ B cells may be used as a surrogate assay.\\n\\n',\n 'Interferes with the following coagulation assessments when using samples drawn 18 hours or less after telavancin administration (causes artificially increased clotting times): PT, INR, aPTT, ACT, Xa (coagulation based assay). Collect blood samples for these coagulation tests as close as possible prior to administration of the next dose of telavancin, use a non-phospholipid dependent coagulation test (eg, bleeding time, factor Xa [chromogenic assay], platelet aggregation study, thrombin time), or select an alternative anticoagulant not requiring aPTT monitoring; concomitant use of telavancin and IV unfractionated heparin is contraindicated.\\n\\nInterferes with urine protein via qualitative dipstick and quantitative dye methods.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'May cause color interference in certain screening tests for 5-HIAA using nitrosonaphthol reagent and in screening tests for urinary VMA using the Gitlow method.\\n\\n',\n nan,\n nan,\n 'May cause falsely elevated free thyrotropin and free triiodothyronine levels when assays involving prolonged incubation periods are used. Thyroid-stimulating hormone and standard competitive free thyroid hormone assays are not usually affected (Burch 2019).\\n\\n',\n nan,\n nan,\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n nan,\n 'Bisphosphonates may interfere with diagnostic imaging agents such as technetium-99m-diphosphonate in bone scans.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n \"Positive direct and indirect Coombs', false-positive urinary glucose test using glucose tests based on Benedict's copper reduction reaction, false- positive serum or urine creatinine with Jaffé reaction.\\n\\n\\n\\nSome penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\\n\\n\\n\\n\",\n 'Esomeprazole may falsely elevate serum chromogranin A (CgA) levels. The increased CgA level may cause false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop esomeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n \"May interfere with urinary glucose tests (Benedict's solution, Clinitest, Fehling's Solution).\\n\\nSome penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\\n\\n\",\n 'See individual agents.\\n\\n',\n nan,\n nan,\n 'Bisphosphonates may interfere with diagnostic imaging agents such as technetium-99m-diphosphonate in bone scans.\\n\\n',\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'Falsely high plasma phenytoin concentrations may occur when measured by immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000). Phenytoin may produce falsely low results for serum concentrations of T4 and T3, and dexamethasone or metyrapone tests. Phenytoin may cause increased serum levels of thyroid-stimulating hormone (TSH; usually in the absence of clinical hypothyroidism).\\n\\n',\n nan,\n nan,\n nan,\n \"May interfere with urine detection of opioids (false-positive); positive Coombs' [direct]; false elevation of urinary steroids (when assayed by Zimmerman method) and catecholamines; qualitative and quantitative urine dipstick protein assays\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May interfere with urine detection of methadone and phencyclidine (false-positives); may cause false-positive serum TCA screen; may suppress the wheal and flare reactions to skin test antigens\\n\\n',\n nan,\n nan,\n 'Ceftazidime: Positive direct Coomb. False-positive reaction for urine glucose with certain methods; use glucose tests based on enzymatic glucose oxidase reactions.\\n\\n',\n 'Serum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration.\\n\\n',\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n 'If edetate CALCIUM disodium is given as a continuous IV infusion, stop the infusion for at least 1 hour before blood is drawn for lead concentration to avoid a falsely elevated value\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Neutralizing antibody assay: Obtain serum samples at least a month after the last dose to prevent assay interference.\\n\\nHbA1c: Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\\n\\n',\n nan,\n nan,\n 'Increased PT is possible.\\n\\nOral factor Xa inhibitors (apixaban, edoxaban, and rivaroxaban) may interfere with anti-factor Xa assays used for monitoring heparin anticoagulation, causing falsely elevated results and leading to inappropriate heparin dose reduction. Oral factor Xa inhibitors have little or minor effect on the aPTT. Consider using aPTT for heparin monitoring for at least 72 hours if there is concern for laboratory inference with the anti-factor Xa assay due to an oral factor Xa inhibitor (Conway 2017; Faust 2016; Levito 2020).\\n\\nMay cause falsely elevated free T4 and free T3 levels when assays involving prolonged incubation periods are used. Thyroid stimulating hormone and standard competitive free thyroid hormone assays are not usually affected (Burch 2019).\\n\\n\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'aPTT (formulation contains heparin)\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'See individual agents.\\n\\n',\n 'Daratumumab binds to CD38 on RBCs and interferes with compatibility testing, including antibody screening and cross matching. Mitigation methods include treating reagent RBCs with dithiothreitol (DTT) to disrupt daratumumab binding or genotyping. As the Kell blood group system is also sensitive to DTT, supply K-negative units after ruling out or identifying alloantibodies using DTT-treated RBCs. If an emergency transfusion is required, administer non-cross-matched ABO/RhD-compatible RBCs per local blood bank practices.\\n\\n\\n\\nDaratumumab may be detected on both serum protein electrophoresis (SPE) and immunofixation (IFE) assays used for monitoring multiple myeloma monoclonal immunoglobulins (M-proteins); false positive SPE and IFE assay results may occur for patients with IgG kappa myeloma protein, and may affect initial assessment of complete response criteria. In patients with persistent very good partial response where daratumumab interference is suspected, consider using a daratumumab-specific IFE assay to distinguish daratumumab from any residual endogenous M protein to evaluate the depth of treatment response.\\n\\n',\n 'PT/INR levels may become elevated in the absence of warfarin. If warfarin is initiated, initial PT/INR goals while on bivalirudin may require modification.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Although amiodarone can cause true hypothyroidism or thyrotoxicosis, changes in thyroid function test results may occur in euthyroid patients. Amiodarone inhibits conversion from T4 to T3; the active metabolite also reduces circulating T3 levels. As a result, T4 levels may be elevated, thyroid stimulating hormone levels may be at the high end of normal range, and T3 levels may be at the low end of normal range (Burch 2019).\\n\\n',\n 'Concurrent or recent use of spironolactone, hydrocortisone, cortisone, etomidate, estrogens\\n\\n',\n nan,\n \"Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\\n\\n\",\n 'Patients who have received betibeglogene autotemcel are likely to test positive by polymerase chain reaction (PCR) assays for HIV due to integrated BB305 LVV proviral DNA, resulting in a false-positive test for HIV; patients who have received betibeglogene autotemcel should not be screened for HIV infection using a PCR-based assay.\\n\\n',\n nan,\n nan,\n \"Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution); false- negative may occur with ferricyanide test. Glucose oxidase or hexokinase-based methods should be used.\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n 'Specific handling procedures must be followed to prevent the degradation of uric acid in plasma samples. Blood must be collected in prechilled tubes containing heparin anticoagulant. Samples must then be immediately immersed and maintained in an ice water bath. Prepare samples by centrifugation in a precooled centrifuge (4°C). Samples must be analyzed within 4 hours of collection.\\n\\n',\n nan,\n nan,\n 'Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'May falsely increase urinary metanephrine values when fluorimetric or photometric methods are used; does not interact with HPLC assay with solid phase extraction for determination of urinary catecholamines; may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\\n\\n',\n 'Omeprazole may falsely elevate serum chromogranin A (CgA) levels. The increased CgA level may cause false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat test if CgA level is initially elevated; use the same laboratory for all testing of CgA levels.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'Interference with serological testing (indirect antiglobulin test): Isatuximab binds to CD38 on RBCs, which may result in a false-positive indirect antiglobulin test (indirect Coombs test), antibody detection (screening) tests, antibody identification panels, and antihuman globulin crossmatches in patients treated with isatuximab. Conduct blood type and screening prior to the first isatuximab infusion; consider phenotyping prior to initiating treatment. If isatuximab treatment has already been initiated, inform the blood bank that the patient is receiving isatuximab and isatuximab interference with blood compatibility testing can be resolved using dithiothreitol-treated RBCs. If an emergency transfusion is required, non–cross-matched ABO/RhD-compatible RBCs can be given per local blood bank practices.\\n\\nSerum protein electrophoresis and immunofixation tests: Isatuximab is an IgG kappa monoclonal antibody that may be incidentally detected by serum protein electrophoresis and immunofixation assays used for endogenous M-protein monitoring and may interfere with the accuracy of determining complete response in some patients with IgG kappa myeloma protein.\\n\\n',\n nan,\n \"Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n 'Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\\n\\n',\n nan,\n nan,\n 'May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May cause transient changes in serum iron, copper, or zinc. May interfere with colorimetric tests for serum calcium (apparent decrease); accurate values can be obtained approximately 90 minutes after injection.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'TIBC may be falsely elevated with high serum iron concentrations or deferoxamine therapy. Imaging results may be distorted due to rapid urinary excretion of deferoxamine-bound gallium-67; discontinue deferoxamine 48 hours prior to scintigraphy.\\n\\n',\n \"Positive Coombs' [direct]\\n\\n\",\n nan,\n nan,\n nan,\n nan,\n nan,\n 'May interfere with AST, ALT, triglycerides, glucose, and LDH testing\\n\\n',\n nan,\n nan,\n nan,\n '\\n\\nSome quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\\n\\n',\n nan,\n 'Daptomycin may cause false prolongation of the PT and increase of INR with certain recombinant thromboplastin reagents. This appears to be a dose-dependent phenomenon. If PT/INR is elevated, repeat PT/INR immediately prior to next daptomycin dose (eg, trough). If PT/INR remains elevated, repeat PT/INR using alternate reagents (if available) and evaluate for other causes of elevated PT/INR.\\n\\n',\n 'Specific whole blood assay for cyclosporine may be falsely elevated if sample is drawn from the same central venous line through which dose was administered (even if flush has been administered and/or dose was given hours before); cyclosporine metabolites cross-react with radioimmunoassay and fluorescence polarization immunoassay\\n\\n',\n nan,\n 'Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\\n\\n\\n\\nPassively transferred antibodies may yield false-positive serologic testing results; may yield false-positive direct and indirect Coombs’ test.\\n\\n',\n nan,\n 'Falsely high plasma phenytoin concentrations (due to cross-reactivity with fosphenytoin) when measured by immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000) prior to complete conversion of fosphenytoin to phenytoin. Phenytoin may produce falsely low results for dexamethasone or metyrapone tests. Phenytoin has the potential to lower serum folate levels.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n 'See individual agents.\\n\\n',\n nan,\n nan,\n nan,\n nan,\n 'May interfere with urine detection of phencyclidine (false-positives) (Marchei 2007). May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016).\\n\\n',\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan,\n nan]"
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_interactions = list(test_interactions_df['Test Interactions'].values[:])\n",
    "test_interactions"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-02T15:25:23.604630700Z",
     "start_time": "2023-05-02T15:25:23.557782800Z"
    }
   }
  },
  {
   "cell_type": "markdown",
   "source": [
    "## Test recognition - And possible result and outcome grasp"
   ],
   "metadata": {
    "collapsed": false
   }
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Positive direct antiglobulin (Coombs) test; false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution), falsely elevated serum or urine creatinine with Jaffé reaction assay.\n",
      "\n",
      "\n",
      "May suppress the wheal and flare reactions to skin test antigens\n",
      "\n",
      "\n",
      "Increased creatinine ( Jaffé alkaline picrate reaction); increased serum methotrexate by dihydrofolate reductase method\n",
      "\n",
      "\n",
      "Omeprazole may falsely elevate serum chromogranin A (CgA) levels due to decreased gastric acidity; may cause false-positive results in the diagnosis of a neuroendocrine tumor. Assess CgA levels at ≥14 days after treatment is completed; repeat level if initially elevated.\n",
      "\n",
      "\n",
      "Crizanlizumab may interfere with automated platelet counts (platelet clumping), particularly when blood samples are collected in tubes containing ethylenediaminetetraacetic acid (EDTA); platelet count may be unevaluable or falsely decreased. Management: Collect blood samples in citrate-containing tubes, and run blood samples within 4 hours of sample collection. If necessary, estimate platelet count through peripheral blood smear.\n",
      "\n",
      "\n",
      "IV formulation: Due to propylene glycol content, triglyceride assays dependent on glycerol oxidase may be falsely elevated.\n",
      "\n",
      "\n",
      "HbA1c: Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\n",
      "\n",
      "\n",
      "Concurrent caffeine or theophylline use may demonstrate a false-negative result with dipyridamole-thallium myocardial imaging.\n",
      "\n",
      "\n",
      "May result in false positive results with some commercial HIV nucleic acid tests.\n",
      "\n",
      "\n",
      "Interferes with urinary glucose determination using Clinitest®; positive Coombs' [direct]\n",
      "\n",
      "\n",
      "Positive Coombs' [direct]\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution); false- negative may occur with ferricyanide test. Glucose oxidase or hexokinase-based methods should be used.\n",
      "\n",
      "\n",
      "May cause transient increase in serum ferritin, urine zinc (with renal disease), or bilirubin (with hepatic metabolic disorders)\n",
      "\n",
      "\n",
      "May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "May interfere with urine detection of methadone and phencyclidine (false-positives); may cause false-positive serum TCA screen; may suppress the wheal and flare reactions to skin test antigens\n",
      "\n",
      "\n",
      "May suppress the wheal and flare reactions to skin test antigens\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Serum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric gluconate administration. Serum ferritin levels may be falsely elevated for 5 days after ferric gluconate administration.\n",
      "\n",
      "\n",
      "May interfere with urine detection of methadone and phencyclidine (false-positives); may cause false-positive serum TCA screen; may suppress the wheal and flare reactions to skin test antigens\n",
      "\n",
      "\n",
      "May alter results of thyroid function tests that are dependent on iodine estimation and may affect results of radioiodine uptake studies; perform these studies prior to diagnostic tests with iodinated contrast media.\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\n",
      "\n",
      "\n",
      "May interfere with urine detection of phencyclidine (false-positive).\n",
      "\n",
      "\n",
      "Interferes with urinary glucose determination using Clinitest®; positive Coombs' [direct]\n",
      "\n",
      "\n",
      "Contains blood group isohemagglutinins; passive transmission of antibodies to erythrocyte antigens may interfere with serological tests for red cell antibodies (eg, Coombs test).\n",
      "\n",
      "\n",
      "Serum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric gluconate administration. Serum ferritin levels may be falsely elevated for 5 days after ferric gluconate administration.\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution); false- negative may occur with ferricyanide test. Glucose oxidase or hexokinase-based methods should be used.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "False-negative urinary glucose determinations when using Clinistix® or Diastix®\n",
      "\n",
      "\n",
      "The following values may be affected, in vitro, following hydroxocobalamin 5 g dose. Interference following hydroxocobalamin 10 g dose can be expected to last up to an additional 24 hours. Note: Extent and duration of interference dependent on analyzer used and patient variability (Shapeton 2019).\n",
      "\n",
      "Falsely elevated:\n",
      "\n",
      "Basophils, hemoglobin, MCH, and MCHC [duration: 12-16 hours]\n",
      "\n",
      "Albumin, alkaline phosphatase, cholesterol, creatinine, glucose, total protein, and triglycerides [duration: 24 hours] Bilirubin [duration: up to 4 days]\n",
      "\n",
      "Urinalysis: Glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite [duration: 2-8 days]\n",
      "\n",
      "Falsely decreased: ALT and amylase [duration: 24 hours]\n",
      "\n",
      "Unpredictable:\n",
      "\n",
      "AST, CK, CKMB, LDH, phosphate, and uric acid [duration: 24 hours] PT (quick or INR) and aPTT [duration: 24-48 hours]\n",
      "\n",
      "Urine pH [duration: 2-8 days]\n",
      "\n",
      "\n",
      "\n",
      "May also turn both the plasma and urine a pinkish color and interfere with colorimetric or spectrophotometric tests (Wong 2016); may cause hemodialysis machines to shut down due to false detection of a blood leak from the blood-like appearance of the solution.\n",
      "\n",
      "\n",
      "Blood glucose: Administration may result in falsely elevated blood glucose concentrations due to the presence of maltose in the botulism antitoxin, specifically when blood glucose is measured using glucose dehydrogenase pyrroloquinoline-quinone (GDH-PQQ) method.\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction, false-positive urinary proteins and steroids\n",
      "\n",
      "\n",
      "Serum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration.\n",
      "\n",
      "\n",
      "Positive Coombs.\n",
      "\n",
      "\n",
      "HbA1c: Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\n",
      "\n",
      "\n",
      "T4-binding globulin (TBG): Factors that alter binding in serum (ATA/AACE [Garber 2012]):\n",
      "\n",
      "Note: T4 is ~99.97% protein bound. Factors that alter protein binding will affect serum total T4 levels; however, measurement of serum free T4 (the metabolically active moiety) has largely replaced serum total T4 for thyroid status assessment.\n",
      "\n",
      "Conditions/states that increase TBG binding: Pregnancy, hepatitis, porphyria, neonatal state\n",
      "\n",
      "Medications that increase TBG binding: Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\n",
      "\n",
      "Conditions/states that decrease TBG binding: Hepatic failure, nephrosis, severe illness.\n",
      "\n",
      "Medications that decrease TBG binding: Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\n",
      "\n",
      "Thyroxine (T4) and triiodothyronine (T3): Serum binding inhibitors (ATA/AACE [Garber 2012]):\n",
      "\n",
      "Medications that inhibit T4 and T3 binding: Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\n",
      "\n",
      "Thyroid gland hormone: Interference with production and secretion (ATA/AACE [Garber 2012]): Medications affecting iodine uptake: Amiodarone, iodinated contrast agents, iodine, ethionamide\n",
      "\n",
      "Medications affecting hormone production: Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil),\n",
      "\n",
      "Medications affecting secretion: Amiodarone, iodinated contrast agents, iodine, lithium\n",
      "\n",
      "Medications inducing thyroiditis: Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\n",
      "\n",
      "Medications potentially causing the development of Graves’: Alemtuzumab, interferon alpha, antiretroviral therapy Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’: Glucocorticoids\n",
      "\n",
      "Hypothalamic-pituitary axis and TSH: Interference with secretion (ATA/AACE [Garber 2012]):\n",
      "\n",
      "Medications decreasing TSH secretion: Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\n",
      "\n",
      "Medications increasing TSH secretion: Amphetamine, interleukin 2, metoclopramide, ritonavir, St John's wort Medications potentially causing hypophysitis: Ipilimumab\n",
      "\n",
      "\n",
      "Iodine-binding capacity of thyroid tissue may be reduced for up to 2 weeks following administration of contrast media; diagnostic tests using iodine-containing isotopes may be affected. Thyroid function tests that are independent of iodine estimation for results are not affected (eg, T3 resin uptake, thyroxine assays).\n",
      "\n",
      "\n",
      "May interfere with urine detection of amphetamines/methamphetamines (false-positive).\n",
      "\n",
      "\n",
      "May interfere with tests for parathyroid function; may lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "T4-binding globulin (TBG): Factors that alter binding in serum (ATA/AACE [Garber 2012]):\n",
      "\n",
      "Note: T4 is ~99.97% protein bound. Factors that alter protein binding will affect serum total T4 levels; however, measurement of serum free T4 (the metabolically active moiety) has largely replaced serum total T4 for thyroid status assessment.\n",
      "\n",
      "Conditions/states that increase TBG binding: Pregnancy, hepatitis, porphyria, neonatal state\n",
      "\n",
      "Medications that increase TBG binding: Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\n",
      "\n",
      "Conditions/states that decrease TBG binding: Hepatic failure, nephrosis, severe illness\n",
      "\n",
      "Medications that decrease TBG binding: Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\n",
      "\n",
      "Thyroxine (T4) and Triiodothyronine (T3): Serum binding inhibitors (ATA/AACE [Garber 2012]):\n",
      "\n",
      "Medications that inhibit T4 and T3 binding: Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\n",
      "\n",
      "Thyroid gland hormone: Interference with production and secretion (ATA/AACE [Garber 2012]): Medications affecting iodine uptake: Amiodarone, iodinated contrast agents, iodine, ethionamide\n",
      "\n",
      "Medications affecting hormone production: Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\n",
      "\n",
      "Medications affecting secretion: Amiodarone, iodinated contrast agents, iodine, lithium\n",
      "\n",
      "\n",
      "\n",
      "Medications inducing thyroiditis: Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\n",
      "\n",
      "Medications potentially causing the development of Graves’: Alemtuzumab, interferon alpha, antiretroviral therapy Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’: Glucocorticoids\n",
      "\n",
      "Hypothalamic-pituitary axis and TSH: Interference with secretion (ATA/AACE [Garber 2012]):\n",
      "\n",
      "Medications decreasing TSH secretion: Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\n",
      "\n",
      "Medications increasing TSH secretion: Amphetamine, interleukin 2, metoclopramide, ritonavir, St John's wort Medications potentially causing hypophysitis: Ipilimumab\n",
      "\n",
      "\n",
      "Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\n",
      "\n",
      "\n",
      "False-negative stool occult blood 48 to 72 hours after ascorbic acid ingestion.\n",
      "\n",
      "Ascorbic acid may interfere with laboratory tests based on oxidation-reduction reactions (eg, blood and urine glucose testing, nitrite and bilirubin levels, leucocyte count). High-dose ascorbic acid has been associated with falsely-elevated glucose measurements by point of care glucometers. Use of plasma laboratory assays or an FDA-approved device that corrects for interferences are recommended (Hager 2019; Tran 2014; Vasudevan 2014). Alternatively, laboratory tests based on oxidation-reduction reactions should be delayed until 24 hours after dose.\n",
      "\n",
      "\n",
      "Interferes with gastric secretion test. Transdermal system should be discontinued ≥10 days prior to testing.\n",
      "\n",
      "\n",
      "May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Fehling’s solution, or Clinitest®).\n",
      "\n",
      "\n",
      "\n",
      "Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\n",
      "\n",
      "\n",
      "Serum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration.\n",
      "\n",
      "\n",
      "Phenothiazines may cause false-positive or negative pregnancy tests.\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "May interfere with urine detection of methadone (false-positive) (Lichtenwalner 1998).\n",
      "\n",
      "\n",
      "False-positive Coombs' test [direct]\n",
      "\n",
      "\n",
      "Methyldopa interferes with the following laboratory tests: urinary uric acid (phosphotungstate method), serum creatinine (alkaline picrate method), AST (colorimetric method), and urinary catecholamines (falsely high levels)\n",
      "\n",
      "May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Plasma glucose, uric acid, free fatty acids, total cholesterol, HDL, HDL/LDL ratio, and urinary free cortisol excretion may be increased by theophylline. Theophylline may decrease triiodothyronine.\n",
      "\n",
      "\n",
      "Altered results of coagulation and fibrinolytic activity tests\n",
      "\n",
      "\n",
      "May suppress the wheal and flare reactions to skin test antigens\n",
      "\n",
      "\n",
      "Ceftazidime: Positive direct Coomb. False-positive reaction for urine glucose with certain methods; use glucose tests based on enzymatic glucose oxidase reactions.\n",
      "\n",
      "\n",
      "Transitory changes in serum iron have been observed. May interfere with colorimetric tests for serum calcium (apparent decrease); alternate testing method is recommended for 12-24 hours after administration.\n",
      "\n",
      "\n",
      "False-positive urinary catecholamines (fluorometric assay), 17-hydroxycorticosteroids and 17-ketosteroids\n",
      "\n",
      "\n",
      "May cause false-positive serum TCA screen. May suppress the wheal and flare reactions to skin test antigens.\n",
      "\n",
      "\n",
      "Positive Coombs' test; may lead to false-positive aldosterone/renin ratio (Funder 2016)\n",
      "\n",
      "\n",
      "May interfere with MR imaging; alterations may persist for ≤3 months following use, with peak alterations anticipated in the first 2 days following administration. If MR imaging is required within 3 months after administration, use T1- or proton density-weighted MR pulse sequences to decrease effect on imaging. Do not use T2-weighted sequence MR imaging prior to 4 weeks following administration.\n",
      "\n",
      "\n",
      "\n",
      "Serum iron and transferrin-bound iron may be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\n",
      "\n",
      "\n",
      "Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\n",
      "\n",
      "\n",
      "\n",
      "Passively transferred antibodies may yield false-positive serologic testing results; may yield false-positive direct and indirect Coombs’ test.\n",
      "\n",
      "\n",
      "Omeprazole may falsely elevate serum chromogranin A (CgA) levels. The increased CgA level may cause false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\n",
      "\n",
      "\n",
      "May interfere with detection of urine protein (false positive) when pyrogallol red reagent is used. Use a laboratory test that does not contain pyrogallol red reagent or use urine free of casimersen (eg, urine obtained prior to infusion or ≥48 hours after infusion).\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Increased amylase (S), increased BSP retention, increased CPK (IM injections)\n",
      "\n",
      "\n",
      "May interfere with the serum progesterone assay; interaction may be observed for up to 30 minutes after a 16 mg/kg dose of sugammadex.\n",
      "\n",
      "\n",
      "May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "May cause false positive results for blood ethylene glycol concentrations. High mannitol concentrations may cause false low results for inorganic phosphorus blood concentrations if assay based on the conversion of phosphate (orthophosphate) to the phosphomolybdate complex is used.\n",
      "\n",
      "\n",
      "Interferes with gastric secretion test. Transdermal system should be discontinued ≥10 days prior to testing.\n",
      "\n",
      "\n",
      "May interfere with bone imaging studies; increased hematopoietic activity of the bone marrow may appear as transient positive bone imaging changes.\n",
      "\n",
      "\n",
      "May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "May interfere with urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest); positive Coombs' test\n",
      "\n",
      "\n",
      "Increased glucose; decreased HDL; may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "Positive direct and indirect Coombs', false-positive urinary glucose test using glucose tests based on Benedict's copper reduction reaction, false- positive serum or urine creatinine with Jaffé reaction.\n",
      "\n",
      "\n",
      "\n",
      "Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "May interfere with urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest); positive Coombs' test\n",
      "\n",
      "\n",
      "May interfere with urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest); positive Coombs' test\n",
      "\n",
      "\n",
      "May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "Altered results of coagulation and fibrinolytic activity tests\n",
      "\n",
      "\n",
      "May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Digoxin immune fab may interfere with digitalis immunoassay measurements, thereby resulting in clinically misleading total serum digoxin concentrations until all Fab fragments are eliminated from the body (may take several days to >1 week after administration). Digoxin serum samples should be obtained before digoxin immune fab administration, if possible.\n",
      "\n",
      "\n",
      "May interfere with urine detection of phencyclidine (false-positive).\n",
      "\n",
      "\n",
      "May suppress the wheal and flare reactions to skin test antigens\n",
      "\n",
      "\n",
      "Acetaminophen may cause false-positive urinary 5-hydroxyindoleacetic acid.\n",
      "\n",
      "\n",
      "May interfere with certain enzymatic methods used to detect opioids, depending on sensitivity and specificity of the test (refer to test manufacturer for details)\n",
      "\n",
      "\n",
      "May decrease response to skin tests\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Ascorbic acid in the urine can cause false-negative urine glucose determinations.\n",
      "\n",
      "Biotin can significantly interfere with certain lab tests and cause incorrect test results that may go undetected, possibly leading to inappropriate patient management or misdiagnosis (FDA Safety Communication 2017).\n",
      "\n",
      "\n",
      "PT/INR, when measuring coumarin derivative activity, is not reliable within 5 hours following danaparoid administration.\n",
      "\n",
      "\n",
      "May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "Methotrexate, pyrimethamine, and most antibiotics invalidate folic acid and vitamin B12 diagnostic blood assays\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Urine specimen assay: Contrast agent instillation into the bladder may interfere with urine specimen assay; collect urine prior to or at least 2 days after contrast administration.\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\n",
      "\n",
      "\n",
      "Rapid plasma reagin (RPR) test: Smallpox vaccine may induce false-positive RPR test for syphilis; confirm positive RPR test using a more specific test (eg, FTA assay).\n",
      "\n",
      "\n",
      "\n",
      "Tuberculin skin (PPD) and blood tests: Smallpox vaccine may diminish the diagnostic utility of tuberculin skin (PPD) and blood tests; avoid skin test for ≥1 month after vaccine to prevent false-negative results.\n",
      "\n",
      "\n",
      "Bisphosphonates may interfere with diagnostic imaging agents such as technetium-99m-diphosphonate in bone scans. Some studies suggest that clodronate may not interfere with radiopharmaceutical bone imaging (Pecherstorfer 1993).\n",
      "\n",
      "\n",
      "Falsely low serum concentrations may occur with the Lactobacillus casei assay method in patients on anti-infectives (eg, tetracycline)\n",
      "\n",
      "\n",
      "May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®); may inactivate aminoglycosides in vitro; false- positive urinary and serum proteins\n",
      "\n",
      "\n",
      "Positive direct Coombs'. False-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution); use test based on enzymatic glucose oxidase. May cause false-positive serum or urine creatinine with Jaffé reaction\n",
      "\n",
      "\n",
      "May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "The use of estrogens and/or progestogens may alter the results of some laboratory tests (eg, coagulation factors, lipids, glucose tolerance, thyroxine-binding globulin, sex hormone–binding globulin, cortisol-binding globulin).\n",
      "\n",
      "\n",
      "Bisphosphonates may interfere with diagnostic imaging agents such as technetium-99m-diphosphonate in bone scans.\n",
      "\n",
      "\n",
      "False-positive Coombs' test [direct]\n",
      "\n",
      "\n",
      "False-negative dexamethasone suppression test; may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "False-positives for phenylketonuria, amylase, uroporphyrins, urobilinogen. May cause false-positive pregnancy test. May interfere with urine detection of amphetamine/methamphetamine and methadone (false-positives).\n",
      "\n",
      "\n",
      "May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®)\n",
      "\n",
      "\n",
      "\n",
      "Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\n",
      "\n",
      "\n",
      "Flucytosine causes markedly false elevations in serum creatinine values when the Ektachem® analyzer is used. The Jaffé reaction is recommended for determining serum creatinine.\n",
      "\n",
      "\n",
      "HbA1c: Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Decreased response to skin tests\n",
      "\n",
      "\n",
      "May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest); may inactivate aminoglycosides in vitro; false- positive urine and serum proteins; false-positive in uric acid, urinary steroids\n",
      "\n",
      "\n",
      "TPMT phenotyping results may not be accurate following recent blood transfusions.\n",
      "\n",
      "\n",
      "Serum renin concentrations and IgG concentrations may be increased. Serum cortisol concentrations may be decreased. May cause a false- negative insulin response to glucagon.\n",
      "\n",
      "\n",
      "May cause interference with fluorescence test for urinary catecholamines (false elevations).\n",
      "\n",
      "\n",
      "Refer to individual agents.\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Thyroid function tests (protein bound and radioactive iodine uptake studies) may be inaccurate for up to 16 days after administration; may cause false positive urine protein test using Multistix; may affect urine specific gravity\n",
      "\n",
      "\n",
      "Argatroban may elevate PT/INR levels in the absence of warfarin. If warfarin is started, initial PT/INR goals while on argatroban may require modification. The American College of Chest Physicians suggests monitoring chromogenic factor X assay when transitioning from argatroban to warfarin (Garcia, 2012) or overlapping administration of warfarin for a minimum of 5 days until INR is within target range; recheck INR after anticoagulant effect of argatroban has dissipated (Guyatt, 2012). Factor Xa levels <45% have been associated with INR values >2 after the effects of argatroban have been eliminated (Arpino, 2005).\n",
      "\n",
      "\n",
      "Patients who have received betibeglogene autotemcel are likely to test positive by polymerase chain reaction (PCR) assays for HIV due to integrated BB305 LVV proviral DNA, resulting in a false-positive test for HIV; patients who have received betibeglogene autotemcel should not be screened for HIV infection using a PCR-based assay.\n",
      "\n",
      "\n",
      "IV administration may produce falsely decreased serum and urine magnesium concentrations\n",
      "\n",
      "\n",
      "Positive Coombs' test, false-positive urinary proteins\n",
      "\n",
      "Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\n",
      "\n",
      "\n",
      "Reduced response to metyrapone test.\n",
      "\n",
      "\n",
      "When the anti-FXa activity assay is performed after administration of andexanet alfa, the FXa inhibitor may dissociate from andexanet alfa, resulting in falsely elevated anti-FXa activity, causing a substantial underestimation of the reversal activity.\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using nonenzymatic methods, false-positive galactosemia tests.\n",
      "\n",
      "\n",
      "Can cause a false-positive amphetamine EMIT assay\n",
      "\n",
      "\n",
      "Iodide may alter thyroid function tests.\n",
      "\n",
      "\n",
      "Plasma glucose, uric acid, free fatty acids, total cholesterol, HDL, HDL/LDL ratio, and urinary free cortisol excretion may be increased by theophylline. Theophylline may decrease triiodothyronine.\n",
      "\n",
      "\n",
      "May interfere with urine detection of phencyclidine (false-positive) (Hull 2006).\n",
      "\n",
      "\n",
      "Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\n",
      "\n",
      "\n",
      "\n",
      "Passively transferred antibodies may yield false-positive serologic testing results; may yield false-positive direct and indirect Coombs’ test.\n",
      "\n",
      "\n",
      "May interfere with AST, ALT, triglycerides, glucose, and LDH testing\n",
      "\n",
      "\n",
      "May suppress the wheal and flare reactions to skin test antigens\n",
      "\n",
      "\n",
      "Spironolactone may interfere with digoxin radioimmunoassay.\n",
      "\n",
      "\n",
      "Methotrexate levels: For up to 48 hours following glucarpidase administration, the preferred method of measuring methotrexate concentrations is the chromatographic method. DAMPA, an inactive methotrexate metabolite with a half-life of ~9 hours, interferes with immunoassays and may result in the overestimation of the methotrexate concentration.\n",
      "\n",
      "\n",
      "False-positive urine catecholamines, metanephrine, normetanephrine, and vanillylmandelic acid (VMA) if measured by fluorometric or photometric methods (high performance liquid chromatographic [HPLC] assay with solid phase extraction should be used to determine levels of catecholamines); false-positive urine amphetamine if measured by thin-layer chromatography or radioenzymatic assay (gas chromatographic-mass spectrometer technique should be used); may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "Interferes with urinary glucose determination using Clinitest®; positive Coombs' [direct]\n",
      "\n",
      "\n",
      "May interfere with urine detection of phencyclidine (false-positives) (Marchei 2007). May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "Iodine-binding capacity of thyroid tissue may be reduced for up to 2 weeks following administration of contrast media; diagnostic tests using iodine-containing isotopes may be affected. Thyroid function tests that are independent of iodine estimation for results are not affected (eg, T3 resin uptake, thyroxine assays).\n",
      "\n",
      "\n",
      "Increased renin (S), increased aldosterone (S)\n",
      "\n",
      "\n",
      "Patients who have received elivaldogene autotemcel are likely to test positive by polymerase chain reaction (PCR) assays for HIV due to lentiviral vector proviral DNA, resulting in a false-positive test for HIV; patients who have received elivaldogene autotemcel should not be screened for HIV infection using a PCR-based assay.\n",
      "\n",
      "\n",
      "Daptomycin may cause false prolongation of the PT and increase of INR with certain recombinant thromboplastin reagents. This appears to be a dose-dependent phenomenon. If PT/INR is elevated, repeat PT/INR immediately prior to next daptomycin dose (eg, trough). If PT/INR remains elevated, repeat PT/INR using alternate reagents (if available) and evaluate for other causes of elevated PT/INR.\n",
      "\n",
      "\n",
      "Plasma glucose, uric acid, free fatty acids, total cholesterol, HDL, HDL/LDL ratio, and urinary free cortisol excretion may be increased by theophylline. Theophylline may decrease triiodothyronine.\n",
      "\n",
      "\n",
      "Can cause a false-positive amphetamine EMIT assay\n",
      "\n",
      "\n",
      "Positive Coombs.\n",
      "\n",
      "\n",
      "Positive Coombs' test (direct), false-positive urinary and serum proteins; may inactivate aminoglycosides in vitro\n",
      "\n",
      "\n",
      "False-negative stool occult blood 48 to 72 hours after ascorbic acid ingestion.\n",
      "\n",
      "Ascorbic acid may interfere with laboratory tests based on oxidation-reduction reactions (eg, blood and urine glucose testing, nitrite and bilirubin levels, leucocyte count). High-dose ascorbic acid has been associated with falsely-elevated glucose measurements by point of care glucometers. Use of plasma laboratory assays or an FDA-approved device that corrects for interferences are recommended (Hager 2019; Tran 2014; Vasudevan 2014). Alternatively, laboratory tests based on oxidation-reduction reactions should be delayed until 24 hours after dose.\n",
      "\n",
      "\n",
      "When using an in vitro activated partial thromboplastin time (aPTT)–based one-stage clotting assay (OSA) for determining factor IX activity, results can be affected both by the type of aPTT reagent and the reference standard used in the assay. The same assay and reagents are recommended to be used when monitoring factor IX activity over time if feasible (the use of different assays or reagents may affect test results). Factor IX activity test results are lower if measured with chromogenic substrate assay (CSA) compared to OSA. In a clinical study, post-dose factor IX activity showed the mean CSA to OSA factor IX activity ratio ranging from 0.41 to 0.55.\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Interferes with urinary glucose determination using Clinitest®; positive Coombs' [direct]\n",
      "\n",
      "\n",
      "Elotuzumab may be detected on both serum protein electrophoresis (SPEP) and serum immunofixation assays used for multiple myeloma endogenous M-protein monitoring, and may affect the determination of complete response and disease progression of some patients with IgG kappa myeloma protein. A small peak in the early gamma region on SPEP that is IgG kappa on serum immunofixation may potentially be attributed to elotuzumab (especially when endogenous myeloma protein is IgA, IgM, IgD, or lambda light chain restricted).\n",
      "\n",
      "\n",
      "Falsely high or low values of serum iron (if determined by complexometric methods) may occur for up to 24 hours following administration.\n",
      "\n",
      "\n",
      "Acetaminophen may cause false-positive urinary 5-hydroxyindoleacetic acid. Ibuprofen may interfere with urine detection of phencyclidine (false-positives) (Marchei 2007), and may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered. False-positive urine methadone screens have been reported in patients taking medications, including diphenhydramine, doxylamine, clomipramine, chlorpromazine, thioridazine, quetiapine, and verapamil.\n",
      "\n",
      "\n",
      "Potential interference with rabbit antibody-based immunoassays and with cross-match or panel-reactive antibody cytotoxicity assays. Has not been shown to interfere with routine clinical laboratory tests which do not use immunoglobulins.\n",
      "\n",
      "\n",
      "Refer to individual agents.\n",
      "\n",
      "\n",
      "May interfere with detection of urine protein (false positive) when pyrogallol red reagent is used. Use a laboratory test that does not contain pyrogallol red reagent or use urine free of viltolarsen (eg, urine obtained prior to infusion or ≥48 hours after infusion).\n",
      "\n",
      "\n",
      "Falsely-elevated serum phosphate may occur when using the PHOSm assay.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "False-positive for uric acid using the phosphotungstate method and for urobilinogen using the Ehrlich's reagent; large doses may interfere with the spectrophotometric determination of serum theophylline concentration\n",
      "\n",
      "\n",
      "May cause false-positive results for urinary protein with Albustix®, Labstix®, Albutest®, Bumintest®; interferes with HPLC theophylline assay and serum uric acid levels; may lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "May interfere with diagnostic serum tests that utilize antibodies.\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Passively transferred antibodies may yield false-positive serologic testing results; may yield false-positive direct and indirect Coombs test.\n",
      "\n",
      "\n",
      "Abatacept for IV infusion contains maltose; may result in falsely elevated blood glucose levels with dehydrogenase pyrroloquinolinequinone or glucose-dye-oxidoreductase testing methods on the day of infusion. Glucose monitoring methods which utilize glucose dehydrogenase nicotine adenine dinucleotide (GDH-NAD), glucose oxidase, or glucose hexokinase are recommended.\n",
      "\n",
      "\n",
      "Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\n",
      "\n",
      "\n",
      "May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "False-positive or negative urinary glucose determination using Clinitest®; positive Coombs' [direct]; false-positive urinary and/or serum proteins by certain test methods\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Daratumumab binds to CD38 on red blood cells; daratumumab-based therapy may result in a positive indirect antiglobulin test (indirect Coombs test). Daratumumab-mediated Coombs test positivity may persist for up to 6 months after the last dose. In addition, daratumumab (bound to red blood cells) masks antibody detection to minor antigens in the patient's serum; ABO and Rh blood type determination are not affected. Notify blood transfusion centers and blood banks that a patient has received daratumumab/hyaluronidase. Type and screen patients prior to treatment initiation.\n",
      "\n",
      "Daratumumab (a human IgG kappa monoclonal antibody) may be detected on serum protein electrophoresis and immunofixation assays that monitor for endogenous M-protein. Interference with these assays by daratumumab-based therapy may affect the determination of complete response and disease progression in some patients with IgG kappa myeloma protein.\n",
      "\n",
      "\n",
      "Interferes with gastric secretion test. Transdermal system should be discontinued ≥10 days prior to testing.\n",
      "\n",
      "\n",
      "T4-binding globulin (TBG): Factors that alter binding in serum (ATA/AACE [Garber 2012]):\n",
      "\n",
      "Note: T4 is ~99.97% protein bound. Factors that alter protein binding will affect serum total T4 levels; however, measurement of serum free T4 (the metabolically active moiety) has largely replaced serum total T4 for thyroid status assessment.\n",
      "\n",
      "Conditions/states that increase TBG binding: Pregnancy, hepatitis, porphyria, neonatal state\n",
      "\n",
      "Medications that increase TBG binding: Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\n",
      "\n",
      "Conditions/states that decrease TBG binding: Hepatic failure, nephrosis, severe illness\n",
      "\n",
      "Medications that decrease TBG binding: Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\n",
      "\n",
      "Thyroxine (T4) and Triiodothyronine (T3): Serum binding inhibitors (ATA/AACE [Garber 2012]):\n",
      "\n",
      "Medications that inhibit T4 and T3 binding: Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\n",
      "\n",
      "Thyroid gland hormone: Interference with production and secretion (ATA/AACE [Garber 2012]): Medications affecting iodine uptake: Amiodarone, iodinated contrast agents, iodine, ethionamide\n",
      "\n",
      "\n",
      "\n",
      "Medications affecting hormone production: Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\n",
      "\n",
      "Medications affecting secretion: Amiodarone, iodinated contrast agents, iodine, lithium\n",
      "\n",
      "Medications inducing thyroiditis: Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\n",
      "\n",
      "Medications potentially causing the development of Graves’: Alemtuzumab, interferon alpha, antiretroviral therapy Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’: Glucocorticoids\n",
      "\n",
      "Hypothalamic-pituitary axis and TSH: Interference with secretion (ATA/AACE [Garber 2012]):\n",
      "\n",
      "Medications decreasing TSH secretion: Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\n",
      "\n",
      "Medications increasing TSH secretion: Amphetamine, interleukin 2, metoclopramide, ritonavir, St John's wort Medications potentially causing hypophysitis: Ipilimumab\n",
      "\n",
      "\n",
      "May cause a false-positive result for urine ketones (valproate partially eliminated as a keto-metabolite in the urine); may alter thyroid function tests\n",
      "\n",
      "\n",
      "May result in false-positive urine dipstick tests (eg, urine protein, ketones, occult blood).\n",
      "\n",
      "\n",
      "False-positives for phenylketonuria, pregnancy\n",
      "\n",
      "\n",
      "Potential interference with rabbit antibody-based immunoassays and with cross-match or panel-reactive antibody cytotoxicity assays. Has not been shown to interfere with routine clinical laboratory tests which do not use immunoglobulins.\n",
      "\n",
      "\n",
      "Positive Coombs'\n",
      "\n",
      "\n",
      "May cause false-positive serum TCA screen (Dasgupta 2007).\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "May interfere with the interpretation of any urine test that relies on a blue indicator (such as the dipstick for leucocyte esterase).\n",
      "\n",
      "\n",
      "Can cause a false-positive amphetamine EMIT assay\n",
      "\n",
      "\n",
      "Urinary ketones: False-positive tests for urinary ketones may occur in patients receiving mesna with the use of nitroprusside-based urine tests, including dipstick tests.\n",
      "\n",
      "CPK activity: Mesna may interfere with enzymatic creatine kinase (CPK) activity tests which use a thiol compound (eg, N-acetylcysteine) for CPK reactivation; may result in a falsely low CPK level.\n",
      "\n",
      "Ascorbic acid: Mesna may result in false-positive reactions in Tillman’s reagent-based urine screening tests for ascorbic acid.\n",
      "\n",
      "\n",
      "May interfere with urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution). Glucose tests based on enzymatic glucose oxidase reactions (eg, Clinistix) are recommended.\n",
      "\n",
      "Ampicillin may transiently interfere with plasma concentrations of total conjugated estriol, estriol-glucuronide, conjugated estrone and estradiol in pregnant women.\n",
      "\n",
      "\n",
      "Ocrelizumab interferes with the CD20 assay for B-cell counts; use the CD19+ assay to measure B-cell counts.\n",
      "\n",
      "\n",
      "In the presence of propranolol or suprapharmacologic concentrations of lidocaine or meprobamate, tests which depend on fluorescence to measure procainamide/N-acetyl procainamide concentrations may be affected.\n",
      "\n",
      "\n",
      "May cause falsely elevated values of serum bilirubin and falsely decreased values of serum calcium. Residual iron dextran may remain in reticuloendothelial cells; may affect accuracy of examination of bone marrow iron stores. Bone scans with 99m Tc-labeled bone seeking agents may show reduced bony uptake, marked renal activity, and excess blood pooling and soft tissue accumulation following IV iron dextran infusion or with high serum ferritin levels. Following IM iron dextran, bone scans with 99m Tc-diphosphonate may show dense activity in the buttocks.\n",
      "\n",
      "\n",
      "May interfere with urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest); positive Coombs' test\n",
      "\n",
      "\n",
      "Iodine-binding capacity of thyroid tissue may be reduced for up to 2 weeks following administration of contrast media; diagnostic tests using iodine-containing isotopes may be affected. Thyroid function tests that are independent of iodine estimation for results are not affected (eg, T3 resin uptake, thyroxine assays).\n",
      "\n",
      "\n",
      "PT/INR levels may become elevated in the absence of warfarin. If warfarin is initiated, initial PT/INR goals while on bivalirudin may require modification.\n",
      "\n",
      "\n",
      "May cause interference with fluorescence test for urinary catecholamines (false elevations)\n",
      "\n",
      "\n",
      "Artificially prolongs coagulation tests (binds to and prevents action of phospholipid reagents), including activated clotting time (ACT; ≤24 hours), aPTT (≤120 hours), prothrombin time (≤12 hours) and international normalized ratio (≤12 hours), silica clot time (SCT; ≤18 hours), dilute Russell's viper venom time (DRVVT; ≤72 hours), and D-dimer (≤72 hours). For patients requiring aPTT monitoring within 120 hours of a dose, consider a nonphospholipid-dependent coagulation test (eg, Factor Xa [chromogenic] assay) or an alternative anticoagulant not requiring aPTT monitoring. Positive indirect and direct antiglobulin tests have occurred in patients receiving oritavancin; positive indirect antiglobulin tests may interfere with cross-matching prior to blood transfusions.\n",
      "\n",
      "\n",
      "Acetaminophen may cause false-positive urinary 5-hydroxyindoleacetic acid. Ibuprofen may interfere with urine detection of phencyclidine (false-positives) (Marchei 2007), and may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "Moxetumomab pasudotox may interfere with detection of cellular CD22; CD19+ B cells may be used as a surrogate assay.\n",
      "\n",
      "\n",
      "Interferes with the following coagulation assessments when using samples drawn 18 hours or less after telavancin administration (causes artificially increased clotting times): PT, INR, aPTT, ACT, Xa (coagulation based assay). Collect blood samples for these coagulation tests as close as possible prior to administration of the next dose of telavancin, use a non-phospholipid dependent coagulation test (eg, bleeding time, factor Xa [chromogenic assay], platelet aggregation study, thrombin time), or select an alternative anticoagulant not requiring aPTT monitoring; concomitant use of telavancin and IV unfractionated heparin is contraindicated.\n",
      "\n",
      "Interferes with urine protein via qualitative dipstick and quantitative dye methods.\n",
      "\n",
      "\n",
      "May cause color interference in certain screening tests for 5-HIAA using nitrosonaphthol reagent and in screening tests for urinary VMA using the Gitlow method.\n",
      "\n",
      "\n",
      "May cause falsely elevated free thyrotropin and free triiodothyronine levels when assays involving prolonged incubation periods are used. Thyroid-stimulating hormone and standard competitive free thyroid hormone assays are not usually affected (Burch 2019).\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Bisphosphonates may interfere with diagnostic imaging agents such as technetium-99m-diphosphonate in bone scans.\n",
      "\n",
      "\n",
      "Positive direct and indirect Coombs', false-positive urinary glucose test using glucose tests based on Benedict's copper reduction reaction, false- positive serum or urine creatinine with Jaffé reaction.\n",
      "\n",
      "\n",
      "\n",
      "Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Esomeprazole may falsely elevate serum chromogranin A (CgA) levels. The increased CgA level may cause false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop esomeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\n",
      "\n",
      "\n",
      "May interfere with urinary glucose tests (Benedict's solution, Clinitest, Fehling's Solution).\n",
      "\n",
      "Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\n",
      "\n",
      "\n",
      "Bisphosphonates may interfere with diagnostic imaging agents such as technetium-99m-diphosphonate in bone scans.\n",
      "\n",
      "\n",
      "Falsely high plasma phenytoin concentrations may occur when measured by immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000). Phenytoin may produce falsely low results for serum concentrations of T4 and T3, and dexamethasone or metyrapone tests. Phenytoin may cause increased serum levels of thyroid-stimulating hormone (TSH; usually in the absence of clinical hypothyroidism).\n",
      "\n",
      "\n",
      "May interfere with urine detection of opioids (false-positive); positive Coombs' [direct]; false elevation of urinary steroids (when assayed by Zimmerman method) and catecholamines; qualitative and quantitative urine dipstick protein assays\n",
      "\n",
      "\n",
      "May interfere with urine detection of methadone and phencyclidine (false-positives); may cause false-positive serum TCA screen; may suppress the wheal and flare reactions to skin test antigens\n",
      "\n",
      "\n",
      "Ceftazidime: Positive direct Coomb. False-positive reaction for urine glucose with certain methods; use glucose tests based on enzymatic glucose oxidase reactions.\n",
      "\n",
      "\n",
      "Serum or transferrin bound iron levels may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration.\n",
      "\n",
      "\n",
      "If edetate CALCIUM disodium is given as a continuous IV infusion, stop the infusion for at least 1 hour before blood is drawn for lead concentration to avoid a falsely elevated value\n",
      "\n",
      "\n",
      "Neutralizing antibody assay: Obtain serum samples at least a month after the last dose to prevent assay interference.\n",
      "\n",
      "HbA1c: Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\n",
      "\n",
      "\n",
      "Increased PT is possible.\n",
      "\n",
      "Oral factor Xa inhibitors (apixaban, edoxaban, and rivaroxaban) may interfere with anti-factor Xa assays used for monitoring heparin anticoagulation, causing falsely elevated results and leading to inappropriate heparin dose reduction. Oral factor Xa inhibitors have little or minor effect on the aPTT. Consider using aPTT for heparin monitoring for at least 72 hours if there is concern for laboratory inference with the anti-factor Xa assay due to an oral factor Xa inhibitor (Conway 2017; Faust 2016; Levito 2020).\n",
      "\n",
      "May cause falsely elevated free T4 and free T3 levels when assays involving prolonged incubation periods are used. Thyroid stimulating hormone and standard competitive free thyroid hormone assays are not usually affected (Burch 2019).\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "aPTT (formulation contains heparin)\n",
      "\n",
      "\n",
      "Daratumumab binds to CD38 on RBCs and interferes with compatibility testing, including antibody screening and cross matching. Mitigation methods include treating reagent RBCs with dithiothreitol (DTT) to disrupt daratumumab binding or genotyping. As the Kell blood group system is also sensitive to DTT, supply K-negative units after ruling out or identifying alloantibodies using DTT-treated RBCs. If an emergency transfusion is required, administer non-cross-matched ABO/RhD-compatible RBCs per local blood bank practices.\n",
      "\n",
      "\n",
      "\n",
      "Daratumumab may be detected on both serum protein electrophoresis (SPE) and immunofixation (IFE) assays used for monitoring multiple myeloma monoclonal immunoglobulins (M-proteins); false positive SPE and IFE assay results may occur for patients with IgG kappa myeloma protein, and may affect initial assessment of complete response criteria. In patients with persistent very good partial response where daratumumab interference is suspected, consider using a daratumumab-specific IFE assay to distinguish daratumumab from any residual endogenous M protein to evaluate the depth of treatment response.\n",
      "\n",
      "\n",
      "PT/INR levels may become elevated in the absence of warfarin. If warfarin is initiated, initial PT/INR goals while on bivalirudin may require modification.\n",
      "\n",
      "\n",
      "Although amiodarone can cause true hypothyroidism or thyrotoxicosis, changes in thyroid function test results may occur in euthyroid patients. Amiodarone inhibits conversion from T4 to T3; the active metabolite also reduces circulating T3 levels. As a result, T4 levels may be elevated, thyroid stimulating hormone levels may be at the high end of normal range, and T3 levels may be at the low end of normal range (Burch 2019).\n",
      "\n",
      "\n",
      "Concurrent or recent use of spironolactone, hydrocortisone, cortisone, etomidate, estrogens\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\n",
      "\n",
      "\n",
      "Patients who have received betibeglogene autotemcel are likely to test positive by polymerase chain reaction (PCR) assays for HIV due to integrated BB305 LVV proviral DNA, resulting in a false-positive test for HIV; patients who have received betibeglogene autotemcel should not be screened for HIV infection using a PCR-based assay.\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution); false- negative may occur with ferricyanide test. Glucose oxidase or hexokinase-based methods should be used.\n",
      "\n",
      "\n",
      "Specific handling procedures must be followed to prevent the degradation of uric acid in plasma samples. Blood must be collected in prechilled tubes containing heparin anticoagulant. Samples must then be immediately immersed and maintained in an ice water bath. Prepare samples by centrifugation in a precooled centrifuge (4°C). Samples must be analyzed within 4 hours of collection.\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "May falsely increase urinary metanephrine values when fluorimetric or photometric methods are used; does not interact with HPLC assay with solid phase extraction for determination of urinary catecholamines; may lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016)\n",
      "\n",
      "\n",
      "Omeprazole may falsely elevate serum chromogranin A (CgA) levels. The increased CgA level may cause false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat test if CgA level is initially elevated; use the same laboratory for all testing of CgA levels.\n",
      "\n",
      "\n",
      "Interference with serological testing (indirect antiglobulin test): Isatuximab binds to CD38 on RBCs, which may result in a false-positive indirect antiglobulin test (indirect Coombs test), antibody detection (screening) tests, antibody identification panels, and antihuman globulin crossmatches in patients treated with isatuximab. Conduct blood type and screening prior to the first isatuximab infusion; consider phenotyping prior to initiating treatment. If isatuximab treatment has already been initiated, inform the blood bank that the patient is receiving isatuximab and isatuximab interference with blood compatibility testing can be resolved using dithiothreitol-treated RBCs. If an emergency transfusion is required, non–cross-matched ABO/RhD-compatible RBCs can be given per local blood bank practices.\n",
      "\n",
      "Serum protein electrophoresis and immunofixation tests: Isatuximab is an IgG kappa monoclonal antibody that may be incidentally detected by serum protein electrophoresis and immunofixation assays used for endogenous M-protein monitoring and may interfere with the accuracy of determining complete response in some patients with IgG kappa myeloma protein.\n",
      "\n",
      "\n",
      "Positive direct Coombs', false-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution), false- positive serum or urine creatinine with Jaffé reaction\n",
      "\n",
      "\n",
      "Some penicillin derivatives may accelerate the degradation of aminoglycosides in vitro, leading to a potential underestimation of aminoglycoside serum concentration.\n",
      "\n",
      "\n",
      "May lead to false-negative aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n",
      "May cause transient changes in serum iron, copper, or zinc. May interfere with colorimetric tests for serum calcium (apparent decrease); accurate values can be obtained approximately 90 minutes after injection.\n",
      "\n",
      "\n",
      "TIBC may be falsely elevated with high serum iron concentrations or deferoxamine therapy. Imaging results may be distorted due to rapid urinary excretion of deferoxamine-bound gallium-67; discontinue deferoxamine 48 hours prior to scintigraphy.\n",
      "\n",
      "\n",
      "Positive Coombs' [direct]\n",
      "\n",
      "\n",
      "May interfere with AST, ALT, triglycerides, glucose, and LDH testing\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Some quinolones may produce a false-positive urine screening result for opioids using commercially-available immunoassay kits. This has been demonstrated most consistently for levofloxacin and ofloxacin, but other quinolones have shown cross-reactivity in certain assay kits. Confirmation of positive opioid screens by more specific methods should be considered.\n",
      "\n",
      "\n",
      "Daptomycin may cause false prolongation of the PT and increase of INR with certain recombinant thromboplastin reagents. This appears to be a dose-dependent phenomenon. If PT/INR is elevated, repeat PT/INR immediately prior to next daptomycin dose (eg, trough). If PT/INR remains elevated, repeat PT/INR using alternate reagents (if available) and evaluate for other causes of elevated PT/INR.\n",
      "\n",
      "\n",
      "Specific whole blood assay for cyclosporine may be falsely elevated if sample is drawn from the same central venous line through which dose was administered (even if flush has been administered and/or dose was given hours before); cyclosporine metabolites cross-react with radioimmunoassay and fluorescence polarization immunoassay\n",
      "\n",
      "\n",
      "Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\n",
      "\n",
      "\n",
      "\n",
      "Passively transferred antibodies may yield false-positive serologic testing results; may yield false-positive direct and indirect Coombs’ test.\n",
      "\n",
      "\n",
      "Falsely high plasma phenytoin concentrations (due to cross-reactivity with fosphenytoin) when measured by immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000) prior to complete conversion of fosphenytoin to phenytoin. Phenytoin may produce falsely low results for dexamethasone or metyrapone tests. Phenytoin has the potential to lower serum folate levels.\n",
      "\n",
      "\n",
      "May interfere with urine detection of phencyclidine (false-positives) (Marchei 2007). May lead to false-positive aldosterone/renin ratio (ARR) (Funder 2016).\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "## To check for useful test-interaction information:\n",
    "for test_interaction in test_interactions:\n",
    "    if type(test_interaction) == str and 'See individual agents' not in test_interaction:\n",
    "        print(test_interaction)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-02T15:27:30.606473800Z",
     "start_time": "2023-05-02T15:27:30.590881300Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "outputs": [],
   "source": [
    "gpt_phrase = '''can you extract the medical test names from the following data; and extract their test result respectively in a json form, the json should have the test name as a key, and the test result as value. Please don't add any of your comments and don't look up in the internet just give a simple straight answer according to the following sentence:\\n'''"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-02T15:30:43.811685600Z",
     "start_time": "2023-05-02T15:30:43.785717600Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n"
     ]
    }
   ],
   "source": [
    "i =0 ; test_conditions = []\n",
    "\n",
    "for test_interaction in test_interactions:\n",
    "    i += 1\n",
    "    if type(test_interaction) == str and 'See individual agents' not in test_interaction:\n",
    "        message,status=chat_gpt.send_message(gpt_phrase+test_interaction)\n",
    "        test_conditions.append(message)\n",
    "    else:\n",
    "        test_conditions.append('Not available')\n",
    "    if i % 3 == 0:\n",
    "        time.sleep(60)\n",
    "    if i % 5 == 0:\n",
    "        chat_gpt.clear_history()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-02T21:06:27.635797700Z",
     "start_time": "2023-05-02T15:38:05.913627600Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "outputs": [
    {
     "data": {
      "text/plain": "['{\\n\"Direct antiglobulin (Coombs) test\": \"Positive\",\\n\"Urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n\"Serum/urine creatinine with Jaffé reaction assay\": \"Falsely elevated\"\\n}',\n 'Not available',\n '{\\n\"Wheal and flare reactions to skin test antigens\": \"May be suppressed\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n    \"creatinine (Jaffé alkaline picrate reaction)\": \"Increased\",\\n    \"serum methotrexate (dihydrofolate reductase method)\": \"Increased\"\\n}',\n '{\\n    \"serum chromogranin A (CgA) levels\": \"falsely elevated (due to decreased gastric acidity with Omeprazole)\",\\n    \"neuroendocrine tumor diagnosis\": \"may cause false-positive results\",\\n    \"CgA levels assessment\": \"≥14 days after treatment is completed\",\\n    \"CgA levels repeat\": \"if initially elevated\"\\n}',\n '{\\n    \"automated platelet counts\": \"may interfere (platelet clumping) with Crizanlizumab\",\\n    \"blood samples collection\": \"in tubes containing ethylenediaminetetraacetic acid (EDTA)\",\\n    \"platelet count\": \"may be unevaluable or falsely decreased\",\\n    \"management\": \"Collect blood samples in citrate-containing tubes\",\\n    \"run blood samples\": \"within 4 hours of sample collection\",\\n    \"estimate platelet count\": \"through peripheral blood smear if necessary\"\\n}',\n '{\\n    \"triglyceride assays\": \"may be falsely elevated (dependent on glycerol oxidase)\",\\n    \"propylene glycol content\": \"in IV formulation\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: HbA1c.\\nTest results: \\n{\\n \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: dipyridamole-thallium myocardial imaging\\n\\nTest Results: {\"dipyridamole-thallium myocardial imaging\": \"false-negative result\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"HIV nucleic acid tests\": \"false positive results\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Urinary Glucose Determination (Clinitest)\": \"Interferes\",\\n  \"Coombs\\' Test (Direct)\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Coombs\\' Test (Direct)\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"direct Coombs\": \"positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"false-positive\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"serum ferritin\": \"transient increase\",\\n   \"urine zinc\": \"transient increase (with renal disease)\",\\n   \"bilirubin\": \"transient increase (with hepatic metabolic disorders)\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Names: \\n1. Urine detection of methadone \\n2. Urine detection of phencyclidine \\n3. Serum TCA screen \\n4. Skin test antigens \\n\\nJSON Form: \\n{\\n   \"Urine detection of methadone\": \"false-positive\",\\n   \"Urine detection of phencyclidine\": \"false-positives\",\\n   \"Serum TCA screen\": \"false-positive\",\\n   \"Skin test antigens\": \"suppressed wheal and flare reactions\"\\n}',\n 'Medical Test Name: \\n1. Skin test antigens \\n\\nJSON Form: \\n{\\n   \"Skin test antigens\": \"suppressed wheal and flare reactions\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Serum or transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric gluconate administration\",\\n  \"Serum ferritin levels\": \"falsely elevated for 5 days after ferric gluconate administration\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"urine detection of methadone\": \"false-positives\",\\n   \"phencyclidine\": \"false-positives\",\\n   \"serum TCA screen\": \"false-positive\",\\n   \"wheal and flare reactions to skin test antigens\": \"suppressed\"\\n}',\n '{\\n   \"thyroid function tests dependent on iodine estimation\": \"altered results\",\\n   \"radioiodine uptake studies\": \"affected results\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n   \"direct Coombs\\' test\": \"positive\",\\n   \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"false-positive\",\\n   \"serum creatinine with Jaffé reaction\": \"false-positive\",\\n   \"urine creatinine with Jaffé reaction\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"Urine detection of phencyclidine\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n   \"Clinitest®\": \"interfered with urinary glucose determination\",\\n   \"Coombs\\' [direct]\": \"positive\"\\n}',\n 'Not available',\n '{\\n   \"blood group isohemagglutinins\": \"presence\",\\n   \"Coombs test\": \"may be interfered with due to passive transmission of antibodies to erythrocyte antigens\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: \\n1. Serum or transferrin bound iron levels \\n2. Serum ferritin levels \\n\\nTest Results:\\n1. {\"Serum or transferrin bound iron levels\": \"May be falsely elevated if assessed within 24 hours of ferric gluconate administration.\"}\\n2. {\"Serum ferritin levels\": \"May be falsely elevated for 5 days after ferric gluconate administration.\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"direct Coombs\\'\": \"Positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\", \"ferricyanide test\": \"False-negative\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n- Urinary glucose determination \\n\\nTest Results in JSON format:\\n{\\n   \"Urinary glucose determination\": \"False-negative when using Clinistix® or Diastix®\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical test names: Basophils, hemoglobin, MCH, MCHC, albumin, alkaline phosphatase, cholesterol, creatinine, glucose, total protein, triglycerides, bilirubin, urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite), ALT, amylase, AST, CK, CKMB, LDH, phosphate, uric acid, PT, aPTT, urine pH.\\n\\nJSON form:\\n{\\n  \"Basophils\": \"Falsely elevated\",\\n  \"Hemoglobin\": \"Falsely elevated\",\\n  \"MCH\": \"Falsely elevated\",\\n  \"MCHC\": \"Falsely elevated\",\\n  \"Albumin\": \"Falsely elevated\",\\n  \"Alkaline phosphatase\": \"Falsely elevated\",\\n  \"Cholesterol\": \"Falsely elevated\",\\n  \"Creatinine\": \"Falsely elevated\",\\n  \"Glucose\": \"Falsely elevated\",\\n  \"Total protein\": \"Falsely elevated\",\\n  \"Triglycerides\": \"Falsely elevated\",\\n  \"Bilirubin\": \"Falsely elevated\",\\n  \"Urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite)\": \"Falsely elevated\",\\n  \"ALT\": \"Falsely decreased\",\\n  \"Amylase\": \"Falsely decreased\",\\n  \"AST\": \"Unpredictable\",\\n  \"CK\": \"Unpredictable\",\\n  \"CKMB\": \"Unpredictable\",\\n  \"LDH\": \"Unpredictable\",\\n  \"Phosphate\": \"Unpredictable\",\\n  \"Uric acid\": \"Unpredictable\",\\n  \"PT\": \"Unpredictable\",\\n  \"aPTT\": \"Unpredictable\",\\n  \"Urine pH\": \"Unpredictable\"\\n}',\n 'Not available',\n 'Medical test name: Blood glucose\\n\\nJSON form:\\n{\\n  \"Blood glucose\": \"falsely elevated\"\\n}',\n 'Not available',\n '{\\n \"Positive direct Coombs\": true,\\n \"Urinary glucose test using cupric sulfate (Benedict\\'s solution)\": false,\\n \"Urinary glucose test using Clinitest\": false,\\n \"Urinary glucose test using Fehling\\'s solution\": false,\\n \"Serum or urine creatinine with Jaffé reaction\": false,\\n \"Urinary proteins\": false,\\n \"Urinary steroids\": false\\n}',\n '{\\n \"Serum iron levels\": \"falsely elevated\",\\n \"Transferrin bound iron levels\": \"falsely elevated\"\\n}',\n '{\\n \"Coombs test\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\"HbA1c\": \"artificially lower through increased circulation of immature erythrocytes\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '1. T4-binding globulin (TBG)\\n{\\n  \"Conditions/states that increase TBG binding\": \"Pregnancy, hepatitis, porphyria, neonatal state\",\\n  \"Medications that increase TBG binding\": \"Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\",\\n  \"Conditions/states that decrease TBG binding\": \"Hepatic failure, nephrosis, severe illness.\",\\n  \"Medications that decrease TBG binding\": \"Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\"\\n}\\n\\n2. Thyroxine (T4) and triiodothyronine (T3)\\n{\\n  \"Medications that inhibit T4 and T3 binding\": \"Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\"\\n}\\n\\n3. Thyroid gland hormone: Interference with production and secretion\\n{\\n  \"Medications affecting iodine uptake\": \"Amiodarone, iodinated contrast agents, iodine, ethionamide\",\\n  \"Medications affecting hormone production\": \"Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\",\\n  \"Medications affecting secretion\": \"Amiodarone, iodinated contrast agents, iodine, lithium\",\\n  \"Medications inducing thyroiditis\": \"Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\",\\n  \"Medications potentially causing the development of Graves’\": \"Alemtuzumab, interferon alpha, antiretroviral therapy\",\\n  \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’\": \"Glucocorticoids\"\\n}\\n\\n4. Hypothalamic-pituitary axis and TSH: Interference with secretion\\n{\\n  \"Medications decreasing TSH secretion\": \"Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\",\\n  \"Medications increasing TSH secretion\": \"Amphetamine, interleukin 2, metoclopramide, ritonavir, St John\\'s wort\",\\n  \"Medications potentially causing hypophysitis\": \"Ipilimumab\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Iodine-binding capacity of thyroid tissue\": \"reduced for up to 2 weeks following administration of contrast media\",\\n  \"diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n  \"Thyroid function tests that are independent of iodine estimation for results\": \"not affected (eg, T3 resin uptake, thyroxine assays)\"\\n}',\n 'Not available',\n '{\\n  \"Urine test for amphetamines/methamphetamines\": \"May interfere with detection (false-positive)\"\\n}',\n '{\\n  \"Parathyroid function tests\": \"may be interfered with\",\\n  \"Aldosterone/renin ratio (ARR) test\": \"may give a false-negative result\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '- Medical test names: T4-binding globulin (TBG), Thyroxine (T4), Triiodothyronine (T3), Thyroid gland hormone, Hypothalamic-pituitary axis, TSH\\n- Extracted test results (in JSON form):\\n\\n{\\n  \"T4-binding globulin (TBG)\": {\\n    \"Conditions/states that increase TBG binding\": \"Pregnancy, hepatitis, porphyria, neonatal state\",\\n    \"Medications that increase TBG binding\": \"Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\",\\n    \"Conditions/states that decrease TBG binding\": \"Hepatic failure, nephrosis, severe illness\",\\n    \"Medications that decrease TBG binding\": \"Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\"\\n  },\\n  \\n  \"Thyroxine (T4) and Triiodothyronine (T3)\": {\\n    \"Medications that inhibit T4 and T3 binding\": \"Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\"\\n  },\\n  \\n  \"Thyroid gland hormone\": {\\n    \"Medications affecting iodine uptake\": \"Amiodarone, iodinated contrast agents, iodine, ethionamide\",\\n    \"Medications affecting hormone production\": \"Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\",\\n    \"Medications affecting secretion\": \"Amiodarone, iodinated contrast agents, iodine, lithium\"\\n  },\\n  \\n  \"Hypothalamic-pituitary axis and TSH\": {\\n    \"Medications decreasing TSH secretion\": \"Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\",\\n    \"Medications increasing TSH secretion\": \"Amphetamine, interleukin 2, metoclopramide, ritonavir, St John\\'s wort\",\\n    \"Medications potentially causing hypophysitis\": \"Ipilimumab\"\\n  }\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: None mentioned\\n\\nTest Results: None mentioned',\n 'Test Names: \\n- Stool occult blood test\\n- Blood glucose testing\\n- Urine glucose testing\\n- Nitrite level testing\\n- Bilirubin level testing\\n- Leucocyte count testing\\n\\nTest Results: \\n- Stool occult blood: False negative 48 to 72 hours after ascorbic acid ingestion\\n- Blood glucose: Falsely elevated glucose measurements by point of care glucometers with high-dose ascorbic acid\\n- Urine glucose: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Nitrite level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Bilirubin level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Leucocyte count: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test name: Interferes with gastric secretion test\\nTest result: Transdermal system should be discontinued ≥10 days prior to testing.\\n\\nJSON format: {\"Interferes with gastric secretion test\": \"Transdermal system should be discontinued ≥10 days prior to testing.\"}',\n 'Not available',\n 'Test name: Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\\nTest result: May interfere\\n\\nTest name: Aminoglycoside serum concentration\\nTest result: Potential underestimation due to the acceleration of degradation by some penicillin derivatives\\n\\nJSON format: {\"Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\": \"May interfere\", \"Aminoglycoside serum concentration\": \"Potential underestimation due to the acceleration of degradation by some penicillin derivatives\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. Serum iron levels\\n2. Transferrin bound iron levels\\n\\nTest results in JSON format:\\n{\\n  \"Serum iron levels\": \"not specified\",\\n  \"Transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}',\n 'Not available',\n 'Test Names: Pregnancy test\\nTest Results: False-positive or false-negative',\n 'Test Names: Urine opioid screening\\nTest Results: False-positive (with some quinolones)',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"Urine detection of methadone\": \"false-positive\"}',\n '{\"Coombs\\' test [direct]\": \"false-positive\"}',\n 'Not available',\n '{\\n  \"urinary uric acid (phosphotungstate method)\": \"interference by Methyldopa\",\\n  \"serum creatinine (alkaline picrate method)\": \"interference by Methyldopa\",\\n  \"AST (colorimetric method)\": \"interference by Methyldopa\",\\n  \"urinary catecholamines (falsely high levels)\": \"interference by Methyldopa\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive by Methyldopa\"\\n}',\n '{\\n  \"urine screening for opioids\": \"false-positive by some quinolones (levofloxacin, ofloxacin, and others)\",\\n  \"confirmation of positive opioid screens\": \"should be considered using more specific methods\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names:\\n1. Plasma glucose\\n2. Uric acid\\n3. Free fatty acids\\n4. Total cholesterol\\n5. HDL\\n6. HDL/LDL ratio\\n7. Urinary free cortisol excretion\\n8. Triiodothyronine\\n\\nTest results in JSON form:\\n{\\n\"Plasma glucose\": \"increased\",\\n\"Uric acid\": \"increased\",\\n\"Free fatty acids\": \"increased\",\\n\"Total cholesterol\": \"increased\",\\n\"HDL\": \"increased\",\\n\"HDL/LDL ratio\": \"increased\",\\n\"Urinary free cortisol excretion\": \"increased\",\\n\"Triiodothyronine\": \"decreased\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"coagulation\": \"Altered\", \"fibrinolytic activity\": \"Altered\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n\"skin test antigens\": \"suppressed\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Ceftazidime\": \"Positive direct Coomb\",\\n  \"Urine Glucose\": \"False-positive reaction with certain methods\"\\n}',\n '{\\n  \"Serum Iron\": \"Transitory changes observed\",\\n  \"Serum Calcium\": \"May interfere with colorimetric tests; alternate testing method recommended for 12-24 hours after administration\"\\n}',\n 'Not available',\n '{\\n  \"Urinary Catecholamines\": \"False-positive (fluorometric assay)\",\\n  \"17-hydroxycorticosteroids\": \"False-positive\",\\n  \"17-ketosteroids\": \"False-positive\"\\n}',\n 'Test names: \\n1. Serum TCA screen\\n2. Skin test antigens\\n\\nTest results:\\n1. False-positive\\n2. Suppressed wheal and flare reactions',\n 'Not available',\n \"Test names: \\n1. Coombs' test\\n2. Aldosterone/renin ratio\\n\\nTest results:\\n1. Positive\\n2. False-positive\",\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: \\n1. MR imaging \\n2. Serum Iron \\n3. Transferrin-bound Iron \\n\\nCorresponding Test Results in JSON:\\n{\\n  \"MR imaging\": \"May interfere with imaging; alterations may persist for ≤3 months following use, with peak alterations anticipated in the first 2 days following administration. If MR imaging is required within 3 months after administration, use T1- or proton density-weighted MR pulse sequences to decrease effect on imaging. Do not use T2-weighted sequence MR imaging prior to 4 weeks following administration.\",\\n  \"Serum Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\",\\n  \"Transferrin-bound Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\"\\n}',\n 'Test Names: \\n1. Blood glucose levels\\n2. Serologic testing results\\n3. Direct Coombs\\' test\\n4. Indirect Coombs\\' test\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Blood glucose levels\": \"Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\",\\n  \"Serologic testing results\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Direct Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Indirect Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\"\\n}',\n 'Test Names: \\n1. Serum chromogranin A (CgA) levels\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Serum chromogranin A (CgA) levels\": \"Omeprazole may falsely elevate CgA levels, causing false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n\"Medical Test Name\": \"Detection of urine protein\",\\n\"Test Result\": \"False positive when pyrogallol red reagent is used\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"amylase\": \"increased\",\\n  \"BSP retention\": \"increased\",\\n  \"CPK\": \"increased\"\\n}',\n 'Not available',\n '{\\n  \"serum progesterone assay\": \"may interfere\",\\n  \"interaction\": \"may be observed\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n '{\\n  \"blood ethylene glycol concentrations\": \"false positive\",\\n  \"inorganic phosphorus blood concentrations\": \"false low\"\\n}',\n '{\\n  \"gastric secretion test\": \"interference\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Bone imaging studies\": \"May interfere with\",\\n  \"Hematopoietic activity\": \"increased\",\\n  \"Bone marrow\": \"May appear as transient positive bone imaging changes.\"\\n}',\n '{\\n  \"aldosterone/renin ratio (ARR)\": \"May lead to false-negative\"\\n}',\n '{\"urine glucose\": \"may interfere with tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}',\n '{\"glucose\": \"increased\", \"HDL\": \"decreased\", \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"}',\n 'Not available',\n 'Not available',\n '{\"direct Coombs\\'\": \"positive\", \"indirect Coombs\\'\": \"positive\", \"urinary glucose test\": \"false-positive using glucose tests based on Benedict\\'s copper reduction reaction\", \"serum or urine creatinine\": \"false-positive with Jaffé reaction\", \"aminoglycoside serum concentration\": \"potential underestimation due to some penicillin derivatives accelerating degradation in vitro\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"urine glucose test\": \"may interfere with containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}',\n 'Not available',\n 'Not available',\n 'Test Names:\\n\\n1. Urine glucose test containing cupric sulfate\\n2. Coombs\\' test\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Urine glucose test containing cupric sulfate\": \"May interfere\",\\n  \"Coombs\\' test\": \"Positive\"\\n}',\n 'Test Names:\\n\\n1. Aldosterone/renin ratio (ARR)\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Aldosterone/renin ratio (ARR)\": \"May lead to false-negative\"\\n}',\n 'Not available',\n '{\"coagulation\": \"Altered results\", \"fibrinolytic activity\": \"Altered results\"}',\n 'Not available',\n 'Not available',\n '{\"aldosterone/renin ratio\": \"false-negative\", \"ARR\": \"false-negative\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: \\n1. Digitalis immunoassay \\n2. Digoxin serum samples\\n\\nTest Results: \\n{\\n   \"Digitalis immunoassay\": \"may be clinically misleading until all Fab fragments are eliminated from the body\",\\n   \"Digoxin serum samples\": \"should be obtained before digoxin immune fab administration, if possible\"\\n}',\n 'Test Names: \\n1. Urine test for phencyclidine\\n\\nTest Results: \\n{\\n   \"Urine test for phencyclidine\": \"false-positive interference may occur\"\\n}',\n 'Not available',\n '{\\n\"skin test antigens\": \"suppressed\"\\n}',\n 'Not available',\n '{\\n\"urinary 5-hydroxyindoleacetic acid\": \"false-positive\"\\n}',\n '{\\n\"enzymatic methods used to detect opioids\": \"interference (refer to test manufacturer for details)\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"skin tests\": \"decreased response\"}',\n 'Not available',\n 'Test Names: \\n- Urine screening test for opioids using commercially-available immunoassay kits\\n\\nTest Results:\\n- Levofloxacin and ofloxacin may produce a false-positive result\\n- Other quinolones may also show cross-reactivity in certain assay kits\\n- Positive opioid screens should be confirmed by more specific methods.',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical tests names: \\n1. Urine glucose determinations \\n2. Certain lab tests \\n\\nJSON output: \\n{\\n  \"Urine glucose determinations\": \"false-negative\",\\n  \"Certain lab tests\": \"incorrect\"\\n}',\n 'Not available',\n 'Not available',\n 'Medical tests names: PT/INR\\n\\nJSON output: {\"PT/INR\": \"unreliable within 5 hours\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-negative.',\n 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-positive.',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Folic acid\": \"invalidated\",\\n  \"Vitamin B12\": \"invalidated\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Opioid screening test\": \"false-positive (when taking some quinolones)\",\\n  \"Specific confirmation test\": \"recommended\"\\n}',\n 'Test names:\\n- Urine specimen assay\\n\\nTest results in JSON form:\\n{\\n \"Urine specimen assay\": \"N/A\"\\n} \\n(Note: \"N/A\" is the value because no specific test result is mentioned in the sentence)',\n 'Not available',\n 'Test names:\\n- Direct Coombs\\' test\\n- Urinary glucose test\\n- Serum creatinine test\\n- Urine creatinine test\\n\\nTest results in JSON form:\\n{\\n \"Direct Coombs\\' test\": \"Positive\",\\n \"Urinary glucose test\": \"False-positive\",\\n \"Serum creatinine test\": \"False-positive\",\\n \"Urine creatinine test\": \"False-positive\"\\n}',\n 'Not available',\n 'Not available',\n '1) Medical test names: \\n- Rapid plasma reagin (RPR) test\\n2) Test results in JSON format:\\n- For RPR test: {\"Rapid plasma reagin (RPR) test\": \"false-positive due to smallpox vaccine\"}\\n\\n1) Medical test names:\\n- Tuberculin skin (PPD) and blood tests\\n2) Test results in JSON format:\\n- For Tuberculin skin (PPD) and blood tests: {\"Tuberculin skin (PPD) and blood tests\": \"false-negative due to smallpox vaccine\"}',\n 'Not available',\n 'Not available',\n '1) Medical test names:\\n- Bone scan (diagnostic imaging with technetium-99m-diphosphonate)\\n2) Test results in JSON format:\\n- For bone scan: {\"Bone scan\": \"may be interfered by bisphosphonates except clodronate, according to some studies\"}',\n 'Not available',\n 'Not available',\n 'Test Names: Lactobacillus casei assay method\\nTest Result: Falsely low serum concentrations may occur in patients on anti-infectives (eg, tetracycline)',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n \"Test Names: \\n1. Urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®)\\n2. Aminoglycoside activity test\\n3. Urinary protein test\\n4. Serum protein test\\n\\nTest Results:\\n1. May interfere\\n2. May inactivate in vitro\\n3. False positive in urinary test\\n4. False positive in serum test\",\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n1) Direct Coombs\\' test\\n2) Urinary glucose test\\n3) Serum or urine creatinine test with Jaffé reaction\\n\\nJSON Form: \\n{\\n  \"Direct Coombs\\' test\": \"Positive\",\\n  \"Urinary glucose test\": \"False-positive\",\\n  \"Serum or urine creatinine test with Jaffé reaction\": \"May cause false-positive\"\\n}',\n 'Not available',\n 'Test Name: Aldosterone/Renin Ratio (ARR)\\nTest Result: May lead to false-negative (Funder 2016)',\n 'Not available',\n 'Test Names: laboratory tests related to coagulation factors, lipids, glucose tolerance, thyroxine-binding globulin, sex hormone-binding globulin, cortisol-binding globulin\\nTest Result: The use of estrogens and/or progestogens may alter the results (general statement)',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. Technetium-99m-diphosphonate bone scan \\n\\nTest results:\\n{\\n\"Technetium-99m-diphosphonate bone scan\": \"may be interfered with by Bisphosphonates\"\\n}',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. Coombs\\' test [direct]\\n\\nTest results:\\n{\\n\"Coombs\\' test [direct]\": \"false-positive \"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"dexamethasone suppression test\": \"false-negative\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n '{\\n    \"phenylketonuria\": \"false-positive\",\\n    \"amylase\": \"false-positive\",\\n    \"uroporphyrins\": \"false-positive\",\\n    \"urobilinogen\": \"false-positive\",\\n    \"pregnancy test\": \"false-positive\",\\n    \"amphetamine/methamphetamine\": \"false-positive\",\\n    \"methadone\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n \"1. Medical test name: Urinary glucose tests\\n   Test result: May interfere with using cupric sulfate (Benedict's solution, Clinitest®)\\n\\n2. Medical test name: Aminoglycoside serum concentration\\n   Test result: Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives.\",\n 'Medical test name: Serum creatinine values\\nTest result: Markedly false elevations when the Ektachem® analyzer is used. The Jaffé reaction is recommended for determining serum creatinine.',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"HbA1c\": \"artificially lowered\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. Urine screening test for opioids using commercially-available immunoassay kits\\n\\nTest results:\\n1. False-positive results for opioids may be produced by some quinolones, especially levofloxacin and ofloxacin\\n2. Other quinolones may also show cross-reactivity in certain assay kits.\\n3. Positive opioid screens should be confirmed by more specific methods.',\n 'Test names: \\n1. Skin test\\n\\nTest results:\\n1. Decreased response to skin tests.',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n    \"Urinary glucose tests using cupric sulfate\": \"May interfere\",\\n    \"Aminoglycosides\": \"May inactivate in vitro\",\\n    \"Urine proteins\": \"False-positive\",\\n    \"Serum proteins\": \"False-positive\",\\n    \"Uric acid\": \"False-positive\",\\n    \"Urinary steroids\": \"False-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Medical Test Name\": \"TPMT phenotyping\",\\n  \"Test Result\": \"May not be accurate following recent blood transfusions.\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Serum renin concentrations\": \"increased\",\\n  \"IgG concentrations\": \"increased\",\\n  \"Serum cortisol concentrations\": \"decreased\",\\n  \"insulin response to glucagon\": \"false-negative\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"fluorescence test for urinary catecholamines\":\"false elevations\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n \"I'm sorry, but I cannot extract the medical test names and their results without any input data. Please provide the data.\",\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"cross-reactivity\", \"ofloxacin\": \"cross-reactivity\", \"other quinolones\": \"cross-reactivity\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Thyroid function tests (protein bound and radioactive iodine uptake studies)\": \"inaccurate for up to 16 days after administration\",\\n  \"Multistix urine protein test\": \"may cause false positive results\",\\n  \"Urine specific gravity\": \"may be affected\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. PT/INR levels\\n2. Chromogenic factor X assay\\n3. Factor Xa levels\\n\\nTest results:\\n{\\n  \"PT/INR levels\": \"elevated in the absence of warfarin, may require modification while on argatroban\",\\n  \"Chromogenic factor X assay\": \"suggested to be monitored when transitioning from argatroban to warfarin or overlapping administration of warfarin for a minimum of 5 days until INR is within target range, recheck INR after anticoagulant effect of argatroban has dissipated\",\\n  \"Factor Xa levels\": \"associated with INR values >2 after the effects of argatroban have been eliminated\"\\n}',\n 'Not available',\n '{\\n  \"Test name\": \"Polymerase chain reaction (PCR) assay for HIV\",\\n  \"Test result\": \"False-positive for HIV in patients who have received betibeglogene autotemcel due to integrated BB305 LVV proviral DNA\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Names: Serum magnesium test and Urine magnesium test.\\n\\nJSON output:\\n{\\n \"Serum magnesium test\": \"falsely decreased\",\\n \"Urine magnesium test\": \"falsely decreased\"\\n}',\n 'Not available',\n 'Medical Test Names: Coombs\\' test and Urinary protein test.\\n\\nJSON output:\\n{\\n \"Coombs\\' test\": \"positive\",\\n \"Urinary protein test\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"metyrapone test\": \"reduced response\"\\n}',\n 'Not available',\n '{\\n  \"anti-FXa activity assay\": \"falsely elevated after andexanet alfa administration\",\\n  \"andexanet alfa\": \"reversal activity\"\\n}',\n '{\\n  \"urine screening test\": \"false-positive for opioids\",\\n  \"immunoassay kits\": \"affected by quinolones\",\\n  \"levofloxacin\": \"produces most consistent false-positive\",\\n  \"ofloxacin\": \"produces false-positive\",\\n  \"other quinolones\": \"may show cross-reactivity\",\\n  \"confirmation test\": \"more specific methods recommended for positive screens\"\\n}',\n '{\\n    \"Positive direct Coombs\\'\": \"positive\",\\n    \"false-positive urinary glucose test using nonenzymatic methods\": \"false-positive\",\\n    \"false-positive galactosemia tests\": \"false-positive\"\\n}',\n '{\\n    \"false-positive amphetamine EMIT assay\": \"positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"Thyroid function tests\": \"Altered\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Plasma glucose\": \"increased\",\\n  \"Uric acid\": \"increased\",\\n  \"Free fatty acids\": \"increased\",\\n  \"Total cholesterol\": \"increased\",\\n  \"HDL\": \"increased\",\\n  \"HDL/LDL ratio\": \"increased\",\\n  \"Urinary free cortisol excretion\": \"increased\",\\n  \"Triiodothyronine\": \"decreased\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Name: Urine Detection of Phencyclidine\\nTest Result: False-Positive',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '1. Medical tests mentioned in the given data:\\n- Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n- Glucose-specific method\\n- Urinalysis\\n- Serologic testing\\n- Direct and indirect Coombs’ test\\n\\n2. Test results in JSON form:\\n{\\n  \"Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\": \"falsely elevated blood glucose levels\",\\n  \"Glucose-specific method\": \"recommended\",\\n  \"Urinalysis\": \"transiently elevated glucose\",\\n  \"Serologic testing\": \"false-positive results\",\\n  \"Direct and indirect Coombs’ test\": \"false-positive results\"\\n}',\n '1. Medical tests mentioned in the given data:\\n- AST testing\\n- ALT testing\\n- Triglycerides testing\\n- Glucose testing\\n- LDH testing\\n\\n2. Test results in JSON form:\\n{\\n  \"AST testing\": \"may be interfered\",\\n  \"ALT testing\": \"may be interfered\",\\n  \"Triglycerides testing\": \"may be interfered\",\\n  \"Glucose testing\": \"may be interfered\",\\n  \"LDH testing\": \"may be interfered\"\\n}',\n '1. Medical test mentioned in the given data:\\n- Skin test for wheal and flare reactions to antigens \\n\\n2. Test result in JSON form:\\n{\\n  \"Skin test for wheal and flare reactions to antigens\": \"may be suppressed\"\\n}',\n 'Not available',\n '1. Medical test mentioned in the given data:\\n- Digoxin radioimmunoassay \\n\\n2. Test result in JSON form:\\n{\\n  \"Digoxin radioimmunoassay\": \"may be interfered\"\\n}',\n 'Not available',\n 'Test Names: Methotrexate levels\\nTest Result: {\"Methotrexate levels\": \"the chromatographic method\"}',\n 'Not available',\n 'Test Names: \\n1. Urine catecholamines\\n2. Metanephrine \\n3. Normetanephrine \\n4. Vanillylmandelic acid (VMA) \\n5. Urine amphetamine \\n6. Aldosterone/renin ratio (ARR)\\n\\nTest Results:\\n{\\n   \"Urine catecholamines\": \"HPLC assay with solid-phase extraction should be used to determine levels of catecholamines\",\\n   \"Metanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of metanephrine\",\\n   \"Normetanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of normetanephrine\",\\n   \"Vanillylmandelic acid (VMA)\": \"HPLC assay with solid-phase extraction should be used to determine levels of VMA\",\\n   \"Urine amphetamine\": \"Gas chromatographic-mass spectrometer technique should be used to determine levels of amphetamine\",\\n   \"Aldosterone/renin ratio (ARR)\": \"May lead to a false-positive result\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names:\\n- Urinary glucose determination using Clinitest®\\n- Coombs\\' direct\\n\\nTest Results (in json format):\\n{\\n  \"Urinary glucose determination using Clinitest®\": \"Interfered\",\\n  \"Coombs\\' direct\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"phencyclidine\": \"false-positives\",\\n  \"aldosterone/renin ratio\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"aldosterone/renin ratio (ARR)\": \"false-positive\"}',\n 'Not available',\n '{\"iodine-binding capacity\": \"reduced for up to 2 weeks following administration of contrast media\", \\n\"diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results\": \"not affected (eg, T3 resin uptake, thyroxine assays)\"}',\n '{\"renin (S)\": \"increased\",\\n \"aldosterone (S)\": \"increased\"}',\n 'Not available',\n 'Not available',\n '{\"PCR assays for HIV\": \"positive\", \"HIV infection using a PCR-based assay\": \"false-positive\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: PT, INR\\nJSON format: {\"PT\": <test result>, \"INR\": <test result>}',\n 'Not available',\n 'Test names: \\n- Plasma glucose\\n- Uric acid\\n- Free fatty acids\\n- Total cholesterol\\n- HDL\\n- HDL/LDL ratio\\n- Urinary free cortisol excretion\\n- Triiodothyronine\\n\\nJSON format: \\n{\\n\"Plasma glucose\": <test result>,\\n\"Uric acid\": <test result>,\\n\"Free fatty acids\": <test result>,\\n\"Total cholesterol\": <test result>,\\n\"HDL\": <test result>,\\n\"HDL/LDL ratio\": <test result>,\\n\"Urinary free cortisol excretion\": <test result>,\\n\"Triiodothyronine\": <test result>\\n}',\n 'Not available',\n '{\\n   \"Test Name\": \"Amphetamine EMIT assay\",\\n   \"Test Result\": \"False-positive\"\\n}',\n '{\\n   \"Test Name\": \"Coombs test\",\\n   \"Test Result\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Coombs\\' test (direct)\": \"Positive\",\\n  \"Urinary proteins\": \"False-positive\",\\n  \"Serum proteins\": \"False-positive\",\\n  \"Aminoglycoside inactivation\": \"In vitro\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Stool occult blood test\": \"False-negative\",\\n  \"Blood glucose testing\": \"Interference (falsely-elevated)\",\\n  \"Urine glucose testing\": \"Interference\",\\n  \"Nitrite levels\": \"Interference\",\\n  \"Bilirubin levels\": \"Interference\",\\n  \"Leucocyte count\": \"Interference\"\\n}',\n '{\\n  \"One-stage clotting assay (OSA)\": \"Affected by aPTT reagent and reference standard used; recommended for monitoring factor IX activity over time with the same assay and reagents\",\\n  \"Activated partial thromboplastin time (aPTT)\": \"Type of reagent used affects results when using OSA to determine factor IX activity\",\\n  \"Chromogenic substrate assay (CSA)\": \"Results in lower factor IX activity compared to OSA; mean CSA to OSA factor IX activity ratio ranging from 0.41 to 0.55 in clinical study\"\\n}',\n 'Not available',\n 'Not available',\n '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"positive\", \"ofloxacin\": \"positive\"}',\n '{\"urinary glucose determination using Clinitest\": \"interferes\", \"Coombs\\' [direct]\": \"positive\"}',\n 'Not available',\n 'Test Names: \\n1. Serum Protein Electrophoresis (SPEP)\\n2. Serum Immunofixation Assays\\n \\nTest Results in JSON Format:\\n{\\n   \"SPEP\": \"A small peak in the early gamma region\",\\n   \"Serum Immunofixation Assays\": \"may potentially be attributed to elotuzumab\"\\n}',\n 'Not available',\n 'Test Name:\\n1. Serum Iron Test\\n\\nTest Result in JSON Format:\\n{\\n   \"Serum Iron Test\": \"Falsely high or low values of serum iron (if determined by complexometric methods) may occur for up to 24 hours following administration.\"\\n}',\n 'Not available',\n 'Test Names:\\n1. Urinary 5-hydroxyindoleacetic acid test\\n2. Urine detection of Phencyclidine test\\n3. Aldosterone/Renin Ratio (ARR) test\\n\\nTest Results in JSON Format:\\n{\\n   \"Urinary 5-hydroxyindoleacetic acid test\": \"false-positive due to Acetaminophen\",\\n   \"Urine detection of Phencyclidine test\": \"false-positives due to Ibuprofen\",\\n   \"Aldosterone/Renin Ratio (ARR) test\": \"false-positive due to Ibuprofen\"\\n}',\n 'Not available',\n 'Not available',\n '1. Medical test names:\\n- Urine screening test for opioids using immunoassay kits\\n- Confirmation test for positive opioid screens using more specific methods\\n- Urine methadone screens using immunoassay kits\\n\\n2. Test Results in JSON format:\\n{\\n  \"Urine screening test for opioids using immunoassay kits\": \"false-positive for opioids with quinolones (levofloxacin and ofloxacin) and other medications (not specified)\",\\n  \"Confirmation test for positive opioid screens using more specific methods\": \"not specified\",\\n  \"Urine methadone screens using immunoassay kits\": \"false-positive in patients taking diphenhydramine, doxylamine, clomipramine, chlorpromazine, thioridazine, quetiapine, and verapamil\"\\n}',\n '1. Medical test names:\\n- Rabbit antibody-based immunoassays\\n- Cross-match or panel-reactive antibody cytotoxicity assays\\n- Routine clinical laboratory tests which use immunoglobulins\\n\\n2. Test Results in JSON format:\\n{\\n  \"Rabbit antibody-based immunoassays\": \"potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"potential interference\",\\n  \"Routine clinical laboratory tests which use immunoglobulins\": \"no interference shown\"\\n}',\n 'Not available',\n \"I'm sorry, I cannot extract the medical test names and their results without any specific data to refer to. Please provide the necessary information.\",\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: Not specified in the given data.\\nTest Results:\\n{\\n\"Urine Protein Detection with Pyrogallol Red reagent\": \"May give false positive results if Viltolarsen is present in urine\",\\n\"Urine Protein Detection with other test methods\": \"Not affected by Viltolarsen\",\\n\"Timeframe for avoiding false positives\": \"Urine obtained prior to infusion or ≥48 hours after infusion\",\\n}',\n 'Not available',\n 'Medical Test Name: PHOSm assay\\n\\nTest Result JSON: {\"PHOSm assay\": \"Falsely-elevated serum phosphate\"}',\n 'Not available',\n 'Medical Test Names: \\n1. Phosphotungstate method for uric acid\\n2. Ehrlich\\'s reagent for urobilinogen\\n3. Spectrophotometric determination of serum theophylline concentration\\n\\nTest Result JSON: \\n{\\n   \"Phosphotungstate method for uric acid\": \"False-positive\",\\n   \"Ehrlich\\'s reagent for urobilinogen\": \"False-positive\",\\n   \"Spectrophotometric determination of serum theophylline concentration\": \"Interference with large doses\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Urinary protein with Albustix\": \"false-positive\",\\n  \"Labstix\": \"false-positive\",\\n  \"Albutest\": \"false-positive\",\\n  \"Bumintest\": \"false-positive\",\\n  \"HPLC theophylline assay\": \"interference\",\\n  \"Serum uric acid levels\": \"interference\",\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n '{\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'Not available',\n '{\\n  \"Diagnostic serum tests that utilize antibodies\": \"interference\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n \"levofloxacin\": \"false-positive urine screening result for opioids\",\\n \"ofloxacin\": \"false-positive urine screening result for opioids\",\\n \"other quinolones\": \"cross-reactivity in certain assay kits\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"serologic testing\": \"false-positive\", \"direct Coombs test\": \"false-positive\", \"indirect Coombs test\": \"false-positive\"}',\n 'Not available',\n 'Not available',\n '{\\n  \"Dehydrogenase Pyrroloquinolinequinone\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose-dye-oxidoreductase\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose Dehydrogenase Nicotine Adenine Dinucleotide (GDH-NAD)\": \"Recommended glucose monitoring method\",\\n  \"Glucose Oxidase\": \"Recommended glucose monitoring method\",\\n  \"Glucose Hexokinase\": \"Recommended glucose monitoring method\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Medical Test Names\": [\\n    \"Aminoglycoside Serum Concentration\"\\n  ],\\n  \"Test Results\": [\\n    \"Potential Underestimation\"\\n  ]\\n}',\n 'Not available',\n '{\\n  \"Medical Test Names\": [\\n    \"Aldosterone/Renin Ratio (ARR)\"\\n  ],\\n  \"Test Results\": [\\n    \"False-Negative\"\\n  ]\\n}',\n '{\\n \"urinary glucose determination using Clinitest\": \"false-positive or negative\",\\n \"Coombs\\' [direct]\": \"positive\",\\n \"urinary and/or serum proteins by certain test methods\": \"false-positive\"\\n}',\n 'Not available',\n '{\\n \"direct Coombs\\'\": \"positive\",\\n \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"false-positive\",\\n \"serum or urine creatinine with Jaffé reaction\": \"false-positive\"\\n}',\n '{\\n \"urine screening result for opioids using commercially-available immunoassay kits\": \"false-positive\",\\n \"levofloxacin and ofloxacin\": \"most consistently shown cross-reactivity\",\\n \"other quinolones\": \"shown cross-reactivity in certain assay kits\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical test names:\\n1. Indirect antiglobulin test (indirect Coombs test)\\n2. Serum protein electrophoresis\\n3. Immunofixation assays\\n\\nJSON form:\\n{\\n  \"Indirect antiglobulin test (indirect Coombs test)\": \"Positive\",\\n  \"Serum protein electrophoresis\": \"Detected\",\\n  \"Immunofixation assays\": \"Interference\"\\n}',\n 'Not available',\n 'Not available',\n 'Medical test names:\\n1. Gastric secretion test\\n\\nJSON form:\\n{\\n  \"Gastric secretion test\": \"Interference\"\\n}',\n 'Test names: T4-binding globulin (TBG), Thyroxine (T4), Triiodothyronine (T3), Thyroid gland hormone, Hypothalamic-pituitary axis and TSH\\n\\nTest results as JSON:\\n\\n{\\n  \"TBG\": {\\n    \"Conditions/Staes that increase TBG binding\": [\"Pregnancy\", \"hepatitis\", \"porphyria\", \"neonatal state\"],\\n    \"Medications that increase TBG binding\": [\"Estrogens\", \"5-fluorouracil\", \"heroin\", \"methadone\", \"mitotane\", \"perphenazine\", \"selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\"],\\n    \"Conditions/states that decrease TBG binding\": [\"Hepatic failure\", \"nephrosis\", \"severe illness\"],\\n    \"Medications that decrease TBG binding\": [\"Androgens\", \"anabolic steroids\", \"glucocorticoids\", \"L-asparaginase\", \"nicotinic acid\"]\\n  },\\n  \"T4\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"T3\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"Thyroid gland hormone\": {\\n    \"Medications affecting iodine uptake\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"ethionamide\"],\\n    \"Medications affecting hormone production\": [\"Amiodarone\", \"ethionamide\", \"iodinated contrast agents\", \"iodine\", \"sulfonylureas\", \"sulfonamides\", \"thionamides (carbimazole, methimazole, propylthiouracil)\"],\\n    \"Medications affecting secretion\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"lithium\"],\\n    \"Medications inducing thyroiditis\": [\"Alemtuzumab\", \"amiodarone\", \"antiangiogenic agents (lenalidomide, thalidomide)\", \"denileukin diftitox\", \"interferon alpha\", \"interleukins\", \"lithium\", \"tyrosine kinase inhibitors (sunitinib, sorafenib)\"],\\n    \"Medications potentially causing the development of Graves’\": [\"Alemtuzumab\", \"interferon alpha\", \"antiretroviral therapy\"],\\n    \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves\\'\": [\"Glucocorticoids\"]\\n  },\\n  \"TSH\": {\\n    \"Medications decreasing TSH secretion\": [\"Bexarotene\", \"dopamine\", \"dopaminergic agonists (bromocriptine, cabergoline)\", \"glucocorticoids\", \"interleukin-6\", \"metformin\", \"opiates\", \"somatostatin analogues (octreotide, lanreotide)\", \"thyroid hormone analogues\"],\\n    \"Medications increasing TSH secretion\": [\"Amphetamine\", \"interleukin 2\", \"metoclopramide\", \"ritonavir\", \"St John\\'s wort\"],\\n    \"Medications potentially causing hypophysitis\": [\"Ipilimumab\"]\\n  }\\n}',\n 'Test names: Urine ketones, Thyroid function tests\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine ketones\": {\\n    \"Effect\": \"May cause a false-positive result\",\\n    \"Medication\": \"Valproate\",\\n    \"Mode of elimination\": \"Partially eliminated as a keto-metabolite in the urine\"\\n  },\\n  \"Thyroid function tests\": {\\n    \"Effect\": \"May alter\"\\n  }\\n}',\n 'Test names: Urine dipstick tests (urine protein, ketones, occult blood)\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine dipstick tests\": {\\n    \"Effects\": [\"May result in false-positive urine dipstick tests\"],\\n    \"Examples of tests affected\": [\"Urine protein\", \"ketones\", \"occult blood\"]\\n  }\\n}',\n 'Test names: Phenylketonuria test, Pregnancy test\\n\\nTest results as JSON:\\n\\n{\\n  \"Phenylketonuria test\": {\\n    \"Effect\": \"False-positives\"\\n  },\\n  \"Pregnancy test\": {\\n    \"Effect\": \"False-positives\"\\n  }\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names:\\n1. Rabbit antibody-based immunoassays\\n2. Cross-match or panel-reactive antibody cytotoxicity assays\\n\\nTest Results (in JSON format):\\n{\\n  \"Rabbit antibody-based immunoassays\": \"Potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"Potential interference\",\\n  \"Routine clinical laboratory tests which do not use immunoglobulins\": \"No interference shown\"\\n}',\n 'Not available',\n '{\"Positive Coombs\\'\": \"Positive\"}',\n '{\"serum TCA screen\": \"false-positive\"}',\n 'Not available',\n '{\"urine screening result for opioids\": \"false-positive\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Name: Urine Test with Blue Indicator\\nTest Result: Interfered',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n    \"test name\": \"amphetamine EMIT assay\",\\n    \"test result\": \"false positive\"\\n}',\n '{\\n    \"test name\": \"Urinary ketones\",\\n    \"test result\": \"false positive in patients receiving mesna with nitroprusside-based urine tests\"\\n},\\n{\\n    \"test name\": \"CPK activity\",\\n    \"test result\": \"may interfere with enzymatic CPK activity tests which use a thiol compound, resulting in a falsely low CPK level\"\\n},\\n{\\n    \"test name\": \"Ascorbic acid\",\\n    \"test result\": \"may result in false-positive reactions in Tillman\\'s reagent-based urine screening tests\"\\n}',\n '{\\n    \"test name\": \"urinary glucose tests\",\\n    \"test result\": \"may interfere with tests using cupric sulfate, but tests based on enzymatic glucose oxidase reactions are recommended\"\\n},\\n{\\n    \"test name\": \"plasma concentrations of certain hormones in pregnant women\",\\n    \"test result\": \"may be transiently interfered with by ampicillin, including total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"CD20 assay\": \"interfered\", \"CD19+ assay\": \"measure B-cell counts\"}',\n 'Not available',\n '{\"procainamide/N-acetyl procainamide concentration test\": \"affected\"}',\n 'Not available',\n 'Not available',\n 'Medical Test Names:\\n1. Serum bilirubin\\n2. Serum calcium\\n3. Examination of bone marrow iron stores\\n4. Bone scans with 99m Tc-labeled bone seeking agents\\n5. Bone scans with 99m Tc-diphosphonate\\n\\nTest Results in JSON Form:\\n{\\n\"Serum bilirubin\": \"falsely elevated values\",\\n\"Serum calcium\": \"falsely decreased values\",\\n\"Examination of bone marrow iron stores\": \"Residual iron dextran may remain in reticuloendothelial cells affecting accuracy\",\\n\"Bone scans with 99m Tc-labeled bone seeking agents\": \"reduced bony uptake, marked renal activity, and excess blood pooling and soft tissue accumulation following IV iron dextran infusion or with high serum ferritin levels\",\\n\"Bone scans with 99m Tc-diphosphonate\": \"dense activity in the buttocks following IM iron dextran\"\\n}',\n 'Medical Test Names:\\n1. Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\\n2. Coombs\\' test\\n\\nTest Results in JSON Form:\\n{\\n\"Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\": \"May interfere\",\\n\"Coombs\\' test\": \"positive\"\\n}',\n 'Medical Test Names:\\n1. Iodine-binding capacity of thyroid tissue\\n2. Diagnostic tests using iodine-containing isotopes\\n3. Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\\n\\nTest Results in JSON Form:\\n{\\n\"Iodine-binding capacity of thyroid tissue\": \"reduced for up to 2 weeks following administration of contrast media\",\\n\"Diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\": \"not affected\"\\n}',\n 'Not available',\n 'Medical Test Names:\\n1. PT/INR levels\\n\\nTest Results in JSON Form:\\n{\\n\"PT/INR levels\": \"may become elevated in the absence of warfarin. If warfarin is initiated, initial PT/INR goals while on bivalirudin may require modification\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '```\\n{\\n    \"Test Name\": \"Fluorescence Test for Urinary Catecholamines\",\\n    \"Test Result\": \"False Elevations\"\\n}\\n```',\n '```\\n{\\n    \"Test Name 1\": \"Activated Clotting Time (ACT)\",\\n    \"Test Result 1\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 2\": \"aPTT\",\\n    \"Test Result 2\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 3\": \"Prothrombin Time\",\\n    \"Test Result 3\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 4\": \"International Normalized Ratio\",\\n    \"Test Result 4\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 5\": \"Silica Clot Time (SCT)\",\\n    \"Test Result 5\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 6\": \"Dilute Russell\\'s Viper Venom Time (DRVVT)\",\\n    \"Test Result 6\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 7\": \"D-dimer\",\\n    \"Test Result 7\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 8\": \"Indirect Antiglobulin Test\",\\n    \"Test Result 8\": \"Positive\",\\n    \\n    \"Test Name 9\": \"Direct Antiglobulin Test\",\\n    \"Test Result 9\": \"Positive\"\\n}\\n```',\n 'Not available',\n 'Medical Tests:\\n1. Urinary 5-hydroxyindoleacetic acid \\n2. Urine detection of phencyclidine \\n3. Aldosterone/Renin ratio\\n\\nTest Results:\\n{\\n\"Urinary 5-hydroxyindoleacetic acid\": \"False-positive\",\\n\"Urine detection of phencyclidine\": \"False-positive\",\\n\"Aldosterone/Renin ratio\": \"False-positive\"\\n}',\n 'Not available',\n 'Medical Tests:\\n1. Cellular CD22 Detection\\n2. CD19+ B Cells Surrogate Assay\\n\\nTest Results:\\n{\\n\"Cellular CD22 Detection\": \"Interference\",\\n\"CD19+ B Cells Surrogate Assay\": \"Normal\"\\n}',\n 'Medical Tests:\\n1. PT\\n2. INR\\n3. aPTT\\n4. ACT\\n5. Xa (coagulation based assay)\\n6. Bleeding time\\n7. Factor Xa (chromogenic assay)\\n8. Platelet aggregation study\\n9. Thrombin time\\n10. Urine protein via qualitative dipstick\\n11. Urine protein via quantitative dye methods\\n\\nTest Results:\\n{\\n\"PT\": \"Artificially increased clotting times\",\\n\"INR\": \"Artificially increased clotting times\",\\n\"aPTT\": \"Artificially increased clotting times\",\\n\"ACT\": \"Artificially increased clotting times\",\\n\"Xa (coagulation based assay)\": \"Artificially increased clotting times\",\\n\"Bleeding time\": \"Normal\",\\n\"Factor Xa (chromogenic assay)\": \"Normal\",\\n\"Platelet aggregation study\": \"Normal\",\\n\"Thrombin time\": \"Normal\",\\n\"Urine protein via qualitative dipstick\": \"Interference\",\\n\"Urine protein via quantitative dye methods\": \"Interference\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"5-HIAA\": \"color interference\",\\n  \"VMA\": \"color interference\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Free Thyrotropin\": \"falsely elevated\",\\n  \"Free Triiodothyronine\": \"falsely elevated\",\\n  \"Thyroid-stimulating hormone\": \"not usually affected\",\\n  \"Standard Competitive Free Thyroid Hormone Assays\": \"not usually affected\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Test Name\": \"Urine Screening for Opioids\",\\n  \"Test Result\": \"false-positive with quinolones; confirmation recommended\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Test Name\": \"Bone Scan with Technetium-99m-diphosphonate\",\\n  \"Test Result\": \"may be interfered with by Bisphosphonates\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names and their respective results:\\n\\n1. Direct and Indirect Coombs\\' - Positive \\n2. Urinary glucose test using Benedict\\'s copper reduction reaction - False-Positive \\n3. Serum or urine creatinine with Jaffé reaction - False-Positive \\n4. Aminoglycoside serum concentration - Potentially underestimated \\n\\nJSON format:\\n\\n{\\n   \"Direct and Indirect Coombs\\'\": \"Positive\",\\n   \"Urinary glucose test using Benedict\\'s copper reduction reaction\": \"False-Positive\",\\n   \"Serum or urine creatinine with Jaffé reaction\": \"False-Positive\",\\n   \"Aminoglycoside serum concentration\": \"Potentially underestimated\"\\n}',\n 'Test names and their respective results:\\n\\n1. Serum chromogranin A (CgA) level - Falsely elevated with Esomeprazole \\n2. Diagnosis of a neuroendocrine tumor - False-positive \\n\\nJSON format:\\n\\n{\\n   \"Serum chromogranin A (CgA) level\": \"Falsely elevated with Esomeprazole\",\\n   \"Diagnosis of a neuroendocrine tumor\": \"False-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '1. Medical Test Names: Benedict\\'s solution, Clinitest, Fehling\\'s Solution\\n   Test Results: {\"Benedict\\'s solution\": \"May interfere with urinary glucose tests\", \\n                  \"Clinitest\": \"May interfere with urinary glucose tests\", \\n                  \"Fehling\\'s Solution\": \"May interfere with urinary glucose tests\"}\\n\\n2. Medical Test Names: Aminoglycoside serum concentration\\n   Test Results: {\"Aminoglycoside serum concentration\": \"Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Names: technetium-99m-diphosphonate bone scans\\nTest Results: {\"technetium-99m-diphosphonate bone scans\": \"May be interfered with by bisphosphonates\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Plasma phenytoin concentrations\": \"Falsely high\",\\n  \"Serum concentrations of T4\": \"Falsely low\",\\n  \"Serum concentrations of T3\": \"Falsely low\",\\n  \"Dexamethasone tests\": \"Falsely low\",\\n  \"Metyrapone tests\": \"Falsely low\",\\n  \"Thyroid-stimulating hormone (TSH) levels\": \"Increased\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Urine detection of opioids\": \"False-positive\",\\n  \"Coombs\\' test\": \"Positive\",\\n  \"Urinary steroids\": \"False elevation\",\\n  \"Catecholamines\": \"False elevation\",\\n  \"Urinary dipstick protein assays\": \"Qualitative and quantitative\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"urine detection of methadone\": \"false-positives\",\\n   \"urine detection of phencyclidine\": \"false-positives\",\\n   \"serum TCA screen\": \"false-positive\",\\n   \"wheal and flare reactions to skin test antigens\": \"suppressed\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Ceftazidime\": \"Positive direct Coomb\",\\n  \"Urine glucose\": \"False-positive with certain methods; use glucose tests based on enzymatic glucose oxidase reactions\"\\n}',\n '{\\n  \"Serum iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\",\\n  \"Transferrin bound iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Sorry, as an AI language model, I am not able to extract the medical test names and their results without any context or clear indication of where they are mentioned in the text. Could you please provide me with a specific text or document so I can help you better?',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Neutralizing antibody assay\": \"Obtain serum samples at least a month after the last dose to prevent assay interference.\", \\n  \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\"\\n}',\n 'Not available',\n 'Not available',\n '1. Medical Test Names: PT, anti-factor Xa assay, aPTT, free T4, free T3, thyroid stimulating hormone, standard competitive free thyroid hormone assays.\\n\\n2. Test Results in JSON format:\\n\\n{\\n \"PT\": \"Increased\",\\n \"anti-factor Xa assay\": \"falsely elevated results\",\\n \"aPTT\": \"little or minor effect\",\\n \"free T4\": \"falsely elevated levels\",\\n \"free T3\": \"falsely elevated levels\",\\n \"thyroid stimulating hormone\": \"not usually affected\",\\n \"standard competitive free thyroid hormone assays\": \"not usually affected\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n \"aPTT\": \"contains heparin\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '1. Medical test names: antibody screening, cross matching, Kell blood group system genotyping, serum protein electrophoresis (SPE), immunofixation (IFE), daratumumab-specific IFE assay.\\n\\n2. Test results in JSON format:\\n\\n{\\n   \"antibody screening\": \"N/A\",\\n   \"cross matching\": \"N/A\",\\n   \"Kell blood group system genotyping\": \"N/A\",\\n   \"serum protein electrophoresis (SPE)\": \"positive if daratumumab is present\",\\n   \"immunofixation (IFE)\": \"positive if daratumumab is present\",\\n   \"daratumumab-specific IFE assay\": \"distinguishes daratumumab from residual endogenous M protein\"\\n}',\n '{\\n  \"PT/INR\": [\"elevated\"], \\n  \"bivalirudin\": [\"modification\"]\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Names: \\n- Thyroid function test\\n\\nTest Results in JSON:\\n{\\n  \"T4 levels\": \"elevated\",\\n  \"Thyroid stimulating hormone levels\": \"at the high end of normal range\",\\n  \"T3 levels\": \"at the low end of normal range\"\\n}',\n 'Medical Test Names: N/A\\n\\nTest Results in JSON: N/A',\n 'Not available',\n '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate\": \"False-positive\",\\n  \"serum or urine creatinine with Jaffé reaction\": \"False-positive\"\\n}',\n '{\\n  \"polymerase chain reaction (PCR) assays for HIV\": \"Positive\",\\n  \"BB305 LVV proviral DNA\": \"Integrated\",\\n  \"screened for HIV infection using a PCR-based assay\": \"Should not\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n  \"ferricyanide test\": \"False-negative\",\\n  \"Glucose oxidase or hexokinase-based methods\": \"Should be used\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"uric acid\": \"N/A\"}',\n 'Not available',\n 'Not available',\n '{\"opioid screening\": \"false-positive result\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"urinary metanephrine\": \"May falsely increase\",\\n  \"HPLC assay with solid phase extraction for determination of urinary catecholamines\": \"does not interact with\",\\n  \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"\\n}',\n '{\\n  \"serum chromogranin A (CgA)\": \"may falsely elevate; may cause false-positive results in the diagnosis of a neuroendocrine tumor\",\\n  \"omeprazole\": \"Temporarily stop ≥14 days prior to assessing CgA level\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names:\\n1. Indirect Antiglobulin Test (indirect Coombs test)\\n2. Antibody Detection (screening) Tests\\n3. Antibody Identification Panels\\n4. Anti-Human Globulin Crossmatches\\n5. Blood Type and Screening\\n6. Phenotyping\\n7. Serum Protein Electrophoresis\\n8. Immunofixation Assays\\n\\nTest Result in JSON form:\\n{\\n   \"Indirect Antiglobulin Test\": \"false-positive\",\\n   \"Antibody Detection Tests\": \"may result in interference\",\\n   \"Antibody Identification Panels\": \"may result in interference\",\\n   \"Anti-Human Globulin Crossmatches\": \"may result in interference\",\\n   \"Blood Type and Screening\": \"recommended prior to the first isatuximab infusion\",\\n   \"Phenotyping\": \"consider prior to initiating treatment\",\\n   \"Serum Protein Electrophoresis\": \"may interfere with accuracy of determining complete response\",\\n   \"Immunofixation Assays\": \"may interfere with accuracy of determining complete response\"\\n}',\n 'Not available',\n '{\\n  \"Positive direct Coombs\\'\": \"Positive\",\\n  \"False-positive urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"Positive\",\\n  \"False-positive serum or urine creatinine with Jaffé reaction\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Medical test names\": [\\n    \"Aminoglycoside serum concentration\"\\n  ],\\n  \"Test results\": [\\n    \"Potential underestimation\"\\n  ]\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Medical test names\": [\\n    \"Aldosterone/renin ratio (ARR)\"\\n  ],\\n  \"Test results\": [\\n    \"False-negative\"\\n  ]\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: serum iron, copper, zinc, serum calcium.\\nTest results: \\n{\\n\"serum iron\": \"transient changes\",\\n\"copper\": \"transient changes\",\\n\"zinc\": \"transient changes\",\\n\"serum calcium\": \"apparent decrease after injection, accurate values can be obtained approximately 90 minutes after injection\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n \"Sorry, as an AI language model, I don't have the capability to extract specific information from unstructured data without any context. Please provide more specific data or context for me to extract the information as per your requirement.\",\n '{\"Coombs\\' [direct]\": \"Positive\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n    \"AST\": \"interfere\",\\n    \"ALT\": \"interfere\",\\n    \"triglycerides\": \"interfere\",\\n    \"glucose\": \"interfere\",\\n    \"LDH\": \"interfere\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: \\n- Urine screening test for opioids \\n\\nTest Results (in JSON form): \\n{\\n  \"Urine screening test for opioids\": \"false-positive for levofloxacin and ofloxacin, cross-reactivity in certain assay kits for other quinolones\"\\n}',\n 'Not available',\n 'Test Names:\\n- PT (Prothrombin Time) test\\n- INR (International Normalized Ratio) test\\n\\nTest Results (in JSON form):\\n{\\n  \"PT (Prothrombin Time) test\": \"false prolongation with certain recombinant thromboplastin reagents when taking daptomycin\",\\n  \"INR (International Normalized Ratio) test\": \"increase with certain recombinant thromboplastin reagents when taking daptomycin\"\\n}',\n 'Test Names:\\n- Whole blood assay for cyclosporine\\n\\nTest Results (in JSON form):\\n{\\n  \"Whole blood assay for cyclosporine\": \"may be falsely elevated if sample is drawn from the same central venous line through which dose was administered; cyclosporine metabolites cross-react with radioimmunoassay and fluorescence polarization immunoassay\"\\n}',\n 'Not available',\n 'Test Names: \\n1. Glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n2. Glucose-specific method\\n3. Anthrax immune globulin administration\\n4. Serologic testing\\n5. Direct and indirect Coombs’ test\\n\\nTest Results:\\n1. Falsely elevated blood glucose levels \\n2. N/A\\n3. Transiently elevated glucose \\n4. False-positive results \\n5. False-positive results',\n 'Not available',\n 'Test Names:\\n1. Immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000)\\n2. Dexamethasone test\\n3. Metyrapone test\\n\\nTest Results:\\n1. Falsely high plasma phenytoin concentrations \\n2. Falsely low results\\n3. Folate levels lowered',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"phencyclidine\": \"false-positives\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available']"
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_conditions"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-02T21:06:27.698283400Z",
     "start_time": "2023-05-02T21:06:27.635797700Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "outputs": [
    {
     "data": {
      "text/plain": "Empty DataFrame\nColumns: []\nIndex: [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, ...]\n\n[964 rows x 0 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n    </tr>\n    <tr>\n      <th>1</th>\n    </tr>\n    <tr>\n      <th>2</th>\n    </tr>\n    <tr>\n      <th>3</th>\n    </tr>\n    <tr>\n      <th>4</th>\n    </tr>\n    <tr>\n      <th>...</th>\n    </tr>\n    <tr>\n      <th>959</th>\n    </tr>\n    <tr>\n      <th>960</th>\n    </tr>\n    <tr>\n      <th>961</th>\n    </tr>\n    <tr>\n      <th>962</th>\n    </tr>\n    <tr>\n      <th>963</th>\n    </tr>\n  </tbody>\n</table>\n<p>964 rows × 0 columns</p>\n</div>"
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_conditions_df = pd.json_normalize(test_conditions)\n",
    "test_conditions_df"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-03T07:46:23.031799800Z",
     "start_time": "2023-05-03T07:46:23.000588800Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "outputs": [
    {
     "data": {
      "text/plain": "['{\\n\"Direct antiglobulin (Coombs) test\": \"Positive\",\\n\"Urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n\"Serum/urine creatinine with Jaffé reaction assay\": \"Falsely elevated\"\\n}',\n 'Not available',\n '{\\n\"Wheal and flare reactions to skin test antigens\": \"May be suppressed\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n    \"creatinine (Jaffé alkaline picrate reaction)\": \"Increased\",\\n    \"serum methotrexate (dihydrofolate reductase method)\": \"Increased\"\\n}',\n '{\\n    \"serum chromogranin A (CgA) levels\": \"falsely elevated (due to decreased gastric acidity with Omeprazole)\",\\n    \"neuroendocrine tumor diagnosis\": \"may cause false-positive results\",\\n    \"CgA levels assessment\": \"≥14 days after treatment is completed\",\\n    \"CgA levels repeat\": \"if initially elevated\"\\n}',\n '{\\n    \"automated platelet counts\": \"may interfere (platelet clumping) with Crizanlizumab\",\\n    \"blood samples collection\": \"in tubes containing ethylenediaminetetraacetic acid (EDTA)\",\\n    \"platelet count\": \"may be unevaluable or falsely decreased\",\\n    \"management\": \"Collect blood samples in citrate-containing tubes\",\\n    \"run blood samples\": \"within 4 hours of sample collection\",\\n    \"estimate platelet count\": \"through peripheral blood smear if necessary\"\\n}',\n '{\\n    \"triglyceride assays\": \"may be falsely elevated (dependent on glycerol oxidase)\",\\n    \"propylene glycol content\": \"in IV formulation\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: HbA1c.\\nTest results: \\n{\\n \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: dipyridamole-thallium myocardial imaging\\n\\nTest Results: {\"dipyridamole-thallium myocardial imaging\": \"false-negative result\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"HIV nucleic acid tests\": \"false positive results\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Urinary Glucose Determination (Clinitest)\": \"Interferes\",\\n  \"Coombs\\' Test (Direct)\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Coombs\\' Test (Direct)\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"direct Coombs\": \"positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"false-positive\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"serum ferritin\": \"transient increase\",\\n   \"urine zinc\": \"transient increase (with renal disease)\",\\n   \"bilirubin\": \"transient increase (with hepatic metabolic disorders)\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Names: \\n1. Urine detection of methadone \\n2. Urine detection of phencyclidine \\n3. Serum TCA screen \\n4. Skin test antigens \\n\\nJSON Form: \\n{\\n   \"Urine detection of methadone\": \"false-positive\",\\n   \"Urine detection of phencyclidine\": \"false-positives\",\\n   \"Serum TCA screen\": \"false-positive\",\\n   \"Skin test antigens\": \"suppressed wheal and flare reactions\"\\n}',\n 'Medical Test Name: \\n1. Skin test antigens \\n\\nJSON Form: \\n{\\n   \"Skin test antigens\": \"suppressed wheal and flare reactions\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Serum or transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric gluconate administration\",\\n  \"Serum ferritin levels\": \"falsely elevated for 5 days after ferric gluconate administration\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"urine detection of methadone\": \"false-positives\",\\n   \"phencyclidine\": \"false-positives\",\\n   \"serum TCA screen\": \"false-positive\",\\n   \"wheal and flare reactions to skin test antigens\": \"suppressed\"\\n}',\n '{\\n   \"thyroid function tests dependent on iodine estimation\": \"altered results\",\\n   \"radioiodine uptake studies\": \"affected results\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n   \"direct Coombs\\' test\": \"positive\",\\n   \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"false-positive\",\\n   \"serum creatinine with Jaffé reaction\": \"false-positive\",\\n   \"urine creatinine with Jaffé reaction\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"Urine detection of phencyclidine\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n   \"Clinitest®\": \"interfered with urinary glucose determination\",\\n   \"Coombs\\' [direct]\": \"positive\"\\n}',\n 'Not available',\n '{\\n   \"blood group isohemagglutinins\": \"presence\",\\n   \"Coombs test\": \"may be interfered with due to passive transmission of antibodies to erythrocyte antigens\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: \\n1. Serum or transferrin bound iron levels \\n2. Serum ferritin levels \\n\\nTest Results:\\n1. {\"Serum or transferrin bound iron levels\": \"May be falsely elevated if assessed within 24 hours of ferric gluconate administration.\"}\\n2. {\"Serum ferritin levels\": \"May be falsely elevated for 5 days after ferric gluconate administration.\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"direct Coombs\\'\": \"Positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\", \"ferricyanide test\": \"False-negative\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n- Urinary glucose determination \\n\\nTest Results in JSON format:\\n{\\n   \"Urinary glucose determination\": \"False-negative when using Clinistix® or Diastix®\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical test names: Basophils, hemoglobin, MCH, MCHC, albumin, alkaline phosphatase, cholesterol, creatinine, glucose, total protein, triglycerides, bilirubin, urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite), ALT, amylase, AST, CK, CKMB, LDH, phosphate, uric acid, PT, aPTT, urine pH.\\n\\nJSON form:\\n{\\n  \"Basophils\": \"Falsely elevated\",\\n  \"Hemoglobin\": \"Falsely elevated\",\\n  \"MCH\": \"Falsely elevated\",\\n  \"MCHC\": \"Falsely elevated\",\\n  \"Albumin\": \"Falsely elevated\",\\n  \"Alkaline phosphatase\": \"Falsely elevated\",\\n  \"Cholesterol\": \"Falsely elevated\",\\n  \"Creatinine\": \"Falsely elevated\",\\n  \"Glucose\": \"Falsely elevated\",\\n  \"Total protein\": \"Falsely elevated\",\\n  \"Triglycerides\": \"Falsely elevated\",\\n  \"Bilirubin\": \"Falsely elevated\",\\n  \"Urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite)\": \"Falsely elevated\",\\n  \"ALT\": \"Falsely decreased\",\\n  \"Amylase\": \"Falsely decreased\",\\n  \"AST\": \"Unpredictable\",\\n  \"CK\": \"Unpredictable\",\\n  \"CKMB\": \"Unpredictable\",\\n  \"LDH\": \"Unpredictable\",\\n  \"Phosphate\": \"Unpredictable\",\\n  \"Uric acid\": \"Unpredictable\",\\n  \"PT\": \"Unpredictable\",\\n  \"aPTT\": \"Unpredictable\",\\n  \"Urine pH\": \"Unpredictable\"\\n}',\n 'Not available',\n 'Medical test name: Blood glucose\\n\\nJSON form:\\n{\\n  \"Blood glucose\": \"falsely elevated\"\\n}',\n 'Not available',\n '{\\n \"Positive direct Coombs\": true,\\n \"Urinary glucose test using cupric sulfate (Benedict\\'s solution)\": false,\\n \"Urinary glucose test using Clinitest\": false,\\n \"Urinary glucose test using Fehling\\'s solution\": false,\\n \"Serum or urine creatinine with Jaffé reaction\": false,\\n \"Urinary proteins\": false,\\n \"Urinary steroids\": false\\n}',\n '{\\n \"Serum iron levels\": \"falsely elevated\",\\n \"Transferrin bound iron levels\": \"falsely elevated\"\\n}',\n '{\\n \"Coombs test\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\"HbA1c\": \"artificially lower through increased circulation of immature erythrocytes\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '1. T4-binding globulin (TBG)\\n{\\n  \"Conditions/states that increase TBG binding\": \"Pregnancy, hepatitis, porphyria, neonatal state\",\\n  \"Medications that increase TBG binding\": \"Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\",\\n  \"Conditions/states that decrease TBG binding\": \"Hepatic failure, nephrosis, severe illness.\",\\n  \"Medications that decrease TBG binding\": \"Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\"\\n}\\n\\n2. Thyroxine (T4) and triiodothyronine (T3)\\n{\\n  \"Medications that inhibit T4 and T3 binding\": \"Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\"\\n}\\n\\n3. Thyroid gland hormone: Interference with production and secretion\\n{\\n  \"Medications affecting iodine uptake\": \"Amiodarone, iodinated contrast agents, iodine, ethionamide\",\\n  \"Medications affecting hormone production\": \"Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\",\\n  \"Medications affecting secretion\": \"Amiodarone, iodinated contrast agents, iodine, lithium\",\\n  \"Medications inducing thyroiditis\": \"Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\",\\n  \"Medications potentially causing the development of Graves’\": \"Alemtuzumab, interferon alpha, antiretroviral therapy\",\\n  \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’\": \"Glucocorticoids\"\\n}\\n\\n4. Hypothalamic-pituitary axis and TSH: Interference with secretion\\n{\\n  \"Medications decreasing TSH secretion\": \"Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\",\\n  \"Medications increasing TSH secretion\": \"Amphetamine, interleukin 2, metoclopramide, ritonavir, St John\\'s wort\",\\n  \"Medications potentially causing hypophysitis\": \"Ipilimumab\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Iodine-binding capacity of thyroid tissue\": \"reduced for up to 2 weeks following administration of contrast media\",\\n  \"diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n  \"Thyroid function tests that are independent of iodine estimation for results\": \"not affected (eg, T3 resin uptake, thyroxine assays)\"\\n}',\n 'Not available',\n '{\\n  \"Urine test for amphetamines/methamphetamines\": \"May interfere with detection (false-positive)\"\\n}',\n '{\\n  \"Parathyroid function tests\": \"may be interfered with\",\\n  \"Aldosterone/renin ratio (ARR) test\": \"may give a false-negative result\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '- Medical test names: T4-binding globulin (TBG), Thyroxine (T4), Triiodothyronine (T3), Thyroid gland hormone, Hypothalamic-pituitary axis, TSH\\n- Extracted test results (in JSON form):\\n\\n{\\n  \"T4-binding globulin (TBG)\": {\\n    \"Conditions/states that increase TBG binding\": \"Pregnancy, hepatitis, porphyria, neonatal state\",\\n    \"Medications that increase TBG binding\": \"Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\",\\n    \"Conditions/states that decrease TBG binding\": \"Hepatic failure, nephrosis, severe illness\",\\n    \"Medications that decrease TBG binding\": \"Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\"\\n  },\\n  \\n  \"Thyroxine (T4) and Triiodothyronine (T3)\": {\\n    \"Medications that inhibit T4 and T3 binding\": \"Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\"\\n  },\\n  \\n  \"Thyroid gland hormone\": {\\n    \"Medications affecting iodine uptake\": \"Amiodarone, iodinated contrast agents, iodine, ethionamide\",\\n    \"Medications affecting hormone production\": \"Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\",\\n    \"Medications affecting secretion\": \"Amiodarone, iodinated contrast agents, iodine, lithium\"\\n  },\\n  \\n  \"Hypothalamic-pituitary axis and TSH\": {\\n    \"Medications decreasing TSH secretion\": \"Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\",\\n    \"Medications increasing TSH secretion\": \"Amphetamine, interleukin 2, metoclopramide, ritonavir, St John\\'s wort\",\\n    \"Medications potentially causing hypophysitis\": \"Ipilimumab\"\\n  }\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: None mentioned\\n\\nTest Results: None mentioned',\n 'Test Names: \\n- Stool occult blood test\\n- Blood glucose testing\\n- Urine glucose testing\\n- Nitrite level testing\\n- Bilirubin level testing\\n- Leucocyte count testing\\n\\nTest Results: \\n- Stool occult blood: False negative 48 to 72 hours after ascorbic acid ingestion\\n- Blood glucose: Falsely elevated glucose measurements by point of care glucometers with high-dose ascorbic acid\\n- Urine glucose: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Nitrite level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Bilirubin level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Leucocyte count: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test name: Interferes with gastric secretion test\\nTest result: Transdermal system should be discontinued ≥10 days prior to testing.\\n\\nJSON format: {\"Interferes with gastric secretion test\": \"Transdermal system should be discontinued ≥10 days prior to testing.\"}',\n 'Not available',\n 'Test name: Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\\nTest result: May interfere\\n\\nTest name: Aminoglycoside serum concentration\\nTest result: Potential underestimation due to the acceleration of degradation by some penicillin derivatives\\n\\nJSON format: {\"Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\": \"May interfere\", \"Aminoglycoside serum concentration\": \"Potential underestimation due to the acceleration of degradation by some penicillin derivatives\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. Serum iron levels\\n2. Transferrin bound iron levels\\n\\nTest results in JSON format:\\n{\\n  \"Serum iron levels\": \"not specified\",\\n  \"Transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}',\n 'Not available',\n 'Test Names: Pregnancy test\\nTest Results: False-positive or false-negative',\n 'Test Names: Urine opioid screening\\nTest Results: False-positive (with some quinolones)',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"Urine detection of methadone\": \"false-positive\"}',\n '{\"Coombs\\' test [direct]\": \"false-positive\"}',\n 'Not available',\n '{\\n  \"urinary uric acid (phosphotungstate method)\": \"interference by Methyldopa\",\\n  \"serum creatinine (alkaline picrate method)\": \"interference by Methyldopa\",\\n  \"AST (colorimetric method)\": \"interference by Methyldopa\",\\n  \"urinary catecholamines (falsely high levels)\": \"interference by Methyldopa\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive by Methyldopa\"\\n}',\n '{\\n  \"urine screening for opioids\": \"false-positive by some quinolones (levofloxacin, ofloxacin, and others)\",\\n  \"confirmation of positive opioid screens\": \"should be considered using more specific methods\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names:\\n1. Plasma glucose\\n2. Uric acid\\n3. Free fatty acids\\n4. Total cholesterol\\n5. HDL\\n6. HDL/LDL ratio\\n7. Urinary free cortisol excretion\\n8. Triiodothyronine\\n\\nTest results in JSON form:\\n{\\n\"Plasma glucose\": \"increased\",\\n\"Uric acid\": \"increased\",\\n\"Free fatty acids\": \"increased\",\\n\"Total cholesterol\": \"increased\",\\n\"HDL\": \"increased\",\\n\"HDL/LDL ratio\": \"increased\",\\n\"Urinary free cortisol excretion\": \"increased\",\\n\"Triiodothyronine\": \"decreased\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"coagulation\": \"Altered\", \"fibrinolytic activity\": \"Altered\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n\"skin test antigens\": \"suppressed\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Ceftazidime\": \"Positive direct Coomb\",\\n  \"Urine Glucose\": \"False-positive reaction with certain methods\"\\n}',\n '{\\n  \"Serum Iron\": \"Transitory changes observed\",\\n  \"Serum Calcium\": \"May interfere with colorimetric tests; alternate testing method recommended for 12-24 hours after administration\"\\n}',\n 'Not available',\n '{\\n  \"Urinary Catecholamines\": \"False-positive (fluorometric assay)\",\\n  \"17-hydroxycorticosteroids\": \"False-positive\",\\n  \"17-ketosteroids\": \"False-positive\"\\n}',\n 'Test names: \\n1. Serum TCA screen\\n2. Skin test antigens\\n\\nTest results:\\n1. False-positive\\n2. Suppressed wheal and flare reactions',\n 'Not available',\n \"Test names: \\n1. Coombs' test\\n2. Aldosterone/renin ratio\\n\\nTest results:\\n1. Positive\\n2. False-positive\",\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: \\n1. MR imaging \\n2. Serum Iron \\n3. Transferrin-bound Iron \\n\\nCorresponding Test Results in JSON:\\n{\\n  \"MR imaging\": \"May interfere with imaging; alterations may persist for ≤3 months following use, with peak alterations anticipated in the first 2 days following administration. If MR imaging is required within 3 months after administration, use T1- or proton density-weighted MR pulse sequences to decrease effect on imaging. Do not use T2-weighted sequence MR imaging prior to 4 weeks following administration.\",\\n  \"Serum Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\",\\n  \"Transferrin-bound Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\"\\n}',\n 'Test Names: \\n1. Blood glucose levels\\n2. Serologic testing results\\n3. Direct Coombs\\' test\\n4. Indirect Coombs\\' test\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Blood glucose levels\": \"Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\",\\n  \"Serologic testing results\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Direct Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Indirect Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\"\\n}',\n 'Test Names: \\n1. Serum chromogranin A (CgA) levels\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Serum chromogranin A (CgA) levels\": \"Omeprazole may falsely elevate CgA levels, causing false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n\"Medical Test Name\": \"Detection of urine protein\",\\n\"Test Result\": \"False positive when pyrogallol red reagent is used\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"amylase\": \"increased\",\\n  \"BSP retention\": \"increased\",\\n  \"CPK\": \"increased\"\\n}',\n 'Not available',\n '{\\n  \"serum progesterone assay\": \"may interfere\",\\n  \"interaction\": \"may be observed\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n '{\\n  \"blood ethylene glycol concentrations\": \"false positive\",\\n  \"inorganic phosphorus blood concentrations\": \"false low\"\\n}',\n '{\\n  \"gastric secretion test\": \"interference\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Bone imaging studies\": \"May interfere with\",\\n  \"Hematopoietic activity\": \"increased\",\\n  \"Bone marrow\": \"May appear as transient positive bone imaging changes.\"\\n}',\n '{\\n  \"aldosterone/renin ratio (ARR)\": \"May lead to false-negative\"\\n}',\n '{\"urine glucose\": \"may interfere with tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}',\n '{\"glucose\": \"increased\", \"HDL\": \"decreased\", \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"}',\n 'Not available',\n 'Not available',\n '{\"direct Coombs\\'\": \"positive\", \"indirect Coombs\\'\": \"positive\", \"urinary glucose test\": \"false-positive using glucose tests based on Benedict\\'s copper reduction reaction\", \"serum or urine creatinine\": \"false-positive with Jaffé reaction\", \"aminoglycoside serum concentration\": \"potential underestimation due to some penicillin derivatives accelerating degradation in vitro\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"urine glucose test\": \"may interfere with containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}',\n 'Not available',\n 'Not available',\n 'Test Names:\\n\\n1. Urine glucose test containing cupric sulfate\\n2. Coombs\\' test\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Urine glucose test containing cupric sulfate\": \"May interfere\",\\n  \"Coombs\\' test\": \"Positive\"\\n}',\n 'Test Names:\\n\\n1. Aldosterone/renin ratio (ARR)\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Aldosterone/renin ratio (ARR)\": \"May lead to false-negative\"\\n}',\n 'Not available',\n '{\"coagulation\": \"Altered results\", \"fibrinolytic activity\": \"Altered results\"}',\n 'Not available',\n 'Not available',\n '{\"aldosterone/renin ratio\": \"false-negative\", \"ARR\": \"false-negative\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: \\n1. Digitalis immunoassay \\n2. Digoxin serum samples\\n\\nTest Results: \\n{\\n   \"Digitalis immunoassay\": \"may be clinically misleading until all Fab fragments are eliminated from the body\",\\n   \"Digoxin serum samples\": \"should be obtained before digoxin immune fab administration, if possible\"\\n}',\n 'Test Names: \\n1. Urine test for phencyclidine\\n\\nTest Results: \\n{\\n   \"Urine test for phencyclidine\": \"false-positive interference may occur\"\\n}',\n 'Not available',\n '{\\n\"skin test antigens\": \"suppressed\"\\n}',\n 'Not available',\n '{\\n\"urinary 5-hydroxyindoleacetic acid\": \"false-positive\"\\n}',\n '{\\n\"enzymatic methods used to detect opioids\": \"interference (refer to test manufacturer for details)\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"skin tests\": \"decreased response\"}',\n 'Not available',\n 'Test Names: \\n- Urine screening test for opioids using commercially-available immunoassay kits\\n\\nTest Results:\\n- Levofloxacin and ofloxacin may produce a false-positive result\\n- Other quinolones may also show cross-reactivity in certain assay kits\\n- Positive opioid screens should be confirmed by more specific methods.',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical tests names: \\n1. Urine glucose determinations \\n2. Certain lab tests \\n\\nJSON output: \\n{\\n  \"Urine glucose determinations\": \"false-negative\",\\n  \"Certain lab tests\": \"incorrect\"\\n}',\n 'Not available',\n 'Not available',\n 'Medical tests names: PT/INR\\n\\nJSON output: {\"PT/INR\": \"unreliable within 5 hours\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-negative.',\n 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-positive.',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Folic acid\": \"invalidated\",\\n  \"Vitamin B12\": \"invalidated\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Opioid screening test\": \"false-positive (when taking some quinolones)\",\\n  \"Specific confirmation test\": \"recommended\"\\n}',\n 'Test names:\\n- Urine specimen assay\\n\\nTest results in JSON form:\\n{\\n \"Urine specimen assay\": \"N/A\"\\n} \\n(Note: \"N/A\" is the value because no specific test result is mentioned in the sentence)',\n 'Not available',\n 'Test names:\\n- Direct Coombs\\' test\\n- Urinary glucose test\\n- Serum creatinine test\\n- Urine creatinine test\\n\\nTest results in JSON form:\\n{\\n \"Direct Coombs\\' test\": \"Positive\",\\n \"Urinary glucose test\": \"False-positive\",\\n \"Serum creatinine test\": \"False-positive\",\\n \"Urine creatinine test\": \"False-positive\"\\n}',\n 'Not available',\n 'Not available',\n '1) Medical test names: \\n- Rapid plasma reagin (RPR) test\\n2) Test results in JSON format:\\n- For RPR test: {\"Rapid plasma reagin (RPR) test\": \"false-positive due to smallpox vaccine\"}\\n\\n1) Medical test names:\\n- Tuberculin skin (PPD) and blood tests\\n2) Test results in JSON format:\\n- For Tuberculin skin (PPD) and blood tests: {\"Tuberculin skin (PPD) and blood tests\": \"false-negative due to smallpox vaccine\"}',\n 'Not available',\n 'Not available',\n '1) Medical test names:\\n- Bone scan (diagnostic imaging with technetium-99m-diphosphonate)\\n2) Test results in JSON format:\\n- For bone scan: {\"Bone scan\": \"may be interfered by bisphosphonates except clodronate, according to some studies\"}',\n 'Not available',\n 'Not available',\n 'Test Names: Lactobacillus casei assay method\\nTest Result: Falsely low serum concentrations may occur in patients on anti-infectives (eg, tetracycline)',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n \"Test Names: \\n1. Urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®)\\n2. Aminoglycoside activity test\\n3. Urinary protein test\\n4. Serum protein test\\n\\nTest Results:\\n1. May interfere\\n2. May inactivate in vitro\\n3. False positive in urinary test\\n4. False positive in serum test\",\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n1) Direct Coombs\\' test\\n2) Urinary glucose test\\n3) Serum or urine creatinine test with Jaffé reaction\\n\\nJSON Form: \\n{\\n  \"Direct Coombs\\' test\": \"Positive\",\\n  \"Urinary glucose test\": \"False-positive\",\\n  \"Serum or urine creatinine test with Jaffé reaction\": \"May cause false-positive\"\\n}',\n 'Not available',\n 'Test Name: Aldosterone/Renin Ratio (ARR)\\nTest Result: May lead to false-negative (Funder 2016)',\n 'Not available',\n 'Test Names: laboratory tests related to coagulation factors, lipids, glucose tolerance, thyroxine-binding globulin, sex hormone-binding globulin, cortisol-binding globulin\\nTest Result: The use of estrogens and/or progestogens may alter the results (general statement)',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. Technetium-99m-diphosphonate bone scan \\n\\nTest results:\\n{\\n\"Technetium-99m-diphosphonate bone scan\": \"may be interfered with by Bisphosphonates\"\\n}',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. Coombs\\' test [direct]\\n\\nTest results:\\n{\\n\"Coombs\\' test [direct]\": \"false-positive \"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"dexamethasone suppression test\": \"false-negative\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n '{\\n    \"phenylketonuria\": \"false-positive\",\\n    \"amylase\": \"false-positive\",\\n    \"uroporphyrins\": \"false-positive\",\\n    \"urobilinogen\": \"false-positive\",\\n    \"pregnancy test\": \"false-positive\",\\n    \"amphetamine/methamphetamine\": \"false-positive\",\\n    \"methadone\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n \"1. Medical test name: Urinary glucose tests\\n   Test result: May interfere with using cupric sulfate (Benedict's solution, Clinitest®)\\n\\n2. Medical test name: Aminoglycoside serum concentration\\n   Test result: Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives.\",\n 'Medical test name: Serum creatinine values\\nTest result: Markedly false elevations when the Ektachem® analyzer is used. The Jaffé reaction is recommended for determining serum creatinine.',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"HbA1c\": \"artificially lowered\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. Urine screening test for opioids using commercially-available immunoassay kits\\n\\nTest results:\\n1. False-positive results for opioids may be produced by some quinolones, especially levofloxacin and ofloxacin\\n2. Other quinolones may also show cross-reactivity in certain assay kits.\\n3. Positive opioid screens should be confirmed by more specific methods.',\n 'Test names: \\n1. Skin test\\n\\nTest results:\\n1. Decreased response to skin tests.',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n    \"Urinary glucose tests using cupric sulfate\": \"May interfere\",\\n    \"Aminoglycosides\": \"May inactivate in vitro\",\\n    \"Urine proteins\": \"False-positive\",\\n    \"Serum proteins\": \"False-positive\",\\n    \"Uric acid\": \"False-positive\",\\n    \"Urinary steroids\": \"False-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Medical Test Name\": \"TPMT phenotyping\",\\n  \"Test Result\": \"May not be accurate following recent blood transfusions.\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Serum renin concentrations\": \"increased\",\\n  \"IgG concentrations\": \"increased\",\\n  \"Serum cortisol concentrations\": \"decreased\",\\n  \"insulin response to glucagon\": \"false-negative\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"fluorescence test for urinary catecholamines\":\"false elevations\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n \"I'm sorry, but I cannot extract the medical test names and their results without any input data. Please provide the data.\",\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"cross-reactivity\", \"ofloxacin\": \"cross-reactivity\", \"other quinolones\": \"cross-reactivity\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Thyroid function tests (protein bound and radioactive iodine uptake studies)\": \"inaccurate for up to 16 days after administration\",\\n  \"Multistix urine protein test\": \"may cause false positive results\",\\n  \"Urine specific gravity\": \"may be affected\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: \\n1. PT/INR levels\\n2. Chromogenic factor X assay\\n3. Factor Xa levels\\n\\nTest results:\\n{\\n  \"PT/INR levels\": \"elevated in the absence of warfarin, may require modification while on argatroban\",\\n  \"Chromogenic factor X assay\": \"suggested to be monitored when transitioning from argatroban to warfarin or overlapping administration of warfarin for a minimum of 5 days until INR is within target range, recheck INR after anticoagulant effect of argatroban has dissipated\",\\n  \"Factor Xa levels\": \"associated with INR values >2 after the effects of argatroban have been eliminated\"\\n}',\n 'Not available',\n '{\\n  \"Test name\": \"Polymerase chain reaction (PCR) assay for HIV\",\\n  \"Test result\": \"False-positive for HIV in patients who have received betibeglogene autotemcel due to integrated BB305 LVV proviral DNA\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Names: Serum magnesium test and Urine magnesium test.\\n\\nJSON output:\\n{\\n \"Serum magnesium test\": \"falsely decreased\",\\n \"Urine magnesium test\": \"falsely decreased\"\\n}',\n 'Not available',\n 'Medical Test Names: Coombs\\' test and Urinary protein test.\\n\\nJSON output:\\n{\\n \"Coombs\\' test\": \"positive\",\\n \"Urinary protein test\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"metyrapone test\": \"reduced response\"\\n}',\n 'Not available',\n '{\\n  \"anti-FXa activity assay\": \"falsely elevated after andexanet alfa administration\",\\n  \"andexanet alfa\": \"reversal activity\"\\n}',\n '{\\n  \"urine screening test\": \"false-positive for opioids\",\\n  \"immunoassay kits\": \"affected by quinolones\",\\n  \"levofloxacin\": \"produces most consistent false-positive\",\\n  \"ofloxacin\": \"produces false-positive\",\\n  \"other quinolones\": \"may show cross-reactivity\",\\n  \"confirmation test\": \"more specific methods recommended for positive screens\"\\n}',\n '{\\n    \"Positive direct Coombs\\'\": \"positive\",\\n    \"false-positive urinary glucose test using nonenzymatic methods\": \"false-positive\",\\n    \"false-positive galactosemia tests\": \"false-positive\"\\n}',\n '{\\n    \"false-positive amphetamine EMIT assay\": \"positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"Thyroid function tests\": \"Altered\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Plasma glucose\": \"increased\",\\n  \"Uric acid\": \"increased\",\\n  \"Free fatty acids\": \"increased\",\\n  \"Total cholesterol\": \"increased\",\\n  \"HDL\": \"increased\",\\n  \"HDL/LDL ratio\": \"increased\",\\n  \"Urinary free cortisol excretion\": \"increased\",\\n  \"Triiodothyronine\": \"decreased\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Name: Urine Detection of Phencyclidine\\nTest Result: False-Positive',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '1. Medical tests mentioned in the given data:\\n- Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n- Glucose-specific method\\n- Urinalysis\\n- Serologic testing\\n- Direct and indirect Coombs’ test\\n\\n2. Test results in JSON form:\\n{\\n  \"Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\": \"falsely elevated blood glucose levels\",\\n  \"Glucose-specific method\": \"recommended\",\\n  \"Urinalysis\": \"transiently elevated glucose\",\\n  \"Serologic testing\": \"false-positive results\",\\n  \"Direct and indirect Coombs’ test\": \"false-positive results\"\\n}',\n '1. Medical tests mentioned in the given data:\\n- AST testing\\n- ALT testing\\n- Triglycerides testing\\n- Glucose testing\\n- LDH testing\\n\\n2. Test results in JSON form:\\n{\\n  \"AST testing\": \"may be interfered\",\\n  \"ALT testing\": \"may be interfered\",\\n  \"Triglycerides testing\": \"may be interfered\",\\n  \"Glucose testing\": \"may be interfered\",\\n  \"LDH testing\": \"may be interfered\"\\n}',\n '1. Medical test mentioned in the given data:\\n- Skin test for wheal and flare reactions to antigens \\n\\n2. Test result in JSON form:\\n{\\n  \"Skin test for wheal and flare reactions to antigens\": \"may be suppressed\"\\n}',\n 'Not available',\n '1. Medical test mentioned in the given data:\\n- Digoxin radioimmunoassay \\n\\n2. Test result in JSON form:\\n{\\n  \"Digoxin radioimmunoassay\": \"may be interfered\"\\n}',\n 'Not available',\n 'Test Names: Methotrexate levels\\nTest Result: {\"Methotrexate levels\": \"the chromatographic method\"}',\n 'Not available',\n 'Test Names: \\n1. Urine catecholamines\\n2. Metanephrine \\n3. Normetanephrine \\n4. Vanillylmandelic acid (VMA) \\n5. Urine amphetamine \\n6. Aldosterone/renin ratio (ARR)\\n\\nTest Results:\\n{\\n   \"Urine catecholamines\": \"HPLC assay with solid-phase extraction should be used to determine levels of catecholamines\",\\n   \"Metanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of metanephrine\",\\n   \"Normetanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of normetanephrine\",\\n   \"Vanillylmandelic acid (VMA)\": \"HPLC assay with solid-phase extraction should be used to determine levels of VMA\",\\n   \"Urine amphetamine\": \"Gas chromatographic-mass spectrometer technique should be used to determine levels of amphetamine\",\\n   \"Aldosterone/renin ratio (ARR)\": \"May lead to a false-positive result\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names:\\n- Urinary glucose determination using Clinitest®\\n- Coombs\\' direct\\n\\nTest Results (in json format):\\n{\\n  \"Urinary glucose determination using Clinitest®\": \"Interfered\",\\n  \"Coombs\\' direct\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"phencyclidine\": \"false-positives\",\\n  \"aldosterone/renin ratio\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"aldosterone/renin ratio (ARR)\": \"false-positive\"}',\n 'Not available',\n '{\"iodine-binding capacity\": \"reduced for up to 2 weeks following administration of contrast media\", \\n\"diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results\": \"not affected (eg, T3 resin uptake, thyroxine assays)\"}',\n '{\"renin (S)\": \"increased\",\\n \"aldosterone (S)\": \"increased\"}',\n 'Not available',\n 'Not available',\n '{\"PCR assays for HIV\": \"positive\", \"HIV infection using a PCR-based assay\": \"false-positive\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: PT, INR\\nJSON format: {\"PT\": <test result>, \"INR\": <test result>}',\n 'Not available',\n 'Test names: \\n- Plasma glucose\\n- Uric acid\\n- Free fatty acids\\n- Total cholesterol\\n- HDL\\n- HDL/LDL ratio\\n- Urinary free cortisol excretion\\n- Triiodothyronine\\n\\nJSON format: \\n{\\n\"Plasma glucose\": <test result>,\\n\"Uric acid\": <test result>,\\n\"Free fatty acids\": <test result>,\\n\"Total cholesterol\": <test result>,\\n\"HDL\": <test result>,\\n\"HDL/LDL ratio\": <test result>,\\n\"Urinary free cortisol excretion\": <test result>,\\n\"Triiodothyronine\": <test result>\\n}',\n 'Not available',\n '{\\n   \"Test Name\": \"Amphetamine EMIT assay\",\\n   \"Test Result\": \"False-positive\"\\n}',\n '{\\n   \"Test Name\": \"Coombs test\",\\n   \"Test Result\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Coombs\\' test (direct)\": \"Positive\",\\n  \"Urinary proteins\": \"False-positive\",\\n  \"Serum proteins\": \"False-positive\",\\n  \"Aminoglycoside inactivation\": \"In vitro\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Stool occult blood test\": \"False-negative\",\\n  \"Blood glucose testing\": \"Interference (falsely-elevated)\",\\n  \"Urine glucose testing\": \"Interference\",\\n  \"Nitrite levels\": \"Interference\",\\n  \"Bilirubin levels\": \"Interference\",\\n  \"Leucocyte count\": \"Interference\"\\n}',\n '{\\n  \"One-stage clotting assay (OSA)\": \"Affected by aPTT reagent and reference standard used; recommended for monitoring factor IX activity over time with the same assay and reagents\",\\n  \"Activated partial thromboplastin time (aPTT)\": \"Type of reagent used affects results when using OSA to determine factor IX activity\",\\n  \"Chromogenic substrate assay (CSA)\": \"Results in lower factor IX activity compared to OSA; mean CSA to OSA factor IX activity ratio ranging from 0.41 to 0.55 in clinical study\"\\n}',\n 'Not available',\n 'Not available',\n '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"positive\", \"ofloxacin\": \"positive\"}',\n '{\"urinary glucose determination using Clinitest\": \"interferes\", \"Coombs\\' [direct]\": \"positive\"}',\n 'Not available',\n 'Test Names: \\n1. Serum Protein Electrophoresis (SPEP)\\n2. Serum Immunofixation Assays\\n \\nTest Results in JSON Format:\\n{\\n   \"SPEP\": \"A small peak in the early gamma region\",\\n   \"Serum Immunofixation Assays\": \"may potentially be attributed to elotuzumab\"\\n}',\n 'Not available',\n 'Test Name:\\n1. Serum Iron Test\\n\\nTest Result in JSON Format:\\n{\\n   \"Serum Iron Test\": \"Falsely high or low values of serum iron (if determined by complexometric methods) may occur for up to 24 hours following administration.\"\\n}',\n 'Not available',\n 'Test Names:\\n1. Urinary 5-hydroxyindoleacetic acid test\\n2. Urine detection of Phencyclidine test\\n3. Aldosterone/Renin Ratio (ARR) test\\n\\nTest Results in JSON Format:\\n{\\n   \"Urinary 5-hydroxyindoleacetic acid test\": \"false-positive due to Acetaminophen\",\\n   \"Urine detection of Phencyclidine test\": \"false-positives due to Ibuprofen\",\\n   \"Aldosterone/Renin Ratio (ARR) test\": \"false-positive due to Ibuprofen\"\\n}',\n 'Not available',\n 'Not available',\n '1. Medical test names:\\n- Urine screening test for opioids using immunoassay kits\\n- Confirmation test for positive opioid screens using more specific methods\\n- Urine methadone screens using immunoassay kits\\n\\n2. Test Results in JSON format:\\n{\\n  \"Urine screening test for opioids using immunoassay kits\": \"false-positive for opioids with quinolones (levofloxacin and ofloxacin) and other medications (not specified)\",\\n  \"Confirmation test for positive opioid screens using more specific methods\": \"not specified\",\\n  \"Urine methadone screens using immunoassay kits\": \"false-positive in patients taking diphenhydramine, doxylamine, clomipramine, chlorpromazine, thioridazine, quetiapine, and verapamil\"\\n}',\n '1. Medical test names:\\n- Rabbit antibody-based immunoassays\\n- Cross-match or panel-reactive antibody cytotoxicity assays\\n- Routine clinical laboratory tests which use immunoglobulins\\n\\n2. Test Results in JSON format:\\n{\\n  \"Rabbit antibody-based immunoassays\": \"potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"potential interference\",\\n  \"Routine clinical laboratory tests which use immunoglobulins\": \"no interference shown\"\\n}',\n 'Not available',\n \"I'm sorry, I cannot extract the medical test names and their results without any specific data to refer to. Please provide the necessary information.\",\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: Not specified in the given data.\\nTest Results:\\n{\\n\"Urine Protein Detection with Pyrogallol Red reagent\": \"May give false positive results if Viltolarsen is present in urine\",\\n\"Urine Protein Detection with other test methods\": \"Not affected by Viltolarsen\",\\n\"Timeframe for avoiding false positives\": \"Urine obtained prior to infusion or ≥48 hours after infusion\",\\n}',\n 'Not available',\n 'Medical Test Name: PHOSm assay\\n\\nTest Result JSON: {\"PHOSm assay\": \"Falsely-elevated serum phosphate\"}',\n 'Not available',\n 'Medical Test Names: \\n1. Phosphotungstate method for uric acid\\n2. Ehrlich\\'s reagent for urobilinogen\\n3. Spectrophotometric determination of serum theophylline concentration\\n\\nTest Result JSON: \\n{\\n   \"Phosphotungstate method for uric acid\": \"False-positive\",\\n   \"Ehrlich\\'s reagent for urobilinogen\": \"False-positive\",\\n   \"Spectrophotometric determination of serum theophylline concentration\": \"Interference with large doses\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Urinary protein with Albustix\": \"false-positive\",\\n  \"Labstix\": \"false-positive\",\\n  \"Albutest\": \"false-positive\",\\n  \"Bumintest\": \"false-positive\",\\n  \"HPLC theophylline assay\": \"interference\",\\n  \"Serum uric acid levels\": \"interference\",\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n '{\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'Not available',\n '{\\n  \"Diagnostic serum tests that utilize antibodies\": \"interference\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n \"levofloxacin\": \"false-positive urine screening result for opioids\",\\n \"ofloxacin\": \"false-positive urine screening result for opioids\",\\n \"other quinolones\": \"cross-reactivity in certain assay kits\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"serologic testing\": \"false-positive\", \"direct Coombs test\": \"false-positive\", \"indirect Coombs test\": \"false-positive\"}',\n 'Not available',\n 'Not available',\n '{\\n  \"Dehydrogenase Pyrroloquinolinequinone\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose-dye-oxidoreductase\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose Dehydrogenase Nicotine Adenine Dinucleotide (GDH-NAD)\": \"Recommended glucose monitoring method\",\\n  \"Glucose Oxidase\": \"Recommended glucose monitoring method\",\\n  \"Glucose Hexokinase\": \"Recommended glucose monitoring method\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Medical Test Names\": [\\n    \"Aminoglycoside Serum Concentration\"\\n  ],\\n  \"Test Results\": [\\n    \"Potential Underestimation\"\\n  ]\\n}',\n 'Not available',\n '{\\n  \"Medical Test Names\": [\\n    \"Aldosterone/Renin Ratio (ARR)\"\\n  ],\\n  \"Test Results\": [\\n    \"False-Negative\"\\n  ]\\n}',\n '{\\n \"urinary glucose determination using Clinitest\": \"false-positive or negative\",\\n \"Coombs\\' [direct]\": \"positive\",\\n \"urinary and/or serum proteins by certain test methods\": \"false-positive\"\\n}',\n 'Not available',\n '{\\n \"direct Coombs\\'\": \"positive\",\\n \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"false-positive\",\\n \"serum or urine creatinine with Jaffé reaction\": \"false-positive\"\\n}',\n '{\\n \"urine screening result for opioids using commercially-available immunoassay kits\": \"false-positive\",\\n \"levofloxacin and ofloxacin\": \"most consistently shown cross-reactivity\",\\n \"other quinolones\": \"shown cross-reactivity in certain assay kits\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical test names:\\n1. Indirect antiglobulin test (indirect Coombs test)\\n2. Serum protein electrophoresis\\n3. Immunofixation assays\\n\\nJSON form:\\n{\\n  \"Indirect antiglobulin test (indirect Coombs test)\": \"Positive\",\\n  \"Serum protein electrophoresis\": \"Detected\",\\n  \"Immunofixation assays\": \"Interference\"\\n}',\n 'Not available',\n 'Not available',\n 'Medical test names:\\n1. Gastric secretion test\\n\\nJSON form:\\n{\\n  \"Gastric secretion test\": \"Interference\"\\n}',\n 'Test names: T4-binding globulin (TBG), Thyroxine (T4), Triiodothyronine (T3), Thyroid gland hormone, Hypothalamic-pituitary axis and TSH\\n\\nTest results as JSON:\\n\\n{\\n  \"TBG\": {\\n    \"Conditions/Staes that increase TBG binding\": [\"Pregnancy\", \"hepatitis\", \"porphyria\", \"neonatal state\"],\\n    \"Medications that increase TBG binding\": [\"Estrogens\", \"5-fluorouracil\", \"heroin\", \"methadone\", \"mitotane\", \"perphenazine\", \"selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\"],\\n    \"Conditions/states that decrease TBG binding\": [\"Hepatic failure\", \"nephrosis\", \"severe illness\"],\\n    \"Medications that decrease TBG binding\": [\"Androgens\", \"anabolic steroids\", \"glucocorticoids\", \"L-asparaginase\", \"nicotinic acid\"]\\n  },\\n  \"T4\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"T3\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"Thyroid gland hormone\": {\\n    \"Medications affecting iodine uptake\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"ethionamide\"],\\n    \"Medications affecting hormone production\": [\"Amiodarone\", \"ethionamide\", \"iodinated contrast agents\", \"iodine\", \"sulfonylureas\", \"sulfonamides\", \"thionamides (carbimazole, methimazole, propylthiouracil)\"],\\n    \"Medications affecting secretion\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"lithium\"],\\n    \"Medications inducing thyroiditis\": [\"Alemtuzumab\", \"amiodarone\", \"antiangiogenic agents (lenalidomide, thalidomide)\", \"denileukin diftitox\", \"interferon alpha\", \"interleukins\", \"lithium\", \"tyrosine kinase inhibitors (sunitinib, sorafenib)\"],\\n    \"Medications potentially causing the development of Graves’\": [\"Alemtuzumab\", \"interferon alpha\", \"antiretroviral therapy\"],\\n    \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves\\'\": [\"Glucocorticoids\"]\\n  },\\n  \"TSH\": {\\n    \"Medications decreasing TSH secretion\": [\"Bexarotene\", \"dopamine\", \"dopaminergic agonists (bromocriptine, cabergoline)\", \"glucocorticoids\", \"interleukin-6\", \"metformin\", \"opiates\", \"somatostatin analogues (octreotide, lanreotide)\", \"thyroid hormone analogues\"],\\n    \"Medications increasing TSH secretion\": [\"Amphetamine\", \"interleukin 2\", \"metoclopramide\", \"ritonavir\", \"St John\\'s wort\"],\\n    \"Medications potentially causing hypophysitis\": [\"Ipilimumab\"]\\n  }\\n}',\n 'Test names: Urine ketones, Thyroid function tests\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine ketones\": {\\n    \"Effect\": \"May cause a false-positive result\",\\n    \"Medication\": \"Valproate\",\\n    \"Mode of elimination\": \"Partially eliminated as a keto-metabolite in the urine\"\\n  },\\n  \"Thyroid function tests\": {\\n    \"Effect\": \"May alter\"\\n  }\\n}',\n 'Test names: Urine dipstick tests (urine protein, ketones, occult blood)\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine dipstick tests\": {\\n    \"Effects\": [\"May result in false-positive urine dipstick tests\"],\\n    \"Examples of tests affected\": [\"Urine protein\", \"ketones\", \"occult blood\"]\\n  }\\n}',\n 'Test names: Phenylketonuria test, Pregnancy test\\n\\nTest results as JSON:\\n\\n{\\n  \"Phenylketonuria test\": {\\n    \"Effect\": \"False-positives\"\\n  },\\n  \"Pregnancy test\": {\\n    \"Effect\": \"False-positives\"\\n  }\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names:\\n1. Rabbit antibody-based immunoassays\\n2. Cross-match or panel-reactive antibody cytotoxicity assays\\n\\nTest Results (in JSON format):\\n{\\n  \"Rabbit antibody-based immunoassays\": \"Potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"Potential interference\",\\n  \"Routine clinical laboratory tests which do not use immunoglobulins\": \"No interference shown\"\\n}',\n 'Not available',\n '{\"Positive Coombs\\'\": \"Positive\"}',\n '{\"serum TCA screen\": \"false-positive\"}',\n 'Not available',\n '{\"urine screening result for opioids\": \"false-positive\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Name: Urine Test with Blue Indicator\\nTest Result: Interfered',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n    \"test name\": \"amphetamine EMIT assay\",\\n    \"test result\": \"false positive\"\\n}',\n '{\\n    \"test name\": \"Urinary ketones\",\\n    \"test result\": \"false positive in patients receiving mesna with nitroprusside-based urine tests\"\\n},\\n{\\n    \"test name\": \"CPK activity\",\\n    \"test result\": \"may interfere with enzymatic CPK activity tests which use a thiol compound, resulting in a falsely low CPK level\"\\n},\\n{\\n    \"test name\": \"Ascorbic acid\",\\n    \"test result\": \"may result in false-positive reactions in Tillman\\'s reagent-based urine screening tests\"\\n}',\n '{\\n    \"test name\": \"urinary glucose tests\",\\n    \"test result\": \"may interfere with tests using cupric sulfate, but tests based on enzymatic glucose oxidase reactions are recommended\"\\n},\\n{\\n    \"test name\": \"plasma concentrations of certain hormones in pregnant women\",\\n    \"test result\": \"may be transiently interfered with by ampicillin, including total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"CD20 assay\": \"interfered\", \"CD19+ assay\": \"measure B-cell counts\"}',\n 'Not available',\n '{\"procainamide/N-acetyl procainamide concentration test\": \"affected\"}',\n 'Not available',\n 'Not available',\n 'Medical Test Names:\\n1. Serum bilirubin\\n2. Serum calcium\\n3. Examination of bone marrow iron stores\\n4. Bone scans with 99m Tc-labeled bone seeking agents\\n5. Bone scans with 99m Tc-diphosphonate\\n\\nTest Results in JSON Form:\\n{\\n\"Serum bilirubin\": \"falsely elevated values\",\\n\"Serum calcium\": \"falsely decreased values\",\\n\"Examination of bone marrow iron stores\": \"Residual iron dextran may remain in reticuloendothelial cells affecting accuracy\",\\n\"Bone scans with 99m Tc-labeled bone seeking agents\": \"reduced bony uptake, marked renal activity, and excess blood pooling and soft tissue accumulation following IV iron dextran infusion or with high serum ferritin levels\",\\n\"Bone scans with 99m Tc-diphosphonate\": \"dense activity in the buttocks following IM iron dextran\"\\n}',\n 'Medical Test Names:\\n1. Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\\n2. Coombs\\' test\\n\\nTest Results in JSON Form:\\n{\\n\"Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\": \"May interfere\",\\n\"Coombs\\' test\": \"positive\"\\n}',\n 'Medical Test Names:\\n1. Iodine-binding capacity of thyroid tissue\\n2. Diagnostic tests using iodine-containing isotopes\\n3. Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\\n\\nTest Results in JSON Form:\\n{\\n\"Iodine-binding capacity of thyroid tissue\": \"reduced for up to 2 weeks following administration of contrast media\",\\n\"Diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\": \"not affected\"\\n}',\n 'Not available',\n 'Medical Test Names:\\n1. PT/INR levels\\n\\nTest Results in JSON Form:\\n{\\n\"PT/INR levels\": \"may become elevated in the absence of warfarin. If warfarin is initiated, initial PT/INR goals while on bivalirudin may require modification\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '```\\n{\\n    \"Test Name\": \"Fluorescence Test for Urinary Catecholamines\",\\n    \"Test Result\": \"False Elevations\"\\n}\\n```',\n '```\\n{\\n    \"Test Name 1\": \"Activated Clotting Time (ACT)\",\\n    \"Test Result 1\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 2\": \"aPTT\",\\n    \"Test Result 2\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 3\": \"Prothrombin Time\",\\n    \"Test Result 3\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 4\": \"International Normalized Ratio\",\\n    \"Test Result 4\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 5\": \"Silica Clot Time (SCT)\",\\n    \"Test Result 5\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 6\": \"Dilute Russell\\'s Viper Venom Time (DRVVT)\",\\n    \"Test Result 6\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 7\": \"D-dimer\",\\n    \"Test Result 7\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 8\": \"Indirect Antiglobulin Test\",\\n    \"Test Result 8\": \"Positive\",\\n    \\n    \"Test Name 9\": \"Direct Antiglobulin Test\",\\n    \"Test Result 9\": \"Positive\"\\n}\\n```',\n 'Not available',\n 'Medical Tests:\\n1. Urinary 5-hydroxyindoleacetic acid \\n2. Urine detection of phencyclidine \\n3. Aldosterone/Renin ratio\\n\\nTest Results:\\n{\\n\"Urinary 5-hydroxyindoleacetic acid\": \"False-positive\",\\n\"Urine detection of phencyclidine\": \"False-positive\",\\n\"Aldosterone/Renin ratio\": \"False-positive\"\\n}',\n 'Not available',\n 'Medical Tests:\\n1. Cellular CD22 Detection\\n2. CD19+ B Cells Surrogate Assay\\n\\nTest Results:\\n{\\n\"Cellular CD22 Detection\": \"Interference\",\\n\"CD19+ B Cells Surrogate Assay\": \"Normal\"\\n}',\n 'Medical Tests:\\n1. PT\\n2. INR\\n3. aPTT\\n4. ACT\\n5. Xa (coagulation based assay)\\n6. Bleeding time\\n7. Factor Xa (chromogenic assay)\\n8. Platelet aggregation study\\n9. Thrombin time\\n10. Urine protein via qualitative dipstick\\n11. Urine protein via quantitative dye methods\\n\\nTest Results:\\n{\\n\"PT\": \"Artificially increased clotting times\",\\n\"INR\": \"Artificially increased clotting times\",\\n\"aPTT\": \"Artificially increased clotting times\",\\n\"ACT\": \"Artificially increased clotting times\",\\n\"Xa (coagulation based assay)\": \"Artificially increased clotting times\",\\n\"Bleeding time\": \"Normal\",\\n\"Factor Xa (chromogenic assay)\": \"Normal\",\\n\"Platelet aggregation study\": \"Normal\",\\n\"Thrombin time\": \"Normal\",\\n\"Urine protein via qualitative dipstick\": \"Interference\",\\n\"Urine protein via quantitative dye methods\": \"Interference\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"5-HIAA\": \"color interference\",\\n  \"VMA\": \"color interference\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Free Thyrotropin\": \"falsely elevated\",\\n  \"Free Triiodothyronine\": \"falsely elevated\",\\n  \"Thyroid-stimulating hormone\": \"not usually affected\",\\n  \"Standard Competitive Free Thyroid Hormone Assays\": \"not usually affected\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Test Name\": \"Urine Screening for Opioids\",\\n  \"Test Result\": \"false-positive with quinolones; confirmation recommended\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Test Name\": \"Bone Scan with Technetium-99m-diphosphonate\",\\n  \"Test Result\": \"may be interfered with by Bisphosphonates\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names and their respective results:\\n\\n1. Direct and Indirect Coombs\\' - Positive \\n2. Urinary glucose test using Benedict\\'s copper reduction reaction - False-Positive \\n3. Serum or urine creatinine with Jaffé reaction - False-Positive \\n4. Aminoglycoside serum concentration - Potentially underestimated \\n\\nJSON format:\\n\\n{\\n   \"Direct and Indirect Coombs\\'\": \"Positive\",\\n   \"Urinary glucose test using Benedict\\'s copper reduction reaction\": \"False-Positive\",\\n   \"Serum or urine creatinine with Jaffé reaction\": \"False-Positive\",\\n   \"Aminoglycoside serum concentration\": \"Potentially underestimated\"\\n}',\n 'Test names and their respective results:\\n\\n1. Serum chromogranin A (CgA) level - Falsely elevated with Esomeprazole \\n2. Diagnosis of a neuroendocrine tumor - False-positive \\n\\nJSON format:\\n\\n{\\n   \"Serum chromogranin A (CgA) level\": \"Falsely elevated with Esomeprazole\",\\n   \"Diagnosis of a neuroendocrine tumor\": \"False-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '1. Medical Test Names: Benedict\\'s solution, Clinitest, Fehling\\'s Solution\\n   Test Results: {\"Benedict\\'s solution\": \"May interfere with urinary glucose tests\", \\n                  \"Clinitest\": \"May interfere with urinary glucose tests\", \\n                  \"Fehling\\'s Solution\": \"May interfere with urinary glucose tests\"}\\n\\n2. Medical Test Names: Aminoglycoside serum concentration\\n   Test Results: {\"Aminoglycoside serum concentration\": \"Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Names: technetium-99m-diphosphonate bone scans\\nTest Results: {\"technetium-99m-diphosphonate bone scans\": \"May be interfered with by bisphosphonates\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Plasma phenytoin concentrations\": \"Falsely high\",\\n  \"Serum concentrations of T4\": \"Falsely low\",\\n  \"Serum concentrations of T3\": \"Falsely low\",\\n  \"Dexamethasone tests\": \"Falsely low\",\\n  \"Metyrapone tests\": \"Falsely low\",\\n  \"Thyroid-stimulating hormone (TSH) levels\": \"Increased\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Urine detection of opioids\": \"False-positive\",\\n  \"Coombs\\' test\": \"Positive\",\\n  \"Urinary steroids\": \"False elevation\",\\n  \"Catecholamines\": \"False elevation\",\\n  \"Urinary dipstick protein assays\": \"Qualitative and quantitative\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n   \"urine detection of methadone\": \"false-positives\",\\n   \"urine detection of phencyclidine\": \"false-positives\",\\n   \"serum TCA screen\": \"false-positive\",\\n   \"wheal and flare reactions to skin test antigens\": \"suppressed\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Ceftazidime\": \"Positive direct Coomb\",\\n  \"Urine glucose\": \"False-positive with certain methods; use glucose tests based on enzymatic glucose oxidase reactions\"\\n}',\n '{\\n  \"Serum iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\",\\n  \"Transferrin bound iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Sorry, as an AI language model, I am not able to extract the medical test names and their results without any context or clear indication of where they are mentioned in the text. Could you please provide me with a specific text or document so I can help you better?',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Neutralizing antibody assay\": \"Obtain serum samples at least a month after the last dose to prevent assay interference.\", \\n  \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\"\\n}',\n 'Not available',\n 'Not available',\n '1. Medical Test Names: PT, anti-factor Xa assay, aPTT, free T4, free T3, thyroid stimulating hormone, standard competitive free thyroid hormone assays.\\n\\n2. Test Results in JSON format:\\n\\n{\\n \"PT\": \"Increased\",\\n \"anti-factor Xa assay\": \"falsely elevated results\",\\n \"aPTT\": \"little or minor effect\",\\n \"free T4\": \"falsely elevated levels\",\\n \"free T3\": \"falsely elevated levels\",\\n \"thyroid stimulating hormone\": \"not usually affected\",\\n \"standard competitive free thyroid hormone assays\": \"not usually affected\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n \"aPTT\": \"contains heparin\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '1. Medical test names: antibody screening, cross matching, Kell blood group system genotyping, serum protein electrophoresis (SPE), immunofixation (IFE), daratumumab-specific IFE assay.\\n\\n2. Test results in JSON format:\\n\\n{\\n   \"antibody screening\": \"N/A\",\\n   \"cross matching\": \"N/A\",\\n   \"Kell blood group system genotyping\": \"N/A\",\\n   \"serum protein electrophoresis (SPE)\": \"positive if daratumumab is present\",\\n   \"immunofixation (IFE)\": \"positive if daratumumab is present\",\\n   \"daratumumab-specific IFE assay\": \"distinguishes daratumumab from residual endogenous M protein\"\\n}',\n '{\\n  \"PT/INR\": [\"elevated\"], \\n  \"bivalirudin\": [\"modification\"]\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Medical Test Names: \\n- Thyroid function test\\n\\nTest Results in JSON:\\n{\\n  \"T4 levels\": \"elevated\",\\n  \"Thyroid stimulating hormone levels\": \"at the high end of normal range\",\\n  \"T3 levels\": \"at the low end of normal range\"\\n}',\n 'Medical Test Names: N/A\\n\\nTest Results in JSON: N/A',\n 'Not available',\n '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate\": \"False-positive\",\\n  \"serum or urine creatinine with Jaffé reaction\": \"False-positive\"\\n}',\n '{\\n  \"polymerase chain reaction (PCR) assays for HIV\": \"Positive\",\\n  \"BB305 LVV proviral DNA\": \"Integrated\",\\n  \"screened for HIV infection using a PCR-based assay\": \"Should not\"\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n  \"ferricyanide test\": \"False-negative\",\\n  \"Glucose oxidase or hexokinase-based methods\": \"Should be used\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\"uric acid\": \"N/A\"}',\n 'Not available',\n 'Not available',\n '{\"opioid screening\": \"false-positive result\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"urinary metanephrine\": \"May falsely increase\",\\n  \"HPLC assay with solid phase extraction for determination of urinary catecholamines\": \"does not interact with\",\\n  \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"\\n}',\n '{\\n  \"serum chromogranin A (CgA)\": \"may falsely elevate; may cause false-positive results in the diagnosis of a neuroendocrine tumor\",\\n  \"omeprazole\": \"Temporarily stop ≥14 days prior to assessing CgA level\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names:\\n1. Indirect Antiglobulin Test (indirect Coombs test)\\n2. Antibody Detection (screening) Tests\\n3. Antibody Identification Panels\\n4. Anti-Human Globulin Crossmatches\\n5. Blood Type and Screening\\n6. Phenotyping\\n7. Serum Protein Electrophoresis\\n8. Immunofixation Assays\\n\\nTest Result in JSON form:\\n{\\n   \"Indirect Antiglobulin Test\": \"false-positive\",\\n   \"Antibody Detection Tests\": \"may result in interference\",\\n   \"Antibody Identification Panels\": \"may result in interference\",\\n   \"Anti-Human Globulin Crossmatches\": \"may result in interference\",\\n   \"Blood Type and Screening\": \"recommended prior to the first isatuximab infusion\",\\n   \"Phenotyping\": \"consider prior to initiating treatment\",\\n   \"Serum Protein Electrophoresis\": \"may interfere with accuracy of determining complete response\",\\n   \"Immunofixation Assays\": \"may interfere with accuracy of determining complete response\"\\n}',\n 'Not available',\n '{\\n  \"Positive direct Coombs\\'\": \"Positive\",\\n  \"False-positive urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"Positive\",\\n  \"False-positive serum or urine creatinine with Jaffé reaction\": \"Positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"Medical test names\": [\\n    \"Aminoglycoside serum concentration\"\\n  ],\\n  \"Test results\": [\\n    \"Potential underestimation\"\\n  ]\\n}',\n 'Not available',\n 'Not available',\n '{\\n  \"Medical test names\": [\\n    \"Aldosterone/renin ratio (ARR)\"\\n  ],\\n  \"Test results\": [\\n    \"False-negative\"\\n  ]\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test names: serum iron, copper, zinc, serum calcium.\\nTest results: \\n{\\n\"serum iron\": \"transient changes\",\\n\"copper\": \"transient changes\",\\n\"zinc\": \"transient changes\",\\n\"serum calcium\": \"apparent decrease after injection, accurate values can be obtained approximately 90 minutes after injection\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n \"Sorry, as an AI language model, I don't have the capability to extract specific information from unstructured data without any context. Please provide more specific data or context for me to extract the information as per your requirement.\",\n '{\"Coombs\\' [direct]\": \"Positive\"}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n    \"AST\": \"interfere\",\\n    \"ALT\": \"interfere\",\\n    \"triglycerides\": \"interfere\",\\n    \"glucose\": \"interfere\",\\n    \"LDH\": \"interfere\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Test Names: \\n- Urine screening test for opioids \\n\\nTest Results (in JSON form): \\n{\\n  \"Urine screening test for opioids\": \"false-positive for levofloxacin and ofloxacin, cross-reactivity in certain assay kits for other quinolones\"\\n}',\n 'Not available',\n 'Test Names:\\n- PT (Prothrombin Time) test\\n- INR (International Normalized Ratio) test\\n\\nTest Results (in JSON form):\\n{\\n  \"PT (Prothrombin Time) test\": \"false prolongation with certain recombinant thromboplastin reagents when taking daptomycin\",\\n  \"INR (International Normalized Ratio) test\": \"increase with certain recombinant thromboplastin reagents when taking daptomycin\"\\n}',\n 'Test Names:\\n- Whole blood assay for cyclosporine\\n\\nTest Results (in JSON form):\\n{\\n  \"Whole blood assay for cyclosporine\": \"may be falsely elevated if sample is drawn from the same central venous line through which dose was administered; cyclosporine metabolites cross-react with radioimmunoassay and fluorescence polarization immunoassay\"\\n}',\n 'Not available',\n 'Test Names: \\n1. Glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n2. Glucose-specific method\\n3. Anthrax immune globulin administration\\n4. Serologic testing\\n5. Direct and indirect Coombs’ test\\n\\nTest Results:\\n1. Falsely elevated blood glucose levels \\n2. N/A\\n3. Transiently elevated glucose \\n4. False-positive results \\n5. False-positive results',\n 'Not available',\n 'Test Names:\\n1. Immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000)\\n2. Dexamethasone test\\n3. Metyrapone test\\n\\nTest Results:\\n1. Falsely high plasma phenytoin concentrations \\n2. Falsely low results\\n3. Folate levels lowered',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n '{\\n  \"phencyclidine\": \"false-positives\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available',\n 'Not available']"
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_conditions"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-03T07:46:29.277446500Z",
     "start_time": "2023-05-03T07:46:29.199376Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "outputs": [
    {
     "data": {
      "text/plain": "['Ceftobiprole (Lexi-Drugs)',\n 'Irinotecan (Conventional) (Lexi-Drugs)',\n 'DexAMETHasone (Systemic) (Pediatric and Neonatal Lexi-Drugs)',\n 'Pegaspargase (Lexi-Drugs)',\n 'Acetylcysteine (Briggs Drugs in Pregnancy and Lactation)',\n 'DOXOrubicin (Conventional) (Lexi-Drugs)',\n 'Tebentafusp (Lexi-Drugs)',\n 'Flumazenil (Lexi-Drugs)',\n 'Diphenhydramine and Phenylephrine (Lexi-Drugs)',\n 'Acetaminophen and Tramadol (Lexi-Drugs)',\n 'Glutamine (Lexi-Drugs)',\n 'Sulfamethoxazole and Trimethoprim (Lexi-Drugs)',\n 'Omeprazole, Amoxicillin, and Rifabutin (Lexi-Drugs)',\n 'Crizanlizumab (Lexi-Drugs)',\n 'Nitroglycerin (Lexi-Drugs)',\n 'Pentostatin-Cyclophosphamide-Rituximab  (CLL)  (Lexi-Drugs)',\n 'Phenylephrine and Thonzylamine (Lexi-Drugs)',\n 'Tranexamic Acid (Lexi-Drugs)',\n 'Bamlanivimab (Lexi-Drugs)',\n 'Micafungin (Lexi-Drugs)',\n 'Tenoxicam (Lexi-Drugs)',\n 'Darbepoetin Alfa (Lexi-Drugs)',\n 'Levorphanol (Lexi-Drugs)',\n 'Antihemophilic Factor/von Willebrand Factor Complex (Human) (Lexi-Drugs)',\n 'LevoFLOXacin (Ophthalmic) (Lexi-Drugs)',\n 'MitoMYcin (Systemic) (Lexi-Drugs)',\n 'Carfilzomib (Lexi-Drugs)',\n 'Tacrolimus (Systemic) (Lexi-Drugs)',\n 'Dipyridamole (Lexi-Drugs)',\n 'Azithromycin (Systemic) (Lexi-Drugs)',\n 'Trace Elements (Lexi-Drugs)',\n 'Trimethobenzamide (Lexi-Drugs)',\n 'Tisagenlecleucel (Lexi-Drugs)',\n 'Ergotamine and Caffeine (Lexi-Drugs)',\n 'PACLitaxel (Protein Bound) (Lexi-Drugs)',\n 'Insulin NPH (Lexi-Drugs)',\n 'Norepinephrine (Lexi-Drugs)',\n 'von Willebrand Factor (Recombinant) (Lexi-Drugs)',\n 'Trastuzumab and Hyaluronidase (Lexi-Drugs)',\n 'Bevacizumab (Lexi-Drugs)',\n 'Imipenem and Cilastatin (Infectious Diseases)',\n 'Isosorbide Dinitrate (Lexi-Drugs)',\n 'Iobenguane I 123 (Lexi-Drugs)',\n 'Meropenem (Lexi-Drugs)',\n 'DOPamine (Lexi-Drugs)',\n 'CycloSPORINE (Ophthalmic) (Lexi-Drugs)',\n 'Lefamulin (Lexi-Drugs)',\n 'CycloPHOSphamide (Lexi-Drugs)',\n 'Nelarabine (Lexi-Drugs)',\n 'Ferric Derisomaltose (Lexi-Drugs)',\n 'Gemtuzumab Ozogamicin (Lexi-Drugs)',\n 'Cefuroxime (Geriatric Lexi-Drugs)',\n 'Factor IX Complex (Human) [(Factors II, IX, X)] (Lexi-Drugs)',\n 'Cemiplimab (Lexi-Drugs)',\n 'Aprepitant (Lexi-Drugs)',\n 'Thiotepa (Lexi-Drugs)',\n 'Vonoprazan, Amoxicillin, and Clarithromycin (Lexi-Drugs)',\n 'Anidulafungin (Lexi-Drugs)',\n 'Gadobenate Dimeglumine (Lexi-Drugs)',\n 'Pembrolizumab (Geriatric Lexi-Drugs)',\n 'Antihemophilic Factor (Recombinant [Fc Fusion Protein]) (Lexi-Drugs)',\n 'Vedolizumab (Lexi-Drugs)',\n 'Chloramphenicol (Systemic) (Lexi-Drugs)',\n 'Clevidipine (Lexi-Drugs)',\n 'Bebtelovimab (Lexi-Drugs)',\n 'Erythromycin and Benzoyl Peroxide (Lexi-Drugs)',\n 'Trastuzumab-Vinorelbine (Breast) (Lexi-Drugs)',\n 'DiphenhydrAMINE (Systemic) (Lexi-Drugs)',\n 'Betamethasone (Topical) (Lexi-Drugs)',\n 'Dexrazoxane (Pediatric and Neonatal Lexi-Drugs)',\n 'Sotrovimab (Lexi-Drugs)',\n 'BChE - Mivacurium (Pharmacogenomics)',\n 'Benzyl Alcohol (Lexi-Drugs)',\n 'Ferric Gluconate (Pediatric and Neonatal Lexi-Drugs)',\n 'Siltuximab (Lexi-Drugs)',\n 'Selenium (Lexi-Drugs)',\n 'Palonosetron (Lexi-Drugs)',\n 'Fluorouracil and Salicylic Acid (Lexi-Drugs)',\n 'VinCRIStine (Lexi-Drugs)',\n 'Octreotide [ANTIDOTE] (Lexi-Tox)',\n 'VinBLAStine (Lexi-Drugs)',\n 'Carboplatin-Paclitaxel-Trastuzumab (Breast) (Lexi-Drugs)',\n 'Vitamin B Complex Combinations (Lexi-Drugs)',\n 'Lidocaine (Ophthalmic) (Lexi-Drugs)',\n 'Insulin Aspart (Lexi-Drugs)',\n 'DiphenhydrAMINE (Systemic) (Lexi-Drugs)',\n 'Iothalamate Meglumine (Lexi-Drugs)',\n 'Insulin Regular (Lexi-Drugs)',\n 'Treprostinil (Lexi-Drugs)',\n 'Cefotaxime (Lexi-Drugs)',\n 'Dantrolene (Lexi-Drugs)',\n 'Gemcitabine-Vinorelbine (NSCLC) (Lexi-Drugs)',\n 'Durvalumab (Lexi-Drugs)',\n 'Brivaracetam (Lexi-Drugs)',\n 'Amifostine (Lexi-Drugs)',\n 'Capreomycin (Lexi-Drugs)',\n 'Neostigmine (Lexi-Drugs)',\n 'Emapalumab (Lexi-Drugs)',\n 'Ketamine (Lexi-Drugs)',\n 'Zinc Chloride (Lexi-Drugs)',\n 'Fosaprepitant (Geriatric Lexi-Drugs)',\n 'Imipenem and Cilastatin (Geriatric Lexi-Drugs)',\n 'DimenhyDRINATE (Lexi-Drugs)',\n 'Anti-inhibitor Coagulant Complex (Human) (Lexi-Drugs)',\n 'Calcitriol (Topical) (Lexi-Drugs)',\n 'Margetuximab (Lexi-Drugs)',\n 'Alfentanil (Briggs Drugs in Pregnancy and Lactation)',\n 'Mycophenolate (Lexi-Drugs)',\n 'Decitabine (Lexi-Drugs)',\n 'Ferric Gluconate (Lexi-Drugs)',\n 'RomiDEPsin (Lexi-Drugs)',\n 'Olipudase Alfa (Lexi-Drugs)',\n 'Brexanolone (Lexi-Drugs)',\n 'Clindamycin (Briggs Drugs in Pregnancy and Lactation)',\n 'Lamivudine and Zidovudine (Lexi-Drugs)',\n 'Cefuroxime (Lexi-Drugs)',\n 'Sodium Phosphates (Lexi-Drugs)',\n 'Amisulpride (Injection) (Lexi-Drugs)',\n 'Ofloxacin (Otic) (Lexi-Drugs)',\n 'Peginterferon Alfa-2b (Lexi-Drugs)',\n 'Succinylcholine (Lexi-Drugs)',\n 'DiazePAM (Lexi-Drugs)',\n 'Ibuprofen and Famotidine (Lexi-Drugs)',\n 'Granisetron (Lexi-Drugs)',\n 'Mepivacaine (Pediatric and Neonatal Lexi-Drugs)',\n 'Clofarabine (Lexi-Drugs)',\n 'Buprenorphine (Lexi-Drugs)',\n 'Inebilizumab (Lexi-Drugs)',\n 'Cabazitaxel (Lexi-Drugs)',\n 'Propofol (Lexi-Drugs)',\n 'Sirolimus (Conventional) (Lexi-Drugs)',\n 'Phenylephrine and Pramoxine (Lexi-Drugs)',\n 'Secretin (Lexi-Drugs)',\n 'Insulin Lispro (Lexi-Drugs)',\n 'Melphalan (Pharmacogenomics)',\n 'Insulin NPH and Insulin Regular (Lexi-Drugs)',\n 'Hydroxocobalamin (Lexi-Drugs)',\n 'Voriconazole (Lexi-Drugs)',\n 'Botulism Antitoxin, Heptavalent (Lexi-Drugs)',\n 'Cefuroxime (Briggs Drugs in Pregnancy and Lactation)',\n 'Cefepime (Lexi-Drugs)',\n 'Ferric Carboxymaltose (Pediatric and Neonatal Lexi-Drugs)',\n 'Imipenem, Cilastatin, and Relebactam (Lexi-Drugs)',\n 'Ceftolozane and Tazobactam (Infectious Diseases)',\n 'Sirolimus (Topical) (Lexi-Drugs)',\n 'Epoetin Alfa (Lexi-Drugs)',\n 'Zidovudine (Lexi-Drugs)',\n 'Ertapenem (Lexi-Drugs)',\n 'Oxytocin (Lexi-Drugs)',\n 'Factor IX (Recombinant [Glycopegylated]) (Lexi-Drugs)',\n 'Gadoteridol (Briggs Drugs in Pregnancy and Lactation)',\n 'Levothyroxine (Lexi-Drugs)',\n 'Tedizolid (Lexi-Drugs)',\n 'ALfentanil (Lexi-Drugs)',\n 'Idecabtagene Vicleucel (Lexi-Drugs)',\n 'Iopamidol (Lexi-Drugs)',\n 'Methohexital (Lexi-Drugs)',\n 'Amantadine (Lexi-Drugs)',\n 'Chlorothiazide (Lexi-Drugs)',\n 'Gemcitabine (Lexi-Drugs)',\n 'Ciprofloxacin (Otic) (Lexi-Drugs)',\n 'Bevacizumab-Carboplatin-Paclitaxel (Ovarian) (Lexi-Drugs)',\n 'Avalglucosidase Alfa (Lexi-Drugs)',\n 'Liothyronine (Lexi-Drugs)',\n 'Pembrolizumab (Lexi-Drugs)',\n 'Bevacizumab FOLFOX (Colorectal) (Lexi-Drugs)',\n 'Daunorubicin and Cytarabine (Liposomal) (Lexi-Drugs)',\n 'Clindamycin (Topical) (Pediatric and Neonatal Lexi-Drugs)',\n 'Isosorbide Dinitrate and Hydralazine (Lexi-Drugs)',\n 'Lidocaine and Hydrocortisone (Lexi-Drugs)',\n 'Ganciclovir (Ophthalmic) (Lexi-Drugs)',\n 'Clot Dissolving Drugs for Heart Attack or Stroke (Patient Education - Disease and Procedure)',\n 'Eteplirsen (Pediatric and Neonatal Lexi-Drugs)',\n 'Gentamicin (Systemic) (Lexi-Drugs)',\n 'Ascorbic Acid (Pediatric and Neonatal Lexi-Drugs)',\n 'Doxapram (Lexi-Drugs)',\n 'Taliglucerase Alfa (Pediatric and Neonatal Lexi-Drugs)',\n 'Dolasetron (Pediatric and Neonatal Lexi-Drugs)',\n 'Omadacycline (Lexi-Drugs)',\n 'Belatacept (Lexi-Drugs)',\n 'Scopolamine (Geriatric Lexi-Drugs)',\n 'Vancomycin (Pediatric and Neonatal Lexi-Drugs)',\n 'Ampicillin and Sulbactam (Lexi-Drugs)',\n 'Buprenorphine and Naloxone (Pediatric and Neonatal Lexi-Drugs)',\n 'Lidocaine (Otic) (Lexi-Drugs)',\n 'BUPivacaine (Lexi-Drugs)',\n 'Growth Hormone, Serum (Lab Tests and Diagnostic Procedures)',\n 'Technetium Tc 99m Albumin Aggregated (Lexi-Drugs)',\n 'Tetracaine (Spinal) (Lexi-Drugs)',\n 'Dexrazoxane (Lexi-Drugs)',\n 'Mepivacaine (Pharmacogenomics)',\n 'Erythromycin (Topical) (Lexi-Drugs)',\n 'Ciprofloxacin (Ophthalmic) (Lexi-Drugs)',\n 'CARBOplatin (Lexi-Drugs)',\n 'Basiliximab (Lexi-Drugs)',\n 'Tromethamine (Lexi-Drugs)',\n 'Alprostadil (Lexi-Drugs)',\n 'Aztreonam (Oral Inhalation) (Infectious Diseases)',\n 'Ferric Carboxymaltose (Geriatric Lexi-Drugs)',\n 'Gadoteridol (Pediatric and Neonatal Lexi-Drugs)',\n 'Methotrimeprazine (Lexi-Drugs)',\n 'Morphine (Systemic) (Lexi-Drugs)',\n 'Sodium Acetate (Lexi-Drugs)',\n 'Topotecan (Lexi-Drugs)',\n 'MetroNIDAZOLE (Topical) (Lexi-Drugs)',\n 'Edrophonium and Atropine (Lexi-Drugs)',\n 'Tranexamic Acid (Pediatric and Neonatal Lexi-Drugs)',\n 'Ciprofloxacin and Dexamethasone (Lexi-Drugs)',\n 'Verapamil (Lexi-Drugs)',\n 'Melphalan (Pediatric and Neonatal Lexi-Drugs)',\n 'PACLitaxel (Conventional) (Lexi-Drugs)',\n 'Methyldopa (Lexi-Drugs)',\n 'Ciprofloxacin (Systemic) (Lexi-Drugs)',\n 'Ambroxol [INT] (Lexi-Drugs International [Concise])',\n 'Aducanumab (Lexi-Drugs)',\n 'Magnesium Chloride (Lexi-Drugs)',\n 'Taliglucerase Alfa (Lexi-Drugs)',\n 'RiTUXimab (Lexi-Drugs)',\n 'Cetirizine and Pseudoephedrine (Lexi-Drugs)',\n 'Clindamycin and Tretinoin (Lexi-Drugs)',\n 'Erythromycin (Ophthalmic) (Lexi-Drugs)',\n 'Neostigmine (Briggs Drugs in Pregnancy and Lactation)',\n 'Nesiritide (Lexi-Drugs)',\n 'Aminophylline (Lexi-Drugs)',\n nan,\n 'Edaravone (Lexi-Drugs)',\n 'Factor IX (Recombinant [Fc Fusion Protein]) (Lexi-Drugs)',\n 'Conivaptan (Lexi-Drugs)',\n 'Glucagon (Pediatric and Neonatal Lexi-Drugs)',\n 'MitoMYcin (Ophthalmic) (Lexi-Drugs)',\n 'Alteplase (Lexi-Drugs)',\n 'Remimazolam (Lexi-Drugs)',\n 'Sodium Nitrite and Sodium Thiosulfate (Lexi-Drugs)',\n 'Nelarabine (Pediatric and Neonatal Lexi-Drugs)',\n 'Plasminogen Activator Inhibitor 1 Activity, Plasma (Lab Tests and Diagnostic Procedures)',\n 'Fludarabine-Cyclophosphamide-Rituximab  (CLL) (Lexi-Drugs)',\n 'DiphenhydrAMINE (Topical) (Lexi-Drugs)',\n 'Ganciclovir (Systemic) (Lexi-Drugs)',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Geriatric Lexi-Drugs)',\n 'Fenoldopam (Lexi-Drugs)',\n 'Temsirolimus (Lexi-Drugs)',\n 'Ceftazidime and Avibactam (Lexi-Drugs)',\n 'Gadodiamide (Lexi-Drugs)',\n 'Antivenin (Latrodectus mactans) (Lexi-Drugs)',\n 'Erythromycin (Systemic) (Lexi-Drugs)',\n 'Cetirizine (Systemic) (Lexi-Drugs)',\n 'Moxifloxacin (Ophthalmic) (Lexi-Drugs)',\n 'CloNIDine (Lexi-Drugs)',\n 'Ofatumumab (Lexi-Drugs)',\n 'InFLIXimab (Lexi-Drugs)',\n 'Dolasetron (Lexi-Drugs)',\n 'Ferumoxytol (Lexi-Drugs)',\n 'Anthrax Immune Globulin (Human) (Pediatric and Neonatal Lexi-Drugs)',\n 'Omeprazole (Lexi-Drugs)',\n 'Raxibacumab (Lexi-Drugs)',\n 'Sarilumab (Lexi-Drugs)',\n 'Streptozocin (Briggs Drugs in Pregnancy and Lactation)',\n 'Ceftaroline Fosamil (Lexi-Drugs)',\n 'Casimersen (Lexi-Drugs)',\n 'Oxycodone and Acetaminophen (Lexi-Drugs)',\n 'Fluorouracil (Topical) (Lexi-Drugs)',\n 'Ibutilide (Lexi-Drugs)',\n 'Elosulfase Alfa (Lexi-Drugs)',\n 'Ceftolozane and Tazobactam (Lexi-Drugs)',\n 'Fludarabine (Lexi-Drugs)',\n 'Magnesium Chloride (Lexi-Drugs)',\n 'Meperidine (Lexi-Drugs)',\n 'Fluorescein and Benoxinate (Lexi-Drugs)',\n 'Sugammadex (Lexi-Drugs)',\n 'Streptozocin (Lexi-Drugs)',\n 'Etoposide Phosphate (Lexi-Drugs)',\n 'Propranolol (Lexi-Drugs)',\n 'Mannitol (Systemic) (Lexi-Drugs)',\n 'Scopolamine (Pediatric and Neonatal Lexi-Drugs)',\n 'Treosulfan (Lexi-Drugs)',\n 'Vindesine (Lexi-Drugs)',\n 'Sincalide (Lexi-Drugs)',\n 'Phenylephrine (Systemic) (Lexi-Drugs)',\n 'Famotidine (Lexi-Drugs)',\n nan,\n 'Methylcobalamin (Natural Products Database)',\n 'Desmopressin (Lexi-Drugs)',\n 'Eptinezumab (Lexi-Drugs)',\n 'Antihemophilic Factor (Recombinant [Fc-VWF-XTEN Fusion Protein]) (Lexi-Drugs)',\n 'Buprenorphine and Naloxone (Lexi-Drugs)',\n 'Gadopentetate Dimeglumine (Lexi-Drugs)',\n 'Fludarabine (Lexi-Drugs)',\n 'DOBUTamine (Lexi-Drugs)',\n 'Filgrastim (Lexi-Drugs)',\n 'Furosemide (Lexi-Drugs)',\n 'Aztreonam (Systemic) (Geriatric Lexi-Drugs)',\n 'Atenolol (Lexi-Drugs)',\n 'Mepivacaine and Levonordefrin (Lexi-Drugs)',\n 'Antihemophilic Factor (Recombinant [Pegylated]) (Lexi-Drugs)',\n 'CeFAZolin (Lexi-Drugs)',\n 'IdaruCIZUmab (Lexi-Drugs)',\n 'Bendamustine (Lexi-Drugs)',\n 'Meperidine and Promethazine (Lexi-Drugs)',\n 'Butorphanol (Lexi-Drugs)',\n 'Aztreonam (Systemic) (Infectious Diseases)',\n 'Ciprofloxacin and Hydrocortisone (Lexi-Drugs)',\n 'Levobupivacaine [INT] (Lexi-Drugs International [Concise])',\n 'Aztreonam (Systemic) (Lexi-Drugs)',\n 'Bumetanide (Lexi-Drugs)',\n 'IDArubicin (Lexi-Drugs)',\n 'Tenecteplase (Lexi-Drugs)',\n 'Caspofungin (Lexi-Drugs)',\n 'Anifrolumab (Lexi-Drugs)',\n 'Clevidipine (Geriatric Lexi-Drugs)',\n 'Copanlisib (Lexi-Drugs)',\n 'Ketorolac (Nasal) (Lexi-Drugs)',\n 'Antihemophilic Factor (Recombinant) (Lexi-Drugs)',\n 'Olaratumab (Lexi-Drugs)',\n 'Digoxin Immune Fab (Lexi-Drugs)',\n 'Ketamine (Lexi-Drugs)',\n 'Digoxin Toxicity (Patient Education - Disease and Procedure)',\n 'DexAMETHasone (Systemic) (Lexi-Drugs)',\n 'Doxercalciferol (Lexi-Drugs)',\n 'Acetaminophen (Lexi-Drugs)',\n 'Nalbuphine (Lexi-Drugs)',\n 'Sildenafil (Lexi-Drugs)',\n 'Gadobutrol (Lexi-Drugs)',\n 'Methotrexate (Lexi-Drugs)',\n 'Pertuzumab (Lexi-Drugs)',\n 'Colistimethate (Pediatric and Neonatal Lexi-Drugs)',\n 'Imiglucerase (Lexi-Drugs)',\n 'Dolasetron (Geriatric Lexi-Drugs)',\n 'Lansoprazole (Lexi-Drugs)',\n 'Smallpox and Monkeypox Vaccine (Live) (Lexi-Drugs)',\n 'Hydrocortisone (Systemic) (Lexi-Drugs)',\n 'Centruroides Immune F(ab’)2 (Equine) (Lexi-Drugs)',\n 'Ciprofloxacin (Systemic) (Lexi-Drugs)',\n 'LORazepam (Lexi-Drugs)',\n 'Tacrolimus (Topical) (Lexi-Drugs)',\n 'Etelcalcetide (Lexi-Drugs)',\n 'Tafasitamab (Lexi-Drugs)',\n 'Vitamins (Multiple/Oral) (Lexi-Drugs)',\n 'Cefotaxime (Briggs Drugs in Pregnancy and Lactation)',\n 'Iron Sucrose (Lexi-Drugs)',\n 'Danaparoid (Lexi-Drugs)',\n 'Gadofosveset (Lexi-Drugs)',\n 'Sodium Glycerophosphate Pentahydrate (Lexi-Drugs)',\n 'Tagraxofusp (Lexi-Drugs)',\n 'Amivantamab (Lexi-Drugs)',\n 'Evinacumab (Lexi-Drugs)',\n 'Amsacrine (Lexi-Drugs)',\n 'Lidocaine and Tetracaine (Lexi-Drugs)',\n 'CARBOplatin (Lexi-Drugs)',\n 'Enalaprilat (Lexi-Drugs)',\n 'Ketorolac (Systemic) (Lexi-Drugs)',\n 'Acetaminophen and Diphenhydramine (Lexi-Drugs)',\n 'Insulin NPH (Pediatric and Neonatal Lexi-Drugs)',\n 'Crotalidae Polyvalent Immune FAB (Ovine) (Lexi-Drugs)',\n 'C1 Inhibitor (Human) (Lexi-Drugs)',\n 'DAUNOrubicin (Liposomal) (Lexi-Drugs)',\n 'Magnesium Sulfate (Lexi-Drugs)',\n 'Cyanocobalamin (Lexi-Drugs)',\n 'Difelikefalin (Lexi-Drugs)',\n 'Fluorouracil (Systemic) (Lexi-Drugs)',\n 'Codeine (Lexi-Drugs)',\n 'Diatrizoate Meglumine (Lexi-Drugs)',\n 'Blinatumomab (Lexi-Drugs)',\n 'Cefotaxime (Pediatric and Neonatal Lexi-Drugs)',\n 'Haloperidol (Lexi-Drugs)',\n 'Sodium Chloride (Lexi-Drugs)',\n 'Smallpox Vaccine Live (Lexi-Drugs)',\n 'Ceftolozane and Tazobactam (Geriatric Lexi-Drugs)',\n 'Bretylium (Lexi-Drugs)',\n 'Clodronate (Lexi-Drugs)',\n 'Vernakalant (Lexi-Drugs)',\n 'Choline C 11 (Lexi-Drugs)',\n 'Folic Acid (Lexi-Drugs)',\n 'Mycophenolate (Pediatric and Neonatal Lexi-Drugs)',\n 'Enfortumab Vedotin (Lexi-Drugs)',\n 'Comparison of Prothrombin Complex Concentrates (Lexi-Drugs)',\n 'Nalmefene (Lexi-Drugs)',\n 'Clindamycin and Benzoyl Peroxide (Pediatric and Neonatal Lexi-Drugs)',\n 'Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride (Lexi-Drugs)',\n 'Aztreonam (Oral Inhalation) (Geriatric Lexi-Drugs)',\n 'Daunorubicin and Cytarabine (Liposomal) (Lexi-Drugs)',\n 'Betamethasone and Clotrimazole (Lexi-Drugs)',\n 'Temozolomide-Rituximab (CNS Lymphoma) (Lexi-Drugs)',\n 'Methyldopa and Hydrochlorothiazide (Lexi-Drugs)',\n 'Vancomycin (Lexi-Drugs)',\n 'Belimumab (Lexi-Drugs)',\n 'PACLitaxel (Conventional) (Lexi-Drugs)',\n 'DOXOrubicin (Conventional) (Lexi-Drugs)',\n 'Vonoprazan and Amoxicillin (Lexi-Drugs)',\n 'Orphenadrine (Lexi-Drugs)',\n 'Acyclovir (Topical) (Lexi-Drugs)',\n 'Phenylephrine and Ketorolac (Lexi-Drugs)',\n 'Aminocaproic Acid (Lexi-Drugs)',\n 'Lurbinectedin (Lexi-Drugs)',\n 'Tigecycline (Lexi-Drugs)',\n 'Oxacillin (Lexi-Drugs)',\n 'Phenylephrine (Nasal) (Lexi-Drugs)',\n 'Tobramycin and Dexamethasone (Lexi-Drugs)',\n 'Chlorpheniramine, Pseudoephedrine, and Dextromethorphan (Lexi-Drugs)',\n 'CefoTEtan (Lexi-Drugs)',\n 'Sacituzumab Govitecan (Lexi-Drugs)',\n 'Ethacrynic Acid (Lexi-Drugs)',\n 'Eteplirsen (Lexi-Drugs)',\n 'Estrogens (Conjugated/Equine, Systemic) (Lexi-Drugs)',\n 'Cidofovir (Lexi-Drugs)',\n 'Ado-Trastuzumab Emtansine (Lexi-Drugs)',\n 'Pamidronate (Lexi-Drugs)',\n 'Golimumab (Lexi-Drugs)',\n 'Gadopiclenol (Lexi-Drugs)',\n 'Melphalan (Lexi-Drugs)',\n 'Benzocaine, Butamben, and Tetracaine (Lexi-Drugs)',\n 'Buprenorphine (Pediatric and Neonatal Lexi-Drugs)',\n 'DOXOrubicin (Liposomal) (Lexi-Drugs)',\n 'Tranexamic Acid (Lexi-Drugs)',\n 'Factor X (Human) (Lexi-Drugs)',\n 'Indomethacin (Lexi-Drugs)',\n 'ChlorproMAZINE (Lexi-Drugs)',\n 'Azithromycin (Ophthalmic) (Lexi-Drugs)',\n 'Angiotensin II (Lexi-Drugs)',\n 'Mannitol (Oral Inhalation) (Lexi-Drugs)',\n 'Benztropine (Geriatric Lexi-Drugs)',\n 'Ampicillin (Lexi-Drugs)',\n 'Flucytosine (Lexi-Drugs)',\n 'Bezlotoxumab (Lexi-Drugs)',\n 'Selenium Sulfide (Lexi-Drugs)',\n 'Hyaluronidase (Lexi-Drugs)',\n 'Carboplatin-Paclitaxel (NSCLC) (Lexi-Drugs)',\n 'Tetracaine (Ophthalmic) (Lexi-Drugs)',\n 'Epoetin Alfa (Lexi-Drugs)',\n 'Vancomycin (Lexi-Drugs)',\n 'Mechlorethamine (Systemic) (Lexi-Drugs)',\n 'DilTIAZem (Lexi-Drugs)',\n 'Moxifloxacin (Systemic) (Lexi-Drugs)',\n 'MethylPREDNISolone (Lexi-Drugs)',\n 'Antihemophilic Factor (Human) (Lexi-Drugs)',\n 'Mirvetuximab Soravtansine (Lexi-Drugs)',\n 'Carbetocin (Lexi-Drugs)',\n 'Cloxacillin (Lexi-Drugs)',\n 'Carmustine (Lexi-Drugs)',\n 'Ibuprofen, Phenylephrine, and Chlorpheniramine (Lexi-Drugs)',\n 'Atoltivimab, Maftivimab, and Odesivimab (Lexi-Drugs)',\n 'AzaTHIOprine (Lexi-Drugs)',\n 'Bromhexine [INT] (Lexi-Drugs International [Concise])',\n 'Axicabtagene Ciloleucel (Lexi-Drugs)',\n 'Insulin Aspart Protamine and Insulin Aspart (Lexi-Drugs)',\n 'Insulin Detemir (Lexi-Drugs)',\n 'HydrALAZINE (Lexi-Drugs)',\n 'Orphenadrine, Aspirin, and Caffeine (Lexi-Drugs)',\n 'Gadopentetate Dimeglumine (Briggs Drugs in Pregnancy and Lactation)',\n 'Fluorescein (Lexi-Drugs)',\n 'Diazoxide (Lexi-Drugs)',\n 'FentaNYL (Lexi-Drugs)',\n nan,\n 'Bortezomib (Lexi-Drugs)',\n 'Caplacizumab (Lexi-Drugs)',\n 'Capmatinib (Lexi-Drugs)',\n 'Pafolacianine (Lexi-Drugs)',\n 'Dostarlimab (Lexi-Drugs)',\n 'Glycopyrrolate (Systemic) (Lexi-Drugs)',\n 'Etoposide (Lexi-Drugs)',\n 'Adenosine (Lexi-Drugs)',\n 'Norepinephrine (Lexi-Drugs)',\n 'Melphalan (Briggs Drugs in Pregnancy and Lactation)',\n 'DOXOrubicin (Liposomal) (Lexi-Drugs)',\n 'Minocycline (Topical) (Lexi-Drugs)',\n 'Tremelimumab (Lexi-Drugs)',\n 'Cimetidine (Lexi-Drugs)',\n 'Copanlisib (Lexi-Drugs)',\n ' ',\n 'Dextromethorphan and Chlorpheniramine (Lexi-Drugs)',\n 'MT-RNR1 - Kanamycin (Pharmacogenomics)',\n nan,\n 'Ofloxacin (Systemic) (Lexi-Drugs)',\n 'Alpha1-Proteinase Inhibitor (Lexi-Drugs)',\n 'Alcohol (Ethyl) (Lexi-Drugs)',\n 'Brentuximab Vedotin (Lexi-Drugs)',\n 'Lutetium Lu 177 Vipivotide Tetraxetan (Lexi-Drugs)',\n 'Methylfolate, Methylcobalamin, and Acetylcysteine (Lexi-Drugs)',\n 'Trabectedin (Lexi-Drugs)',\n 'Mechlorethamine (Topical) (Lexi-Drugs)',\n nan,\n 'DroPERidol (Lexi-Drugs)',\n 'PACLitaxel (Protein Bound) (Lexi-Drugs)',\n 'Ustekinumab (Lexi-Drugs)',\n 'Argatroban (Lexi-Drugs)',\n 'Vestronidase Alfa (Lexi-Drugs)',\n 'Betibeglogene Autotemcel (Pediatric and Neonatal Lexi-Drugs)',\n nan,\n 'Copper Cu 64 Dotatate (Lexi-Drugs)',\n 'Diphenhydramine and Ibuprofen (Lexi-Drugs)',\n 'Abciximab (Lexi-Drugs)',\n 'Calcium Gluconate (Lexi-Drugs)',\n 'Ferric Pyrophosphate Citrate (Lexi-Drugs)',\n 'Ticarcillin and Clavulanate Potassium (Infectious Diseases)',\n 'Teprotumumab (Lexi-Drugs)',\n 'Hydrocortisone (Topical) (Lexi-Drugs)',\n 'Lidocaine and Prilocaine (Lexi-Drugs)',\n 'Cytarabine (Conventional) (Lexi-Drugs)',\n 'Celecoxib and Tramadol (Lexi-Drugs)',\n 'Fosdenopterin (Lexi-Drugs)',\n 'Galsulfase (Lexi-Drugs)',\n 'Terbutaline (Lexi-Drugs)',\n 'Estrogens (Conjugated/Equine, Topical) (Lexi-Drugs)',\n 'Fomepizole (Lexi-Drugs)',\n 'Andexanet Alfa (Coagulation Factor Xa [Recombinant], Inactivated) (Lexi-Drugs)',\n 'Ciprofloxacin (Systemic) (Lexi-Drugs)',\n 'CefTRIAXone (Lexi-Drugs)',\n 'EPHEDrine (Systemic) (Lexi-Drugs)',\n 'Ixabepilone (Lexi-Drugs)',\n 'Amikacin Liposome (Oral Inhalation) (Lexi-Drugs)',\n 'Vasopressin (Geriatric Lexi-Drugs)',\n 'Lisocabtagene Maraleucel (Lexi-Drugs)',\n 'Vasopressin (Lexi-Drugs)',\n 'Sirolimus (Protein Bound) (Lexi-Drugs)',\n 'Acetylcysteine (Lexi-Drugs)',\n 'Potassium Iodide (Lexi-Drugs)',\n 'Irinotecan (Liposomal) (Lexi-Drugs)',\n 'EpiRUBicin (Lexi-Drugs)',\n 'Theophylline (Lexi-Drugs)',\n 'Methylfolate, Methylcobalamin, and Acetylcysteine (Geriatric Lexi-Drugs)',\n 'Atropine (Ophthalmic) (Lexi-Drugs)',\n 'Tetracaine (Topical) (Lexi-Drugs)',\n 'Ciprofloxacin and Fluocinolone (Lexi-Drugs)',\n 'Vancomycin (Geriatric Lexi-Drugs)',\n 'DexAMETHasone (Ophthalmic) (Pediatric and Neonatal Lexi-Drugs)',\n 'Iobenguane I 131 (Lexi-Drugs)',\n 'Neostigmine and Glycopyrrolate (Pediatric and Neonatal Lexi-Drugs)',\n 'Decitabine and Cedazuridine (Lexi-Drugs)',\n 'Ansuvimab (Lexi-Drugs)',\n 'Copper IUD (Lexi-Drugs)',\n 'Esmolol (Lexi-Drugs)',\n 'Dalteparin (Lexi-Drugs)',\n 'Onasemnogene Abeparvovec (Lexi-Drugs)',\n 'Manganese (Lexi-Drugs)',\n 'Ipilimumab (Lexi-Drugs)',\n 'Bamlanivimab and Etesevimab (Lexi-Drugs)',\n 'TraMADol (Lexi-Drugs)',\n 'Fluoroestradiol F18 (Lexi-Drugs)',\n 'Bendamustine (Lexi-Drugs)',\n 'Obinutuzumab (Lexi-Drugs)',\n 'PHENobarbital (Lexi-Drugs)',\n 'Anthrax Immune Globulin (Human) [ANTIDOTE] (Lexi-Tox)',\n 'MetroNIDAZOLE (Systemic) (Lexi-Drugs)',\n 'Betamethasone (Systemic) (Lexi-Drugs)',\n 'Dihydroergotamine (Lexi-Drugs)',\n 'Digoxin (Lexi-Drugs)',\n 'Betamethasone (Briggs Drugs in Pregnancy and Lactation)',\n 'Glucarpidase (Lexi-Drugs)',\n 'Oxycodone and Naloxone (Lexi-Drugs)',\n 'Labetalol (Lexi-Drugs)',\n 'C1 Inhibitor (Recombinant) (Lexi-Drugs)',\n 'Ramucirumab (Lexi-Drugs)',\n 'Flecainide (Lexi-Drugs)',\n 'Gadoteridol (Lexi-Drugs)',\n 'Patisiran (Lexi-Drugs)',\n 'Imipenem and Cilastatin (Pediatric and Neonatal Lexi-Drugs)',\n 'PENTobarbital (Lexi-Drugs)',\n 'Lidocaine and Chlorhexidine (Lexi-Drugs)',\n 'Ibuprofen (Lexi-Drugs)',\n 'Ceftolozane and Tazobactam (Pediatric and Neonatal Lexi-Drugs)',\n 'Sodium Tetradecyl Sulfate (Lexi-Drugs)',\n 'DexAMETHasone (Ophthalmic) (Lexi-Drugs)',\n 'Doxycycline Hyclate Periodontal Extended-Release Liquid (Lexi-Drugs)',\n 'Flortaucipir F18 (Lexi-Drugs)',\n 'Dinutuximab (Lexi-Drugs)',\n 'Eravacycline (Lexi-Drugs)',\n 'Meloxicam (Lexi-Drugs)',\n 'Busulfan (Lexi-Drugs)',\n 'Iopamidol (Lexi-Drugs)',\n 'Albuterol (Lexi-Drugs)',\n 'Etomidate (Lexi-Drugs)',\n 'Melphalan-Prednisone (Multiple Myeloma) (Lexi-Drugs)',\n 'Elivaldogene Autotemcel (Lexi-Drugs)',\n 'Indigotindisulfonate Sodium (Lexi-Drugs)',\n 'Iopamidol (Briggs Drugs in Pregnancy and Lactation)',\n 'Sargramostim (Lexi-Drugs)',\n 'Terbutaline (Lexi-Drugs)',\n 'Belinostat (Lexi-Drugs)',\n 'Naxitamab (Lexi-Drugs)',\n 'Glycopyrronium (Topical) (Lexi-Drugs)',\n 'Antihemophilic Factor (Recombinant [Porcine Sequence]) (Lexi-Drugs)',\n 'DAUNOrubicin (Conventional) (Lexi-Drugs)',\n 'Foscarnet (Lexi-Drugs)',\n 'DAPTOmycin (Lexi-Drugs)',\n 'Metoprolol (Lexi-Drugs)',\n 'Aminophylline (Lexi-Drugs)',\n 'Mogamulizumab (Lexi-Drugs)',\n 'EPHEDrine (Systemic) (Lexi-Drugs)',\n 'Imipenem, Cilastatin, and Relebactam (Infectious Diseases)',\n 'Reslizumab (Lexi-Drugs)',\n 'Ifosfamide (Lexi-Drugs)',\n 'Nafcillin (Lexi-Drugs)',\n 'Procyclidine (Lexi-Drugs)',\n 'Loteprednol and Tobramycin (Lexi-Drugs)',\n 'Ascorbic Acid (Lexi-Drugs)',\n 'Etranacogene Dezaparvovec (Lexi-Drugs)',\n 'Nivolumab (Lexi-Drugs)',\n 'Spesolimab (Lexi-Drugs)',\n 'LevoFLOXacin (Systemic) (Lexi-Drugs)',\n 'Imipenem and Cilastatin (Lexi-Drugs)',\n 'Loncastuximab Tesirine (Lexi-Drugs)',\n 'Elotuzumab (Lexi-Drugs)',\n 'Lidocaine and Epinephrine (Lexi-Drugs)',\n 'Gadoxetate (Lexi-Drugs)',\n 'Acyclovir (Topical) (Lexi-Drugs)',\n 'Ibuprofen and Acetaminophen (Pediatric and Neonatal Lexi-Drugs)',\n 'Betamethasone and Gentamicin (Lexi-Drugs)',\n 'Phytonadione (Lexi-Drugs)',\n 'Methadone (Lexi-Drugs)',\n 'Antithymocyte Globulin (Rabbit) (Lexi-Drugs)',\n 'Crizotinib (Lexi-Drugs)',\n 'Oxycodone and Aspirin (Lexi-Drugs)',\n 'Ibuprofen, Pseudoephedrine, and Chlorpheniramine (Lexi-Drugs)',\n 'Amobarbital (Lexi-Drugs)',\n 'Sodium Phenylacetate and Sodium Benzoate (Lexi-Drugs)',\n 'Metoclopramide (Lexi-Drugs)',\n 'Cytomegalovirus Immune Globulin (Intravenous-Human) (Lexi-Drugs)',\n 'Lidocaine (Topical) (Lexi-Drugs)',\n 'Oxycodone and Ibuprofen (Lexi-Drugs)',\n 'Viltolarsen (Lexi-Drugs)',\n 'Posaconazole (Lexi-Drugs)',\n 'Amphotericin B (Liposomal) (Lexi-Drugs)',\n 'Diclofenac (Topical) (Lexi-Drugs)',\n 'Thiamine (Lexi-Drugs)',\n 'Linezolid (Lexi-Drugs)',\n 'Selexipag (Lexi-Drugs)',\n 'Dacarbazine (Lexi-Drugs)',\n 'Arsenic Trioxide (Lexi-Drugs)',\n 'Laronidase (Lexi-Drugs)',\n 'Insulin Glulisine (Lexi-Drugs)',\n 'Mepivacaine (Lexi-Drugs)',\n 'AcetaZOLAMIDE (Lexi-Drugs)',\n 'NiMODipine (Lexi-Drugs)',\n 'Necitumumab (Lexi-Drugs)',\n 'Alemtuzumab (Lexi-Drugs)',\n 'Neostigmine and Glycopyrrolate (Lexi-Drugs)',\n 'Tobramycin (Oral Inhalation) (Lexi-Drugs)',\n 'Tisotumab Vedotin (Lexi-Drugs)',\n 'Ondansetron (Lexi-Drugs)',\n 'PyRIDostigmine (Lexi-Drugs)',\n 'Oxaliplatin (Lexi-Drugs)',\n 'Ciprofloxacin (Systemic) (Lexi-Drugs)',\n 'Fludarabine-Cyclophosphamide (CLL) (Lexi-Drugs)',\n 'Pentazocine and Naloxone (Lexi-Drugs)',\n 'Dalbavancin (Lexi-Drugs)',\n 'Ibalizumab (Lexi-Drugs)',\n 'MitoMYcin (Ureteral Gel) (Lexi-Drugs)',\n 'Efgartigimod Alfa (Lexi-Drugs)',\n 'Caffeine (Lexi-Drugs)',\n 'Benztropine (Lexi-Drugs)',\n 'ROPivacaine (Lexi-Drugs)',\n 'Verteporfin (Lexi-Drugs)',\n 'Sutimlimab (Lexi-Drugs)',\n 'Sebelipase Alfa (Lexi-Drugs)',\n 'Cladribine (Lexi-Drugs)',\n 'Vaccinia Immune Globulin (Intravenous) (Lexi-Drugs)',\n 'Mycophenolate (Lexi-Drugs)',\n 'Vinorelbine (Lexi-Drugs)',\n 'Abatacept (Lexi-Drugs)',\n 'VinCRIStine (Liposomal) (Lexi-Drugs)',\n 'Acetaminophen, Diphenhydramine, and Phenylephrine (Lexi-Drugs)',\n 'Glucagon (Geriatric Lexi-Drugs)',\n 'Gallium Ga 68 Dotatate (Lexi-Drugs)',\n 'Tobramycin (Systemic) (Lexi-Drugs)',\n 'Porfimer (Lexi-Drugs)',\n 'NiCARdipine (Lexi-Drugs)',\n 'Penicillin G (Parenteral/Aqueous) (Lexi-Drugs)',\n 'DOXOrubicin (Conventional) (Pediatric and Neonatal Lexi-Drugs)',\n 'CefTAZidime (Lexi-Drugs)',\n 'Morphine (Systemic) (Lexi-Drugs)',\n 'Norepinephrine (Pediatric and Neonatal Lexi-Drugs)',\n 'Insulin (Oral Inhalation) (Lexi-Drugs)',\n 'Tirofiban (Lexi-Drugs)',\n 'Ciltacabtagene Autoleucel (Lexi-Drugs)',\n 'Acetylcysteine (Pediatric and Neonatal Lexi-Drugs)',\n 'Cetirizine (Ophthalmic) (Lexi-Drugs)',\n 'Floxuridine (Lexi-Drugs)',\n 'Neostigmine (Pediatric and Neonatal Lexi-Drugs)',\n 'Vancomycin (Infectious Diseases)',\n 'Vestronidase Alfa (Pediatric and Neonatal Lexi-Drugs)',\n 'Lidocaine (Systemic) (Lexi-Drugs)',\n 'Antithymocyte Globulin (Equine) (Pediatric and Neonatal Lexi-Drugs)',\n 'Daratumumab and Hyaluronidase (Lexi-Drugs)',\n 'Sodium Nitrite (Lexi-Drugs)',\n 'Antipsychotic Agents, Atypical (Lexi-Tox)',\n 'Scopolamine (Lexi-Drugs)',\n 'Liothyronine (Lexi-Drugs)',\n 'Valproic Acid and Derivatives (Lexi-Drugs)',\n 'Cefiderocol (Lexi-Drugs)',\n 'Prochlorperazine (Lexi-Drugs)',\n \"Crotalidae Immune F(ab')2 (Equine) (Lexi-Drugs)\",\n 'Doripenem (Lexi-Drugs)',\n 'Idursulfase (Lexi-Drugs)',\n 'MitoMYcin (Systemic) (Lexi-Drugs)',\n 'Sarilumab (Lexi-Drugs)',\n 'Antithymocyte Globulin (Rabbit) (Pediatric and Neonatal Lexi-Drugs)',\n 'DAUNOrubicin (Liposomal) (Lexi-Drugs)',\n 'Meropenem and Vaborbactam (Lexi-Drugs)',\n 'HydrOXYzine (Lexi-Drugs)',\n 'Minocycline Hydrochloride Periodontal Microspheres (Lexi-Drugs)',\n 'OxyCODONE (Lexi-Drugs)',\n 'Pentostatin (Lexi-Drugs)',\n 'Folic Acid, Cyanocobalamin, and Pyridoxine (Lexi-Drugs)',\n 'Potassium Phosphate and Sodium Phosphate (Lexi-Drugs)',\n 'SUFentanil (Lexi-Drugs)',\n 'Tobramycin (Ophthalmic) (Lexi-Drugs)',\n 'Leucovorin Calcium (Lexi-Drugs)',\n 'Methylene Blue (Lexi-Drugs)',\n 'Colistimethate (Lexi-Drugs)',\n 'Docetaxel-Oxaliplatin-Leucovorin-Fluorouracil (Esophageal) (Lexi-Drugs)',\n 'Clindamycin and Tretinoin (Pediatric and Neonatal Lexi-Drugs)',\n 'Isosorbide Mononitrate (Lexi-Drugs)',\n 'Gallium Ga 68 Dotatate (Pediatric and Neonatal Lexi-Drugs)',\n 'Trandolapril and Verapamil (Lexi-Drugs)',\n 'Antivenin (Micrurus fulvius) (Lexi-Drugs)',\n 'Iodine I-125 Iothalamate (Lexi-Drugs)',\n 'DAUNOrubicin (Conventional) (Lexi-Drugs)',\n 'Cisatracurium (Lexi-Drugs)',\n 'VinCRIStine (Pediatric and Neonatal Lexi-Drugs)',\n 'Benztropine (Pediatric and Neonatal Lexi-Drugs)',\n 'Albumin (Lexi-Drugs)',\n 'EPHEDrine (Systemic) (Lexi-Drugs)',\n 'Mesna (Lexi-Drugs)',\n 'Amoxicillin and Clavulanate (Lexi-Drugs)',\n 'ClonazePAM (Lexi-Drugs)',\n 'Lincomycin (Lexi-Drugs)',\n 'Insulin Glulisine (Pediatric and Neonatal Lexi-Drugs)',\n 'Plasminogen Activity, Plasma (Lab Tests and Diagnostic Procedures)',\n 'Insulin Glargine (Lexi-Drugs)',\n 'Sipuleucel-T (Lexi-Drugs)',\n 'QuiNIDine (Lexi-Drugs)',\n 'Ocrelizumab (Lexi-Drugs)',\n 'Methylergonovine (Lexi-Drugs)',\n 'Procainamide (Lexi-Drugs)',\n 'Ado-Trastuzumab Emtansine (Lexi-Drugs)',\n 'Naproxen and Diphenhydramine (Lexi-Drugs)',\n 'Iron Dextran Complex (Lexi-Drugs)',\n 'Aztreonam (Systemic) (Pediatric and Neonatal Lexi-Drugs)',\n 'Iohexol (Lexi-Drugs)',\n 'Tecovirimat (Lexi-Drugs)',\n 'Bivalirudin (Lexi-Drugs)',\n 'DACTINomycin (Lexi-Drugs)',\n 'Vecuronium (Lexi-Drugs)',\n 'Fosaprepitant (Pediatric and Neonatal Lexi-Drugs)',\n 'Minocycline (Systemic) (Lexi-Drugs)',\n 'Oritavancin (Lexi-Drugs)',\n 'Artesunate (Lexi-Drugs)',\n 'Ibuprofen and Acetaminophen (Lexi-Drugs)',\n 'Diamorphine (Lexi-Drugs)',\n 'Moxetumomab Pasudotox (Lexi-Drugs)',\n 'Telavancin (Lexi-Drugs)',\n 'Zinc Sulfate (Lexi-Drugs)',\n 'Vasopressin (Pediatric and Neonatal Lexi-Drugs)',\n 'Streptomycin (Lexi-Drugs)',\n 'DexAMETHasone (Systemic) [SUPPORTIVE] (Lexi-Tox)',\n 'Methocarbamol (Lexi-Drugs)',\n 'Calaspargase Pegol (Lexi-Drugs)',\n 'Hemin (Lexi-Drugs)',\n 'Enoxaparin (Lexi-Drugs)',\n 'Nivolumab and Relatlimab (Lexi-Drugs)',\n 'Fluorouracil-Leucovorin-Oxaliplatin  (Gastric/Esophageal)  (Lexi-Drugs)',\n 'Fosaprepitant (Lexi-Drugs)',\n 'LevoFLOXacin (Oral Inhalation) (Lexi-Drugs)',\n 'Ziv-Aflibercept (Systemic) (Lexi-Drugs)',\n 'Insulin NPH (Lexi-Tox)',\n 'Zoledronic Acid (Lexi-Drugs)',\n 'Potassium Phosphate (Lexi-Drugs)',\n 'Benztropine (Lexi-Drugs)',\n 'Abacavir, Lamivudine, and Zidovudine (Lexi-Drugs)',\n 'Natalizumab (Lexi-Drugs)',\n 'Regadenoson (Lexi-Drugs)',\n 'Antithymocyte Globulin (Equine) (Lexi-Drugs)',\n 'CeFAZolin (Lexi-Drugs)',\n 'Esomeprazole (Lexi-Drugs)',\n 'Sodium Thiosulfate (Lexi-Drugs)',\n 'Cetuximab (Lexi-Drugs)',\n 'Pyridoxine (Lexi-Drugs)',\n 'Lutetium Lu 177 Dotatate (Lexi-Drugs)',\n 'DexAMETHasone (Ophthalmic) (Lexi-Drugs)',\n 'Clarithromycin (Lexi-Drugs)',\n 'Glutathione (Natural Products Database)',\n 'Amoxicillin (Lexi-Drugs)',\n 'Chlorpheniramine, Phenylephrine, and Dextromethorphan (Lexi-Drugs)',\n 'Casirivimab and Imdevimab (Lexi-Drugs)',\n 'Atracurium (Lexi-Drugs)',\n 'Ibandronate (Lexi-Drugs)',\n 'Acetaminophen and Caffeine (Lexi-Drugs)',\n 'Bendamustine-Rituximab (CLL) (Lexi-Drugs)',\n 'Gadopentetate Dimeglumine (Pediatric and Neonatal Lexi-Drugs)',\n 'Sodium Iodide I123 (Lexi-Drugs)',\n 'Local Anesthetics (Lexi-Tox)',\n 'Phenytoin (Lexi-Drugs)',\n 'Antihemophilic Factor (Recombinant) (Lexi-Drugs)',\n 'Iodinated I 131 Albumin (Lexi-Drugs)',\n 'Temozolomide (Lexi-Drugs)',\n 'QuiNINE (Lexi-Drugs)',\n 'Fluorouracil-Leucovorin Bolus (Colorectal) (Lexi-Drugs)',\n 'Interferon Alfa-2b (Lexi-Drugs)',\n 'Factor IX (Recombinant) (Lexi-Drugs)',\n 'Asparaginase (Erwinia) (Lexi-Drugs)',\n 'Fam-Trastuzumab Deruxtecan (Lexi-Drugs)',\n 'Ziconotide (Lexi-Drugs)',\n 'Fluconazole (Lexi-Drugs)',\n 'Isoproterenol (Lexi-Drugs)',\n 'Bacitracin and Polymyxin B (Topical) (Lexi-Drugs)',\n 'Trastuzumab (Lexi-Drugs)',\n 'Oliceridine (Lexi-Drugs)',\n 'Lacosamide (Lexi-Drugs)',\n 'DiphenhydrAMINE (Systemic) (Lexi-Drugs)',\n 'Tocilizumab (Lexi-Drugs)',\n 'Elotuzumab-Pomalidomide-Dexamethasone (Multiple Myeloma) (Lexi-Drugs)',\n 'Ceftazidime and Avibactam (Lexi-Drugs)',\n 'Ferric Carboxymaltose (Lexi-Drugs)',\n 'Glycerin and Lidocaine (Lexi-Drugs)',\n 'PEMEtrexed (Lexi-Drugs)',\n 'Naloxone (Lexi-Drugs)',\n 'Aminocaproic Acid (Lexi-Drugs)',\n 'Amphotericin B Deoxycholate (Lexi-Drugs)',\n 'Acyclovir (Systemic) (Lexi-Drugs)',\n 'Edetate CALCIUM Disodium (Lexi-Drugs)',\n 'Eculizumab (Lexi-Drugs)',\n 'Teplizumab (Lexi-Drugs)',\n 'LevOCARNitine (Lexi-Drugs)',\n 'PRALAtrexate (Lexi-Drugs)',\n 'Bendamustine-Bortezomib-Rituximab (NHL-Follicular) (Lexi-Drugs)',\n 'Delafloxacin (Lexi-Drugs)',\n 'Eptifibatide (Lexi-Drugs)',\n 'Ofloxacin (Ophthalmic) (Lexi-Drugs)',\n 'Mycophenolate (Briggs Drugs in Pregnancy and Lactation)',\n 'Stanford V (Hodgkin) (Lexi-Drugs)',\n 'Methoxy Polyethylene Glycol-Epoetin Beta (Lexi-Drugs)',\n 'Glycopyrrolate (Oral Inhalation) (Lexi-Drugs)',\n 'Asparaginase (Erwinia [Recombinant]) (Lexi-Drugs)',\n 'Heparin (Lexi-Drugs)',\n 'AzaCITIDine (Lexi-Drugs)',\n 'Arginine (Lexi-Drugs)',\n 'Cisplatin-Vinblastine (NSCLC) (Lexi-Drugs)',\n 'Aztreonam (Oral Inhalation) (Pediatric and Neonatal Lexi-Drugs)',\n 'Prothrombin Complex Concentrate (Human) [(Factors II, VII, IX, X), Protein C, and Protein S]',\n 'Trilaciclib (Lexi-Drugs)',\n 'Agalsidase Alfa (Lexi-Drugs)',\n 'Belantamab Mafodotin (Lexi-Drugs)',\n 'Nitroprusside (Lexi-Drugs)',\n 'Gatifloxacin (Lexi-Drugs)',\n 'Trastuzumab (Lexi-Drugs)',\n 'DOCEtaxel (Lexi-Drugs)',\n 'Pantothenic Acid (Natural Products Database)',\n 'LEVOleucovorin (Lexi-Drugs)',\n 'Fosnetupitant and Palonosetron (Lexi-Drugs)',\n 'Metoprolol and Hydrochlorothiazide (Lexi-Drugs)',\n 'Daratumumab (Lexi-Drugs)',\n 'Bivalirudin (Lexi-Drugs)',\n 'Lidocaine and Menthol (Lexi-Drugs)',\n 'Bleomycin (Lexi-Drugs)',\n 'Baclofen (Lexi-Drugs)',\n 'Milrinone (Lexi-Drugs)',\n 'LevETIRAcetam (Lexi-Drugs)',\n 'Sodium Thiosulfate: Calciphylaxis (Facts and Comparisons Off-Label)',\n 'Defibrotide (Lexi-Drugs)',\n 'Metoprolol (Lexi-Drugs)',\n 'Calcium Chloride (Lexi-Drugs)',\n 'Buprenorphine (Briggs Drugs in Pregnancy and Lactation)',\n 'Phenylephrine (Topical) (Lexi-Drugs)',\n 'Amiodarone (Lexi-Drugs)',\n 'Cosyntropin (Lexi-Drugs)',\n 'Thiotepa (Lexi-Drugs)',\n 'CefTAZidime (Lexi-Drugs)',\n 'Betibeglogene Autotemcel (Lexi-Drugs)',\n 'Mycophenolate (Lexi-Drugs)',\n 'Benztropine (Briggs Drugs in Pregnancy and Lactation)',\n 'Cefuroxime (Pediatric and Neonatal Lexi-Drugs)',\n 'Octreotide (Lexi-Drugs)',\n 'Gadoterate Meglumine (Lexi-Drugs)',\n 'Velaglucerase Alfa (Lexi-Drugs)',\n 'Allopurinol (Lexi-Drugs)',\n 'Avelumab (Lexi-Drugs)',\n 'Rasburicase (Lexi-Drugs)',\n 'Clindamycin and Benzoyl Peroxide (Lexi-Drugs)',\n 'Insulin Lispro Protamine and Insulin Lispro (Lexi-Drugs)',\n 'Morphine (Systemic) (Lexi-Drugs)',\n 'Doxorubicin (Briggs Drugs in Pregnancy and Lactation)',\n 'Agalsidase Beta (Lexi-Drugs)',\n 'Obiltoxaximab (Lexi-Drugs)',\n 'Factor VIIa (Recombinant) (Lexi-Drugs)',\n 'Sotalol (Lexi-Drugs)',\n 'Omeprazole and Sodium Bicarbonate (Lexi-Drugs)',\n 'Melphalan Flufenamide (Lexi-Drugs)',\n 'Iodine I-125 Human Serum Albumin (Lexi-Drugs)',\n 'Sodium Bicarbonate (Lexi-Drugs)',\n 'Factor IX (Recombinant [Albumin Fusion Protein]) (Lexi-Drugs)',\n 'Lansoprazole, Amoxicillin, and Clarithromycin (Lexi-Drugs)',\n 'Midazolam (Lexi-Drugs)',\n 'Melphalan-Prednisone-Thalidomide (Multiple Myeloma) (Lexi-Drugs)',\n 'CISplatin (Lexi-Drugs)',\n 'Amphotericin B Cholesteryl Sulfate Complex (Lexi-Drugs)',\n 'Isatuximab (Lexi-Drugs)',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Lexi-Drugs)',\n 'CefOXitin (Lexi-Drugs)',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Pediatric and Neonatal Lexi-Drugs)',\n 'Insulin Degludec (Lexi-Drugs)',\n 'Phenylephrine (Ophthalmic) (Lexi-Drugs)',\n 'Quinupristin and Dalfopristin (Lexi-Drugs)',\n 'Amikacin (Systemic) (Lexi-Drugs)',\n 'Insulin Glargine and Lixisenatide (Lexi-Drugs)',\n 'Alglucosidase Alfa (Lexi-Drugs)',\n 'Furosemide (Lexi-Drugs)',\n 'Mitoxantrone-Prednisone (Prostate) (Lexi-Drugs)',\n 'Proparacaine and Fluorescein (Lexi-Drugs)',\n 'Glutamine (Patient Education - Natural Products)',\n 'Alcohol (Isopropyl) (Lexi-Drugs)',\n 'MitoXANTRONE (Lexi-Drugs)',\n 'Octreotide (Lexi-Drugs)',\n 'Gadoversetamide (Lexi-Drugs)',\n 'Methotrexate (Lexi-Drugs)',\n 'Aldesleukin (Lexi-Drugs)',\n 'Anticholinergic Agents (Lexi-Tox)',\n 'Epoprostenol (Lexi-Drugs)',\n 'Tranexamic Acid [SUPPORTIVE] (Lexi-Tox)',\n 'Ibuprofen and Phenylephrine (Lexi-Drugs)',\n 'Insulin Degludec and Liraglutide (Lexi-Drugs)',\n 'Deferoxamine (Lexi-Drugs)',\n 'Meropenem (Lexi-Drugs)',\n 'Palifermin (Lexi-Drugs)',\n 'Pegloticase (Lexi-Drugs)',\n 'LEVOleucovorin (Lexi-Drugs)',\n 'Amphotericin B (Lipid Complex) (Lexi-Drugs)',\n 'Atezolizumab (Lexi-Drugs)',\n 'MetroNIDAZOLE (Systemic) (Lexi-Drugs)',\n 'Inotuzumab Ozogamicin (Lexi-Drugs)',\n 'Itraconazole (Lexi-Drugs)',\n 'Sodium Chloride and Sodium Citrate (Lexi-Drugs)',\n 'HYDROmorphone (Lexi-Drugs)',\n 'Brexucabtagene Autoleucel (Lexi-Drugs)',\n 'DAPTOmycin (Lexi-Drugs)',\n 'CycloSPORINE (Systemic) (Lexi-Drugs)',\n 'Gemcitabine (Lexi-Drugs)',\n 'Anthrax Immune Globulin (Human) (Lexi-Drugs)',\n 'EriBULin (Lexi-Drugs)',\n 'Fosphenytoin (Lexi-Drugs)',\n 'ALfentanil (Pediatric and Neonatal Lexi-Drugs)',\n 'Clindamycin (Systemic) (Lexi-Drugs)',\n 'Calcitriol (Systemic) (Lexi-Drugs)',\n nan,\n 'Clindamycin (Systemic) (Pediatric and Neonatal Lexi-Drugs)',\n 'Phenylephrine and Pyrilamine (Lexi-Drugs)',\n 'Fosfomycin (Lexi-Drugs)',\n 'DexmedeTOMIDine (Lexi-Drugs)',\n 'Ergonovine (Lexi-Drugs)',\n 'Terlipressin (Lexi-Drugs)',\n 'Acyclovir (Systemic) (Lexi-Drugs)',\n 'Insulin NPH and Insulin Regular (Pediatric and Neonatal Lexi-Drugs)',\n 'Pseudoephedrine and Ibuprofen (Pediatric and Neonatal Lexi-Drugs)',\n 'Scopolamine (Briggs Drugs in Pregnancy and Lactation)',\n 'Fibrinogen Concentrate (Human) (Lexi-Drugs)',\n 'Buprenorphine (Geriatric Lexi-Drugs)',\n 'DilTIAZem (Lexi-Drugs)',\n 'Ibuprofen (Lexi-Drugs)',\n 'Betamethasone and Salicylic Acid (Lexi-Drugs)',\n 'Diclofenac (Ophthalmic) (Lexi-Drugs)',\n 'Aztreonam (Oral Inhalation) (Lexi-Drugs)',\n 'Bupivacaine and Meloxicam (Lexi-Drugs)',\n 'Acyclovir (Ophthalmic) (Lexi-Drugs)',\n 'Asparaginase (Briggs Drugs in Pregnancy and Lactation)',\n 'Golodirsen (Lexi-Drugs)',\n 'Clindamycin (Topical) (Lexi-Drugs)']"
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "titles = list(test_interactions_df['Title'].values[:])\n",
    "titles"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-03T08:16:26.368723900Z",
     "start_time": "2023-05-03T08:16:26.351038400Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "outputs": [],
   "source": [
    "drugs_test_conditions = {}\n",
    "i = 0\n",
    "\n",
    "for i in range(len(test_conditions)):\n",
    "    drugs_test_conditions[titles[i]] = test_conditions[i]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-03T08:22:57.463505100Z",
     "start_time": "2023-05-03T08:22:57.447884100Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "outputs": [
    {
     "data": {
      "text/plain": "{'Ceftobiprole (Lexi-Drugs)': '{\\n\"Direct antiglobulin (Coombs) test\": \"Positive\",\\n\"Urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n\"Serum/urine creatinine with Jaffé reaction assay\": \"Falsely elevated\"\\n}',\n 'Irinotecan (Conventional) (Lexi-Drugs)': 'Not available',\n 'DexAMETHasone (Systemic) (Pediatric and Neonatal Lexi-Drugs)': '{\\n\"Wheal and flare reactions to skin test antigens\": \"May be suppressed\"\\n}',\n 'Pegaspargase (Lexi-Drugs)': 'Not available',\n 'Acetylcysteine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'DOXOrubicin (Conventional) (Lexi-Drugs)': 'Not available',\n 'Tebentafusp (Lexi-Drugs)': 'Not available',\n 'Flumazenil (Lexi-Drugs)': 'Not available',\n 'Diphenhydramine and Phenylephrine (Lexi-Drugs)': 'Not available',\n 'Acetaminophen and Tramadol (Lexi-Drugs)': 'Not available',\n 'Glutamine (Lexi-Drugs)': 'Not available',\n 'Sulfamethoxazole and Trimethoprim (Lexi-Drugs)': '{\\n    \"creatinine (Jaffé alkaline picrate reaction)\": \"Increased\",\\n    \"serum methotrexate (dihydrofolate reductase method)\": \"Increased\"\\n}',\n 'Omeprazole, Amoxicillin, and Rifabutin (Lexi-Drugs)': '{\\n    \"serum chromogranin A (CgA) levels\": \"falsely elevated (due to decreased gastric acidity with Omeprazole)\",\\n    \"neuroendocrine tumor diagnosis\": \"may cause false-positive results\",\\n    \"CgA levels assessment\": \"≥14 days after treatment is completed\",\\n    \"CgA levels repeat\": \"if initially elevated\"\\n}',\n 'Crizanlizumab (Lexi-Drugs)': '{\\n    \"automated platelet counts\": \"may interfere (platelet clumping) with Crizanlizumab\",\\n    \"blood samples collection\": \"in tubes containing ethylenediaminetetraacetic acid (EDTA)\",\\n    \"platelet count\": \"may be unevaluable or falsely decreased\",\\n    \"management\": \"Collect blood samples in citrate-containing tubes\",\\n    \"run blood samples\": \"within 4 hours of sample collection\",\\n    \"estimate platelet count\": \"through peripheral blood smear if necessary\"\\n}',\n 'Nitroglycerin (Lexi-Drugs)': '{\\n    \"triglyceride assays\": \"may be falsely elevated (dependent on glycerol oxidase)\",\\n    \"propylene glycol content\": \"in IV formulation\"\\n}',\n 'Pentostatin-Cyclophosphamide-Rituximab  (CLL)  (Lexi-Drugs)': 'Not available',\n 'Phenylephrine and Thonzylamine (Lexi-Drugs)': 'Not available',\n 'Tranexamic Acid (Lexi-Drugs)': 'Not available',\n 'Bamlanivimab (Lexi-Drugs)': 'Not available',\n 'Micafungin (Lexi-Drugs)': 'Not available',\n 'Tenoxicam (Lexi-Drugs)': 'Not available',\n 'Darbepoetin Alfa (Lexi-Drugs)': 'Test names: HbA1c.\\nTest results: \\n{\\n \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose\"\\n}',\n 'Levorphanol (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor/von Willebrand Factor Complex (Human) (Lexi-Drugs)': 'Not available',\n 'LevoFLOXacin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'MitoMYcin (Systemic) (Lexi-Drugs)': 'Not available',\n 'Carfilzomib (Lexi-Drugs)': 'Not available',\n 'Tacrolimus (Systemic) (Lexi-Drugs)': 'Not available',\n 'Dipyridamole (Lexi-Drugs)': 'Test Names: dipyridamole-thallium myocardial imaging\\n\\nTest Results: {\"dipyridamole-thallium myocardial imaging\": \"false-negative result\"}',\n 'Azithromycin (Systemic) (Lexi-Drugs)': 'Not available',\n 'Trace Elements (Lexi-Drugs)': 'Not available',\n 'Trimethobenzamide (Lexi-Drugs)': 'Not available',\n 'Tisagenlecleucel (Lexi-Drugs)': '{\"HIV nucleic acid tests\": \"false positive results\"}',\n 'Ergotamine and Caffeine (Lexi-Drugs)': 'Not available',\n 'PACLitaxel (Protein Bound) (Lexi-Drugs)': 'Not available',\n 'Insulin NPH (Lexi-Drugs)': 'Not available',\n 'Norepinephrine (Lexi-Drugs)': 'Not available',\n 'von Willebrand Factor (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Trastuzumab and Hyaluronidase (Lexi-Drugs)': 'Not available',\n 'Bevacizumab (Lexi-Drugs)': 'Not available',\n 'Imipenem and Cilastatin (Infectious Diseases)': '{\\n  \"Urinary Glucose Determination (Clinitest)\": \"Interferes\",\\n  \"Coombs\\' Test (Direct)\": \"Positive\"\\n}',\n 'Isosorbide Dinitrate (Lexi-Drugs)': 'Not available',\n 'Iobenguane I 123 (Lexi-Drugs)': 'Not available',\n 'Meropenem (Lexi-Drugs)': '{\"Coombs\\' [direct]\": \"Positive\"}',\n 'DOPamine (Lexi-Drugs)': 'Not available',\n 'CycloSPORINE (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Lefamulin (Lexi-Drugs)': 'Not available',\n 'CycloPHOSphamide (Lexi-Drugs)': 'Not available',\n 'Nelarabine (Lexi-Drugs)': 'Not available',\n 'Ferric Derisomaltose (Lexi-Drugs)': 'Not available',\n 'Gemtuzumab Ozogamicin (Lexi-Drugs)': 'Not available',\n 'Cefuroxime (Geriatric Lexi-Drugs)': '{\"direct Coombs\": \"positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"false-positive\"}',\n 'Factor IX Complex (Human) [(Factors II, IX, X)] (Lexi-Drugs)': 'Not available',\n 'Cemiplimab (Lexi-Drugs)': 'Not available',\n 'Aprepitant (Lexi-Drugs)': 'Not available',\n 'Thiotepa (Lexi-Drugs)': 'Not available',\n 'Vonoprazan, Amoxicillin, and Clarithromycin (Lexi-Drugs)': 'Not available',\n 'Anidulafungin (Lexi-Drugs)': 'Not available',\n 'Gadobenate Dimeglumine (Lexi-Drugs)': '{\\n   \"serum ferritin\": \"transient increase\",\\n   \"urine zinc\": \"transient increase (with renal disease)\",\\n   \"bilirubin\": \"transient increase (with hepatic metabolic disorders)\"\\n}',\n 'Pembrolizumab (Geriatric Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant [Fc Fusion Protein]) (Lexi-Drugs)': 'Not available',\n 'Vedolizumab (Lexi-Drugs)': 'Not available',\n 'Chloramphenicol (Systemic) (Lexi-Drugs)': 'Not available',\n 'Clevidipine (Lexi-Drugs)': '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'Bebtelovimab (Lexi-Drugs)': 'Not available',\n 'Erythromycin and Benzoyl Peroxide (Lexi-Drugs)': 'Not available',\n 'Trastuzumab-Vinorelbine (Breast) (Lexi-Drugs)': 'Not available',\n 'DiphenhydrAMINE (Systemic) (Lexi-Drugs)': '{\\n   \"urine detection of methadone\": \"false-positives\",\\n   \"urine detection of phencyclidine\": \"false-positives\",\\n   \"serum TCA screen\": \"false-positive\",\\n   \"wheal and flare reactions to skin test antigens\": \"suppressed\"\\n}',\n 'Betamethasone (Topical) (Lexi-Drugs)': 'Medical Test Name: \\n1. Skin test antigens \\n\\nJSON Form: \\n{\\n   \"Skin test antigens\": \"suppressed wheal and flare reactions\"\\n}',\n 'Dexrazoxane (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Sotrovimab (Lexi-Drugs)': 'Not available',\n 'BChE - Mivacurium (Pharmacogenomics)': 'Not available',\n 'Benzyl Alcohol (Lexi-Drugs)': 'Not available',\n 'Ferric Gluconate (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"Serum or transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric gluconate administration\",\\n  \"Serum ferritin levels\": \"falsely elevated for 5 days after ferric gluconate administration\"\\n}',\n 'Siltuximab (Lexi-Drugs)': 'Not available',\n 'Selenium (Lexi-Drugs)': 'Not available',\n 'Palonosetron (Lexi-Drugs)': 'Not available',\n 'Fluorouracil and Salicylic Acid (Lexi-Drugs)': 'Not available',\n 'VinCRIStine (Lexi-Drugs)': 'Not available',\n 'Octreotide [ANTIDOTE] (Lexi-Tox)': 'Not available',\n 'VinBLAStine (Lexi-Drugs)': 'Not available',\n 'Carboplatin-Paclitaxel-Trastuzumab (Breast) (Lexi-Drugs)': 'Not available',\n 'Vitamin B Complex Combinations (Lexi-Drugs)': 'Not available',\n 'Lidocaine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Insulin Aspart (Lexi-Drugs)': 'Not available',\n 'Iothalamate Meglumine (Lexi-Drugs)': '{\\n   \"thyroid function tests dependent on iodine estimation\": \"altered results\",\\n   \"radioiodine uptake studies\": \"affected results\"\\n}',\n 'Insulin Regular (Lexi-Drugs)': 'Not available',\n 'Treprostinil (Lexi-Drugs)': 'Not available',\n 'Cefotaxime (Lexi-Drugs)': '{\\n   \"direct Coombs\\' test\": \"positive\",\\n   \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"false-positive\",\\n   \"serum creatinine with Jaffé reaction\": \"false-positive\",\\n   \"urine creatinine with Jaffé reaction\": \"false-positive\"\\n}',\n 'Dantrolene (Lexi-Drugs)': 'Not available',\n 'Gemcitabine-Vinorelbine (NSCLC) (Lexi-Drugs)': 'Not available',\n 'Durvalumab (Lexi-Drugs)': 'Not available',\n 'Brivaracetam (Lexi-Drugs)': 'Not available',\n 'Amifostine (Lexi-Drugs)': 'Not available',\n 'Capreomycin (Lexi-Drugs)': 'Not available',\n 'Neostigmine (Lexi-Drugs)': 'Not available',\n 'Emapalumab (Lexi-Drugs)': 'Not available',\n 'Ketamine (Lexi-Drugs)': 'Test Names: \\n1. Urine test for phencyclidine\\n\\nTest Results: \\n{\\n   \"Urine test for phencyclidine\": \"false-positive interference may occur\"\\n}',\n 'Zinc Chloride (Lexi-Drugs)': 'Not available',\n 'Fosaprepitant (Geriatric Lexi-Drugs)': 'Not available',\n 'Imipenem and Cilastatin (Geriatric Lexi-Drugs)': '{\\n   \"Clinitest®\": \"interfered with urinary glucose determination\",\\n   \"Coombs\\' [direct]\": \"positive\"\\n}',\n 'DimenhyDRINATE (Lexi-Drugs)': 'Not available',\n 'Anti-inhibitor Coagulant Complex (Human) (Lexi-Drugs)': '{\\n   \"blood group isohemagglutinins\": \"presence\",\\n   \"Coombs test\": \"may be interfered with due to passive transmission of antibodies to erythrocyte antigens\"\\n}',\n 'Calcitriol (Topical) (Lexi-Drugs)': 'Not available',\n 'Margetuximab (Lexi-Drugs)': 'Not available',\n 'Alfentanil (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Mycophenolate (Lexi-Drugs)': 'Not available',\n 'Decitabine (Lexi-Drugs)': 'Not available',\n 'Ferric Gluconate (Lexi-Drugs)': 'Test Names: \\n1. Serum or transferrin bound iron levels \\n2. Serum ferritin levels \\n\\nTest Results:\\n1. {\"Serum or transferrin bound iron levels\": \"May be falsely elevated if assessed within 24 hours of ferric gluconate administration.\"}\\n2. {\"Serum ferritin levels\": \"May be falsely elevated for 5 days after ferric gluconate administration.\"}',\n 'RomiDEPsin (Lexi-Drugs)': 'Not available',\n 'Olipudase Alfa (Lexi-Drugs)': 'Not available',\n 'Brexanolone (Lexi-Drugs)': 'Not available',\n 'Clindamycin (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Lamivudine and Zidovudine (Lexi-Drugs)': 'Not available',\n 'Cefuroxime (Lexi-Drugs)': '{\"direct Coombs\\'\": \"Positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\", \"ferricyanide test\": \"False-negative\"}',\n 'Sodium Phosphates (Lexi-Drugs)': 'Not available',\n 'Amisulpride (Injection) (Lexi-Drugs)': 'Not available',\n 'Ofloxacin (Otic) (Lexi-Drugs)': 'Not available',\n 'Peginterferon Alfa-2b (Lexi-Drugs)': 'Not available',\n 'Succinylcholine (Lexi-Drugs)': 'Not available',\n 'DiazePAM (Lexi-Drugs)': 'Test names: \\n- Urinary glucose determination \\n\\nTest Results in JSON format:\\n{\\n   \"Urinary glucose determination\": \"False-negative when using Clinistix® or Diastix®\"\\n}',\n 'Ibuprofen and Famotidine (Lexi-Drugs)': 'Not available',\n 'Granisetron (Lexi-Drugs)': 'Not available',\n 'Mepivacaine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Clofarabine (Lexi-Drugs)': 'Not available',\n 'Buprenorphine (Lexi-Drugs)': 'Not available',\n 'Inebilizumab (Lexi-Drugs)': 'Not available',\n 'Cabazitaxel (Lexi-Drugs)': 'Not available',\n 'Propofol (Lexi-Drugs)': 'Not available',\n 'Sirolimus (Conventional) (Lexi-Drugs)': 'Not available',\n 'Phenylephrine and Pramoxine (Lexi-Drugs)': 'Not available',\n 'Secretin (Lexi-Drugs)': 'Not available',\n 'Insulin Lispro (Lexi-Drugs)': 'Not available',\n 'Melphalan (Pharmacogenomics)': 'Not available',\n 'Insulin NPH and Insulin Regular (Lexi-Drugs)': 'Not available',\n 'Hydroxocobalamin (Lexi-Drugs)': 'Medical test names: Basophils, hemoglobin, MCH, MCHC, albumin, alkaline phosphatase, cholesterol, creatinine, glucose, total protein, triglycerides, bilirubin, urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite), ALT, amylase, AST, CK, CKMB, LDH, phosphate, uric acid, PT, aPTT, urine pH.\\n\\nJSON form:\\n{\\n  \"Basophils\": \"Falsely elevated\",\\n  \"Hemoglobin\": \"Falsely elevated\",\\n  \"MCH\": \"Falsely elevated\",\\n  \"MCHC\": \"Falsely elevated\",\\n  \"Albumin\": \"Falsely elevated\",\\n  \"Alkaline phosphatase\": \"Falsely elevated\",\\n  \"Cholesterol\": \"Falsely elevated\",\\n  \"Creatinine\": \"Falsely elevated\",\\n  \"Glucose\": \"Falsely elevated\",\\n  \"Total protein\": \"Falsely elevated\",\\n  \"Triglycerides\": \"Falsely elevated\",\\n  \"Bilirubin\": \"Falsely elevated\",\\n  \"Urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite)\": \"Falsely elevated\",\\n  \"ALT\": \"Falsely decreased\",\\n  \"Amylase\": \"Falsely decreased\",\\n  \"AST\": \"Unpredictable\",\\n  \"CK\": \"Unpredictable\",\\n  \"CKMB\": \"Unpredictable\",\\n  \"LDH\": \"Unpredictable\",\\n  \"Phosphate\": \"Unpredictable\",\\n  \"Uric acid\": \"Unpredictable\",\\n  \"PT\": \"Unpredictable\",\\n  \"aPTT\": \"Unpredictable\",\\n  \"Urine pH\": \"Unpredictable\"\\n}',\n 'Voriconazole (Lexi-Drugs)': 'Not available',\n 'Botulism Antitoxin, Heptavalent (Lexi-Drugs)': 'Medical test name: Blood glucose\\n\\nJSON form:\\n{\\n  \"Blood glucose\": \"falsely elevated\"\\n}',\n 'Cefuroxime (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Cefepime (Lexi-Drugs)': '{\\n \"Positive direct Coombs\": true,\\n \"Urinary glucose test using cupric sulfate (Benedict\\'s solution)\": false,\\n \"Urinary glucose test using Clinitest\": false,\\n \"Urinary glucose test using Fehling\\'s solution\": false,\\n \"Serum or urine creatinine with Jaffé reaction\": false,\\n \"Urinary proteins\": false,\\n \"Urinary steroids\": false\\n}',\n 'Ferric Carboxymaltose (Pediatric and Neonatal Lexi-Drugs)': '{\\n \"Serum iron levels\": \"falsely elevated\",\\n \"Transferrin bound iron levels\": \"falsely elevated\"\\n}',\n 'Imipenem, Cilastatin, and Relebactam (Lexi-Drugs)': '{\\n \"Coombs test\": \"Positive\"\\n}',\n 'Ceftolozane and Tazobactam (Infectious Diseases)': 'Not available',\n 'Sirolimus (Topical) (Lexi-Drugs)': 'Not available',\n 'Epoetin Alfa (Lexi-Drugs)': '{\\n  \"HbA1c\": \"artificially lowered\"\\n}',\n 'Zidovudine (Lexi-Drugs)': 'Not available',\n 'Ertapenem (Lexi-Drugs)': 'Not available',\n 'Oxytocin (Lexi-Drugs)': 'Not available',\n 'Factor IX (Recombinant [Glycopegylated]) (Lexi-Drugs)': 'Not available',\n 'Gadoteridol (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Levothyroxine (Lexi-Drugs)': '1. T4-binding globulin (TBG)\\n{\\n  \"Conditions/states that increase TBG binding\": \"Pregnancy, hepatitis, porphyria, neonatal state\",\\n  \"Medications that increase TBG binding\": \"Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\",\\n  \"Conditions/states that decrease TBG binding\": \"Hepatic failure, nephrosis, severe illness.\",\\n  \"Medications that decrease TBG binding\": \"Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\"\\n}\\n\\n2. Thyroxine (T4) and triiodothyronine (T3)\\n{\\n  \"Medications that inhibit T4 and T3 binding\": \"Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\"\\n}\\n\\n3. Thyroid gland hormone: Interference with production and secretion\\n{\\n  \"Medications affecting iodine uptake\": \"Amiodarone, iodinated contrast agents, iodine, ethionamide\",\\n  \"Medications affecting hormone production\": \"Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\",\\n  \"Medications affecting secretion\": \"Amiodarone, iodinated contrast agents, iodine, lithium\",\\n  \"Medications inducing thyroiditis\": \"Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\",\\n  \"Medications potentially causing the development of Graves’\": \"Alemtuzumab, interferon alpha, antiretroviral therapy\",\\n  \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’\": \"Glucocorticoids\"\\n}\\n\\n4. Hypothalamic-pituitary axis and TSH: Interference with secretion\\n{\\n  \"Medications decreasing TSH secretion\": \"Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\",\\n  \"Medications increasing TSH secretion\": \"Amphetamine, interleukin 2, metoclopramide, ritonavir, St John\\'s wort\",\\n  \"Medications potentially causing hypophysitis\": \"Ipilimumab\"\\n}',\n 'Tedizolid (Lexi-Drugs)': 'Not available',\n 'ALfentanil (Lexi-Drugs)': 'Not available',\n 'Idecabtagene Vicleucel (Lexi-Drugs)': 'Not available',\n 'Iopamidol (Lexi-Drugs)': '{\"iodine-binding capacity\": \"reduced for up to 2 weeks following administration of contrast media\", \\n\"diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results\": \"not affected (eg, T3 resin uptake, thyroxine assays)\"}',\n 'Methohexital (Lexi-Drugs)': 'Not available',\n 'Amantadine (Lexi-Drugs)': '{\\n  \"Urine test for amphetamines/methamphetamines\": \"May interfere with detection (false-positive)\"\\n}',\n 'Chlorothiazide (Lexi-Drugs)': '{\\n  \"Parathyroid function tests\": \"may be interfered with\",\\n  \"Aldosterone/renin ratio (ARR) test\": \"may give a false-negative result\"\\n}',\n 'Gemcitabine (Lexi-Drugs)': 'Not available',\n 'Ciprofloxacin (Otic) (Lexi-Drugs)': 'Not available',\n 'Bevacizumab-Carboplatin-Paclitaxel (Ovarian) (Lexi-Drugs)': 'Not available',\n 'Avalglucosidase Alfa (Lexi-Drugs)': 'Not available',\n 'Liothyronine (Lexi-Drugs)': 'Test names: T4-binding globulin (TBG), Thyroxine (T4), Triiodothyronine (T3), Thyroid gland hormone, Hypothalamic-pituitary axis and TSH\\n\\nTest results as JSON:\\n\\n{\\n  \"TBG\": {\\n    \"Conditions/Staes that increase TBG binding\": [\"Pregnancy\", \"hepatitis\", \"porphyria\", \"neonatal state\"],\\n    \"Medications that increase TBG binding\": [\"Estrogens\", \"5-fluorouracil\", \"heroin\", \"methadone\", \"mitotane\", \"perphenazine\", \"selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\"],\\n    \"Conditions/states that decrease TBG binding\": [\"Hepatic failure\", \"nephrosis\", \"severe illness\"],\\n    \"Medications that decrease TBG binding\": [\"Androgens\", \"anabolic steroids\", \"glucocorticoids\", \"L-asparaginase\", \"nicotinic acid\"]\\n  },\\n  \"T4\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"T3\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"Thyroid gland hormone\": {\\n    \"Medications affecting iodine uptake\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"ethionamide\"],\\n    \"Medications affecting hormone production\": [\"Amiodarone\", \"ethionamide\", \"iodinated contrast agents\", \"iodine\", \"sulfonylureas\", \"sulfonamides\", \"thionamides (carbimazole, methimazole, propylthiouracil)\"],\\n    \"Medications affecting secretion\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"lithium\"],\\n    \"Medications inducing thyroiditis\": [\"Alemtuzumab\", \"amiodarone\", \"antiangiogenic agents (lenalidomide, thalidomide)\", \"denileukin diftitox\", \"interferon alpha\", \"interleukins\", \"lithium\", \"tyrosine kinase inhibitors (sunitinib, sorafenib)\"],\\n    \"Medications potentially causing the development of Graves’\": [\"Alemtuzumab\", \"interferon alpha\", \"antiretroviral therapy\"],\\n    \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves\\'\": [\"Glucocorticoids\"]\\n  },\\n  \"TSH\": {\\n    \"Medications decreasing TSH secretion\": [\"Bexarotene\", \"dopamine\", \"dopaminergic agonists (bromocriptine, cabergoline)\", \"glucocorticoids\", \"interleukin-6\", \"metformin\", \"opiates\", \"somatostatin analogues (octreotide, lanreotide)\", \"thyroid hormone analogues\"],\\n    \"Medications increasing TSH secretion\": [\"Amphetamine\", \"interleukin 2\", \"metoclopramide\", \"ritonavir\", \"St John\\'s wort\"],\\n    \"Medications potentially causing hypophysitis\": [\"Ipilimumab\"]\\n  }\\n}',\n 'Pembrolizumab (Lexi-Drugs)': 'Not available',\n 'Bevacizumab FOLFOX (Colorectal) (Lexi-Drugs)': 'Not available',\n 'Daunorubicin and Cytarabine (Liposomal) (Lexi-Drugs)': 'Not available',\n 'Clindamycin (Topical) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Isosorbide Dinitrate and Hydralazine (Lexi-Drugs)': 'Not available',\n 'Lidocaine and Hydrocortisone (Lexi-Drugs)': 'Not available',\n 'Ganciclovir (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Clot Dissolving Drugs for Heart Attack or Stroke (Patient Education - Disease and Procedure)': 'Not available',\n 'Eteplirsen (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Gentamicin (Systemic) (Lexi-Drugs)': 'Test Names: None mentioned\\n\\nTest Results: None mentioned',\n 'Ascorbic Acid (Pediatric and Neonatal Lexi-Drugs)': 'Test Names: \\n- Stool occult blood test\\n- Blood glucose testing\\n- Urine glucose testing\\n- Nitrite level testing\\n- Bilirubin level testing\\n- Leucocyte count testing\\n\\nTest Results: \\n- Stool occult blood: False negative 48 to 72 hours after ascorbic acid ingestion\\n- Blood glucose: Falsely elevated glucose measurements by point of care glucometers with high-dose ascorbic acid\\n- Urine glucose: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Nitrite level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Bilirubin level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Leucocyte count: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion',\n 'Doxapram (Lexi-Drugs)': 'Not available',\n 'Taliglucerase Alfa (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Dolasetron (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Omadacycline (Lexi-Drugs)': 'Not available',\n 'Belatacept (Lexi-Drugs)': 'Not available',\n 'Scopolamine (Geriatric Lexi-Drugs)': 'Test name: Interferes with gastric secretion test\\nTest result: Transdermal system should be discontinued ≥10 days prior to testing.\\n\\nJSON format: {\"Interferes with gastric secretion test\": \"Transdermal system should be discontinued ≥10 days prior to testing.\"}',\n 'Vancomycin (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Ampicillin and Sulbactam (Lexi-Drugs)': 'Test name: Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\\nTest result: May interfere\\n\\nTest name: Aminoglycoside serum concentration\\nTest result: Potential underestimation due to the acceleration of degradation by some penicillin derivatives\\n\\nJSON format: {\"Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\": \"May interfere\", \"Aminoglycoside serum concentration\": \"Potential underestimation due to the acceleration of degradation by some penicillin derivatives\"}',\n 'Buprenorphine and Naloxone (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Lidocaine (Otic) (Lexi-Drugs)': 'Not available',\n 'BUPivacaine (Lexi-Drugs)': 'Not available',\n 'Growth Hormone, Serum (Lab Tests and Diagnostic Procedures)': 'Not available',\n 'Technetium Tc 99m Albumin Aggregated (Lexi-Drugs)': 'Not available',\n 'Tetracaine (Spinal) (Lexi-Drugs)': 'Not available',\n 'Dexrazoxane (Lexi-Drugs)': 'Not available',\n 'Mepivacaine (Pharmacogenomics)': 'Not available',\n 'Erythromycin (Topical) (Lexi-Drugs)': 'Not available',\n 'Ciprofloxacin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'CARBOplatin (Lexi-Drugs)': 'Not available',\n 'Basiliximab (Lexi-Drugs)': 'Not available',\n 'Tromethamine (Lexi-Drugs)': 'Not available',\n 'Alprostadil (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Oral Inhalation) (Infectious Diseases)': 'Not available',\n 'Ferric Carboxymaltose (Geriatric Lexi-Drugs)': 'Test names: \\n1. Serum iron levels\\n2. Transferrin bound iron levels\\n\\nTest results in JSON format:\\n{\\n  \"Serum iron levels\": \"not specified\",\\n  \"Transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}',\n 'Gadoteridol (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Methotrimeprazine (Lexi-Drugs)': 'Test Names: Pregnancy test\\nTest Results: False-positive or false-negative',\n 'Morphine (Systemic) (Lexi-Drugs)': '{\"opioid screening\": \"false-positive result\"}',\n 'Sodium Acetate (Lexi-Drugs)': 'Not available',\n 'Topotecan (Lexi-Drugs)': 'Not available',\n 'MetroNIDAZOLE (Topical) (Lexi-Drugs)': 'Not available',\n 'Edrophonium and Atropine (Lexi-Drugs)': 'Not available',\n 'Tranexamic Acid (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Ciprofloxacin and Dexamethasone (Lexi-Drugs)': 'Not available',\n 'Verapamil (Lexi-Drugs)': '{\"Urine detection of methadone\": \"false-positive\"}',\n 'Melphalan (Pediatric and Neonatal Lexi-Drugs)': '{\"Coombs\\' test [direct]\": \"false-positive\"}',\n 'PACLitaxel (Conventional) (Lexi-Drugs)': 'Not available',\n 'Methyldopa (Lexi-Drugs)': '{\\n  \"urinary uric acid (phosphotungstate method)\": \"interference by Methyldopa\",\\n  \"serum creatinine (alkaline picrate method)\": \"interference by Methyldopa\",\\n  \"AST (colorimetric method)\": \"interference by Methyldopa\",\\n  \"urinary catecholamines (falsely high levels)\": \"interference by Methyldopa\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive by Methyldopa\"\\n}',\n 'Ciprofloxacin (Systemic) (Lexi-Drugs)': '{\\n \"levofloxacin\": \"false-positive urine screening result for opioids\",\\n \"ofloxacin\": \"false-positive urine screening result for opioids\",\\n \"other quinolones\": \"cross-reactivity in certain assay kits\"\\n}',\n 'Ambroxol [INT] (Lexi-Drugs International [Concise])': 'Not available',\n 'Aducanumab (Lexi-Drugs)': 'Not available',\n 'Magnesium Chloride (Lexi-Drugs)': 'Not available',\n 'Taliglucerase Alfa (Lexi-Drugs)': 'Not available',\n 'RiTUXimab (Lexi-Drugs)': 'Not available',\n 'Cetirizine and Pseudoephedrine (Lexi-Drugs)': 'Not available',\n 'Clindamycin and Tretinoin (Lexi-Drugs)': 'Not available',\n 'Erythromycin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Neostigmine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Nesiritide (Lexi-Drugs)': 'Not available',\n 'Aminophylline (Lexi-Drugs)': 'Test names: \\n- Plasma glucose\\n- Uric acid\\n- Free fatty acids\\n- Total cholesterol\\n- HDL\\n- HDL/LDL ratio\\n- Urinary free cortisol excretion\\n- Triiodothyronine\\n\\nJSON format: \\n{\\n\"Plasma glucose\": <test result>,\\n\"Uric acid\": <test result>,\\n\"Free fatty acids\": <test result>,\\n\"Total cholesterol\": <test result>,\\n\"HDL\": <test result>,\\n\"HDL/LDL ratio\": <test result>,\\n\"Urinary free cortisol excretion\": <test result>,\\n\"Triiodothyronine\": <test result>\\n}',\n nan: 'Not available',\n 'Edaravone (Lexi-Drugs)': 'Not available',\n 'Factor IX (Recombinant [Fc Fusion Protein]) (Lexi-Drugs)': 'Not available',\n 'Conivaptan (Lexi-Drugs)': 'Not available',\n 'Glucagon (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'MitoMYcin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Alteplase (Lexi-Drugs)': '{\"coagulation\": \"Altered\", \"fibrinolytic activity\": \"Altered\"}',\n 'Remimazolam (Lexi-Drugs)': 'Not available',\n 'Sodium Nitrite and Sodium Thiosulfate (Lexi-Drugs)': 'Not available',\n 'Nelarabine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Plasminogen Activator Inhibitor 1 Activity, Plasma (Lab Tests and Diagnostic Procedures)': 'Not available',\n 'Fludarabine-Cyclophosphamide-Rituximab  (CLL) (Lexi-Drugs)': 'Not available',\n 'DiphenhydrAMINE (Topical) (Lexi-Drugs)': '{\\n\"skin test antigens\": \"suppressed\"\\n}',\n 'Ganciclovir (Systemic) (Lexi-Drugs)': 'Not available',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Geriatric Lexi-Drugs)': 'Not available',\n 'Fenoldopam (Lexi-Drugs)': 'Not available',\n 'Temsirolimus (Lexi-Drugs)': 'Not available',\n 'Ceftazidime and Avibactam (Lexi-Drugs)': '{\\n  \"Ceftazidime\": \"Positive direct Coomb\",\\n  \"Urine glucose\": \"False-positive with certain methods; use glucose tests based on enzymatic glucose oxidase reactions\"\\n}',\n 'Gadodiamide (Lexi-Drugs)': '{\\n  \"Serum Iron\": \"Transitory changes observed\",\\n  \"Serum Calcium\": \"May interfere with colorimetric tests; alternate testing method recommended for 12-24 hours after administration\"\\n}',\n 'Antivenin (Latrodectus mactans) (Lexi-Drugs)': 'Not available',\n 'Erythromycin (Systemic) (Lexi-Drugs)': '{\\n  \"Urinary Catecholamines\": \"False-positive (fluorometric assay)\",\\n  \"17-hydroxycorticosteroids\": \"False-positive\",\\n  \"17-ketosteroids\": \"False-positive\"\\n}',\n 'Cetirizine (Systemic) (Lexi-Drugs)': 'Test names: \\n1. Serum TCA screen\\n2. Skin test antigens\\n\\nTest results:\\n1. False-positive\\n2. Suppressed wheal and flare reactions',\n 'Moxifloxacin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'CloNIDine (Lexi-Drugs)': \"Test names: \\n1. Coombs' test\\n2. Aldosterone/renin ratio\\n\\nTest results:\\n1. Positive\\n2. False-positive\",\n 'Ofatumumab (Lexi-Drugs)': 'Not available',\n 'InFLIXimab (Lexi-Drugs)': 'Not available',\n 'Dolasetron (Lexi-Drugs)': 'Not available',\n 'Ferumoxytol (Lexi-Drugs)': 'Test Names: \\n1. MR imaging \\n2. Serum Iron \\n3. Transferrin-bound Iron \\n\\nCorresponding Test Results in JSON:\\n{\\n  \"MR imaging\": \"May interfere with imaging; alterations may persist for ≤3 months following use, with peak alterations anticipated in the first 2 days following administration. If MR imaging is required within 3 months after administration, use T1- or proton density-weighted MR pulse sequences to decrease effect on imaging. Do not use T2-weighted sequence MR imaging prior to 4 weeks following administration.\",\\n  \"Serum Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\",\\n  \"Transferrin-bound Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\"\\n}',\n 'Anthrax Immune Globulin (Human) (Pediatric and Neonatal Lexi-Drugs)': 'Test Names: \\n1. Blood glucose levels\\n2. Serologic testing results\\n3. Direct Coombs\\' test\\n4. Indirect Coombs\\' test\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Blood glucose levels\": \"Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\",\\n  \"Serologic testing results\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Direct Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Indirect Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\"\\n}',\n 'Omeprazole (Lexi-Drugs)': 'Test Names: \\n1. Serum chromogranin A (CgA) levels\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Serum chromogranin A (CgA) levels\": \"Omeprazole may falsely elevate CgA levels, causing false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\"\\n}',\n 'Raxibacumab (Lexi-Drugs)': 'Not available',\n 'Sarilumab (Lexi-Drugs)': 'Not available',\n 'Streptozocin (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Ceftaroline Fosamil (Lexi-Drugs)': 'Not available',\n 'Casimersen (Lexi-Drugs)': '{\\n\"Medical Test Name\": \"Detection of urine protein\",\\n\"Test Result\": \"False positive when pyrogallol red reagent is used\"\\n}',\n 'Oxycodone and Acetaminophen (Lexi-Drugs)': 'Not available',\n 'Fluorouracil (Topical) (Lexi-Drugs)': 'Not available',\n 'Ibutilide (Lexi-Drugs)': 'Not available',\n 'Elosulfase Alfa (Lexi-Drugs)': 'Not available',\n 'Ceftolozane and Tazobactam (Lexi-Drugs)': 'Not available',\n 'Fludarabine (Lexi-Drugs)': 'Not available',\n 'Meperidine (Lexi-Drugs)': '{\\n  \"amylase\": \"increased\",\\n  \"BSP retention\": \"increased\",\\n  \"CPK\": \"increased\"\\n}',\n 'Fluorescein and Benoxinate (Lexi-Drugs)': 'Not available',\n 'Sugammadex (Lexi-Drugs)': '{\\n  \"serum progesterone assay\": \"may interfere\",\\n  \"interaction\": \"may be observed\"\\n}',\n 'Streptozocin (Lexi-Drugs)': 'Not available',\n 'Etoposide Phosphate (Lexi-Drugs)': 'Not available',\n 'Propranolol (Lexi-Drugs)': '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n 'Mannitol (Systemic) (Lexi-Drugs)': '{\\n  \"blood ethylene glycol concentrations\": \"false positive\",\\n  \"inorganic phosphorus blood concentrations\": \"false low\"\\n}',\n 'Scopolamine (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"gastric secretion test\": \"interference\"\\n}',\n 'Treosulfan (Lexi-Drugs)': 'Not available',\n 'Vindesine (Lexi-Drugs)': 'Not available',\n 'Sincalide (Lexi-Drugs)': 'Not available',\n 'Phenylephrine (Systemic) (Lexi-Drugs)': 'Not available',\n 'Famotidine (Lexi-Drugs)': 'Not available',\n 'Methylcobalamin (Natural Products Database)': 'Not available',\n 'Desmopressin (Lexi-Drugs)': 'Not available',\n 'Eptinezumab (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant [Fc-VWF-XTEN Fusion Protein]) (Lexi-Drugs)': 'Not available',\n 'Buprenorphine and Naloxone (Lexi-Drugs)': 'Not available',\n 'Gadopentetate Dimeglumine (Lexi-Drugs)': 'Not available',\n 'DOBUTamine (Lexi-Drugs)': 'Not available',\n 'Filgrastim (Lexi-Drugs)': '{\\n  \"Bone imaging studies\": \"May interfere with\",\\n  \"Hematopoietic activity\": \"increased\",\\n  \"Bone marrow\": \"May appear as transient positive bone imaging changes.\"\\n}',\n 'Furosemide (Lexi-Drugs)': '{\\n  \"Medical test names\": [\\n    \"Aldosterone/renin ratio (ARR)\"\\n  ],\\n  \"Test results\": [\\n    \"False-negative\"\\n  ]\\n}',\n 'Aztreonam (Systemic) (Geriatric Lexi-Drugs)': '{\"urine glucose\": \"may interfere with tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}',\n 'Atenolol (Lexi-Drugs)': '{\"glucose\": \"increased\", \"HDL\": \"decreased\", \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"}',\n 'Mepivacaine and Levonordefrin (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant [Pegylated]) (Lexi-Drugs)': 'Not available',\n 'CeFAZolin (Lexi-Drugs)': 'Test names and their respective results:\\n\\n1. Direct and Indirect Coombs\\' - Positive \\n2. Urinary glucose test using Benedict\\'s copper reduction reaction - False-Positive \\n3. Serum or urine creatinine with Jaffé reaction - False-Positive \\n4. Aminoglycoside serum concentration - Potentially underestimated \\n\\nJSON format:\\n\\n{\\n   \"Direct and Indirect Coombs\\'\": \"Positive\",\\n   \"Urinary glucose test using Benedict\\'s copper reduction reaction\": \"False-Positive\",\\n   \"Serum or urine creatinine with Jaffé reaction\": \"False-Positive\",\\n   \"Aminoglycoside serum concentration\": \"Potentially underestimated\"\\n}',\n 'IdaruCIZUmab (Lexi-Drugs)': 'Not available',\n 'Bendamustine (Lexi-Drugs)': 'Not available',\n 'Meperidine and Promethazine (Lexi-Drugs)': 'Not available',\n 'Butorphanol (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Systemic) (Infectious Diseases)': '{\"urine glucose test\": \"may interfere with containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}',\n 'Ciprofloxacin and Hydrocortisone (Lexi-Drugs)': 'Not available',\n 'Levobupivacaine [INT] (Lexi-Drugs International [Concise])': 'Not available',\n 'Aztreonam (Systemic) (Lexi-Drugs)': 'Test Names:\\n\\n1. Urine glucose test containing cupric sulfate\\n2. Coombs\\' test\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Urine glucose test containing cupric sulfate\": \"May interfere\",\\n  \"Coombs\\' test\": \"Positive\"\\n}',\n 'Bumetanide (Lexi-Drugs)': 'Test Names:\\n\\n1. Aldosterone/renin ratio (ARR)\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Aldosterone/renin ratio (ARR)\": \"May lead to false-negative\"\\n}',\n 'IDArubicin (Lexi-Drugs)': 'Not available',\n 'Tenecteplase (Lexi-Drugs)': '{\"coagulation\": \"Altered results\", \"fibrinolytic activity\": \"Altered results\"}',\n 'Caspofungin (Lexi-Drugs)': 'Not available',\n 'Anifrolumab (Lexi-Drugs)': 'Not available',\n 'Clevidipine (Geriatric Lexi-Drugs)': '{\"aldosterone/renin ratio\": \"false-negative\", \"ARR\": \"false-negative\"}',\n 'Copanlisib (Lexi-Drugs)': 'Not available',\n 'Ketorolac (Nasal) (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Olaratumab (Lexi-Drugs)': 'Not available',\n 'Digoxin Immune Fab (Lexi-Drugs)': 'Test Names: \\n1. Digitalis immunoassay \\n2. Digoxin serum samples\\n\\nTest Results: \\n{\\n   \"Digitalis immunoassay\": \"may be clinically misleading until all Fab fragments are eliminated from the body\",\\n   \"Digoxin serum samples\": \"should be obtained before digoxin immune fab administration, if possible\"\\n}',\n 'Digoxin Toxicity (Patient Education - Disease and Procedure)': 'Not available',\n 'DexAMETHasone (Systemic) (Lexi-Drugs)': '{\\n\"skin test antigens\": \"suppressed\"\\n}',\n 'Doxercalciferol (Lexi-Drugs)': 'Not available',\n 'Acetaminophen (Lexi-Drugs)': '{\\n\"urinary 5-hydroxyindoleacetic acid\": \"false-positive\"\\n}',\n 'Nalbuphine (Lexi-Drugs)': '{\\n\"enzymatic methods used to detect opioids\": \"interference (refer to test manufacturer for details)\"\\n}',\n 'Sildenafil (Lexi-Drugs)': 'Not available',\n 'Gadobutrol (Lexi-Drugs)': 'Not available',\n 'Methotrexate (Lexi-Drugs)': 'Not available',\n 'Pertuzumab (Lexi-Drugs)': 'Not available',\n 'Colistimethate (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Imiglucerase (Lexi-Drugs)': 'Not available',\n 'Dolasetron (Geriatric Lexi-Drugs)': 'Not available',\n 'Lansoprazole (Lexi-Drugs)': 'Not available',\n 'Smallpox and Monkeypox Vaccine (Live) (Lexi-Drugs)': 'Not available',\n 'Hydrocortisone (Systemic) (Lexi-Drugs)': '{\"skin tests\": \"decreased response\"}',\n 'Centruroides Immune F(ab’)2 (Equine) (Lexi-Drugs)': 'Not available',\n 'LORazepam (Lexi-Drugs)': 'Not available',\n 'Tacrolimus (Topical) (Lexi-Drugs)': 'Not available',\n 'Etelcalcetide (Lexi-Drugs)': 'Not available',\n 'Tafasitamab (Lexi-Drugs)': 'Not available',\n 'Vitamins (Multiple/Oral) (Lexi-Drugs)': 'Medical tests names: \\n1. Urine glucose determinations \\n2. Certain lab tests \\n\\nJSON output: \\n{\\n  \"Urine glucose determinations\": \"false-negative\",\\n  \"Certain lab tests\": \"incorrect\"\\n}',\n 'Cefotaxime (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Iron Sucrose (Lexi-Drugs)': 'Not available',\n 'Danaparoid (Lexi-Drugs)': 'Medical tests names: PT/INR\\n\\nJSON output: {\"PT/INR\": \"unreliable within 5 hours\"}',\n 'Gadofosveset (Lexi-Drugs)': 'Not available',\n 'Sodium Glycerophosphate Pentahydrate (Lexi-Drugs)': 'Not available',\n 'Tagraxofusp (Lexi-Drugs)': 'Not available',\n 'Amivantamab (Lexi-Drugs)': 'Not available',\n 'Evinacumab (Lexi-Drugs)': 'Not available',\n 'Amsacrine (Lexi-Drugs)': 'Not available',\n 'Lidocaine and Tetracaine (Lexi-Drugs)': 'Not available',\n 'Enalaprilat (Lexi-Drugs)': 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-negative.',\n 'Ketorolac (Systemic) (Lexi-Drugs)': 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-positive.',\n 'Acetaminophen and Diphenhydramine (Lexi-Drugs)': 'Not available',\n 'Insulin NPH (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Crotalidae Polyvalent Immune FAB (Ovine) (Lexi-Drugs)': 'Not available',\n 'C1 Inhibitor (Human) (Lexi-Drugs)': 'Not available',\n 'DAUNOrubicin (Liposomal) (Lexi-Drugs)': 'Not available',\n 'Magnesium Sulfate (Lexi-Drugs)': 'Not available',\n 'Cyanocobalamin (Lexi-Drugs)': '{\\n  \"Folic acid\": \"invalidated\",\\n  \"Vitamin B12\": \"invalidated\"\\n}',\n 'Difelikefalin (Lexi-Drugs)': 'Not available',\n 'Fluorouracil (Systemic) (Lexi-Drugs)': 'Not available',\n 'Codeine (Lexi-Drugs)': '{\\n  \"Opioid screening test\": \"false-positive (when taking some quinolones)\",\\n  \"Specific confirmation test\": \"recommended\"\\n}',\n 'Diatrizoate Meglumine (Lexi-Drugs)': 'Test names:\\n- Urine specimen assay\\n\\nTest results in JSON form:\\n{\\n \"Urine specimen assay\": \"N/A\"\\n} \\n(Note: \"N/A\" is the value because no specific test result is mentioned in the sentence)',\n 'Blinatumomab (Lexi-Drugs)': 'Not available',\n 'Cefotaxime (Pediatric and Neonatal Lexi-Drugs)': 'Test names:\\n- Direct Coombs\\' test\\n- Urinary glucose test\\n- Serum creatinine test\\n- Urine creatinine test\\n\\nTest results in JSON form:\\n{\\n \"Direct Coombs\\' test\": \"Positive\",\\n \"Urinary glucose test\": \"False-positive\",\\n \"Serum creatinine test\": \"False-positive\",\\n \"Urine creatinine test\": \"False-positive\"\\n}',\n 'Haloperidol (Lexi-Drugs)': 'Not available',\n 'Sodium Chloride (Lexi-Drugs)': 'Not available',\n 'Smallpox Vaccine Live (Lexi-Drugs)': '1) Medical test names: \\n- Rapid plasma reagin (RPR) test\\n2) Test results in JSON format:\\n- For RPR test: {\"Rapid plasma reagin (RPR) test\": \"false-positive due to smallpox vaccine\"}\\n\\n1) Medical test names:\\n- Tuberculin skin (PPD) and blood tests\\n2) Test results in JSON format:\\n- For Tuberculin skin (PPD) and blood tests: {\"Tuberculin skin (PPD) and blood tests\": \"false-negative due to smallpox vaccine\"}',\n 'Ceftolozane and Tazobactam (Geriatric Lexi-Drugs)': 'Not available',\n 'Bretylium (Lexi-Drugs)': 'Not available',\n 'Clodronate (Lexi-Drugs)': '1) Medical test names:\\n- Bone scan (diagnostic imaging with technetium-99m-diphosphonate)\\n2) Test results in JSON format:\\n- For bone scan: {\"Bone scan\": \"may be interfered by bisphosphonates except clodronate, according to some studies\"}',\n 'Vernakalant (Lexi-Drugs)': 'Not available',\n 'Choline C 11 (Lexi-Drugs)': 'Not available',\n 'Folic Acid (Lexi-Drugs)': 'Test Names: Lactobacillus casei assay method\\nTest Result: Falsely low serum concentrations may occur in patients on anti-infectives (eg, tetracycline)',\n 'Mycophenolate (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Enfortumab Vedotin (Lexi-Drugs)': 'Not available',\n 'Comparison of Prothrombin Complex Concentrates (Lexi-Drugs)': 'Not available',\n 'Nalmefene (Lexi-Drugs)': 'Not available',\n 'Clindamycin and Benzoyl Peroxide (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Oral Inhalation) (Geriatric Lexi-Drugs)': 'Not available',\n 'Betamethasone and Clotrimazole (Lexi-Drugs)': 'Not available',\n 'Temozolomide-Rituximab (CNS Lymphoma) (Lexi-Drugs)': 'Not available',\n 'Methyldopa and Hydrochlorothiazide (Lexi-Drugs)': 'Not available',\n 'Vancomycin (Lexi-Drugs)': 'Not available',\n 'Belimumab (Lexi-Drugs)': 'Not available',\n 'Vonoprazan and Amoxicillin (Lexi-Drugs)': 'Not available',\n 'Orphenadrine (Lexi-Drugs)': 'Not available',\n 'Acyclovir (Topical) (Lexi-Drugs)': 'Not available',\n 'Phenylephrine and Ketorolac (Lexi-Drugs)': 'Not available',\n 'Aminocaproic Acid (Lexi-Drugs)': 'Not available',\n 'Lurbinectedin (Lexi-Drugs)': 'Not available',\n 'Tigecycline (Lexi-Drugs)': 'Not available',\n 'Oxacillin (Lexi-Drugs)': \"Test Names: \\n1. Urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®)\\n2. Aminoglycoside activity test\\n3. Urinary protein test\\n4. Serum protein test\\n\\nTest Results:\\n1. May interfere\\n2. May inactivate in vitro\\n3. False positive in urinary test\\n4. False positive in serum test\",\n 'Phenylephrine (Nasal) (Lexi-Drugs)': 'Not available',\n 'Tobramycin and Dexamethasone (Lexi-Drugs)': 'Not available',\n 'Chlorpheniramine, Pseudoephedrine, and Dextromethorphan (Lexi-Drugs)': 'Not available',\n 'CefoTEtan (Lexi-Drugs)': 'Test names: \\n1) Direct Coombs\\' test\\n2) Urinary glucose test\\n3) Serum or urine creatinine test with Jaffé reaction\\n\\nJSON Form: \\n{\\n  \"Direct Coombs\\' test\": \"Positive\",\\n  \"Urinary glucose test\": \"False-positive\",\\n  \"Serum or urine creatinine test with Jaffé reaction\": \"May cause false-positive\"\\n}',\n 'Sacituzumab Govitecan (Lexi-Drugs)': 'Not available',\n 'Ethacrynic Acid (Lexi-Drugs)': 'Test Name: Aldosterone/Renin Ratio (ARR)\\nTest Result: May lead to false-negative (Funder 2016)',\n 'Eteplirsen (Lexi-Drugs)': 'Not available',\n 'Estrogens (Conjugated/Equine, Systemic) (Lexi-Drugs)': 'Test Names: laboratory tests related to coagulation factors, lipids, glucose tolerance, thyroxine-binding globulin, sex hormone-binding globulin, cortisol-binding globulin\\nTest Result: The use of estrogens and/or progestogens may alter the results (general statement)',\n 'Cidofovir (Lexi-Drugs)': 'Not available',\n 'Ado-Trastuzumab Emtansine (Lexi-Drugs)': 'Not available',\n 'Pamidronate (Lexi-Drugs)': 'Test names: \\n1. Technetium-99m-diphosphonate bone scan \\n\\nTest results:\\n{\\n\"Technetium-99m-diphosphonate bone scan\": \"may be interfered with by Bisphosphonates\"\\n}',\n 'Golimumab (Lexi-Drugs)': 'Not available',\n 'Gadopiclenol (Lexi-Drugs)': 'Not available',\n 'Melphalan (Lexi-Drugs)': 'Test names: \\n1. Coombs\\' test [direct]\\n\\nTest results:\\n{\\n\"Coombs\\' test [direct]\": \"false-positive \"\\n}',\n 'Benzocaine, Butamben, and Tetracaine (Lexi-Drugs)': 'Not available',\n 'Buprenorphine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'DOXOrubicin (Liposomal) (Lexi-Drugs)': 'Not available',\n 'Factor X (Human) (Lexi-Drugs)': 'Not available',\n 'Indomethacin (Lexi-Drugs)': '{\\n  \"dexamethasone suppression test\": \"false-negative\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n 'ChlorproMAZINE (Lexi-Drugs)': '{\\n    \"phenylketonuria\": \"false-positive\",\\n    \"amylase\": \"false-positive\",\\n    \"uroporphyrins\": \"false-positive\",\\n    \"urobilinogen\": \"false-positive\",\\n    \"pregnancy test\": \"false-positive\",\\n    \"amphetamine/methamphetamine\": \"false-positive\",\\n    \"methadone\": \"false-positive\"\\n}',\n 'Azithromycin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Angiotensin II (Lexi-Drugs)': 'Not available',\n 'Mannitol (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Benztropine (Geriatric Lexi-Drugs)': 'Not available',\n 'Ampicillin (Lexi-Drugs)': \"1. Medical test name: Urinary glucose tests\\n   Test result: May interfere with using cupric sulfate (Benedict's solution, Clinitest®)\\n\\n2. Medical test name: Aminoglycoside serum concentration\\n   Test result: Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives.\",\n 'Flucytosine (Lexi-Drugs)': 'Medical test name: Serum creatinine values\\nTest result: Markedly false elevations when the Ektachem® analyzer is used. The Jaffé reaction is recommended for determining serum creatinine.',\n 'Bezlotoxumab (Lexi-Drugs)': 'Not available',\n 'Selenium Sulfide (Lexi-Drugs)': 'Not available',\n 'Hyaluronidase (Lexi-Drugs)': 'Not available',\n 'Carboplatin-Paclitaxel (NSCLC) (Lexi-Drugs)': 'Not available',\n 'Tetracaine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Mechlorethamine (Systemic) (Lexi-Drugs)': 'Not available',\n 'DilTIAZem (Lexi-Drugs)': 'Not available',\n 'Moxifloxacin (Systemic) (Lexi-Drugs)': 'Test names: \\n1. Urine screening test for opioids using commercially-available immunoassay kits\\n\\nTest results:\\n1. False-positive results for opioids may be produced by some quinolones, especially levofloxacin and ofloxacin\\n2. Other quinolones may also show cross-reactivity in certain assay kits.\\n3. Positive opioid screens should be confirmed by more specific methods.',\n 'MethylPREDNISolone (Lexi-Drugs)': 'Test names: \\n1. Skin test\\n\\nTest results:\\n1. Decreased response to skin tests.',\n 'Antihemophilic Factor (Human) (Lexi-Drugs)': 'Not available',\n 'Mirvetuximab Soravtansine (Lexi-Drugs)': 'Not available',\n 'Carbetocin (Lexi-Drugs)': 'Not available',\n 'Cloxacillin (Lexi-Drugs)': '{\\n    \"Urinary glucose tests using cupric sulfate\": \"May interfere\",\\n    \"Aminoglycosides\": \"May inactivate in vitro\",\\n    \"Urine proteins\": \"False-positive\",\\n    \"Serum proteins\": \"False-positive\",\\n    \"Uric acid\": \"False-positive\",\\n    \"Urinary steroids\": \"False-positive\"\\n}',\n 'Carmustine (Lexi-Drugs)': 'Not available',\n 'Ibuprofen, Phenylephrine, and Chlorpheniramine (Lexi-Drugs)': 'Not available',\n 'Atoltivimab, Maftivimab, and Odesivimab (Lexi-Drugs)': 'Not available',\n 'AzaTHIOprine (Lexi-Drugs)': '{\\n  \"Medical Test Name\": \"TPMT phenotyping\",\\n  \"Test Result\": \"May not be accurate following recent blood transfusions.\"\\n}',\n 'Bromhexine [INT] (Lexi-Drugs International [Concise])': 'Not available',\n 'Axicabtagene Ciloleucel (Lexi-Drugs)': 'Not available',\n 'Insulin Aspart Protamine and Insulin Aspart (Lexi-Drugs)': 'Not available',\n 'Insulin Detemir (Lexi-Drugs)': 'Not available',\n 'HydrALAZINE (Lexi-Drugs)': 'Not available',\n 'Orphenadrine, Aspirin, and Caffeine (Lexi-Drugs)': 'Not available',\n 'Gadopentetate Dimeglumine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Fluorescein (Lexi-Drugs)': 'Not available',\n 'Diazoxide (Lexi-Drugs)': '{\\n  \"Serum renin concentrations\": \"increased\",\\n  \"IgG concentrations\": \"increased\",\\n  \"Serum cortisol concentrations\": \"decreased\",\\n  \"insulin response to glucagon\": \"false-negative\"\\n}',\n 'FentaNYL (Lexi-Drugs)': 'Not available',\n 'Bortezomib (Lexi-Drugs)': 'Not available',\n 'Caplacizumab (Lexi-Drugs)': 'Not available',\n 'Capmatinib (Lexi-Drugs)': 'Not available',\n 'Pafolacianine (Lexi-Drugs)': 'Not available',\n 'Dostarlimab (Lexi-Drugs)': 'Not available',\n 'Glycopyrrolate (Systemic) (Lexi-Drugs)': 'Not available',\n 'Etoposide (Lexi-Drugs)': 'Not available',\n 'Adenosine (Lexi-Drugs)': 'Not available',\n 'Melphalan (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Minocycline (Topical) (Lexi-Drugs)': '{\"fluorescence test for urinary catecholamines\":\"false elevations\"}',\n 'Tremelimumab (Lexi-Drugs)': 'Not available',\n 'Cimetidine (Lexi-Drugs)': 'Not available',\n ' ': \"I'm sorry, but I cannot extract the medical test names and their results without any input data. Please provide the data.\",\n 'Dextromethorphan and Chlorpheniramine (Lexi-Drugs)': 'Not available',\n 'MT-RNR1 - Kanamycin (Pharmacogenomics)': 'Not available',\n 'Ofloxacin (Systemic) (Lexi-Drugs)': '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"cross-reactivity\", \"ofloxacin\": \"cross-reactivity\", \"other quinolones\": \"cross-reactivity\"}',\n 'Alpha1-Proteinase Inhibitor (Lexi-Drugs)': 'Not available',\n 'Alcohol (Ethyl) (Lexi-Drugs)': 'Not available',\n 'Brentuximab Vedotin (Lexi-Drugs)': 'Not available',\n 'Lutetium Lu 177 Vipivotide Tetraxetan (Lexi-Drugs)': 'Not available',\n 'Methylfolate, Methylcobalamin, and Acetylcysteine (Lexi-Drugs)': 'Not available',\n 'Trabectedin (Lexi-Drugs)': 'Not available',\n 'Mechlorethamine (Topical) (Lexi-Drugs)': 'Not available',\n 'DroPERidol (Lexi-Drugs)': 'Not available',\n 'Ustekinumab (Lexi-Drugs)': 'Not available',\n 'Argatroban (Lexi-Drugs)': 'Test names: \\n1. PT/INR levels\\n2. Chromogenic factor X assay\\n3. Factor Xa levels\\n\\nTest results:\\n{\\n  \"PT/INR levels\": \"elevated in the absence of warfarin, may require modification while on argatroban\",\\n  \"Chromogenic factor X assay\": \"suggested to be monitored when transitioning from argatroban to warfarin or overlapping administration of warfarin for a minimum of 5 days until INR is within target range, recheck INR after anticoagulant effect of argatroban has dissipated\",\\n  \"Factor Xa levels\": \"associated with INR values >2 after the effects of argatroban have been eliminated\"\\n}',\n 'Vestronidase Alfa (Lexi-Drugs)': 'Not available',\n 'Betibeglogene Autotemcel (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"Test name\": \"Polymerase chain reaction (PCR) assay for HIV\",\\n  \"Test result\": \"False-positive for HIV in patients who have received betibeglogene autotemcel due to integrated BB305 LVV proviral DNA\"\\n}',\n 'Copper Cu 64 Dotatate (Lexi-Drugs)': 'Not available',\n 'Diphenhydramine and Ibuprofen (Lexi-Drugs)': 'Not available',\n 'Abciximab (Lexi-Drugs)': 'Not available',\n 'Calcium Gluconate (Lexi-Drugs)': 'Medical Test Names: Serum magnesium test and Urine magnesium test.\\n\\nJSON output:\\n{\\n \"Serum magnesium test\": \"falsely decreased\",\\n \"Urine magnesium test\": \"falsely decreased\"\\n}',\n 'Ferric Pyrophosphate Citrate (Lexi-Drugs)': 'Not available',\n 'Ticarcillin and Clavulanate Potassium (Infectious Diseases)': 'Medical Test Names: Coombs\\' test and Urinary protein test.\\n\\nJSON output:\\n{\\n \"Coombs\\' test\": \"positive\",\\n \"Urinary protein test\": \"false-positive\"\\n}',\n 'Teprotumumab (Lexi-Drugs)': 'Not available',\n 'Hydrocortisone (Topical) (Lexi-Drugs)': 'Not available',\n 'Lidocaine and Prilocaine (Lexi-Drugs)': 'Not available',\n 'Cytarabine (Conventional) (Lexi-Drugs)': 'Not available',\n 'Celecoxib and Tramadol (Lexi-Drugs)': 'Not available',\n 'Fosdenopterin (Lexi-Drugs)': 'Not available',\n 'Galsulfase (Lexi-Drugs)': 'Not available',\n 'Terbutaline (Lexi-Drugs)': 'Not available',\n 'Estrogens (Conjugated/Equine, Topical) (Lexi-Drugs)': '{\\n  \"metyrapone test\": \"reduced response\"\\n}',\n 'Fomepizole (Lexi-Drugs)': 'Not available',\n 'Andexanet Alfa (Coagulation Factor Xa [Recombinant], Inactivated) (Lexi-Drugs)': '{\\n  \"anti-FXa activity assay\": \"falsely elevated after andexanet alfa administration\",\\n  \"andexanet alfa\": \"reversal activity\"\\n}',\n 'CefTRIAXone (Lexi-Drugs)': '{\\n    \"Positive direct Coombs\\'\": \"positive\",\\n    \"false-positive urinary glucose test using nonenzymatic methods\": \"false-positive\",\\n    \"false-positive galactosemia tests\": \"false-positive\"\\n}',\n 'EPHEDrine (Systemic) (Lexi-Drugs)': '{\\n    \"test name\": \"amphetamine EMIT assay\",\\n    \"test result\": \"false positive\"\\n}',\n 'Ixabepilone (Lexi-Drugs)': 'Not available',\n 'Amikacin Liposome (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Vasopressin (Geriatric Lexi-Drugs)': 'Not available',\n 'Lisocabtagene Maraleucel (Lexi-Drugs)': 'Not available',\n 'Vasopressin (Lexi-Drugs)': 'Not available',\n 'Sirolimus (Protein Bound) (Lexi-Drugs)': 'Not available',\n 'Acetylcysteine (Lexi-Drugs)': 'Not available',\n 'Potassium Iodide (Lexi-Drugs)': '{\\n   \"Thyroid function tests\": \"Altered\"\\n}',\n 'Irinotecan (Liposomal) (Lexi-Drugs)': 'Not available',\n 'EpiRUBicin (Lexi-Drugs)': 'Not available',\n 'Theophylline (Lexi-Drugs)': '{\\n  \"Plasma glucose\": \"increased\",\\n  \"Uric acid\": \"increased\",\\n  \"Free fatty acids\": \"increased\",\\n  \"Total cholesterol\": \"increased\",\\n  \"HDL\": \"increased\",\\n  \"HDL/LDL ratio\": \"increased\",\\n  \"Urinary free cortisol excretion\": \"increased\",\\n  \"Triiodothyronine\": \"decreased\"\\n}',\n 'Methylfolate, Methylcobalamin, and Acetylcysteine (Geriatric Lexi-Drugs)': 'Not available',\n 'Atropine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Tetracaine (Topical) (Lexi-Drugs)': 'Not available',\n 'Ciprofloxacin and Fluocinolone (Lexi-Drugs)': 'Not available',\n 'Vancomycin (Geriatric Lexi-Drugs)': 'Not available',\n 'DexAMETHasone (Ophthalmic) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Iobenguane I 131 (Lexi-Drugs)': 'Not available',\n 'Neostigmine and Glycopyrrolate (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Decitabine and Cedazuridine (Lexi-Drugs)': 'Not available',\n 'Ansuvimab (Lexi-Drugs)': 'Not available',\n 'Copper IUD (Lexi-Drugs)': 'Not available',\n 'Esmolol (Lexi-Drugs)': 'Not available',\n 'Dalteparin (Lexi-Drugs)': 'Not available',\n 'Onasemnogene Abeparvovec (Lexi-Drugs)': 'Not available',\n 'Manganese (Lexi-Drugs)': 'Not available',\n 'Ipilimumab (Lexi-Drugs)': 'Not available',\n 'Bamlanivimab and Etesevimab (Lexi-Drugs)': 'Not available',\n 'TraMADol (Lexi-Drugs)': 'Medical Test Name: Urine Detection of Phencyclidine\\nTest Result: False-Positive',\n 'Fluoroestradiol F18 (Lexi-Drugs)': 'Not available',\n 'Obinutuzumab (Lexi-Drugs)': 'Not available',\n 'PHENobarbital (Lexi-Drugs)': 'Not available',\n 'Anthrax Immune Globulin (Human) [ANTIDOTE] (Lexi-Tox)': '1. Medical tests mentioned in the given data:\\n- Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n- Glucose-specific method\\n- Urinalysis\\n- Serologic testing\\n- Direct and indirect Coombs’ test\\n\\n2. Test results in JSON form:\\n{\\n  \"Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\": \"falsely elevated blood glucose levels\",\\n  \"Glucose-specific method\": \"recommended\",\\n  \"Urinalysis\": \"transiently elevated glucose\",\\n  \"Serologic testing\": \"false-positive results\",\\n  \"Direct and indirect Coombs’ test\": \"false-positive results\"\\n}',\n 'MetroNIDAZOLE (Systemic) (Lexi-Drugs)': '{\\n    \"AST\": \"interfere\",\\n    \"ALT\": \"interfere\",\\n    \"triglycerides\": \"interfere\",\\n    \"glucose\": \"interfere\",\\n    \"LDH\": \"interfere\"\\n}',\n 'Betamethasone (Systemic) (Lexi-Drugs)': '1. Medical test mentioned in the given data:\\n- Skin test for wheal and flare reactions to antigens \\n\\n2. Test result in JSON form:\\n{\\n  \"Skin test for wheal and flare reactions to antigens\": \"may be suppressed\"\\n}',\n 'Dihydroergotamine (Lexi-Drugs)': 'Not available',\n 'Digoxin (Lexi-Drugs)': '1. Medical test mentioned in the given data:\\n- Digoxin radioimmunoassay \\n\\n2. Test result in JSON form:\\n{\\n  \"Digoxin radioimmunoassay\": \"may be interfered\"\\n}',\n 'Betamethasone (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Glucarpidase (Lexi-Drugs)': 'Test Names: Methotrexate levels\\nTest Result: {\"Methotrexate levels\": \"the chromatographic method\"}',\n 'Oxycodone and Naloxone (Lexi-Drugs)': 'Not available',\n 'Labetalol (Lexi-Drugs)': 'Test Names: \\n1. Urine catecholamines\\n2. Metanephrine \\n3. Normetanephrine \\n4. Vanillylmandelic acid (VMA) \\n5. Urine amphetamine \\n6. Aldosterone/renin ratio (ARR)\\n\\nTest Results:\\n{\\n   \"Urine catecholamines\": \"HPLC assay with solid-phase extraction should be used to determine levels of catecholamines\",\\n   \"Metanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of metanephrine\",\\n   \"Normetanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of normetanephrine\",\\n   \"Vanillylmandelic acid (VMA)\": \"HPLC assay with solid-phase extraction should be used to determine levels of VMA\",\\n   \"Urine amphetamine\": \"Gas chromatographic-mass spectrometer technique should be used to determine levels of amphetamine\",\\n   \"Aldosterone/renin ratio (ARR)\": \"May lead to a false-positive result\"\\n}',\n 'C1 Inhibitor (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Ramucirumab (Lexi-Drugs)': 'Not available',\n 'Flecainide (Lexi-Drugs)': 'Not available',\n 'Gadoteridol (Lexi-Drugs)': 'Not available',\n 'Patisiran (Lexi-Drugs)': 'Not available',\n 'Imipenem and Cilastatin (Pediatric and Neonatal Lexi-Drugs)': 'Test Names:\\n- Urinary glucose determination using Clinitest®\\n- Coombs\\' direct\\n\\nTest Results (in json format):\\n{\\n  \"Urinary glucose determination using Clinitest®\": \"Interfered\",\\n  \"Coombs\\' direct\": \"Positive\"\\n}',\n 'PENTobarbital (Lexi-Drugs)': 'Not available',\n 'Lidocaine and Chlorhexidine (Lexi-Drugs)': 'Not available',\n 'Ibuprofen (Lexi-Drugs)': '{\\n  \"phencyclidine\": \"false-positives\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n 'Ceftolozane and Tazobactam (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Sodium Tetradecyl Sulfate (Lexi-Drugs)': 'Not available',\n 'DexAMETHasone (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Doxycycline Hyclate Periodontal Extended-Release Liquid (Lexi-Drugs)': 'Not available',\n 'Flortaucipir F18 (Lexi-Drugs)': 'Not available',\n 'Dinutuximab (Lexi-Drugs)': 'Not available',\n 'Eravacycline (Lexi-Drugs)': 'Not available',\n 'Meloxicam (Lexi-Drugs)': '{\"aldosterone/renin ratio (ARR)\": \"false-positive\"}',\n 'Busulfan (Lexi-Drugs)': 'Not available',\n 'Albuterol (Lexi-Drugs)': '{\"renin (S)\": \"increased\",\\n \"aldosterone (S)\": \"increased\"}',\n 'Etomidate (Lexi-Drugs)': 'Not available',\n 'Melphalan-Prednisone (Multiple Myeloma) (Lexi-Drugs)': 'Not available',\n 'Elivaldogene Autotemcel (Lexi-Drugs)': '{\"PCR assays for HIV\": \"positive\", \"HIV infection using a PCR-based assay\": \"false-positive\"}',\n 'Indigotindisulfonate Sodium (Lexi-Drugs)': 'Not available',\n 'Iopamidol (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Sargramostim (Lexi-Drugs)': 'Not available',\n 'Belinostat (Lexi-Drugs)': 'Not available',\n 'Naxitamab (Lexi-Drugs)': 'Not available',\n 'Glycopyrronium (Topical) (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant [Porcine Sequence]) (Lexi-Drugs)': 'Not available',\n 'DAUNOrubicin (Conventional) (Lexi-Drugs)': 'Not available',\n 'Foscarnet (Lexi-Drugs)': 'Not available',\n 'DAPTOmycin (Lexi-Drugs)': 'Test Names:\\n- PT (Prothrombin Time) test\\n- INR (International Normalized Ratio) test\\n\\nTest Results (in JSON form):\\n{\\n  \"PT (Prothrombin Time) test\": \"false prolongation with certain recombinant thromboplastin reagents when taking daptomycin\",\\n  \"INR (International Normalized Ratio) test\": \"increase with certain recombinant thromboplastin reagents when taking daptomycin\"\\n}',\n 'Metoprolol (Lexi-Drugs)': 'Not available',\n 'Mogamulizumab (Lexi-Drugs)': 'Not available',\n 'Imipenem, Cilastatin, and Relebactam (Infectious Diseases)': '{\\n   \"Test Name\": \"Coombs test\",\\n   \"Test Result\": \"Positive\"\\n}',\n 'Reslizumab (Lexi-Drugs)': 'Not available',\n 'Ifosfamide (Lexi-Drugs)': 'Not available',\n 'Nafcillin (Lexi-Drugs)': '{\\n  \"Coombs\\' test (direct)\": \"Positive\",\\n  \"Urinary proteins\": \"False-positive\",\\n  \"Serum proteins\": \"False-positive\",\\n  \"Aminoglycoside inactivation\": \"In vitro\"\\n}',\n 'Procyclidine (Lexi-Drugs)': 'Not available',\n 'Loteprednol and Tobramycin (Lexi-Drugs)': 'Not available',\n 'Ascorbic Acid (Lexi-Drugs)': '{\\n  \"Stool occult blood test\": \"False-negative\",\\n  \"Blood glucose testing\": \"Interference (falsely-elevated)\",\\n  \"Urine glucose testing\": \"Interference\",\\n  \"Nitrite levels\": \"Interference\",\\n  \"Bilirubin levels\": \"Interference\",\\n  \"Leucocyte count\": \"Interference\"\\n}',\n 'Etranacogene Dezaparvovec (Lexi-Drugs)': '{\\n  \"One-stage clotting assay (OSA)\": \"Affected by aPTT reagent and reference standard used; recommended for monitoring factor IX activity over time with the same assay and reagents\",\\n  \"Activated partial thromboplastin time (aPTT)\": \"Type of reagent used affects results when using OSA to determine factor IX activity\",\\n  \"Chromogenic substrate assay (CSA)\": \"Results in lower factor IX activity compared to OSA; mean CSA to OSA factor IX activity ratio ranging from 0.41 to 0.55 in clinical study\"\\n}',\n 'Nivolumab (Lexi-Drugs)': 'Not available',\n 'Spesolimab (Lexi-Drugs)': 'Not available',\n 'LevoFLOXacin (Systemic) (Lexi-Drugs)': '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"positive\", \"ofloxacin\": \"positive\"}',\n 'Imipenem and Cilastatin (Lexi-Drugs)': '{\"urinary glucose determination using Clinitest\": \"interferes\", \"Coombs\\' [direct]\": \"positive\"}',\n 'Loncastuximab Tesirine (Lexi-Drugs)': 'Not available',\n 'Elotuzumab (Lexi-Drugs)': 'Test Names: \\n1. Serum Protein Electrophoresis (SPEP)\\n2. Serum Immunofixation Assays\\n \\nTest Results in JSON Format:\\n{\\n   \"SPEP\": \"A small peak in the early gamma region\",\\n   \"Serum Immunofixation Assays\": \"may potentially be attributed to elotuzumab\"\\n}',\n 'Lidocaine and Epinephrine (Lexi-Drugs)': 'Not available',\n 'Gadoxetate (Lexi-Drugs)': 'Test Name:\\n1. Serum Iron Test\\n\\nTest Result in JSON Format:\\n{\\n   \"Serum Iron Test\": \"Falsely high or low values of serum iron (if determined by complexometric methods) may occur for up to 24 hours following administration.\"\\n}',\n 'Ibuprofen and Acetaminophen (Pediatric and Neonatal Lexi-Drugs)': 'Test Names:\\n1. Urinary 5-hydroxyindoleacetic acid test\\n2. Urine detection of Phencyclidine test\\n3. Aldosterone/Renin Ratio (ARR) test\\n\\nTest Results in JSON Format:\\n{\\n   \"Urinary 5-hydroxyindoleacetic acid test\": \"false-positive due to Acetaminophen\",\\n   \"Urine detection of Phencyclidine test\": \"false-positives due to Ibuprofen\",\\n   \"Aldosterone/Renin Ratio (ARR) test\": \"false-positive due to Ibuprofen\"\\n}',\n 'Betamethasone and Gentamicin (Lexi-Drugs)': 'Not available',\n 'Phytonadione (Lexi-Drugs)': 'Not available',\n 'Methadone (Lexi-Drugs)': '1. Medical test names:\\n- Urine screening test for opioids using immunoassay kits\\n- Confirmation test for positive opioid screens using more specific methods\\n- Urine methadone screens using immunoassay kits\\n\\n2. Test Results in JSON format:\\n{\\n  \"Urine screening test for opioids using immunoassay kits\": \"false-positive for opioids with quinolones (levofloxacin and ofloxacin) and other medications (not specified)\",\\n  \"Confirmation test for positive opioid screens using more specific methods\": \"not specified\",\\n  \"Urine methadone screens using immunoassay kits\": \"false-positive in patients taking diphenhydramine, doxylamine, clomipramine, chlorpromazine, thioridazine, quetiapine, and verapamil\"\\n}',\n 'Antithymocyte Globulin (Rabbit) (Lexi-Drugs)': '1. Medical test names:\\n- Rabbit antibody-based immunoassays\\n- Cross-match or panel-reactive antibody cytotoxicity assays\\n- Routine clinical laboratory tests which use immunoglobulins\\n\\n2. Test Results in JSON format:\\n{\\n  \"Rabbit antibody-based immunoassays\": \"potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"potential interference\",\\n  \"Routine clinical laboratory tests which use immunoglobulins\": \"no interference shown\"\\n}',\n 'Crizotinib (Lexi-Drugs)': 'Not available',\n 'Oxycodone and Aspirin (Lexi-Drugs)': \"I'm sorry, I cannot extract the medical test names and their results without any specific data to refer to. Please provide the necessary information.\",\n 'Ibuprofen, Pseudoephedrine, and Chlorpheniramine (Lexi-Drugs)': 'Not available',\n 'Amobarbital (Lexi-Drugs)': 'Not available',\n 'Sodium Phenylacetate and Sodium Benzoate (Lexi-Drugs)': 'Not available',\n 'Metoclopramide (Lexi-Drugs)': 'Not available',\n 'Cytomegalovirus Immune Globulin (Intravenous-Human) (Lexi-Drugs)': 'Not available',\n 'Lidocaine (Topical) (Lexi-Drugs)': 'Not available',\n 'Oxycodone and Ibuprofen (Lexi-Drugs)': 'Not available',\n 'Viltolarsen (Lexi-Drugs)': 'Test Names: Not specified in the given data.\\nTest Results:\\n{\\n\"Urine Protein Detection with Pyrogallol Red reagent\": \"May give false positive results if Viltolarsen is present in urine\",\\n\"Urine Protein Detection with other test methods\": \"Not affected by Viltolarsen\",\\n\"Timeframe for avoiding false positives\": \"Urine obtained prior to infusion or ≥48 hours after infusion\",\\n}',\n 'Posaconazole (Lexi-Drugs)': 'Not available',\n 'Amphotericin B (Liposomal) (Lexi-Drugs)': 'Medical Test Name: PHOSm assay\\n\\nTest Result JSON: {\"PHOSm assay\": \"Falsely-elevated serum phosphate\"}',\n 'Diclofenac (Topical) (Lexi-Drugs)': 'Not available',\n 'Thiamine (Lexi-Drugs)': 'Medical Test Names: \\n1. Phosphotungstate method for uric acid\\n2. Ehrlich\\'s reagent for urobilinogen\\n3. Spectrophotometric determination of serum theophylline concentration\\n\\nTest Result JSON: \\n{\\n   \"Phosphotungstate method for uric acid\": \"False-positive\",\\n   \"Ehrlich\\'s reagent for urobilinogen\": \"False-positive\",\\n   \"Spectrophotometric determination of serum theophylline concentration\": \"Interference with large doses\"\\n}',\n 'Linezolid (Lexi-Drugs)': 'Not available',\n 'Selexipag (Lexi-Drugs)': 'Not available',\n 'Dacarbazine (Lexi-Drugs)': 'Not available',\n 'Arsenic Trioxide (Lexi-Drugs)': 'Not available',\n 'Laronidase (Lexi-Drugs)': 'Not available',\n 'Insulin Glulisine (Lexi-Drugs)': 'Not available',\n 'Mepivacaine (Lexi-Drugs)': 'Not available',\n 'AcetaZOLAMIDE (Lexi-Drugs)': '{\\n  \"Urinary protein with Albustix\": \"false-positive\",\\n  \"Labstix\": \"false-positive\",\\n  \"Albutest\": \"false-positive\",\\n  \"Bumintest\": \"false-positive\",\\n  \"HPLC theophylline assay\": \"interference\",\\n  \"Serum uric acid levels\": \"interference\",\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'NiMODipine (Lexi-Drugs)': '{\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'Necitumumab (Lexi-Drugs)': 'Not available',\n 'Alemtuzumab (Lexi-Drugs)': '{\\n  \"Diagnostic serum tests that utilize antibodies\": \"interference\"\\n}',\n 'Neostigmine and Glycopyrrolate (Lexi-Drugs)': 'Not available',\n 'Tobramycin (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Tisotumab Vedotin (Lexi-Drugs)': 'Not available',\n 'Ondansetron (Lexi-Drugs)': 'Not available',\n 'PyRIDostigmine (Lexi-Drugs)': 'Not available',\n 'Oxaliplatin (Lexi-Drugs)': 'Not available',\n 'Fludarabine-Cyclophosphamide (CLL) (Lexi-Drugs)': 'Not available',\n 'Pentazocine and Naloxone (Lexi-Drugs)': 'Not available',\n 'Dalbavancin (Lexi-Drugs)': 'Not available',\n 'Ibalizumab (Lexi-Drugs)': 'Not available',\n 'MitoMYcin (Ureteral Gel) (Lexi-Drugs)': 'Not available',\n 'Efgartigimod Alfa (Lexi-Drugs)': 'Not available',\n 'Caffeine (Lexi-Drugs)': 'Not available',\n 'Benztropine (Lexi-Drugs)': 'Not available',\n 'ROPivacaine (Lexi-Drugs)': 'Not available',\n 'Verteporfin (Lexi-Drugs)': 'Not available',\n 'Sutimlimab (Lexi-Drugs)': 'Not available',\n 'Sebelipase Alfa (Lexi-Drugs)': 'Not available',\n 'Cladribine (Lexi-Drugs)': 'Not available',\n 'Vaccinia Immune Globulin (Intravenous) (Lexi-Drugs)': '{\"serologic testing\": \"false-positive\", \"direct Coombs test\": \"false-positive\", \"indirect Coombs test\": \"false-positive\"}',\n 'Vinorelbine (Lexi-Drugs)': 'Not available',\n 'Abatacept (Lexi-Drugs)': '{\\n  \"Dehydrogenase Pyrroloquinolinequinone\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose-dye-oxidoreductase\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose Dehydrogenase Nicotine Adenine Dinucleotide (GDH-NAD)\": \"Recommended glucose monitoring method\",\\n  \"Glucose Oxidase\": \"Recommended glucose monitoring method\",\\n  \"Glucose Hexokinase\": \"Recommended glucose monitoring method\"\\n}',\n 'VinCRIStine (Liposomal) (Lexi-Drugs)': 'Not available',\n 'Acetaminophen, Diphenhydramine, and Phenylephrine (Lexi-Drugs)': 'Not available',\n 'Glucagon (Geriatric Lexi-Drugs)': 'Not available',\n 'Gallium Ga 68 Dotatate (Lexi-Drugs)': 'Not available',\n 'Tobramycin (Systemic) (Lexi-Drugs)': '{\\n  \"Medical Test Names\": [\\n    \"Aminoglycoside Serum Concentration\"\\n  ],\\n  \"Test Results\": [\\n    \"Potential Underestimation\"\\n  ]\\n}',\n 'Porfimer (Lexi-Drugs)': 'Not available',\n 'NiCARdipine (Lexi-Drugs)': '{\\n  \"Medical Test Names\": [\\n    \"Aldosterone/Renin Ratio (ARR)\"\\n  ],\\n  \"Test Results\": [\\n    \"False-Negative\"\\n  ]\\n}',\n 'Penicillin G (Parenteral/Aqueous) (Lexi-Drugs)': '{\\n \"urinary glucose determination using Clinitest\": \"false-positive or negative\",\\n \"Coombs\\' [direct]\": \"positive\",\\n \"urinary and/or serum proteins by certain test methods\": \"false-positive\"\\n}',\n 'DOXOrubicin (Conventional) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'CefTAZidime (Lexi-Drugs)': '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate\": \"False-positive\",\\n  \"serum or urine creatinine with Jaffé reaction\": \"False-positive\"\\n}',\n 'Norepinephrine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Insulin (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Tirofiban (Lexi-Drugs)': 'Not available',\n 'Ciltacabtagene Autoleucel (Lexi-Drugs)': 'Not available',\n 'Acetylcysteine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Cetirizine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Floxuridine (Lexi-Drugs)': 'Not available',\n 'Neostigmine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Vancomycin (Infectious Diseases)': 'Not available',\n 'Vestronidase Alfa (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Lidocaine (Systemic) (Lexi-Drugs)': 'Not available',\n 'Antithymocyte Globulin (Equine) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Daratumumab and Hyaluronidase (Lexi-Drugs)': 'Medical test names:\\n1. Indirect antiglobulin test (indirect Coombs test)\\n2. Serum protein electrophoresis\\n3. Immunofixation assays\\n\\nJSON form:\\n{\\n  \"Indirect antiglobulin test (indirect Coombs test)\": \"Positive\",\\n  \"Serum protein electrophoresis\": \"Detected\",\\n  \"Immunofixation assays\": \"Interference\"\\n}',\n 'Sodium Nitrite (Lexi-Drugs)': 'Not available',\n 'Antipsychotic Agents, Atypical (Lexi-Tox)': 'Not available',\n 'Scopolamine (Lexi-Drugs)': 'Medical test names:\\n1. Gastric secretion test\\n\\nJSON form:\\n{\\n  \"Gastric secretion test\": \"Interference\"\\n}',\n 'Valproic Acid and Derivatives (Lexi-Drugs)': 'Test names: Urine ketones, Thyroid function tests\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine ketones\": {\\n    \"Effect\": \"May cause a false-positive result\",\\n    \"Medication\": \"Valproate\",\\n    \"Mode of elimination\": \"Partially eliminated as a keto-metabolite in the urine\"\\n  },\\n  \"Thyroid function tests\": {\\n    \"Effect\": \"May alter\"\\n  }\\n}',\n 'Cefiderocol (Lexi-Drugs)': 'Test names: Urine dipstick tests (urine protein, ketones, occult blood)\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine dipstick tests\": {\\n    \"Effects\": [\"May result in false-positive urine dipstick tests\"],\\n    \"Examples of tests affected\": [\"Urine protein\", \"ketones\", \"occult blood\"]\\n  }\\n}',\n 'Prochlorperazine (Lexi-Drugs)': 'Test names: Phenylketonuria test, Pregnancy test\\n\\nTest results as JSON:\\n\\n{\\n  \"Phenylketonuria test\": {\\n    \"Effect\": \"False-positives\"\\n  },\\n  \"Pregnancy test\": {\\n    \"Effect\": \"False-positives\"\\n  }\\n}',\n \"Crotalidae Immune F(ab')2 (Equine) (Lexi-Drugs)\": 'Not available',\n 'Doripenem (Lexi-Drugs)': 'Not available',\n 'Idursulfase (Lexi-Drugs)': 'Not available',\n 'Antithymocyte Globulin (Rabbit) (Pediatric and Neonatal Lexi-Drugs)': 'Test Names:\\n1. Rabbit antibody-based immunoassays\\n2. Cross-match or panel-reactive antibody cytotoxicity assays\\n\\nTest Results (in JSON format):\\n{\\n  \"Rabbit antibody-based immunoassays\": \"Potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"Potential interference\",\\n  \"Routine clinical laboratory tests which do not use immunoglobulins\": \"No interference shown\"\\n}',\n 'Meropenem and Vaborbactam (Lexi-Drugs)': '{\"Positive Coombs\\'\": \"Positive\"}',\n 'HydrOXYzine (Lexi-Drugs)': '{\"serum TCA screen\": \"false-positive\"}',\n 'Minocycline Hydrochloride Periodontal Microspheres (Lexi-Drugs)': 'Not available',\n 'OxyCODONE (Lexi-Drugs)': '{\"urine screening result for opioids\": \"false-positive\"}',\n 'Pentostatin (Lexi-Drugs)': 'Not available',\n 'Folic Acid, Cyanocobalamin, and Pyridoxine (Lexi-Drugs)': 'Not available',\n 'Potassium Phosphate and Sodium Phosphate (Lexi-Drugs)': 'Not available',\n 'SUFentanil (Lexi-Drugs)': 'Not available',\n 'Tobramycin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Leucovorin Calcium (Lexi-Drugs)': 'Not available',\n 'Methylene Blue (Lexi-Drugs)': 'Test Name: Urine Test with Blue Indicator\\nTest Result: Interfered',\n 'Colistimethate (Lexi-Drugs)': 'Not available',\n 'Docetaxel-Oxaliplatin-Leucovorin-Fluorouracil (Esophageal) (Lexi-Drugs)': 'Not available',\n 'Clindamycin and Tretinoin (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Isosorbide Mononitrate (Lexi-Drugs)': 'Not available',\n 'Gallium Ga 68 Dotatate (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Trandolapril and Verapamil (Lexi-Drugs)': 'Not available',\n 'Antivenin (Micrurus fulvius) (Lexi-Drugs)': 'Not available',\n 'Iodine I-125 Iothalamate (Lexi-Drugs)': 'Not available',\n 'Cisatracurium (Lexi-Drugs)': 'Not available',\n 'VinCRIStine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Benztropine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Albumin (Lexi-Drugs)': 'Not available',\n 'Mesna (Lexi-Drugs)': '{\\n    \"test name\": \"Urinary ketones\",\\n    \"test result\": \"false positive in patients receiving mesna with nitroprusside-based urine tests\"\\n},\\n{\\n    \"test name\": \"CPK activity\",\\n    \"test result\": \"may interfere with enzymatic CPK activity tests which use a thiol compound, resulting in a falsely low CPK level\"\\n},\\n{\\n    \"test name\": \"Ascorbic acid\",\\n    \"test result\": \"may result in false-positive reactions in Tillman\\'s reagent-based urine screening tests\"\\n}',\n 'Amoxicillin and Clavulanate (Lexi-Drugs)': '{\\n    \"test name\": \"urinary glucose tests\",\\n    \"test result\": \"may interfere with tests using cupric sulfate, but tests based on enzymatic glucose oxidase reactions are recommended\"\\n},\\n{\\n    \"test name\": \"plasma concentrations of certain hormones in pregnant women\",\\n    \"test result\": \"may be transiently interfered with by ampicillin, including total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol\"\\n}',\n 'ClonazePAM (Lexi-Drugs)': 'Not available',\n 'Lincomycin (Lexi-Drugs)': 'Not available',\n 'Insulin Glulisine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Plasminogen Activity, Plasma (Lab Tests and Diagnostic Procedures)': 'Not available',\n 'Insulin Glargine (Lexi-Drugs)': 'Not available',\n 'Sipuleucel-T (Lexi-Drugs)': 'Not available',\n 'QuiNIDine (Lexi-Drugs)': 'Not available',\n 'Ocrelizumab (Lexi-Drugs)': '{\"CD20 assay\": \"interfered\", \"CD19+ assay\": \"measure B-cell counts\"}',\n 'Methylergonovine (Lexi-Drugs)': 'Not available',\n 'Procainamide (Lexi-Drugs)': '{\"procainamide/N-acetyl procainamide concentration test\": \"affected\"}',\n 'Naproxen and Diphenhydramine (Lexi-Drugs)': 'Not available',\n 'Iron Dextran Complex (Lexi-Drugs)': 'Medical Test Names:\\n1. Serum bilirubin\\n2. Serum calcium\\n3. Examination of bone marrow iron stores\\n4. Bone scans with 99m Tc-labeled bone seeking agents\\n5. Bone scans with 99m Tc-diphosphonate\\n\\nTest Results in JSON Form:\\n{\\n\"Serum bilirubin\": \"falsely elevated values\",\\n\"Serum calcium\": \"falsely decreased values\",\\n\"Examination of bone marrow iron stores\": \"Residual iron dextran may remain in reticuloendothelial cells affecting accuracy\",\\n\"Bone scans with 99m Tc-labeled bone seeking agents\": \"reduced bony uptake, marked renal activity, and excess blood pooling and soft tissue accumulation following IV iron dextran infusion or with high serum ferritin levels\",\\n\"Bone scans with 99m Tc-diphosphonate\": \"dense activity in the buttocks following IM iron dextran\"\\n}',\n 'Aztreonam (Systemic) (Pediatric and Neonatal Lexi-Drugs)': 'Medical Test Names:\\n1. Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\\n2. Coombs\\' test\\n\\nTest Results in JSON Form:\\n{\\n\"Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\": \"May interfere\",\\n\"Coombs\\' test\": \"positive\"\\n}',\n 'Iohexol (Lexi-Drugs)': 'Medical Test Names:\\n1. Iodine-binding capacity of thyroid tissue\\n2. Diagnostic tests using iodine-containing isotopes\\n3. Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\\n\\nTest Results in JSON Form:\\n{\\n\"Iodine-binding capacity of thyroid tissue\": \"reduced for up to 2 weeks following administration of contrast media\",\\n\"Diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\": \"not affected\"\\n}',\n 'Tecovirimat (Lexi-Drugs)': 'Not available',\n 'Bivalirudin (Lexi-Drugs)': '{\\n  \"PT/INR\": [\"elevated\"], \\n  \"bivalirudin\": [\"modification\"]\\n}',\n 'DACTINomycin (Lexi-Drugs)': 'Not available',\n 'Vecuronium (Lexi-Drugs)': 'Not available',\n 'Fosaprepitant (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Minocycline (Systemic) (Lexi-Drugs)': '```\\n{\\n    \"Test Name\": \"Fluorescence Test for Urinary Catecholamines\",\\n    \"Test Result\": \"False Elevations\"\\n}\\n```',\n 'Oritavancin (Lexi-Drugs)': '```\\n{\\n    \"Test Name 1\": \"Activated Clotting Time (ACT)\",\\n    \"Test Result 1\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 2\": \"aPTT\",\\n    \"Test Result 2\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 3\": \"Prothrombin Time\",\\n    \"Test Result 3\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 4\": \"International Normalized Ratio\",\\n    \"Test Result 4\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 5\": \"Silica Clot Time (SCT)\",\\n    \"Test Result 5\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 6\": \"Dilute Russell\\'s Viper Venom Time (DRVVT)\",\\n    \"Test Result 6\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 7\": \"D-dimer\",\\n    \"Test Result 7\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 8\": \"Indirect Antiglobulin Test\",\\n    \"Test Result 8\": \"Positive\",\\n    \\n    \"Test Name 9\": \"Direct Antiglobulin Test\",\\n    \"Test Result 9\": \"Positive\"\\n}\\n```',\n 'Artesunate (Lexi-Drugs)': 'Not available',\n 'Ibuprofen and Acetaminophen (Lexi-Drugs)': 'Medical Tests:\\n1. Urinary 5-hydroxyindoleacetic acid \\n2. Urine detection of phencyclidine \\n3. Aldosterone/Renin ratio\\n\\nTest Results:\\n{\\n\"Urinary 5-hydroxyindoleacetic acid\": \"False-positive\",\\n\"Urine detection of phencyclidine\": \"False-positive\",\\n\"Aldosterone/Renin ratio\": \"False-positive\"\\n}',\n 'Diamorphine (Lexi-Drugs)': 'Not available',\n 'Moxetumomab Pasudotox (Lexi-Drugs)': 'Medical Tests:\\n1. Cellular CD22 Detection\\n2. CD19+ B Cells Surrogate Assay\\n\\nTest Results:\\n{\\n\"Cellular CD22 Detection\": \"Interference\",\\n\"CD19+ B Cells Surrogate Assay\": \"Normal\"\\n}',\n 'Telavancin (Lexi-Drugs)': 'Medical Tests:\\n1. PT\\n2. INR\\n3. aPTT\\n4. ACT\\n5. Xa (coagulation based assay)\\n6. Bleeding time\\n7. Factor Xa (chromogenic assay)\\n8. Platelet aggregation study\\n9. Thrombin time\\n10. Urine protein via qualitative dipstick\\n11. Urine protein via quantitative dye methods\\n\\nTest Results:\\n{\\n\"PT\": \"Artificially increased clotting times\",\\n\"INR\": \"Artificially increased clotting times\",\\n\"aPTT\": \"Artificially increased clotting times\",\\n\"ACT\": \"Artificially increased clotting times\",\\n\"Xa (coagulation based assay)\": \"Artificially increased clotting times\",\\n\"Bleeding time\": \"Normal\",\\n\"Factor Xa (chromogenic assay)\": \"Normal\",\\n\"Platelet aggregation study\": \"Normal\",\\n\"Thrombin time\": \"Normal\",\\n\"Urine protein via qualitative dipstick\": \"Interference\",\\n\"Urine protein via quantitative dye methods\": \"Interference\"\\n}',\n 'Zinc Sulfate (Lexi-Drugs)': 'Not available',\n 'Vasopressin (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Streptomycin (Lexi-Drugs)': 'Not available',\n 'DexAMETHasone (Systemic) [SUPPORTIVE] (Lexi-Tox)': 'Not available',\n 'Methocarbamol (Lexi-Drugs)': '{\\n  \"5-HIAA\": \"color interference\",\\n  \"VMA\": \"color interference\"\\n}',\n 'Calaspargase Pegol (Lexi-Drugs)': 'Not available',\n 'Hemin (Lexi-Drugs)': 'Not available',\n 'Enoxaparin (Lexi-Drugs)': '{\\n  \"Free Thyrotropin\": \"falsely elevated\",\\n  \"Free Triiodothyronine\": \"falsely elevated\",\\n  \"Thyroid-stimulating hormone\": \"not usually affected\",\\n  \"Standard Competitive Free Thyroid Hormone Assays\": \"not usually affected\"\\n}',\n 'Nivolumab and Relatlimab (Lexi-Drugs)': 'Not available',\n 'Fluorouracil-Leucovorin-Oxaliplatin  (Gastric/Esophageal)  (Lexi-Drugs)': 'Not available',\n 'Fosaprepitant (Lexi-Drugs)': 'Not available',\n 'LevoFLOXacin (Oral Inhalation) (Lexi-Drugs)': '{\\n  \"Test Name\": \"Urine Screening for Opioids\",\\n  \"Test Result\": \"false-positive with quinolones; confirmation recommended\"\\n}',\n 'Ziv-Aflibercept (Systemic) (Lexi-Drugs)': 'Not available',\n 'Insulin NPH (Lexi-Tox)': 'Not available',\n 'Zoledronic Acid (Lexi-Drugs)': '{\\n  \"Test Name\": \"Bone Scan with Technetium-99m-diphosphonate\",\\n  \"Test Result\": \"may be interfered with by Bisphosphonates\"\\n}',\n 'Potassium Phosphate (Lexi-Drugs)': 'Not available',\n 'Abacavir, Lamivudine, and Zidovudine (Lexi-Drugs)': 'Not available',\n 'Natalizumab (Lexi-Drugs)': 'Not available',\n 'Regadenoson (Lexi-Drugs)': 'Not available',\n 'Antithymocyte Globulin (Equine) (Lexi-Drugs)': 'Not available',\n 'Esomeprazole (Lexi-Drugs)': 'Test names and their respective results:\\n\\n1. Serum chromogranin A (CgA) level - Falsely elevated with Esomeprazole \\n2. Diagnosis of a neuroendocrine tumor - False-positive \\n\\nJSON format:\\n\\n{\\n   \"Serum chromogranin A (CgA) level\": \"Falsely elevated with Esomeprazole\",\\n   \"Diagnosis of a neuroendocrine tumor\": \"False-positive\"\\n}',\n 'Sodium Thiosulfate (Lexi-Drugs)': 'Not available',\n 'Cetuximab (Lexi-Drugs)': 'Not available',\n 'Pyridoxine (Lexi-Drugs)': 'Not available',\n 'Lutetium Lu 177 Dotatate (Lexi-Drugs)': 'Not available',\n 'Clarithromycin (Lexi-Drugs)': 'Not available',\n 'Glutathione (Natural Products Database)': 'Not available',\n 'Amoxicillin (Lexi-Drugs)': '1. Medical Test Names: Benedict\\'s solution, Clinitest, Fehling\\'s Solution\\n   Test Results: {\"Benedict\\'s solution\": \"May interfere with urinary glucose tests\", \\n                  \"Clinitest\": \"May interfere with urinary glucose tests\", \\n                  \"Fehling\\'s Solution\": \"May interfere with urinary glucose tests\"}\\n\\n2. Medical Test Names: Aminoglycoside serum concentration\\n   Test Results: {\"Aminoglycoside serum concentration\": \"Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives\"}',\n 'Chlorpheniramine, Phenylephrine, and Dextromethorphan (Lexi-Drugs)': 'Not available',\n 'Casirivimab and Imdevimab (Lexi-Drugs)': 'Not available',\n 'Atracurium (Lexi-Drugs)': 'Not available',\n 'Ibandronate (Lexi-Drugs)': 'Medical Test Names: technetium-99m-diphosphonate bone scans\\nTest Results: {\"technetium-99m-diphosphonate bone scans\": \"May be interfered with by bisphosphonates\"}',\n 'Acetaminophen and Caffeine (Lexi-Drugs)': 'Not available',\n 'Bendamustine-Rituximab (CLL) (Lexi-Drugs)': 'Not available',\n 'Gadopentetate Dimeglumine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Sodium Iodide I123 (Lexi-Drugs)': 'Not available',\n 'Local Anesthetics (Lexi-Tox)': 'Not available',\n 'Phenytoin (Lexi-Drugs)': '{\\n  \"Plasma phenytoin concentrations\": \"Falsely high\",\\n  \"Serum concentrations of T4\": \"Falsely low\",\\n  \"Serum concentrations of T3\": \"Falsely low\",\\n  \"Dexamethasone tests\": \"Falsely low\",\\n  \"Metyrapone tests\": \"Falsely low\",\\n  \"Thyroid-stimulating hormone (TSH) levels\": \"Increased\"\\n}',\n 'Iodinated I 131 Albumin (Lexi-Drugs)': 'Not available',\n 'Temozolomide (Lexi-Drugs)': 'Not available',\n 'QuiNINE (Lexi-Drugs)': '{\\n  \"Urine detection of opioids\": \"False-positive\",\\n  \"Coombs\\' test\": \"Positive\",\\n  \"Urinary steroids\": \"False elevation\",\\n  \"Catecholamines\": \"False elevation\",\\n  \"Urinary dipstick protein assays\": \"Qualitative and quantitative\"\\n}',\n 'Fluorouracil-Leucovorin Bolus (Colorectal) (Lexi-Drugs)': 'Not available',\n 'Interferon Alfa-2b (Lexi-Drugs)': 'Not available',\n 'Factor IX (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Asparaginase (Erwinia) (Lexi-Drugs)': 'Not available',\n 'Fam-Trastuzumab Deruxtecan (Lexi-Drugs)': 'Not available',\n 'Ziconotide (Lexi-Drugs)': 'Not available',\n 'Fluconazole (Lexi-Drugs)': 'Not available',\n 'Isoproterenol (Lexi-Drugs)': 'Not available',\n 'Bacitracin and Polymyxin B (Topical) (Lexi-Drugs)': 'Not available',\n 'Trastuzumab (Lexi-Drugs)': 'Not available',\n 'Oliceridine (Lexi-Drugs)': 'Not available',\n 'Lacosamide (Lexi-Drugs)': 'Not available',\n 'Tocilizumab (Lexi-Drugs)': 'Not available',\n 'Elotuzumab-Pomalidomide-Dexamethasone (Multiple Myeloma) (Lexi-Drugs)': 'Not available',\n 'Ferric Carboxymaltose (Lexi-Drugs)': '{\\n  \"Serum iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\",\\n  \"Transferrin bound iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}',\n 'Glycerin and Lidocaine (Lexi-Drugs)': 'Not available',\n 'PEMEtrexed (Lexi-Drugs)': 'Not available',\n 'Naloxone (Lexi-Drugs)': 'Not available',\n 'Amphotericin B Deoxycholate (Lexi-Drugs)': 'Not available',\n 'Acyclovir (Systemic) (Lexi-Drugs)': 'Not available',\n 'Edetate CALCIUM Disodium (Lexi-Drugs)': 'Sorry, as an AI language model, I am not able to extract the medical test names and their results without any context or clear indication of where they are mentioned in the text. Could you please provide me with a specific text or document so I can help you better?',\n 'Eculizumab (Lexi-Drugs)': 'Not available',\n 'Teplizumab (Lexi-Drugs)': 'Not available',\n 'LevOCARNitine (Lexi-Drugs)': 'Not available',\n 'PRALAtrexate (Lexi-Drugs)': 'Not available',\n 'Bendamustine-Bortezomib-Rituximab (NHL-Follicular) (Lexi-Drugs)': 'Not available',\n 'Delafloxacin (Lexi-Drugs)': 'Not available',\n 'Eptifibatide (Lexi-Drugs)': 'Not available',\n 'Ofloxacin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Mycophenolate (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Stanford V (Hodgkin) (Lexi-Drugs)': 'Not available',\n 'Methoxy Polyethylene Glycol-Epoetin Beta (Lexi-Drugs)': '{\\n  \"Neutralizing antibody assay\": \"Obtain serum samples at least a month after the last dose to prevent assay interference.\", \\n  \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\"\\n}',\n 'Glycopyrrolate (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Asparaginase (Erwinia [Recombinant]) (Lexi-Drugs)': 'Not available',\n 'Heparin (Lexi-Drugs)': '1. Medical Test Names: PT, anti-factor Xa assay, aPTT, free T4, free T3, thyroid stimulating hormone, standard competitive free thyroid hormone assays.\\n\\n2. Test Results in JSON format:\\n\\n{\\n \"PT\": \"Increased\",\\n \"anti-factor Xa assay\": \"falsely elevated results\",\\n \"aPTT\": \"little or minor effect\",\\n \"free T4\": \"falsely elevated levels\",\\n \"free T3\": \"falsely elevated levels\",\\n \"thyroid stimulating hormone\": \"not usually affected\",\\n \"standard competitive free thyroid hormone assays\": \"not usually affected\"\\n}',\n 'AzaCITIDine (Lexi-Drugs)': 'Not available',\n 'Arginine (Lexi-Drugs)': 'Not available',\n 'Cisplatin-Vinblastine (NSCLC) (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Oral Inhalation) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Prothrombin Complex Concentrate (Human) [(Factors II, VII, IX, X), Protein C, and Protein S]': '{\\n \"aPTT\": \"contains heparin\"\\n}',\n 'Trilaciclib (Lexi-Drugs)': 'Not available',\n 'Agalsidase Alfa (Lexi-Drugs)': 'Not available',\n 'Belantamab Mafodotin (Lexi-Drugs)': 'Not available',\n 'Nitroprusside (Lexi-Drugs)': 'Not available',\n 'Gatifloxacin (Lexi-Drugs)': 'Not available',\n 'DOCEtaxel (Lexi-Drugs)': 'Not available',\n 'Pantothenic Acid (Natural Products Database)': 'Not available',\n 'LEVOleucovorin (Lexi-Drugs)': 'Not available',\n 'Fosnetupitant and Palonosetron (Lexi-Drugs)': 'Not available',\n 'Metoprolol and Hydrochlorothiazide (Lexi-Drugs)': 'Not available',\n 'Daratumumab (Lexi-Drugs)': '1. Medical test names: antibody screening, cross matching, Kell blood group system genotyping, serum protein electrophoresis (SPE), immunofixation (IFE), daratumumab-specific IFE assay.\\n\\n2. Test results in JSON format:\\n\\n{\\n   \"antibody screening\": \"N/A\",\\n   \"cross matching\": \"N/A\",\\n   \"Kell blood group system genotyping\": \"N/A\",\\n   \"serum protein electrophoresis (SPE)\": \"positive if daratumumab is present\",\\n   \"immunofixation (IFE)\": \"positive if daratumumab is present\",\\n   \"daratumumab-specific IFE assay\": \"distinguishes daratumumab from residual endogenous M protein\"\\n}',\n 'Lidocaine and Menthol (Lexi-Drugs)': 'Not available',\n 'Bleomycin (Lexi-Drugs)': 'Not available',\n 'Baclofen (Lexi-Drugs)': 'Not available',\n 'Milrinone (Lexi-Drugs)': 'Not available',\n 'LevETIRAcetam (Lexi-Drugs)': 'Not available',\n 'Sodium Thiosulfate: Calciphylaxis (Facts and Comparisons Off-Label)': 'Not available',\n 'Defibrotide (Lexi-Drugs)': 'Not available',\n 'Calcium Chloride (Lexi-Drugs)': 'Not available',\n 'Buprenorphine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Phenylephrine (Topical) (Lexi-Drugs)': 'Not available',\n 'Amiodarone (Lexi-Drugs)': 'Medical Test Names: \\n- Thyroid function test\\n\\nTest Results in JSON:\\n{\\n  \"T4 levels\": \"elevated\",\\n  \"Thyroid stimulating hormone levels\": \"at the high end of normal range\",\\n  \"T3 levels\": \"at the low end of normal range\"\\n}',\n 'Cosyntropin (Lexi-Drugs)': 'Medical Test Names: N/A\\n\\nTest Results in JSON: N/A',\n 'Betibeglogene Autotemcel (Lexi-Drugs)': '{\\n  \"polymerase chain reaction (PCR) assays for HIV\": \"Positive\",\\n  \"BB305 LVV proviral DNA\": \"Integrated\",\\n  \"screened for HIV infection using a PCR-based assay\": \"Should not\"\\n}',\n 'Benztropine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Cefuroxime (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n  \"ferricyanide test\": \"False-negative\",\\n  \"Glucose oxidase or hexokinase-based methods\": \"Should be used\"\\n}',\n 'Octreotide (Lexi-Drugs)': 'Not available',\n 'Gadoterate Meglumine (Lexi-Drugs)': 'Not available',\n 'Velaglucerase Alfa (Lexi-Drugs)': 'Not available',\n 'Allopurinol (Lexi-Drugs)': 'Not available',\n 'Avelumab (Lexi-Drugs)': 'Not available',\n 'Rasburicase (Lexi-Drugs)': '{\"uric acid\": \"N/A\"}',\n 'Clindamycin and Benzoyl Peroxide (Lexi-Drugs)': 'Not available',\n 'Insulin Lispro Protamine and Insulin Lispro (Lexi-Drugs)': 'Not available',\n 'Doxorubicin (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Agalsidase Beta (Lexi-Drugs)': 'Not available',\n 'Obiltoxaximab (Lexi-Drugs)': 'Not available',\n 'Factor VIIa (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Sotalol (Lexi-Drugs)': '{\\n  \"urinary metanephrine\": \"May falsely increase\",\\n  \"HPLC assay with solid phase extraction for determination of urinary catecholamines\": \"does not interact with\",\\n  \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"\\n}',\n 'Omeprazole and Sodium Bicarbonate (Lexi-Drugs)': '{\\n  \"serum chromogranin A (CgA)\": \"may falsely elevate; may cause false-positive results in the diagnosis of a neuroendocrine tumor\",\\n  \"omeprazole\": \"Temporarily stop ≥14 days prior to assessing CgA level\"\\n}',\n 'Melphalan Flufenamide (Lexi-Drugs)': 'Not available',\n 'Iodine I-125 Human Serum Albumin (Lexi-Drugs)': 'Not available',\n 'Sodium Bicarbonate (Lexi-Drugs)': 'Not available',\n 'Factor IX (Recombinant [Albumin Fusion Protein]) (Lexi-Drugs)': 'Not available',\n 'Lansoprazole, Amoxicillin, and Clarithromycin (Lexi-Drugs)': 'Not available',\n 'Midazolam (Lexi-Drugs)': 'Not available',\n 'Melphalan-Prednisone-Thalidomide (Multiple Myeloma) (Lexi-Drugs)': 'Not available',\n 'CISplatin (Lexi-Drugs)': 'Not available',\n 'Amphotericin B Cholesteryl Sulfate Complex (Lexi-Drugs)': 'Not available',\n 'Isatuximab (Lexi-Drugs)': 'Test Names:\\n1. Indirect Antiglobulin Test (indirect Coombs test)\\n2. Antibody Detection (screening) Tests\\n3. Antibody Identification Panels\\n4. Anti-Human Globulin Crossmatches\\n5. Blood Type and Screening\\n6. Phenotyping\\n7. Serum Protein Electrophoresis\\n8. Immunofixation Assays\\n\\nTest Result in JSON form:\\n{\\n   \"Indirect Antiglobulin Test\": \"false-positive\",\\n   \"Antibody Detection Tests\": \"may result in interference\",\\n   \"Antibody Identification Panels\": \"may result in interference\",\\n   \"Anti-Human Globulin Crossmatches\": \"may result in interference\",\\n   \"Blood Type and Screening\": \"recommended prior to the first isatuximab infusion\",\\n   \"Phenotyping\": \"consider prior to initiating treatment\",\\n   \"Serum Protein Electrophoresis\": \"may interfere with accuracy of determining complete response\",\\n   \"Immunofixation Assays\": \"may interfere with accuracy of determining complete response\"\\n}',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Lexi-Drugs)': 'Not available',\n 'CefOXitin (Lexi-Drugs)': '{\\n  \"Positive direct Coombs\\'\": \"Positive\",\\n  \"False-positive urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"Positive\",\\n  \"False-positive serum or urine creatinine with Jaffé reaction\": \"Positive\"\\n}',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Insulin Degludec (Lexi-Drugs)': 'Not available',\n 'Phenylephrine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Quinupristin and Dalfopristin (Lexi-Drugs)': 'Not available',\n 'Amikacin (Systemic) (Lexi-Drugs)': '{\\n  \"Medical test names\": [\\n    \"Aminoglycoside serum concentration\"\\n  ],\\n  \"Test results\": [\\n    \"Potential underestimation\"\\n  ]\\n}',\n 'Insulin Glargine and Lixisenatide (Lexi-Drugs)': 'Not available',\n 'Alglucosidase Alfa (Lexi-Drugs)': 'Not available',\n 'Mitoxantrone-Prednisone (Prostate) (Lexi-Drugs)': 'Not available',\n 'Proparacaine and Fluorescein (Lexi-Drugs)': 'Not available',\n 'Glutamine (Patient Education - Natural Products)': 'Not available',\n 'Alcohol (Isopropyl) (Lexi-Drugs)': 'Not available',\n 'MitoXANTRONE (Lexi-Drugs)': 'Not available',\n 'Gadoversetamide (Lexi-Drugs)': 'Test names: serum iron, copper, zinc, serum calcium.\\nTest results: \\n{\\n\"serum iron\": \"transient changes\",\\n\"copper\": \"transient changes\",\\n\"zinc\": \"transient changes\",\\n\"serum calcium\": \"apparent decrease after injection, accurate values can be obtained approximately 90 minutes after injection\"\\n}',\n 'Aldesleukin (Lexi-Drugs)': 'Not available',\n 'Anticholinergic Agents (Lexi-Tox)': 'Not available',\n 'Epoprostenol (Lexi-Drugs)': 'Not available',\n 'Tranexamic Acid [SUPPORTIVE] (Lexi-Tox)': 'Not available',\n 'Ibuprofen and Phenylephrine (Lexi-Drugs)': 'Not available',\n 'Insulin Degludec and Liraglutide (Lexi-Drugs)': 'Not available',\n 'Deferoxamine (Lexi-Drugs)': \"Sorry, as an AI language model, I don't have the capability to extract specific information from unstructured data without any context. Please provide more specific data or context for me to extract the information as per your requirement.\",\n 'Palifermin (Lexi-Drugs)': 'Not available',\n 'Pegloticase (Lexi-Drugs)': 'Not available',\n 'Amphotericin B (Lipid Complex) (Lexi-Drugs)': 'Not available',\n 'Atezolizumab (Lexi-Drugs)': 'Not available',\n 'Inotuzumab Ozogamicin (Lexi-Drugs)': 'Not available',\n 'Itraconazole (Lexi-Drugs)': 'Not available',\n 'Sodium Chloride and Sodium Citrate (Lexi-Drugs)': 'Not available',\n 'HYDROmorphone (Lexi-Drugs)': 'Test Names: \\n- Urine screening test for opioids \\n\\nTest Results (in JSON form): \\n{\\n  \"Urine screening test for opioids\": \"false-positive for levofloxacin and ofloxacin, cross-reactivity in certain assay kits for other quinolones\"\\n}',\n 'Brexucabtagene Autoleucel (Lexi-Drugs)': 'Not available',\n 'CycloSPORINE (Systemic) (Lexi-Drugs)': 'Test Names:\\n- Whole blood assay for cyclosporine\\n\\nTest Results (in JSON form):\\n{\\n  \"Whole blood assay for cyclosporine\": \"may be falsely elevated if sample is drawn from the same central venous line through which dose was administered; cyclosporine metabolites cross-react with radioimmunoassay and fluorescence polarization immunoassay\"\\n}',\n 'Anthrax Immune Globulin (Human) (Lexi-Drugs)': 'Test Names: \\n1. Glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n2. Glucose-specific method\\n3. Anthrax immune globulin administration\\n4. Serologic testing\\n5. Direct and indirect Coombs’ test\\n\\nTest Results:\\n1. Falsely elevated blood glucose levels \\n2. N/A\\n3. Transiently elevated glucose \\n4. False-positive results \\n5. False-positive results',\n 'EriBULin (Lexi-Drugs)': 'Not available',\n 'Fosphenytoin (Lexi-Drugs)': 'Test Names:\\n1. Immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000)\\n2. Dexamethasone test\\n3. Metyrapone test\\n\\nTest Results:\\n1. Falsely high plasma phenytoin concentrations \\n2. Falsely low results\\n3. Folate levels lowered',\n 'ALfentanil (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Clindamycin (Systemic) (Lexi-Drugs)': 'Not available',\n 'Calcitriol (Systemic) (Lexi-Drugs)': 'Not available',\n 'Clindamycin (Systemic) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Phenylephrine and Pyrilamine (Lexi-Drugs)': 'Not available',\n 'Fosfomycin (Lexi-Drugs)': 'Not available',\n 'DexmedeTOMIDine (Lexi-Drugs)': 'Not available',\n 'Ergonovine (Lexi-Drugs)': 'Not available',\n 'Terlipressin (Lexi-Drugs)': 'Not available',\n 'Insulin NPH and Insulin Regular (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Pseudoephedrine and Ibuprofen (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Scopolamine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Fibrinogen Concentrate (Human) (Lexi-Drugs)': 'Not available',\n 'Buprenorphine (Geriatric Lexi-Drugs)': 'Not available',\n 'Betamethasone and Salicylic Acid (Lexi-Drugs)': 'Not available',\n 'Diclofenac (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Bupivacaine and Meloxicam (Lexi-Drugs)': 'Not available',\n 'Acyclovir (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Asparaginase (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Golodirsen (Lexi-Drugs)': 'Not available',\n 'Clindamycin (Topical) (Lexi-Drugs)': 'Not available'}"
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drugs_test_conditions"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-03T08:23:01.871873100Z",
     "start_time": "2023-05-03T08:23:01.840630500Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "# Save the dictionary as a JSON file\n",
    "with open('Drugs test conditions.json', 'w') as f:\n",
    "    json.dump(drugs_test_conditions, f)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-03T08:23:27.628255Z",
     "start_time": "2023-05-03T08:23:27.612631Z"
    }
   }
  },
  {
   "cell_type": "markdown",
   "source": [
    "## Drugs Recongition - See individual agents exception"
   ],
   "metadata": {
    "collapsed": false
   }
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "outputs": [],
   "source": [
    "tests_splitting = []\n",
    "\n",
    "for i in range(len(test_interactions_df)):\n",
    "    if (str(test_interactions_df['Test Interactions'].loc[i]).strip() == 'See individual agents.'):\n",
    "        tests_splitting.append(test_interactions_df['Title'].loc[i])\n",
    "\n",
    "    else:\n",
    "        tests_splitting.append('None')"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-07T05:57:50.414141500Z",
     "start_time": "2023-05-07T05:57:50.402173500Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "outputs": [
    {
     "data": {
      "text/plain": "['None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Diphenhydramine and Phenylephrine (Lexi-Drugs)',\n 'Acetaminophen and Tramadol (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Lidocaine and Hydrocortisone (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Cetirizine and Pseudoephedrine (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Oxycodone and Acetaminophen (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Ciprofloxacin and Hydrocortisone (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Acetaminophen and Diphenhydramine (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Betamethasone and Clotrimazole (Lexi-Drugs)',\n 'None',\n 'Methyldopa and Hydrochlorothiazide (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Chlorpheniramine, Pseudoephedrine, and Dextromethorphan (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Dextromethorphan and Chlorpheniramine (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Ibuprofen, Pseudoephedrine, and Chlorpheniramine (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Acetaminophen, Diphenhydramine, and Phenylephrine (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Chlorpheniramine, Phenylephrine, and Dextromethorphan (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'Acetaminophen and Caffeine (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Glycerin and Lidocaine (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Metoprolol and Hydrochlorothiazide (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Lansoprazole, Amoxicillin, and Clarithromycin (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Pseudoephedrine and Ibuprofen (Pediatric and Neonatal Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None']"
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tests_splitting"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-07T05:57:53.779932100Z",
     "start_time": "2023-05-07T05:57:53.736020100Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "outputs": [],
   "source": [
    "gpt_phrase = '''extract the drug names from the following text file; and extract them seperated by a comma. Please don't add any of your comments and don't look up in the internet just give me a simple straight answer according to the sentence you receive next in a string in the form \"drugname , drugname, ..etc\", your answer should contain only a Python string:\\n'''"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-07T06:05:44.903877100Z",
     "start_time": "2023-05-07T06:05:44.881937Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n"
     ]
    },
    {
     "ename": "RateLimitError",
     "evalue": "That model is currently overloaded with other requests. You can retry your request, or contact us through our help center at help.openai.com if the error persists. (Please include the request ID 2288e2410f5a971122984062490de7b8 in your message.)",
     "output_type": "error",
     "traceback": [
      "\u001B[1;31m---------------------------------------------------------------------------\u001B[0m",
      "\u001B[1;31mRateLimitError\u001B[0m                            Traceback (most recent call last)",
      "Cell \u001B[1;32mIn[35], line 5\u001B[0m\n\u001B[0;32m      2\u001B[0m \u001B[38;5;28;01mfor\u001B[39;00m i \u001B[38;5;129;01min\u001B[39;00m \u001B[38;5;28mrange\u001B[39m(\u001B[38;5;28mlen\u001B[39m(test_interactions)):\n\u001B[0;32m      4\u001B[0m     \u001B[38;5;28;01mif\u001B[39;00m tests_splitting[i] \u001B[38;5;241m!=\u001B[39m \u001B[38;5;124m'\u001B[39m\u001B[38;5;124mNone\u001B[39m\u001B[38;5;124m'\u001B[39m:\n\u001B[1;32m----> 5\u001B[0m         message,status\u001B[38;5;241m=\u001B[39m\u001B[43mchat_gpt\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43msend_message\u001B[49m\u001B[43m(\u001B[49m\u001B[43mgpt_phrase\u001B[49m\u001B[38;5;241;43m+\u001B[39;49m\u001B[43mtests_splitting\u001B[49m\u001B[43m[\u001B[49m\u001B[43mi\u001B[49m\u001B[43m]\u001B[49m\u001B[43m)\u001B[49m\n\u001B[0;32m      6\u001B[0m         output \u001B[38;5;241m=\u001B[39m message\u001B[38;5;241m.\u001B[39msplit(\u001B[38;5;124m'\u001B[39m\u001B[38;5;130;01m\\n\u001B[39;00m\u001B[38;5;124m'\u001B[39m)[\u001B[38;5;241m0\u001B[39m]\n\u001B[0;32m      7\u001B[0m         \u001B[38;5;28;01mif\u001B[39;00m j \u001B[38;5;241m==\u001B[39m \u001B[38;5;241m0\u001B[39m:\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\chatGPT_api\\chatGPT_api.py:32\u001B[0m, in \u001B[0;36mChatGPT.send_message\u001B[1;34m(self, message)\u001B[0m\n\u001B[0;32m     30\u001B[0m \u001B[38;5;28;01mtry\u001B[39;00m:\n\u001B[0;32m     31\u001B[0m     try_again \u001B[38;5;241m=\u001B[39m \u001B[38;5;28;01mFalse\u001B[39;00m\n\u001B[1;32m---> 32\u001B[0m     completion \u001B[38;5;241m=\u001B[39m \u001B[43mopenai\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mChatCompletion\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mcreate\u001B[49m\u001B[43m(\u001B[49m\n\u001B[0;32m     33\u001B[0m \u001B[43m        \u001B[49m\u001B[43mmodel\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43m_model\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m     34\u001B[0m \u001B[43m        \u001B[49m\u001B[43mmessages\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43m_message_history\u001B[49m\u001B[43m)\u001B[49m\n\u001B[0;32m     35\u001B[0m \u001B[38;5;28;01mexcept\u001B[39;00m APIConnectionError:\n\u001B[0;32m     36\u001B[0m     \u001B[38;5;28;01mif\u001B[39;00m try_count \u001B[38;5;241m<\u001B[39m\u001B[38;5;241m=\u001B[39m retry_count:\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\openai\\api_resources\\chat_completion.py:25\u001B[0m, in \u001B[0;36mChatCompletion.create\u001B[1;34m(cls, *args, **kwargs)\u001B[0m\n\u001B[0;32m     23\u001B[0m \u001B[38;5;28;01mwhile\u001B[39;00m \u001B[38;5;28;01mTrue\u001B[39;00m:\n\u001B[0;32m     24\u001B[0m     \u001B[38;5;28;01mtry\u001B[39;00m:\n\u001B[1;32m---> 25\u001B[0m         \u001B[38;5;28;01mreturn\u001B[39;00m \u001B[38;5;28msuper\u001B[39m()\u001B[38;5;241m.\u001B[39mcreate(\u001B[38;5;241m*\u001B[39margs, \u001B[38;5;241m*\u001B[39m\u001B[38;5;241m*\u001B[39mkwargs)\n\u001B[0;32m     26\u001B[0m     \u001B[38;5;28;01mexcept\u001B[39;00m TryAgain \u001B[38;5;28;01mas\u001B[39;00m e:\n\u001B[0;32m     27\u001B[0m         \u001B[38;5;28;01mif\u001B[39;00m timeout \u001B[38;5;129;01mis\u001B[39;00m \u001B[38;5;129;01mnot\u001B[39;00m \u001B[38;5;28;01mNone\u001B[39;00m \u001B[38;5;129;01mand\u001B[39;00m time\u001B[38;5;241m.\u001B[39mtime() \u001B[38;5;241m>\u001B[39m start \u001B[38;5;241m+\u001B[39m timeout:\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\openai\\api_resources\\abstract\\engine_api_resource.py:153\u001B[0m, in \u001B[0;36mEngineAPIResource.create\u001B[1;34m(cls, api_key, api_base, api_type, request_id, api_version, organization, **params)\u001B[0m\n\u001B[0;32m    127\u001B[0m \u001B[38;5;129m@classmethod\u001B[39m\n\u001B[0;32m    128\u001B[0m \u001B[38;5;28;01mdef\u001B[39;00m \u001B[38;5;21mcreate\u001B[39m(\n\u001B[0;32m    129\u001B[0m     \u001B[38;5;28mcls\u001B[39m,\n\u001B[1;32m   (...)\u001B[0m\n\u001B[0;32m    136\u001B[0m     \u001B[38;5;241m*\u001B[39m\u001B[38;5;241m*\u001B[39mparams,\n\u001B[0;32m    137\u001B[0m ):\n\u001B[0;32m    138\u001B[0m     (\n\u001B[0;32m    139\u001B[0m         deployment_id,\n\u001B[0;32m    140\u001B[0m         engine,\n\u001B[1;32m   (...)\u001B[0m\n\u001B[0;32m    150\u001B[0m         api_key, api_base, api_type, api_version, organization, \u001B[38;5;241m*\u001B[39m\u001B[38;5;241m*\u001B[39mparams\n\u001B[0;32m    151\u001B[0m     )\n\u001B[1;32m--> 153\u001B[0m     response, _, api_key \u001B[38;5;241m=\u001B[39m \u001B[43mrequestor\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mrequest\u001B[49m\u001B[43m(\u001B[49m\n\u001B[0;32m    154\u001B[0m \u001B[43m        \u001B[49m\u001B[38;5;124;43m\"\u001B[39;49m\u001B[38;5;124;43mpost\u001B[39;49m\u001B[38;5;124;43m\"\u001B[39;49m\u001B[43m,\u001B[49m\n\u001B[0;32m    155\u001B[0m \u001B[43m        \u001B[49m\u001B[43murl\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m    156\u001B[0m \u001B[43m        \u001B[49m\u001B[43mparams\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mparams\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m    157\u001B[0m \u001B[43m        \u001B[49m\u001B[43mheaders\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mheaders\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m    158\u001B[0m \u001B[43m        \u001B[49m\u001B[43mstream\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mstream\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m    159\u001B[0m \u001B[43m        \u001B[49m\u001B[43mrequest_id\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mrequest_id\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m    160\u001B[0m \u001B[43m        \u001B[49m\u001B[43mrequest_timeout\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mrequest_timeout\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m    161\u001B[0m \u001B[43m    \u001B[49m\u001B[43m)\u001B[49m\n\u001B[0;32m    163\u001B[0m     \u001B[38;5;28;01mif\u001B[39;00m stream:\n\u001B[0;32m    164\u001B[0m         \u001B[38;5;66;03m# must be an iterator\u001B[39;00m\n\u001B[0;32m    165\u001B[0m         \u001B[38;5;28;01massert\u001B[39;00m \u001B[38;5;129;01mnot\u001B[39;00m \u001B[38;5;28misinstance\u001B[39m(response, OpenAIResponse)\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\openai\\api_requestor.py:226\u001B[0m, in \u001B[0;36mAPIRequestor.request\u001B[1;34m(self, method, url, params, headers, files, stream, request_id, request_timeout)\u001B[0m\n\u001B[0;32m    205\u001B[0m \u001B[38;5;28;01mdef\u001B[39;00m \u001B[38;5;21mrequest\u001B[39m(\n\u001B[0;32m    206\u001B[0m     \u001B[38;5;28mself\u001B[39m,\n\u001B[0;32m    207\u001B[0m     method,\n\u001B[1;32m   (...)\u001B[0m\n\u001B[0;32m    214\u001B[0m     request_timeout: Optional[Union[\u001B[38;5;28mfloat\u001B[39m, Tuple[\u001B[38;5;28mfloat\u001B[39m, \u001B[38;5;28mfloat\u001B[39m]]] \u001B[38;5;241m=\u001B[39m \u001B[38;5;28;01mNone\u001B[39;00m,\n\u001B[0;32m    215\u001B[0m ) \u001B[38;5;241m-\u001B[39m\u001B[38;5;241m>\u001B[39m Tuple[Union[OpenAIResponse, Iterator[OpenAIResponse]], \u001B[38;5;28mbool\u001B[39m, \u001B[38;5;28mstr\u001B[39m]:\n\u001B[0;32m    216\u001B[0m     result \u001B[38;5;241m=\u001B[39m \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39mrequest_raw(\n\u001B[0;32m    217\u001B[0m         method\u001B[38;5;241m.\u001B[39mlower(),\n\u001B[0;32m    218\u001B[0m         url,\n\u001B[1;32m   (...)\u001B[0m\n\u001B[0;32m    224\u001B[0m         request_timeout\u001B[38;5;241m=\u001B[39mrequest_timeout,\n\u001B[0;32m    225\u001B[0m     )\n\u001B[1;32m--> 226\u001B[0m     resp, got_stream \u001B[38;5;241m=\u001B[39m \u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43m_interpret_response\u001B[49m\u001B[43m(\u001B[49m\u001B[43mresult\u001B[49m\u001B[43m,\u001B[49m\u001B[43m \u001B[49m\u001B[43mstream\u001B[49m\u001B[43m)\u001B[49m\n\u001B[0;32m    227\u001B[0m     \u001B[38;5;28;01mreturn\u001B[39;00m resp, got_stream, \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39mapi_key\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\openai\\api_requestor.py:620\u001B[0m, in \u001B[0;36mAPIRequestor._interpret_response\u001B[1;34m(self, result, stream)\u001B[0m\n\u001B[0;32m    612\u001B[0m     \u001B[38;5;28;01mreturn\u001B[39;00m (\n\u001B[0;32m    613\u001B[0m         \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_interpret_response_line(\n\u001B[0;32m    614\u001B[0m             line, result\u001B[38;5;241m.\u001B[39mstatus_code, result\u001B[38;5;241m.\u001B[39mheaders, stream\u001B[38;5;241m=\u001B[39m\u001B[38;5;28;01mTrue\u001B[39;00m\n\u001B[0;32m    615\u001B[0m         )\n\u001B[0;32m    616\u001B[0m         \u001B[38;5;28;01mfor\u001B[39;00m line \u001B[38;5;129;01min\u001B[39;00m parse_stream(result\u001B[38;5;241m.\u001B[39miter_lines())\n\u001B[0;32m    617\u001B[0m     ), \u001B[38;5;28;01mTrue\u001B[39;00m\n\u001B[0;32m    618\u001B[0m \u001B[38;5;28;01melse\u001B[39;00m:\n\u001B[0;32m    619\u001B[0m     \u001B[38;5;28;01mreturn\u001B[39;00m (\n\u001B[1;32m--> 620\u001B[0m         \u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43m_interpret_response_line\u001B[49m\u001B[43m(\u001B[49m\n\u001B[0;32m    621\u001B[0m \u001B[43m            \u001B[49m\u001B[43mresult\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mcontent\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mdecode\u001B[49m\u001B[43m(\u001B[49m\u001B[38;5;124;43m\"\u001B[39;49m\u001B[38;5;124;43mutf-8\u001B[39;49m\u001B[38;5;124;43m\"\u001B[39;49m\u001B[43m)\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m    622\u001B[0m \u001B[43m            \u001B[49m\u001B[43mresult\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mstatus_code\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m    623\u001B[0m \u001B[43m            \u001B[49m\u001B[43mresult\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mheaders\u001B[49m\u001B[43m,\u001B[49m\n\u001B[0;32m    624\u001B[0m \u001B[43m            \u001B[49m\u001B[43mstream\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[38;5;28;43;01mFalse\u001B[39;49;00m\u001B[43m,\u001B[49m\n\u001B[0;32m    625\u001B[0m \u001B[43m        \u001B[49m\u001B[43m)\u001B[49m,\n\u001B[0;32m    626\u001B[0m         \u001B[38;5;28;01mFalse\u001B[39;00m,\n\u001B[0;32m    627\u001B[0m     )\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\openai\\api_requestor.py:683\u001B[0m, in \u001B[0;36mAPIRequestor._interpret_response_line\u001B[1;34m(self, rbody, rcode, rheaders, stream)\u001B[0m\n\u001B[0;32m    681\u001B[0m stream_error \u001B[38;5;241m=\u001B[39m stream \u001B[38;5;129;01mand\u001B[39;00m \u001B[38;5;124m\"\u001B[39m\u001B[38;5;124merror\u001B[39m\u001B[38;5;124m\"\u001B[39m \u001B[38;5;129;01min\u001B[39;00m resp\u001B[38;5;241m.\u001B[39mdata\n\u001B[0;32m    682\u001B[0m \u001B[38;5;28;01mif\u001B[39;00m stream_error \u001B[38;5;129;01mor\u001B[39;00m \u001B[38;5;129;01mnot\u001B[39;00m \u001B[38;5;241m200\u001B[39m \u001B[38;5;241m<\u001B[39m\u001B[38;5;241m=\u001B[39m rcode \u001B[38;5;241m<\u001B[39m \u001B[38;5;241m300\u001B[39m:\n\u001B[1;32m--> 683\u001B[0m     \u001B[38;5;28;01mraise\u001B[39;00m \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39mhandle_error_response(\n\u001B[0;32m    684\u001B[0m         rbody, rcode, resp\u001B[38;5;241m.\u001B[39mdata, rheaders, stream_error\u001B[38;5;241m=\u001B[39mstream_error\n\u001B[0;32m    685\u001B[0m     )\n\u001B[0;32m    686\u001B[0m \u001B[38;5;28;01mreturn\u001B[39;00m resp\n",
      "\u001B[1;31mRateLimitError\u001B[0m: That model is currently overloaded with other requests. You can retry your request, or contact us through our help center at help.openai.com if the error persists. (Please include the request ID 2288e2410f5a971122984062490de7b8 in your message.)"
     ]
    }
   ],
   "source": [
    "j = 0\n",
    "for i in range(len(test_interactions)):\n",
    "\n",
    "    if tests_splitting[i] != 'None':\n",
    "        message,status=chat_gpt.send_message(gpt_phrase+tests_splitting[i])\n",
    "        output = message.split('\\n')[0]\n",
    "        if j == 0:\n",
    "            tests_splitting[i] = output\n",
    "\n",
    "    j = 0\n",
    "    if i % 5 == 0:\n",
    "        time.sleep(60)\n",
    "        chat_gpt.clear_history()\n",
    "        j = 1; i -=1"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-07T07:32:35.127247Z",
     "start_time": "2023-05-07T06:15:56.633014300Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "outputs": [
    {
     "data": {
      "text/plain": "380"
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "i"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-07T07:58:53.435342200Z",
     "start_time": "2023-05-07T07:58:53.419473700Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n",
      "History cleared\n"
     ]
    }
   ],
   "source": [
    "j = 0\n",
    "for i in range(381,len(test_interactions)):\n",
    "\n",
    "    if tests_splitting[i] != 'None':\n",
    "        message,status=chat_gpt.send_message(gpt_phrase+tests_splitting[i])\n",
    "        output = message.split('\\n')[0]\n",
    "        if j == 0:\n",
    "            tests_splitting[i] = output\n",
    "\n",
    "    j = 0\n",
    "    if i % 5 == 0:\n",
    "        time.sleep(60)\n",
    "        chat_gpt.clear_history()\n",
    "        j = 1; i -=1"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-07T09:57:07.130528200Z",
     "start_time": "2023-05-07T08:00:55.019480500Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "outputs": [
    {
     "data": {
      "text/plain": "964"
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(tests_splitting)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-07T09:57:07.139426600Z",
     "start_time": "2023-05-07T09:57:07.131453300Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "outputs": [
    {
     "data": {
      "text/plain": "['None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Diphenhydramine, Phenylephrine\"',\n '\"Acetaminophen, Tramadol\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Lidocaine, Hydrocortisone\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Cetirizine, Pseudoephedrine\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Oxycodone, Acetaminophen\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Ciprofloxacin, Hydrocortisone\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Acetaminophen, Diphenhydramine\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Betamethasone and Clotrimazole (Lexi-Drugs)',\n 'None',\n '\"Methyldopa, Hydrochlorothiazide\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Chlorpheniramine, Pseudoephedrine, Dextromethorphan\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Dextromethorphan, Chlorpheniramine\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Ibuprofen, Pseudoephedrine, and Chlorpheniramine (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Acetaminophen, Diphenhydramine, Phenylephrine\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Chlorpheniramine, Phenylephrine, and Dextromethorphan (Lexi-Drugs)',\n 'None',\n 'None',\n 'None',\n '\"Acetaminophen, Caffeine\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Glycerin, Lidocaine\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'Metoprolol, Hydrochlorothiazide',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Lansoprazole, Amoxicillin, Clarithromycin\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n '\"Pseudoephedrine, Ibuprofen\"',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None',\n 'None']"
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tests_splitting"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-07T12:20:01.553160300Z",
     "start_time": "2023-05-07T12:20:01.521917800Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "outputs": [],
   "source": [
    "pd.DataFrame(tests_splitting).to_excel('Tests Names Splitted.xlsx')"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-07T12:20:46.872752200Z",
     "start_time": "2023-05-07T12:20:46.255873300Z"
    }
   }
  },
  {
   "cell_type": "markdown",
   "source": [
    "## (Drug type) Removal"
   ],
   "metadata": {
    "collapsed": false
   }
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "outputs": [],
   "source": [
    "test_interactions_df = pd.read_excel('fdsfds.xlsx')"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-09T14:13:52.356392200Z",
     "start_time": "2023-05-09T14:13:52.067647500Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "outputs": [
    {
     "data": {
      "text/plain": "                                                      0\n0     Abacavir, Lamivudine, and Zidovudine (Lexi-Drugs)\n1                                Abatacept (Lexi-Drugs)\n2                                Abciximab (Lexi-Drugs)\n3     Abiraterone-Methylprednisolone (Prostate) (Lex...\n4         Acalabrutinib-Obinutuzumab (CLL) (Lexi-Drugs)\n...                                                 ...\n1030                         Zinc Chloride (Lexi-Drugs)\n1031                          Zinc Sulfate (Lexi-Drugs)\n1032            Ziv-Aflibercept (Systemic) (Lexi-Drugs)\n1033  Ziv-Aflibercept + FOLFIRI (Colorectal) (Lexi-D...\n1034                       Zoledronic Acid (Lexi-Drugs)\n\n[1035 rows x 1 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>0</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Abacavir, Lamivudine, and Zidovudine (Lexi-Drugs)</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Abatacept (Lexi-Drugs)</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>Abciximab (Lexi-Drugs)</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>Abiraterone-Methylprednisolone (Prostate) (Lex...</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>Acalabrutinib-Obinutuzumab (CLL) (Lexi-Drugs)</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>1030</th>\n      <td>Zinc Chloride (Lexi-Drugs)</td>\n    </tr>\n    <tr>\n      <th>1031</th>\n      <td>Zinc Sulfate (Lexi-Drugs)</td>\n    </tr>\n    <tr>\n      <th>1032</th>\n      <td>Ziv-Aflibercept (Systemic) (Lexi-Drugs)</td>\n    </tr>\n    <tr>\n      <th>1033</th>\n      <td>Ziv-Aflibercept + FOLFIRI (Colorectal) (Lexi-D...</td>\n    </tr>\n    <tr>\n      <th>1034</th>\n      <td>Zoledronic Acid (Lexi-Drugs)</td>\n    </tr>\n  </tbody>\n</table>\n<p>1035 rows × 1 columns</p>\n</div>"
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_interactions_df"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-09T14:13:53.799426500Z",
     "start_time": "2023-05-09T14:13:53.783457500Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "outputs": [
    {
     "ename": "KeyError",
     "evalue": "'Title'",
     "output_type": "error",
     "traceback": [
      "\u001B[1;31m---------------------------------------------------------------------------\u001B[0m",
      "\u001B[1;31mKeyError\u001B[0m                                  Traceback (most recent call last)",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\pandas\\core\\indexes\\base.py:3652\u001B[0m, in \u001B[0;36mIndex.get_loc\u001B[1;34m(self, key)\u001B[0m\n\u001B[0;32m   3651\u001B[0m \u001B[38;5;28;01mtry\u001B[39;00m:\n\u001B[1;32m-> 3652\u001B[0m     \u001B[38;5;28;01mreturn\u001B[39;00m \u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43m_engine\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mget_loc\u001B[49m\u001B[43m(\u001B[49m\u001B[43mcasted_key\u001B[49m\u001B[43m)\u001B[49m\n\u001B[0;32m   3653\u001B[0m \u001B[38;5;28;01mexcept\u001B[39;00m \u001B[38;5;167;01mKeyError\u001B[39;00m \u001B[38;5;28;01mas\u001B[39;00m err:\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\pandas\\_libs\\index.pyx:147\u001B[0m, in \u001B[0;36mpandas._libs.index.IndexEngine.get_loc\u001B[1;34m()\u001B[0m\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\pandas\\_libs\\index.pyx:155\u001B[0m, in \u001B[0;36mpandas._libs.index.IndexEngine.get_loc\u001B[1;34m()\u001B[0m\n",
      "File \u001B[1;32mpandas\\_libs\\index_class_helper.pxi:70\u001B[0m, in \u001B[0;36mpandas._libs.index.Int64Engine._check_type\u001B[1;34m()\u001B[0m\n",
      "\u001B[1;31mKeyError\u001B[0m: 'Title'",
      "\nThe above exception was the direct cause of the following exception:\n",
      "\u001B[1;31mKeyError\u001B[0m                                  Traceback (most recent call last)",
      "Cell \u001B[1;32mIn[33], line 1\u001B[0m\n\u001B[1;32m----> 1\u001B[0m \u001B[38;5;28mlist\u001B[39m(\u001B[43mtest_interactions_df\u001B[49m\u001B[43m[\u001B[49m\u001B[38;5;124;43m'\u001B[39;49m\u001B[38;5;124;43mTitle\u001B[39;49m\u001B[38;5;124;43m'\u001B[39;49m\u001B[43m]\u001B[49m\u001B[38;5;241m.\u001B[39mvalues[\u001B[38;5;241m300\u001B[39m:\u001B[38;5;241m500\u001B[39m])\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\pandas\\core\\frame.py:3760\u001B[0m, in \u001B[0;36mDataFrame.__getitem__\u001B[1;34m(self, key)\u001B[0m\n\u001B[0;32m   3758\u001B[0m \u001B[38;5;28;01mif\u001B[39;00m \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39mcolumns\u001B[38;5;241m.\u001B[39mnlevels \u001B[38;5;241m>\u001B[39m \u001B[38;5;241m1\u001B[39m:\n\u001B[0;32m   3759\u001B[0m     \u001B[38;5;28;01mreturn\u001B[39;00m \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_getitem_multilevel(key)\n\u001B[1;32m-> 3760\u001B[0m indexer \u001B[38;5;241m=\u001B[39m \u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mcolumns\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mget_loc\u001B[49m\u001B[43m(\u001B[49m\u001B[43mkey\u001B[49m\u001B[43m)\u001B[49m\n\u001B[0;32m   3761\u001B[0m \u001B[38;5;28;01mif\u001B[39;00m is_integer(indexer):\n\u001B[0;32m   3762\u001B[0m     indexer \u001B[38;5;241m=\u001B[39m [indexer]\n",
      "File \u001B[1;32mE:\\Projects\\DrugDatabase-GPT\\venv\\lib\\site-packages\\pandas\\core\\indexes\\base.py:3654\u001B[0m, in \u001B[0;36mIndex.get_loc\u001B[1;34m(self, key)\u001B[0m\n\u001B[0;32m   3652\u001B[0m     \u001B[38;5;28;01mreturn\u001B[39;00m \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_engine\u001B[38;5;241m.\u001B[39mget_loc(casted_key)\n\u001B[0;32m   3653\u001B[0m \u001B[38;5;28;01mexcept\u001B[39;00m \u001B[38;5;167;01mKeyError\u001B[39;00m \u001B[38;5;28;01mas\u001B[39;00m err:\n\u001B[1;32m-> 3654\u001B[0m     \u001B[38;5;28;01mraise\u001B[39;00m \u001B[38;5;167;01mKeyError\u001B[39;00m(key) \u001B[38;5;28;01mfrom\u001B[39;00m \u001B[38;5;21;01merr\u001B[39;00m\n\u001B[0;32m   3655\u001B[0m \u001B[38;5;28;01mexcept\u001B[39;00m \u001B[38;5;167;01mTypeError\u001B[39;00m:\n\u001B[0;32m   3656\u001B[0m     \u001B[38;5;66;03m# If we have a listlike key, _check_indexing_error will raise\u001B[39;00m\n\u001B[0;32m   3657\u001B[0m     \u001B[38;5;66;03m#  InvalidIndexError. Otherwise we fall through and re-raise\u001B[39;00m\n\u001B[0;32m   3658\u001B[0m     \u001B[38;5;66;03m#  the TypeError.\u001B[39;00m\n\u001B[0;32m   3659\u001B[0m     \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_check_indexing_error(key)\n",
      "\u001B[1;31mKeyError\u001B[0m: 'Title'"
     ]
    }
   ],
   "source": [
    "list(test_interactions_df['Title'].values[300:500])"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-09T14:13:59.347449400Z",
     "start_time": "2023-05-09T14:13:58.012467500Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "outputs": [],
   "source": [
    "def filtrate_titles(title:str):\n",
    "\n",
    "    for s in ['(Briggs Drugs in Pregnancy and Lactation)','(Lexi-Drugs)','(Pediatric and Neonatal Lexi-Drugs)','(Lab Tests and Diagnostic Procedures)','(Pharmacogenomics)','(Geriatric Lexi-Drugs)','(Lexi-Drugs International [Concise])']:\n",
    "        title = title.replace(s,'')\n",
    "\n",
    "    title = title.strip()\n",
    "    return title"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-09T14:14:01.545297Z",
     "start_time": "2023-05-09T14:14:01.515344300Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "outputs": [],
   "source": [
    "titles_filtrated = []\n",
    "for title in test_interactions_df[0].values[:]:\n",
    "    title = filtrate_titles(str(title))\n",
    "    titles_filtrated.append(title)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-09T14:14:09.817105200Z",
     "start_time": "2023-05-09T14:14:09.783682100Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "outputs": [
    {
     "data": {
      "text/plain": "['Abacavir, Lamivudine, and Zidovudine',\n 'Abatacept',\n 'Abciximab',\n 'Abiraterone-Methylprednisolone (Prostate)',\n 'Acalabrutinib-Obinutuzumab (CLL)',\n 'Acetaminophen',\n 'Acetaminophen and Caffeine',\n 'Acetaminophen and Diphenhydramine',\n 'Acetaminophen and Tramadol',\n 'Acetaminophen, Diphenhydramine, and Phenylephrine',\n 'AcetaZOLAMIDE',\n 'Acetylcysteine',\n 'Acetylcysteine',\n 'Acetylcysteine',\n 'Acyclovir (Ophthalmic)',\n 'Acyclovir (refer to route-specific monograph)',\n 'Acyclovir (Systemic)',\n 'Acyclovir (Topical)',\n 'Adenosine',\n 'Ado-Trastuzumab Emtansine',\n 'Aducanumab',\n 'Agalsidase Alfa',\n 'Agalsidase Beta',\n 'Albumin',\n 'Albuterol',\n 'Alcohol (Ethyl)',\n 'Alcohol (Isopropyl)',\n 'Aldesleukin',\n 'Alemtuzumab',\n 'Alfentanil',\n 'ALfentanil',\n 'ALfentanil (Lexi-Tox)',\n 'ALfentanil',\n 'Alglucosidase Alfa',\n 'Allopurinol',\n 'Alpha1-Proteinase Inhibitor',\n 'Alprostadil',\n 'Alteplase',\n 'Amantadine',\n 'Ambroxol [INT]',\n 'Amifostine',\n 'Amikacin (refer to route-specific monograph)',\n 'Amikacin (Systemic)',\n 'Amikacin Liposome (Oral Inhalation)',\n 'Aminocaproic Acid',\n 'Aminophylline',\n 'Amiodarone',\n 'Amisulpride (Injection)',\n 'Amisulpride (Injection) (Lexi-Tox)',\n 'Amisulpride (Oral) [INT]',\n 'Amivantamab',\n 'Amobarbital',\n 'Amoxicillin',\n 'Amoxicillin and Clavulanate',\n 'Amoxicillin and Flucloxacillin',\n 'Amphotericin B (Lipid Complex)',\n 'Amphotericin B (Liposomal)',\n 'Amphotericin B Cholesteryl Sulfate Complex',\n 'Amphotericin B Deoxycholate',\n 'Ampicillin',\n 'Ampicillin and Cloxacillin [INT]',\n 'Ampicillin and Sulbactam',\n 'Amsacrine',\n 'Andexanet Alfa (Coagulation Factor Xa [Recombinant], Inactivated)',\n 'Angiotensin II',\n 'Anidulafungin',\n 'Anifrolumab',\n 'Ansuvimab',\n 'Anthrax Immune Globulin (Human)',\n 'Anthrax Immune Globulin (Human)',\n 'Anthrax Immune Globulin (Human) [ANTIDOTE] (Lexi-Tox)',\n 'Anti-inhibitor Coagulant Complex (Human)',\n 'Anticholinergic Agents (Lexi-Tox)',\n 'Antihemophilic Factor (Human)',\n 'Antihemophilic Factor (Recombinant [Fc Fusion Protein])',\n 'Antihemophilic Factor (Recombinant [Fc-VWF-XTEN Fusion Protein])',\n 'Antihemophilic Factor (Recombinant [Pegylated])',\n 'Antihemophilic Factor (Recombinant [Porcine Sequence])',\n 'Antihemophilic Factor (Recombinant)',\n 'Antihemophilic Factor-von Willebrand Factor Complex (Human)',\n 'Antipsychotic Agents, Atypical (Lexi-Tox)',\n 'Antithymocyte Globulin (Equine)',\n 'Antithymocyte Globulin (Equine)',\n 'Antithymocyte Globulin (Rabbit)',\n 'Antithymocyte Globulin (Rabbit)',\n 'Antivenin (Latrodectus mactans)',\n 'Antivenin (Micrurus fulvius)',\n 'Aprepitant',\n 'Argatroban',\n 'Arginine',\n 'Arsenic Trioxide',\n 'Artesunate',\n 'Artesunate and Amodiaquine [INT]',\n 'Ascorbic Acid',\n 'Ascorbic Acid',\n 'Asparaginase',\n 'Asparaginase (Erwinia [Recombinant])',\n 'Asparaginase (Erwinia)',\n 'Aspirin and Ascorbic Acid (Drug Allergy and Idiosyncratic Reactions)',\n 'Atenolol',\n 'Atezolizumab',\n 'Atezolizumab-Carboplatin-Etoposide (Small Cell Lung Cancer)',\n 'Atoltivimab, Maftivimab, and Odesivimab',\n 'Atosiban [INT]',\n 'Atracurium',\n 'Atropine (Ophthalmic)',\n 'Avalglucosidase Alfa',\n 'Avelumab',\n 'Avelumab-Axitinib (RCC)',\n 'Axicabtagene Ciloleucel',\n 'AzaCITIDine',\n 'AzaTHIOprine',\n 'Azithromycin (Ophthalmic)',\n 'Azithromycin (refer to route-specific monograph)',\n 'Azithromycin (Systemic)',\n 'Aztreonam (Oral Inhalation)',\n 'Aztreonam (Oral Inhalation)',\n 'Aztreonam (Oral Inhalation)',\n 'Aztreonam (Oral Inhalation)',\n 'Aztreonam (refer to route-specific monograph)',\n 'Aztreonam (Systemic)',\n 'Aztreonam (Systemic)',\n 'Aztreonam (Systemic)',\n 'Aztreonam (Systemic)',\n 'Bacitracin and Polymyxin B (Topical)',\n 'Baclofen',\n 'Bambuterol [INT]',\n 'Bamlanivimab',\n 'Bamlanivimab and Etesevimab',\n 'Basiliximab',\n 'BChE - Mivacurium',\n 'Bebtelovimab',\n 'Belantamab Mafodotin',\n 'Belatacept',\n 'Belimumab',\n 'Belinostat',\n 'Bendamustine',\n 'Bendamustine-Bortezomib-Rituximab (NHL-Follicular)',\n 'Bendamustine-Lenalidomide-Dexamethasone (Multiple Myeloma)',\n 'Bendamustine-Rituximab (CLL)',\n 'Benzocaine, Butamben, and Tetracaine',\n 'Benztropine',\n 'Benztropine',\n 'Benztropine',\n 'Benztropine (Lexi-Tox)',\n 'Benztropine',\n 'Benzyl Alcohol',\n 'Betamethasone',\n 'Betamethasone (Systemic)',\n 'Betamethasone (Topical)',\n 'Betamethasone and Clotrimazole',\n 'Betamethasone and Gentamicin',\n 'Betamethasone and Salicylic Acid',\n 'Betibeglogene Autotemcel',\n 'Betibeglogene Autotemcel',\n 'Bevacizumab',\n 'Bevacizumab + FOLFIRI (Colorectal)',\n 'Bevacizumab FOLFOX (Colorectal)',\n 'Bevacizumab-Carboplatin-Doxorubicin (Liposomal) (Ovarian)',\n 'Bevacizumab-Carboplatin-Paclitaxel (NSCLC)',\n 'Bevacizumab-Carboplatin-Paclitaxel (Ovarian)',\n 'Bevacizumab-Cisplatin-Paclitaxel (Cervical)',\n 'Bevacizumab-Doxorubicin (Liposomal) (Ovarian)',\n 'Bezlotoxumab',\n 'Biperiden (Lexi-Tox)',\n 'Biperiden [INT]',\n 'Bivalirudin',\n 'Bleomycin',\n 'Blinatumomab',\n 'Bortezomib',\n 'Botulism Antitoxin, Heptavalent',\n 'Brentuximab Vedotin',\n 'Bretylium',\n 'Brexanolone',\n 'Brexucabtagene Autoleucel',\n 'Brivaracetam',\n 'Bromhexine [INT]',\n 'Bromopride [INT]',\n 'Bumetanide',\n 'BUPivacaine',\n 'Bupivacaine and Meloxicam',\n 'Buprenorphine',\n 'Buprenorphine',\n 'Buprenorphine',\n 'Buprenorphine',\n 'Buprenorphine and Naloxone',\n 'Buprenorphine and Naloxone',\n 'Busulfan',\n 'Butorphanol',\n 'C1 Inhibitor (Human)',\n 'C1 Inhibitor (Recombinant)',\n 'Cabazitaxel',\n 'Caffeine',\n 'Calaspargase Pegol',\n 'Calcitriol (refer to route-specific monograph)',\n 'Calcitriol (Systemic)',\n 'Calcitriol (Topical)',\n 'Calcium Chloride',\n 'Calcium Gluconate',\n 'Capecitabine-Ixabepilone (Breast)',\n 'Capecitabine-Oxaliplatin (Gastric)',\n 'Caplacizumab',\n 'Capmatinib',\n 'Capreomycin',\n 'Carbetocin',\n 'CARBOplatin',\n 'Carboplatin-Docetaxel (Ovarian)',\n 'Carboplatin-Docetaxel (Unknown Primary, Adenocarcinoma)',\n 'Carboplatin-Etoposide (Ovarian Germ Cell Tumor)',\n 'Carboplatin-Paclitaxel (NSCLC)',\n 'Carboplatin-Paclitaxel-Trastuzumab (Breast)',\n 'Carfilzomib',\n 'Carmustine',\n 'Casimersen',\n 'Casirivimab and Imdevimab',\n 'Caspofungin',\n 'CeFAZolin',\n 'Cefepime',\n 'Cefiderocol',\n 'Cefoperazone and Sulbactam [INT]',\n 'Cefotaxime',\n 'Cefotaxime',\n 'Cefotaxime',\n 'CefoTEtan',\n 'CefOXitin',\n 'Cefpirome [INT]',\n 'Ceftaroline Fosamil',\n 'CefTAZidime',\n 'Ceftazidime and Avibactam',\n 'Ceftezole (Drug Allergy and Idiosyncratic Reactions)',\n 'Ceftobiprole',\n 'Ceftolozane and Tazobactam',\n 'Ceftolozane and Tazobactam',\n 'Ceftolozane and Tazobactam',\n 'Ceftolozane and Tazobactam',\n 'CefTRIAXone',\n 'Cefuroxime',\n 'Cefuroxime',\n 'Cefuroxime',\n 'Cefuroxime',\n 'Celecoxib and Tramadol',\n 'Cemiplimab',\n 'Centruroides Immune F(ab’)2 (Equine)',\n 'Cetirizine (Ophthalmic)',\n 'Cetirizine (refer to route-specific monograph)',\n 'Cetirizine (Systemic)',\n 'Cetirizine and Pseudoephedrine',\n 'Cetuximab',\n 'Chlorambucil-Ofatumumab (CLL)',\n 'Chloramphenicol (Systemic)',\n 'Chlorothiazide',\n 'Chlorpheniramine, Phenylephrine, and Dextromethorphan',\n 'Chlorpheniramine, Pseudoephedrine, and Dextromethorphan',\n 'ChlorproMAZINE',\n 'Choline C 11',\n 'Cidofovir',\n 'Cimetidine',\n 'Cimetropium (Lexi-Tox)',\n 'Ciprofl oxacin (Systemic)',\n 'Ciprofloxacin (Ophthalmic)',\n 'Ciprofloxacin (Otic)',\n 'Ciprofloxacin (refer to route-specific monograph)',\n 'Ciprofloxacin (Systemic)',\n 'Ciprofloxacin and Dexamethasone',\n 'Ciprofloxacin and Fluocinolone',\n 'Ciprofloxacin and Hydrocortisone',\n 'Cisatracurium',\n 'CISplatin',\n 'Cisplatin-Capecitabine (Gastric Cancer)',\n 'Cisplatin-Docetaxel (NSCLC)',\n 'Cisplatin-Gemcitabine (Cervical)',\n 'Cisplatin-Gemcitabine (Mesothelioma)',\n 'Cisplatin-Raltitrexed (Mesothelioma)',\n 'Cisplatin-Vinblastine (NSCLC)',\n 'Cladribine',\n 'Clarithromycin',\n 'Clevidipine',\n 'Clevidipine',\n 'Clevidipine',\n 'Clindamycin',\n 'Clindamycin (Systemic)',\n 'Clindamycin (Systemic)',\n 'Clindamycin (Topical)',\n 'Clindamycin (Topical)',\n 'Clindamycin and Benzoyl Peroxide',\n 'Clindamycin and Benzoyl Peroxide',\n 'Clindamycin and Tretinoin',\n 'Clindamycin and Tretinoin',\n 'Clodronate',\n 'Clofarabine',\n 'Clofarabine-Cyclophosphamide-Etoposide (ALL)',\n 'ClonazePAM',\n 'CloNIDine',\n 'Clot Dissolving Drugs for Heart Attack or Stroke',\n 'Clothiapine [INT]',\n 'Cloxacillin',\n 'Codeine',\n 'Colistimethate',\n 'Colistimethate',\n 'Comparison of Prothrombin Complex Concentrates',\n 'Conivaptan',\n 'Copanlisib',\n 'Copper Cu 64 Dotatate',\n 'Copper IUD',\n 'Cosyntropin',\n 'Crizanlizumab',\n 'Crizotinib',\n \"Crotalidae Immune F(ab')2 (Equine)\",\n 'Crotalidae Polyvalent Immune FAB (Ovine)',\n 'Cyanocobalamin',\n 'Cyclizine [INT]',\n 'CycloPHOSphamide',\n 'Cyclophosphamide-Epirubicin (Breast)',\n 'CycloSPORINE (Ophthalmic)',\n 'CycloSPORINE (refer to route-specific monograph)',\n 'CycloSPORINE (Systemic)',\n 'Cytarabine (Conventional)',\n 'Cytomegalovirus Immune Globulin (Intravenous-Human)',\n 'Dacarbazine',\n 'DACTINomycin',\n 'Dalbavancin',\n 'Dalteparin',\n 'Danaparoid',\n 'Dantrolene',\n 'DAPTOmycin',\n 'Daratumumab',\n 'Daratumumab and Hyaluronidase',\n 'Darbepoetin Alfa',\n 'DAUNOrubicin (Conventional)',\n 'DAUNOrubicin (Liposomal)',\n 'Daunorubicin and Cytarabine (Liposomal)',\n 'Decitabine',\n 'Decitabine and Cedazuridine',\n 'Deferoxamine',\n 'Defibrotide',\n 'Delafloxacin',\n 'Desmopressin',\n 'DexAMETHasone (Ophthalmic)',\n 'DexAMETHasone (Ophthalmic)',\n 'DexAMETHasone (Systemic)',\n 'DexAMETHasone (Systemic)',\n 'DexAMETHasone (Systemic) [SUPPORTIVE] (Lexi-Tox)',\n 'Dexamethasone and Salicylic Acid (Lexi-Tox)',\n 'Dexketoprofen [INT]',\n 'DexmedeTOMIDine',\n 'Dexrazoxane',\n 'Dexrazoxane',\n 'Dexrazoxane',\n 'Dextromethorphan and Chlorpheniramine',\n 'Diamorphine',\n 'Diatrizoate Meglumine',\n 'DiazePAM',\n 'Diazoxide',\n 'Diclofenac (Ophthalmic)',\n 'Diclofenac (Topical)',\n 'Difelikefalin',\n 'Digoxin',\n 'Digoxin Immune Fab',\n 'Digoxin Toxicity',\n 'Dihydroergotamine',\n 'DilTIAZem',\n 'DimenhyDRINATE',\n 'Dinutuximab',\n 'DiphenhydrAMINE (Systemic)',\n 'DiphenhydrAMINE (Topical)',\n 'Diphenhydramine and Ammonium Chloride (Lexi-Tox)',\n 'Diphenhydramine and Ibuprofen',\n 'Diphenhydramine and Phenylephrine',\n 'Dipyridamole',\n 'Dipyrone [INT]',\n 'DOBUTamine',\n 'DOCEtaxel',\n 'Docetaxel Every 3 Weeks-Trastuzumab (Breast)',\n 'Docetaxel-Oxaliplatin-Leucovorin-Fluorouracil (Esophageal)',\n 'Dolasetron',\n 'Dolasetron',\n 'Dolasetron',\n 'DOPamine',\n 'Doripenem',\n 'Dostarlimab',\n 'Doxapram',\n 'Doxercalciferol',\n 'Doxorubicin',\n 'DOXOrubicin (Conventional)',\n 'DOXOrubicin (Conventional)',\n 'DOXOrubicin (Liposomal)',\n 'Doxycycline Hyclate Periodontal Extended-Release Liquid',\n 'DroPERidol',\n 'Durvalumab',\n 'Eculizumab',\n 'Edaravone',\n 'Edetate CALCIUM Disodium',\n 'Edrophonium and Atropine',\n 'Efgartigimod Alfa',\n 'Elivaldogene Autotemcel',\n 'Elosulfase Alfa',\n 'Elotuzumab',\n 'Elotuzumab-Lenalidomide-Dexamethasone (Multiple Myeloma)',\n 'Elotuzumab-Pomalidomide-Dexamethasone (Multiple Myeloma)',\n 'Emapalumab',\n 'Enalaprilat',\n 'Enfortumab Vedotin',\n 'Enoxaparin',\n 'Enoximone [INT]',\n 'EPHEDrine (Systemic)',\n 'EpiRUBicin',\n 'Epirubicin-Ifosfamide (Soft Tissue Sarcoma)',\n 'Epoetin Alfa',\n 'Epoetin Lambda (Drug Allergy and Idiosyncratic Reactions)',\n 'Epoetin Zeta (Drug Allergy and Idiosyncratic Reactions)',\n 'Epoprostenol',\n 'Eptifibatide',\n 'Eptinezumab',\n 'Eravacycline',\n 'Ergonovine',\n 'Ergotamine and Caffeine',\n 'EriBULin',\n 'Ertapenem',\n 'Erythromycin (Ophthalmic)',\n 'Erythromycin (Systemic)',\n 'Erythromycin (Topical)',\n 'Erythromycin and Benzoyl Peroxide',\n 'Esmolol',\n 'Esomeprazole',\n 'Estrogens (Conjugated Equine Systemic)',\n 'Estrogens (Conjugated Equine Topical)',\n 'Estrogens (ConjugatedEquine) (refer to route-specific monograph)',\n 'Etamsylate [INT]',\n 'Etelcalcetide',\n 'Eteplirsen',\n 'Eteplirsen',\n 'Ethacrynic Acid',\n 'Etomidate',\n 'Etoposide',\n 'Etoposide Phosphate',\n 'Etranacogene Dezaparvovec',\n 'Evinacumab',\n 'Factor IX (Recombinant [Albumin Fusion Protein])',\n 'Factor IX (Recombinant [Fc Fusion Protein])',\n 'Factor IX (Recombinant [Glycopegylated])',\n 'Factor IX (Recombinant)',\n 'Factor IX Complex (Human) [(Factors II, IX, X)]',\n 'Factor VIIa (Recombinant)',\n 'Factor X (Human)',\n 'Fam-Trastuzumab Deruxtecan',\n 'Famotidine',\n 'Fenoldopam',\n 'FentaNYL',\n 'Ferric Carboxymaltose',\n 'Ferric Carboxymaltose',\n 'Ferric Carboxymaltose',\n 'Ferric Derisomaltose',\n 'Ferric Gluconate',\n 'Ferric Gluconate (Lexi-Tox)',\n 'Ferric Gluconate',\n 'Ferric Hydroxide Polymaltose Complex [INT]',\n 'Ferric Pyrophosphate Citrate',\n 'Ferumoxytol',\n 'Fibrinogen Concentrate (Human)',\n 'Filgrastim',\n 'Flecainide',\n 'Flomoxef [INT]',\n 'Flortaucipir F18',\n 'Floxuridine',\n 'Flucloxacillin [INT]',\n 'Fluconazole',\n 'Flucytosine',\n 'Fludarabine',\n 'Fludarabine-Cyclophosphamide (CLL)',\n 'Fludarabine-Cyclophosphamide-Ofatumumab (CLL)',\n 'Fludarabine-Cyclophosphamide-Rituximab  (CLL)',\n 'Fludarabine-Rituximab (CLL)',\n 'Flumazenil',\n 'Fluorescein',\n 'Fluorescein and Benoxinate',\n 'Fluoroestradiol F18',\n 'Fluorouracil (refer to route-specific monograph)',\n 'Fluorouracil (Systemic)',\n 'Fluorouracil (Topical)',\n 'Fluorouracil and Salicylic Acid',\n 'Fluorouracil-Hydroxyurea (Head and Neck Cancer)',\n 'Fluorouracil-Leucovorin Bolus (Colorectal)',\n 'Fluorouracil-Leucovorin Infusional (Colorectal)',\n 'Fluorouracil-Leucovorin-Oxaliplatin (Gastric-Esophageal)',\n 'Fluorouracil-Mitomycin (Anal Cancer)',\n 'Folic Acid',\n 'Folic Acid, Cyanocobalamin, and Pyridoxine',\n 'Fomepizole',\n 'Fosaprepitant',\n 'Fosaprepitant',\n 'Fosaprepitant',\n 'Foscarnet',\n 'Fosdenopterin',\n 'Fosfomycin',\n 'Fosnetupitant and Palonosetron',\n 'Fosphenytoin',\n 'Fotemustine [INT]',\n 'Furosemide',\n 'Gadobenate Dimeglumine',\n 'Gadobutrol',\n 'Gadodiamide',\n 'Gadofosveset',\n 'Gadopentetate Dimeglumine',\n 'Gadopentetate Dimeglumine',\n 'Gadopentetate Dimeglumine',\n 'Gadopiclenol',\n 'Gadoterate Meglumine',\n 'Gadoteridol',\n 'Gadoteridol',\n 'Gadoteridol',\n 'Gadoversetamide',\n 'Gadoxetate',\n 'Gallium Ga 68 Dotatate',\n 'Gallium Ga 68 Dotatate',\n 'Galsulfase',\n 'Ganciclovir (Ophthalmic)',\n 'Ganciclovir (Systemic)',\n 'Gatifloxacin',\n 'Gemcitabine',\n 'Gemcitabine-Dexamethasone-Carboplatin (Hodgkin)',\n 'Gemcitabine-Vinorelbine (NSCLC)',\n 'GEMOX-R (NHL-DLBCL)',\n 'Gemtuzumab Ozogamicin',\n 'Gentamicin (refer to route-specific monograph)',\n 'Gentamicin (Systemic)',\n 'Glucagon',\n 'Glucagon',\n 'Glucarpidase',\n 'Glutamine',\n 'Glutamine (Patient Education - Natural Products)',\n 'Glutathione',\n 'Glycerin and Lidocaine',\n 'Glycopyrrolate (Oral Inhalation)',\n 'Glycopyrrolate (refer to route-specific monograph)',\n 'Glycopyrrolate (Systemic)',\n 'Glycopyrronium (Topical)',\n 'Golimumab',\n 'Golodirsen',\n 'Granisetron',\n 'Growth Hormone, Serum',\n 'Haloperidol',\n 'Hemin',\n 'Heparin',\n 'Hyaluronidase',\n 'HydrALAZINE',\n 'Hydrocortisone (Systemic)',\n 'Hydrocortisone (Topical)',\n 'HYDROmorphone',\n 'Hydroxocobalamin',\n 'HydrOXYzine',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital',\n 'Ibalizumab',\n 'Ibandronate',\n 'Ibuprofen',\n 'Ibuprofen and Acetaminophen',\n 'Ibuprofen and Acetaminophen',\n 'Ibuprofen and Famotidine',\n 'Ibuprofen and Phenylephrine',\n 'Ibuprofen, Phenylephrine, and Chlorpheniramine',\n 'Ibuprofen, Pseudoephedrine, and Chlorpheniramine',\n 'Ibutilide',\n 'IDArubicin',\n 'IdaruCIZUmab',\n 'Idecabtagene Vicleucel',\n 'Idursulfase',\n 'Ifosfamide',\n 'Imiglucerase',\n 'Imipenem and Cilastatin',\n 'Imipenem and Cilastatin',\n 'Imipenem and Cilastatin',\n 'Imipenem and Cilastatin',\n 'Imipenem, Cilastatin, and Relebactam',\n 'Imipenem, Cilastatin, and Relebactam',\n 'Indigotindisulfonate Sodium',\n 'Indomethacin',\n 'Inebilizumab',\n 'InFLIXimab',\n 'Inotuzumab Ozogamicin',\n 'Insulin (Oral Inhalation)',\n 'Insulin Aspart',\n 'Insulin Aspart Protamine and Insulin Aspart',\n 'Insulin Degludec',\n 'Insulin Degludec and Liraglutide',\n 'Insulin Detemir',\n 'Insulin Glargine',\n 'Insulin Glargine and Lixisenatide',\n 'Insulin Glulisine',\n 'Insulin Glulisine',\n 'Insulin Glulisine',\n 'Insulin Lispro',\n 'Insulin Lispro Protamine and Insulin Lispro',\n 'Insulin NPH',\n 'Insulin NPH (Lexi-Tox)',\n 'Insulin NPH',\n 'Insulin NPH and Insulin Regular',\n 'Insulin NPH and Insulin Regular',\n 'Insulin Regular',\n 'Interferon Alfa-2b',\n 'Iobenguane I 123',\n 'Iobenguane I 131',\n 'Iobitridol (Drug Allergy and Idiosyncratic Reactions)',\n 'Iodinated I 131 Albumin',\n 'Iodine I-125 Human Serum Albumin',\n 'Iodine I-125 Iothalamate',\n 'Iohexol',\n 'Iopamidol',\n 'Iopamidol (Drug Allergy and Idiosyncratic Reactions)',\n 'Iopamidol',\n 'Iothalamate Meglumine',\n 'Ioxitalamate Meglumine (Drug Allergy and Idiosyncratic Reactions)',\n 'Ipilimumab',\n 'Irinotecan (Conventional)',\n 'Irinotecan (Liposomal)',\n 'Irinotecan-Capecitabine (Esophageal Cancer)',\n 'Irinotecan-Fluorouracil-Leucovorin (Esophageal Cancer)',\n 'Irinotecan-Temozolomide (Ewing Sarcoma)',\n 'Iron Dextran Complex',\n 'Iron Sucrose',\n 'Isatuximab',\n 'Isepamicin [INT]',\n 'Isoproterenol',\n 'Isosorbide Dinitrate',\n 'Isosorbide Dinitrate and Hydralazine',\n 'Isosorbide Mononitrate',\n 'Itraconazole',\n 'Ixabepilone',\n 'Ixabepilone',\n 'Kanamycin',\n 'Ketamine',\n 'Ketorolac (Nasal)',\n 'Ketorolac (Ophthalmic)',\n 'Ketorolac (refer to route-specific monograph)',\n 'Ketorolac (Systemic)',\n 'Labetalol',\n 'Lacosamide',\n 'Lamivudine and Zidovudine',\n 'Lansoprazole',\n 'Lansoprazole, Amoxicillin, and Clarithromycin',\n 'Laronidase',\n 'Lefamulin',\n 'Lenograstim [INT]',\n 'Lenvatinib-Pembrolizumab (Endometrial)',\n 'Letermovir',\n 'Leucovorin Calcium',\n 'LevETIRAcetam',\n 'Levobupivacaine (Lexi-Tox)',\n 'Levobupivacaine [INT]',\n 'LevOCARNitine',\n 'LevoFLOXacin (Ophthalmic)',\n 'LevoFLOXacin (Oral Inhalation)',\n 'LevoFLOXacin (refer to route-specific monograph)',\n 'LevoFLOXacin (Systemic)',\n 'LEVOleucovorin',\n 'Levorphanol',\n 'Levosimendan [INT]',\n 'Levothyroxine',\n 'Lidocaine (Ophthalmic)',\n 'Lidocaine (Otic)',\n 'Lidocaine (Systemic)',\n 'Lidocaine (Topical)',\n 'Lidocaine and Chlorhexidine',\n 'Lidocaine and Epinephrine',\n 'Lidocaine and Hydrocortisone',\n 'Lidocaine and Menthol',\n 'Lidocaine and Prilocaine',\n 'Lidocaine and Tetracaine',\n 'Lincomycin',\n 'Linezolid',\n 'Liothyronine',\n 'Lisocabtagene Maraleucel',\n 'Local Anesthetics (Lexi-Tox)',\n 'Loncastuximab Tesirine',\n 'LORazepam',\n 'Lornoxicam (Lexi-Tox)',\n 'Lornoxicam [INT]',\n 'Loteprednol and Tobramycin',\n 'Lurbinectedin',\n 'Lutetium Lu 177 Dotatate',\n 'Lutetium Lu 177 Vipivotide Tetraxetan',\n 'Magnesium Chloride',\n 'Magnesium Sulfate',\n 'Manganese',\n 'Mannitol (Oral Inhalation)',\n 'Mannitol (refer to route-specific monograph)',\n 'Mannitol (Systemic)',\n 'Margetuximab',\n 'Mechlorethamine (Systemic)',\n 'Mechlorethamine (Topical)',\n 'Meloxicam',\n 'Melphalan',\n 'Melphalan',\n 'Melphalan',\n 'Melphalan',\n 'Melphalan Flufenamide',\n 'Melphalan-Prednisone (Multiple Myeloma)',\n 'Melphalan-Prednisone-Thalidomide (Multiple Myeloma)',\n 'Meperidine',\n 'Meperidine and Promethazine',\n 'Mepivacaine',\n 'Mepivacaine',\n 'Mepivacaine',\n 'Mepivacaine and Epinephrine',\n 'Mepivacaine and Levonordefrin',\n 'Meptazinol (Lexi-Tox)',\n 'Meropenem',\n 'Meropenem and Vaborbactam',\n 'Mesna',\n 'Methadone',\n 'Methocarbamol',\n 'Methohexital',\n 'Methotrexate',\n 'Methotrexate-Vinblastine (Soft Tissue Sarcoma)',\n 'Methotrimeprazine',\n 'Methoxy Polyethylene Glycol-Epoetin Beta',\n 'Methylcobalamin',\n 'Methyldopa',\n 'Methyldopa and Hydrochlorothiazide',\n 'Methylene Blue',\n 'Methylergonovine',\n 'Methylfolate, Methylcobalamin, and Acetylcysteine',\n 'Methylfolate, Methylcobalamin, and Acetylcysteine',\n 'MethylPREDNISolone',\n 'Metoclopramide',\n 'Metoprolol',\n 'Metoprolol and Hydrochlorothiazide',\n 'MetroNIDAZOLE (refer to route-specific monograph)',\n 'MetroNIDAZOLE (Systemic)',\n 'MetroNIDAZOLE (Topical)',\n 'Micafungin',\n 'Midazolam',\n 'Milrinone',\n 'Minocycline (Systemic)',\n 'Minocycline (Topical)',\n 'Minocycline Hydrochloride Periodontal Microspheres',\n 'Mirvetuximab Soravtansine',\n 'MitoMYcin (Ophthalmic)',\n 'MitoMYcin (Systemic)',\n 'MitoMYcin (Ureteral Gel)',\n 'Mitomycin Ophthalmic',\n 'MitoXANTRONE',\n 'Mitoxantrone-Etoposide-Cytarabine (AML)',\n 'Mitoxantrone-Prednisone (Prostate)',\n 'Mivacurium  (2)',\n 'Mivacurium',\n 'Mogamulizumab',\n 'Morphine (Systemic)',\n 'Morphine (Systemic)',\n 'Morphine and Naltrexone',\n 'Morphine Sulfate (refer to route-specific monograph)',\n 'Moxetumomab Pasudotox',\n 'Moxifloxacin (Ophthalmic)',\n 'Moxifloxacin (Systemic)',\n 'MT-RNR1 - Kanamycin',\n 'Mycophenolate',\n 'Mycophenolate',\n 'Mycophenolate',\n 'Nafcillin',\n 'Nalbuphine',\n 'Nalmefene',\n 'Naloxone',\n 'Naproxen and Diphenhydramine',\n 'Natalizumab',\n 'Naxitamab',\n 'Necitumumab',\n 'Nelarabine',\n 'Nelarabine',\n 'Neostigmine',\n 'Neostigmine',\n 'Neostigmine',\n 'Neostigmine and Glycopyrrolate',\n 'Neostigmine and Glycopyrrolate',\n 'Nesiritide',\n 'NiCARdipine',\n 'Nicorandil [INT]',\n 'NiMODipine',\n 'Nitroglycerin',\n 'Nitroprusside',\n 'Nivolumab',\n 'Nivolumab and Relatlimab',\n 'Norepinephrine',\n 'Norepinephrine',\n 'Norepinephrine',\n 'Obiltoxaximab',\n 'Obinutuzumab',\n 'Ocrelizumab',\n 'Octreotide',\n 'Octreotide [ANTIDOTE] (Lexi-Tox)',\n 'Ofatumumab',\n 'Ofloxacin (Ophthalmic)',\n 'Ofloxacin (Otic)',\n 'Ofloxacin (Systemic)',\n 'Olaratumab',\n 'Oliceridine',\n 'Olipudase Alfa',\n 'Omadacycline',\n 'Omeprazole',\n 'Omeprazole and Sodium Bicarbonate',\n 'Omeprazole, Amoxicillin, and Rifabutin',\n 'Onasemnogene Abeparvovec',\n 'Ondansetron',\n 'Oritavancin',\n 'Ornidazole [INT]',\n 'Orphenadrine',\n 'Orphenadrine, Aspirin, and Caffeine',\n 'Oxacillin',\n 'Oxaliplatin',\n 'OxyCODONE',\n 'Oxycodone and Acetaminophen',\n 'Oxycodone and Aspirin',\n 'Oxycodone and Ibuprofen',\n 'Oxycodone and Naloxone',\n 'Oxytocin',\n 'Oxytocin and Ergometrine Maleate [INT]',\n 'PACLitaxel (Conventional)',\n 'Paclitaxel (Conventional)-Pembrolizumab (Breast)',\n 'PACLitaxel (Protein Bound)',\n 'Paclitaxel-Ifosfamide-Cisplatin (Penile)',\n 'Pafolacianine',\n 'Palifermin',\n 'Palonosetron',\n 'Pamidronate',\n 'Pantothenic Acid',\n 'Parecoxib [INT]',\n 'Patisiran',\n 'Pegaspargase',\n 'Peginterferon Alfa-2b',\n 'Pegloticase',\n 'Pembrolizumab',\n 'Pembrolizumab',\n 'Pembrolizumab',\n 'PEMEtrexed',\n 'Penicillin G (Parenteral Aqueous)',\n 'Pentazocine and Naloxone',\n 'PENTobarbital',\n 'Pentostatin',\n 'Pentostatin-Cyclophosphamide-Rituximab  (CLL)',\n 'Pertuzumab',\n 'PHENobarbital',\n 'Phenylephrine (Nasal)',\n 'Phenylephrine (Ophthalmic)',\n 'Phenylephrine (Systemic)',\n 'Phenylephrine (Topical)',\n 'Phenylephrine and Ketorolac',\n 'Phenylephrine and Pramoxine',\n 'Phenylephrine and Pyrilamine',\n 'Phenylephrine and Thonzylamine',\n 'Phenytoin',\n 'Phytonadione',\n 'Plasminogen Activator Inhibitor 1 Activity, Plasma',\n 'Plasminogen Activity, Plasma',\n 'Porfimer',\n 'Posaconazole',\n 'Potassium Iodide',\n 'Potassium Phosphate',\n 'Potassium Phosphate and Sodium Phosphate',\n 'PRALAtrexate',\n 'Procainamide',\n 'Prochlorperazine',\n 'Procyclidine',\n 'Proparacaine and Fluorescein',\n 'Propofol',\n 'Propranolol',\n 'Prothrombin Complex Concentrate (Human) [(Factors II, VII, IX, X), Protein C, and Protein S]',\n 'Pseudoephedrine and Ibuprofen',\n 'PyRIDostigmine',\n 'Pyridoxine',\n 'QuiNIDine',\n 'QuiNINE',\n 'Quinupristin and Dalfopristin',\n 'Ramosetron [INT]',\n 'Ramucirumab',\n 'Rasburicase',\n 'Raxibacumab',\n 'Regadenoson',\n 'Remimazolam',\n 'Reslizumab',\n 'RiTUXimab',\n 'RomiDEPsin',\n 'ROPivacaine',\n 'Sacituzumab Govitecan',\n 'Sargramostim',\n 'Sarilumab',\n 'Scopolamine',\n 'Scopolamine',\n 'Scopolamine',\n 'Scopolamine',\n 'Sebelipase Alfa',\n 'Secretin',\n 'Selenium',\n 'Selenium Sulfide',\n 'Selexipag',\n 'Sildenafil',\n 'Siltuximab',\n 'Sincalide',\n 'Sipuleucel-T',\n 'Sirolimus (Conventional)',\n 'Sirolimus (Protein Bound)',\n 'Sirolimus (Topical)',\n 'Smallpox and Monkeypox Vaccine (Live)',\n 'Smallpox Vaccine Live',\n 'Sodium Acetate',\n 'Sodium Bicarbonate',\n 'Sodium Chloride',\n 'Sodium Chloride and Sodium Citrate',\n 'Sodium Glycerophosphate Pentahydrate',\n 'Sodium Iodide I123',\n 'Sodium Nitrite',\n 'Sodium Nitrite and Sodium Thiosulfate',\n 'Sodium Phenylacetate and Sodium Benzoate',\n 'Sodium Phosphates',\n 'Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride',\n 'Sodium Tetradecyl Sulfate',\n 'Sodium Thiosulfate',\n 'Sodium Thiosulfate Calciphylaxis (Facts and Comparisons Off-Label)',\n 'Sotalol',\n 'Sotrovimab',\n 'Spesolimab',\n 'Stanford V (Hodgkin)',\n 'Streptomycin',\n 'Streptozocin',\n 'Streptozocin',\n 'Succinylcholine',\n 'SUFentanil',\n 'Sugammadex',\n 'Sulfamethoxazole and Trimethoprim',\n 'Sutimlimab',\n 'Tacrolimus (refer to route-specific monograph)',\n 'Tacrolimus (Systemic)',\n 'Tacrolimus (Topical)',\n 'Tafasitamab',\n 'Tafasitamab-Lenalidomide (NHL-DLBCL)',\n 'Tagraxofusp',\n 'Taliglucerase Alfa',\n 'Taliglucerase Alfa',\n 'Taliglucerase Alfa',\n 'Tebentafusp',\n 'Technetium Tc 99m Albumin Aggregated',\n 'Tecovirimat',\n 'Tedizolid',\n 'Teicoplanin [INT]',\n 'Telavancin',\n 'Temocillin [INT]',\n 'Temozolomide',\n 'Temozolomide-Rituximab (CNS Lymphoma)',\n 'Temsirolimus',\n 'Tenecteplase',\n 'Teniposide',\n 'Tenoxicam',\n 'Teplizumab',\n 'Teprotumumab',\n 'Terbutaline',\n 'Terlipressin',\n 'Tetracaine (Ophthalmic)',\n 'Tetracaine (Spinal)',\n 'Tetracaine (Topical)',\n 'Theophylline',\n 'Thiamine',\n 'Thiopental (Lexi-Tox)',\n 'Thiopental [INT]',\n 'Thiotepa',\n 'Ticarcillin and Clavulanate Potassium',\n 'Tigecycline',\n 'Tirofiban',\n 'Tiropramide (Lexi-Tox)',\n 'Tisagenlecleucel',\n 'Tisotumab Vedotin',\n 'Tobramycin (Ophthalmic)',\n 'Tobramycin (Oral Inhalation)',\n 'Tobramycin (Systemic)',\n 'Tobramycin and Dexamethasone',\n 'Tocilizumab',\n 'Tolazoline (Lexi-Tox)',\n 'Topotecan',\n 'Trabectedin',\n 'Trabectedin-Doxorubicin (Liposomal) (Ovarian)',\n 'Trace Elements',\n 'TraMADol',\n 'Trandolapril and Verapamil',\n 'Tranexamic Acid',\n 'Tranexamic Acid',\n 'Tranexamic Acid [SUPPORTIVE] (Lexi-Tox)',\n 'Trastuzumab',\n 'Trastuzumab and Hyaluronidase',\n 'Trastuzumab-Cisplatin-Capecitabine (Gastric Cancer)',\n 'Trastuzumab-Vinorelbine (Breast)',\n 'Tremelimumab',\n 'Treosulfan',\n 'Treprostinil',\n 'Tretinoin-Arsenic Trioxide (APL)',\n 'Trilaciclib',\n 'Trimethobenzamide',\n 'Tromethamine',\n 'Tropisetron [INT]',\n 'Urapidil (Lexi-Tox)',\n 'Ustekinumab',\n 'Vaccinia Immune Globulin (Intravenous)',\n 'Valproic Acid and Derivatives',\n 'Vancomycin',\n ...]"
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "titles_filtrated"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-09T14:14:10.986498900Z",
     "start_time": "2023-05-09T14:14:10.900726500Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "outputs": [],
   "source": [
    "df1 = pd.DataFrame()\n",
    "df1['Titles 2'] = titles_filtrated"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-09T14:14:15.203788300Z",
     "start_time": "2023-05-09T14:14:15.174866800Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "outputs": [],
   "source": [
    "df1.to_excel('Titles filteredfdsgsd.xlsx')"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-09T14:14:18.813870600Z",
     "start_time": "2023-05-09T14:14:18.636345600Z"
    }
   }
  },
  {
   "cell_type": "markdown",
   "source": [
    "## Find test names accordingly - Sheet Formulation"
   ],
   "metadata": {
    "collapsed": false
   }
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'Ceftobiprole (Lexi-Drugs)': '{\\n\"Direct antiglobulin (Coombs) test\": \"Positive\",\\n\"Urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n\"Serum/urine creatinine with Jaffé reaction assay\": \"Falsely elevated\"\\n}', 'Irinotecan (Conventional) (Lexi-Drugs)': 'Not available', 'DexAMETHasone (Systemic) (Pediatric and Neonatal Lexi-Drugs)': '{\\n\"Wheal and flare reactions to skin test antigens\": \"May be suppressed\"\\n}', 'Pegaspargase (Lexi-Drugs)': 'Not available', 'Acetylcysteine (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'DOXOrubicin (Conventional) (Lexi-Drugs)': 'Not available', 'Tebentafusp (Lexi-Drugs)': 'Not available', 'Flumazenil (Lexi-Drugs)': 'Not available', 'Diphenhydramine and Phenylephrine (Lexi-Drugs)': 'Not available', 'Acetaminophen and Tramadol (Lexi-Drugs)': 'Not available', 'Glutamine (Lexi-Drugs)': 'Not available', 'Sulfamethoxazole and Trimethoprim (Lexi-Drugs)': '{\\n    \"creatinine (Jaffé alkaline picrate reaction)\": \"Increased\",\\n    \"serum methotrexate (dihydrofolate reductase method)\": \"Increased\"\\n}', 'Omeprazole, Amoxicillin, and Rifabutin (Lexi-Drugs)': '{\\n    \"serum chromogranin A (CgA) levels\": \"falsely elevated (due to decreased gastric acidity with Omeprazole)\",\\n    \"neuroendocrine tumor diagnosis\": \"may cause false-positive results\",\\n    \"CgA levels assessment\": \"≥14 days after treatment is completed\",\\n    \"CgA levels repeat\": \"if initially elevated\"\\n}', 'Crizanlizumab (Lexi-Drugs)': '{\\n    \"automated platelet counts\": \"may interfere (platelet clumping) with Crizanlizumab\",\\n    \"blood samples collection\": \"in tubes containing ethylenediaminetetraacetic acid (EDTA)\",\\n    \"platelet count\": \"may be unevaluable or falsely decreased\",\\n    \"management\": \"Collect blood samples in citrate-containing tubes\",\\n    \"run blood samples\": \"within 4 hours of sample collection\",\\n    \"estimate platelet count\": \"through peripheral blood smear if necessary\"\\n}', 'Nitroglycerin (Lexi-Drugs)': '{\\n    \"triglyceride assays\": \"may be falsely elevated (dependent on glycerol oxidase)\",\\n    \"propylene glycol content\": \"in IV formulation\"\\n}', 'Pentostatin-Cyclophosphamide-Rituximab  (CLL)  (Lexi-Drugs)': 'Not available', 'Phenylephrine and Thonzylamine (Lexi-Drugs)': 'Not available', 'Tranexamic Acid (Lexi-Drugs)': 'Not available', 'Bamlanivimab (Lexi-Drugs)': 'Not available', 'Micafungin (Lexi-Drugs)': 'Not available', 'Tenoxicam (Lexi-Drugs)': 'Not available', 'Darbepoetin Alfa (Lexi-Drugs)': 'Test names: HbA1c.\\nTest results: \\n{\\n \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose\"\\n}', 'Levorphanol (Lexi-Drugs)': 'Not available', 'Antihemophilic Factor/von Willebrand Factor Complex (Human) (Lexi-Drugs)': 'Not available', 'LevoFLOXacin (Ophthalmic) (Lexi-Drugs)': 'Not available', 'MitoMYcin (Systemic) (Lexi-Drugs)': 'Not available', 'Carfilzomib (Lexi-Drugs)': 'Not available', 'Tacrolimus (Systemic) (Lexi-Drugs)': 'Not available', 'Dipyridamole (Lexi-Drugs)': 'Test Names: dipyridamole-thallium myocardial imaging\\n\\nTest Results: {\"dipyridamole-thallium myocardial imaging\": \"false-negative result\"}', 'Azithromycin (Systemic) (Lexi-Drugs)': 'Not available', 'Trace Elements (Lexi-Drugs)': 'Not available', 'Trimethobenzamide (Lexi-Drugs)': 'Not available', 'Tisagenlecleucel (Lexi-Drugs)': '{\"HIV nucleic acid tests\": \"false positive results\"}', 'Ergotamine and Caffeine (Lexi-Drugs)': 'Not available', 'PACLitaxel (Protein Bound) (Lexi-Drugs)': 'Not available', 'Insulin NPH (Lexi-Drugs)': 'Not available', 'Norepinephrine (Lexi-Drugs)': 'Not available', 'von Willebrand Factor (Recombinant) (Lexi-Drugs)': 'Not available', 'Trastuzumab and Hyaluronidase (Lexi-Drugs)': 'Not available', 'Bevacizumab (Lexi-Drugs)': 'Not available', 'Imipenem and Cilastatin (Infectious Diseases)': '{\\n  \"Urinary Glucose Determination (Clinitest)\": \"Interferes\",\\n  \"Coombs\\' Test (Direct)\": \"Positive\"\\n}', 'Isosorbide Dinitrate (Lexi-Drugs)': 'Not available', 'Iobenguane I 123 (Lexi-Drugs)': 'Not available', 'Meropenem (Lexi-Drugs)': '{\"Coombs\\' [direct]\": \"Positive\"}', 'DOPamine (Lexi-Drugs)': 'Not available', 'CycloSPORINE (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Lefamulin (Lexi-Drugs)': 'Not available', 'CycloPHOSphamide (Lexi-Drugs)': 'Not available', 'Nelarabine (Lexi-Drugs)': 'Not available', 'Ferric Derisomaltose (Lexi-Drugs)': 'Not available', 'Gemtuzumab Ozogamicin (Lexi-Drugs)': 'Not available', 'Cefuroxime (Geriatric Lexi-Drugs)': '{\"direct Coombs\": \"positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"false-positive\"}', 'Factor IX Complex (Human) [(Factors II, IX, X)] (Lexi-Drugs)': 'Not available', 'Cemiplimab (Lexi-Drugs)': 'Not available', 'Aprepitant (Lexi-Drugs)': 'Not available', 'Thiotepa (Lexi-Drugs)': 'Not available', 'Vonoprazan, Amoxicillin, and Clarithromycin (Lexi-Drugs)': 'Not available', 'Anidulafungin (Lexi-Drugs)': 'Not available', 'Gadobenate Dimeglumine (Lexi-Drugs)': '{\\n   \"serum ferritin\": \"transient increase\",\\n   \"urine zinc\": \"transient increase (with renal disease)\",\\n   \"bilirubin\": \"transient increase (with hepatic metabolic disorders)\"\\n}', 'Pembrolizumab (Geriatric Lexi-Drugs)': 'Not available', 'Antihemophilic Factor (Recombinant [Fc Fusion Protein]) (Lexi-Drugs)': 'Not available', 'Vedolizumab (Lexi-Drugs)': 'Not available', 'Chloramphenicol (Systemic) (Lexi-Drugs)': 'Not available', 'Clevidipine (Lexi-Drugs)': '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}', 'Bebtelovimab (Lexi-Drugs)': 'Not available', 'Erythromycin and Benzoyl Peroxide (Lexi-Drugs)': 'Not available', 'Trastuzumab-Vinorelbine (Breast) (Lexi-Drugs)': 'Not available', 'DiphenhydrAMINE (Systemic) (Lexi-Drugs)': '{\\n   \"urine detection of methadone\": \"false-positives\",\\n   \"urine detection of phencyclidine\": \"false-positives\",\\n   \"serum TCA screen\": \"false-positive\",\\n   \"wheal and flare reactions to skin test antigens\": \"suppressed\"\\n}', 'Betamethasone (Topical) (Lexi-Drugs)': 'Medical Test Name: \\n1. Skin test antigens \\n\\nJSON Form: \\n{\\n   \"Skin test antigens\": \"suppressed wheal and flare reactions\"\\n}', 'Dexrazoxane (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Sotrovimab (Lexi-Drugs)': 'Not available', 'BChE - Mivacurium (Pharmacogenomics)': 'Not available', 'Benzyl Alcohol (Lexi-Drugs)': 'Not available', 'Ferric Gluconate (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"Serum or transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric gluconate administration\",\\n  \"Serum ferritin levels\": \"falsely elevated for 5 days after ferric gluconate administration\"\\n}', 'Siltuximab (Lexi-Drugs)': 'Not available', 'Selenium (Lexi-Drugs)': 'Not available', 'Palonosetron (Lexi-Drugs)': 'Not available', 'Fluorouracil and Salicylic Acid (Lexi-Drugs)': 'Not available', 'VinCRIStine (Lexi-Drugs)': 'Not available', 'Octreotide [ANTIDOTE] (Lexi-Tox)': 'Not available', 'VinBLAStine (Lexi-Drugs)': 'Not available', 'Carboplatin-Paclitaxel-Trastuzumab (Breast) (Lexi-Drugs)': 'Not available', 'Vitamin B Complex Combinations (Lexi-Drugs)': 'Not available', 'Lidocaine (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Insulin Aspart (Lexi-Drugs)': 'Not available', 'Iothalamate Meglumine (Lexi-Drugs)': '{\\n   \"thyroid function tests dependent on iodine estimation\": \"altered results\",\\n   \"radioiodine uptake studies\": \"affected results\"\\n}', 'Insulin Regular (Lexi-Drugs)': 'Not available', 'Treprostinil (Lexi-Drugs)': 'Not available', 'Cefotaxime (Lexi-Drugs)': '{\\n   \"direct Coombs\\' test\": \"positive\",\\n   \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"false-positive\",\\n   \"serum creatinine with Jaffé reaction\": \"false-positive\",\\n   \"urine creatinine with Jaffé reaction\": \"false-positive\"\\n}', 'Dantrolene (Lexi-Drugs)': 'Not available', 'Gemcitabine-Vinorelbine (NSCLC) (Lexi-Drugs)': 'Not available', 'Durvalumab (Lexi-Drugs)': 'Not available', 'Brivaracetam (Lexi-Drugs)': 'Not available', 'Amifostine (Lexi-Drugs)': 'Not available', 'Capreomycin (Lexi-Drugs)': 'Not available', 'Neostigmine (Lexi-Drugs)': 'Not available', 'Emapalumab (Lexi-Drugs)': 'Not available', 'Ketamine (Lexi-Drugs)': 'Test Names: \\n1. Urine test for phencyclidine\\n\\nTest Results: \\n{\\n   \"Urine test for phencyclidine\": \"false-positive interference may occur\"\\n}', 'Zinc Chloride (Lexi-Drugs)': 'Not available', 'Fosaprepitant (Geriatric Lexi-Drugs)': 'Not available', 'Imipenem and Cilastatin (Geriatric Lexi-Drugs)': '{\\n   \"Clinitest®\": \"interfered with urinary glucose determination\",\\n   \"Coombs\\' [direct]\": \"positive\"\\n}', 'DimenhyDRINATE (Lexi-Drugs)': 'Not available', 'Anti-inhibitor Coagulant Complex (Human) (Lexi-Drugs)': '{\\n   \"blood group isohemagglutinins\": \"presence\",\\n   \"Coombs test\": \"may be interfered with due to passive transmission of antibodies to erythrocyte antigens\"\\n}', 'Calcitriol (Topical) (Lexi-Drugs)': 'Not available', 'Margetuximab (Lexi-Drugs)': 'Not available', 'Alfentanil (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Mycophenolate (Lexi-Drugs)': 'Not available', 'Decitabine (Lexi-Drugs)': 'Not available', 'Ferric Gluconate (Lexi-Drugs)': 'Test Names: \\n1. Serum or transferrin bound iron levels \\n2. Serum ferritin levels \\n\\nTest Results:\\n1. {\"Serum or transferrin bound iron levels\": \"May be falsely elevated if assessed within 24 hours of ferric gluconate administration.\"}\\n2. {\"Serum ferritin levels\": \"May be falsely elevated for 5 days after ferric gluconate administration.\"}', 'RomiDEPsin (Lexi-Drugs)': 'Not available', 'Olipudase Alfa (Lexi-Drugs)': 'Not available', 'Brexanolone (Lexi-Drugs)': 'Not available', 'Clindamycin (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Lamivudine and Zidovudine (Lexi-Drugs)': 'Not available', 'Cefuroxime (Lexi-Drugs)': '{\"direct Coombs\\'\": \"Positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\", \"ferricyanide test\": \"False-negative\"}', 'Sodium Phosphates (Lexi-Drugs)': 'Not available', 'Amisulpride (Injection) (Lexi-Drugs)': 'Not available', 'Ofloxacin (Otic) (Lexi-Drugs)': 'Not available', 'Peginterferon Alfa-2b (Lexi-Drugs)': 'Not available', 'Succinylcholine (Lexi-Drugs)': 'Not available', 'DiazePAM (Lexi-Drugs)': 'Test names: \\n- Urinary glucose determination \\n\\nTest Results in JSON format:\\n{\\n   \"Urinary glucose determination\": \"False-negative when using Clinistix® or Diastix®\"\\n}', 'Ibuprofen and Famotidine (Lexi-Drugs)': 'Not available', 'Granisetron (Lexi-Drugs)': 'Not available', 'Mepivacaine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Clofarabine (Lexi-Drugs)': 'Not available', 'Buprenorphine (Lexi-Drugs)': 'Not available', 'Inebilizumab (Lexi-Drugs)': 'Not available', 'Cabazitaxel (Lexi-Drugs)': 'Not available', 'Propofol (Lexi-Drugs)': 'Not available', 'Sirolimus (Conventional) (Lexi-Drugs)': 'Not available', 'Phenylephrine and Pramoxine (Lexi-Drugs)': 'Not available', 'Secretin (Lexi-Drugs)': 'Not available', 'Insulin Lispro (Lexi-Drugs)': 'Not available', 'Melphalan (Pharmacogenomics)': 'Not available', 'Insulin NPH and Insulin Regular (Lexi-Drugs)': 'Not available', 'Hydroxocobalamin (Lexi-Drugs)': 'Medical test names: Basophils, hemoglobin, MCH, MCHC, albumin, alkaline phosphatase, cholesterol, creatinine, glucose, total protein, triglycerides, bilirubin, urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite), ALT, amylase, AST, CK, CKMB, LDH, phosphate, uric acid, PT, aPTT, urine pH.\\n\\nJSON form:\\n{\\n  \"Basophils\": \"Falsely elevated\",\\n  \"Hemoglobin\": \"Falsely elevated\",\\n  \"MCH\": \"Falsely elevated\",\\n  \"MCHC\": \"Falsely elevated\",\\n  \"Albumin\": \"Falsely elevated\",\\n  \"Alkaline phosphatase\": \"Falsely elevated\",\\n  \"Cholesterol\": \"Falsely elevated\",\\n  \"Creatinine\": \"Falsely elevated\",\\n  \"Glucose\": \"Falsely elevated\",\\n  \"Total protein\": \"Falsely elevated\",\\n  \"Triglycerides\": \"Falsely elevated\",\\n  \"Bilirubin\": \"Falsely elevated\",\\n  \"Urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite)\": \"Falsely elevated\",\\n  \"ALT\": \"Falsely decreased\",\\n  \"Amylase\": \"Falsely decreased\",\\n  \"AST\": \"Unpredictable\",\\n  \"CK\": \"Unpredictable\",\\n  \"CKMB\": \"Unpredictable\",\\n  \"LDH\": \"Unpredictable\",\\n  \"Phosphate\": \"Unpredictable\",\\n  \"Uric acid\": \"Unpredictable\",\\n  \"PT\": \"Unpredictable\",\\n  \"aPTT\": \"Unpredictable\",\\n  \"Urine pH\": \"Unpredictable\"\\n}', 'Voriconazole (Lexi-Drugs)': 'Not available', 'Botulism Antitoxin, Heptavalent (Lexi-Drugs)': 'Medical test name: Blood glucose\\n\\nJSON form:\\n{\\n  \"Blood glucose\": \"falsely elevated\"\\n}', 'Cefuroxime (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Cefepime (Lexi-Drugs)': '{\\n \"Positive direct Coombs\": true,\\n \"Urinary glucose test using cupric sulfate (Benedict\\'s solution)\": false,\\n \"Urinary glucose test using Clinitest\": false,\\n \"Urinary glucose test using Fehling\\'s solution\": false,\\n \"Serum or urine creatinine with Jaffé reaction\": false,\\n \"Urinary proteins\": false,\\n \"Urinary steroids\": false\\n}', 'Ferric Carboxymaltose (Pediatric and Neonatal Lexi-Drugs)': '{\\n \"Serum iron levels\": \"falsely elevated\",\\n \"Transferrin bound iron levels\": \"falsely elevated\"\\n}', 'Imipenem, Cilastatin, and Relebactam (Lexi-Drugs)': '{\\n \"Coombs test\": \"Positive\"\\n}', 'Ceftolozane and Tazobactam (Infectious Diseases)': 'Not available', 'Sirolimus (Topical) (Lexi-Drugs)': 'Not available', 'Epoetin Alfa (Lexi-Drugs)': '{\\n  \"HbA1c\": \"artificially lowered\"\\n}', 'Zidovudine (Lexi-Drugs)': 'Not available', 'Ertapenem (Lexi-Drugs)': 'Not available', 'Oxytocin (Lexi-Drugs)': 'Not available', 'Factor IX (Recombinant [Glycopegylated]) (Lexi-Drugs)': 'Not available', 'Gadoteridol (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Levothyroxine (Lexi-Drugs)': '1. T4-binding globulin (TBG)\\n{\\n  \"Conditions/states that increase TBG binding\": \"Pregnancy, hepatitis, porphyria, neonatal state\",\\n  \"Medications that increase TBG binding\": \"Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\",\\n  \"Conditions/states that decrease TBG binding\": \"Hepatic failure, nephrosis, severe illness.\",\\n  \"Medications that decrease TBG binding\": \"Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\"\\n}\\n\\n2. Thyroxine (T4) and triiodothyronine (T3)\\n{\\n  \"Medications that inhibit T4 and T3 binding\": \"Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\"\\n}\\n\\n3. Thyroid gland hormone: Interference with production and secretion\\n{\\n  \"Medications affecting iodine uptake\": \"Amiodarone, iodinated contrast agents, iodine, ethionamide\",\\n  \"Medications affecting hormone production\": \"Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\",\\n  \"Medications affecting secretion\": \"Amiodarone, iodinated contrast agents, iodine, lithium\",\\n  \"Medications inducing thyroiditis\": \"Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\",\\n  \"Medications potentially causing the development of Graves’\": \"Alemtuzumab, interferon alpha, antiretroviral therapy\",\\n  \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’\": \"Glucocorticoids\"\\n}\\n\\n4. Hypothalamic-pituitary axis and TSH: Interference with secretion\\n{\\n  \"Medications decreasing TSH secretion\": \"Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\",\\n  \"Medications increasing TSH secretion\": \"Amphetamine, interleukin 2, metoclopramide, ritonavir, St John\\'s wort\",\\n  \"Medications potentially causing hypophysitis\": \"Ipilimumab\"\\n}', 'Tedizolid (Lexi-Drugs)': 'Not available', 'ALfentanil (Lexi-Drugs)': 'Not available', 'Idecabtagene Vicleucel (Lexi-Drugs)': 'Not available', 'Iopamidol (Lexi-Drugs)': '{\"iodine-binding capacity\": \"reduced for up to 2 weeks following administration of contrast media\", \\n\"diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results\": \"not affected (eg, T3 resin uptake, thyroxine assays)\"}', 'Methohexital (Lexi-Drugs)': 'Not available', 'Amantadine (Lexi-Drugs)': '{\\n  \"Urine test for amphetamines/methamphetamines\": \"May interfere with detection (false-positive)\"\\n}', 'Chlorothiazide (Lexi-Drugs)': '{\\n  \"Parathyroid function tests\": \"may be interfered with\",\\n  \"Aldosterone/renin ratio (ARR) test\": \"may give a false-negative result\"\\n}', 'Gemcitabine (Lexi-Drugs)': 'Not available', 'Ciprofloxacin (Otic) (Lexi-Drugs)': 'Not available', 'Bevacizumab-Carboplatin-Paclitaxel (Ovarian) (Lexi-Drugs)': 'Not available', 'Avalglucosidase Alfa (Lexi-Drugs)': 'Not available', 'Liothyronine (Lexi-Drugs)': 'Test names: T4-binding globulin (TBG), Thyroxine (T4), Triiodothyronine (T3), Thyroid gland hormone, Hypothalamic-pituitary axis and TSH\\n\\nTest results as JSON:\\n\\n{\\n  \"TBG\": {\\n    \"Conditions/Staes that increase TBG binding\": [\"Pregnancy\", \"hepatitis\", \"porphyria\", \"neonatal state\"],\\n    \"Medications that increase TBG binding\": [\"Estrogens\", \"5-fluorouracil\", \"heroin\", \"methadone\", \"mitotane\", \"perphenazine\", \"selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\"],\\n    \"Conditions/states that decrease TBG binding\": [\"Hepatic failure\", \"nephrosis\", \"severe illness\"],\\n    \"Medications that decrease TBG binding\": [\"Androgens\", \"anabolic steroids\", \"glucocorticoids\", \"L-asparaginase\", \"nicotinic acid\"]\\n  },\\n  \"T4\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"T3\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"Thyroid gland hormone\": {\\n    \"Medications affecting iodine uptake\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"ethionamide\"],\\n    \"Medications affecting hormone production\": [\"Amiodarone\", \"ethionamide\", \"iodinated contrast agents\", \"iodine\", \"sulfonylureas\", \"sulfonamides\", \"thionamides (carbimazole, methimazole, propylthiouracil)\"],\\n    \"Medications affecting secretion\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"lithium\"],\\n    \"Medications inducing thyroiditis\": [\"Alemtuzumab\", \"amiodarone\", \"antiangiogenic agents (lenalidomide, thalidomide)\", \"denileukin diftitox\", \"interferon alpha\", \"interleukins\", \"lithium\", \"tyrosine kinase inhibitors (sunitinib, sorafenib)\"],\\n    \"Medications potentially causing the development of Graves’\": [\"Alemtuzumab\", \"interferon alpha\", \"antiretroviral therapy\"],\\n    \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves\\'\": [\"Glucocorticoids\"]\\n  },\\n  \"TSH\": {\\n    \"Medications decreasing TSH secretion\": [\"Bexarotene\", \"dopamine\", \"dopaminergic agonists (bromocriptine, cabergoline)\", \"glucocorticoids\", \"interleukin-6\", \"metformin\", \"opiates\", \"somatostatin analogues (octreotide, lanreotide)\", \"thyroid hormone analogues\"],\\n    \"Medications increasing TSH secretion\": [\"Amphetamine\", \"interleukin 2\", \"metoclopramide\", \"ritonavir\", \"St John\\'s wort\"],\\n    \"Medications potentially causing hypophysitis\": [\"Ipilimumab\"]\\n  }\\n}', 'Pembrolizumab (Lexi-Drugs)': 'Not available', 'Bevacizumab FOLFOX (Colorectal) (Lexi-Drugs)': 'Not available', 'Daunorubicin and Cytarabine (Liposomal) (Lexi-Drugs)': 'Not available', 'Clindamycin (Topical) (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Isosorbide Dinitrate and Hydralazine (Lexi-Drugs)': 'Not available', 'Lidocaine and Hydrocortisone (Lexi-Drugs)': 'Not available', 'Ganciclovir (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Clot Dissolving Drugs for Heart Attack or Stroke (Patient Education - Disease and Procedure)': 'Not available', 'Eteplirsen (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Gentamicin (Systemic) (Lexi-Drugs)': 'Test Names: None mentioned\\n\\nTest Results: None mentioned', 'Ascorbic Acid (Pediatric and Neonatal Lexi-Drugs)': 'Test Names: \\n- Stool occult blood test\\n- Blood glucose testing\\n- Urine glucose testing\\n- Nitrite level testing\\n- Bilirubin level testing\\n- Leucocyte count testing\\n\\nTest Results: \\n- Stool occult blood: False negative 48 to 72 hours after ascorbic acid ingestion\\n- Blood glucose: Falsely elevated glucose measurements by point of care glucometers with high-dose ascorbic acid\\n- Urine glucose: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Nitrite level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Bilirubin level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Leucocyte count: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion', 'Doxapram (Lexi-Drugs)': 'Not available', 'Taliglucerase Alfa (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Dolasetron (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Omadacycline (Lexi-Drugs)': 'Not available', 'Belatacept (Lexi-Drugs)': 'Not available', 'Scopolamine (Geriatric Lexi-Drugs)': 'Test name: Interferes with gastric secretion test\\nTest result: Transdermal system should be discontinued ≥10 days prior to testing.\\n\\nJSON format: {\"Interferes with gastric secretion test\": \"Transdermal system should be discontinued ≥10 days prior to testing.\"}', 'Vancomycin (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Ampicillin and Sulbactam (Lexi-Drugs)': 'Test name: Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\\nTest result: May interfere\\n\\nTest name: Aminoglycoside serum concentration\\nTest result: Potential underestimation due to the acceleration of degradation by some penicillin derivatives\\n\\nJSON format: {\"Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\": \"May interfere\", \"Aminoglycoside serum concentration\": \"Potential underestimation due to the acceleration of degradation by some penicillin derivatives\"}', 'Buprenorphine and Naloxone (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Lidocaine (Otic) (Lexi-Drugs)': 'Not available', 'BUPivacaine (Lexi-Drugs)': 'Not available', 'Growth Hormone, Serum (Lab Tests and Diagnostic Procedures)': 'Not available', 'Technetium Tc 99m Albumin Aggregated (Lexi-Drugs)': 'Not available', 'Tetracaine (Spinal) (Lexi-Drugs)': 'Not available', 'Dexrazoxane (Lexi-Drugs)': 'Not available', 'Mepivacaine (Pharmacogenomics)': 'Not available', 'Erythromycin (Topical) (Lexi-Drugs)': 'Not available', 'Ciprofloxacin (Ophthalmic) (Lexi-Drugs)': 'Not available', 'CARBOplatin (Lexi-Drugs)': 'Not available', 'Basiliximab (Lexi-Drugs)': 'Not available', 'Tromethamine (Lexi-Drugs)': 'Not available', 'Alprostadil (Lexi-Drugs)': 'Not available', 'Aztreonam (Oral Inhalation) (Infectious Diseases)': 'Not available', 'Ferric Carboxymaltose (Geriatric Lexi-Drugs)': 'Test names: \\n1. Serum iron levels\\n2. Transferrin bound iron levels\\n\\nTest results in JSON format:\\n{\\n  \"Serum iron levels\": \"not specified\",\\n  \"Transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}', 'Gadoteridol (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Methotrimeprazine (Lexi-Drugs)': 'Test Names: Pregnancy test\\nTest Results: False-positive or false-negative', 'Morphine (Systemic) (Lexi-Drugs)': '{\"opioid screening\": \"false-positive result\"}', 'Sodium Acetate (Lexi-Drugs)': 'Not available', 'Topotecan (Lexi-Drugs)': 'Not available', 'MetroNIDAZOLE (Topical) (Lexi-Drugs)': 'Not available', 'Edrophonium and Atropine (Lexi-Drugs)': 'Not available', 'Tranexamic Acid (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Ciprofloxacin and Dexamethasone (Lexi-Drugs)': 'Not available', 'Verapamil (Lexi-Drugs)': '{\"Urine detection of methadone\": \"false-positive\"}', 'Melphalan (Pediatric and Neonatal Lexi-Drugs)': '{\"Coombs\\' test [direct]\": \"false-positive\"}', 'PACLitaxel (Conventional) (Lexi-Drugs)': 'Not available', 'Methyldopa (Lexi-Drugs)': '{\\n  \"urinary uric acid (phosphotungstate method)\": \"interference by Methyldopa\",\\n  \"serum creatinine (alkaline picrate method)\": \"interference by Methyldopa\",\\n  \"AST (colorimetric method)\": \"interference by Methyldopa\",\\n  \"urinary catecholamines (falsely high levels)\": \"interference by Methyldopa\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive by Methyldopa\"\\n}', 'Ciprofloxacin (Systemic) (Lexi-Drugs)': '{\\n \"levofloxacin\": \"false-positive urine screening result for opioids\",\\n \"ofloxacin\": \"false-positive urine screening result for opioids\",\\n \"other quinolones\": \"cross-reactivity in certain assay kits\"\\n}', 'Ambroxol [INT] (Lexi-Drugs International [Concise])': 'Not available', 'Aducanumab (Lexi-Drugs)': 'Not available', 'Magnesium Chloride (Lexi-Drugs)': 'Not available', 'Taliglucerase Alfa (Lexi-Drugs)': 'Not available', 'RiTUXimab (Lexi-Drugs)': 'Not available', 'Cetirizine and Pseudoephedrine (Lexi-Drugs)': 'Not available', 'Clindamycin and Tretinoin (Lexi-Drugs)': 'Not available', 'Erythromycin (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Neostigmine (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Nesiritide (Lexi-Drugs)': 'Not available', 'Aminophylline (Lexi-Drugs)': 'Test names: \\n- Plasma glucose\\n- Uric acid\\n- Free fatty acids\\n- Total cholesterol\\n- HDL\\n- HDL/LDL ratio\\n- Urinary free cortisol excretion\\n- Triiodothyronine\\n\\nJSON format: \\n{\\n\"Plasma glucose\": <test result>,\\n\"Uric acid\": <test result>,\\n\"Free fatty acids\": <test result>,\\n\"Total cholesterol\": <test result>,\\n\"HDL\": <test result>,\\n\"HDL/LDL ratio\": <test result>,\\n\"Urinary free cortisol excretion\": <test result>,\\n\"Triiodothyronine\": <test result>\\n}', 'NaN': 'Not available', 'Edaravone (Lexi-Drugs)': 'Not available', 'Factor IX (Recombinant [Fc Fusion Protein]) (Lexi-Drugs)': 'Not available', 'Conivaptan (Lexi-Drugs)': 'Not available', 'Glucagon (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'MitoMYcin (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Alteplase (Lexi-Drugs)': '{\"coagulation\": \"Altered\", \"fibrinolytic activity\": \"Altered\"}', 'Remimazolam (Lexi-Drugs)': 'Not available', 'Sodium Nitrite and Sodium Thiosulfate (Lexi-Drugs)': 'Not available', 'Nelarabine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Plasminogen Activator Inhibitor 1 Activity, Plasma (Lab Tests and Diagnostic Procedures)': 'Not available', 'Fludarabine-Cyclophosphamide-Rituximab  (CLL) (Lexi-Drugs)': 'Not available', 'DiphenhydrAMINE (Topical) (Lexi-Drugs)': '{\\n\"skin test antigens\": \"suppressed\"\\n}', 'Ganciclovir (Systemic) (Lexi-Drugs)': 'Not available', 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Geriatric Lexi-Drugs)': 'Not available', 'Fenoldopam (Lexi-Drugs)': 'Not available', 'Temsirolimus (Lexi-Drugs)': 'Not available', 'Ceftazidime and Avibactam (Lexi-Drugs)': '{\\n  \"Ceftazidime\": \"Positive direct Coomb\",\\n  \"Urine glucose\": \"False-positive with certain methods; use glucose tests based on enzymatic glucose oxidase reactions\"\\n}', 'Gadodiamide (Lexi-Drugs)': '{\\n  \"Serum Iron\": \"Transitory changes observed\",\\n  \"Serum Calcium\": \"May interfere with colorimetric tests; alternate testing method recommended for 12-24 hours after administration\"\\n}', 'Antivenin (Latrodectus mactans) (Lexi-Drugs)': 'Not available', 'Erythromycin (Systemic) (Lexi-Drugs)': '{\\n  \"Urinary Catecholamines\": \"False-positive (fluorometric assay)\",\\n  \"17-hydroxycorticosteroids\": \"False-positive\",\\n  \"17-ketosteroids\": \"False-positive\"\\n}', 'Cetirizine (Systemic) (Lexi-Drugs)': 'Test names: \\n1. Serum TCA screen\\n2. Skin test antigens\\n\\nTest results:\\n1. False-positive\\n2. Suppressed wheal and flare reactions', 'Moxifloxacin (Ophthalmic) (Lexi-Drugs)': 'Not available', 'CloNIDine (Lexi-Drugs)': \"Test names: \\n1. Coombs' test\\n2. Aldosterone/renin ratio\\n\\nTest results:\\n1. Positive\\n2. False-positive\", 'Ofatumumab (Lexi-Drugs)': 'Not available', 'InFLIXimab (Lexi-Drugs)': 'Not available', 'Dolasetron (Lexi-Drugs)': 'Not available', 'Ferumoxytol (Lexi-Drugs)': 'Test Names: \\n1. MR imaging \\n2. Serum Iron \\n3. Transferrin-bound Iron \\n\\nCorresponding Test Results in JSON:\\n{\\n  \"MR imaging\": \"May interfere with imaging; alterations may persist for ≤3 months following use, with peak alterations anticipated in the first 2 days following administration. If MR imaging is required within 3 months after administration, use T1- or proton density-weighted MR pulse sequences to decrease effect on imaging. Do not use T2-weighted sequence MR imaging prior to 4 weeks following administration.\",\\n  \"Serum Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\",\\n  \"Transferrin-bound Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\"\\n}', 'Anthrax Immune Globulin (Human) (Pediatric and Neonatal Lexi-Drugs)': 'Test Names: \\n1. Blood glucose levels\\n2. Serologic testing results\\n3. Direct Coombs\\' test\\n4. Indirect Coombs\\' test\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Blood glucose levels\": \"Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\",\\n  \"Serologic testing results\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Direct Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Indirect Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\"\\n}', 'Omeprazole (Lexi-Drugs)': 'Test Names: \\n1. Serum chromogranin A (CgA) levels\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Serum chromogranin A (CgA) levels\": \"Omeprazole may falsely elevate CgA levels, causing false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\"\\n}', 'Raxibacumab (Lexi-Drugs)': 'Not available', 'Sarilumab (Lexi-Drugs)': 'Not available', 'Streptozocin (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Ceftaroline Fosamil (Lexi-Drugs)': 'Not available', 'Casimersen (Lexi-Drugs)': '{\\n\"Medical Test Name\": \"Detection of urine protein\",\\n\"Test Result\": \"False positive when pyrogallol red reagent is used\"\\n}', 'Oxycodone and Acetaminophen (Lexi-Drugs)': 'Not available', 'Fluorouracil (Topical) (Lexi-Drugs)': 'Not available', 'Ibutilide (Lexi-Drugs)': 'Not available', 'Elosulfase Alfa (Lexi-Drugs)': 'Not available', 'Ceftolozane and Tazobactam (Lexi-Drugs)': 'Not available', 'Fludarabine (Lexi-Drugs)': 'Not available', 'Meperidine (Lexi-Drugs)': '{\\n  \"amylase\": \"increased\",\\n  \"BSP retention\": \"increased\",\\n  \"CPK\": \"increased\"\\n}', 'Fluorescein and Benoxinate (Lexi-Drugs)': 'Not available', 'Sugammadex (Lexi-Drugs)': '{\\n  \"serum progesterone assay\": \"may interfere\",\\n  \"interaction\": \"may be observed\"\\n}', 'Streptozocin (Lexi-Drugs)': 'Not available', 'Etoposide Phosphate (Lexi-Drugs)': 'Not available', 'Propranolol (Lexi-Drugs)': '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}', 'Mannitol (Systemic) (Lexi-Drugs)': '{\\n  \"blood ethylene glycol concentrations\": \"false positive\",\\n  \"inorganic phosphorus blood concentrations\": \"false low\"\\n}', 'Scopolamine (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"gastric secretion test\": \"interference\"\\n}', 'Treosulfan (Lexi-Drugs)': 'Not available', 'Vindesine (Lexi-Drugs)': 'Not available', 'Sincalide (Lexi-Drugs)': 'Not available', 'Phenylephrine (Systemic) (Lexi-Drugs)': 'Not available', 'Famotidine (Lexi-Drugs)': 'Not available', 'Methylcobalamin (Natural Products Database)': 'Not available', 'Desmopressin (Lexi-Drugs)': 'Not available', 'Eptinezumab (Lexi-Drugs)': 'Not available', 'Antihemophilic Factor (Recombinant [Fc-VWF-XTEN Fusion Protein]) (Lexi-Drugs)': 'Not available', 'Buprenorphine and Naloxone (Lexi-Drugs)': 'Not available', 'Gadopentetate Dimeglumine (Lexi-Drugs)': 'Not available', 'DOBUTamine (Lexi-Drugs)': 'Not available', 'Filgrastim (Lexi-Drugs)': '{\\n  \"Bone imaging studies\": \"May interfere with\",\\n  \"Hematopoietic activity\": \"increased\",\\n  \"Bone marrow\": \"May appear as transient positive bone imaging changes.\"\\n}', 'Furosemide (Lexi-Drugs)': '{\\n  \"Medical test names\": [\\n    \"Aldosterone/renin ratio (ARR)\"\\n  ],\\n  \"Test results\": [\\n    \"False-negative\"\\n  ]\\n}', 'Aztreonam (Systemic) (Geriatric Lexi-Drugs)': '{\"urine glucose\": \"may interfere with tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}', 'Atenolol (Lexi-Drugs)': '{\"glucose\": \"increased\", \"HDL\": \"decreased\", \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"}', 'Mepivacaine and Levonordefrin (Lexi-Drugs)': 'Not available', 'Antihemophilic Factor (Recombinant [Pegylated]) (Lexi-Drugs)': 'Not available', 'CeFAZolin (Lexi-Drugs)': 'Test names and their respective results:\\n\\n1. Direct and Indirect Coombs\\' - Positive \\n2. Urinary glucose test using Benedict\\'s copper reduction reaction - False-Positive \\n3. Serum or urine creatinine with Jaffé reaction - False-Positive \\n4. Aminoglycoside serum concentration - Potentially underestimated \\n\\nJSON format:\\n\\n{\\n   \"Direct and Indirect Coombs\\'\": \"Positive\",\\n   \"Urinary glucose test using Benedict\\'s copper reduction reaction\": \"False-Positive\",\\n   \"Serum or urine creatinine with Jaffé reaction\": \"False-Positive\",\\n   \"Aminoglycoside serum concentration\": \"Potentially underestimated\"\\n}', 'IdaruCIZUmab (Lexi-Drugs)': 'Not available', 'Bendamustine (Lexi-Drugs)': 'Not available', 'Meperidine and Promethazine (Lexi-Drugs)': 'Not available', 'Butorphanol (Lexi-Drugs)': 'Not available', 'Aztreonam (Systemic) (Infectious Diseases)': '{\"urine glucose test\": \"may interfere with containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}', 'Ciprofloxacin and Hydrocortisone (Lexi-Drugs)': 'Not available', 'Levobupivacaine [INT] (Lexi-Drugs International [Concise])': 'Not available', 'Aztreonam (Systemic) (Lexi-Drugs)': 'Test Names:\\n\\n1. Urine glucose test containing cupric sulfate\\n2. Coombs\\' test\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Urine glucose test containing cupric sulfate\": \"May interfere\",\\n  \"Coombs\\' test\": \"Positive\"\\n}', 'Bumetanide (Lexi-Drugs)': 'Test Names:\\n\\n1. Aldosterone/renin ratio (ARR)\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Aldosterone/renin ratio (ARR)\": \"May lead to false-negative\"\\n}', 'IDArubicin (Lexi-Drugs)': 'Not available', 'Tenecteplase (Lexi-Drugs)': '{\"coagulation\": \"Altered results\", \"fibrinolytic activity\": \"Altered results\"}', 'Caspofungin (Lexi-Drugs)': 'Not available', 'Anifrolumab (Lexi-Drugs)': 'Not available', 'Clevidipine (Geriatric Lexi-Drugs)': '{\"aldosterone/renin ratio\": \"false-negative\", \"ARR\": \"false-negative\"}', 'Copanlisib (Lexi-Drugs)': 'Not available', 'Ketorolac (Nasal) (Lexi-Drugs)': 'Not available', 'Antihemophilic Factor (Recombinant) (Lexi-Drugs)': 'Not available', 'Olaratumab (Lexi-Drugs)': 'Not available', 'Digoxin Immune Fab (Lexi-Drugs)': 'Test Names: \\n1. Digitalis immunoassay \\n2. Digoxin serum samples\\n\\nTest Results: \\n{\\n   \"Digitalis immunoassay\": \"may be clinically misleading until all Fab fragments are eliminated from the body\",\\n   \"Digoxin serum samples\": \"should be obtained before digoxin immune fab administration, if possible\"\\n}', 'Digoxin Toxicity (Patient Education - Disease and Procedure)': 'Not available', 'DexAMETHasone (Systemic) (Lexi-Drugs)': '{\\n\"skin test antigens\": \"suppressed\"\\n}', 'Doxercalciferol (Lexi-Drugs)': 'Not available', 'Acetaminophen (Lexi-Drugs)': '{\\n\"urinary 5-hydroxyindoleacetic acid\": \"false-positive\"\\n}', 'Nalbuphine (Lexi-Drugs)': '{\\n\"enzymatic methods used to detect opioids\": \"interference (refer to test manufacturer for details)\"\\n}', 'Sildenafil (Lexi-Drugs)': 'Not available', 'Gadobutrol (Lexi-Drugs)': 'Not available', 'Methotrexate (Lexi-Drugs)': 'Not available', 'Pertuzumab (Lexi-Drugs)': 'Not available', 'Colistimethate (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Imiglucerase (Lexi-Drugs)': 'Not available', 'Dolasetron (Geriatric Lexi-Drugs)': 'Not available', 'Lansoprazole (Lexi-Drugs)': 'Not available', 'Smallpox and Monkeypox Vaccine (Live) (Lexi-Drugs)': 'Not available', 'Hydrocortisone (Systemic) (Lexi-Drugs)': '{\"skin tests\": \"decreased response\"}', 'Centruroides Immune F(ab’)2 (Equine) (Lexi-Drugs)': 'Not available', 'LORazepam (Lexi-Drugs)': 'Not available', 'Tacrolimus (Topical) (Lexi-Drugs)': 'Not available', 'Etelcalcetide (Lexi-Drugs)': 'Not available', 'Tafasitamab (Lexi-Drugs)': 'Not available', 'Vitamins (Multiple/Oral) (Lexi-Drugs)': 'Medical tests names: \\n1. Urine glucose determinations \\n2. Certain lab tests \\n\\nJSON output: \\n{\\n  \"Urine glucose determinations\": \"false-negative\",\\n  \"Certain lab tests\": \"incorrect\"\\n}', 'Cefotaxime (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Iron Sucrose (Lexi-Drugs)': 'Not available', 'Danaparoid (Lexi-Drugs)': 'Medical tests names: PT/INR\\n\\nJSON output: {\"PT/INR\": \"unreliable within 5 hours\"}', 'Gadofosveset (Lexi-Drugs)': 'Not available', 'Sodium Glycerophosphate Pentahydrate (Lexi-Drugs)': 'Not available', 'Tagraxofusp (Lexi-Drugs)': 'Not available', 'Amivantamab (Lexi-Drugs)': 'Not available', 'Evinacumab (Lexi-Drugs)': 'Not available', 'Amsacrine (Lexi-Drugs)': 'Not available', 'Lidocaine and Tetracaine (Lexi-Drugs)': 'Not available', 'Enalaprilat (Lexi-Drugs)': 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-negative.', 'Ketorolac (Systemic) (Lexi-Drugs)': 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-positive.', 'Acetaminophen and Diphenhydramine (Lexi-Drugs)': 'Not available', 'Insulin NPH (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Crotalidae Polyvalent Immune FAB (Ovine) (Lexi-Drugs)': 'Not available', 'C1 Inhibitor (Human) (Lexi-Drugs)': 'Not available', 'DAUNOrubicin (Liposomal) (Lexi-Drugs)': 'Not available', 'Magnesium Sulfate (Lexi-Drugs)': 'Not available', 'Cyanocobalamin (Lexi-Drugs)': '{\\n  \"Folic acid\": \"invalidated\",\\n  \"Vitamin B12\": \"invalidated\"\\n}', 'Difelikefalin (Lexi-Drugs)': 'Not available', 'Fluorouracil (Systemic) (Lexi-Drugs)': 'Not available', 'Codeine (Lexi-Drugs)': '{\\n  \"Opioid screening test\": \"false-positive (when taking some quinolones)\",\\n  \"Specific confirmation test\": \"recommended\"\\n}', 'Diatrizoate Meglumine (Lexi-Drugs)': 'Test names:\\n- Urine specimen assay\\n\\nTest results in JSON form:\\n{\\n \"Urine specimen assay\": \"N/A\"\\n} \\n(Note: \"N/A\" is the value because no specific test result is mentioned in the sentence)', 'Blinatumomab (Lexi-Drugs)': 'Not available', 'Cefotaxime (Pediatric and Neonatal Lexi-Drugs)': 'Test names:\\n- Direct Coombs\\' test\\n- Urinary glucose test\\n- Serum creatinine test\\n- Urine creatinine test\\n\\nTest results in JSON form:\\n{\\n \"Direct Coombs\\' test\": \"Positive\",\\n \"Urinary glucose test\": \"False-positive\",\\n \"Serum creatinine test\": \"False-positive\",\\n \"Urine creatinine test\": \"False-positive\"\\n}', 'Haloperidol (Lexi-Drugs)': 'Not available', 'Sodium Chloride (Lexi-Drugs)': 'Not available', 'Smallpox Vaccine Live (Lexi-Drugs)': '1) Medical test names: \\n- Rapid plasma reagin (RPR) test\\n2) Test results in JSON format:\\n- For RPR test: {\"Rapid plasma reagin (RPR) test\": \"false-positive due to smallpox vaccine\"}\\n\\n1) Medical test names:\\n- Tuberculin skin (PPD) and blood tests\\n2) Test results in JSON format:\\n- For Tuberculin skin (PPD) and blood tests: {\"Tuberculin skin (PPD) and blood tests\": \"false-negative due to smallpox vaccine\"}', 'Ceftolozane and Tazobactam (Geriatric Lexi-Drugs)': 'Not available', 'Bretylium (Lexi-Drugs)': 'Not available', 'Clodronate (Lexi-Drugs)': '1) Medical test names:\\n- Bone scan (diagnostic imaging with technetium-99m-diphosphonate)\\n2) Test results in JSON format:\\n- For bone scan: {\"Bone scan\": \"may be interfered by bisphosphonates except clodronate, according to some studies\"}', 'Vernakalant (Lexi-Drugs)': 'Not available', 'Choline C 11 (Lexi-Drugs)': 'Not available', 'Folic Acid (Lexi-Drugs)': 'Test Names: Lactobacillus casei assay method\\nTest Result: Falsely low serum concentrations may occur in patients on anti-infectives (eg, tetracycline)', 'Mycophenolate (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Enfortumab Vedotin (Lexi-Drugs)': 'Not available', 'Comparison of Prothrombin Complex Concentrates (Lexi-Drugs)': 'Not available', 'Nalmefene (Lexi-Drugs)': 'Not available', 'Clindamycin and Benzoyl Peroxide (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride (Lexi-Drugs)': 'Not available', 'Aztreonam (Oral Inhalation) (Geriatric Lexi-Drugs)': 'Not available', 'Betamethasone and Clotrimazole (Lexi-Drugs)': 'Not available', 'Temozolomide-Rituximab (CNS Lymphoma) (Lexi-Drugs)': 'Not available', 'Methyldopa and Hydrochlorothiazide (Lexi-Drugs)': 'Not available', 'Vancomycin (Lexi-Drugs)': 'Not available', 'Belimumab (Lexi-Drugs)': 'Not available', 'Vonoprazan and Amoxicillin (Lexi-Drugs)': 'Not available', 'Orphenadrine (Lexi-Drugs)': 'Not available', 'Acyclovir (Topical) (Lexi-Drugs)': 'Not available', 'Phenylephrine and Ketorolac (Lexi-Drugs)': 'Not available', 'Aminocaproic Acid (Lexi-Drugs)': 'Not available', 'Lurbinectedin (Lexi-Drugs)': 'Not available', 'Tigecycline (Lexi-Drugs)': 'Not available', 'Oxacillin (Lexi-Drugs)': \"Test Names: \\n1. Urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®)\\n2. Aminoglycoside activity test\\n3. Urinary protein test\\n4. Serum protein test\\n\\nTest Results:\\n1. May interfere\\n2. May inactivate in vitro\\n3. False positive in urinary test\\n4. False positive in serum test\", 'Phenylephrine (Nasal) (Lexi-Drugs)': 'Not available', 'Tobramycin and Dexamethasone (Lexi-Drugs)': 'Not available', 'Chlorpheniramine, Pseudoephedrine, and Dextromethorphan (Lexi-Drugs)': 'Not available', 'CefoTEtan (Lexi-Drugs)': 'Test names: \\n1) Direct Coombs\\' test\\n2) Urinary glucose test\\n3) Serum or urine creatinine test with Jaffé reaction\\n\\nJSON Form: \\n{\\n  \"Direct Coombs\\' test\": \"Positive\",\\n  \"Urinary glucose test\": \"False-positive\",\\n  \"Serum or urine creatinine test with Jaffé reaction\": \"May cause false-positive\"\\n}', 'Sacituzumab Govitecan (Lexi-Drugs)': 'Not available', 'Ethacrynic Acid (Lexi-Drugs)': 'Test Name: Aldosterone/Renin Ratio (ARR)\\nTest Result: May lead to false-negative (Funder 2016)', 'Eteplirsen (Lexi-Drugs)': 'Not available', 'Estrogens (Conjugated/Equine, Systemic) (Lexi-Drugs)': 'Test Names: laboratory tests related to coagulation factors, lipids, glucose tolerance, thyroxine-binding globulin, sex hormone-binding globulin, cortisol-binding globulin\\nTest Result: The use of estrogens and/or progestogens may alter the results (general statement)', 'Cidofovir (Lexi-Drugs)': 'Not available', 'Ado-Trastuzumab Emtansine (Lexi-Drugs)': 'Not available', 'Pamidronate (Lexi-Drugs)': 'Test names: \\n1. Technetium-99m-diphosphonate bone scan \\n\\nTest results:\\n{\\n\"Technetium-99m-diphosphonate bone scan\": \"may be interfered with by Bisphosphonates\"\\n}', 'Golimumab (Lexi-Drugs)': 'Not available', 'Gadopiclenol (Lexi-Drugs)': 'Not available', 'Melphalan (Lexi-Drugs)': 'Test names: \\n1. Coombs\\' test [direct]\\n\\nTest results:\\n{\\n\"Coombs\\' test [direct]\": \"false-positive \"\\n}', 'Benzocaine, Butamben, and Tetracaine (Lexi-Drugs)': 'Not available', 'Buprenorphine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'DOXOrubicin (Liposomal) (Lexi-Drugs)': 'Not available', 'Factor X (Human) (Lexi-Drugs)': 'Not available', 'Indomethacin (Lexi-Drugs)': '{\\n  \"dexamethasone suppression test\": \"false-negative\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}', 'ChlorproMAZINE (Lexi-Drugs)': '{\\n    \"phenylketonuria\": \"false-positive\",\\n    \"amylase\": \"false-positive\",\\n    \"uroporphyrins\": \"false-positive\",\\n    \"urobilinogen\": \"false-positive\",\\n    \"pregnancy test\": \"false-positive\",\\n    \"amphetamine/methamphetamine\": \"false-positive\",\\n    \"methadone\": \"false-positive\"\\n}', 'Azithromycin (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Angiotensin II (Lexi-Drugs)': 'Not available', 'Mannitol (Oral Inhalation) (Lexi-Drugs)': 'Not available', 'Benztropine (Geriatric Lexi-Drugs)': 'Not available', 'Ampicillin (Lexi-Drugs)': \"1. Medical test name: Urinary glucose tests\\n   Test result: May interfere with using cupric sulfate (Benedict's solution, Clinitest®)\\n\\n2. Medical test name: Aminoglycoside serum concentration\\n   Test result: Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives.\", 'Flucytosine (Lexi-Drugs)': 'Medical test name: Serum creatinine values\\nTest result: Markedly false elevations when the Ektachem® analyzer is used. The Jaffé reaction is recommended for determining serum creatinine.', 'Bezlotoxumab (Lexi-Drugs)': 'Not available', 'Selenium Sulfide (Lexi-Drugs)': 'Not available', 'Hyaluronidase (Lexi-Drugs)': 'Not available', 'Carboplatin-Paclitaxel (NSCLC) (Lexi-Drugs)': 'Not available', 'Tetracaine (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Mechlorethamine (Systemic) (Lexi-Drugs)': 'Not available', 'DilTIAZem (Lexi-Drugs)': 'Not available', 'Moxifloxacin (Systemic) (Lexi-Drugs)': 'Test names: \\n1. Urine screening test for opioids using commercially-available immunoassay kits\\n\\nTest results:\\n1. False-positive results for opioids may be produced by some quinolones, especially levofloxacin and ofloxacin\\n2. Other quinolones may also show cross-reactivity in certain assay kits.\\n3. Positive opioid screens should be confirmed by more specific methods.', 'MethylPREDNISolone (Lexi-Drugs)': 'Test names: \\n1. Skin test\\n\\nTest results:\\n1. Decreased response to skin tests.', 'Antihemophilic Factor (Human) (Lexi-Drugs)': 'Not available', 'Mirvetuximab Soravtansine (Lexi-Drugs)': 'Not available', 'Carbetocin (Lexi-Drugs)': 'Not available', 'Cloxacillin (Lexi-Drugs)': '{\\n    \"Urinary glucose tests using cupric sulfate\": \"May interfere\",\\n    \"Aminoglycosides\": \"May inactivate in vitro\",\\n    \"Urine proteins\": \"False-positive\",\\n    \"Serum proteins\": \"False-positive\",\\n    \"Uric acid\": \"False-positive\",\\n    \"Urinary steroids\": \"False-positive\"\\n}', 'Carmustine (Lexi-Drugs)': 'Not available', 'Ibuprofen, Phenylephrine, and Chlorpheniramine (Lexi-Drugs)': 'Not available', 'Atoltivimab, Maftivimab, and Odesivimab (Lexi-Drugs)': 'Not available', 'AzaTHIOprine (Lexi-Drugs)': '{\\n  \"Medical Test Name\": \"TPMT phenotyping\",\\n  \"Test Result\": \"May not be accurate following recent blood transfusions.\"\\n}', 'Bromhexine [INT] (Lexi-Drugs International [Concise])': 'Not available', 'Axicabtagene Ciloleucel (Lexi-Drugs)': 'Not available', 'Insulin Aspart Protamine and Insulin Aspart (Lexi-Drugs)': 'Not available', 'Insulin Detemir (Lexi-Drugs)': 'Not available', 'HydrALAZINE (Lexi-Drugs)': 'Not available', 'Orphenadrine, Aspirin, and Caffeine (Lexi-Drugs)': 'Not available', 'Gadopentetate Dimeglumine (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Fluorescein (Lexi-Drugs)': 'Not available', 'Diazoxide (Lexi-Drugs)': '{\\n  \"Serum renin concentrations\": \"increased\",\\n  \"IgG concentrations\": \"increased\",\\n  \"Serum cortisol concentrations\": \"decreased\",\\n  \"insulin response to glucagon\": \"false-negative\"\\n}', 'FentaNYL (Lexi-Drugs)': 'Not available', 'Bortezomib (Lexi-Drugs)': 'Not available', 'Caplacizumab (Lexi-Drugs)': 'Not available', 'Capmatinib (Lexi-Drugs)': 'Not available', 'Pafolacianine (Lexi-Drugs)': 'Not available', 'Dostarlimab (Lexi-Drugs)': 'Not available', 'Glycopyrrolate (Systemic) (Lexi-Drugs)': 'Not available', 'Etoposide (Lexi-Drugs)': 'Not available', 'Adenosine (Lexi-Drugs)': 'Not available', 'Melphalan (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Minocycline (Topical) (Lexi-Drugs)': '{\"fluorescence test for urinary catecholamines\":\"false elevations\"}', 'Tremelimumab (Lexi-Drugs)': 'Not available', 'Cimetidine (Lexi-Drugs)': 'Not available', ' ': \"I'm sorry, but I cannot extract the medical test names and their results without any input data. Please provide the data.\", 'Dextromethorphan and Chlorpheniramine (Lexi-Drugs)': 'Not available', 'MT-RNR1 - Kanamycin (Pharmacogenomics)': 'Not available', 'Ofloxacin (Systemic) (Lexi-Drugs)': '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"cross-reactivity\", \"ofloxacin\": \"cross-reactivity\", \"other quinolones\": \"cross-reactivity\"}', 'Alpha1-Proteinase Inhibitor (Lexi-Drugs)': 'Not available', 'Alcohol (Ethyl) (Lexi-Drugs)': 'Not available', 'Brentuximab Vedotin (Lexi-Drugs)': 'Not available', 'Lutetium Lu 177 Vipivotide Tetraxetan (Lexi-Drugs)': 'Not available', 'Methylfolate, Methylcobalamin, and Acetylcysteine (Lexi-Drugs)': 'Not available', 'Trabectedin (Lexi-Drugs)': 'Not available', 'Mechlorethamine (Topical) (Lexi-Drugs)': 'Not available', 'DroPERidol (Lexi-Drugs)': 'Not available', 'Ustekinumab (Lexi-Drugs)': 'Not available', 'Argatroban (Lexi-Drugs)': 'Test names: \\n1. PT/INR levels\\n2. Chromogenic factor X assay\\n3. Factor Xa levels\\n\\nTest results:\\n{\\n  \"PT/INR levels\": \"elevated in the absence of warfarin, may require modification while on argatroban\",\\n  \"Chromogenic factor X assay\": \"suggested to be monitored when transitioning from argatroban to warfarin or overlapping administration of warfarin for a minimum of 5 days until INR is within target range, recheck INR after anticoagulant effect of argatroban has dissipated\",\\n  \"Factor Xa levels\": \"associated with INR values >2 after the effects of argatroban have been eliminated\"\\n}', 'Vestronidase Alfa (Lexi-Drugs)': 'Not available', 'Betibeglogene Autotemcel (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"Test name\": \"Polymerase chain reaction (PCR) assay for HIV\",\\n  \"Test result\": \"False-positive for HIV in patients who have received betibeglogene autotemcel due to integrated BB305 LVV proviral DNA\"\\n}', 'Copper Cu 64 Dotatate (Lexi-Drugs)': 'Not available', 'Diphenhydramine and Ibuprofen (Lexi-Drugs)': 'Not available', 'Abciximab (Lexi-Drugs)': 'Not available', 'Calcium Gluconate (Lexi-Drugs)': 'Medical Test Names: Serum magnesium test and Urine magnesium test.\\n\\nJSON output:\\n{\\n \"Serum magnesium test\": \"falsely decreased\",\\n \"Urine magnesium test\": \"falsely decreased\"\\n}', 'Ferric Pyrophosphate Citrate (Lexi-Drugs)': 'Not available', 'Ticarcillin and Clavulanate Potassium (Infectious Diseases)': 'Medical Test Names: Coombs\\' test and Urinary protein test.\\n\\nJSON output:\\n{\\n \"Coombs\\' test\": \"positive\",\\n \"Urinary protein test\": \"false-positive\"\\n}', 'Teprotumumab (Lexi-Drugs)': 'Not available', 'Hydrocortisone (Topical) (Lexi-Drugs)': 'Not available', 'Lidocaine and Prilocaine (Lexi-Drugs)': 'Not available', 'Cytarabine (Conventional) (Lexi-Drugs)': 'Not available', 'Celecoxib and Tramadol (Lexi-Drugs)': 'Not available', 'Fosdenopterin (Lexi-Drugs)': 'Not available', 'Galsulfase (Lexi-Drugs)': 'Not available', 'Terbutaline (Lexi-Drugs)': 'Not available', 'Estrogens (Conjugated/Equine, Topical) (Lexi-Drugs)': '{\\n  \"metyrapone test\": \"reduced response\"\\n}', 'Fomepizole (Lexi-Drugs)': 'Not available', 'Andexanet Alfa (Coagulation Factor Xa [Recombinant], Inactivated) (Lexi-Drugs)': '{\\n  \"anti-FXa activity assay\": \"falsely elevated after andexanet alfa administration\",\\n  \"andexanet alfa\": \"reversal activity\"\\n}', 'CefTRIAXone (Lexi-Drugs)': '{\\n    \"Positive direct Coombs\\'\": \"positive\",\\n    \"false-positive urinary glucose test using nonenzymatic methods\": \"false-positive\",\\n    \"false-positive galactosemia tests\": \"false-positive\"\\n}', 'EPHEDrine (Systemic) (Lexi-Drugs)': '{\\n    \"test name\": \"amphetamine EMIT assay\",\\n    \"test result\": \"false positive\"\\n}', 'Ixabepilone (Lexi-Drugs)': 'Not available', 'Amikacin Liposome (Oral Inhalation) (Lexi-Drugs)': 'Not available', 'Vasopressin (Geriatric Lexi-Drugs)': 'Not available', 'Lisocabtagene Maraleucel (Lexi-Drugs)': 'Not available', 'Vasopressin (Lexi-Drugs)': 'Not available', 'Sirolimus (Protein Bound) (Lexi-Drugs)': 'Not available', 'Acetylcysteine (Lexi-Drugs)': 'Not available', 'Potassium Iodide (Lexi-Drugs)': '{\\n   \"Thyroid function tests\": \"Altered\"\\n}', 'Irinotecan (Liposomal) (Lexi-Drugs)': 'Not available', 'EpiRUBicin (Lexi-Drugs)': 'Not available', 'Theophylline (Lexi-Drugs)': '{\\n  \"Plasma glucose\": \"increased\",\\n  \"Uric acid\": \"increased\",\\n  \"Free fatty acids\": \"increased\",\\n  \"Total cholesterol\": \"increased\",\\n  \"HDL\": \"increased\",\\n  \"HDL/LDL ratio\": \"increased\",\\n  \"Urinary free cortisol excretion\": \"increased\",\\n  \"Triiodothyronine\": \"decreased\"\\n}', 'Methylfolate, Methylcobalamin, and Acetylcysteine (Geriatric Lexi-Drugs)': 'Not available', 'Atropine (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Tetracaine (Topical) (Lexi-Drugs)': 'Not available', 'Ciprofloxacin and Fluocinolone (Lexi-Drugs)': 'Not available', 'Vancomycin (Geriatric Lexi-Drugs)': 'Not available', 'DexAMETHasone (Ophthalmic) (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Iobenguane I 131 (Lexi-Drugs)': 'Not available', 'Neostigmine and Glycopyrrolate (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Decitabine and Cedazuridine (Lexi-Drugs)': 'Not available', 'Ansuvimab (Lexi-Drugs)': 'Not available', 'Copper IUD (Lexi-Drugs)': 'Not available', 'Esmolol (Lexi-Drugs)': 'Not available', 'Dalteparin (Lexi-Drugs)': 'Not available', 'Onasemnogene Abeparvovec (Lexi-Drugs)': 'Not available', 'Manganese (Lexi-Drugs)': 'Not available', 'Ipilimumab (Lexi-Drugs)': 'Not available', 'Bamlanivimab and Etesevimab (Lexi-Drugs)': 'Not available', 'TraMADol (Lexi-Drugs)': 'Medical Test Name: Urine Detection of Phencyclidine\\nTest Result: False-Positive', 'Fluoroestradiol F18 (Lexi-Drugs)': 'Not available', 'Obinutuzumab (Lexi-Drugs)': 'Not available', 'PHENobarbital (Lexi-Drugs)': 'Not available', 'Anthrax Immune Globulin (Human) [ANTIDOTE] (Lexi-Tox)': '1. Medical tests mentioned in the given data:\\n- Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n- Glucose-specific method\\n- Urinalysis\\n- Serologic testing\\n- Direct and indirect Coombs’ test\\n\\n2. Test results in JSON form:\\n{\\n  \"Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\": \"falsely elevated blood glucose levels\",\\n  \"Glucose-specific method\": \"recommended\",\\n  \"Urinalysis\": \"transiently elevated glucose\",\\n  \"Serologic testing\": \"false-positive results\",\\n  \"Direct and indirect Coombs’ test\": \"false-positive results\"\\n}', 'MetroNIDAZOLE (Systemic) (Lexi-Drugs)': '{\\n    \"AST\": \"interfere\",\\n    \"ALT\": \"interfere\",\\n    \"triglycerides\": \"interfere\",\\n    \"glucose\": \"interfere\",\\n    \"LDH\": \"interfere\"\\n}', 'Betamethasone (Systemic) (Lexi-Drugs)': '1. Medical test mentioned in the given data:\\n- Skin test for wheal and flare reactions to antigens \\n\\n2. Test result in JSON form:\\n{\\n  \"Skin test for wheal and flare reactions to antigens\": \"may be suppressed\"\\n}', 'Dihydroergotamine (Lexi-Drugs)': 'Not available', 'Digoxin (Lexi-Drugs)': '1. Medical test mentioned in the given data:\\n- Digoxin radioimmunoassay \\n\\n2. Test result in JSON form:\\n{\\n  \"Digoxin radioimmunoassay\": \"may be interfered\"\\n}', 'Betamethasone (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Glucarpidase (Lexi-Drugs)': 'Test Names: Methotrexate levels\\nTest Result: {\"Methotrexate levels\": \"the chromatographic method\"}', 'Oxycodone and Naloxone (Lexi-Drugs)': 'Not available', 'Labetalol (Lexi-Drugs)': 'Test Names: \\n1. Urine catecholamines\\n2. Metanephrine \\n3. Normetanephrine \\n4. Vanillylmandelic acid (VMA) \\n5. Urine amphetamine \\n6. Aldosterone/renin ratio (ARR)\\n\\nTest Results:\\n{\\n   \"Urine catecholamines\": \"HPLC assay with solid-phase extraction should be used to determine levels of catecholamines\",\\n   \"Metanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of metanephrine\",\\n   \"Normetanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of normetanephrine\",\\n   \"Vanillylmandelic acid (VMA)\": \"HPLC assay with solid-phase extraction should be used to determine levels of VMA\",\\n   \"Urine amphetamine\": \"Gas chromatographic-mass spectrometer technique should be used to determine levels of amphetamine\",\\n   \"Aldosterone/renin ratio (ARR)\": \"May lead to a false-positive result\"\\n}', 'C1 Inhibitor (Recombinant) (Lexi-Drugs)': 'Not available', 'Ramucirumab (Lexi-Drugs)': 'Not available', 'Flecainide (Lexi-Drugs)': 'Not available', 'Gadoteridol (Lexi-Drugs)': 'Not available', 'Patisiran (Lexi-Drugs)': 'Not available', 'Imipenem and Cilastatin (Pediatric and Neonatal Lexi-Drugs)': 'Test Names:\\n- Urinary glucose determination using Clinitest®\\n- Coombs\\' direct\\n\\nTest Results (in json format):\\n{\\n  \"Urinary glucose determination using Clinitest®\": \"Interfered\",\\n  \"Coombs\\' direct\": \"Positive\"\\n}', 'PENTobarbital (Lexi-Drugs)': 'Not available', 'Lidocaine and Chlorhexidine (Lexi-Drugs)': 'Not available', 'Ibuprofen (Lexi-Drugs)': '{\\n  \"phencyclidine\": \"false-positives\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}', 'Ceftolozane and Tazobactam (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Sodium Tetradecyl Sulfate (Lexi-Drugs)': 'Not available', 'DexAMETHasone (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Doxycycline Hyclate Periodontal Extended-Release Liquid (Lexi-Drugs)': 'Not available', 'Flortaucipir F18 (Lexi-Drugs)': 'Not available', 'Dinutuximab (Lexi-Drugs)': 'Not available', 'Eravacycline (Lexi-Drugs)': 'Not available', 'Meloxicam (Lexi-Drugs)': '{\"aldosterone/renin ratio (ARR)\": \"false-positive\"}', 'Busulfan (Lexi-Drugs)': 'Not available', 'Albuterol (Lexi-Drugs)': '{\"renin (S)\": \"increased\",\\n \"aldosterone (S)\": \"increased\"}', 'Etomidate (Lexi-Drugs)': 'Not available', 'Melphalan-Prednisone (Multiple Myeloma) (Lexi-Drugs)': 'Not available', 'Elivaldogene Autotemcel (Lexi-Drugs)': '{\"PCR assays for HIV\": \"positive\", \"HIV infection using a PCR-based assay\": \"false-positive\"}', 'Indigotindisulfonate Sodium (Lexi-Drugs)': 'Not available', 'Iopamidol (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Sargramostim (Lexi-Drugs)': 'Not available', 'Belinostat (Lexi-Drugs)': 'Not available', 'Naxitamab (Lexi-Drugs)': 'Not available', 'Glycopyrronium (Topical) (Lexi-Drugs)': 'Not available', 'Antihemophilic Factor (Recombinant [Porcine Sequence]) (Lexi-Drugs)': 'Not available', 'DAUNOrubicin (Conventional) (Lexi-Drugs)': 'Not available', 'Foscarnet (Lexi-Drugs)': 'Not available', 'DAPTOmycin (Lexi-Drugs)': 'Test Names:\\n- PT (Prothrombin Time) test\\n- INR (International Normalized Ratio) test\\n\\nTest Results (in JSON form):\\n{\\n  \"PT (Prothrombin Time) test\": \"false prolongation with certain recombinant thromboplastin reagents when taking daptomycin\",\\n  \"INR (International Normalized Ratio) test\": \"increase with certain recombinant thromboplastin reagents when taking daptomycin\"\\n}', 'Metoprolol (Lexi-Drugs)': 'Not available', 'Mogamulizumab (Lexi-Drugs)': 'Not available', 'Imipenem, Cilastatin, and Relebactam (Infectious Diseases)': '{\\n   \"Test Name\": \"Coombs test\",\\n   \"Test Result\": \"Positive\"\\n}', 'Reslizumab (Lexi-Drugs)': 'Not available', 'Ifosfamide (Lexi-Drugs)': 'Not available', 'Nafcillin (Lexi-Drugs)': '{\\n  \"Coombs\\' test (direct)\": \"Positive\",\\n  \"Urinary proteins\": \"False-positive\",\\n  \"Serum proteins\": \"False-positive\",\\n  \"Aminoglycoside inactivation\": \"In vitro\"\\n}', 'Procyclidine (Lexi-Drugs)': 'Not available', 'Loteprednol and Tobramycin (Lexi-Drugs)': 'Not available', 'Ascorbic Acid (Lexi-Drugs)': '{\\n  \"Stool occult blood test\": \"False-negative\",\\n  \"Blood glucose testing\": \"Interference (falsely-elevated)\",\\n  \"Urine glucose testing\": \"Interference\",\\n  \"Nitrite levels\": \"Interference\",\\n  \"Bilirubin levels\": \"Interference\",\\n  \"Leucocyte count\": \"Interference\"\\n}', 'Etranacogene Dezaparvovec (Lexi-Drugs)': '{\\n  \"One-stage clotting assay (OSA)\": \"Affected by aPTT reagent and reference standard used; recommended for monitoring factor IX activity over time with the same assay and reagents\",\\n  \"Activated partial thromboplastin time (aPTT)\": \"Type of reagent used affects results when using OSA to determine factor IX activity\",\\n  \"Chromogenic substrate assay (CSA)\": \"Results in lower factor IX activity compared to OSA; mean CSA to OSA factor IX activity ratio ranging from 0.41 to 0.55 in clinical study\"\\n}', 'Nivolumab (Lexi-Drugs)': 'Not available', 'Spesolimab (Lexi-Drugs)': 'Not available', 'LevoFLOXacin (Systemic) (Lexi-Drugs)': '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"positive\", \"ofloxacin\": \"positive\"}', 'Imipenem and Cilastatin (Lexi-Drugs)': '{\"urinary glucose determination using Clinitest\": \"interferes\", \"Coombs\\' [direct]\": \"positive\"}', 'Loncastuximab Tesirine (Lexi-Drugs)': 'Not available', 'Elotuzumab (Lexi-Drugs)': 'Test Names: \\n1. Serum Protein Electrophoresis (SPEP)\\n2. Serum Immunofixation Assays\\n \\nTest Results in JSON Format:\\n{\\n   \"SPEP\": \"A small peak in the early gamma region\",\\n   \"Serum Immunofixation Assays\": \"may potentially be attributed to elotuzumab\"\\n}', 'Lidocaine and Epinephrine (Lexi-Drugs)': 'Not available', 'Gadoxetate (Lexi-Drugs)': 'Test Name:\\n1. Serum Iron Test\\n\\nTest Result in JSON Format:\\n{\\n   \"Serum Iron Test\": \"Falsely high or low values of serum iron (if determined by complexometric methods) may occur for up to 24 hours following administration.\"\\n}', 'Ibuprofen and Acetaminophen (Pediatric and Neonatal Lexi-Drugs)': 'Test Names:\\n1. Urinary 5-hydroxyindoleacetic acid test\\n2. Urine detection of Phencyclidine test\\n3. Aldosterone/Renin Ratio (ARR) test\\n\\nTest Results in JSON Format:\\n{\\n   \"Urinary 5-hydroxyindoleacetic acid test\": \"false-positive due to Acetaminophen\",\\n   \"Urine detection of Phencyclidine test\": \"false-positives due to Ibuprofen\",\\n   \"Aldosterone/Renin Ratio (ARR) test\": \"false-positive due to Ibuprofen\"\\n}', 'Betamethasone and Gentamicin (Lexi-Drugs)': 'Not available', 'Phytonadione (Lexi-Drugs)': 'Not available', 'Methadone (Lexi-Drugs)': '1. Medical test names:\\n- Urine screening test for opioids using immunoassay kits\\n- Confirmation test for positive opioid screens using more specific methods\\n- Urine methadone screens using immunoassay kits\\n\\n2. Test Results in JSON format:\\n{\\n  \"Urine screening test for opioids using immunoassay kits\": \"false-positive for opioids with quinolones (levofloxacin and ofloxacin) and other medications (not specified)\",\\n  \"Confirmation test for positive opioid screens using more specific methods\": \"not specified\",\\n  \"Urine methadone screens using immunoassay kits\": \"false-positive in patients taking diphenhydramine, doxylamine, clomipramine, chlorpromazine, thioridazine, quetiapine, and verapamil\"\\n}', 'Antithymocyte Globulin (Rabbit) (Lexi-Drugs)': '1. Medical test names:\\n- Rabbit antibody-based immunoassays\\n- Cross-match or panel-reactive antibody cytotoxicity assays\\n- Routine clinical laboratory tests which use immunoglobulins\\n\\n2. Test Results in JSON format:\\n{\\n  \"Rabbit antibody-based immunoassays\": \"potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"potential interference\",\\n  \"Routine clinical laboratory tests which use immunoglobulins\": \"no interference shown\"\\n}', 'Crizotinib (Lexi-Drugs)': 'Not available', 'Oxycodone and Aspirin (Lexi-Drugs)': \"I'm sorry, I cannot extract the medical test names and their results without any specific data to refer to. Please provide the necessary information.\", 'Ibuprofen, Pseudoephedrine, and Chlorpheniramine (Lexi-Drugs)': 'Not available', 'Amobarbital (Lexi-Drugs)': 'Not available', 'Sodium Phenylacetate and Sodium Benzoate (Lexi-Drugs)': 'Not available', 'Metoclopramide (Lexi-Drugs)': 'Not available', 'Cytomegalovirus Immune Globulin (Intravenous-Human) (Lexi-Drugs)': 'Not available', 'Lidocaine (Topical) (Lexi-Drugs)': 'Not available', 'Oxycodone and Ibuprofen (Lexi-Drugs)': 'Not available', 'Viltolarsen (Lexi-Drugs)': 'Test Names: Not specified in the given data.\\nTest Results:\\n{\\n\"Urine Protein Detection with Pyrogallol Red reagent\": \"May give false positive results if Viltolarsen is present in urine\",\\n\"Urine Protein Detection with other test methods\": \"Not affected by Viltolarsen\",\\n\"Timeframe for avoiding false positives\": \"Urine obtained prior to infusion or ≥48 hours after infusion\",\\n}', 'Posaconazole (Lexi-Drugs)': 'Not available', 'Amphotericin B (Liposomal) (Lexi-Drugs)': 'Medical Test Name: PHOSm assay\\n\\nTest Result JSON: {\"PHOSm assay\": \"Falsely-elevated serum phosphate\"}', 'Diclofenac (Topical) (Lexi-Drugs)': 'Not available', 'Thiamine (Lexi-Drugs)': 'Medical Test Names: \\n1. Phosphotungstate method for uric acid\\n2. Ehrlich\\'s reagent for urobilinogen\\n3. Spectrophotometric determination of serum theophylline concentration\\n\\nTest Result JSON: \\n{\\n   \"Phosphotungstate method for uric acid\": \"False-positive\",\\n   \"Ehrlich\\'s reagent for urobilinogen\": \"False-positive\",\\n   \"Spectrophotometric determination of serum theophylline concentration\": \"Interference with large doses\"\\n}', 'Linezolid (Lexi-Drugs)': 'Not available', 'Selexipag (Lexi-Drugs)': 'Not available', 'Dacarbazine (Lexi-Drugs)': 'Not available', 'Arsenic Trioxide (Lexi-Drugs)': 'Not available', 'Laronidase (Lexi-Drugs)': 'Not available', 'Insulin Glulisine (Lexi-Drugs)': 'Not available', 'Mepivacaine (Lexi-Drugs)': 'Not available', 'AcetaZOLAMIDE (Lexi-Drugs)': '{\\n  \"Urinary protein with Albustix\": \"false-positive\",\\n  \"Labstix\": \"false-positive\",\\n  \"Albutest\": \"false-positive\",\\n  \"Bumintest\": \"false-positive\",\\n  \"HPLC theophylline assay\": \"interference\",\\n  \"Serum uric acid levels\": \"interference\",\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}', 'NiMODipine (Lexi-Drugs)': '{\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}', 'Necitumumab (Lexi-Drugs)': 'Not available', 'Alemtuzumab (Lexi-Drugs)': '{\\n  \"Diagnostic serum tests that utilize antibodies\": \"interference\"\\n}', 'Neostigmine and Glycopyrrolate (Lexi-Drugs)': 'Not available', 'Tobramycin (Oral Inhalation) (Lexi-Drugs)': 'Not available', 'Tisotumab Vedotin (Lexi-Drugs)': 'Not available', 'Ondansetron (Lexi-Drugs)': 'Not available', 'PyRIDostigmine (Lexi-Drugs)': 'Not available', 'Oxaliplatin (Lexi-Drugs)': 'Not available', 'Fludarabine-Cyclophosphamide (CLL) (Lexi-Drugs)': 'Not available', 'Pentazocine and Naloxone (Lexi-Drugs)': 'Not available', 'Dalbavancin (Lexi-Drugs)': 'Not available', 'Ibalizumab (Lexi-Drugs)': 'Not available', 'MitoMYcin (Ureteral Gel) (Lexi-Drugs)': 'Not available', 'Efgartigimod Alfa (Lexi-Drugs)': 'Not available', 'Caffeine (Lexi-Drugs)': 'Not available', 'Benztropine (Lexi-Drugs)': 'Not available', 'ROPivacaine (Lexi-Drugs)': 'Not available', 'Verteporfin (Lexi-Drugs)': 'Not available', 'Sutimlimab (Lexi-Drugs)': 'Not available', 'Sebelipase Alfa (Lexi-Drugs)': 'Not available', 'Cladribine (Lexi-Drugs)': 'Not available', 'Vaccinia Immune Globulin (Intravenous) (Lexi-Drugs)': '{\"serologic testing\": \"false-positive\", \"direct Coombs test\": \"false-positive\", \"indirect Coombs test\": \"false-positive\"}', 'Vinorelbine (Lexi-Drugs)': 'Not available', 'Abatacept (Lexi-Drugs)': '{\\n  \"Dehydrogenase Pyrroloquinolinequinone\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose-dye-oxidoreductase\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose Dehydrogenase Nicotine Adenine Dinucleotide (GDH-NAD)\": \"Recommended glucose monitoring method\",\\n  \"Glucose Oxidase\": \"Recommended glucose monitoring method\",\\n  \"Glucose Hexokinase\": \"Recommended glucose monitoring method\"\\n}', 'VinCRIStine (Liposomal) (Lexi-Drugs)': 'Not available', 'Acetaminophen, Diphenhydramine, and Phenylephrine (Lexi-Drugs)': 'Not available', 'Glucagon (Geriatric Lexi-Drugs)': 'Not available', 'Gallium Ga 68 Dotatate (Lexi-Drugs)': 'Not available', 'Tobramycin (Systemic) (Lexi-Drugs)': '{\\n  \"Medical Test Names\": [\\n    \"Aminoglycoside Serum Concentration\"\\n  ],\\n  \"Test Results\": [\\n    \"Potential Underestimation\"\\n  ]\\n}', 'Porfimer (Lexi-Drugs)': 'Not available', 'NiCARdipine (Lexi-Drugs)': '{\\n  \"Medical Test Names\": [\\n    \"Aldosterone/Renin Ratio (ARR)\"\\n  ],\\n  \"Test Results\": [\\n    \"False-Negative\"\\n  ]\\n}', 'Penicillin G (Parenteral/Aqueous) (Lexi-Drugs)': '{\\n \"urinary glucose determination using Clinitest\": \"false-positive or negative\",\\n \"Coombs\\' [direct]\": \"positive\",\\n \"urinary and/or serum proteins by certain test methods\": \"false-positive\"\\n}', 'DOXOrubicin (Conventional) (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'CefTAZidime (Lexi-Drugs)': '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate\": \"False-positive\",\\n  \"serum or urine creatinine with Jaffé reaction\": \"False-positive\"\\n}', 'Norepinephrine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Insulin (Oral Inhalation) (Lexi-Drugs)': 'Not available', 'Tirofiban (Lexi-Drugs)': 'Not available', 'Ciltacabtagene Autoleucel (Lexi-Drugs)': 'Not available', 'Acetylcysteine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Cetirizine (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Floxuridine (Lexi-Drugs)': 'Not available', 'Neostigmine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Vancomycin (Infectious Diseases)': 'Not available', 'Vestronidase Alfa (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Lidocaine (Systemic) (Lexi-Drugs)': 'Not available', 'Antithymocyte Globulin (Equine) (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Daratumumab and Hyaluronidase (Lexi-Drugs)': 'Medical test names:\\n1. Indirect antiglobulin test (indirect Coombs test)\\n2. Serum protein electrophoresis\\n3. Immunofixation assays\\n\\nJSON form:\\n{\\n  \"Indirect antiglobulin test (indirect Coombs test)\": \"Positive\",\\n  \"Serum protein electrophoresis\": \"Detected\",\\n  \"Immunofixation assays\": \"Interference\"\\n}', 'Sodium Nitrite (Lexi-Drugs)': 'Not available', 'Antipsychotic Agents, Atypical (Lexi-Tox)': 'Not available', 'Scopolamine (Lexi-Drugs)': 'Medical test names:\\n1. Gastric secretion test\\n\\nJSON form:\\n{\\n  \"Gastric secretion test\": \"Interference\"\\n}', 'Valproic Acid and Derivatives (Lexi-Drugs)': 'Test names: Urine ketones, Thyroid function tests\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine ketones\": {\\n    \"Effect\": \"May cause a false-positive result\",\\n    \"Medication\": \"Valproate\",\\n    \"Mode of elimination\": \"Partially eliminated as a keto-metabolite in the urine\"\\n  },\\n  \"Thyroid function tests\": {\\n    \"Effect\": \"May alter\"\\n  }\\n}', 'Cefiderocol (Lexi-Drugs)': 'Test names: Urine dipstick tests (urine protein, ketones, occult blood)\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine dipstick tests\": {\\n    \"Effects\": [\"May result in false-positive urine dipstick tests\"],\\n    \"Examples of tests affected\": [\"Urine protein\", \"ketones\", \"occult blood\"]\\n  }\\n}', 'Prochlorperazine (Lexi-Drugs)': 'Test names: Phenylketonuria test, Pregnancy test\\n\\nTest results as JSON:\\n\\n{\\n  \"Phenylketonuria test\": {\\n    \"Effect\": \"False-positives\"\\n  },\\n  \"Pregnancy test\": {\\n    \"Effect\": \"False-positives\"\\n  }\\n}', \"Crotalidae Immune F(ab')2 (Equine) (Lexi-Drugs)\": 'Not available', 'Doripenem (Lexi-Drugs)': 'Not available', 'Idursulfase (Lexi-Drugs)': 'Not available', 'Antithymocyte Globulin (Rabbit) (Pediatric and Neonatal Lexi-Drugs)': 'Test Names:\\n1. Rabbit antibody-based immunoassays\\n2. Cross-match or panel-reactive antibody cytotoxicity assays\\n\\nTest Results (in JSON format):\\n{\\n  \"Rabbit antibody-based immunoassays\": \"Potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"Potential interference\",\\n  \"Routine clinical laboratory tests which do not use immunoglobulins\": \"No interference shown\"\\n}', 'Meropenem and Vaborbactam (Lexi-Drugs)': '{\"Positive Coombs\\'\": \"Positive\"}', 'HydrOXYzine (Lexi-Drugs)': '{\"serum TCA screen\": \"false-positive\"}', 'Minocycline Hydrochloride Periodontal Microspheres (Lexi-Drugs)': 'Not available', 'OxyCODONE (Lexi-Drugs)': '{\"urine screening result for opioids\": \"false-positive\"}', 'Pentostatin (Lexi-Drugs)': 'Not available', 'Folic Acid, Cyanocobalamin, and Pyridoxine (Lexi-Drugs)': 'Not available', 'Potassium Phosphate and Sodium Phosphate (Lexi-Drugs)': 'Not available', 'SUFentanil (Lexi-Drugs)': 'Not available', 'Tobramycin (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Leucovorin Calcium (Lexi-Drugs)': 'Not available', 'Methylene Blue (Lexi-Drugs)': 'Test Name: Urine Test with Blue Indicator\\nTest Result: Interfered', 'Colistimethate (Lexi-Drugs)': 'Not available', 'Docetaxel-Oxaliplatin-Leucovorin-Fluorouracil (Esophageal) (Lexi-Drugs)': 'Not available', 'Clindamycin and Tretinoin (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Isosorbide Mononitrate (Lexi-Drugs)': 'Not available', 'Gallium Ga 68 Dotatate (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Trandolapril and Verapamil (Lexi-Drugs)': 'Not available', 'Antivenin (Micrurus fulvius) (Lexi-Drugs)': 'Not available', 'Iodine I-125 Iothalamate (Lexi-Drugs)': 'Not available', 'Cisatracurium (Lexi-Drugs)': 'Not available', 'VinCRIStine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Benztropine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Albumin (Lexi-Drugs)': 'Not available', 'Mesna (Lexi-Drugs)': '{\\n    \"test name\": \"Urinary ketones\",\\n    \"test result\": \"false positive in patients receiving mesna with nitroprusside-based urine tests\"\\n},\\n{\\n    \"test name\": \"CPK activity\",\\n    \"test result\": \"may interfere with enzymatic CPK activity tests which use a thiol compound, resulting in a falsely low CPK level\"\\n},\\n{\\n    \"test name\": \"Ascorbic acid\",\\n    \"test result\": \"may result in false-positive reactions in Tillman\\'s reagent-based urine screening tests\"\\n}', 'Amoxicillin and Clavulanate (Lexi-Drugs)': '{\\n    \"test name\": \"urinary glucose tests\",\\n    \"test result\": \"may interfere with tests using cupric sulfate, but tests based on enzymatic glucose oxidase reactions are recommended\"\\n},\\n{\\n    \"test name\": \"plasma concentrations of certain hormones in pregnant women\",\\n    \"test result\": \"may be transiently interfered with by ampicillin, including total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol\"\\n}', 'ClonazePAM (Lexi-Drugs)': 'Not available', 'Lincomycin (Lexi-Drugs)': 'Not available', 'Insulin Glulisine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Plasminogen Activity, Plasma (Lab Tests and Diagnostic Procedures)': 'Not available', 'Insulin Glargine (Lexi-Drugs)': 'Not available', 'Sipuleucel-T (Lexi-Drugs)': 'Not available', 'QuiNIDine (Lexi-Drugs)': 'Not available', 'Ocrelizumab (Lexi-Drugs)': '{\"CD20 assay\": \"interfered\", \"CD19+ assay\": \"measure B-cell counts\"}', 'Methylergonovine (Lexi-Drugs)': 'Not available', 'Procainamide (Lexi-Drugs)': '{\"procainamide/N-acetyl procainamide concentration test\": \"affected\"}', 'Naproxen and Diphenhydramine (Lexi-Drugs)': 'Not available', 'Iron Dextran Complex (Lexi-Drugs)': 'Medical Test Names:\\n1. Serum bilirubin\\n2. Serum calcium\\n3. Examination of bone marrow iron stores\\n4. Bone scans with 99m Tc-labeled bone seeking agents\\n5. Bone scans with 99m Tc-diphosphonate\\n\\nTest Results in JSON Form:\\n{\\n\"Serum bilirubin\": \"falsely elevated values\",\\n\"Serum calcium\": \"falsely decreased values\",\\n\"Examination of bone marrow iron stores\": \"Residual iron dextran may remain in reticuloendothelial cells affecting accuracy\",\\n\"Bone scans with 99m Tc-labeled bone seeking agents\": \"reduced bony uptake, marked renal activity, and excess blood pooling and soft tissue accumulation following IV iron dextran infusion or with high serum ferritin levels\",\\n\"Bone scans with 99m Tc-diphosphonate\": \"dense activity in the buttocks following IM iron dextran\"\\n}', 'Aztreonam (Systemic) (Pediatric and Neonatal Lexi-Drugs)': 'Medical Test Names:\\n1. Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\\n2. Coombs\\' test\\n\\nTest Results in JSON Form:\\n{\\n\"Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\": \"May interfere\",\\n\"Coombs\\' test\": \"positive\"\\n}', 'Iohexol (Lexi-Drugs)': 'Medical Test Names:\\n1. Iodine-binding capacity of thyroid tissue\\n2. Diagnostic tests using iodine-containing isotopes\\n3. Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\\n\\nTest Results in JSON Form:\\n{\\n\"Iodine-binding capacity of thyroid tissue\": \"reduced for up to 2 weeks following administration of contrast media\",\\n\"Diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\": \"not affected\"\\n}', 'Tecovirimat (Lexi-Drugs)': 'Not available', 'Bivalirudin (Lexi-Drugs)': '{\\n  \"PT/INR\": [\"elevated\"], \\n  \"bivalirudin\": [\"modification\"]\\n}', 'DACTINomycin (Lexi-Drugs)': 'Not available', 'Vecuronium (Lexi-Drugs)': 'Not available', 'Fosaprepitant (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Minocycline (Systemic) (Lexi-Drugs)': '```\\n{\\n    \"Test Name\": \"Fluorescence Test for Urinary Catecholamines\",\\n    \"Test Result\": \"False Elevations\"\\n}\\n```', 'Oritavancin (Lexi-Drugs)': '```\\n{\\n    \"Test Name 1\": \"Activated Clotting Time (ACT)\",\\n    \"Test Result 1\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 2\": \"aPTT\",\\n    \"Test Result 2\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 3\": \"Prothrombin Time\",\\n    \"Test Result 3\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 4\": \"International Normalized Ratio\",\\n    \"Test Result 4\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 5\": \"Silica Clot Time (SCT)\",\\n    \"Test Result 5\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 6\": \"Dilute Russell\\'s Viper Venom Time (DRVVT)\",\\n    \"Test Result 6\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 7\": \"D-dimer\",\\n    \"Test Result 7\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 8\": \"Indirect Antiglobulin Test\",\\n    \"Test Result 8\": \"Positive\",\\n    \\n    \"Test Name 9\": \"Direct Antiglobulin Test\",\\n    \"Test Result 9\": \"Positive\"\\n}\\n```', 'Artesunate (Lexi-Drugs)': 'Not available', 'Ibuprofen and Acetaminophen (Lexi-Drugs)': 'Medical Tests:\\n1. Urinary 5-hydroxyindoleacetic acid \\n2. Urine detection of phencyclidine \\n3. Aldosterone/Renin ratio\\n\\nTest Results:\\n{\\n\"Urinary 5-hydroxyindoleacetic acid\": \"False-positive\",\\n\"Urine detection of phencyclidine\": \"False-positive\",\\n\"Aldosterone/Renin ratio\": \"False-positive\"\\n}', 'Diamorphine (Lexi-Drugs)': 'Not available', 'Moxetumomab Pasudotox (Lexi-Drugs)': 'Medical Tests:\\n1. Cellular CD22 Detection\\n2. CD19+ B Cells Surrogate Assay\\n\\nTest Results:\\n{\\n\"Cellular CD22 Detection\": \"Interference\",\\n\"CD19+ B Cells Surrogate Assay\": \"Normal\"\\n}', 'Telavancin (Lexi-Drugs)': 'Medical Tests:\\n1. PT\\n2. INR\\n3. aPTT\\n4. ACT\\n5. Xa (coagulation based assay)\\n6. Bleeding time\\n7. Factor Xa (chromogenic assay)\\n8. Platelet aggregation study\\n9. Thrombin time\\n10. Urine protein via qualitative dipstick\\n11. Urine protein via quantitative dye methods\\n\\nTest Results:\\n{\\n\"PT\": \"Artificially increased clotting times\",\\n\"INR\": \"Artificially increased clotting times\",\\n\"aPTT\": \"Artificially increased clotting times\",\\n\"ACT\": \"Artificially increased clotting times\",\\n\"Xa (coagulation based assay)\": \"Artificially increased clotting times\",\\n\"Bleeding time\": \"Normal\",\\n\"Factor Xa (chromogenic assay)\": \"Normal\",\\n\"Platelet aggregation study\": \"Normal\",\\n\"Thrombin time\": \"Normal\",\\n\"Urine protein via qualitative dipstick\": \"Interference\",\\n\"Urine protein via quantitative dye methods\": \"Interference\"\\n}', 'Zinc Sulfate (Lexi-Drugs)': 'Not available', 'Vasopressin (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Streptomycin (Lexi-Drugs)': 'Not available', 'DexAMETHasone (Systemic) [SUPPORTIVE] (Lexi-Tox)': 'Not available', 'Methocarbamol (Lexi-Drugs)': '{\\n  \"5-HIAA\": \"color interference\",\\n  \"VMA\": \"color interference\"\\n}', 'Calaspargase Pegol (Lexi-Drugs)': 'Not available', 'Hemin (Lexi-Drugs)': 'Not available', 'Enoxaparin (Lexi-Drugs)': '{\\n  \"Free Thyrotropin\": \"falsely elevated\",\\n  \"Free Triiodothyronine\": \"falsely elevated\",\\n  \"Thyroid-stimulating hormone\": \"not usually affected\",\\n  \"Standard Competitive Free Thyroid Hormone Assays\": \"not usually affected\"\\n}', 'Nivolumab and Relatlimab (Lexi-Drugs)': 'Not available', 'Fluorouracil-Leucovorin-Oxaliplatin  (Gastric/Esophageal)  (Lexi-Drugs)': 'Not available', 'Fosaprepitant (Lexi-Drugs)': 'Not available', 'LevoFLOXacin (Oral Inhalation) (Lexi-Drugs)': '{\\n  \"Test Name\": \"Urine Screening for Opioids\",\\n  \"Test Result\": \"false-positive with quinolones; confirmation recommended\"\\n}', 'Ziv-Aflibercept (Systemic) (Lexi-Drugs)': 'Not available', 'Insulin NPH (Lexi-Tox)': 'Not available', 'Zoledronic Acid (Lexi-Drugs)': '{\\n  \"Test Name\": \"Bone Scan with Technetium-99m-diphosphonate\",\\n  \"Test Result\": \"may be interfered with by Bisphosphonates\"\\n}', 'Potassium Phosphate (Lexi-Drugs)': 'Not available', 'Abacavir, Lamivudine, and Zidovudine (Lexi-Drugs)': 'Not available', 'Natalizumab (Lexi-Drugs)': 'Not available', 'Regadenoson (Lexi-Drugs)': 'Not available', 'Antithymocyte Globulin (Equine) (Lexi-Drugs)': 'Not available', 'Esomeprazole (Lexi-Drugs)': 'Test names and their respective results:\\n\\n1. Serum chromogranin A (CgA) level - Falsely elevated with Esomeprazole \\n2. Diagnosis of a neuroendocrine tumor - False-positive \\n\\nJSON format:\\n\\n{\\n   \"Serum chromogranin A (CgA) level\": \"Falsely elevated with Esomeprazole\",\\n   \"Diagnosis of a neuroendocrine tumor\": \"False-positive\"\\n}', 'Sodium Thiosulfate (Lexi-Drugs)': 'Not available', 'Cetuximab (Lexi-Drugs)': 'Not available', 'Pyridoxine (Lexi-Drugs)': 'Not available', 'Lutetium Lu 177 Dotatate (Lexi-Drugs)': 'Not available', 'Clarithromycin (Lexi-Drugs)': 'Not available', 'Glutathione (Natural Products Database)': 'Not available', 'Amoxicillin (Lexi-Drugs)': '1. Medical Test Names: Benedict\\'s solution, Clinitest, Fehling\\'s Solution\\n   Test Results: {\"Benedict\\'s solution\": \"May interfere with urinary glucose tests\", \\n                  \"Clinitest\": \"May interfere with urinary glucose tests\", \\n                  \"Fehling\\'s Solution\": \"May interfere with urinary glucose tests\"}\\n\\n2. Medical Test Names: Aminoglycoside serum concentration\\n   Test Results: {\"Aminoglycoside serum concentration\": \"Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives\"}', 'Chlorpheniramine, Phenylephrine, and Dextromethorphan (Lexi-Drugs)': 'Not available', 'Casirivimab and Imdevimab (Lexi-Drugs)': 'Not available', 'Atracurium (Lexi-Drugs)': 'Not available', 'Ibandronate (Lexi-Drugs)': 'Medical Test Names: technetium-99m-diphosphonate bone scans\\nTest Results: {\"technetium-99m-diphosphonate bone scans\": \"May be interfered with by bisphosphonates\"}', 'Acetaminophen and Caffeine (Lexi-Drugs)': 'Not available', 'Bendamustine-Rituximab (CLL) (Lexi-Drugs)': 'Not available', 'Gadopentetate Dimeglumine (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Sodium Iodide I123 (Lexi-Drugs)': 'Not available', 'Local Anesthetics (Lexi-Tox)': 'Not available', 'Phenytoin (Lexi-Drugs)': '{\\n  \"Plasma phenytoin concentrations\": \"Falsely high\",\\n  \"Serum concentrations of T4\": \"Falsely low\",\\n  \"Serum concentrations of T3\": \"Falsely low\",\\n  \"Dexamethasone tests\": \"Falsely low\",\\n  \"Metyrapone tests\": \"Falsely low\",\\n  \"Thyroid-stimulating hormone (TSH) levels\": \"Increased\"\\n}', 'Iodinated I 131 Albumin (Lexi-Drugs)': 'Not available', 'Temozolomide (Lexi-Drugs)': 'Not available', 'QuiNINE (Lexi-Drugs)': '{\\n  \"Urine detection of opioids\": \"False-positive\",\\n  \"Coombs\\' test\": \"Positive\",\\n  \"Urinary steroids\": \"False elevation\",\\n  \"Catecholamines\": \"False elevation\",\\n  \"Urinary dipstick protein assays\": \"Qualitative and quantitative\"\\n}', 'Fluorouracil-Leucovorin Bolus (Colorectal) (Lexi-Drugs)': 'Not available', 'Interferon Alfa-2b (Lexi-Drugs)': 'Not available', 'Factor IX (Recombinant) (Lexi-Drugs)': 'Not available', 'Asparaginase (Erwinia) (Lexi-Drugs)': 'Not available', 'Fam-Trastuzumab Deruxtecan (Lexi-Drugs)': 'Not available', 'Ziconotide (Lexi-Drugs)': 'Not available', 'Fluconazole (Lexi-Drugs)': 'Not available', 'Isoproterenol (Lexi-Drugs)': 'Not available', 'Bacitracin and Polymyxin B (Topical) (Lexi-Drugs)': 'Not available', 'Trastuzumab (Lexi-Drugs)': 'Not available', 'Oliceridine (Lexi-Drugs)': 'Not available', 'Lacosamide (Lexi-Drugs)': 'Not available', 'Tocilizumab (Lexi-Drugs)': 'Not available', 'Elotuzumab-Pomalidomide-Dexamethasone (Multiple Myeloma) (Lexi-Drugs)': 'Not available', 'Ferric Carboxymaltose (Lexi-Drugs)': '{\\n  \"Serum iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\",\\n  \"Transferrin bound iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}', 'Glycerin and Lidocaine (Lexi-Drugs)': 'Not available', 'PEMEtrexed (Lexi-Drugs)': 'Not available', 'Naloxone (Lexi-Drugs)': 'Not available', 'Amphotericin B Deoxycholate (Lexi-Drugs)': 'Not available', 'Acyclovir (Systemic) (Lexi-Drugs)': 'Not available', 'Edetate CALCIUM Disodium (Lexi-Drugs)': 'Sorry, as an AI language model, I am not able to extract the medical test names and their results without any context or clear indication of where they are mentioned in the text. Could you please provide me with a specific text or document so I can help you better?', 'Eculizumab (Lexi-Drugs)': 'Not available', 'Teplizumab (Lexi-Drugs)': 'Not available', 'LevOCARNitine (Lexi-Drugs)': 'Not available', 'PRALAtrexate (Lexi-Drugs)': 'Not available', 'Bendamustine-Bortezomib-Rituximab (NHL-Follicular) (Lexi-Drugs)': 'Not available', 'Delafloxacin (Lexi-Drugs)': 'Not available', 'Eptifibatide (Lexi-Drugs)': 'Not available', 'Ofloxacin (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Mycophenolate (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Stanford V (Hodgkin) (Lexi-Drugs)': 'Not available', 'Methoxy Polyethylene Glycol-Epoetin Beta (Lexi-Drugs)': '{\\n  \"Neutralizing antibody assay\": \"Obtain serum samples at least a month after the last dose to prevent assay interference.\", \\n  \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\"\\n}', 'Glycopyrrolate (Oral Inhalation) (Lexi-Drugs)': 'Not available', 'Asparaginase (Erwinia [Recombinant]) (Lexi-Drugs)': 'Not available', 'Heparin (Lexi-Drugs)': '1. Medical Test Names: PT, anti-factor Xa assay, aPTT, free T4, free T3, thyroid stimulating hormone, standard competitive free thyroid hormone assays.\\n\\n2. Test Results in JSON format:\\n\\n{\\n \"PT\": \"Increased\",\\n \"anti-factor Xa assay\": \"falsely elevated results\",\\n \"aPTT\": \"little or minor effect\",\\n \"free T4\": \"falsely elevated levels\",\\n \"free T3\": \"falsely elevated levels\",\\n \"thyroid stimulating hormone\": \"not usually affected\",\\n \"standard competitive free thyroid hormone assays\": \"not usually affected\"\\n}', 'AzaCITIDine (Lexi-Drugs)': 'Not available', 'Arginine (Lexi-Drugs)': 'Not available', 'Cisplatin-Vinblastine (NSCLC) (Lexi-Drugs)': 'Not available', 'Aztreonam (Oral Inhalation) (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Prothrombin Complex Concentrate (Human) [(Factors II, VII, IX, X), Protein C, and Protein S]': '{\\n \"aPTT\": \"contains heparin\"\\n}', 'Trilaciclib (Lexi-Drugs)': 'Not available', 'Agalsidase Alfa (Lexi-Drugs)': 'Not available', 'Belantamab Mafodotin (Lexi-Drugs)': 'Not available', 'Nitroprusside (Lexi-Drugs)': 'Not available', 'Gatifloxacin (Lexi-Drugs)': 'Not available', 'DOCEtaxel (Lexi-Drugs)': 'Not available', 'Pantothenic Acid (Natural Products Database)': 'Not available', 'LEVOleucovorin (Lexi-Drugs)': 'Not available', 'Fosnetupitant and Palonosetron (Lexi-Drugs)': 'Not available', 'Metoprolol and Hydrochlorothiazide (Lexi-Drugs)': 'Not available', 'Daratumumab (Lexi-Drugs)': '1. Medical test names: antibody screening, cross matching, Kell blood group system genotyping, serum protein electrophoresis (SPE), immunofixation (IFE), daratumumab-specific IFE assay.\\n\\n2. Test results in JSON format:\\n\\n{\\n   \"antibody screening\": \"N/A\",\\n   \"cross matching\": \"N/A\",\\n   \"Kell blood group system genotyping\": \"N/A\",\\n   \"serum protein electrophoresis (SPE)\": \"positive if daratumumab is present\",\\n   \"immunofixation (IFE)\": \"positive if daratumumab is present\",\\n   \"daratumumab-specific IFE assay\": \"distinguishes daratumumab from residual endogenous M protein\"\\n}', 'Lidocaine and Menthol (Lexi-Drugs)': 'Not available', 'Bleomycin (Lexi-Drugs)': 'Not available', 'Baclofen (Lexi-Drugs)': 'Not available', 'Milrinone (Lexi-Drugs)': 'Not available', 'LevETIRAcetam (Lexi-Drugs)': 'Not available', 'Sodium Thiosulfate: Calciphylaxis (Facts and Comparisons Off-Label)': 'Not available', 'Defibrotide (Lexi-Drugs)': 'Not available', 'Calcium Chloride (Lexi-Drugs)': 'Not available', 'Buprenorphine (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Phenylephrine (Topical) (Lexi-Drugs)': 'Not available', 'Amiodarone (Lexi-Drugs)': 'Medical Test Names: \\n- Thyroid function test\\n\\nTest Results in JSON:\\n{\\n  \"T4 levels\": \"elevated\",\\n  \"Thyroid stimulating hormone levels\": \"at the high end of normal range\",\\n  \"T3 levels\": \"at the low end of normal range\"\\n}', 'Cosyntropin (Lexi-Drugs)': 'Medical Test Names: N/A\\n\\nTest Results in JSON: N/A', 'Betibeglogene Autotemcel (Lexi-Drugs)': '{\\n  \"polymerase chain reaction (PCR) assays for HIV\": \"Positive\",\\n  \"BB305 LVV proviral DNA\": \"Integrated\",\\n  \"screened for HIV infection using a PCR-based assay\": \"Should not\"\\n}', 'Benztropine (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Cefuroxime (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n  \"ferricyanide test\": \"False-negative\",\\n  \"Glucose oxidase or hexokinase-based methods\": \"Should be used\"\\n}', 'Octreotide (Lexi-Drugs)': 'Not available', 'Gadoterate Meglumine (Lexi-Drugs)': 'Not available', 'Velaglucerase Alfa (Lexi-Drugs)': 'Not available', 'Allopurinol (Lexi-Drugs)': 'Not available', 'Avelumab (Lexi-Drugs)': 'Not available', 'Rasburicase (Lexi-Drugs)': '{\"uric acid\": \"N/A\"}', 'Clindamycin and Benzoyl Peroxide (Lexi-Drugs)': 'Not available', 'Insulin Lispro Protamine and Insulin Lispro (Lexi-Drugs)': 'Not available', 'Doxorubicin (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Agalsidase Beta (Lexi-Drugs)': 'Not available', 'Obiltoxaximab (Lexi-Drugs)': 'Not available', 'Factor VIIa (Recombinant) (Lexi-Drugs)': 'Not available', 'Sotalol (Lexi-Drugs)': '{\\n  \"urinary metanephrine\": \"May falsely increase\",\\n  \"HPLC assay with solid phase extraction for determination of urinary catecholamines\": \"does not interact with\",\\n  \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"\\n}', 'Omeprazole and Sodium Bicarbonate (Lexi-Drugs)': '{\\n  \"serum chromogranin A (CgA)\": \"may falsely elevate; may cause false-positive results in the diagnosis of a neuroendocrine tumor\",\\n  \"omeprazole\": \"Temporarily stop ≥14 days prior to assessing CgA level\"\\n}', 'Melphalan Flufenamide (Lexi-Drugs)': 'Not available', 'Iodine I-125 Human Serum Albumin (Lexi-Drugs)': 'Not available', 'Sodium Bicarbonate (Lexi-Drugs)': 'Not available', 'Factor IX (Recombinant [Albumin Fusion Protein]) (Lexi-Drugs)': 'Not available', 'Lansoprazole, Amoxicillin, and Clarithromycin (Lexi-Drugs)': 'Not available', 'Midazolam (Lexi-Drugs)': 'Not available', 'Melphalan-Prednisone-Thalidomide (Multiple Myeloma) (Lexi-Drugs)': 'Not available', 'CISplatin (Lexi-Drugs)': 'Not available', 'Amphotericin B Cholesteryl Sulfate Complex (Lexi-Drugs)': 'Not available', 'Isatuximab (Lexi-Drugs)': 'Test Names:\\n1. Indirect Antiglobulin Test (indirect Coombs test)\\n2. Antibody Detection (screening) Tests\\n3. Antibody Identification Panels\\n4. Anti-Human Globulin Crossmatches\\n5. Blood Type and Screening\\n6. Phenotyping\\n7. Serum Protein Electrophoresis\\n8. Immunofixation Assays\\n\\nTest Result in JSON form:\\n{\\n   \"Indirect Antiglobulin Test\": \"false-positive\",\\n   \"Antibody Detection Tests\": \"may result in interference\",\\n   \"Antibody Identification Panels\": \"may result in interference\",\\n   \"Anti-Human Globulin Crossmatches\": \"may result in interference\",\\n   \"Blood Type and Screening\": \"recommended prior to the first isatuximab infusion\",\\n   \"Phenotyping\": \"consider prior to initiating treatment\",\\n   \"Serum Protein Electrophoresis\": \"may interfere with accuracy of determining complete response\",\\n   \"Immunofixation Assays\": \"may interfere with accuracy of determining complete response\"\\n}', 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Lexi-Drugs)': 'Not available', 'CefOXitin (Lexi-Drugs)': '{\\n  \"Positive direct Coombs\\'\": \"Positive\",\\n  \"False-positive urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"Positive\",\\n  \"False-positive serum or urine creatinine with Jaffé reaction\": \"Positive\"\\n}', 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Insulin Degludec (Lexi-Drugs)': 'Not available', 'Phenylephrine (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Quinupristin and Dalfopristin (Lexi-Drugs)': 'Not available', 'Amikacin (Systemic) (Lexi-Drugs)': '{\\n  \"Medical test names\": [\\n    \"Aminoglycoside serum concentration\"\\n  ],\\n  \"Test results\": [\\n    \"Potential underestimation\"\\n  ]\\n}', 'Insulin Glargine and Lixisenatide (Lexi-Drugs)': 'Not available', 'Alglucosidase Alfa (Lexi-Drugs)': 'Not available', 'Mitoxantrone-Prednisone (Prostate) (Lexi-Drugs)': 'Not available', 'Proparacaine and Fluorescein (Lexi-Drugs)': 'Not available', 'Glutamine (Patient Education - Natural Products)': 'Not available', 'Alcohol (Isopropyl) (Lexi-Drugs)': 'Not available', 'MitoXANTRONE (Lexi-Drugs)': 'Not available', 'Gadoversetamide (Lexi-Drugs)': 'Test names: serum iron, copper, zinc, serum calcium.\\nTest results: \\n{\\n\"serum iron\": \"transient changes\",\\n\"copper\": \"transient changes\",\\n\"zinc\": \"transient changes\",\\n\"serum calcium\": \"apparent decrease after injection, accurate values can be obtained approximately 90 minutes after injection\"\\n}', 'Aldesleukin (Lexi-Drugs)': 'Not available', 'Anticholinergic Agents (Lexi-Tox)': 'Not available', 'Epoprostenol (Lexi-Drugs)': 'Not available', 'Tranexamic Acid [SUPPORTIVE] (Lexi-Tox)': 'Not available', 'Ibuprofen and Phenylephrine (Lexi-Drugs)': 'Not available', 'Insulin Degludec and Liraglutide (Lexi-Drugs)': 'Not available', 'Deferoxamine (Lexi-Drugs)': \"Sorry, as an AI language model, I don't have the capability to extract specific information from unstructured data without any context. Please provide more specific data or context for me to extract the information as per your requirement.\", 'Palifermin (Lexi-Drugs)': 'Not available', 'Pegloticase (Lexi-Drugs)': 'Not available', 'Amphotericin B (Lipid Complex) (Lexi-Drugs)': 'Not available', 'Atezolizumab (Lexi-Drugs)': 'Not available', 'Inotuzumab Ozogamicin (Lexi-Drugs)': 'Not available', 'Itraconazole (Lexi-Drugs)': 'Not available', 'Sodium Chloride and Sodium Citrate (Lexi-Drugs)': 'Not available', 'HYDROmorphone (Lexi-Drugs)': 'Test Names: \\n- Urine screening test for opioids \\n\\nTest Results (in JSON form): \\n{\\n  \"Urine screening test for opioids\": \"false-positive for levofloxacin and ofloxacin, cross-reactivity in certain assay kits for other quinolones\"\\n}', 'Brexucabtagene Autoleucel (Lexi-Drugs)': 'Not available', 'CycloSPORINE (Systemic) (Lexi-Drugs)': 'Test Names:\\n- Whole blood assay for cyclosporine\\n\\nTest Results (in JSON form):\\n{\\n  \"Whole blood assay for cyclosporine\": \"may be falsely elevated if sample is drawn from the same central venous line through which dose was administered; cyclosporine metabolites cross-react with radioimmunoassay and fluorescence polarization immunoassay\"\\n}', 'Anthrax Immune Globulin (Human) (Lexi-Drugs)': 'Test Names: \\n1. Glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n2. Glucose-specific method\\n3. Anthrax immune globulin administration\\n4. Serologic testing\\n5. Direct and indirect Coombs’ test\\n\\nTest Results:\\n1. Falsely elevated blood glucose levels \\n2. N/A\\n3. Transiently elevated glucose \\n4. False-positive results \\n5. False-positive results', 'EriBULin (Lexi-Drugs)': 'Not available', 'Fosphenytoin (Lexi-Drugs)': 'Test Names:\\n1. Immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000)\\n2. Dexamethasone test\\n3. Metyrapone test\\n\\nTest Results:\\n1. Falsely high plasma phenytoin concentrations \\n2. Falsely low results\\n3. Folate levels lowered', 'ALfentanil (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Clindamycin (Systemic) (Lexi-Drugs)': 'Not available', 'Calcitriol (Systemic) (Lexi-Drugs)': 'Not available', 'Clindamycin (Systemic) (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Phenylephrine and Pyrilamine (Lexi-Drugs)': 'Not available', 'Fosfomycin (Lexi-Drugs)': 'Not available', 'DexmedeTOMIDine (Lexi-Drugs)': 'Not available', 'Ergonovine (Lexi-Drugs)': 'Not available', 'Terlipressin (Lexi-Drugs)': 'Not available', 'Insulin NPH and Insulin Regular (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Pseudoephedrine and Ibuprofen (Pediatric and Neonatal Lexi-Drugs)': 'Not available', 'Scopolamine (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Fibrinogen Concentrate (Human) (Lexi-Drugs)': 'Not available', 'Buprenorphine (Geriatric Lexi-Drugs)': 'Not available', 'Betamethasone and Salicylic Acid (Lexi-Drugs)': 'Not available', 'Diclofenac (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Aztreonam (Oral Inhalation) (Lexi-Drugs)': 'Not available', 'Bupivacaine and Meloxicam (Lexi-Drugs)': 'Not available', 'Acyclovir (Ophthalmic) (Lexi-Drugs)': 'Not available', 'Asparaginase (Briggs Drugs in Pregnancy and Lactation)': 'Not available', 'Golodirsen (Lexi-Drugs)': 'Not available', 'Clindamycin (Topical) (Lexi-Drugs)': 'Not available'}\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import json\n",
    "\n",
    "with open('meeting4/Drugs test conditions.json', 'r') as file:\n",
    "    drugs_test_conditions_df = json.load(file)\n",
    "\n",
    "print(drugs_test_conditions_df)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T06:26:16.781716600Z",
     "start_time": "2023-05-10T06:26:16.750441400Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "\"Direct antiglobulin (Coombs) test\": \"Positive\",\n",
      "\"Urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\": \"False-positive\",\n",
      "\"Serum/urine creatinine with Jaffé reaction assay\": \"Falsely elevated\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "\"Wheal and flare reactions to skin test antigens\": \"May be suppressed\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "    \"creatinine (Jaffé alkaline picrate reaction)\": \"Increased\",\n",
      "    \"serum methotrexate (dihydrofolate reductase method)\": \"Increased\"\n",
      "}\n",
      "{\n",
      "    \"serum chromogranin A (CgA) levels\": \"falsely elevated (due to decreased gastric acidity with Omeprazole)\",\n",
      "    \"neuroendocrine tumor diagnosis\": \"may cause false-positive results\",\n",
      "    \"CgA levels assessment\": \"≥14 days after treatment is completed\",\n",
      "    \"CgA levels repeat\": \"if initially elevated\"\n",
      "}\n",
      "{\n",
      "    \"automated platelet counts\": \"may interfere (platelet clumping) with Crizanlizumab\",\n",
      "    \"blood samples collection\": \"in tubes containing ethylenediaminetetraacetic acid (EDTA)\",\n",
      "    \"platelet count\": \"may be unevaluable or falsely decreased\",\n",
      "    \"management\": \"Collect blood samples in citrate-containing tubes\",\n",
      "    \"run blood samples\": \"within 4 hours of sample collection\",\n",
      "    \"estimate platelet count\": \"through peripheral blood smear if necessary\"\n",
      "}\n",
      "{\n",
      "    \"triglyceride assays\": \"may be falsely elevated (dependent on glycerol oxidase)\",\n",
      "    \"propylene glycol content\": \"in IV formulation\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names: HbA1c.\n",
      "Test results: \n",
      "{\n",
      " \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names: dipyridamole-thallium myocardial imaging\n",
      "\n",
      "Test Results: {\"dipyridamole-thallium myocardial imaging\": \"false-negative result\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"HIV nucleic acid tests\": \"false positive results\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Urinary Glucose Determination (Clinitest)\": \"Interferes\",\n",
      "  \"Coombs' Test (Direct)\": \"Positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\"Coombs' [direct]\": \"Positive\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"direct Coombs\": \"positive\", \"urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\": \"false-positive\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "   \"serum ferritin\": \"transient increase\",\n",
      "   \"urine zinc\": \"transient increase (with renal disease)\",\n",
      "   \"bilirubin\": \"transient increase (with hepatic metabolic disorders)\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"aldosterone/renin ratio (ARR)\": \"false-negative\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "   \"urine detection of methadone\": \"false-positives\",\n",
      "   \"urine detection of phencyclidine\": \"false-positives\",\n",
      "   \"serum TCA screen\": \"false-positive\",\n",
      "   \"wheal and flare reactions to skin test antigens\": \"suppressed\"\n",
      "}\n",
      "Medical Test Name: \n",
      "1. Skin test antigens \n",
      "\n",
      "JSON Form: \n",
      "{\n",
      "   \"Skin test antigens\": \"suppressed wheal and flare reactions\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Serum or transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric gluconate administration\",\n",
      "  \"Serum ferritin levels\": \"falsely elevated for 5 days after ferric gluconate administration\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "   \"thyroid function tests dependent on iodine estimation\": \"altered results\",\n",
      "   \"radioiodine uptake studies\": \"affected results\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "   \"direct Coombs' test\": \"positive\",\n",
      "   \"urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution)\": \"false-positive\",\n",
      "   \"serum creatinine with Jaffé reaction\": \"false-positive\",\n",
      "   \"urine creatinine with Jaffé reaction\": \"false-positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names: \n",
      "1. Urine test for phencyclidine\n",
      "\n",
      "Test Results: \n",
      "{\n",
      "   \"Urine test for phencyclidine\": \"false-positive interference may occur\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "   \"Clinitest®\": \"interfered with urinary glucose determination\",\n",
      "   \"Coombs' [direct]\": \"positive\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "   \"blood group isohemagglutinins\": \"presence\",\n",
      "   \"Coombs test\": \"may be interfered with due to passive transmission of antibodies to erythrocyte antigens\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names: \n",
      "1. Serum or transferrin bound iron levels \n",
      "2. Serum ferritin levels \n",
      "\n",
      "Test Results:\n",
      "1. {\"Serum or transferrin bound iron levels\": \"May be falsely elevated if assessed within 24 hours of ferric gluconate administration.\"}\n",
      "2. {\"Serum ferritin levels\": \"May be falsely elevated for 5 days after ferric gluconate administration.\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"direct Coombs'\": \"Positive\", \"urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\": \"False-positive\", \"ferricyanide test\": \"False-negative\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names: \n",
      "- Urinary glucose determination \n",
      "\n",
      "Test Results in JSON format:\n",
      "{\n",
      "   \"Urinary glucose determination\": \"False-negative when using Clinistix® or Diastix®\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Medical test names: Basophils, hemoglobin, MCH, MCHC, albumin, alkaline phosphatase, cholesterol, creatinine, glucose, total protein, triglycerides, bilirubin, urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite), ALT, amylase, AST, CK, CKMB, LDH, phosphate, uric acid, PT, aPTT, urine pH.\n",
      "\n",
      "JSON form:\n",
      "{\n",
      "  \"Basophils\": \"Falsely elevated\",\n",
      "  \"Hemoglobin\": \"Falsely elevated\",\n",
      "  \"MCH\": \"Falsely elevated\",\n",
      "  \"MCHC\": \"Falsely elevated\",\n",
      "  \"Albumin\": \"Falsely elevated\",\n",
      "  \"Alkaline phosphatase\": \"Falsely elevated\",\n",
      "  \"Cholesterol\": \"Falsely elevated\",\n",
      "  \"Creatinine\": \"Falsely elevated\",\n",
      "  \"Glucose\": \"Falsely elevated\",\n",
      "  \"Total protein\": \"Falsely elevated\",\n",
      "  \"Triglycerides\": \"Falsely elevated\",\n",
      "  \"Bilirubin\": \"Falsely elevated\",\n",
      "  \"Urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite)\": \"Falsely elevated\",\n",
      "  \"ALT\": \"Falsely decreased\",\n",
      "  \"Amylase\": \"Falsely decreased\",\n",
      "  \"AST\": \"Unpredictable\",\n",
      "  \"CK\": \"Unpredictable\",\n",
      "  \"CKMB\": \"Unpredictable\",\n",
      "  \"LDH\": \"Unpredictable\",\n",
      "  \"Phosphate\": \"Unpredictable\",\n",
      "  \"Uric acid\": \"Unpredictable\",\n",
      "  \"PT\": \"Unpredictable\",\n",
      "  \"aPTT\": \"Unpredictable\",\n",
      "  \"Urine pH\": \"Unpredictable\"\n",
      "}\n",
      "Not available\n",
      "Medical test name: Blood glucose\n",
      "\n",
      "JSON form:\n",
      "{\n",
      "  \"Blood glucose\": \"falsely elevated\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      " \"Positive direct Coombs\": true,\n",
      " \"Urinary glucose test using cupric sulfate (Benedict's solution)\": false,\n",
      " \"Urinary glucose test using Clinitest\": false,\n",
      " \"Urinary glucose test using Fehling's solution\": false,\n",
      " \"Serum or urine creatinine with Jaffé reaction\": false,\n",
      " \"Urinary proteins\": false,\n",
      " \"Urinary steroids\": false\n",
      "}\n",
      "{\n",
      " \"Serum iron levels\": \"falsely elevated\",\n",
      " \"Transferrin bound iron levels\": \"falsely elevated\"\n",
      "}\n",
      "{\n",
      " \"Coombs test\": \"Positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"HbA1c\": \"artificially lowered\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "1. T4-binding globulin (TBG)\n",
      "{\n",
      "  \"Conditions/states that increase TBG binding\": \"Pregnancy, hepatitis, porphyria, neonatal state\",\n",
      "  \"Medications that increase TBG binding\": \"Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\",\n",
      "  \"Conditions/states that decrease TBG binding\": \"Hepatic failure, nephrosis, severe illness.\",\n",
      "  \"Medications that decrease TBG binding\": \"Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\"\n",
      "}\n",
      "\n",
      "2. Thyroxine (T4) and triiodothyronine (T3)\n",
      "{\n",
      "  \"Medications that inhibit T4 and T3 binding\": \"Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\"\n",
      "}\n",
      "\n",
      "3. Thyroid gland hormone: Interference with production and secretion\n",
      "{\n",
      "  \"Medications affecting iodine uptake\": \"Amiodarone, iodinated contrast agents, iodine, ethionamide\",\n",
      "  \"Medications affecting hormone production\": \"Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\",\n",
      "  \"Medications affecting secretion\": \"Amiodarone, iodinated contrast agents, iodine, lithium\",\n",
      "  \"Medications inducing thyroiditis\": \"Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\",\n",
      "  \"Medications potentially causing the development of Graves’\": \"Alemtuzumab, interferon alpha, antiretroviral therapy\",\n",
      "  \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’\": \"Glucocorticoids\"\n",
      "}\n",
      "\n",
      "4. Hypothalamic-pituitary axis and TSH: Interference with secretion\n",
      "{\n",
      "  \"Medications decreasing TSH secretion\": \"Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\",\n",
      "  \"Medications increasing TSH secretion\": \"Amphetamine, interleukin 2, metoclopramide, ritonavir, St John's wort\",\n",
      "  \"Medications potentially causing hypophysitis\": \"Ipilimumab\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"iodine-binding capacity\": \"reduced for up to 2 weeks following administration of contrast media\", \n",
      "\"diagnostic tests using iodine-containing isotopes\": \"may be affected\",\n",
      "\"Thyroid function tests that are independent of iodine estimation for results\": \"not affected (eg, T3 resin uptake, thyroxine assays)\"}\n",
      "Not available\n",
      "{\n",
      "  \"Urine test for amphetamines/methamphetamines\": \"May interfere with detection (false-positive)\"\n",
      "}\n",
      "{\n",
      "  \"Parathyroid function tests\": \"may be interfered with\",\n",
      "  \"Aldosterone/renin ratio (ARR) test\": \"may give a false-negative result\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names: T4-binding globulin (TBG), Thyroxine (T4), Triiodothyronine (T3), Thyroid gland hormone, Hypothalamic-pituitary axis and TSH\n",
      "\n",
      "Test results as JSON:\n",
      "\n",
      "{\n",
      "  \"TBG\": {\n",
      "    \"Conditions/Staes that increase TBG binding\": [\"Pregnancy\", \"hepatitis\", \"porphyria\", \"neonatal state\"],\n",
      "    \"Medications that increase TBG binding\": [\"Estrogens\", \"5-fluorouracil\", \"heroin\", \"methadone\", \"mitotane\", \"perphenazine\", \"selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\"],\n",
      "    \"Conditions/states that decrease TBG binding\": [\"Hepatic failure\", \"nephrosis\", \"severe illness\"],\n",
      "    \"Medications that decrease TBG binding\": [\"Androgens\", \"anabolic steroids\", \"glucocorticoids\", \"L-asparaginase\", \"nicotinic acid\"]\n",
      "  },\n",
      "  \"T4\": {\n",
      "    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\n",
      "  },\n",
      "  \"T3\": {\n",
      "    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\n",
      "  },\n",
      "  \"Thyroid gland hormone\": {\n",
      "    \"Medications affecting iodine uptake\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"ethionamide\"],\n",
      "    \"Medications affecting hormone production\": [\"Amiodarone\", \"ethionamide\", \"iodinated contrast agents\", \"iodine\", \"sulfonylureas\", \"sulfonamides\", \"thionamides (carbimazole, methimazole, propylthiouracil)\"],\n",
      "    \"Medications affecting secretion\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"lithium\"],\n",
      "    \"Medications inducing thyroiditis\": [\"Alemtuzumab\", \"amiodarone\", \"antiangiogenic agents (lenalidomide, thalidomide)\", \"denileukin diftitox\", \"interferon alpha\", \"interleukins\", \"lithium\", \"tyrosine kinase inhibitors (sunitinib, sorafenib)\"],\n",
      "    \"Medications potentially causing the development of Graves’\": [\"Alemtuzumab\", \"interferon alpha\", \"antiretroviral therapy\"],\n",
      "    \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves'\": [\"Glucocorticoids\"]\n",
      "  },\n",
      "  \"TSH\": {\n",
      "    \"Medications decreasing TSH secretion\": [\"Bexarotene\", \"dopamine\", \"dopaminergic agonists (bromocriptine, cabergoline)\", \"glucocorticoids\", \"interleukin-6\", \"metformin\", \"opiates\", \"somatostatin analogues (octreotide, lanreotide)\", \"thyroid hormone analogues\"],\n",
      "    \"Medications increasing TSH secretion\": [\"Amphetamine\", \"interleukin 2\", \"metoclopramide\", \"ritonavir\", \"St John's wort\"],\n",
      "    \"Medications potentially causing hypophysitis\": [\"Ipilimumab\"]\n",
      "  }\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names: None mentioned\n",
      "\n",
      "Test Results: None mentioned\n",
      "Test Names: \n",
      "- Stool occult blood test\n",
      "- Blood glucose testing\n",
      "- Urine glucose testing\n",
      "- Nitrite level testing\n",
      "- Bilirubin level testing\n",
      "- Leucocyte count testing\n",
      "\n",
      "Test Results: \n",
      "- Stool occult blood: False negative 48 to 72 hours after ascorbic acid ingestion\n",
      "- Blood glucose: Falsely elevated glucose measurements by point of care glucometers with high-dose ascorbic acid\n",
      "- Urine glucose: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\n",
      "- Nitrite level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\n",
      "- Bilirubin level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\n",
      "- Leucocyte count: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test name: Interferes with gastric secretion test\n",
      "Test result: Transdermal system should be discontinued ≥10 days prior to testing.\n",
      "\n",
      "JSON format: {\"Interferes with gastric secretion test\": \"Transdermal system should be discontinued ≥10 days prior to testing.\"}\n",
      "Not available\n",
      "Test name: Urinary glucose tests using cupric sulfate (Benedict's solution, Fehling’s solution, or Clinitest®)\n",
      "Test result: May interfere\n",
      "\n",
      "Test name: Aminoglycoside serum concentration\n",
      "Test result: Potential underestimation due to the acceleration of degradation by some penicillin derivatives\n",
      "\n",
      "JSON format: {\"Urinary glucose tests using cupric sulfate (Benedict's solution, Fehling’s solution, or Clinitest®)\": \"May interfere\", \"Aminoglycoside serum concentration\": \"Potential underestimation due to the acceleration of degradation by some penicillin derivatives\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names: \n",
      "1. Serum iron levels\n",
      "2. Transferrin bound iron levels\n",
      "\n",
      "Test results in JSON format:\n",
      "{\n",
      "  \"Serum iron levels\": \"not specified\",\n",
      "  \"Transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\n",
      "}\n",
      "Not available\n",
      "Test Names: Pregnancy test\n",
      "Test Results: False-positive or false-negative\n",
      "{\"opioid screening\": \"false-positive result\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"Urine detection of methadone\": \"false-positive\"}\n",
      "{\"Coombs' test [direct]\": \"false-positive\"}\n",
      "Not available\n",
      "{\n",
      "  \"urinary uric acid (phosphotungstate method)\": \"interference by Methyldopa\",\n",
      "  \"serum creatinine (alkaline picrate method)\": \"interference by Methyldopa\",\n",
      "  \"AST (colorimetric method)\": \"interference by Methyldopa\",\n",
      "  \"urinary catecholamines (falsely high levels)\": \"interference by Methyldopa\",\n",
      "  \"aldosterone/renin ratio (ARR)\": \"false-positive by Methyldopa\"\n",
      "}\n",
      "{\n",
      " \"levofloxacin\": \"false-positive urine screening result for opioids\",\n",
      " \"ofloxacin\": \"false-positive urine screening result for opioids\",\n",
      " \"other quinolones\": \"cross-reactivity in certain assay kits\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names: \n",
      "- Plasma glucose\n",
      "- Uric acid\n",
      "- Free fatty acids\n",
      "- Total cholesterol\n",
      "- HDL\n",
      "- HDL/LDL ratio\n",
      "- Urinary free cortisol excretion\n",
      "- Triiodothyronine\n",
      "\n",
      "JSON format: \n",
      "{\n",
      "\"Plasma glucose\": <test result>,\n",
      "\"Uric acid\": <test result>,\n",
      "\"Free fatty acids\": <test result>,\n",
      "\"Total cholesterol\": <test result>,\n",
      "\"HDL\": <test result>,\n",
      "\"HDL/LDL ratio\": <test result>,\n",
      "\"Urinary free cortisol excretion\": <test result>,\n",
      "\"Triiodothyronine\": <test result>\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"coagulation\": \"Altered\", \"fibrinolytic activity\": \"Altered\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "\"skin test antigens\": \"suppressed\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Ceftazidime\": \"Positive direct Coomb\",\n",
      "  \"Urine glucose\": \"False-positive with certain methods; use glucose tests based on enzymatic glucose oxidase reactions\"\n",
      "}\n",
      "{\n",
      "  \"Serum Iron\": \"Transitory changes observed\",\n",
      "  \"Serum Calcium\": \"May interfere with colorimetric tests; alternate testing method recommended for 12-24 hours after administration\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"Urinary Catecholamines\": \"False-positive (fluorometric assay)\",\n",
      "  \"17-hydroxycorticosteroids\": \"False-positive\",\n",
      "  \"17-ketosteroids\": \"False-positive\"\n",
      "}\n",
      "Test names: \n",
      "1. Serum TCA screen\n",
      "2. Skin test antigens\n",
      "\n",
      "Test results:\n",
      "1. False-positive\n",
      "2. Suppressed wheal and flare reactions\n",
      "Not available\n",
      "Test names: \n",
      "1. Coombs' test\n",
      "2. Aldosterone/renin ratio\n",
      "\n",
      "Test results:\n",
      "1. Positive\n",
      "2. False-positive\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names: \n",
      "1. MR imaging \n",
      "2. Serum Iron \n",
      "3. Transferrin-bound Iron \n",
      "\n",
      "Corresponding Test Results in JSON:\n",
      "{\n",
      "  \"MR imaging\": \"May interfere with imaging; alterations may persist for ≤3 months following use, with peak alterations anticipated in the first 2 days following administration. If MR imaging is required within 3 months after administration, use T1- or proton density-weighted MR pulse sequences to decrease effect on imaging. Do not use T2-weighted sequence MR imaging prior to 4 weeks following administration.\",\n",
      "  \"Serum Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\",\n",
      "  \"Transferrin-bound Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\"\n",
      "}\n",
      "Test Names: \n",
      "1. Blood glucose levels\n",
      "2. Serologic testing results\n",
      "3. Direct Coombs' test\n",
      "4. Indirect Coombs' test\n",
      "\n",
      "Corresponding Test Results in JSON:\n",
      "{\n",
      "  \"Blood glucose levels\": \"Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\",\n",
      "  \"Serologic testing results\": \"Passively transferred antibodies may yield false-positive results.\",\n",
      "  \"Direct Coombs' test\": \"Passively transferred antibodies may yield false-positive results.\",\n",
      "  \"Indirect Coombs' test\": \"Passively transferred antibodies may yield false-positive results.\"\n",
      "}\n",
      "Test Names: \n",
      "1. Serum chromogranin A (CgA) levels\n",
      "\n",
      "Corresponding Test Results in JSON:\n",
      "{\n",
      "  \"Serum chromogranin A (CgA) levels\": \"Omeprazole may falsely elevate CgA levels, causing false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "\"Medical Test Name\": \"Detection of urine protein\",\n",
      "\"Test Result\": \"False positive when pyrogallol red reagent is used\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"amylase\": \"increased\",\n",
      "  \"BSP retention\": \"increased\",\n",
      "  \"CPK\": \"increased\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"serum progesterone assay\": \"may interfere\",\n",
      "  \"interaction\": \"may be observed\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\n",
      "}\n",
      "{\n",
      "  \"blood ethylene glycol concentrations\": \"false positive\",\n",
      "  \"inorganic phosphorus blood concentrations\": \"false low\"\n",
      "}\n",
      "{\n",
      "  \"gastric secretion test\": \"interference\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Bone imaging studies\": \"May interfere with\",\n",
      "  \"Hematopoietic activity\": \"increased\",\n",
      "  \"Bone marrow\": \"May appear as transient positive bone imaging changes.\"\n",
      "}\n",
      "{\n",
      "  \"Medical test names\": [\n",
      "    \"Aldosterone/renin ratio (ARR)\"\n",
      "  ],\n",
      "  \"Test results\": [\n",
      "    \"False-negative\"\n",
      "  ]\n",
      "}\n",
      "{\"urine glucose\": \"may interfere with tests containing cupric sulfate (Benedict's solution, Clinitest)\", \"Coombs' test\": \"positive\"}\n",
      "{\"glucose\": \"increased\", \"HDL\": \"decreased\", \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"}\n",
      "Not available\n",
      "Not available\n",
      "Test names and their respective results:\n",
      "\n",
      "1. Direct and Indirect Coombs' - Positive \n",
      "2. Urinary glucose test using Benedict's copper reduction reaction - False-Positive \n",
      "3. Serum or urine creatinine with Jaffé reaction - False-Positive \n",
      "4. Aminoglycoside serum concentration - Potentially underestimated \n",
      "\n",
      "JSON format:\n",
      "\n",
      "{\n",
      "   \"Direct and Indirect Coombs'\": \"Positive\",\n",
      "   \"Urinary glucose test using Benedict's copper reduction reaction\": \"False-Positive\",\n",
      "   \"Serum or urine creatinine with Jaffé reaction\": \"False-Positive\",\n",
      "   \"Aminoglycoside serum concentration\": \"Potentially underestimated\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"urine glucose test\": \"may interfere with containing cupric sulfate (Benedict's solution, Clinitest)\", \"Coombs' test\": \"positive\"}\n",
      "Not available\n",
      "Not available\n",
      "Test Names:\n",
      "\n",
      "1. Urine glucose test containing cupric sulfate\n",
      "2. Coombs' test\n",
      "\n",
      "Test Results in JSON format:\n",
      "\n",
      "{\n",
      "  \"Urine glucose test containing cupric sulfate\": \"May interfere\",\n",
      "  \"Coombs' test\": \"Positive\"\n",
      "}\n",
      "Test Names:\n",
      "\n",
      "1. Aldosterone/renin ratio (ARR)\n",
      "\n",
      "Test Results in JSON format:\n",
      "\n",
      "{\n",
      "  \"Aldosterone/renin ratio (ARR)\": \"May lead to false-negative\"\n",
      "}\n",
      "Not available\n",
      "{\"coagulation\": \"Altered results\", \"fibrinolytic activity\": \"Altered results\"}\n",
      "Not available\n",
      "Not available\n",
      "{\"aldosterone/renin ratio\": \"false-negative\", \"ARR\": \"false-negative\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names: \n",
      "1. Digitalis immunoassay \n",
      "2. Digoxin serum samples\n",
      "\n",
      "Test Results: \n",
      "{\n",
      "   \"Digitalis immunoassay\": \"may be clinically misleading until all Fab fragments are eliminated from the body\",\n",
      "   \"Digoxin serum samples\": \"should be obtained before digoxin immune fab administration, if possible\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "\"skin test antigens\": \"suppressed\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "\"urinary 5-hydroxyindoleacetic acid\": \"false-positive\"\n",
      "}\n",
      "{\n",
      "\"enzymatic methods used to detect opioids\": \"interference (refer to test manufacturer for details)\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"skin tests\": \"decreased response\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Medical tests names: \n",
      "1. Urine glucose determinations \n",
      "2. Certain lab tests \n",
      "\n",
      "JSON output: \n",
      "{\n",
      "  \"Urine glucose determinations\": \"false-negative\",\n",
      "  \"Certain lab tests\": \"incorrect\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Medical tests names: PT/INR\n",
      "\n",
      "JSON output: {\"PT/INR\": \"unreliable within 5 hours\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Name: Aldosterone/Renin ratio (ARR)\n",
      "Test Result: May lead to false-negative.\n",
      "Test Name: Aldosterone/Renin ratio (ARR)\n",
      "Test Result: May lead to false-positive.\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Folic acid\": \"invalidated\",\n",
      "  \"Vitamin B12\": \"invalidated\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Opioid screening test\": \"false-positive (when taking some quinolones)\",\n",
      "  \"Specific confirmation test\": \"recommended\"\n",
      "}\n",
      "Test names:\n",
      "- Urine specimen assay\n",
      "\n",
      "Test results in JSON form:\n",
      "{\n",
      " \"Urine specimen assay\": \"N/A\"\n",
      "} \n",
      "(Note: \"N/A\" is the value because no specific test result is mentioned in the sentence)\n",
      "Not available\n",
      "Test names:\n",
      "- Direct Coombs' test\n",
      "- Urinary glucose test\n",
      "- Serum creatinine test\n",
      "- Urine creatinine test\n",
      "\n",
      "Test results in JSON form:\n",
      "{\n",
      " \"Direct Coombs' test\": \"Positive\",\n",
      " \"Urinary glucose test\": \"False-positive\",\n",
      " \"Serum creatinine test\": \"False-positive\",\n",
      " \"Urine creatinine test\": \"False-positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "1) Medical test names: \n",
      "- Rapid plasma reagin (RPR) test\n",
      "2) Test results in JSON format:\n",
      "- For RPR test: {\"Rapid plasma reagin (RPR) test\": \"false-positive due to smallpox vaccine\"}\n",
      "\n",
      "1) Medical test names:\n",
      "- Tuberculin skin (PPD) and blood tests\n",
      "2) Test results in JSON format:\n",
      "- For Tuberculin skin (PPD) and blood tests: {\"Tuberculin skin (PPD) and blood tests\": \"false-negative due to smallpox vaccine\"}\n",
      "Not available\n",
      "Not available\n",
      "1) Medical test names:\n",
      "- Bone scan (diagnostic imaging with technetium-99m-diphosphonate)\n",
      "2) Test results in JSON format:\n",
      "- For bone scan: {\"Bone scan\": \"may be interfered by bisphosphonates except clodronate, according to some studies\"}\n",
      "Not available\n",
      "Not available\n",
      "Test Names: Lactobacillus casei assay method\n",
      "Test Result: Falsely low serum concentrations may occur in patients on anti-infectives (eg, tetracycline)\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names: \n",
      "1. Urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®)\n",
      "2. Aminoglycoside activity test\n",
      "3. Urinary protein test\n",
      "4. Serum protein test\n",
      "\n",
      "Test Results:\n",
      "1. May interfere\n",
      "2. May inactivate in vitro\n",
      "3. False positive in urinary test\n",
      "4. False positive in serum test\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names: \n",
      "1) Direct Coombs' test\n",
      "2) Urinary glucose test\n",
      "3) Serum or urine creatinine test with Jaffé reaction\n",
      "\n",
      "JSON Form: \n",
      "{\n",
      "  \"Direct Coombs' test\": \"Positive\",\n",
      "  \"Urinary glucose test\": \"False-positive\",\n",
      "  \"Serum or urine creatinine test with Jaffé reaction\": \"May cause false-positive\"\n",
      "}\n",
      "Not available\n",
      "Test Name: Aldosterone/Renin Ratio (ARR)\n",
      "Test Result: May lead to false-negative (Funder 2016)\n",
      "Not available\n",
      "Test Names: laboratory tests related to coagulation factors, lipids, glucose tolerance, thyroxine-binding globulin, sex hormone-binding globulin, cortisol-binding globulin\n",
      "Test Result: The use of estrogens and/or progestogens may alter the results (general statement)\n",
      "Not available\n",
      "Not available\n",
      "Test names: \n",
      "1. Technetium-99m-diphosphonate bone scan \n",
      "\n",
      "Test results:\n",
      "{\n",
      "\"Technetium-99m-diphosphonate bone scan\": \"may be interfered with by Bisphosphonates\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Test names: \n",
      "1. Coombs' test [direct]\n",
      "\n",
      "Test results:\n",
      "{\n",
      "\"Coombs' test [direct]\": \"false-positive \"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"dexamethasone suppression test\": \"false-negative\",\n",
      "  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\n",
      "}\n",
      "{\n",
      "    \"phenylketonuria\": \"false-positive\",\n",
      "    \"amylase\": \"false-positive\",\n",
      "    \"uroporphyrins\": \"false-positive\",\n",
      "    \"urobilinogen\": \"false-positive\",\n",
      "    \"pregnancy test\": \"false-positive\",\n",
      "    \"amphetamine/methamphetamine\": \"false-positive\",\n",
      "    \"methadone\": \"false-positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "1. Medical test name: Urinary glucose tests\n",
      "   Test result: May interfere with using cupric sulfate (Benedict's solution, Clinitest®)\n",
      "\n",
      "2. Medical test name: Aminoglycoside serum concentration\n",
      "   Test result: Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives.\n",
      "Medical test name: Serum creatinine values\n",
      "Test result: Markedly false elevations when the Ektachem® analyzer is used. The Jaffé reaction is recommended for determining serum creatinine.\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names: \n",
      "1. Urine screening test for opioids using commercially-available immunoassay kits\n",
      "\n",
      "Test results:\n",
      "1. False-positive results for opioids may be produced by some quinolones, especially levofloxacin and ofloxacin\n",
      "2. Other quinolones may also show cross-reactivity in certain assay kits.\n",
      "3. Positive opioid screens should be confirmed by more specific methods.\n",
      "Test names: \n",
      "1. Skin test\n",
      "\n",
      "Test results:\n",
      "1. Decreased response to skin tests.\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "    \"Urinary glucose tests using cupric sulfate\": \"May interfere\",\n",
      "    \"Aminoglycosides\": \"May inactivate in vitro\",\n",
      "    \"Urine proteins\": \"False-positive\",\n",
      "    \"Serum proteins\": \"False-positive\",\n",
      "    \"Uric acid\": \"False-positive\",\n",
      "    \"Urinary steroids\": \"False-positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Medical Test Name\": \"TPMT phenotyping\",\n",
      "  \"Test Result\": \"May not be accurate following recent blood transfusions.\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Serum renin concentrations\": \"increased\",\n",
      "  \"IgG concentrations\": \"increased\",\n",
      "  \"Serum cortisol concentrations\": \"decreased\",\n",
      "  \"insulin response to glucagon\": \"false-negative\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"fluorescence test for urinary catecholamines\":\"false elevations\"}\n",
      "Not available\n",
      "Not available\n",
      "I'm sorry, but I cannot extract the medical test names and their results without any input data. Please provide the data.\n",
      "Not available\n",
      "Not available\n",
      "{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"cross-reactivity\", \"ofloxacin\": \"cross-reactivity\", \"other quinolones\": \"cross-reactivity\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names: \n",
      "1. PT/INR levels\n",
      "2. Chromogenic factor X assay\n",
      "3. Factor Xa levels\n",
      "\n",
      "Test results:\n",
      "{\n",
      "  \"PT/INR levels\": \"elevated in the absence of warfarin, may require modification while on argatroban\",\n",
      "  \"Chromogenic factor X assay\": \"suggested to be monitored when transitioning from argatroban to warfarin or overlapping administration of warfarin for a minimum of 5 days until INR is within target range, recheck INR after anticoagulant effect of argatroban has dissipated\",\n",
      "  \"Factor Xa levels\": \"associated with INR values >2 after the effects of argatroban have been eliminated\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"Test name\": \"Polymerase chain reaction (PCR) assay for HIV\",\n",
      "  \"Test result\": \"False-positive for HIV in patients who have received betibeglogene autotemcel due to integrated BB305 LVV proviral DNA\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Medical Test Names: Serum magnesium test and Urine magnesium test.\n",
      "\n",
      "JSON output:\n",
      "{\n",
      " \"Serum magnesium test\": \"falsely decreased\",\n",
      " \"Urine magnesium test\": \"falsely decreased\"\n",
      "}\n",
      "Not available\n",
      "Medical Test Names: Coombs' test and Urinary protein test.\n",
      "\n",
      "JSON output:\n",
      "{\n",
      " \"Coombs' test\": \"positive\",\n",
      " \"Urinary protein test\": \"false-positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"metyrapone test\": \"reduced response\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"anti-FXa activity assay\": \"falsely elevated after andexanet alfa administration\",\n",
      "  \"andexanet alfa\": \"reversal activity\"\n",
      "}\n",
      "{\n",
      "    \"Positive direct Coombs'\": \"positive\",\n",
      "    \"false-positive urinary glucose test using nonenzymatic methods\": \"false-positive\",\n",
      "    \"false-positive galactosemia tests\": \"false-positive\"\n",
      "}\n",
      "{\n",
      "    \"test name\": \"amphetamine EMIT assay\",\n",
      "    \"test result\": \"false positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "   \"Thyroid function tests\": \"Altered\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Plasma glucose\": \"increased\",\n",
      "  \"Uric acid\": \"increased\",\n",
      "  \"Free fatty acids\": \"increased\",\n",
      "  \"Total cholesterol\": \"increased\",\n",
      "  \"HDL\": \"increased\",\n",
      "  \"HDL/LDL ratio\": \"increased\",\n",
      "  \"Urinary free cortisol excretion\": \"increased\",\n",
      "  \"Triiodothyronine\": \"decreased\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Medical Test Name: Urine Detection of Phencyclidine\n",
      "Test Result: False-Positive\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "1. Medical tests mentioned in the given data:\n",
      "- Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\n",
      "- Glucose-specific method\n",
      "- Urinalysis\n",
      "- Serologic testing\n",
      "- Direct and indirect Coombs’ test\n",
      "\n",
      "2. Test results in JSON form:\n",
      "{\n",
      "  \"Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\": \"falsely elevated blood glucose levels\",\n",
      "  \"Glucose-specific method\": \"recommended\",\n",
      "  \"Urinalysis\": \"transiently elevated glucose\",\n",
      "  \"Serologic testing\": \"false-positive results\",\n",
      "  \"Direct and indirect Coombs’ test\": \"false-positive results\"\n",
      "}\n",
      "{\n",
      "    \"AST\": \"interfere\",\n",
      "    \"ALT\": \"interfere\",\n",
      "    \"triglycerides\": \"interfere\",\n",
      "    \"glucose\": \"interfere\",\n",
      "    \"LDH\": \"interfere\"\n",
      "}\n",
      "1. Medical test mentioned in the given data:\n",
      "- Skin test for wheal and flare reactions to antigens \n",
      "\n",
      "2. Test result in JSON form:\n",
      "{\n",
      "  \"Skin test for wheal and flare reactions to antigens\": \"may be suppressed\"\n",
      "}\n",
      "Not available\n",
      "1. Medical test mentioned in the given data:\n",
      "- Digoxin radioimmunoassay \n",
      "\n",
      "2. Test result in JSON form:\n",
      "{\n",
      "  \"Digoxin radioimmunoassay\": \"may be interfered\"\n",
      "}\n",
      "Not available\n",
      "Test Names: Methotrexate levels\n",
      "Test Result: {\"Methotrexate levels\": \"the chromatographic method\"}\n",
      "Not available\n",
      "Test Names: \n",
      "1. Urine catecholamines\n",
      "2. Metanephrine \n",
      "3. Normetanephrine \n",
      "4. Vanillylmandelic acid (VMA) \n",
      "5. Urine amphetamine \n",
      "6. Aldosterone/renin ratio (ARR)\n",
      "\n",
      "Test Results:\n",
      "{\n",
      "   \"Urine catecholamines\": \"HPLC assay with solid-phase extraction should be used to determine levels of catecholamines\",\n",
      "   \"Metanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of metanephrine\",\n",
      "   \"Normetanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of normetanephrine\",\n",
      "   \"Vanillylmandelic acid (VMA)\": \"HPLC assay with solid-phase extraction should be used to determine levels of VMA\",\n",
      "   \"Urine amphetamine\": \"Gas chromatographic-mass spectrometer technique should be used to determine levels of amphetamine\",\n",
      "   \"Aldosterone/renin ratio (ARR)\": \"May lead to a false-positive result\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names:\n",
      "- Urinary glucose determination using Clinitest®\n",
      "- Coombs' direct\n",
      "\n",
      "Test Results (in json format):\n",
      "{\n",
      "  \"Urinary glucose determination using Clinitest®\": \"Interfered\",\n",
      "  \"Coombs' direct\": \"Positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"phencyclidine\": \"false-positives\",\n",
      "  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"aldosterone/renin ratio (ARR)\": \"false-positive\"}\n",
      "Not available\n",
      "{\"renin (S)\": \"increased\",\n",
      " \"aldosterone (S)\": \"increased\"}\n",
      "Not available\n",
      "Not available\n",
      "{\"PCR assays for HIV\": \"positive\", \"HIV infection using a PCR-based assay\": \"false-positive\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names:\n",
      "- PT (Prothrombin Time) test\n",
      "- INR (International Normalized Ratio) test\n",
      "\n",
      "Test Results (in JSON form):\n",
      "{\n",
      "  \"PT (Prothrombin Time) test\": \"false prolongation with certain recombinant thromboplastin reagents when taking daptomycin\",\n",
      "  \"INR (International Normalized Ratio) test\": \"increase with certain recombinant thromboplastin reagents when taking daptomycin\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "   \"Test Name\": \"Coombs test\",\n",
      "   \"Test Result\": \"Positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Coombs' test (direct)\": \"Positive\",\n",
      "  \"Urinary proteins\": \"False-positive\",\n",
      "  \"Serum proteins\": \"False-positive\",\n",
      "  \"Aminoglycoside inactivation\": \"In vitro\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Stool occult blood test\": \"False-negative\",\n",
      "  \"Blood glucose testing\": \"Interference (falsely-elevated)\",\n",
      "  \"Urine glucose testing\": \"Interference\",\n",
      "  \"Nitrite levels\": \"Interference\",\n",
      "  \"Bilirubin levels\": \"Interference\",\n",
      "  \"Leucocyte count\": \"Interference\"\n",
      "}\n",
      "{\n",
      "  \"One-stage clotting assay (OSA)\": \"Affected by aPTT reagent and reference standard used; recommended for monitoring factor IX activity over time with the same assay and reagents\",\n",
      "  \"Activated partial thromboplastin time (aPTT)\": \"Type of reagent used affects results when using OSA to determine factor IX activity\",\n",
      "  \"Chromogenic substrate assay (CSA)\": \"Results in lower factor IX activity compared to OSA; mean CSA to OSA factor IX activity ratio ranging from 0.41 to 0.55 in clinical study\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"positive\", \"ofloxacin\": \"positive\"}\n",
      "{\"urinary glucose determination using Clinitest\": \"interferes\", \"Coombs' [direct]\": \"positive\"}\n",
      "Not available\n",
      "Test Names: \n",
      "1. Serum Protein Electrophoresis (SPEP)\n",
      "2. Serum Immunofixation Assays\n",
      " \n",
      "Test Results in JSON Format:\n",
      "{\n",
      "   \"SPEP\": \"A small peak in the early gamma region\",\n",
      "   \"Serum Immunofixation Assays\": \"may potentially be attributed to elotuzumab\"\n",
      "}\n",
      "Not available\n",
      "Test Name:\n",
      "1. Serum Iron Test\n",
      "\n",
      "Test Result in JSON Format:\n",
      "{\n",
      "   \"Serum Iron Test\": \"Falsely high or low values of serum iron (if determined by complexometric methods) may occur for up to 24 hours following administration.\"\n",
      "}\n",
      "Test Names:\n",
      "1. Urinary 5-hydroxyindoleacetic acid test\n",
      "2. Urine detection of Phencyclidine test\n",
      "3. Aldosterone/Renin Ratio (ARR) test\n",
      "\n",
      "Test Results in JSON Format:\n",
      "{\n",
      "   \"Urinary 5-hydroxyindoleacetic acid test\": \"false-positive due to Acetaminophen\",\n",
      "   \"Urine detection of Phencyclidine test\": \"false-positives due to Ibuprofen\",\n",
      "   \"Aldosterone/Renin Ratio (ARR) test\": \"false-positive due to Ibuprofen\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "1. Medical test names:\n",
      "- Urine screening test for opioids using immunoassay kits\n",
      "- Confirmation test for positive opioid screens using more specific methods\n",
      "- Urine methadone screens using immunoassay kits\n",
      "\n",
      "2. Test Results in JSON format:\n",
      "{\n",
      "  \"Urine screening test for opioids using immunoassay kits\": \"false-positive for opioids with quinolones (levofloxacin and ofloxacin) and other medications (not specified)\",\n",
      "  \"Confirmation test for positive opioid screens using more specific methods\": \"not specified\",\n",
      "  \"Urine methadone screens using immunoassay kits\": \"false-positive in patients taking diphenhydramine, doxylamine, clomipramine, chlorpromazine, thioridazine, quetiapine, and verapamil\"\n",
      "}\n",
      "1. Medical test names:\n",
      "- Rabbit antibody-based immunoassays\n",
      "- Cross-match or panel-reactive antibody cytotoxicity assays\n",
      "- Routine clinical laboratory tests which use immunoglobulins\n",
      "\n",
      "2. Test Results in JSON format:\n",
      "{\n",
      "  \"Rabbit antibody-based immunoassays\": \"potential interference\",\n",
      "  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"potential interference\",\n",
      "  \"Routine clinical laboratory tests which use immunoglobulins\": \"no interference shown\"\n",
      "}\n",
      "Not available\n",
      "I'm sorry, I cannot extract the medical test names and their results without any specific data to refer to. Please provide the necessary information.\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names: Not specified in the given data.\n",
      "Test Results:\n",
      "{\n",
      "\"Urine Protein Detection with Pyrogallol Red reagent\": \"May give false positive results if Viltolarsen is present in urine\",\n",
      "\"Urine Protein Detection with other test methods\": \"Not affected by Viltolarsen\",\n",
      "\"Timeframe for avoiding false positives\": \"Urine obtained prior to infusion or ≥48 hours after infusion\",\n",
      "}\n",
      "Not available\n",
      "Medical Test Name: PHOSm assay\n",
      "\n",
      "Test Result JSON: {\"PHOSm assay\": \"Falsely-elevated serum phosphate\"}\n",
      "Not available\n",
      "Medical Test Names: \n",
      "1. Phosphotungstate method for uric acid\n",
      "2. Ehrlich's reagent for urobilinogen\n",
      "3. Spectrophotometric determination of serum theophylline concentration\n",
      "\n",
      "Test Result JSON: \n",
      "{\n",
      "   \"Phosphotungstate method for uric acid\": \"False-positive\",\n",
      "   \"Ehrlich's reagent for urobilinogen\": \"False-positive\",\n",
      "   \"Spectrophotometric determination of serum theophylline concentration\": \"Interference with large doses\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Urinary protein with Albustix\": \"false-positive\",\n",
      "  \"Labstix\": \"false-positive\",\n",
      "  \"Albutest\": \"false-positive\",\n",
      "  \"Bumintest\": \"false-positive\",\n",
      "  \"HPLC theophylline assay\": \"interference\",\n",
      "  \"Serum uric acid levels\": \"interference\",\n",
      "  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\n",
      "}\n",
      "{\n",
      "  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"Diagnostic serum tests that utilize antibodies\": \"interference\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"serologic testing\": \"false-positive\", \"direct Coombs test\": \"false-positive\", \"indirect Coombs test\": \"false-positive\"}\n",
      "Not available\n",
      "{\n",
      "  \"Dehydrogenase Pyrroloquinolinequinone\": \"Falsely elevated blood glucose levels\",\n",
      "  \"Glucose-dye-oxidoreductase\": \"Falsely elevated blood glucose levels\",\n",
      "  \"Glucose Dehydrogenase Nicotine Adenine Dinucleotide (GDH-NAD)\": \"Recommended glucose monitoring method\",\n",
      "  \"Glucose Oxidase\": \"Recommended glucose monitoring method\",\n",
      "  \"Glucose Hexokinase\": \"Recommended glucose monitoring method\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Medical Test Names\": [\n",
      "    \"Aminoglycoside Serum Concentration\"\n",
      "  ],\n",
      "  \"Test Results\": [\n",
      "    \"Potential Underestimation\"\n",
      "  ]\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"Medical Test Names\": [\n",
      "    \"Aldosterone/Renin Ratio (ARR)\"\n",
      "  ],\n",
      "  \"Test Results\": [\n",
      "    \"False-Negative\"\n",
      "  ]\n",
      "}\n",
      "{\n",
      " \"urinary glucose determination using Clinitest\": \"false-positive or negative\",\n",
      " \"Coombs' [direct]\": \"positive\",\n",
      " \"urinary and/or serum proteins by certain test methods\": \"false-positive\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"Positive direct Coombs\": \"Positive\",\n",
      "  \"urinary glucose test using cupric sulfate\": \"False-positive\",\n",
      "  \"serum or urine creatinine with Jaffé reaction\": \"False-positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Medical test names:\n",
      "1. Indirect antiglobulin test (indirect Coombs test)\n",
      "2. Serum protein electrophoresis\n",
      "3. Immunofixation assays\n",
      "\n",
      "JSON form:\n",
      "{\n",
      "  \"Indirect antiglobulin test (indirect Coombs test)\": \"Positive\",\n",
      "  \"Serum protein electrophoresis\": \"Detected\",\n",
      "  \"Immunofixation assays\": \"Interference\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Medical test names:\n",
      "1. Gastric secretion test\n",
      "\n",
      "JSON form:\n",
      "{\n",
      "  \"Gastric secretion test\": \"Interference\"\n",
      "}\n",
      "Test names: Urine ketones, Thyroid function tests\n",
      "\n",
      "Test results as JSON:\n",
      "\n",
      "{\n",
      "  \"Urine ketones\": {\n",
      "    \"Effect\": \"May cause a false-positive result\",\n",
      "    \"Medication\": \"Valproate\",\n",
      "    \"Mode of elimination\": \"Partially eliminated as a keto-metabolite in the urine\"\n",
      "  },\n",
      "  \"Thyroid function tests\": {\n",
      "    \"Effect\": \"May alter\"\n",
      "  }\n",
      "}\n",
      "Test names: Urine dipstick tests (urine protein, ketones, occult blood)\n",
      "\n",
      "Test results as JSON:\n",
      "\n",
      "{\n",
      "  \"Urine dipstick tests\": {\n",
      "    \"Effects\": [\"May result in false-positive urine dipstick tests\"],\n",
      "    \"Examples of tests affected\": [\"Urine protein\", \"ketones\", \"occult blood\"]\n",
      "  }\n",
      "}\n",
      "Test names: Phenylketonuria test, Pregnancy test\n",
      "\n",
      "Test results as JSON:\n",
      "\n",
      "{\n",
      "  \"Phenylketonuria test\": {\n",
      "    \"Effect\": \"False-positives\"\n",
      "  },\n",
      "  \"Pregnancy test\": {\n",
      "    \"Effect\": \"False-positives\"\n",
      "  }\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names:\n",
      "1. Rabbit antibody-based immunoassays\n",
      "2. Cross-match or panel-reactive antibody cytotoxicity assays\n",
      "\n",
      "Test Results (in JSON format):\n",
      "{\n",
      "  \"Rabbit antibody-based immunoassays\": \"Potential interference\",\n",
      "  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"Potential interference\",\n",
      "  \"Routine clinical laboratory tests which do not use immunoglobulins\": \"No interference shown\"\n",
      "}\n",
      "{\"Positive Coombs'\": \"Positive\"}\n",
      "{\"serum TCA screen\": \"false-positive\"}\n",
      "Not available\n",
      "{\"urine screening result for opioids\": \"false-positive\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Name: Urine Test with Blue Indicator\n",
      "Test Result: Interfered\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "    \"test name\": \"Urinary ketones\",\n",
      "    \"test result\": \"false positive in patients receiving mesna with nitroprusside-based urine tests\"\n",
      "},\n",
      "{\n",
      "    \"test name\": \"CPK activity\",\n",
      "    \"test result\": \"may interfere with enzymatic CPK activity tests which use a thiol compound, resulting in a falsely low CPK level\"\n",
      "},\n",
      "{\n",
      "    \"test name\": \"Ascorbic acid\",\n",
      "    \"test result\": \"may result in false-positive reactions in Tillman's reagent-based urine screening tests\"\n",
      "}\n",
      "{\n",
      "    \"test name\": \"urinary glucose tests\",\n",
      "    \"test result\": \"may interfere with tests using cupric sulfate, but tests based on enzymatic glucose oxidase reactions are recommended\"\n",
      "},\n",
      "{\n",
      "    \"test name\": \"plasma concentrations of certain hormones in pregnant women\",\n",
      "    \"test result\": \"may be transiently interfered with by ampicillin, including total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"CD20 assay\": \"interfered\", \"CD19+ assay\": \"measure B-cell counts\"}\n",
      "Not available\n",
      "{\"procainamide/N-acetyl procainamide concentration test\": \"affected\"}\n",
      "Not available\n",
      "Medical Test Names:\n",
      "1. Serum bilirubin\n",
      "2. Serum calcium\n",
      "3. Examination of bone marrow iron stores\n",
      "4. Bone scans with 99m Tc-labeled bone seeking agents\n",
      "5. Bone scans with 99m Tc-diphosphonate\n",
      "\n",
      "Test Results in JSON Form:\n",
      "{\n",
      "\"Serum bilirubin\": \"falsely elevated values\",\n",
      "\"Serum calcium\": \"falsely decreased values\",\n",
      "\"Examination of bone marrow iron stores\": \"Residual iron dextran may remain in reticuloendothelial cells affecting accuracy\",\n",
      "\"Bone scans with 99m Tc-labeled bone seeking agents\": \"reduced bony uptake, marked renal activity, and excess blood pooling and soft tissue accumulation following IV iron dextran infusion or with high serum ferritin levels\",\n",
      "\"Bone scans with 99m Tc-diphosphonate\": \"dense activity in the buttocks following IM iron dextran\"\n",
      "}\n",
      "Medical Test Names:\n",
      "1. Urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest)\n",
      "2. Coombs' test\n",
      "\n",
      "Test Results in JSON Form:\n",
      "{\n",
      "\"Urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest)\": \"May interfere\",\n",
      "\"Coombs' test\": \"positive\"\n",
      "}\n",
      "Medical Test Names:\n",
      "1. Iodine-binding capacity of thyroid tissue\n",
      "2. Diagnostic tests using iodine-containing isotopes\n",
      "3. Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\n",
      "\n",
      "Test Results in JSON Form:\n",
      "{\n",
      "\"Iodine-binding capacity of thyroid tissue\": \"reduced for up to 2 weeks following administration of contrast media\",\n",
      "\"Diagnostic tests using iodine-containing isotopes\": \"may be affected\",\n",
      "\"Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\": \"not affected\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"PT/INR\": [\"elevated\"], \n",
      "  \"bivalirudin\": [\"modification\"]\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "```\n",
      "{\n",
      "    \"Test Name\": \"Fluorescence Test for Urinary Catecholamines\",\n",
      "    \"Test Result\": \"False Elevations\"\n",
      "}\n",
      "```\n",
      "```\n",
      "{\n",
      "    \"Test Name 1\": \"Activated Clotting Time (ACT)\",\n",
      "    \"Test Result 1\": \"Artificially Prolonged\",\n",
      "    \n",
      "    \"Test Name 2\": \"aPTT\",\n",
      "    \"Test Result 2\": \"Artificially Prolonged\",\n",
      "    \n",
      "    \"Test Name 3\": \"Prothrombin Time\",\n",
      "    \"Test Result 3\": \"Artificially Prolonged\",\n",
      "    \n",
      "    \"Test Name 4\": \"International Normalized Ratio\",\n",
      "    \"Test Result 4\": \"Artificially Prolonged\",\n",
      "    \n",
      "    \"Test Name 5\": \"Silica Clot Time (SCT)\",\n",
      "    \"Test Result 5\": \"Artificially Prolonged\",\n",
      "    \n",
      "    \"Test Name 6\": \"Dilute Russell's Viper Venom Time (DRVVT)\",\n",
      "    \"Test Result 6\": \"Artificially Prolonged\",\n",
      "    \n",
      "    \"Test Name 7\": \"D-dimer\",\n",
      "    \"Test Result 7\": \"Artificially Prolonged\",\n",
      "    \n",
      "    \"Test Name 8\": \"Indirect Antiglobulin Test\",\n",
      "    \"Test Result 8\": \"Positive\",\n",
      "    \n",
      "    \"Test Name 9\": \"Direct Antiglobulin Test\",\n",
      "    \"Test Result 9\": \"Positive\"\n",
      "}\n",
      "```\n",
      "Not available\n",
      "Medical Tests:\n",
      "1. Urinary 5-hydroxyindoleacetic acid \n",
      "2. Urine detection of phencyclidine \n",
      "3. Aldosterone/Renin ratio\n",
      "\n",
      "Test Results:\n",
      "{\n",
      "\"Urinary 5-hydroxyindoleacetic acid\": \"False-positive\",\n",
      "\"Urine detection of phencyclidine\": \"False-positive\",\n",
      "\"Aldosterone/Renin ratio\": \"False-positive\"\n",
      "}\n",
      "Not available\n",
      "Medical Tests:\n",
      "1. Cellular CD22 Detection\n",
      "2. CD19+ B Cells Surrogate Assay\n",
      "\n",
      "Test Results:\n",
      "{\n",
      "\"Cellular CD22 Detection\": \"Interference\",\n",
      "\"CD19+ B Cells Surrogate Assay\": \"Normal\"\n",
      "}\n",
      "Medical Tests:\n",
      "1. PT\n",
      "2. INR\n",
      "3. aPTT\n",
      "4. ACT\n",
      "5. Xa (coagulation based assay)\n",
      "6. Bleeding time\n",
      "7. Factor Xa (chromogenic assay)\n",
      "8. Platelet aggregation study\n",
      "9. Thrombin time\n",
      "10. Urine protein via qualitative dipstick\n",
      "11. Urine protein via quantitative dye methods\n",
      "\n",
      "Test Results:\n",
      "{\n",
      "\"PT\": \"Artificially increased clotting times\",\n",
      "\"INR\": \"Artificially increased clotting times\",\n",
      "\"aPTT\": \"Artificially increased clotting times\",\n",
      "\"ACT\": \"Artificially increased clotting times\",\n",
      "\"Xa (coagulation based assay)\": \"Artificially increased clotting times\",\n",
      "\"Bleeding time\": \"Normal\",\n",
      "\"Factor Xa (chromogenic assay)\": \"Normal\",\n",
      "\"Platelet aggregation study\": \"Normal\",\n",
      "\"Thrombin time\": \"Normal\",\n",
      "\"Urine protein via qualitative dipstick\": \"Interference\",\n",
      "\"Urine protein via quantitative dye methods\": \"Interference\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"5-HIAA\": \"color interference\",\n",
      "  \"VMA\": \"color interference\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Free Thyrotropin\": \"falsely elevated\",\n",
      "  \"Free Triiodothyronine\": \"falsely elevated\",\n",
      "  \"Thyroid-stimulating hormone\": \"not usually affected\",\n",
      "  \"Standard Competitive Free Thyroid Hormone Assays\": \"not usually affected\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Test Name\": \"Urine Screening for Opioids\",\n",
      "  \"Test Result\": \"false-positive with quinolones; confirmation recommended\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Test Name\": \"Bone Scan with Technetium-99m-diphosphonate\",\n",
      "  \"Test Result\": \"may be interfered with by Bisphosphonates\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names and their respective results:\n",
      "\n",
      "1. Serum chromogranin A (CgA) level - Falsely elevated with Esomeprazole \n",
      "2. Diagnosis of a neuroendocrine tumor - False-positive \n",
      "\n",
      "JSON format:\n",
      "\n",
      "{\n",
      "   \"Serum chromogranin A (CgA) level\": \"Falsely elevated with Esomeprazole\",\n",
      "   \"Diagnosis of a neuroendocrine tumor\": \"False-positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "1. Medical Test Names: Benedict's solution, Clinitest, Fehling's Solution\n",
      "   Test Results: {\"Benedict's solution\": \"May interfere with urinary glucose tests\", \n",
      "                  \"Clinitest\": \"May interfere with urinary glucose tests\", \n",
      "                  \"Fehling's Solution\": \"May interfere with urinary glucose tests\"}\n",
      "\n",
      "2. Medical Test Names: Aminoglycoside serum concentration\n",
      "   Test Results: {\"Aminoglycoside serum concentration\": \"Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Medical Test Names: technetium-99m-diphosphonate bone scans\n",
      "Test Results: {\"technetium-99m-diphosphonate bone scans\": \"May be interfered with by bisphosphonates\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Plasma phenytoin concentrations\": \"Falsely high\",\n",
      "  \"Serum concentrations of T4\": \"Falsely low\",\n",
      "  \"Serum concentrations of T3\": \"Falsely low\",\n",
      "  \"Dexamethasone tests\": \"Falsely low\",\n",
      "  \"Metyrapone tests\": \"Falsely low\",\n",
      "  \"Thyroid-stimulating hormone (TSH) levels\": \"Increased\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Urine detection of opioids\": \"False-positive\",\n",
      "  \"Coombs' test\": \"Positive\",\n",
      "  \"Urinary steroids\": \"False elevation\",\n",
      "  \"Catecholamines\": \"False elevation\",\n",
      "  \"Urinary dipstick protein assays\": \"Qualitative and quantitative\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Serum iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\",\n",
      "  \"Transferrin bound iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Sorry, as an AI language model, I am not able to extract the medical test names and their results without any context or clear indication of where they are mentioned in the text. Could you please provide me with a specific text or document so I can help you better?\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Neutralizing antibody assay\": \"Obtain serum samples at least a month after the last dose to prevent assay interference.\", \n",
      "  \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "1. Medical Test Names: PT, anti-factor Xa assay, aPTT, free T4, free T3, thyroid stimulating hormone, standard competitive free thyroid hormone assays.\n",
      "\n",
      "2. Test Results in JSON format:\n",
      "\n",
      "{\n",
      " \"PT\": \"Increased\",\n",
      " \"anti-factor Xa assay\": \"falsely elevated results\",\n",
      " \"aPTT\": \"little or minor effect\",\n",
      " \"free T4\": \"falsely elevated levels\",\n",
      " \"free T3\": \"falsely elevated levels\",\n",
      " \"thyroid stimulating hormone\": \"not usually affected\",\n",
      " \"standard competitive free thyroid hormone assays\": \"not usually affected\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      " \"aPTT\": \"contains heparin\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "1. Medical test names: antibody screening, cross matching, Kell blood group system genotyping, serum protein electrophoresis (SPE), immunofixation (IFE), daratumumab-specific IFE assay.\n",
      "\n",
      "2. Test results in JSON format:\n",
      "\n",
      "{\n",
      "   \"antibody screening\": \"N/A\",\n",
      "   \"cross matching\": \"N/A\",\n",
      "   \"Kell blood group system genotyping\": \"N/A\",\n",
      "   \"serum protein electrophoresis (SPE)\": \"positive if daratumumab is present\",\n",
      "   \"immunofixation (IFE)\": \"positive if daratumumab is present\",\n",
      "   \"daratumumab-specific IFE assay\": \"distinguishes daratumumab from residual endogenous M protein\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Medical Test Names: \n",
      "- Thyroid function test\n",
      "\n",
      "Test Results in JSON:\n",
      "{\n",
      "  \"T4 levels\": \"elevated\",\n",
      "  \"Thyroid stimulating hormone levels\": \"at the high end of normal range\",\n",
      "  \"T3 levels\": \"at the low end of normal range\"\n",
      "}\n",
      "Medical Test Names: N/A\n",
      "\n",
      "Test Results in JSON: N/A\n",
      "{\n",
      "  \"polymerase chain reaction (PCR) assays for HIV\": \"Positive\",\n",
      "  \"BB305 LVV proviral DNA\": \"Integrated\",\n",
      "  \"screened for HIV infection using a PCR-based assay\": \"Should not\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"Positive direct Coombs\": \"Positive\",\n",
      "  \"urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\": \"False-positive\",\n",
      "  \"ferricyanide test\": \"False-negative\",\n",
      "  \"Glucose oxidase or hexokinase-based methods\": \"Should be used\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\"uric acid\": \"N/A\"}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"urinary metanephrine\": \"May falsely increase\",\n",
      "  \"HPLC assay with solid phase extraction for determination of urinary catecholamines\": \"does not interact with\",\n",
      "  \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"\n",
      "}\n",
      "{\n",
      "  \"serum chromogranin A (CgA)\": \"may falsely elevate; may cause false-positive results in the diagnosis of a neuroendocrine tumor\",\n",
      "  \"omeprazole\": \"Temporarily stop ≥14 days prior to assessing CgA level\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names:\n",
      "1. Indirect Antiglobulin Test (indirect Coombs test)\n",
      "2. Antibody Detection (screening) Tests\n",
      "3. Antibody Identification Panels\n",
      "4. Anti-Human Globulin Crossmatches\n",
      "5. Blood Type and Screening\n",
      "6. Phenotyping\n",
      "7. Serum Protein Electrophoresis\n",
      "8. Immunofixation Assays\n",
      "\n",
      "Test Result in JSON form:\n",
      "{\n",
      "   \"Indirect Antiglobulin Test\": \"false-positive\",\n",
      "   \"Antibody Detection Tests\": \"may result in interference\",\n",
      "   \"Antibody Identification Panels\": \"may result in interference\",\n",
      "   \"Anti-Human Globulin Crossmatches\": \"may result in interference\",\n",
      "   \"Blood Type and Screening\": \"recommended prior to the first isatuximab infusion\",\n",
      "   \"Phenotyping\": \"consider prior to initiating treatment\",\n",
      "   \"Serum Protein Electrophoresis\": \"may interfere with accuracy of determining complete response\",\n",
      "   \"Immunofixation Assays\": \"may interfere with accuracy of determining complete response\"\n",
      "}\n",
      "Not available\n",
      "{\n",
      "  \"Positive direct Coombs'\": \"Positive\",\n",
      "  \"False-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution)\": \"Positive\",\n",
      "  \"False-positive serum or urine creatinine with Jaffé reaction\": \"Positive\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "{\n",
      "  \"Medical test names\": [\n",
      "    \"Aminoglycoside serum concentration\"\n",
      "  ],\n",
      "  \"Test results\": [\n",
      "    \"Potential underestimation\"\n",
      "  ]\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test names: serum iron, copper, zinc, serum calcium.\n",
      "Test results: \n",
      "{\n",
      "\"serum iron\": \"transient changes\",\n",
      "\"copper\": \"transient changes\",\n",
      "\"zinc\": \"transient changes\",\n",
      "\"serum calcium\": \"apparent decrease after injection, accurate values can be obtained approximately 90 minutes after injection\"\n",
      "}\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Sorry, as an AI language model, I don't have the capability to extract specific information from unstructured data without any context. Please provide more specific data or context for me to extract the information as per your requirement.\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Test Names: \n",
      "- Urine screening test for opioids \n",
      "\n",
      "Test Results (in JSON form): \n",
      "{\n",
      "  \"Urine screening test for opioids\": \"false-positive for levofloxacin and ofloxacin, cross-reactivity in certain assay kits for other quinolones\"\n",
      "}\n",
      "Not available\n",
      "Test Names:\n",
      "- Whole blood assay for cyclosporine\n",
      "\n",
      "Test Results (in JSON form):\n",
      "{\n",
      "  \"Whole blood assay for cyclosporine\": \"may be falsely elevated if sample is drawn from the same central venous line through which dose was administered; cyclosporine metabolites cross-react with radioimmunoassay and fluorescence polarization immunoassay\"\n",
      "}\n",
      "Test Names: \n",
      "1. Glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\n",
      "2. Glucose-specific method\n",
      "3. Anthrax immune globulin administration\n",
      "4. Serologic testing\n",
      "5. Direct and indirect Coombs’ test\n",
      "\n",
      "Test Results:\n",
      "1. Falsely elevated blood glucose levels \n",
      "2. N/A\n",
      "3. Transiently elevated glucose \n",
      "4. False-positive results \n",
      "5. False-positive results\n",
      "Not available\n",
      "Test Names:\n",
      "1. Immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000)\n",
      "2. Dexamethasone test\n",
      "3. Metyrapone test\n",
      "\n",
      "Test Results:\n",
      "1. Falsely high plasma phenytoin concentrations \n",
      "2. Falsely low results\n",
      "3. Folate levels lowered\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n",
      "Not available\n"
     ]
    }
   ],
   "source": [
    "for key,val in drugs_test_conditions_df.items():\n",
    "    print(val)\n",
    "    '''\n",
    "    if type(val) == dict:\n",
    "        for key2,val2 in val.items():\n",
    "            print(key2)\n",
    "    '''"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T06:24:11.837664Z",
     "start_time": "2023-05-10T06:24:11.822074100Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "\"Direct antiglobulin (Coombs) test\": \"Positive\",\n",
      "\"Urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\": \"False-positive\",\n",
      "\"Serum/urine creatinine with Jaffé reaction assay\": \"Falsely elevated\"\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "for key,val in drugs_test_conditions_df.items():\n",
    "    print(val)\n",
    "    break"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T06:24:49.407044700Z",
     "start_time": "2023-05-10T06:24:49.391426700Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "outputs": [
    {
     "data": {
      "text/plain": "{'Ceftobiprole (Lexi-Drugs)': '{\\n\"Direct antiglobulin (Coombs) test\": \"Positive\",\\n\"Urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n\"Serum/urine creatinine with Jaffé reaction assay\": \"Falsely elevated\"\\n}',\n 'Irinotecan (Conventional) (Lexi-Drugs)': 'Not available',\n 'DexAMETHasone (Systemic) (Pediatric and Neonatal Lexi-Drugs)': '{\\n\"Wheal and flare reactions to skin test antigens\": \"May be suppressed\"\\n}',\n 'Pegaspargase (Lexi-Drugs)': 'Not available',\n 'Acetylcysteine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'DOXOrubicin (Conventional) (Lexi-Drugs)': 'Not available',\n 'Tebentafusp (Lexi-Drugs)': 'Not available',\n 'Flumazenil (Lexi-Drugs)': 'Not available',\n 'Diphenhydramine and Phenylephrine (Lexi-Drugs)': 'Not available',\n 'Acetaminophen and Tramadol (Lexi-Drugs)': 'Not available',\n 'Glutamine (Lexi-Drugs)': 'Not available',\n 'Sulfamethoxazole and Trimethoprim (Lexi-Drugs)': '{\\n    \"creatinine (Jaffé alkaline picrate reaction)\": \"Increased\",\\n    \"serum methotrexate (dihydrofolate reductase method)\": \"Increased\"\\n}',\n 'Omeprazole, Amoxicillin, and Rifabutin (Lexi-Drugs)': '{\\n    \"serum chromogranin A (CgA) levels\": \"falsely elevated (due to decreased gastric acidity with Omeprazole)\",\\n    \"neuroendocrine tumor diagnosis\": \"may cause false-positive results\",\\n    \"CgA levels assessment\": \"≥14 days after treatment is completed\",\\n    \"CgA levels repeat\": \"if initially elevated\"\\n}',\n 'Crizanlizumab (Lexi-Drugs)': '{\\n    \"automated platelet counts\": \"may interfere (platelet clumping) with Crizanlizumab\",\\n    \"blood samples collection\": \"in tubes containing ethylenediaminetetraacetic acid (EDTA)\",\\n    \"platelet count\": \"may be unevaluable or falsely decreased\",\\n    \"management\": \"Collect blood samples in citrate-containing tubes\",\\n    \"run blood samples\": \"within 4 hours of sample collection\",\\n    \"estimate platelet count\": \"through peripheral blood smear if necessary\"\\n}',\n 'Nitroglycerin (Lexi-Drugs)': '{\\n    \"triglyceride assays\": \"may be falsely elevated (dependent on glycerol oxidase)\",\\n    \"propylene glycol content\": \"in IV formulation\"\\n}',\n 'Pentostatin-Cyclophosphamide-Rituximab  (CLL)  (Lexi-Drugs)': 'Not available',\n 'Phenylephrine and Thonzylamine (Lexi-Drugs)': 'Not available',\n 'Tranexamic Acid (Lexi-Drugs)': 'Not available',\n 'Bamlanivimab (Lexi-Drugs)': 'Not available',\n 'Micafungin (Lexi-Drugs)': 'Not available',\n 'Tenoxicam (Lexi-Drugs)': 'Not available',\n 'Darbepoetin Alfa (Lexi-Drugs)': 'Test names: HbA1c.\\nTest results: \\n{\\n \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose\"\\n}',\n 'Levorphanol (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor/von Willebrand Factor Complex (Human) (Lexi-Drugs)': 'Not available',\n 'LevoFLOXacin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'MitoMYcin (Systemic) (Lexi-Drugs)': 'Not available',\n 'Carfilzomib (Lexi-Drugs)': 'Not available',\n 'Tacrolimus (Systemic) (Lexi-Drugs)': 'Not available',\n 'Dipyridamole (Lexi-Drugs)': 'Test Names: dipyridamole-thallium myocardial imaging\\n\\nTest Results: {\"dipyridamole-thallium myocardial imaging\": \"false-negative result\"}',\n 'Azithromycin (Systemic) (Lexi-Drugs)': 'Not available',\n 'Trace Elements (Lexi-Drugs)': 'Not available',\n 'Trimethobenzamide (Lexi-Drugs)': 'Not available',\n 'Tisagenlecleucel (Lexi-Drugs)': '{\"HIV nucleic acid tests\": \"false positive results\"}',\n 'Ergotamine and Caffeine (Lexi-Drugs)': 'Not available',\n 'PACLitaxel (Protein Bound) (Lexi-Drugs)': 'Not available',\n 'Insulin NPH (Lexi-Drugs)': 'Not available',\n 'Norepinephrine (Lexi-Drugs)': 'Not available',\n 'von Willebrand Factor (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Trastuzumab and Hyaluronidase (Lexi-Drugs)': 'Not available',\n 'Bevacizumab (Lexi-Drugs)': 'Not available',\n 'Imipenem and Cilastatin (Infectious Diseases)': '{\\n  \"Urinary Glucose Determination (Clinitest)\": \"Interferes\",\\n  \"Coombs\\' Test (Direct)\": \"Positive\"\\n}',\n 'Isosorbide Dinitrate (Lexi-Drugs)': 'Not available',\n 'Iobenguane I 123 (Lexi-Drugs)': 'Not available',\n 'Meropenem (Lexi-Drugs)': '{\"Coombs\\' [direct]\": \"Positive\"}',\n 'DOPamine (Lexi-Drugs)': 'Not available',\n 'CycloSPORINE (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Lefamulin (Lexi-Drugs)': 'Not available',\n 'CycloPHOSphamide (Lexi-Drugs)': 'Not available',\n 'Nelarabine (Lexi-Drugs)': 'Not available',\n 'Ferric Derisomaltose (Lexi-Drugs)': 'Not available',\n 'Gemtuzumab Ozogamicin (Lexi-Drugs)': 'Not available',\n 'Cefuroxime (Geriatric Lexi-Drugs)': '{\"direct Coombs\": \"positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"false-positive\"}',\n 'Factor IX Complex (Human) [(Factors II, IX, X)] (Lexi-Drugs)': 'Not available',\n 'Cemiplimab (Lexi-Drugs)': 'Not available',\n 'Aprepitant (Lexi-Drugs)': 'Not available',\n 'Thiotepa (Lexi-Drugs)': 'Not available',\n 'Vonoprazan, Amoxicillin, and Clarithromycin (Lexi-Drugs)': 'Not available',\n 'Anidulafungin (Lexi-Drugs)': 'Not available',\n 'Gadobenate Dimeglumine (Lexi-Drugs)': '{\\n   \"serum ferritin\": \"transient increase\",\\n   \"urine zinc\": \"transient increase (with renal disease)\",\\n   \"bilirubin\": \"transient increase (with hepatic metabolic disorders)\"\\n}',\n 'Pembrolizumab (Geriatric Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant [Fc Fusion Protein]) (Lexi-Drugs)': 'Not available',\n 'Vedolizumab (Lexi-Drugs)': 'Not available',\n 'Chloramphenicol (Systemic) (Lexi-Drugs)': 'Not available',\n 'Clevidipine (Lexi-Drugs)': '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'Bebtelovimab (Lexi-Drugs)': 'Not available',\n 'Erythromycin and Benzoyl Peroxide (Lexi-Drugs)': 'Not available',\n 'Trastuzumab-Vinorelbine (Breast) (Lexi-Drugs)': 'Not available',\n 'DiphenhydrAMINE (Systemic) (Lexi-Drugs)': '{\\n   \"urine detection of methadone\": \"false-positives\",\\n   \"urine detection of phencyclidine\": \"false-positives\",\\n   \"serum TCA screen\": \"false-positive\",\\n   \"wheal and flare reactions to skin test antigens\": \"suppressed\"\\n}',\n 'Betamethasone (Topical) (Lexi-Drugs)': 'Medical Test Name: \\n1. Skin test antigens \\n\\nJSON Form: \\n{\\n   \"Skin test antigens\": \"suppressed wheal and flare reactions\"\\n}',\n 'Dexrazoxane (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Sotrovimab (Lexi-Drugs)': 'Not available',\n 'BChE - Mivacurium (Pharmacogenomics)': 'Not available',\n 'Benzyl Alcohol (Lexi-Drugs)': 'Not available',\n 'Ferric Gluconate (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"Serum or transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric gluconate administration\",\\n  \"Serum ferritin levels\": \"falsely elevated for 5 days after ferric gluconate administration\"\\n}',\n 'Siltuximab (Lexi-Drugs)': 'Not available',\n 'Selenium (Lexi-Drugs)': 'Not available',\n 'Palonosetron (Lexi-Drugs)': 'Not available',\n 'Fluorouracil and Salicylic Acid (Lexi-Drugs)': 'Not available',\n 'VinCRIStine (Lexi-Drugs)': 'Not available',\n 'Octreotide [ANTIDOTE] (Lexi-Tox)': 'Not available',\n 'VinBLAStine (Lexi-Drugs)': 'Not available',\n 'Carboplatin-Paclitaxel-Trastuzumab (Breast) (Lexi-Drugs)': 'Not available',\n 'Vitamin B Complex Combinations (Lexi-Drugs)': 'Not available',\n 'Lidocaine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Insulin Aspart (Lexi-Drugs)': 'Not available',\n 'Iothalamate Meglumine (Lexi-Drugs)': '{\\n   \"thyroid function tests dependent on iodine estimation\": \"altered results\",\\n   \"radioiodine uptake studies\": \"affected results\"\\n}',\n 'Insulin Regular (Lexi-Drugs)': 'Not available',\n 'Treprostinil (Lexi-Drugs)': 'Not available',\n 'Cefotaxime (Lexi-Drugs)': '{\\n   \"direct Coombs\\' test\": \"positive\",\\n   \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"false-positive\",\\n   \"serum creatinine with Jaffé reaction\": \"false-positive\",\\n   \"urine creatinine with Jaffé reaction\": \"false-positive\"\\n}',\n 'Dantrolene (Lexi-Drugs)': 'Not available',\n 'Gemcitabine-Vinorelbine (NSCLC) (Lexi-Drugs)': 'Not available',\n 'Durvalumab (Lexi-Drugs)': 'Not available',\n 'Brivaracetam (Lexi-Drugs)': 'Not available',\n 'Amifostine (Lexi-Drugs)': 'Not available',\n 'Capreomycin (Lexi-Drugs)': 'Not available',\n 'Neostigmine (Lexi-Drugs)': 'Not available',\n 'Emapalumab (Lexi-Drugs)': 'Not available',\n 'Ketamine (Lexi-Drugs)': 'Test Names: \\n1. Urine test for phencyclidine\\n\\nTest Results: \\n{\\n   \"Urine test for phencyclidine\": \"false-positive interference may occur\"\\n}',\n 'Zinc Chloride (Lexi-Drugs)': 'Not available',\n 'Fosaprepitant (Geriatric Lexi-Drugs)': 'Not available',\n 'Imipenem and Cilastatin (Geriatric Lexi-Drugs)': '{\\n   \"Clinitest®\": \"interfered with urinary glucose determination\",\\n   \"Coombs\\' [direct]\": \"positive\"\\n}',\n 'DimenhyDRINATE (Lexi-Drugs)': 'Not available',\n 'Anti-inhibitor Coagulant Complex (Human) (Lexi-Drugs)': '{\\n   \"blood group isohemagglutinins\": \"presence\",\\n   \"Coombs test\": \"may be interfered with due to passive transmission of antibodies to erythrocyte antigens\"\\n}',\n 'Calcitriol (Topical) (Lexi-Drugs)': 'Not available',\n 'Margetuximab (Lexi-Drugs)': 'Not available',\n 'Alfentanil (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Mycophenolate (Lexi-Drugs)': 'Not available',\n 'Decitabine (Lexi-Drugs)': 'Not available',\n 'Ferric Gluconate (Lexi-Drugs)': 'Test Names: \\n1. Serum or transferrin bound iron levels \\n2. Serum ferritin levels \\n\\nTest Results:\\n1. {\"Serum or transferrin bound iron levels\": \"May be falsely elevated if assessed within 24 hours of ferric gluconate administration.\"}\\n2. {\"Serum ferritin levels\": \"May be falsely elevated for 5 days after ferric gluconate administration.\"}',\n 'RomiDEPsin (Lexi-Drugs)': 'Not available',\n 'Olipudase Alfa (Lexi-Drugs)': 'Not available',\n 'Brexanolone (Lexi-Drugs)': 'Not available',\n 'Clindamycin (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Lamivudine and Zidovudine (Lexi-Drugs)': 'Not available',\n 'Cefuroxime (Lexi-Drugs)': '{\"direct Coombs\\'\": \"Positive\", \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\", \"ferricyanide test\": \"False-negative\"}',\n 'Sodium Phosphates (Lexi-Drugs)': 'Not available',\n 'Amisulpride (Injection) (Lexi-Drugs)': 'Not available',\n 'Ofloxacin (Otic) (Lexi-Drugs)': 'Not available',\n 'Peginterferon Alfa-2b (Lexi-Drugs)': 'Not available',\n 'Succinylcholine (Lexi-Drugs)': 'Not available',\n 'DiazePAM (Lexi-Drugs)': 'Test names: \\n- Urinary glucose determination \\n\\nTest Results in JSON format:\\n{\\n   \"Urinary glucose determination\": \"False-negative when using Clinistix® or Diastix®\"\\n}',\n 'Ibuprofen and Famotidine (Lexi-Drugs)': 'Not available',\n 'Granisetron (Lexi-Drugs)': 'Not available',\n 'Mepivacaine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Clofarabine (Lexi-Drugs)': 'Not available',\n 'Buprenorphine (Lexi-Drugs)': 'Not available',\n 'Inebilizumab (Lexi-Drugs)': 'Not available',\n 'Cabazitaxel (Lexi-Drugs)': 'Not available',\n 'Propofol (Lexi-Drugs)': 'Not available',\n 'Sirolimus (Conventional) (Lexi-Drugs)': 'Not available',\n 'Phenylephrine and Pramoxine (Lexi-Drugs)': 'Not available',\n 'Secretin (Lexi-Drugs)': 'Not available',\n 'Insulin Lispro (Lexi-Drugs)': 'Not available',\n 'Melphalan (Pharmacogenomics)': 'Not available',\n 'Insulin NPH and Insulin Regular (Lexi-Drugs)': 'Not available',\n 'Hydroxocobalamin (Lexi-Drugs)': 'Medical test names: Basophils, hemoglobin, MCH, MCHC, albumin, alkaline phosphatase, cholesterol, creatinine, glucose, total protein, triglycerides, bilirubin, urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite), ALT, amylase, AST, CK, CKMB, LDH, phosphate, uric acid, PT, aPTT, urine pH.\\n\\nJSON form:\\n{\\n  \"Basophils\": \"Falsely elevated\",\\n  \"Hemoglobin\": \"Falsely elevated\",\\n  \"MCH\": \"Falsely elevated\",\\n  \"MCHC\": \"Falsely elevated\",\\n  \"Albumin\": \"Falsely elevated\",\\n  \"Alkaline phosphatase\": \"Falsely elevated\",\\n  \"Cholesterol\": \"Falsely elevated\",\\n  \"Creatinine\": \"Falsely elevated\",\\n  \"Glucose\": \"Falsely elevated\",\\n  \"Total protein\": \"Falsely elevated\",\\n  \"Triglycerides\": \"Falsely elevated\",\\n  \"Bilirubin\": \"Falsely elevated\",\\n  \"Urinalysis (glucose, protein, erythrocytes, leukocytes, ketones, bilirubin, urobilinogen, nitrite)\": \"Falsely elevated\",\\n  \"ALT\": \"Falsely decreased\",\\n  \"Amylase\": \"Falsely decreased\",\\n  \"AST\": \"Unpredictable\",\\n  \"CK\": \"Unpredictable\",\\n  \"CKMB\": \"Unpredictable\",\\n  \"LDH\": \"Unpredictable\",\\n  \"Phosphate\": \"Unpredictable\",\\n  \"Uric acid\": \"Unpredictable\",\\n  \"PT\": \"Unpredictable\",\\n  \"aPTT\": \"Unpredictable\",\\n  \"Urine pH\": \"Unpredictable\"\\n}',\n 'Voriconazole (Lexi-Drugs)': 'Not available',\n 'Botulism Antitoxin, Heptavalent (Lexi-Drugs)': 'Medical test name: Blood glucose\\n\\nJSON form:\\n{\\n  \"Blood glucose\": \"falsely elevated\"\\n}',\n 'Cefuroxime (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Cefepime (Lexi-Drugs)': '{\\n \"Positive direct Coombs\": true,\\n \"Urinary glucose test using cupric sulfate (Benedict\\'s solution)\": false,\\n \"Urinary glucose test using Clinitest\": false,\\n \"Urinary glucose test using Fehling\\'s solution\": false,\\n \"Serum or urine creatinine with Jaffé reaction\": false,\\n \"Urinary proteins\": false,\\n \"Urinary steroids\": false\\n}',\n 'Ferric Carboxymaltose (Pediatric and Neonatal Lexi-Drugs)': '{\\n \"Serum iron levels\": \"falsely elevated\",\\n \"Transferrin bound iron levels\": \"falsely elevated\"\\n}',\n 'Imipenem, Cilastatin, and Relebactam (Lexi-Drugs)': '{\\n \"Coombs test\": \"Positive\"\\n}',\n 'Ceftolozane and Tazobactam (Infectious Diseases)': 'Not available',\n 'Sirolimus (Topical) (Lexi-Drugs)': 'Not available',\n 'Epoetin Alfa (Lexi-Drugs)': '{\\n  \"HbA1c\": \"artificially lowered\"\\n}',\n 'Zidovudine (Lexi-Drugs)': 'Not available',\n 'Ertapenem (Lexi-Drugs)': 'Not available',\n 'Oxytocin (Lexi-Drugs)': 'Not available',\n 'Factor IX (Recombinant [Glycopegylated]) (Lexi-Drugs)': 'Not available',\n 'Gadoteridol (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Levothyroxine (Lexi-Drugs)': '1. T4-binding globulin (TBG)\\n{\\n  \"Conditions/states that increase TBG binding\": \"Pregnancy, hepatitis, porphyria, neonatal state\",\\n  \"Medications that increase TBG binding\": \"Estrogens, 5-fluorouracil, heroin, methadone, mitotane, perphenazine, selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\",\\n  \"Conditions/states that decrease TBG binding\": \"Hepatic failure, nephrosis, severe illness.\",\\n  \"Medications that decrease TBG binding\": \"Androgens, anabolic steroids, glucocorticoids, L-asparaginase, nicotinic acid\"\\n}\\n\\n2. Thyroxine (T4) and triiodothyronine (T3)\\n{\\n  \"Medications that inhibit T4 and T3 binding\": \"Carbamazepine, furosemide, free fatty acids, heparin, NSAIDS (variable, transient), phenytoin, salicylates\"\\n}\\n\\n3. Thyroid gland hormone: Interference with production and secretion\\n{\\n  \"Medications affecting iodine uptake\": \"Amiodarone, iodinated contrast agents, iodine, ethionamide\",\\n  \"Medications affecting hormone production\": \"Amiodarone, ethionamide, iodinated contrast agents, iodine, sulfonylureas, sulfonamides, thionamides (carbimazole, methimazole, propylthiouracil)\",\\n  \"Medications affecting secretion\": \"Amiodarone, iodinated contrast agents, iodine, lithium\",\\n  \"Medications inducing thyroiditis\": \"Alemtuzumab, amiodarone, antiangiogenic agents (lenalidomide, thalidomide), denileukin diftitox, interferon alpha, interleukins, lithium, tyrosine kinase inhibitors (sunitinib, sorafenib)\",\\n  \"Medications potentially causing the development of Graves’\": \"Alemtuzumab, interferon alpha, antiretroviral therapy\",\\n  \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves’\": \"Glucocorticoids\"\\n}\\n\\n4. Hypothalamic-pituitary axis and TSH: Interference with secretion\\n{\\n  \"Medications decreasing TSH secretion\": \"Bexarotene, dopamine, dopaminergic agonists (bromocriptine, cabergoline), glucocorticoids, interleukin-6, metformin, opiates, somatostatin analogues (octreotide, lanreotide), thyroid hormone analogues\",\\n  \"Medications increasing TSH secretion\": \"Amphetamine, interleukin 2, metoclopramide, ritonavir, St John\\'s wort\",\\n  \"Medications potentially causing hypophysitis\": \"Ipilimumab\"\\n}',\n 'Tedizolid (Lexi-Drugs)': 'Not available',\n 'ALfentanil (Lexi-Drugs)': 'Not available',\n 'Idecabtagene Vicleucel (Lexi-Drugs)': 'Not available',\n 'Iopamidol (Lexi-Drugs)': '{\"iodine-binding capacity\": \"reduced for up to 2 weeks following administration of contrast media\", \\n\"diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results\": \"not affected (eg, T3 resin uptake, thyroxine assays)\"}',\n 'Methohexital (Lexi-Drugs)': 'Not available',\n 'Amantadine (Lexi-Drugs)': '{\\n  \"Urine test for amphetamines/methamphetamines\": \"May interfere with detection (false-positive)\"\\n}',\n 'Chlorothiazide (Lexi-Drugs)': '{\\n  \"Parathyroid function tests\": \"may be interfered with\",\\n  \"Aldosterone/renin ratio (ARR) test\": \"may give a false-negative result\"\\n}',\n 'Gemcitabine (Lexi-Drugs)': 'Not available',\n 'Ciprofloxacin (Otic) (Lexi-Drugs)': 'Not available',\n 'Bevacizumab-Carboplatin-Paclitaxel (Ovarian) (Lexi-Drugs)': 'Not available',\n 'Avalglucosidase Alfa (Lexi-Drugs)': 'Not available',\n 'Liothyronine (Lexi-Drugs)': 'Test names: T4-binding globulin (TBG), Thyroxine (T4), Triiodothyronine (T3), Thyroid gland hormone, Hypothalamic-pituitary axis and TSH\\n\\nTest results as JSON:\\n\\n{\\n  \"TBG\": {\\n    \"Conditions/Staes that increase TBG binding\": [\"Pregnancy\", \"hepatitis\", \"porphyria\", \"neonatal state\"],\\n    \"Medications that increase TBG binding\": [\"Estrogens\", \"5-fluorouracil\", \"heroin\", \"methadone\", \"mitotane\", \"perphenazine\", \"selective estrogen receptor modulators (eg, tamoxifen, raloxifene)\"],\\n    \"Conditions/states that decrease TBG binding\": [\"Hepatic failure\", \"nephrosis\", \"severe illness\"],\\n    \"Medications that decrease TBG binding\": [\"Androgens\", \"anabolic steroids\", \"glucocorticoids\", \"L-asparaginase\", \"nicotinic acid\"]\\n  },\\n  \"T4\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"T3\": {\\n    \"Medications that inhibit T4 and T3 binding\": [\"Carbamazepine\", \"furosemide\", \"free fatty acids\", \"heparin\", \"NSAIDS (variable, transient)\", \"phenytoin\", \"salicylates\"]\\n  },\\n  \"Thyroid gland hormone\": {\\n    \"Medications affecting iodine uptake\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"ethionamide\"],\\n    \"Medications affecting hormone production\": [\"Amiodarone\", \"ethionamide\", \"iodinated contrast agents\", \"iodine\", \"sulfonylureas\", \"sulfonamides\", \"thionamides (carbimazole, methimazole, propylthiouracil)\"],\\n    \"Medications affecting secretion\": [\"Amiodarone\", \"iodinated contrast agents\", \"iodine\", \"lithium\"],\\n    \"Medications inducing thyroiditis\": [\"Alemtuzumab\", \"amiodarone\", \"antiangiogenic agents (lenalidomide, thalidomide)\", \"denileukin diftitox\", \"interferon alpha\", \"interleukins\", \"lithium\", \"tyrosine kinase inhibitors (sunitinib, sorafenib)\"],\\n    \"Medications potentially causing the development of Graves’\": [\"Alemtuzumab\", \"interferon alpha\", \"antiretroviral therapy\"],\\n    \"Medications potentially ameliorating thyroiditis (if autoimmune) or Graves\\'\": [\"Glucocorticoids\"]\\n  },\\n  \"TSH\": {\\n    \"Medications decreasing TSH secretion\": [\"Bexarotene\", \"dopamine\", \"dopaminergic agonists (bromocriptine, cabergoline)\", \"glucocorticoids\", \"interleukin-6\", \"metformin\", \"opiates\", \"somatostatin analogues (octreotide, lanreotide)\", \"thyroid hormone analogues\"],\\n    \"Medications increasing TSH secretion\": [\"Amphetamine\", \"interleukin 2\", \"metoclopramide\", \"ritonavir\", \"St John\\'s wort\"],\\n    \"Medications potentially causing hypophysitis\": [\"Ipilimumab\"]\\n  }\\n}',\n 'Pembrolizumab (Lexi-Drugs)': 'Not available',\n 'Bevacizumab FOLFOX (Colorectal) (Lexi-Drugs)': 'Not available',\n 'Daunorubicin and Cytarabine (Liposomal) (Lexi-Drugs)': 'Not available',\n 'Clindamycin (Topical) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Isosorbide Dinitrate and Hydralazine (Lexi-Drugs)': 'Not available',\n 'Lidocaine and Hydrocortisone (Lexi-Drugs)': 'Not available',\n 'Ganciclovir (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Clot Dissolving Drugs for Heart Attack or Stroke (Patient Education - Disease and Procedure)': 'Not available',\n 'Eteplirsen (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Gentamicin (Systemic) (Lexi-Drugs)': 'Test Names: None mentioned\\n\\nTest Results: None mentioned',\n 'Ascorbic Acid (Pediatric and Neonatal Lexi-Drugs)': 'Test Names: \\n- Stool occult blood test\\n- Blood glucose testing\\n- Urine glucose testing\\n- Nitrite level testing\\n- Bilirubin level testing\\n- Leucocyte count testing\\n\\nTest Results: \\n- Stool occult blood: False negative 48 to 72 hours after ascorbic acid ingestion\\n- Blood glucose: Falsely elevated glucose measurements by point of care glucometers with high-dose ascorbic acid\\n- Urine glucose: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Nitrite level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Bilirubin level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\\n- Leucocyte count: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion',\n 'Doxapram (Lexi-Drugs)': 'Not available',\n 'Taliglucerase Alfa (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Dolasetron (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Omadacycline (Lexi-Drugs)': 'Not available',\n 'Belatacept (Lexi-Drugs)': 'Not available',\n 'Scopolamine (Geriatric Lexi-Drugs)': 'Test name: Interferes with gastric secretion test\\nTest result: Transdermal system should be discontinued ≥10 days prior to testing.\\n\\nJSON format: {\"Interferes with gastric secretion test\": \"Transdermal system should be discontinued ≥10 days prior to testing.\"}',\n 'Vancomycin (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Ampicillin and Sulbactam (Lexi-Drugs)': 'Test name: Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\\nTest result: May interfere\\n\\nTest name: Aminoglycoside serum concentration\\nTest result: Potential underestimation due to the acceleration of degradation by some penicillin derivatives\\n\\nJSON format: {\"Urinary glucose tests using cupric sulfate (Benedict\\'s solution, Fehling’s solution, or Clinitest®)\": \"May interfere\", \"Aminoglycoside serum concentration\": \"Potential underestimation due to the acceleration of degradation by some penicillin derivatives\"}',\n 'Buprenorphine and Naloxone (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Lidocaine (Otic) (Lexi-Drugs)': 'Not available',\n 'BUPivacaine (Lexi-Drugs)': 'Not available',\n 'Growth Hormone, Serum (Lab Tests and Diagnostic Procedures)': 'Not available',\n 'Technetium Tc 99m Albumin Aggregated (Lexi-Drugs)': 'Not available',\n 'Tetracaine (Spinal) (Lexi-Drugs)': 'Not available',\n 'Dexrazoxane (Lexi-Drugs)': 'Not available',\n 'Mepivacaine (Pharmacogenomics)': 'Not available',\n 'Erythromycin (Topical) (Lexi-Drugs)': 'Not available',\n 'Ciprofloxacin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'CARBOplatin (Lexi-Drugs)': 'Not available',\n 'Basiliximab (Lexi-Drugs)': 'Not available',\n 'Tromethamine (Lexi-Drugs)': 'Not available',\n 'Alprostadil (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Oral Inhalation) (Infectious Diseases)': 'Not available',\n 'Ferric Carboxymaltose (Geriatric Lexi-Drugs)': 'Test names: \\n1. Serum iron levels\\n2. Transferrin bound iron levels\\n\\nTest results in JSON format:\\n{\\n  \"Serum iron levels\": \"not specified\",\\n  \"Transferrin bound iron levels\": \"falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}',\n 'Gadoteridol (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Methotrimeprazine (Lexi-Drugs)': 'Test Names: Pregnancy test\\nTest Results: False-positive or false-negative',\n 'Morphine (Systemic) (Lexi-Drugs)': '{\"opioid screening\": \"false-positive result\"}',\n 'Sodium Acetate (Lexi-Drugs)': 'Not available',\n 'Topotecan (Lexi-Drugs)': 'Not available',\n 'MetroNIDAZOLE (Topical) (Lexi-Drugs)': 'Not available',\n 'Edrophonium and Atropine (Lexi-Drugs)': 'Not available',\n 'Tranexamic Acid (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Ciprofloxacin and Dexamethasone (Lexi-Drugs)': 'Not available',\n 'Verapamil (Lexi-Drugs)': '{\"Urine detection of methadone\": \"false-positive\"}',\n 'Melphalan (Pediatric and Neonatal Lexi-Drugs)': '{\"Coombs\\' test [direct]\": \"false-positive\"}',\n 'PACLitaxel (Conventional) (Lexi-Drugs)': 'Not available',\n 'Methyldopa (Lexi-Drugs)': '{\\n  \"urinary uric acid (phosphotungstate method)\": \"interference by Methyldopa\",\\n  \"serum creatinine (alkaline picrate method)\": \"interference by Methyldopa\",\\n  \"AST (colorimetric method)\": \"interference by Methyldopa\",\\n  \"urinary catecholamines (falsely high levels)\": \"interference by Methyldopa\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive by Methyldopa\"\\n}',\n 'Ciprofloxacin (Systemic) (Lexi-Drugs)': '{\\n \"levofloxacin\": \"false-positive urine screening result for opioids\",\\n \"ofloxacin\": \"false-positive urine screening result for opioids\",\\n \"other quinolones\": \"cross-reactivity in certain assay kits\"\\n}',\n 'Ambroxol [INT] (Lexi-Drugs International [Concise])': 'Not available',\n 'Aducanumab (Lexi-Drugs)': 'Not available',\n 'Magnesium Chloride (Lexi-Drugs)': 'Not available',\n 'Taliglucerase Alfa (Lexi-Drugs)': 'Not available',\n 'RiTUXimab (Lexi-Drugs)': 'Not available',\n 'Cetirizine and Pseudoephedrine (Lexi-Drugs)': 'Not available',\n 'Clindamycin and Tretinoin (Lexi-Drugs)': 'Not available',\n 'Erythromycin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Neostigmine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Nesiritide (Lexi-Drugs)': 'Not available',\n 'Aminophylline (Lexi-Drugs)': 'Test names: \\n- Plasma glucose\\n- Uric acid\\n- Free fatty acids\\n- Total cholesterol\\n- HDL\\n- HDL/LDL ratio\\n- Urinary free cortisol excretion\\n- Triiodothyronine\\n\\nJSON format: \\n{\\n\"Plasma glucose\": <test result>,\\n\"Uric acid\": <test result>,\\n\"Free fatty acids\": <test result>,\\n\"Total cholesterol\": <test result>,\\n\"HDL\": <test result>,\\n\"HDL/LDL ratio\": <test result>,\\n\"Urinary free cortisol excretion\": <test result>,\\n\"Triiodothyronine\": <test result>\\n}',\n 'NaN': 'Not available',\n 'Edaravone (Lexi-Drugs)': 'Not available',\n 'Factor IX (Recombinant [Fc Fusion Protein]) (Lexi-Drugs)': 'Not available',\n 'Conivaptan (Lexi-Drugs)': 'Not available',\n 'Glucagon (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'MitoMYcin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Alteplase (Lexi-Drugs)': '{\"coagulation\": \"Altered\", \"fibrinolytic activity\": \"Altered\"}',\n 'Remimazolam (Lexi-Drugs)': 'Not available',\n 'Sodium Nitrite and Sodium Thiosulfate (Lexi-Drugs)': 'Not available',\n 'Nelarabine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Plasminogen Activator Inhibitor 1 Activity, Plasma (Lab Tests and Diagnostic Procedures)': 'Not available',\n 'Fludarabine-Cyclophosphamide-Rituximab  (CLL) (Lexi-Drugs)': 'Not available',\n 'DiphenhydrAMINE (Topical) (Lexi-Drugs)': '{\\n\"skin test antigens\": \"suppressed\"\\n}',\n 'Ganciclovir (Systemic) (Lexi-Drugs)': 'Not available',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Geriatric Lexi-Drugs)': 'Not available',\n 'Fenoldopam (Lexi-Drugs)': 'Not available',\n 'Temsirolimus (Lexi-Drugs)': 'Not available',\n 'Ceftazidime and Avibactam (Lexi-Drugs)': '{\\n  \"Ceftazidime\": \"Positive direct Coomb\",\\n  \"Urine glucose\": \"False-positive with certain methods; use glucose tests based on enzymatic glucose oxidase reactions\"\\n}',\n 'Gadodiamide (Lexi-Drugs)': '{\\n  \"Serum Iron\": \"Transitory changes observed\",\\n  \"Serum Calcium\": \"May interfere with colorimetric tests; alternate testing method recommended for 12-24 hours after administration\"\\n}',\n 'Antivenin (Latrodectus mactans) (Lexi-Drugs)': 'Not available',\n 'Erythromycin (Systemic) (Lexi-Drugs)': '{\\n  \"Urinary Catecholamines\": \"False-positive (fluorometric assay)\",\\n  \"17-hydroxycorticosteroids\": \"False-positive\",\\n  \"17-ketosteroids\": \"False-positive\"\\n}',\n 'Cetirizine (Systemic) (Lexi-Drugs)': 'Test names: \\n1. Serum TCA screen\\n2. Skin test antigens\\n\\nTest results:\\n1. False-positive\\n2. Suppressed wheal and flare reactions',\n 'Moxifloxacin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'CloNIDine (Lexi-Drugs)': \"Test names: \\n1. Coombs' test\\n2. Aldosterone/renin ratio\\n\\nTest results:\\n1. Positive\\n2. False-positive\",\n 'Ofatumumab (Lexi-Drugs)': 'Not available',\n 'InFLIXimab (Lexi-Drugs)': 'Not available',\n 'Dolasetron (Lexi-Drugs)': 'Not available',\n 'Ferumoxytol (Lexi-Drugs)': 'Test Names: \\n1. MR imaging \\n2. Serum Iron \\n3. Transferrin-bound Iron \\n\\nCorresponding Test Results in JSON:\\n{\\n  \"MR imaging\": \"May interfere with imaging; alterations may persist for ≤3 months following use, with peak alterations anticipated in the first 2 days following administration. If MR imaging is required within 3 months after administration, use T1- or proton density-weighted MR pulse sequences to decrease effect on imaging. Do not use T2-weighted sequence MR imaging prior to 4 weeks following administration.\",\\n  \"Serum Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\",\\n  \"Transferrin-bound Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\"\\n}',\n 'Anthrax Immune Globulin (Human) (Pediatric and Neonatal Lexi-Drugs)': 'Test Names: \\n1. Blood glucose levels\\n2. Serologic testing results\\n3. Direct Coombs\\' test\\n4. Indirect Coombs\\' test\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Blood glucose levels\": \"Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\",\\n  \"Serologic testing results\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Direct Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\",\\n  \"Indirect Coombs\\' test\": \"Passively transferred antibodies may yield false-positive results.\"\\n}',\n 'Omeprazole (Lexi-Drugs)': 'Test Names: \\n1. Serum chromogranin A (CgA) levels\\n\\nCorresponding Test Results in JSON:\\n{\\n  \"Serum chromogranin A (CgA) levels\": \"Omeprazole may falsely elevate CgA levels, causing false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\"\\n}',\n 'Raxibacumab (Lexi-Drugs)': 'Not available',\n 'Sarilumab (Lexi-Drugs)': 'Not available',\n 'Streptozocin (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Ceftaroline Fosamil (Lexi-Drugs)': 'Not available',\n 'Casimersen (Lexi-Drugs)': '{\\n\"Medical Test Name\": \"Detection of urine protein\",\\n\"Test Result\": \"False positive when pyrogallol red reagent is used\"\\n}',\n 'Oxycodone and Acetaminophen (Lexi-Drugs)': 'Not available',\n 'Fluorouracil (Topical) (Lexi-Drugs)': 'Not available',\n 'Ibutilide (Lexi-Drugs)': 'Not available',\n 'Elosulfase Alfa (Lexi-Drugs)': 'Not available',\n 'Ceftolozane and Tazobactam (Lexi-Drugs)': 'Not available',\n 'Fludarabine (Lexi-Drugs)': 'Not available',\n 'Meperidine (Lexi-Drugs)': '{\\n  \"amylase\": \"increased\",\\n  \"BSP retention\": \"increased\",\\n  \"CPK\": \"increased\"\\n}',\n 'Fluorescein and Benoxinate (Lexi-Drugs)': 'Not available',\n 'Sugammadex (Lexi-Drugs)': '{\\n  \"serum progesterone assay\": \"may interfere\",\\n  \"interaction\": \"may be observed\"\\n}',\n 'Streptozocin (Lexi-Drugs)': 'Not available',\n 'Etoposide Phosphate (Lexi-Drugs)': 'Not available',\n 'Propranolol (Lexi-Drugs)': '{\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n 'Mannitol (Systemic) (Lexi-Drugs)': '{\\n  \"blood ethylene glycol concentrations\": \"false positive\",\\n  \"inorganic phosphorus blood concentrations\": \"false low\"\\n}',\n 'Scopolamine (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"gastric secretion test\": \"interference\"\\n}',\n 'Treosulfan (Lexi-Drugs)': 'Not available',\n 'Vindesine (Lexi-Drugs)': 'Not available',\n 'Sincalide (Lexi-Drugs)': 'Not available',\n 'Phenylephrine (Systemic) (Lexi-Drugs)': 'Not available',\n 'Famotidine (Lexi-Drugs)': 'Not available',\n 'Methylcobalamin (Natural Products Database)': 'Not available',\n 'Desmopressin (Lexi-Drugs)': 'Not available',\n 'Eptinezumab (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant [Fc-VWF-XTEN Fusion Protein]) (Lexi-Drugs)': 'Not available',\n 'Buprenorphine and Naloxone (Lexi-Drugs)': 'Not available',\n 'Gadopentetate Dimeglumine (Lexi-Drugs)': 'Not available',\n 'DOBUTamine (Lexi-Drugs)': 'Not available',\n 'Filgrastim (Lexi-Drugs)': '{\\n  \"Bone imaging studies\": \"May interfere with\",\\n  \"Hematopoietic activity\": \"increased\",\\n  \"Bone marrow\": \"May appear as transient positive bone imaging changes.\"\\n}',\n 'Furosemide (Lexi-Drugs)': '{\\n  \"Medical test names\": [\\n    \"Aldosterone/renin ratio (ARR)\"\\n  ],\\n  \"Test results\": [\\n    \"False-negative\"\\n  ]\\n}',\n 'Aztreonam (Systemic) (Geriatric Lexi-Drugs)': '{\"urine glucose\": \"may interfere with tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}',\n 'Atenolol (Lexi-Drugs)': '{\"glucose\": \"increased\", \"HDL\": \"decreased\", \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"}',\n 'Mepivacaine and Levonordefrin (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant [Pegylated]) (Lexi-Drugs)': 'Not available',\n 'CeFAZolin (Lexi-Drugs)': 'Test names and their respective results:\\n\\n1. Direct and Indirect Coombs\\' - Positive \\n2. Urinary glucose test using Benedict\\'s copper reduction reaction - False-Positive \\n3. Serum or urine creatinine with Jaffé reaction - False-Positive \\n4. Aminoglycoside serum concentration - Potentially underestimated \\n\\nJSON format:\\n\\n{\\n   \"Direct and Indirect Coombs\\'\": \"Positive\",\\n   \"Urinary glucose test using Benedict\\'s copper reduction reaction\": \"False-Positive\",\\n   \"Serum or urine creatinine with Jaffé reaction\": \"False-Positive\",\\n   \"Aminoglycoside serum concentration\": \"Potentially underestimated\"\\n}',\n 'IdaruCIZUmab (Lexi-Drugs)': 'Not available',\n 'Bendamustine (Lexi-Drugs)': 'Not available',\n 'Meperidine and Promethazine (Lexi-Drugs)': 'Not available',\n 'Butorphanol (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Systemic) (Infectious Diseases)': '{\"urine glucose test\": \"may interfere with containing cupric sulfate (Benedict\\'s solution, Clinitest)\", \"Coombs\\' test\": \"positive\"}',\n 'Ciprofloxacin and Hydrocortisone (Lexi-Drugs)': 'Not available',\n 'Levobupivacaine [INT] (Lexi-Drugs International [Concise])': 'Not available',\n 'Aztreonam (Systemic) (Lexi-Drugs)': 'Test Names:\\n\\n1. Urine glucose test containing cupric sulfate\\n2. Coombs\\' test\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Urine glucose test containing cupric sulfate\": \"May interfere\",\\n  \"Coombs\\' test\": \"Positive\"\\n}',\n 'Bumetanide (Lexi-Drugs)': 'Test Names:\\n\\n1. Aldosterone/renin ratio (ARR)\\n\\nTest Results in JSON format:\\n\\n{\\n  \"Aldosterone/renin ratio (ARR)\": \"May lead to false-negative\"\\n}',\n 'IDArubicin (Lexi-Drugs)': 'Not available',\n 'Tenecteplase (Lexi-Drugs)': '{\"coagulation\": \"Altered results\", \"fibrinolytic activity\": \"Altered results\"}',\n 'Caspofungin (Lexi-Drugs)': 'Not available',\n 'Anifrolumab (Lexi-Drugs)': 'Not available',\n 'Clevidipine (Geriatric Lexi-Drugs)': '{\"aldosterone/renin ratio\": \"false-negative\", \"ARR\": \"false-negative\"}',\n 'Copanlisib (Lexi-Drugs)': 'Not available',\n 'Ketorolac (Nasal) (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Olaratumab (Lexi-Drugs)': 'Not available',\n 'Digoxin Immune Fab (Lexi-Drugs)': 'Test Names: \\n1. Digitalis immunoassay \\n2. Digoxin serum samples\\n\\nTest Results: \\n{\\n   \"Digitalis immunoassay\": \"may be clinically misleading until all Fab fragments are eliminated from the body\",\\n   \"Digoxin serum samples\": \"should be obtained before digoxin immune fab administration, if possible\"\\n}',\n 'Digoxin Toxicity (Patient Education - Disease and Procedure)': 'Not available',\n 'DexAMETHasone (Systemic) (Lexi-Drugs)': '{\\n\"skin test antigens\": \"suppressed\"\\n}',\n 'Doxercalciferol (Lexi-Drugs)': 'Not available',\n 'Acetaminophen (Lexi-Drugs)': '{\\n\"urinary 5-hydroxyindoleacetic acid\": \"false-positive\"\\n}',\n 'Nalbuphine (Lexi-Drugs)': '{\\n\"enzymatic methods used to detect opioids\": \"interference (refer to test manufacturer for details)\"\\n}',\n 'Sildenafil (Lexi-Drugs)': 'Not available',\n 'Gadobutrol (Lexi-Drugs)': 'Not available',\n 'Methotrexate (Lexi-Drugs)': 'Not available',\n 'Pertuzumab (Lexi-Drugs)': 'Not available',\n 'Colistimethate (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Imiglucerase (Lexi-Drugs)': 'Not available',\n 'Dolasetron (Geriatric Lexi-Drugs)': 'Not available',\n 'Lansoprazole (Lexi-Drugs)': 'Not available',\n 'Smallpox and Monkeypox Vaccine (Live) (Lexi-Drugs)': 'Not available',\n 'Hydrocortisone (Systemic) (Lexi-Drugs)': '{\"skin tests\": \"decreased response\"}',\n 'Centruroides Immune F(ab’)2 (Equine) (Lexi-Drugs)': 'Not available',\n 'LORazepam (Lexi-Drugs)': 'Not available',\n 'Tacrolimus (Topical) (Lexi-Drugs)': 'Not available',\n 'Etelcalcetide (Lexi-Drugs)': 'Not available',\n 'Tafasitamab (Lexi-Drugs)': 'Not available',\n 'Vitamins (Multiple/Oral) (Lexi-Drugs)': 'Medical tests names: \\n1. Urine glucose determinations \\n2. Certain lab tests \\n\\nJSON output: \\n{\\n  \"Urine glucose determinations\": \"false-negative\",\\n  \"Certain lab tests\": \"incorrect\"\\n}',\n 'Cefotaxime (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Iron Sucrose (Lexi-Drugs)': 'Not available',\n 'Danaparoid (Lexi-Drugs)': 'Medical tests names: PT/INR\\n\\nJSON output: {\"PT/INR\": \"unreliable within 5 hours\"}',\n 'Gadofosveset (Lexi-Drugs)': 'Not available',\n 'Sodium Glycerophosphate Pentahydrate (Lexi-Drugs)': 'Not available',\n 'Tagraxofusp (Lexi-Drugs)': 'Not available',\n 'Amivantamab (Lexi-Drugs)': 'Not available',\n 'Evinacumab (Lexi-Drugs)': 'Not available',\n 'Amsacrine (Lexi-Drugs)': 'Not available',\n 'Lidocaine and Tetracaine (Lexi-Drugs)': 'Not available',\n 'Enalaprilat (Lexi-Drugs)': 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-negative.',\n 'Ketorolac (Systemic) (Lexi-Drugs)': 'Test Name: Aldosterone/Renin ratio (ARR)\\nTest Result: May lead to false-positive.',\n 'Acetaminophen and Diphenhydramine (Lexi-Drugs)': 'Not available',\n 'Insulin NPH (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Crotalidae Polyvalent Immune FAB (Ovine) (Lexi-Drugs)': 'Not available',\n 'C1 Inhibitor (Human) (Lexi-Drugs)': 'Not available',\n 'DAUNOrubicin (Liposomal) (Lexi-Drugs)': 'Not available',\n 'Magnesium Sulfate (Lexi-Drugs)': 'Not available',\n 'Cyanocobalamin (Lexi-Drugs)': '{\\n  \"Folic acid\": \"invalidated\",\\n  \"Vitamin B12\": \"invalidated\"\\n}',\n 'Difelikefalin (Lexi-Drugs)': 'Not available',\n 'Fluorouracil (Systemic) (Lexi-Drugs)': 'Not available',\n 'Codeine (Lexi-Drugs)': '{\\n  \"Opioid screening test\": \"false-positive (when taking some quinolones)\",\\n  \"Specific confirmation test\": \"recommended\"\\n}',\n 'Diatrizoate Meglumine (Lexi-Drugs)': 'Test names:\\n- Urine specimen assay\\n\\nTest results in JSON form:\\n{\\n \"Urine specimen assay\": \"N/A\"\\n} \\n(Note: \"N/A\" is the value because no specific test result is mentioned in the sentence)',\n 'Blinatumomab (Lexi-Drugs)': 'Not available',\n 'Cefotaxime (Pediatric and Neonatal Lexi-Drugs)': 'Test names:\\n- Direct Coombs\\' test\\n- Urinary glucose test\\n- Serum creatinine test\\n- Urine creatinine test\\n\\nTest results in JSON form:\\n{\\n \"Direct Coombs\\' test\": \"Positive\",\\n \"Urinary glucose test\": \"False-positive\",\\n \"Serum creatinine test\": \"False-positive\",\\n \"Urine creatinine test\": \"False-positive\"\\n}',\n 'Haloperidol (Lexi-Drugs)': 'Not available',\n 'Sodium Chloride (Lexi-Drugs)': 'Not available',\n 'Smallpox Vaccine Live (Lexi-Drugs)': '1) Medical test names: \\n- Rapid plasma reagin (RPR) test\\n2) Test results in JSON format:\\n- For RPR test: {\"Rapid plasma reagin (RPR) test\": \"false-positive due to smallpox vaccine\"}\\n\\n1) Medical test names:\\n- Tuberculin skin (PPD) and blood tests\\n2) Test results in JSON format:\\n- For Tuberculin skin (PPD) and blood tests: {\"Tuberculin skin (PPD) and blood tests\": \"false-negative due to smallpox vaccine\"}',\n 'Ceftolozane and Tazobactam (Geriatric Lexi-Drugs)': 'Not available',\n 'Bretylium (Lexi-Drugs)': 'Not available',\n 'Clodronate (Lexi-Drugs)': '1) Medical test names:\\n- Bone scan (diagnostic imaging with technetium-99m-diphosphonate)\\n2) Test results in JSON format:\\n- For bone scan: {\"Bone scan\": \"may be interfered by bisphosphonates except clodronate, according to some studies\"}',\n 'Vernakalant (Lexi-Drugs)': 'Not available',\n 'Choline C 11 (Lexi-Drugs)': 'Not available',\n 'Folic Acid (Lexi-Drugs)': 'Test Names: Lactobacillus casei assay method\\nTest Result: Falsely low serum concentrations may occur in patients on anti-infectives (eg, tetracycline)',\n 'Mycophenolate (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Enfortumab Vedotin (Lexi-Drugs)': 'Not available',\n 'Comparison of Prothrombin Complex Concentrates (Lexi-Drugs)': 'Not available',\n 'Nalmefene (Lexi-Drugs)': 'Not available',\n 'Clindamycin and Benzoyl Peroxide (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Oral Inhalation) (Geriatric Lexi-Drugs)': 'Not available',\n 'Betamethasone and Clotrimazole (Lexi-Drugs)': 'Not available',\n 'Temozolomide-Rituximab (CNS Lymphoma) (Lexi-Drugs)': 'Not available',\n 'Methyldopa and Hydrochlorothiazide (Lexi-Drugs)': 'Not available',\n 'Vancomycin (Lexi-Drugs)': 'Not available',\n 'Belimumab (Lexi-Drugs)': 'Not available',\n 'Vonoprazan and Amoxicillin (Lexi-Drugs)': 'Not available',\n 'Orphenadrine (Lexi-Drugs)': 'Not available',\n 'Acyclovir (Topical) (Lexi-Drugs)': 'Not available',\n 'Phenylephrine and Ketorolac (Lexi-Drugs)': 'Not available',\n 'Aminocaproic Acid (Lexi-Drugs)': 'Not available',\n 'Lurbinectedin (Lexi-Drugs)': 'Not available',\n 'Tigecycline (Lexi-Drugs)': 'Not available',\n 'Oxacillin (Lexi-Drugs)': \"Test Names: \\n1. Urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®)\\n2. Aminoglycoside activity test\\n3. Urinary protein test\\n4. Serum protein test\\n\\nTest Results:\\n1. May interfere\\n2. May inactivate in vitro\\n3. False positive in urinary test\\n4. False positive in serum test\",\n 'Phenylephrine (Nasal) (Lexi-Drugs)': 'Not available',\n 'Tobramycin and Dexamethasone (Lexi-Drugs)': 'Not available',\n 'Chlorpheniramine, Pseudoephedrine, and Dextromethorphan (Lexi-Drugs)': 'Not available',\n 'CefoTEtan (Lexi-Drugs)': 'Test names: \\n1) Direct Coombs\\' test\\n2) Urinary glucose test\\n3) Serum or urine creatinine test with Jaffé reaction\\n\\nJSON Form: \\n{\\n  \"Direct Coombs\\' test\": \"Positive\",\\n  \"Urinary glucose test\": \"False-positive\",\\n  \"Serum or urine creatinine test with Jaffé reaction\": \"May cause false-positive\"\\n}',\n 'Sacituzumab Govitecan (Lexi-Drugs)': 'Not available',\n 'Ethacrynic Acid (Lexi-Drugs)': 'Test Name: Aldosterone/Renin Ratio (ARR)\\nTest Result: May lead to false-negative (Funder 2016)',\n 'Eteplirsen (Lexi-Drugs)': 'Not available',\n 'Estrogens (Conjugated/Equine, Systemic) (Lexi-Drugs)': 'Test Names: laboratory tests related to coagulation factors, lipids, glucose tolerance, thyroxine-binding globulin, sex hormone-binding globulin, cortisol-binding globulin\\nTest Result: The use of estrogens and/or progestogens may alter the results (general statement)',\n 'Cidofovir (Lexi-Drugs)': 'Not available',\n 'Ado-Trastuzumab Emtansine (Lexi-Drugs)': 'Not available',\n 'Pamidronate (Lexi-Drugs)': 'Test names: \\n1. Technetium-99m-diphosphonate bone scan \\n\\nTest results:\\n{\\n\"Technetium-99m-diphosphonate bone scan\": \"may be interfered with by Bisphosphonates\"\\n}',\n 'Golimumab (Lexi-Drugs)': 'Not available',\n 'Gadopiclenol (Lexi-Drugs)': 'Not available',\n 'Melphalan (Lexi-Drugs)': 'Test names: \\n1. Coombs\\' test [direct]\\n\\nTest results:\\n{\\n\"Coombs\\' test [direct]\": \"false-positive \"\\n}',\n 'Benzocaine, Butamben, and Tetracaine (Lexi-Drugs)': 'Not available',\n 'Buprenorphine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'DOXOrubicin (Liposomal) (Lexi-Drugs)': 'Not available',\n 'Factor X (Human) (Lexi-Drugs)': 'Not available',\n 'Indomethacin (Lexi-Drugs)': '{\\n  \"dexamethasone suppression test\": \"false-negative\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n 'ChlorproMAZINE (Lexi-Drugs)': '{\\n    \"phenylketonuria\": \"false-positive\",\\n    \"amylase\": \"false-positive\",\\n    \"uroporphyrins\": \"false-positive\",\\n    \"urobilinogen\": \"false-positive\",\\n    \"pregnancy test\": \"false-positive\",\\n    \"amphetamine/methamphetamine\": \"false-positive\",\\n    \"methadone\": \"false-positive\"\\n}',\n 'Azithromycin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Angiotensin II (Lexi-Drugs)': 'Not available',\n 'Mannitol (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Benztropine (Geriatric Lexi-Drugs)': 'Not available',\n 'Ampicillin (Lexi-Drugs)': \"1. Medical test name: Urinary glucose tests\\n   Test result: May interfere with using cupric sulfate (Benedict's solution, Clinitest®)\\n\\n2. Medical test name: Aminoglycoside serum concentration\\n   Test result: Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives.\",\n 'Flucytosine (Lexi-Drugs)': 'Medical test name: Serum creatinine values\\nTest result: Markedly false elevations when the Ektachem® analyzer is used. The Jaffé reaction is recommended for determining serum creatinine.',\n 'Bezlotoxumab (Lexi-Drugs)': 'Not available',\n 'Selenium Sulfide (Lexi-Drugs)': 'Not available',\n 'Hyaluronidase (Lexi-Drugs)': 'Not available',\n 'Carboplatin-Paclitaxel (NSCLC) (Lexi-Drugs)': 'Not available',\n 'Tetracaine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Mechlorethamine (Systemic) (Lexi-Drugs)': 'Not available',\n 'DilTIAZem (Lexi-Drugs)': 'Not available',\n 'Moxifloxacin (Systemic) (Lexi-Drugs)': 'Test names: \\n1. Urine screening test for opioids using commercially-available immunoassay kits\\n\\nTest results:\\n1. False-positive results for opioids may be produced by some quinolones, especially levofloxacin and ofloxacin\\n2. Other quinolones may also show cross-reactivity in certain assay kits.\\n3. Positive opioid screens should be confirmed by more specific methods.',\n 'MethylPREDNISolone (Lexi-Drugs)': 'Test names: \\n1. Skin test\\n\\nTest results:\\n1. Decreased response to skin tests.',\n 'Antihemophilic Factor (Human) (Lexi-Drugs)': 'Not available',\n 'Mirvetuximab Soravtansine (Lexi-Drugs)': 'Not available',\n 'Carbetocin (Lexi-Drugs)': 'Not available',\n 'Cloxacillin (Lexi-Drugs)': '{\\n    \"Urinary glucose tests using cupric sulfate\": \"May interfere\",\\n    \"Aminoglycosides\": \"May inactivate in vitro\",\\n    \"Urine proteins\": \"False-positive\",\\n    \"Serum proteins\": \"False-positive\",\\n    \"Uric acid\": \"False-positive\",\\n    \"Urinary steroids\": \"False-positive\"\\n}',\n 'Carmustine (Lexi-Drugs)': 'Not available',\n 'Ibuprofen, Phenylephrine, and Chlorpheniramine (Lexi-Drugs)': 'Not available',\n 'Atoltivimab, Maftivimab, and Odesivimab (Lexi-Drugs)': 'Not available',\n 'AzaTHIOprine (Lexi-Drugs)': '{\\n  \"Medical Test Name\": \"TPMT phenotyping\",\\n  \"Test Result\": \"May not be accurate following recent blood transfusions.\"\\n}',\n 'Bromhexine [INT] (Lexi-Drugs International [Concise])': 'Not available',\n 'Axicabtagene Ciloleucel (Lexi-Drugs)': 'Not available',\n 'Insulin Aspart Protamine and Insulin Aspart (Lexi-Drugs)': 'Not available',\n 'Insulin Detemir (Lexi-Drugs)': 'Not available',\n 'HydrALAZINE (Lexi-Drugs)': 'Not available',\n 'Orphenadrine, Aspirin, and Caffeine (Lexi-Drugs)': 'Not available',\n 'Gadopentetate Dimeglumine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Fluorescein (Lexi-Drugs)': 'Not available',\n 'Diazoxide (Lexi-Drugs)': '{\\n  \"Serum renin concentrations\": \"increased\",\\n  \"IgG concentrations\": \"increased\",\\n  \"Serum cortisol concentrations\": \"decreased\",\\n  \"insulin response to glucagon\": \"false-negative\"\\n}',\n 'FentaNYL (Lexi-Drugs)': 'Not available',\n 'Bortezomib (Lexi-Drugs)': 'Not available',\n 'Caplacizumab (Lexi-Drugs)': 'Not available',\n 'Capmatinib (Lexi-Drugs)': 'Not available',\n 'Pafolacianine (Lexi-Drugs)': 'Not available',\n 'Dostarlimab (Lexi-Drugs)': 'Not available',\n 'Glycopyrrolate (Systemic) (Lexi-Drugs)': 'Not available',\n 'Etoposide (Lexi-Drugs)': 'Not available',\n 'Adenosine (Lexi-Drugs)': 'Not available',\n 'Melphalan (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Minocycline (Topical) (Lexi-Drugs)': '{\"fluorescence test for urinary catecholamines\":\"false elevations\"}',\n 'Tremelimumab (Lexi-Drugs)': 'Not available',\n 'Cimetidine (Lexi-Drugs)': 'Not available',\n ' ': \"I'm sorry, but I cannot extract the medical test names and their results without any input data. Please provide the data.\",\n 'Dextromethorphan and Chlorpheniramine (Lexi-Drugs)': 'Not available',\n 'MT-RNR1 - Kanamycin (Pharmacogenomics)': 'Not available',\n 'Ofloxacin (Systemic) (Lexi-Drugs)': '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"cross-reactivity\", \"ofloxacin\": \"cross-reactivity\", \"other quinolones\": \"cross-reactivity\"}',\n 'Alpha1-Proteinase Inhibitor (Lexi-Drugs)': 'Not available',\n 'Alcohol (Ethyl) (Lexi-Drugs)': 'Not available',\n 'Brentuximab Vedotin (Lexi-Drugs)': 'Not available',\n 'Lutetium Lu 177 Vipivotide Tetraxetan (Lexi-Drugs)': 'Not available',\n 'Methylfolate, Methylcobalamin, and Acetylcysteine (Lexi-Drugs)': 'Not available',\n 'Trabectedin (Lexi-Drugs)': 'Not available',\n 'Mechlorethamine (Topical) (Lexi-Drugs)': 'Not available',\n 'DroPERidol (Lexi-Drugs)': 'Not available',\n 'Ustekinumab (Lexi-Drugs)': 'Not available',\n 'Argatroban (Lexi-Drugs)': 'Test names: \\n1. PT/INR levels\\n2. Chromogenic factor X assay\\n3. Factor Xa levels\\n\\nTest results:\\n{\\n  \"PT/INR levels\": \"elevated in the absence of warfarin, may require modification while on argatroban\",\\n  \"Chromogenic factor X assay\": \"suggested to be monitored when transitioning from argatroban to warfarin or overlapping administration of warfarin for a minimum of 5 days until INR is within target range, recheck INR after anticoagulant effect of argatroban has dissipated\",\\n  \"Factor Xa levels\": \"associated with INR values >2 after the effects of argatroban have been eliminated\"\\n}',\n 'Vestronidase Alfa (Lexi-Drugs)': 'Not available',\n 'Betibeglogene Autotemcel (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"Test name\": \"Polymerase chain reaction (PCR) assay for HIV\",\\n  \"Test result\": \"False-positive for HIV in patients who have received betibeglogene autotemcel due to integrated BB305 LVV proviral DNA\"\\n}',\n 'Copper Cu 64 Dotatate (Lexi-Drugs)': 'Not available',\n 'Diphenhydramine and Ibuprofen (Lexi-Drugs)': 'Not available',\n 'Abciximab (Lexi-Drugs)': 'Not available',\n 'Calcium Gluconate (Lexi-Drugs)': 'Medical Test Names: Serum magnesium test and Urine magnesium test.\\n\\nJSON output:\\n{\\n \"Serum magnesium test\": \"falsely decreased\",\\n \"Urine magnesium test\": \"falsely decreased\"\\n}',\n 'Ferric Pyrophosphate Citrate (Lexi-Drugs)': 'Not available',\n 'Ticarcillin and Clavulanate Potassium (Infectious Diseases)': 'Medical Test Names: Coombs\\' test and Urinary protein test.\\n\\nJSON output:\\n{\\n \"Coombs\\' test\": \"positive\",\\n \"Urinary protein test\": \"false-positive\"\\n}',\n 'Teprotumumab (Lexi-Drugs)': 'Not available',\n 'Hydrocortisone (Topical) (Lexi-Drugs)': 'Not available',\n 'Lidocaine and Prilocaine (Lexi-Drugs)': 'Not available',\n 'Cytarabine (Conventional) (Lexi-Drugs)': 'Not available',\n 'Celecoxib and Tramadol (Lexi-Drugs)': 'Not available',\n 'Fosdenopterin (Lexi-Drugs)': 'Not available',\n 'Galsulfase (Lexi-Drugs)': 'Not available',\n 'Terbutaline (Lexi-Drugs)': 'Not available',\n 'Estrogens (Conjugated/Equine, Topical) (Lexi-Drugs)': '{\\n  \"metyrapone test\": \"reduced response\"\\n}',\n 'Fomepizole (Lexi-Drugs)': 'Not available',\n 'Andexanet Alfa (Coagulation Factor Xa [Recombinant], Inactivated) (Lexi-Drugs)': '{\\n  \"anti-FXa activity assay\": \"falsely elevated after andexanet alfa administration\",\\n  \"andexanet alfa\": \"reversal activity\"\\n}',\n 'CefTRIAXone (Lexi-Drugs)': '{\\n    \"Positive direct Coombs\\'\": \"positive\",\\n    \"false-positive urinary glucose test using nonenzymatic methods\": \"false-positive\",\\n    \"false-positive galactosemia tests\": \"false-positive\"\\n}',\n 'EPHEDrine (Systemic) (Lexi-Drugs)': '{\\n    \"test name\": \"amphetamine EMIT assay\",\\n    \"test result\": \"false positive\"\\n}',\n 'Ixabepilone (Lexi-Drugs)': 'Not available',\n 'Amikacin Liposome (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Vasopressin (Geriatric Lexi-Drugs)': 'Not available',\n 'Lisocabtagene Maraleucel (Lexi-Drugs)': 'Not available',\n 'Vasopressin (Lexi-Drugs)': 'Not available',\n 'Sirolimus (Protein Bound) (Lexi-Drugs)': 'Not available',\n 'Acetylcysteine (Lexi-Drugs)': 'Not available',\n 'Potassium Iodide (Lexi-Drugs)': '{\\n   \"Thyroid function tests\": \"Altered\"\\n}',\n 'Irinotecan (Liposomal) (Lexi-Drugs)': 'Not available',\n 'EpiRUBicin (Lexi-Drugs)': 'Not available',\n 'Theophylline (Lexi-Drugs)': '{\\n  \"Plasma glucose\": \"increased\",\\n  \"Uric acid\": \"increased\",\\n  \"Free fatty acids\": \"increased\",\\n  \"Total cholesterol\": \"increased\",\\n  \"HDL\": \"increased\",\\n  \"HDL/LDL ratio\": \"increased\",\\n  \"Urinary free cortisol excretion\": \"increased\",\\n  \"Triiodothyronine\": \"decreased\"\\n}',\n 'Methylfolate, Methylcobalamin, and Acetylcysteine (Geriatric Lexi-Drugs)': 'Not available',\n 'Atropine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Tetracaine (Topical) (Lexi-Drugs)': 'Not available',\n 'Ciprofloxacin and Fluocinolone (Lexi-Drugs)': 'Not available',\n 'Vancomycin (Geriatric Lexi-Drugs)': 'Not available',\n 'DexAMETHasone (Ophthalmic) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Iobenguane I 131 (Lexi-Drugs)': 'Not available',\n 'Neostigmine and Glycopyrrolate (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Decitabine and Cedazuridine (Lexi-Drugs)': 'Not available',\n 'Ansuvimab (Lexi-Drugs)': 'Not available',\n 'Copper IUD (Lexi-Drugs)': 'Not available',\n 'Esmolol (Lexi-Drugs)': 'Not available',\n 'Dalteparin (Lexi-Drugs)': 'Not available',\n 'Onasemnogene Abeparvovec (Lexi-Drugs)': 'Not available',\n 'Manganese (Lexi-Drugs)': 'Not available',\n 'Ipilimumab (Lexi-Drugs)': 'Not available',\n 'Bamlanivimab and Etesevimab (Lexi-Drugs)': 'Not available',\n 'TraMADol (Lexi-Drugs)': 'Medical Test Name: Urine Detection of Phencyclidine\\nTest Result: False-Positive',\n 'Fluoroestradiol F18 (Lexi-Drugs)': 'Not available',\n 'Obinutuzumab (Lexi-Drugs)': 'Not available',\n 'PHENobarbital (Lexi-Drugs)': 'Not available',\n 'Anthrax Immune Globulin (Human) [ANTIDOTE] (Lexi-Tox)': '1. Medical tests mentioned in the given data:\\n- Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n- Glucose-specific method\\n- Urinalysis\\n- Serologic testing\\n- Direct and indirect Coombs’ test\\n\\n2. Test results in JSON form:\\n{\\n  \"Glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\": \"falsely elevated blood glucose levels\",\\n  \"Glucose-specific method\": \"recommended\",\\n  \"Urinalysis\": \"transiently elevated glucose\",\\n  \"Serologic testing\": \"false-positive results\",\\n  \"Direct and indirect Coombs’ test\": \"false-positive results\"\\n}',\n 'MetroNIDAZOLE (Systemic) (Lexi-Drugs)': '{\\n    \"AST\": \"interfere\",\\n    \"ALT\": \"interfere\",\\n    \"triglycerides\": \"interfere\",\\n    \"glucose\": \"interfere\",\\n    \"LDH\": \"interfere\"\\n}',\n 'Betamethasone (Systemic) (Lexi-Drugs)': '1. Medical test mentioned in the given data:\\n- Skin test for wheal and flare reactions to antigens \\n\\n2. Test result in JSON form:\\n{\\n  \"Skin test for wheal and flare reactions to antigens\": \"may be suppressed\"\\n}',\n 'Dihydroergotamine (Lexi-Drugs)': 'Not available',\n 'Digoxin (Lexi-Drugs)': '1. Medical test mentioned in the given data:\\n- Digoxin radioimmunoassay \\n\\n2. Test result in JSON form:\\n{\\n  \"Digoxin radioimmunoassay\": \"may be interfered\"\\n}',\n 'Betamethasone (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Glucarpidase (Lexi-Drugs)': 'Test Names: Methotrexate levels\\nTest Result: {\"Methotrexate levels\": \"the chromatographic method\"}',\n 'Oxycodone and Naloxone (Lexi-Drugs)': 'Not available',\n 'Labetalol (Lexi-Drugs)': 'Test Names: \\n1. Urine catecholamines\\n2. Metanephrine \\n3. Normetanephrine \\n4. Vanillylmandelic acid (VMA) \\n5. Urine amphetamine \\n6. Aldosterone/renin ratio (ARR)\\n\\nTest Results:\\n{\\n   \"Urine catecholamines\": \"HPLC assay with solid-phase extraction should be used to determine levels of catecholamines\",\\n   \"Metanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of metanephrine\",\\n   \"Normetanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of normetanephrine\",\\n   \"Vanillylmandelic acid (VMA)\": \"HPLC assay with solid-phase extraction should be used to determine levels of VMA\",\\n   \"Urine amphetamine\": \"Gas chromatographic-mass spectrometer technique should be used to determine levels of amphetamine\",\\n   \"Aldosterone/renin ratio (ARR)\": \"May lead to a false-positive result\"\\n}',\n 'C1 Inhibitor (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Ramucirumab (Lexi-Drugs)': 'Not available',\n 'Flecainide (Lexi-Drugs)': 'Not available',\n 'Gadoteridol (Lexi-Drugs)': 'Not available',\n 'Patisiran (Lexi-Drugs)': 'Not available',\n 'Imipenem and Cilastatin (Pediatric and Neonatal Lexi-Drugs)': 'Test Names:\\n- Urinary glucose determination using Clinitest®\\n- Coombs\\' direct\\n\\nTest Results (in json format):\\n{\\n  \"Urinary glucose determination using Clinitest®\": \"Interfered\",\\n  \"Coombs\\' direct\": \"Positive\"\\n}',\n 'PENTobarbital (Lexi-Drugs)': 'Not available',\n 'Lidocaine and Chlorhexidine (Lexi-Drugs)': 'Not available',\n 'Ibuprofen (Lexi-Drugs)': '{\\n  \"phencyclidine\": \"false-positives\",\\n  \"aldosterone/renin ratio (ARR)\": \"false-positive\"\\n}',\n 'Ceftolozane and Tazobactam (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Sodium Tetradecyl Sulfate (Lexi-Drugs)': 'Not available',\n 'DexAMETHasone (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Doxycycline Hyclate Periodontal Extended-Release Liquid (Lexi-Drugs)': 'Not available',\n 'Flortaucipir F18 (Lexi-Drugs)': 'Not available',\n 'Dinutuximab (Lexi-Drugs)': 'Not available',\n 'Eravacycline (Lexi-Drugs)': 'Not available',\n 'Meloxicam (Lexi-Drugs)': '{\"aldosterone/renin ratio (ARR)\": \"false-positive\"}',\n 'Busulfan (Lexi-Drugs)': 'Not available',\n 'Albuterol (Lexi-Drugs)': '{\"renin (S)\": \"increased\",\\n \"aldosterone (S)\": \"increased\"}',\n 'Etomidate (Lexi-Drugs)': 'Not available',\n 'Melphalan-Prednisone (Multiple Myeloma) (Lexi-Drugs)': 'Not available',\n 'Elivaldogene Autotemcel (Lexi-Drugs)': '{\"PCR assays for HIV\": \"positive\", \"HIV infection using a PCR-based assay\": \"false-positive\"}',\n 'Indigotindisulfonate Sodium (Lexi-Drugs)': 'Not available',\n 'Iopamidol (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Sargramostim (Lexi-Drugs)': 'Not available',\n 'Belinostat (Lexi-Drugs)': 'Not available',\n 'Naxitamab (Lexi-Drugs)': 'Not available',\n 'Glycopyrronium (Topical) (Lexi-Drugs)': 'Not available',\n 'Antihemophilic Factor (Recombinant [Porcine Sequence]) (Lexi-Drugs)': 'Not available',\n 'DAUNOrubicin (Conventional) (Lexi-Drugs)': 'Not available',\n 'Foscarnet (Lexi-Drugs)': 'Not available',\n 'DAPTOmycin (Lexi-Drugs)': 'Test Names:\\n- PT (Prothrombin Time) test\\n- INR (International Normalized Ratio) test\\n\\nTest Results (in JSON form):\\n{\\n  \"PT (Prothrombin Time) test\": \"false prolongation with certain recombinant thromboplastin reagents when taking daptomycin\",\\n  \"INR (International Normalized Ratio) test\": \"increase with certain recombinant thromboplastin reagents when taking daptomycin\"\\n}',\n 'Metoprolol (Lexi-Drugs)': 'Not available',\n 'Mogamulizumab (Lexi-Drugs)': 'Not available',\n 'Imipenem, Cilastatin, and Relebactam (Infectious Diseases)': '{\\n   \"Test Name\": \"Coombs test\",\\n   \"Test Result\": \"Positive\"\\n}',\n 'Reslizumab (Lexi-Drugs)': 'Not available',\n 'Ifosfamide (Lexi-Drugs)': 'Not available',\n 'Nafcillin (Lexi-Drugs)': '{\\n  \"Coombs\\' test (direct)\": \"Positive\",\\n  \"Urinary proteins\": \"False-positive\",\\n  \"Serum proteins\": \"False-positive\",\\n  \"Aminoglycoside inactivation\": \"In vitro\"\\n}',\n 'Procyclidine (Lexi-Drugs)': 'Not available',\n 'Loteprednol and Tobramycin (Lexi-Drugs)': 'Not available',\n 'Ascorbic Acid (Lexi-Drugs)': '{\\n  \"Stool occult blood test\": \"False-negative\",\\n  \"Blood glucose testing\": \"Interference (falsely-elevated)\",\\n  \"Urine glucose testing\": \"Interference\",\\n  \"Nitrite levels\": \"Interference\",\\n  \"Bilirubin levels\": \"Interference\",\\n  \"Leucocyte count\": \"Interference\"\\n}',\n 'Etranacogene Dezaparvovec (Lexi-Drugs)': '{\\n  \"One-stage clotting assay (OSA)\": \"Affected by aPTT reagent and reference standard used; recommended for monitoring factor IX activity over time with the same assay and reagents\",\\n  \"Activated partial thromboplastin time (aPTT)\": \"Type of reagent used affects results when using OSA to determine factor IX activity\",\\n  \"Chromogenic substrate assay (CSA)\": \"Results in lower factor IX activity compared to OSA; mean CSA to OSA factor IX activity ratio ranging from 0.41 to 0.55 in clinical study\"\\n}',\n 'Nivolumab (Lexi-Drugs)': 'Not available',\n 'Spesolimab (Lexi-Drugs)': 'Not available',\n 'LevoFLOXacin (Systemic) (Lexi-Drugs)': '{\"urine screening result for opioids\": \"false-positive\", \"levofloxacin\": \"positive\", \"ofloxacin\": \"positive\"}',\n 'Imipenem and Cilastatin (Lexi-Drugs)': '{\"urinary glucose determination using Clinitest\": \"interferes\", \"Coombs\\' [direct]\": \"positive\"}',\n 'Loncastuximab Tesirine (Lexi-Drugs)': 'Not available',\n 'Elotuzumab (Lexi-Drugs)': 'Test Names: \\n1. Serum Protein Electrophoresis (SPEP)\\n2. Serum Immunofixation Assays\\n \\nTest Results in JSON Format:\\n{\\n   \"SPEP\": \"A small peak in the early gamma region\",\\n   \"Serum Immunofixation Assays\": \"may potentially be attributed to elotuzumab\"\\n}',\n 'Lidocaine and Epinephrine (Lexi-Drugs)': 'Not available',\n 'Gadoxetate (Lexi-Drugs)': 'Test Name:\\n1. Serum Iron Test\\n\\nTest Result in JSON Format:\\n{\\n   \"Serum Iron Test\": \"Falsely high or low values of serum iron (if determined by complexometric methods) may occur for up to 24 hours following administration.\"\\n}',\n 'Ibuprofen and Acetaminophen (Pediatric and Neonatal Lexi-Drugs)': 'Test Names:\\n1. Urinary 5-hydroxyindoleacetic acid test\\n2. Urine detection of Phencyclidine test\\n3. Aldosterone/Renin Ratio (ARR) test\\n\\nTest Results in JSON Format:\\n{\\n   \"Urinary 5-hydroxyindoleacetic acid test\": \"false-positive due to Acetaminophen\",\\n   \"Urine detection of Phencyclidine test\": \"false-positives due to Ibuprofen\",\\n   \"Aldosterone/Renin Ratio (ARR) test\": \"false-positive due to Ibuprofen\"\\n}',\n 'Betamethasone and Gentamicin (Lexi-Drugs)': 'Not available',\n 'Phytonadione (Lexi-Drugs)': 'Not available',\n 'Methadone (Lexi-Drugs)': '1. Medical test names:\\n- Urine screening test for opioids using immunoassay kits\\n- Confirmation test for positive opioid screens using more specific methods\\n- Urine methadone screens using immunoassay kits\\n\\n2. Test Results in JSON format:\\n{\\n  \"Urine screening test for opioids using immunoassay kits\": \"false-positive for opioids with quinolones (levofloxacin and ofloxacin) and other medications (not specified)\",\\n  \"Confirmation test for positive opioid screens using more specific methods\": \"not specified\",\\n  \"Urine methadone screens using immunoassay kits\": \"false-positive in patients taking diphenhydramine, doxylamine, clomipramine, chlorpromazine, thioridazine, quetiapine, and verapamil\"\\n}',\n 'Antithymocyte Globulin (Rabbit) (Lexi-Drugs)': '1. Medical test names:\\n- Rabbit antibody-based immunoassays\\n- Cross-match or panel-reactive antibody cytotoxicity assays\\n- Routine clinical laboratory tests which use immunoglobulins\\n\\n2. Test Results in JSON format:\\n{\\n  \"Rabbit antibody-based immunoassays\": \"potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"potential interference\",\\n  \"Routine clinical laboratory tests which use immunoglobulins\": \"no interference shown\"\\n}',\n 'Crizotinib (Lexi-Drugs)': 'Not available',\n 'Oxycodone and Aspirin (Lexi-Drugs)': \"I'm sorry, I cannot extract the medical test names and their results without any specific data to refer to. Please provide the necessary information.\",\n 'Ibuprofen, Pseudoephedrine, and Chlorpheniramine (Lexi-Drugs)': 'Not available',\n 'Amobarbital (Lexi-Drugs)': 'Not available',\n 'Sodium Phenylacetate and Sodium Benzoate (Lexi-Drugs)': 'Not available',\n 'Metoclopramide (Lexi-Drugs)': 'Not available',\n 'Cytomegalovirus Immune Globulin (Intravenous-Human) (Lexi-Drugs)': 'Not available',\n 'Lidocaine (Topical) (Lexi-Drugs)': 'Not available',\n 'Oxycodone and Ibuprofen (Lexi-Drugs)': 'Not available',\n 'Viltolarsen (Lexi-Drugs)': 'Test Names: Not specified in the given data.\\nTest Results:\\n{\\n\"Urine Protein Detection with Pyrogallol Red reagent\": \"May give false positive results if Viltolarsen is present in urine\",\\n\"Urine Protein Detection with other test methods\": \"Not affected by Viltolarsen\",\\n\"Timeframe for avoiding false positives\": \"Urine obtained prior to infusion or ≥48 hours after infusion\",\\n}',\n 'Posaconazole (Lexi-Drugs)': 'Not available',\n 'Amphotericin B (Liposomal) (Lexi-Drugs)': 'Medical Test Name: PHOSm assay\\n\\nTest Result JSON: {\"PHOSm assay\": \"Falsely-elevated serum phosphate\"}',\n 'Diclofenac (Topical) (Lexi-Drugs)': 'Not available',\n 'Thiamine (Lexi-Drugs)': 'Medical Test Names: \\n1. Phosphotungstate method for uric acid\\n2. Ehrlich\\'s reagent for urobilinogen\\n3. Spectrophotometric determination of serum theophylline concentration\\n\\nTest Result JSON: \\n{\\n   \"Phosphotungstate method for uric acid\": \"False-positive\",\\n   \"Ehrlich\\'s reagent for urobilinogen\": \"False-positive\",\\n   \"Spectrophotometric determination of serum theophylline concentration\": \"Interference with large doses\"\\n}',\n 'Linezolid (Lexi-Drugs)': 'Not available',\n 'Selexipag (Lexi-Drugs)': 'Not available',\n 'Dacarbazine (Lexi-Drugs)': 'Not available',\n 'Arsenic Trioxide (Lexi-Drugs)': 'Not available',\n 'Laronidase (Lexi-Drugs)': 'Not available',\n 'Insulin Glulisine (Lexi-Drugs)': 'Not available',\n 'Mepivacaine (Lexi-Drugs)': 'Not available',\n 'AcetaZOLAMIDE (Lexi-Drugs)': '{\\n  \"Urinary protein with Albustix\": \"false-positive\",\\n  \"Labstix\": \"false-positive\",\\n  \"Albutest\": \"false-positive\",\\n  \"Bumintest\": \"false-positive\",\\n  \"HPLC theophylline assay\": \"interference\",\\n  \"Serum uric acid levels\": \"interference\",\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'NiMODipine (Lexi-Drugs)': '{\\n  \"Aldosterone/renin ratio (ARR)\": \"false-negative\"\\n}',\n 'Necitumumab (Lexi-Drugs)': 'Not available',\n 'Alemtuzumab (Lexi-Drugs)': '{\\n  \"Diagnostic serum tests that utilize antibodies\": \"interference\"\\n}',\n 'Neostigmine and Glycopyrrolate (Lexi-Drugs)': 'Not available',\n 'Tobramycin (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Tisotumab Vedotin (Lexi-Drugs)': 'Not available',\n 'Ondansetron (Lexi-Drugs)': 'Not available',\n 'PyRIDostigmine (Lexi-Drugs)': 'Not available',\n 'Oxaliplatin (Lexi-Drugs)': 'Not available',\n 'Fludarabine-Cyclophosphamide (CLL) (Lexi-Drugs)': 'Not available',\n 'Pentazocine and Naloxone (Lexi-Drugs)': 'Not available',\n 'Dalbavancin (Lexi-Drugs)': 'Not available',\n 'Ibalizumab (Lexi-Drugs)': 'Not available',\n 'MitoMYcin (Ureteral Gel) (Lexi-Drugs)': 'Not available',\n 'Efgartigimod Alfa (Lexi-Drugs)': 'Not available',\n 'Caffeine (Lexi-Drugs)': 'Not available',\n 'Benztropine (Lexi-Drugs)': 'Not available',\n 'ROPivacaine (Lexi-Drugs)': 'Not available',\n 'Verteporfin (Lexi-Drugs)': 'Not available',\n 'Sutimlimab (Lexi-Drugs)': 'Not available',\n 'Sebelipase Alfa (Lexi-Drugs)': 'Not available',\n 'Cladribine (Lexi-Drugs)': 'Not available',\n 'Vaccinia Immune Globulin (Intravenous) (Lexi-Drugs)': '{\"serologic testing\": \"false-positive\", \"direct Coombs test\": \"false-positive\", \"indirect Coombs test\": \"false-positive\"}',\n 'Vinorelbine (Lexi-Drugs)': 'Not available',\n 'Abatacept (Lexi-Drugs)': '{\\n  \"Dehydrogenase Pyrroloquinolinequinone\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose-dye-oxidoreductase\": \"Falsely elevated blood glucose levels\",\\n  \"Glucose Dehydrogenase Nicotine Adenine Dinucleotide (GDH-NAD)\": \"Recommended glucose monitoring method\",\\n  \"Glucose Oxidase\": \"Recommended glucose monitoring method\",\\n  \"Glucose Hexokinase\": \"Recommended glucose monitoring method\"\\n}',\n 'VinCRIStine (Liposomal) (Lexi-Drugs)': 'Not available',\n 'Acetaminophen, Diphenhydramine, and Phenylephrine (Lexi-Drugs)': 'Not available',\n 'Glucagon (Geriatric Lexi-Drugs)': 'Not available',\n 'Gallium Ga 68 Dotatate (Lexi-Drugs)': 'Not available',\n 'Tobramycin (Systemic) (Lexi-Drugs)': '{\\n  \"Medical Test Names\": [\\n    \"Aminoglycoside Serum Concentration\"\\n  ],\\n  \"Test Results\": [\\n    \"Potential Underestimation\"\\n  ]\\n}',\n 'Porfimer (Lexi-Drugs)': 'Not available',\n 'NiCARdipine (Lexi-Drugs)': '{\\n  \"Medical Test Names\": [\\n    \"Aldosterone/Renin Ratio (ARR)\"\\n  ],\\n  \"Test Results\": [\\n    \"False-Negative\"\\n  ]\\n}',\n 'Penicillin G (Parenteral/Aqueous) (Lexi-Drugs)': '{\\n \"urinary glucose determination using Clinitest\": \"false-positive or negative\",\\n \"Coombs\\' [direct]\": \"positive\",\\n \"urinary and/or serum proteins by certain test methods\": \"false-positive\"\\n}',\n 'DOXOrubicin (Conventional) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'CefTAZidime (Lexi-Drugs)': '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate\": \"False-positive\",\\n  \"serum or urine creatinine with Jaffé reaction\": \"False-positive\"\\n}',\n 'Norepinephrine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Insulin (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Tirofiban (Lexi-Drugs)': 'Not available',\n 'Ciltacabtagene Autoleucel (Lexi-Drugs)': 'Not available',\n 'Acetylcysteine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Cetirizine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Floxuridine (Lexi-Drugs)': 'Not available',\n 'Neostigmine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Vancomycin (Infectious Diseases)': 'Not available',\n 'Vestronidase Alfa (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Lidocaine (Systemic) (Lexi-Drugs)': 'Not available',\n 'Antithymocyte Globulin (Equine) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Daratumumab and Hyaluronidase (Lexi-Drugs)': 'Medical test names:\\n1. Indirect antiglobulin test (indirect Coombs test)\\n2. Serum protein electrophoresis\\n3. Immunofixation assays\\n\\nJSON form:\\n{\\n  \"Indirect antiglobulin test (indirect Coombs test)\": \"Positive\",\\n  \"Serum protein electrophoresis\": \"Detected\",\\n  \"Immunofixation assays\": \"Interference\"\\n}',\n 'Sodium Nitrite (Lexi-Drugs)': 'Not available',\n 'Antipsychotic Agents, Atypical (Lexi-Tox)': 'Not available',\n 'Scopolamine (Lexi-Drugs)': 'Medical test names:\\n1. Gastric secretion test\\n\\nJSON form:\\n{\\n  \"Gastric secretion test\": \"Interference\"\\n}',\n 'Valproic Acid and Derivatives (Lexi-Drugs)': 'Test names: Urine ketones, Thyroid function tests\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine ketones\": {\\n    \"Effect\": \"May cause a false-positive result\",\\n    \"Medication\": \"Valproate\",\\n    \"Mode of elimination\": \"Partially eliminated as a keto-metabolite in the urine\"\\n  },\\n  \"Thyroid function tests\": {\\n    \"Effect\": \"May alter\"\\n  }\\n}',\n 'Cefiderocol (Lexi-Drugs)': 'Test names: Urine dipstick tests (urine protein, ketones, occult blood)\\n\\nTest results as JSON:\\n\\n{\\n  \"Urine dipstick tests\": {\\n    \"Effects\": [\"May result in false-positive urine dipstick tests\"],\\n    \"Examples of tests affected\": [\"Urine protein\", \"ketones\", \"occult blood\"]\\n  }\\n}',\n 'Prochlorperazine (Lexi-Drugs)': 'Test names: Phenylketonuria test, Pregnancy test\\n\\nTest results as JSON:\\n\\n{\\n  \"Phenylketonuria test\": {\\n    \"Effect\": \"False-positives\"\\n  },\\n  \"Pregnancy test\": {\\n    \"Effect\": \"False-positives\"\\n  }\\n}',\n \"Crotalidae Immune F(ab')2 (Equine) (Lexi-Drugs)\": 'Not available',\n 'Doripenem (Lexi-Drugs)': 'Not available',\n 'Idursulfase (Lexi-Drugs)': 'Not available',\n 'Antithymocyte Globulin (Rabbit) (Pediatric and Neonatal Lexi-Drugs)': 'Test Names:\\n1. Rabbit antibody-based immunoassays\\n2. Cross-match or panel-reactive antibody cytotoxicity assays\\n\\nTest Results (in JSON format):\\n{\\n  \"Rabbit antibody-based immunoassays\": \"Potential interference\",\\n  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"Potential interference\",\\n  \"Routine clinical laboratory tests which do not use immunoglobulins\": \"No interference shown\"\\n}',\n 'Meropenem and Vaborbactam (Lexi-Drugs)': '{\"Positive Coombs\\'\": \"Positive\"}',\n 'HydrOXYzine (Lexi-Drugs)': '{\"serum TCA screen\": \"false-positive\"}',\n 'Minocycline Hydrochloride Periodontal Microspheres (Lexi-Drugs)': 'Not available',\n 'OxyCODONE (Lexi-Drugs)': '{\"urine screening result for opioids\": \"false-positive\"}',\n 'Pentostatin (Lexi-Drugs)': 'Not available',\n 'Folic Acid, Cyanocobalamin, and Pyridoxine (Lexi-Drugs)': 'Not available',\n 'Potassium Phosphate and Sodium Phosphate (Lexi-Drugs)': 'Not available',\n 'SUFentanil (Lexi-Drugs)': 'Not available',\n 'Tobramycin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Leucovorin Calcium (Lexi-Drugs)': 'Not available',\n 'Methylene Blue (Lexi-Drugs)': 'Test Name: Urine Test with Blue Indicator\\nTest Result: Interfered',\n 'Colistimethate (Lexi-Drugs)': 'Not available',\n 'Docetaxel-Oxaliplatin-Leucovorin-Fluorouracil (Esophageal) (Lexi-Drugs)': 'Not available',\n 'Clindamycin and Tretinoin (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Isosorbide Mononitrate (Lexi-Drugs)': 'Not available',\n 'Gallium Ga 68 Dotatate (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Trandolapril and Verapamil (Lexi-Drugs)': 'Not available',\n 'Antivenin (Micrurus fulvius) (Lexi-Drugs)': 'Not available',\n 'Iodine I-125 Iothalamate (Lexi-Drugs)': 'Not available',\n 'Cisatracurium (Lexi-Drugs)': 'Not available',\n 'VinCRIStine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Benztropine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Albumin (Lexi-Drugs)': 'Not available',\n 'Mesna (Lexi-Drugs)': '{\\n    \"test name\": \"Urinary ketones\",\\n    \"test result\": \"false positive in patients receiving mesna with nitroprusside-based urine tests\"\\n},\\n{\\n    \"test name\": \"CPK activity\",\\n    \"test result\": \"may interfere with enzymatic CPK activity tests which use a thiol compound, resulting in a falsely low CPK level\"\\n},\\n{\\n    \"test name\": \"Ascorbic acid\",\\n    \"test result\": \"may result in false-positive reactions in Tillman\\'s reagent-based urine screening tests\"\\n}',\n 'Amoxicillin and Clavulanate (Lexi-Drugs)': '{\\n    \"test name\": \"urinary glucose tests\",\\n    \"test result\": \"may interfere with tests using cupric sulfate, but tests based on enzymatic glucose oxidase reactions are recommended\"\\n},\\n{\\n    \"test name\": \"plasma concentrations of certain hormones in pregnant women\",\\n    \"test result\": \"may be transiently interfered with by ampicillin, including total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol\"\\n}',\n 'ClonazePAM (Lexi-Drugs)': 'Not available',\n 'Lincomycin (Lexi-Drugs)': 'Not available',\n 'Insulin Glulisine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Plasminogen Activity, Plasma (Lab Tests and Diagnostic Procedures)': 'Not available',\n 'Insulin Glargine (Lexi-Drugs)': 'Not available',\n 'Sipuleucel-T (Lexi-Drugs)': 'Not available',\n 'QuiNIDine (Lexi-Drugs)': 'Not available',\n 'Ocrelizumab (Lexi-Drugs)': '{\"CD20 assay\": \"interfered\", \"CD19+ assay\": \"measure B-cell counts\"}',\n 'Methylergonovine (Lexi-Drugs)': 'Not available',\n 'Procainamide (Lexi-Drugs)': '{\"procainamide/N-acetyl procainamide concentration test\": \"affected\"}',\n 'Naproxen and Diphenhydramine (Lexi-Drugs)': 'Not available',\n 'Iron Dextran Complex (Lexi-Drugs)': 'Medical Test Names:\\n1. Serum bilirubin\\n2. Serum calcium\\n3. Examination of bone marrow iron stores\\n4. Bone scans with 99m Tc-labeled bone seeking agents\\n5. Bone scans with 99m Tc-diphosphonate\\n\\nTest Results in JSON Form:\\n{\\n\"Serum bilirubin\": \"falsely elevated values\",\\n\"Serum calcium\": \"falsely decreased values\",\\n\"Examination of bone marrow iron stores\": \"Residual iron dextran may remain in reticuloendothelial cells affecting accuracy\",\\n\"Bone scans with 99m Tc-labeled bone seeking agents\": \"reduced bony uptake, marked renal activity, and excess blood pooling and soft tissue accumulation following IV iron dextran infusion or with high serum ferritin levels\",\\n\"Bone scans with 99m Tc-diphosphonate\": \"dense activity in the buttocks following IM iron dextran\"\\n}',\n 'Aztreonam (Systemic) (Pediatric and Neonatal Lexi-Drugs)': 'Medical Test Names:\\n1. Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\\n2. Coombs\\' test\\n\\nTest Results in JSON Form:\\n{\\n\"Urine glucose tests containing cupric sulfate (Benedict\\'s solution, Clinitest)\": \"May interfere\",\\n\"Coombs\\' test\": \"positive\"\\n}',\n 'Iohexol (Lexi-Drugs)': 'Medical Test Names:\\n1. Iodine-binding capacity of thyroid tissue\\n2. Diagnostic tests using iodine-containing isotopes\\n3. Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\\n\\nTest Results in JSON Form:\\n{\\n\"Iodine-binding capacity of thyroid tissue\": \"reduced for up to 2 weeks following administration of contrast media\",\\n\"Diagnostic tests using iodine-containing isotopes\": \"may be affected\",\\n\"Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\": \"not affected\"\\n}',\n 'Tecovirimat (Lexi-Drugs)': 'Not available',\n 'Bivalirudin (Lexi-Drugs)': '{\\n  \"PT/INR\": [\"elevated\"], \\n  \"bivalirudin\": [\"modification\"]\\n}',\n 'DACTINomycin (Lexi-Drugs)': 'Not available',\n 'Vecuronium (Lexi-Drugs)': 'Not available',\n 'Fosaprepitant (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Minocycline (Systemic) (Lexi-Drugs)': '```\\n{\\n    \"Test Name\": \"Fluorescence Test for Urinary Catecholamines\",\\n    \"Test Result\": \"False Elevations\"\\n}\\n```',\n 'Oritavancin (Lexi-Drugs)': '```\\n{\\n    \"Test Name 1\": \"Activated Clotting Time (ACT)\",\\n    \"Test Result 1\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 2\": \"aPTT\",\\n    \"Test Result 2\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 3\": \"Prothrombin Time\",\\n    \"Test Result 3\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 4\": \"International Normalized Ratio\",\\n    \"Test Result 4\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 5\": \"Silica Clot Time (SCT)\",\\n    \"Test Result 5\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 6\": \"Dilute Russell\\'s Viper Venom Time (DRVVT)\",\\n    \"Test Result 6\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 7\": \"D-dimer\",\\n    \"Test Result 7\": \"Artificially Prolonged\",\\n    \\n    \"Test Name 8\": \"Indirect Antiglobulin Test\",\\n    \"Test Result 8\": \"Positive\",\\n    \\n    \"Test Name 9\": \"Direct Antiglobulin Test\",\\n    \"Test Result 9\": \"Positive\"\\n}\\n```',\n 'Artesunate (Lexi-Drugs)': 'Not available',\n 'Ibuprofen and Acetaminophen (Lexi-Drugs)': 'Medical Tests:\\n1. Urinary 5-hydroxyindoleacetic acid \\n2. Urine detection of phencyclidine \\n3. Aldosterone/Renin ratio\\n\\nTest Results:\\n{\\n\"Urinary 5-hydroxyindoleacetic acid\": \"False-positive\",\\n\"Urine detection of phencyclidine\": \"False-positive\",\\n\"Aldosterone/Renin ratio\": \"False-positive\"\\n}',\n 'Diamorphine (Lexi-Drugs)': 'Not available',\n 'Moxetumomab Pasudotox (Lexi-Drugs)': 'Medical Tests:\\n1. Cellular CD22 Detection\\n2. CD19+ B Cells Surrogate Assay\\n\\nTest Results:\\n{\\n\"Cellular CD22 Detection\": \"Interference\",\\n\"CD19+ B Cells Surrogate Assay\": \"Normal\"\\n}',\n 'Telavancin (Lexi-Drugs)': 'Medical Tests:\\n1. PT\\n2. INR\\n3. aPTT\\n4. ACT\\n5. Xa (coagulation based assay)\\n6. Bleeding time\\n7. Factor Xa (chromogenic assay)\\n8. Platelet aggregation study\\n9. Thrombin time\\n10. Urine protein via qualitative dipstick\\n11. Urine protein via quantitative dye methods\\n\\nTest Results:\\n{\\n\"PT\": \"Artificially increased clotting times\",\\n\"INR\": \"Artificially increased clotting times\",\\n\"aPTT\": \"Artificially increased clotting times\",\\n\"ACT\": \"Artificially increased clotting times\",\\n\"Xa (coagulation based assay)\": \"Artificially increased clotting times\",\\n\"Bleeding time\": \"Normal\",\\n\"Factor Xa (chromogenic assay)\": \"Normal\",\\n\"Platelet aggregation study\": \"Normal\",\\n\"Thrombin time\": \"Normal\",\\n\"Urine protein via qualitative dipstick\": \"Interference\",\\n\"Urine protein via quantitative dye methods\": \"Interference\"\\n}',\n 'Zinc Sulfate (Lexi-Drugs)': 'Not available',\n 'Vasopressin (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Streptomycin (Lexi-Drugs)': 'Not available',\n 'DexAMETHasone (Systemic) [SUPPORTIVE] (Lexi-Tox)': 'Not available',\n 'Methocarbamol (Lexi-Drugs)': '{\\n  \"5-HIAA\": \"color interference\",\\n  \"VMA\": \"color interference\"\\n}',\n 'Calaspargase Pegol (Lexi-Drugs)': 'Not available',\n 'Hemin (Lexi-Drugs)': 'Not available',\n 'Enoxaparin (Lexi-Drugs)': '{\\n  \"Free Thyrotropin\": \"falsely elevated\",\\n  \"Free Triiodothyronine\": \"falsely elevated\",\\n  \"Thyroid-stimulating hormone\": \"not usually affected\",\\n  \"Standard Competitive Free Thyroid Hormone Assays\": \"not usually affected\"\\n}',\n 'Nivolumab and Relatlimab (Lexi-Drugs)': 'Not available',\n 'Fluorouracil-Leucovorin-Oxaliplatin  (Gastric/Esophageal)  (Lexi-Drugs)': 'Not available',\n 'Fosaprepitant (Lexi-Drugs)': 'Not available',\n 'LevoFLOXacin (Oral Inhalation) (Lexi-Drugs)': '{\\n  \"Test Name\": \"Urine Screening for Opioids\",\\n  \"Test Result\": \"false-positive with quinolones; confirmation recommended\"\\n}',\n 'Ziv-Aflibercept (Systemic) (Lexi-Drugs)': 'Not available',\n 'Insulin NPH (Lexi-Tox)': 'Not available',\n 'Zoledronic Acid (Lexi-Drugs)': '{\\n  \"Test Name\": \"Bone Scan with Technetium-99m-diphosphonate\",\\n  \"Test Result\": \"may be interfered with by Bisphosphonates\"\\n}',\n 'Potassium Phosphate (Lexi-Drugs)': 'Not available',\n 'Abacavir, Lamivudine, and Zidovudine (Lexi-Drugs)': 'Not available',\n 'Natalizumab (Lexi-Drugs)': 'Not available',\n 'Regadenoson (Lexi-Drugs)': 'Not available',\n 'Antithymocyte Globulin (Equine) (Lexi-Drugs)': 'Not available',\n 'Esomeprazole (Lexi-Drugs)': 'Test names and their respective results:\\n\\n1. Serum chromogranin A (CgA) level - Falsely elevated with Esomeprazole \\n2. Diagnosis of a neuroendocrine tumor - False-positive \\n\\nJSON format:\\n\\n{\\n   \"Serum chromogranin A (CgA) level\": \"Falsely elevated with Esomeprazole\",\\n   \"Diagnosis of a neuroendocrine tumor\": \"False-positive\"\\n}',\n 'Sodium Thiosulfate (Lexi-Drugs)': 'Not available',\n 'Cetuximab (Lexi-Drugs)': 'Not available',\n 'Pyridoxine (Lexi-Drugs)': 'Not available',\n 'Lutetium Lu 177 Dotatate (Lexi-Drugs)': 'Not available',\n 'Clarithromycin (Lexi-Drugs)': 'Not available',\n 'Glutathione (Natural Products Database)': 'Not available',\n 'Amoxicillin (Lexi-Drugs)': '1. Medical Test Names: Benedict\\'s solution, Clinitest, Fehling\\'s Solution\\n   Test Results: {\"Benedict\\'s solution\": \"May interfere with urinary glucose tests\", \\n                  \"Clinitest\": \"May interfere with urinary glucose tests\", \\n                  \"Fehling\\'s Solution\": \"May interfere with urinary glucose tests\"}\\n\\n2. Medical Test Names: Aminoglycoside serum concentration\\n   Test Results: {\"Aminoglycoside serum concentration\": \"Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives\"}',\n 'Chlorpheniramine, Phenylephrine, and Dextromethorphan (Lexi-Drugs)': 'Not available',\n 'Casirivimab and Imdevimab (Lexi-Drugs)': 'Not available',\n 'Atracurium (Lexi-Drugs)': 'Not available',\n 'Ibandronate (Lexi-Drugs)': 'Medical Test Names: technetium-99m-diphosphonate bone scans\\nTest Results: {\"technetium-99m-diphosphonate bone scans\": \"May be interfered with by bisphosphonates\"}',\n 'Acetaminophen and Caffeine (Lexi-Drugs)': 'Not available',\n 'Bendamustine-Rituximab (CLL) (Lexi-Drugs)': 'Not available',\n 'Gadopentetate Dimeglumine (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Sodium Iodide I123 (Lexi-Drugs)': 'Not available',\n 'Local Anesthetics (Lexi-Tox)': 'Not available',\n 'Phenytoin (Lexi-Drugs)': '{\\n  \"Plasma phenytoin concentrations\": \"Falsely high\",\\n  \"Serum concentrations of T4\": \"Falsely low\",\\n  \"Serum concentrations of T3\": \"Falsely low\",\\n  \"Dexamethasone tests\": \"Falsely low\",\\n  \"Metyrapone tests\": \"Falsely low\",\\n  \"Thyroid-stimulating hormone (TSH) levels\": \"Increased\"\\n}',\n 'Iodinated I 131 Albumin (Lexi-Drugs)': 'Not available',\n 'Temozolomide (Lexi-Drugs)': 'Not available',\n 'QuiNINE (Lexi-Drugs)': '{\\n  \"Urine detection of opioids\": \"False-positive\",\\n  \"Coombs\\' test\": \"Positive\",\\n  \"Urinary steroids\": \"False elevation\",\\n  \"Catecholamines\": \"False elevation\",\\n  \"Urinary dipstick protein assays\": \"Qualitative and quantitative\"\\n}',\n 'Fluorouracil-Leucovorin Bolus (Colorectal) (Lexi-Drugs)': 'Not available',\n 'Interferon Alfa-2b (Lexi-Drugs)': 'Not available',\n 'Factor IX (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Asparaginase (Erwinia) (Lexi-Drugs)': 'Not available',\n 'Fam-Trastuzumab Deruxtecan (Lexi-Drugs)': 'Not available',\n 'Ziconotide (Lexi-Drugs)': 'Not available',\n 'Fluconazole (Lexi-Drugs)': 'Not available',\n 'Isoproterenol (Lexi-Drugs)': 'Not available',\n 'Bacitracin and Polymyxin B (Topical) (Lexi-Drugs)': 'Not available',\n 'Trastuzumab (Lexi-Drugs)': 'Not available',\n 'Oliceridine (Lexi-Drugs)': 'Not available',\n 'Lacosamide (Lexi-Drugs)': 'Not available',\n 'Tocilizumab (Lexi-Drugs)': 'Not available',\n 'Elotuzumab-Pomalidomide-Dexamethasone (Multiple Myeloma) (Lexi-Drugs)': 'Not available',\n 'Ferric Carboxymaltose (Lexi-Drugs)': '{\\n  \"Serum iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\",\\n  \"Transferrin bound iron levels\": \"may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration\"\\n}',\n 'Glycerin and Lidocaine (Lexi-Drugs)': 'Not available',\n 'PEMEtrexed (Lexi-Drugs)': 'Not available',\n 'Naloxone (Lexi-Drugs)': 'Not available',\n 'Amphotericin B Deoxycholate (Lexi-Drugs)': 'Not available',\n 'Acyclovir (Systemic) (Lexi-Drugs)': 'Not available',\n 'Edetate CALCIUM Disodium (Lexi-Drugs)': 'Sorry, as an AI language model, I am not able to extract the medical test names and their results without any context or clear indication of where they are mentioned in the text. Could you please provide me with a specific text or document so I can help you better?',\n 'Eculizumab (Lexi-Drugs)': 'Not available',\n 'Teplizumab (Lexi-Drugs)': 'Not available',\n 'LevOCARNitine (Lexi-Drugs)': 'Not available',\n 'PRALAtrexate (Lexi-Drugs)': 'Not available',\n 'Bendamustine-Bortezomib-Rituximab (NHL-Follicular) (Lexi-Drugs)': 'Not available',\n 'Delafloxacin (Lexi-Drugs)': 'Not available',\n 'Eptifibatide (Lexi-Drugs)': 'Not available',\n 'Ofloxacin (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Mycophenolate (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Stanford V (Hodgkin) (Lexi-Drugs)': 'Not available',\n 'Methoxy Polyethylene Glycol-Epoetin Beta (Lexi-Drugs)': '{\\n  \"Neutralizing antibody assay\": \"Obtain serum samples at least a month after the last dose to prevent assay interference.\", \\n  \"HbA1c\": \"Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).\"\\n}',\n 'Glycopyrrolate (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Asparaginase (Erwinia [Recombinant]) (Lexi-Drugs)': 'Not available',\n 'Heparin (Lexi-Drugs)': '1. Medical Test Names: PT, anti-factor Xa assay, aPTT, free T4, free T3, thyroid stimulating hormone, standard competitive free thyroid hormone assays.\\n\\n2. Test Results in JSON format:\\n\\n{\\n \"PT\": \"Increased\",\\n \"anti-factor Xa assay\": \"falsely elevated results\",\\n \"aPTT\": \"little or minor effect\",\\n \"free T4\": \"falsely elevated levels\",\\n \"free T3\": \"falsely elevated levels\",\\n \"thyroid stimulating hormone\": \"not usually affected\",\\n \"standard competitive free thyroid hormone assays\": \"not usually affected\"\\n}',\n 'AzaCITIDine (Lexi-Drugs)': 'Not available',\n 'Arginine (Lexi-Drugs)': 'Not available',\n 'Cisplatin-Vinblastine (NSCLC) (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Oral Inhalation) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Prothrombin Complex Concentrate (Human) [(Factors II, VII, IX, X), Protein C, and Protein S]': '{\\n \"aPTT\": \"contains heparin\"\\n}',\n 'Trilaciclib (Lexi-Drugs)': 'Not available',\n 'Agalsidase Alfa (Lexi-Drugs)': 'Not available',\n 'Belantamab Mafodotin (Lexi-Drugs)': 'Not available',\n 'Nitroprusside (Lexi-Drugs)': 'Not available',\n 'Gatifloxacin (Lexi-Drugs)': 'Not available',\n 'DOCEtaxel (Lexi-Drugs)': 'Not available',\n 'Pantothenic Acid (Natural Products Database)': 'Not available',\n 'LEVOleucovorin (Lexi-Drugs)': 'Not available',\n 'Fosnetupitant and Palonosetron (Lexi-Drugs)': 'Not available',\n 'Metoprolol and Hydrochlorothiazide (Lexi-Drugs)': 'Not available',\n 'Daratumumab (Lexi-Drugs)': '1. Medical test names: antibody screening, cross matching, Kell blood group system genotyping, serum protein electrophoresis (SPE), immunofixation (IFE), daratumumab-specific IFE assay.\\n\\n2. Test results in JSON format:\\n\\n{\\n   \"antibody screening\": \"N/A\",\\n   \"cross matching\": \"N/A\",\\n   \"Kell blood group system genotyping\": \"N/A\",\\n   \"serum protein electrophoresis (SPE)\": \"positive if daratumumab is present\",\\n   \"immunofixation (IFE)\": \"positive if daratumumab is present\",\\n   \"daratumumab-specific IFE assay\": \"distinguishes daratumumab from residual endogenous M protein\"\\n}',\n 'Lidocaine and Menthol (Lexi-Drugs)': 'Not available',\n 'Bleomycin (Lexi-Drugs)': 'Not available',\n 'Baclofen (Lexi-Drugs)': 'Not available',\n 'Milrinone (Lexi-Drugs)': 'Not available',\n 'LevETIRAcetam (Lexi-Drugs)': 'Not available',\n 'Sodium Thiosulfate: Calciphylaxis (Facts and Comparisons Off-Label)': 'Not available',\n 'Defibrotide (Lexi-Drugs)': 'Not available',\n 'Calcium Chloride (Lexi-Drugs)': 'Not available',\n 'Buprenorphine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Phenylephrine (Topical) (Lexi-Drugs)': 'Not available',\n 'Amiodarone (Lexi-Drugs)': 'Medical Test Names: \\n- Thyroid function test\\n\\nTest Results in JSON:\\n{\\n  \"T4 levels\": \"elevated\",\\n  \"Thyroid stimulating hormone levels\": \"at the high end of normal range\",\\n  \"T3 levels\": \"at the low end of normal range\"\\n}',\n 'Cosyntropin (Lexi-Drugs)': 'Medical Test Names: N/A\\n\\nTest Results in JSON: N/A',\n 'Betibeglogene Autotemcel (Lexi-Drugs)': '{\\n  \"polymerase chain reaction (PCR) assays for HIV\": \"Positive\",\\n  \"BB305 LVV proviral DNA\": \"Integrated\",\\n  \"screened for HIV infection using a PCR-based assay\": \"Should not\"\\n}',\n 'Benztropine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Cefuroxime (Pediatric and Neonatal Lexi-Drugs)': '{\\n  \"Positive direct Coombs\": \"Positive\",\\n  \"urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest, Fehling\\'s solution)\": \"False-positive\",\\n  \"ferricyanide test\": \"False-negative\",\\n  \"Glucose oxidase or hexokinase-based methods\": \"Should be used\"\\n}',\n 'Octreotide (Lexi-Drugs)': 'Not available',\n 'Gadoterate Meglumine (Lexi-Drugs)': 'Not available',\n 'Velaglucerase Alfa (Lexi-Drugs)': 'Not available',\n 'Allopurinol (Lexi-Drugs)': 'Not available',\n 'Avelumab (Lexi-Drugs)': 'Not available',\n 'Rasburicase (Lexi-Drugs)': '{\"uric acid\": \"N/A\"}',\n 'Clindamycin and Benzoyl Peroxide (Lexi-Drugs)': 'Not available',\n 'Insulin Lispro Protamine and Insulin Lispro (Lexi-Drugs)': 'Not available',\n 'Doxorubicin (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Agalsidase Beta (Lexi-Drugs)': 'Not available',\n 'Obiltoxaximab (Lexi-Drugs)': 'Not available',\n 'Factor VIIa (Recombinant) (Lexi-Drugs)': 'Not available',\n 'Sotalol (Lexi-Drugs)': '{\\n  \"urinary metanephrine\": \"May falsely increase\",\\n  \"HPLC assay with solid phase extraction for determination of urinary catecholamines\": \"does not interact with\",\\n  \"aldosterone/renin ratio (ARR)\": \"may lead to false-positive\"\\n}',\n 'Omeprazole and Sodium Bicarbonate (Lexi-Drugs)': '{\\n  \"serum chromogranin A (CgA)\": \"may falsely elevate; may cause false-positive results in the diagnosis of a neuroendocrine tumor\",\\n  \"omeprazole\": \"Temporarily stop ≥14 days prior to assessing CgA level\"\\n}',\n 'Melphalan Flufenamide (Lexi-Drugs)': 'Not available',\n 'Iodine I-125 Human Serum Albumin (Lexi-Drugs)': 'Not available',\n 'Sodium Bicarbonate (Lexi-Drugs)': 'Not available',\n 'Factor IX (Recombinant [Albumin Fusion Protein]) (Lexi-Drugs)': 'Not available',\n 'Lansoprazole, Amoxicillin, and Clarithromycin (Lexi-Drugs)': 'Not available',\n 'Midazolam (Lexi-Drugs)': 'Not available',\n 'Melphalan-Prednisone-Thalidomide (Multiple Myeloma) (Lexi-Drugs)': 'Not available',\n 'CISplatin (Lexi-Drugs)': 'Not available',\n 'Amphotericin B Cholesteryl Sulfate Complex (Lexi-Drugs)': 'Not available',\n 'Isatuximab (Lexi-Drugs)': 'Test Names:\\n1. Indirect Antiglobulin Test (indirect Coombs test)\\n2. Antibody Detection (screening) Tests\\n3. Antibody Identification Panels\\n4. Anti-Human Globulin Crossmatches\\n5. Blood Type and Screening\\n6. Phenotyping\\n7. Serum Protein Electrophoresis\\n8. Immunofixation Assays\\n\\nTest Result in JSON form:\\n{\\n   \"Indirect Antiglobulin Test\": \"false-positive\",\\n   \"Antibody Detection Tests\": \"may result in interference\",\\n   \"Antibody Identification Panels\": \"may result in interference\",\\n   \"Anti-Human Globulin Crossmatches\": \"may result in interference\",\\n   \"Blood Type and Screening\": \"recommended prior to the first isatuximab infusion\",\\n   \"Phenotyping\": \"consider prior to initiating treatment\",\\n   \"Serum Protein Electrophoresis\": \"may interfere with accuracy of determining complete response\",\\n   \"Immunofixation Assays\": \"may interfere with accuracy of determining complete response\"\\n}',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Lexi-Drugs)': 'Not available',\n 'CefOXitin (Lexi-Drugs)': '{\\n  \"Positive direct Coombs\\'\": \"Positive\",\\n  \"False-positive urinary glucose test using cupric sulfate (Benedict\\'s solution, Clinitest®, Fehling\\'s solution)\": \"Positive\",\\n  \"False-positive serum or urine creatinine with Jaffé reaction\": \"Positive\"\\n}',\n 'Hyoscyamine, Atropine, Scopolamine, and Phenobarbital (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Insulin Degludec (Lexi-Drugs)': 'Not available',\n 'Phenylephrine (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Quinupristin and Dalfopristin (Lexi-Drugs)': 'Not available',\n 'Amikacin (Systemic) (Lexi-Drugs)': '{\\n  \"Medical test names\": [\\n    \"Aminoglycoside serum concentration\"\\n  ],\\n  \"Test results\": [\\n    \"Potential underestimation\"\\n  ]\\n}',\n 'Insulin Glargine and Lixisenatide (Lexi-Drugs)': 'Not available',\n 'Alglucosidase Alfa (Lexi-Drugs)': 'Not available',\n 'Mitoxantrone-Prednisone (Prostate) (Lexi-Drugs)': 'Not available',\n 'Proparacaine and Fluorescein (Lexi-Drugs)': 'Not available',\n 'Glutamine (Patient Education - Natural Products)': 'Not available',\n 'Alcohol (Isopropyl) (Lexi-Drugs)': 'Not available',\n 'MitoXANTRONE (Lexi-Drugs)': 'Not available',\n 'Gadoversetamide (Lexi-Drugs)': 'Test names: serum iron, copper, zinc, serum calcium.\\nTest results: \\n{\\n\"serum iron\": \"transient changes\",\\n\"copper\": \"transient changes\",\\n\"zinc\": \"transient changes\",\\n\"serum calcium\": \"apparent decrease after injection, accurate values can be obtained approximately 90 minutes after injection\"\\n}',\n 'Aldesleukin (Lexi-Drugs)': 'Not available',\n 'Anticholinergic Agents (Lexi-Tox)': 'Not available',\n 'Epoprostenol (Lexi-Drugs)': 'Not available',\n 'Tranexamic Acid [SUPPORTIVE] (Lexi-Tox)': 'Not available',\n 'Ibuprofen and Phenylephrine (Lexi-Drugs)': 'Not available',\n 'Insulin Degludec and Liraglutide (Lexi-Drugs)': 'Not available',\n 'Deferoxamine (Lexi-Drugs)': \"Sorry, as an AI language model, I don't have the capability to extract specific information from unstructured data without any context. Please provide more specific data or context for me to extract the information as per your requirement.\",\n 'Palifermin (Lexi-Drugs)': 'Not available',\n 'Pegloticase (Lexi-Drugs)': 'Not available',\n 'Amphotericin B (Lipid Complex) (Lexi-Drugs)': 'Not available',\n 'Atezolizumab (Lexi-Drugs)': 'Not available',\n 'Inotuzumab Ozogamicin (Lexi-Drugs)': 'Not available',\n 'Itraconazole (Lexi-Drugs)': 'Not available',\n 'Sodium Chloride and Sodium Citrate (Lexi-Drugs)': 'Not available',\n 'HYDROmorphone (Lexi-Drugs)': 'Test Names: \\n- Urine screening test for opioids \\n\\nTest Results (in JSON form): \\n{\\n  \"Urine screening test for opioids\": \"false-positive for levofloxacin and ofloxacin, cross-reactivity in certain assay kits for other quinolones\"\\n}',\n 'Brexucabtagene Autoleucel (Lexi-Drugs)': 'Not available',\n 'CycloSPORINE (Systemic) (Lexi-Drugs)': 'Test Names:\\n- Whole blood assay for cyclosporine\\n\\nTest Results (in JSON form):\\n{\\n  \"Whole blood assay for cyclosporine\": \"may be falsely elevated if sample is drawn from the same central venous line through which dose was administered; cyclosporine metabolites cross-react with radioimmunoassay and fluorescence polarization immunoassay\"\\n}',\n 'Anthrax Immune Globulin (Human) (Lexi-Drugs)': 'Test Names: \\n1. Glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\\n2. Glucose-specific method\\n3. Anthrax immune globulin administration\\n4. Serologic testing\\n5. Direct and indirect Coombs’ test\\n\\nTest Results:\\n1. Falsely elevated blood glucose levels \\n2. N/A\\n3. Transiently elevated glucose \\n4. False-positive results \\n5. False-positive results',\n 'EriBULin (Lexi-Drugs)': 'Not available',\n 'Fosphenytoin (Lexi-Drugs)': 'Test Names:\\n1. Immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000)\\n2. Dexamethasone test\\n3. Metyrapone test\\n\\nTest Results:\\n1. Falsely high plasma phenytoin concentrations \\n2. Falsely low results\\n3. Folate levels lowered',\n 'ALfentanil (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Clindamycin (Systemic) (Lexi-Drugs)': 'Not available',\n 'Calcitriol (Systemic) (Lexi-Drugs)': 'Not available',\n 'Clindamycin (Systemic) (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Phenylephrine and Pyrilamine (Lexi-Drugs)': 'Not available',\n 'Fosfomycin (Lexi-Drugs)': 'Not available',\n 'DexmedeTOMIDine (Lexi-Drugs)': 'Not available',\n 'Ergonovine (Lexi-Drugs)': 'Not available',\n 'Terlipressin (Lexi-Drugs)': 'Not available',\n 'Insulin NPH and Insulin Regular (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Pseudoephedrine and Ibuprofen (Pediatric and Neonatal Lexi-Drugs)': 'Not available',\n 'Scopolamine (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Fibrinogen Concentrate (Human) (Lexi-Drugs)': 'Not available',\n 'Buprenorphine (Geriatric Lexi-Drugs)': 'Not available',\n 'Betamethasone and Salicylic Acid (Lexi-Drugs)': 'Not available',\n 'Diclofenac (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Aztreonam (Oral Inhalation) (Lexi-Drugs)': 'Not available',\n 'Bupivacaine and Meloxicam (Lexi-Drugs)': 'Not available',\n 'Acyclovir (Ophthalmic) (Lexi-Drugs)': 'Not available',\n 'Asparaginase (Briggs Drugs in Pregnancy and Lactation)': 'Not available',\n 'Golodirsen (Lexi-Drugs)': 'Not available',\n 'Clindamycin (Topical) (Lexi-Drugs)': 'Not available'}"
     },
     "execution_count": 90,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drugs_test_conditions_df"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T07:33:29.128051100Z",
     "start_time": "2023-05-10T07:33:29.082066600Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "outputs": [],
   "source": [
    "max_len = []\n",
    "for key,val in drugs_test_conditions_df.items():\n",
    "    try:\n",
    "        val = json.loads(val)\n",
    "        max_len.append(len(val))\n",
    "    except:\n",
    "        val = 1"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T07:48:28.948749100Z",
     "start_time": "2023-05-10T07:48:28.917479400Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Test Names: dipyridamole-thallium myocardial imaging\n",
      "\n",
      "Test Results: {\"dipyridamole-thallium myocardial imaging\": \"false-negative result\"}\n",
      "Test Names: \n",
      "1. Urine test for phencyclidine\n",
      "\n",
      "Test Results: \n",
      "{\n",
      "   \"Urine test for phencyclidine\": \"false-positive interference may occur\"\n",
      "}\n",
      "Test Names: \n",
      "1. Serum or transferrin bound iron levels \n",
      "2. Serum ferritin levels \n",
      "\n",
      "Test Results:\n",
      "1. {\"Serum or transferrin bound iron levels\": \"May be falsely elevated if assessed within 24 hours of ferric gluconate administration.\"}\n",
      "2. {\"Serum ferritin levels\": \"May be falsely elevated for 5 days after ferric gluconate administration.\"}\n",
      "Test Names: None mentioned\n",
      "\n",
      "Test Results: None mentioned\n",
      "Test Names: \n",
      "- Stool occult blood test\n",
      "- Blood glucose testing\n",
      "- Urine glucose testing\n",
      "- Nitrite level testing\n",
      "- Bilirubin level testing\n",
      "- Leucocyte count testing\n",
      "\n",
      "Test Results: \n",
      "- Stool occult blood: False negative 48 to 72 hours after ascorbic acid ingestion\n",
      "- Blood glucose: Falsely elevated glucose measurements by point of care glucometers with high-dose ascorbic acid\n",
      "- Urine glucose: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\n",
      "- Nitrite level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\n",
      "- Bilirubin level: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\n",
      "- Leucocyte count: Interference with laboratory tests based on oxidation-reduction reactions with ascorbic acid ingestion\n",
      "Test Names: Pregnancy test\n",
      "Test Results: False-positive or false-negative\n",
      "Test Names: \n",
      "1. MR imaging \n",
      "2. Serum Iron \n",
      "3. Transferrin-bound Iron \n",
      "\n",
      "Corresponding Test Results in JSON:\n",
      "{\n",
      "  \"MR imaging\": \"May interfere with imaging; alterations may persist for ≤3 months following use, with peak alterations anticipated in the first 2 days following administration. If MR imaging is required within 3 months after administration, use T1- or proton density-weighted MR pulse sequences to decrease effect on imaging. Do not use T2-weighted sequence MR imaging prior to 4 weeks following administration.\",\n",
      "  \"Serum Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\",\n",
      "  \"Transferrin-bound Iron\": \"May be overestimated in laboratory assays if level is drawn during the first 24 hours following administration (due to contribution of iron in ferumoxytol).\"\n",
      "}\n",
      "Test Names: \n",
      "1. Blood glucose levels\n",
      "2. Serologic testing results\n",
      "3. Direct Coombs' test\n",
      "4. Indirect Coombs' test\n",
      "\n",
      "Corresponding Test Results in JSON:\n",
      "{\n",
      "  \"Blood glucose levels\": \"Contains maltose; falsely elevated blood glucose levels may occur when glucose monitoring devices and test strips utilizing the glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods are used. Glucose monitoring devices and test strips which utilize the glucose-specific method are recommended. Urinalysis after anthrax immune globulin administration may result in transiently elevated glucose; testing should be repeated to determine if action is warranted.\",\n",
      "  \"Serologic testing results\": \"Passively transferred antibodies may yield false-positive results.\",\n",
      "  \"Direct Coombs' test\": \"Passively transferred antibodies may yield false-positive results.\",\n",
      "  \"Indirect Coombs' test\": \"Passively transferred antibodies may yield false-positive results.\"\n",
      "}\n",
      "Test Names: \n",
      "1. Serum chromogranin A (CgA) levels\n",
      "\n",
      "Corresponding Test Results in JSON:\n",
      "{\n",
      "  \"Serum chromogranin A (CgA) levels\": \"Omeprazole may falsely elevate CgA levels, causing false-positive results in the diagnosis of a neuroendocrine tumor. Temporarily stop omeprazole ≥14 days prior to assessing CgA level; repeat level if initially elevated; use the same laboratory for all testing of CgA levels.\"\n",
      "}\n",
      "Test Names:\n",
      "\n",
      "1. Urine glucose test containing cupric sulfate\n",
      "2. Coombs' test\n",
      "\n",
      "Test Results in JSON format:\n",
      "\n",
      "{\n",
      "  \"Urine glucose test containing cupric sulfate\": \"May interfere\",\n",
      "  \"Coombs' test\": \"Positive\"\n",
      "}\n",
      "Test Names:\n",
      "\n",
      "1. Aldosterone/renin ratio (ARR)\n",
      "\n",
      "Test Results in JSON format:\n",
      "\n",
      "{\n",
      "  \"Aldosterone/renin ratio (ARR)\": \"May lead to false-negative\"\n",
      "}\n",
      "Test Names: \n",
      "1. Digitalis immunoassay \n",
      "2. Digoxin serum samples\n",
      "\n",
      "Test Results: \n",
      "{\n",
      "   \"Digitalis immunoassay\": \"may be clinically misleading until all Fab fragments are eliminated from the body\",\n",
      "   \"Digoxin serum samples\": \"should be obtained before digoxin immune fab administration, if possible\"\n",
      "}\n",
      "Test Names: Lactobacillus casei assay method\n",
      "Test Result: Falsely low serum concentrations may occur in patients on anti-infectives (eg, tetracycline)\n",
      "Test Names: \n",
      "1. Urinary glucose tests using cupric sulfate (Benedict's solution, Clinitest®)\n",
      "2. Aminoglycoside activity test\n",
      "3. Urinary protein test\n",
      "4. Serum protein test\n",
      "\n",
      "Test Results:\n",
      "1. May interfere\n",
      "2. May inactivate in vitro\n",
      "3. False positive in urinary test\n",
      "4. False positive in serum test\n",
      "Test Names: laboratory tests related to coagulation factors, lipids, glucose tolerance, thyroxine-binding globulin, sex hormone-binding globulin, cortisol-binding globulin\n",
      "Test Result: The use of estrogens and/or progestogens may alter the results (general statement)\n",
      "Medical Test Names: Serum magnesium test and Urine magnesium test.\n",
      "\n",
      "JSON output:\n",
      "{\n",
      " \"Serum magnesium test\": \"falsely decreased\",\n",
      " \"Urine magnesium test\": \"falsely decreased\"\n",
      "}\n",
      "Medical Test Names: Coombs' test and Urinary protein test.\n",
      "\n",
      "JSON output:\n",
      "{\n",
      " \"Coombs' test\": \"positive\",\n",
      " \"Urinary protein test\": \"false-positive\"\n",
      "}\n",
      "Test Names: Methotrexate levels\n",
      "Test Result: {\"Methotrexate levels\": \"the chromatographic method\"}\n",
      "Test Names: \n",
      "1. Urine catecholamines\n",
      "2. Metanephrine \n",
      "3. Normetanephrine \n",
      "4. Vanillylmandelic acid (VMA) \n",
      "5. Urine amphetamine \n",
      "6. Aldosterone/renin ratio (ARR)\n",
      "\n",
      "Test Results:\n",
      "{\n",
      "   \"Urine catecholamines\": \"HPLC assay with solid-phase extraction should be used to determine levels of catecholamines\",\n",
      "   \"Metanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of metanephrine\",\n",
      "   \"Normetanephrine\": \"HPLC assay with solid-phase extraction should be used to determine levels of normetanephrine\",\n",
      "   \"Vanillylmandelic acid (VMA)\": \"HPLC assay with solid-phase extraction should be used to determine levels of VMA\",\n",
      "   \"Urine amphetamine\": \"Gas chromatographic-mass spectrometer technique should be used to determine levels of amphetamine\",\n",
      "   \"Aldosterone/renin ratio (ARR)\": \"May lead to a false-positive result\"\n",
      "}\n",
      "Test Names:\n",
      "- Urinary glucose determination using Clinitest®\n",
      "- Coombs' direct\n",
      "\n",
      "Test Results (in json format):\n",
      "{\n",
      "  \"Urinary glucose determination using Clinitest®\": \"Interfered\",\n",
      "  \"Coombs' direct\": \"Positive\"\n",
      "}\n",
      "Test Names:\n",
      "- PT (Prothrombin Time) test\n",
      "- INR (International Normalized Ratio) test\n",
      "\n",
      "Test Results (in JSON form):\n",
      "{\n",
      "  \"PT (Prothrombin Time) test\": \"false prolongation with certain recombinant thromboplastin reagents when taking daptomycin\",\n",
      "  \"INR (International Normalized Ratio) test\": \"increase with certain recombinant thromboplastin reagents when taking daptomycin\"\n",
      "}\n",
      "Test Names: \n",
      "1. Serum Protein Electrophoresis (SPEP)\n",
      "2. Serum Immunofixation Assays\n",
      " \n",
      "Test Results in JSON Format:\n",
      "{\n",
      "   \"SPEP\": \"A small peak in the early gamma region\",\n",
      "   \"Serum Immunofixation Assays\": \"may potentially be attributed to elotuzumab\"\n",
      "}\n",
      "Test Names:\n",
      "1. Urinary 5-hydroxyindoleacetic acid test\n",
      "2. Urine detection of Phencyclidine test\n",
      "3. Aldosterone/Renin Ratio (ARR) test\n",
      "\n",
      "Test Results in JSON Format:\n",
      "{\n",
      "   \"Urinary 5-hydroxyindoleacetic acid test\": \"false-positive due to Acetaminophen\",\n",
      "   \"Urine detection of Phencyclidine test\": \"false-positives due to Ibuprofen\",\n",
      "   \"Aldosterone/Renin Ratio (ARR) test\": \"false-positive due to Ibuprofen\"\n",
      "}\n",
      "Test Names: Not specified in the given data.\n",
      "Test Results:\n",
      "{\n",
      "\"Urine Protein Detection with Pyrogallol Red reagent\": \"May give false positive results if Viltolarsen is present in urine\",\n",
      "\"Urine Protein Detection with other test methods\": \"Not affected by Viltolarsen\",\n",
      "\"Timeframe for avoiding false positives\": \"Urine obtained prior to infusion or ≥48 hours after infusion\",\n",
      "}\n",
      "Medical Test Names: \n",
      "1. Phosphotungstate method for uric acid\n",
      "2. Ehrlich's reagent for urobilinogen\n",
      "3. Spectrophotometric determination of serum theophylline concentration\n",
      "\n",
      "Test Result JSON: \n",
      "{\n",
      "   \"Phosphotungstate method for uric acid\": \"False-positive\",\n",
      "   \"Ehrlich's reagent for urobilinogen\": \"False-positive\",\n",
      "   \"Spectrophotometric determination of serum theophylline concentration\": \"Interference with large doses\"\n",
      "}\n",
      "{\n",
      "  \"Medical Test Names\": [\n",
      "    \"Aminoglycoside Serum Concentration\"\n",
      "  ],\n",
      "  \"Test Results\": [\n",
      "    \"Potential Underestimation\"\n",
      "  ]\n",
      "}\n",
      "{\n",
      "  \"Medical Test Names\": [\n",
      "    \"Aldosterone/Renin Ratio (ARR)\"\n",
      "  ],\n",
      "  \"Test Results\": [\n",
      "    \"False-Negative\"\n",
      "  ]\n",
      "}\n",
      "Test Names:\n",
      "1. Rabbit antibody-based immunoassays\n",
      "2. Cross-match or panel-reactive antibody cytotoxicity assays\n",
      "\n",
      "Test Results (in JSON format):\n",
      "{\n",
      "  \"Rabbit antibody-based immunoassays\": \"Potential interference\",\n",
      "  \"Cross-match or panel-reactive antibody cytotoxicity assays\": \"Potential interference\",\n",
      "  \"Routine clinical laboratory tests which do not use immunoglobulins\": \"No interference shown\"\n",
      "}\n",
      "Medical Test Names:\n",
      "1. Serum bilirubin\n",
      "2. Serum calcium\n",
      "3. Examination of bone marrow iron stores\n",
      "4. Bone scans with 99m Tc-labeled bone seeking agents\n",
      "5. Bone scans with 99m Tc-diphosphonate\n",
      "\n",
      "Test Results in JSON Form:\n",
      "{\n",
      "\"Serum bilirubin\": \"falsely elevated values\",\n",
      "\"Serum calcium\": \"falsely decreased values\",\n",
      "\"Examination of bone marrow iron stores\": \"Residual iron dextran may remain in reticuloendothelial cells affecting accuracy\",\n",
      "\"Bone scans with 99m Tc-labeled bone seeking agents\": \"reduced bony uptake, marked renal activity, and excess blood pooling and soft tissue accumulation following IV iron dextran infusion or with high serum ferritin levels\",\n",
      "\"Bone scans with 99m Tc-diphosphonate\": \"dense activity in the buttocks following IM iron dextran\"\n",
      "}\n",
      "Medical Test Names:\n",
      "1. Urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest)\n",
      "2. Coombs' test\n",
      "\n",
      "Test Results in JSON Form:\n",
      "{\n",
      "\"Urine glucose tests containing cupric sulfate (Benedict's solution, Clinitest)\": \"May interfere\",\n",
      "\"Coombs' test\": \"positive\"\n",
      "}\n",
      "Medical Test Names:\n",
      "1. Iodine-binding capacity of thyroid tissue\n",
      "2. Diagnostic tests using iodine-containing isotopes\n",
      "3. Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\n",
      "\n",
      "Test Results in JSON Form:\n",
      "{\n",
      "\"Iodine-binding capacity of thyroid tissue\": \"reduced for up to 2 weeks following administration of contrast media\",\n",
      "\"Diagnostic tests using iodine-containing isotopes\": \"may be affected\",\n",
      "\"Thyroid function tests that are independent of iodine estimation for results (eg, T3 resin uptake, thyroxine assays)\": \"not affected\"\n",
      "}\n",
      "1. Medical Test Names: Benedict's solution, Clinitest, Fehling's Solution\n",
      "   Test Results: {\"Benedict's solution\": \"May interfere with urinary glucose tests\", \n",
      "                  \"Clinitest\": \"May interfere with urinary glucose tests\", \n",
      "                  \"Fehling's Solution\": \"May interfere with urinary glucose tests\"}\n",
      "\n",
      "2. Medical Test Names: Aminoglycoside serum concentration\n",
      "   Test Results: {\"Aminoglycoside serum concentration\": \"Potential underestimation due to accelerated degradation in vitro by some penicillin derivatives\"}\n",
      "Medical Test Names: technetium-99m-diphosphonate bone scans\n",
      "Test Results: {\"technetium-99m-diphosphonate bone scans\": \"May be interfered with by bisphosphonates\"}\n",
      "1. Medical Test Names: PT, anti-factor Xa assay, aPTT, free T4, free T3, thyroid stimulating hormone, standard competitive free thyroid hormone assays.\n",
      "\n",
      "2. Test Results in JSON format:\n",
      "\n",
      "{\n",
      " \"PT\": \"Increased\",\n",
      " \"anti-factor Xa assay\": \"falsely elevated results\",\n",
      " \"aPTT\": \"little or minor effect\",\n",
      " \"free T4\": \"falsely elevated levels\",\n",
      " \"free T3\": \"falsely elevated levels\",\n",
      " \"thyroid stimulating hormone\": \"not usually affected\",\n",
      " \"standard competitive free thyroid hormone assays\": \"not usually affected\"\n",
      "}\n",
      "Medical Test Names: \n",
      "- Thyroid function test\n",
      "\n",
      "Test Results in JSON:\n",
      "{\n",
      "  \"T4 levels\": \"elevated\",\n",
      "  \"Thyroid stimulating hormone levels\": \"at the high end of normal range\",\n",
      "  \"T3 levels\": \"at the low end of normal range\"\n",
      "}\n",
      "Medical Test Names: N/A\n",
      "\n",
      "Test Results in JSON: N/A\n",
      "Test Names:\n",
      "1. Indirect Antiglobulin Test (indirect Coombs test)\n",
      "2. Antibody Detection (screening) Tests\n",
      "3. Antibody Identification Panels\n",
      "4. Anti-Human Globulin Crossmatches\n",
      "5. Blood Type and Screening\n",
      "6. Phenotyping\n",
      "7. Serum Protein Electrophoresis\n",
      "8. Immunofixation Assays\n",
      "\n",
      "Test Result in JSON form:\n",
      "{\n",
      "   \"Indirect Antiglobulin Test\": \"false-positive\",\n",
      "   \"Antibody Detection Tests\": \"may result in interference\",\n",
      "   \"Antibody Identification Panels\": \"may result in interference\",\n",
      "   \"Anti-Human Globulin Crossmatches\": \"may result in interference\",\n",
      "   \"Blood Type and Screening\": \"recommended prior to the first isatuximab infusion\",\n",
      "   \"Phenotyping\": \"consider prior to initiating treatment\",\n",
      "   \"Serum Protein Electrophoresis\": \"may interfere with accuracy of determining complete response\",\n",
      "   \"Immunofixation Assays\": \"may interfere with accuracy of determining complete response\"\n",
      "}\n",
      "Test Names: \n",
      "- Urine screening test for opioids \n",
      "\n",
      "Test Results (in JSON form): \n",
      "{\n",
      "  \"Urine screening test for opioids\": \"false-positive for levofloxacin and ofloxacin, cross-reactivity in certain assay kits for other quinolones\"\n",
      "}\n",
      "Test Names:\n",
      "- Whole blood assay for cyclosporine\n",
      "\n",
      "Test Results (in JSON form):\n",
      "{\n",
      "  \"Whole blood assay for cyclosporine\": \"may be falsely elevated if sample is drawn from the same central venous line through which dose was administered; cyclosporine metabolites cross-react with radioimmunoassay and fluorescence polarization immunoassay\"\n",
      "}\n",
      "Test Names: \n",
      "1. Glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase based methods\n",
      "2. Glucose-specific method\n",
      "3. Anthrax immune globulin administration\n",
      "4. Serologic testing\n",
      "5. Direct and indirect Coombs’ test\n",
      "\n",
      "Test Results:\n",
      "1. Falsely elevated blood glucose levels \n",
      "2. N/A\n",
      "3. Transiently elevated glucose \n",
      "4. False-positive results \n",
      "5. False-positive results\n",
      "Test Names:\n",
      "1. Immunoanalytical techniques (eg, TDX, TDXFLX, Emit 2000)\n",
      "2. Dexamethasone test\n",
      "3. Metyrapone test\n",
      "\n",
      "Test Results:\n",
      "1. Falsely high plasma phenytoin concentrations \n",
      "2. Falsely low results\n",
      "3. Folate levels lowered\n"
     ]
    }
   ],
   "source": [
    "#list_of_dicts = {}\n",
    "k = 0\n",
    "for key,val in drugs_test_conditions_df.items():\n",
    "    if 'Test Names' in val:\n",
    "        k +=1\n",
    "        print(val)\n",
    "\n",
    "#print(list_of_dicts)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T08:02:24.540705700Z",
     "start_time": "2023-05-10T08:02:24.462599100Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "41\n"
     ]
    }
   ],
   "source": [
    "print(k)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T08:00:33.847292400Z",
     "start_time": "2023-05-10T08:00:33.831644600Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "outputs": [
    {
     "data": {
      "text/plain": "{'Direct antiglobulin (Coombs) test': 'Positive',\n \"Urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\": 'False-positive',\n 'Serum/urine creatinine with Jaffé reaction assay': 'Falsely elevated'}"
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "json.loads(val)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T06:27:21.979753300Z",
     "start_time": "2023-05-10T06:27:21.964107400Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "outputs": [
    {
     "data": {
      "text/plain": "8"
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max(max_len)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T06:32:01.674382800Z",
     "start_time": "2023-05-10T06:32:01.627497Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [
    "list_of_dicts = {}\n",
    "for key,val in drugs_test_conditions_df.items():\n",
    "    try:\n",
    "        list_of_dicts[key] = json.loads(val)\n",
    "    except:\n",
    "        val =1\n",
    "\n",
    "print(list_of_dicts)"
   ],
   "metadata": {
    "collapsed": false
   }
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "outputs": [
    {
     "data": {
      "text/plain": "111"
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(list_of_dicts)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T06:48:10.607684400Z",
     "start_time": "2023-05-10T06:48:10.592036500Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "outputs": [
    {
     "ename": "AttributeError",
     "evalue": "'dict' object has no attribute 'split'",
     "output_type": "error",
     "traceback": [
      "\u001B[1;31m---------------------------------------------------------------------------\u001B[0m",
      "\u001B[1;31mAttributeError\u001B[0m                            Traceback (most recent call last)",
      "Cell \u001B[1;32mIn[79], line 5\u001B[0m\n\u001B[0;32m      3\u001B[0m \u001B[38;5;66;03m# split the values of the dictionary by the delimiter\u001B[39;00m\n\u001B[0;32m      4\u001B[0m \u001B[38;5;28;01mfor\u001B[39;00m key \u001B[38;5;129;01min\u001B[39;00m list_of_dicts:\n\u001B[1;32m----> 5\u001B[0m     list_of_dicts2[key] \u001B[38;5;241m=\u001B[39m \u001B[43mlist_of_dicts\u001B[49m\u001B[43m[\u001B[49m\u001B[43mkey\u001B[49m\u001B[43m]\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43msplit\u001B[49m(delimiter)\n\u001B[0;32m      7\u001B[0m \u001B[38;5;28mprint\u001B[39m(list_of_dicts2)\n",
      "\u001B[1;31mAttributeError\u001B[0m: 'dict' object has no attribute 'split'"
     ]
    }
   ],
   "source": [
    "delimiter = \",\"\n",
    "list_of_dicts2 = {}\n",
    "# split the values of the dictionary by the delimiter\n",
    "for key in list_of_dicts:\n",
    "    list_of_dicts2[key] = list_of_dicts[key].split(delimiter)\n",
    "\n",
    "print(list_of_dicts2)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T07:02:36.285559400Z",
     "start_time": "2023-05-10T07:02:36.207453100Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "outputs": [
    {
     "data": {
      "text/plain": "111"
     },
     "execution_count": 87,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r1,r2,r3,r4,r5,r6,r7,r8 = [[0]*111][0],[[0]*111][0], [[0]*111][0],[[0]*111][0],[[0]*111][0],[[0]*111][0],[[0]*111][0],[[0]*111][0]\n",
    "len(r1)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T07:11:25.194621Z",
     "start_time": "2023-05-10T07:11:25.179002200Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "outputs": [
    {
     "data": {
      "text/plain": "[('Direct antiglobulin (Coombs) test', 'Positive'),\n {'Wheal and flare reactions to skin test antigens': 'May be suppressed'},\n ('creatinine (Jaffé alkaline picrate reaction)', 'Increased'),\n ('serum chromogranin A (CgA) levels',\n  'falsely elevated (due to decreased gastric acidity with Omeprazole)'),\n ('automated platelet counts',\n  'may interfere (platelet clumping) with Crizanlizumab'),\n ('triglyceride assays',\n  'may be falsely elevated (dependent on glycerol oxidase)'),\n {'HIV nucleic acid tests': 'false positive results'},\n ('Urinary Glucose Determination (Clinitest)', 'Interferes'),\n {\"Coombs' [direct]\": 'Positive'},\n ('direct Coombs', 'positive'),\n ('serum ferritin', 'transient increase'),\n {'aldosterone/renin ratio (ARR)': 'false-negative'},\n ('urine detection of methadone', 'false-positives'),\n ('Serum or transferrin bound iron levels',\n  'falsely elevated if assessed within 24 hours of ferric gluconate administration'),\n ('thyroid function tests dependent on iodine estimation', 'altered results'),\n (\"direct Coombs' test\", 'positive'),\n ('Clinitest®', 'interfered with urinary glucose determination'),\n ('blood group isohemagglutinins', 'presence'),\n (\"direct Coombs'\", 'Positive'),\n ('Positive direct Coombs', True),\n ('Serum iron levels', 'falsely elevated'),\n {'Coombs test': 'Positive'},\n {'HbA1c': 'artificially lowered'},\n ('iodine-binding capacity',\n  'reduced for up to 2 weeks following administration of contrast media'),\n {'Urine test for amphetamines/methamphetamines': 'May interfere with detection (false-positive)'},\n ('Parathyroid function tests', 'may be interfered with'),\n {'opioid screening': 'false-positive result'},\n {'Urine detection of methadone': 'false-positive'},\n {\"Coombs' test [direct]\": 'false-positive'},\n ('urinary uric acid (phosphotungstate method)', 'interference by Methyldopa'),\n ('levofloxacin', 'false-positive urine screening result for opioids'),\n ('coagulation', 'Altered'),\n {'skin test antigens': 'suppressed'},\n ('Ceftazidime', 'Positive direct Coomb'),\n ('Serum Iron', 'Transitory changes observed'),\n ('Urinary Catecholamines', 'False-positive (fluorometric assay)'),\n ('Medical Test Name', 'Detection of urine protein'),\n ('amylase', 'increased'),\n ('serum progesterone assay', 'may interfere'),\n {'aldosterone/renin ratio (ARR)': 'false-positive'},\n ('blood ethylene glycol concentrations', 'false positive'),\n {'gastric secretion test': 'interference'},\n ('Bone imaging studies', 'May interfere with'),\n ('Medical test names', ['Aldosterone/renin ratio (ARR)']),\n ('urine glucose',\n  \"may interfere with tests containing cupric sulfate (Benedict's solution, Clinitest)\"),\n ('glucose', 'increased'),\n ('urine glucose test',\n  \"may interfere with containing cupric sulfate (Benedict's solution, Clinitest)\"),\n ('coagulation', 'Altered results'),\n ('aldosterone/renin ratio', 'false-negative'),\n {'skin test antigens': 'suppressed'},\n {'urinary 5-hydroxyindoleacetic acid': 'false-positive'},\n {'enzymatic methods used to detect opioids': 'interference (refer to test manufacturer for details)'},\n {'skin tests': 'decreased response'},\n ('Folic acid', 'invalidated'),\n ('Opioid screening test', 'false-positive (when taking some quinolones)'),\n ('dexamethasone suppression test', 'false-negative'),\n ('phenylketonuria', 'false-positive'),\n ('Urinary glucose tests using cupric sulfate', 'May interfere'),\n ('Medical Test Name', 'TPMT phenotyping'),\n ('Serum renin concentrations', 'increased'),\n {'fluorescence test for urinary catecholamines': 'false elevations'},\n ('urine screening result for opioids', 'false-positive'),\n ('Test name', 'Polymerase chain reaction (PCR) assay for HIV'),\n {'metyrapone test': 'reduced response'},\n ('anti-FXa activity assay',\n  'falsely elevated after andexanet alfa administration'),\n (\"Positive direct Coombs'\", 'positive'),\n ('test name', 'amphetamine EMIT assay'),\n {'Thyroid function tests': 'Altered'},\n ('Plasma glucose', 'increased'),\n ('AST', 'interfere'),\n ('phencyclidine', 'false-positives'),\n {'aldosterone/renin ratio (ARR)': 'false-positive'},\n ('renin (S)', 'increased'),\n ('PCR assays for HIV', 'positive'),\n ('Test Name', 'Coombs test'),\n (\"Coombs' test (direct)\", 'Positive'),\n ('Stool occult blood test', 'False-negative'),\n ('One-stage clotting assay (OSA)',\n  'Affected by aPTT reagent and reference standard used; recommended for monitoring factor IX activity over time with the same assay and reagents'),\n ('urine screening result for opioids', 'false-positive'),\n ('urinary glucose determination using Clinitest', 'interferes'),\n ('Urinary protein with Albustix', 'false-positive'),\n {'Aldosterone/renin ratio (ARR)': 'false-negative'},\n {'Diagnostic serum tests that utilize antibodies': 'interference'},\n ('serologic testing', 'false-positive'),\n ('Dehydrogenase Pyrroloquinolinequinone',\n  'Falsely elevated blood glucose levels'),\n ('Medical Test Names', ['Aminoglycoside Serum Concentration']),\n ('Medical Test Names', ['Aldosterone/Renin Ratio (ARR)']),\n ('urinary glucose determination using Clinitest',\n  'false-positive or negative'),\n ('Positive direct Coombs', 'Positive'),\n {\"Positive Coombs'\": 'Positive'},\n {'serum TCA screen': 'false-positive'},\n {'urine screening result for opioids': 'false-positive'},\n ('CD20 assay', 'interfered'),\n {'procainamide/N-acetyl procainamide concentration test': 'affected'},\n ('PT/INR', ['elevated']),\n ('5-HIAA', 'color interference'),\n ('Free Thyrotropin', 'falsely elevated'),\n ('Test Name', 'Urine Screening for Opioids'),\n ('Test Name', 'Bone Scan with Technetium-99m-diphosphonate'),\n ('Plasma phenytoin concentrations', 'Falsely high'),\n ('Urine detection of opioids', 'False-positive'),\n ('Serum iron levels',\n  'may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration'),\n ('Neutralizing antibody assay',\n  'Obtain serum samples at least a month after the last dose to prevent assay interference.'),\n {'aPTT': 'contains heparin'},\n ('polymerase chain reaction (PCR) assays for HIV', 'Positive'),\n ('Positive direct Coombs', 'Positive'),\n {'uric acid': 'N/A'},\n ('urinary metanephrine', 'May falsely increase'),\n ('serum chromogranin A (CgA)',\n  'may falsely elevate; may cause false-positive results in the diagnosis of a neuroendocrine tumor'),\n (\"Positive direct Coombs'\", 'Positive'),\n ('Medical test names', ['Aminoglycoside serum concentration'])]"
     },
     "execution_count": 98,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "i = 0\n",
    "for key,val in list_of_dicts.items():\n",
    "    if 'Test Names' in val:\n",
    "\n",
    "        try:\n",
    "            val = json.loads(val = val['Test Names'])\n",
    "        except:\n",
    "            val = val['Test Names']\n",
    "\n",
    "    space = len(val)\n",
    "\n",
    "    if space == 1:\n",
    "        r1[i] = val\n",
    "\n",
    "    elif space == 2:\n",
    "        j = 0\n",
    "        for v in val.items():\n",
    "            if j == 0:\n",
    "                r1[i] = v\n",
    "                j += 1\n",
    "            elif j == 1:\n",
    "                r2[i] = v\n",
    "\n",
    "    elif space == 3:\n",
    "        j = 0\n",
    "        for v in val.items():\n",
    "            if j == 0:\n",
    "                r1[i] = v\n",
    "            elif j == 1:\n",
    "                r2[i] = v\n",
    "            elif j == 2:\n",
    "                r3[i] = v\n",
    "            j += 1\n",
    "\n",
    "    elif space == 4:\n",
    "        j = 0\n",
    "        for v in val.items():\n",
    "            if j == 0:\n",
    "                r1[i] = v\n",
    "            elif j == 1:\n",
    "                r2[i] = v\n",
    "            elif j == 2:\n",
    "                r3[i] = v\n",
    "            elif j == 3:\n",
    "                r4[i] = v\n",
    "            j += 1\n",
    "\n",
    "    elif space == 5:\n",
    "        j = 0\n",
    "        for v in val.items():\n",
    "            if j == 0:\n",
    "                r1[i] = v\n",
    "            elif j == 1:\n",
    "                r2[i] = v\n",
    "            elif j == 2:\n",
    "                r3[i] = v\n",
    "            elif j == 3:\n",
    "                r4[i] = v\n",
    "            elif j == 4:\n",
    "                r5[i] = v\n",
    "            j += 1\n",
    "\n",
    "    elif space == 6:\n",
    "        j = 0\n",
    "        for v in val.items():\n",
    "            if j == 0:\n",
    "                r1[i] = v\n",
    "            elif j == 1:\n",
    "                r2[i] = v\n",
    "            elif j == 2:\n",
    "                r3[i] = v\n",
    "            elif j == 3:\n",
    "                r4[i] = v\n",
    "            elif j == 4:\n",
    "                r5[i] = v\n",
    "            elif j == 5:\n",
    "                r6[i] = v\n",
    "            j += 1\n",
    "\n",
    "    elif space == 7:\n",
    "        j = 0\n",
    "        for v in val.items():\n",
    "            if j == 0:\n",
    "                r1[i] = v\n",
    "            elif j == 1:\n",
    "                r2[i] = v\n",
    "            elif j == 2:\n",
    "                r3[i] = v\n",
    "            elif j == 3:\n",
    "                r4[i] = v\n",
    "            elif j == 4:\n",
    "                r5[i] = v\n",
    "            elif j == 5:\n",
    "                r6[i] = v\n",
    "            elif j == 6:\n",
    "                r7[i] = v\n",
    "            j += 1\n",
    "\n",
    "    elif space == 8:\n",
    "        j = 0\n",
    "        for v in val.items():\n",
    "            if j == 0:\n",
    "                r1[i] = v\n",
    "            elif j == 1:\n",
    "                r2[i] = v\n",
    "            elif j == 2:\n",
    "                r3[i] = v\n",
    "            elif j == 3:\n",
    "                r4[i] = v\n",
    "            elif j == 4:\n",
    "                r5[i] = v\n",
    "            elif j == 5:\n",
    "                r6[i] = v\n",
    "            elif j == 6:\n",
    "                r7[i] = v\n",
    "            elif j == 7:\n",
    "                r8[i] = v\n",
    "            j += 1\n",
    "\n",
    "    i +=1\n",
    "r1"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T08:12:57.887746700Z",
     "start_time": "2023-05-10T08:12:57.825233600Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "outputs": [
    {
     "data": {
      "text/plain": "[(\"Urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\",\n  'False-positive'),\n 0,\n ('serum methotrexate (dihydrofolate reductase method)', 'Increased'),\n ('neuroendocrine tumor diagnosis', 'may cause false-positive results'),\n ('blood samples collection',\n  'in tubes containing ethylenediaminetetraacetic acid (EDTA)'),\n ('propylene glycol content', 'in IV formulation'),\n 0,\n (\"Coombs' Test (Direct)\", 'Positive'),\n 0,\n (\"urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\",\n  'false-positive'),\n ('urine zinc', 'transient increase (with renal disease)'),\n 0,\n ('urine detection of phencyclidine', 'false-positives'),\n ('Serum ferritin levels',\n  'falsely elevated for 5 days after ferric gluconate administration'),\n ('radioiodine uptake studies', 'affected results'),\n (\"urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution)\",\n  'false-positive'),\n (\"Coombs' [direct]\", 'positive'),\n ('Coombs test',\n  'may be interfered with due to passive transmission of antibodies to erythrocyte antigens'),\n (\"urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\",\n  'False-positive'),\n (\"Urinary glucose test using cupric sulfate (Benedict's solution)\", False),\n ('Transferrin bound iron levels', 'falsely elevated'),\n 0,\n 0,\n ('diagnostic tests using iodine-containing isotopes', 'may be affected'),\n 0,\n ('Aldosterone/renin ratio (ARR) test', 'may give a false-negative result'),\n 0,\n 0,\n 0,\n ('serum creatinine (alkaline picrate method)', 'interference by Methyldopa'),\n ('ofloxacin', 'false-positive urine screening result for opioids'),\n ('fibrinolytic activity', 'Altered'),\n 0,\n ('Urine glucose',\n  'False-positive with certain methods; use glucose tests based on enzymatic glucose oxidase reactions'),\n ('Serum Calcium',\n  'May interfere with colorimetric tests; alternate testing method recommended for 12-24 hours after administration'),\n ('17-hydroxycorticosteroids', 'False-positive'),\n ('Test Result', 'False positive when pyrogallol red reagent is used'),\n ('BSP retention', 'increased'),\n ('interaction', 'may be observed'),\n 0,\n ('inorganic phosphorus blood concentrations', 'false low'),\n 0,\n ('Hematopoietic activity', 'increased'),\n ('Test results', ['False-negative']),\n (\"Coombs' test\", 'positive'),\n ('HDL', 'decreased'),\n (\"Coombs' test\", 'positive'),\n ('fibrinolytic activity', 'Altered results'),\n ('ARR', 'false-negative'),\n 0,\n 0,\n 0,\n 0,\n ('Vitamin B12', 'invalidated'),\n ('Specific confirmation test', 'recommended'),\n ('aldosterone/renin ratio (ARR)', 'false-positive'),\n ('amylase', 'false-positive'),\n ('Aminoglycosides', 'May inactivate in vitro'),\n ('Test Result', 'May not be accurate following recent blood transfusions.'),\n ('IgG concentrations', 'increased'),\n 0,\n ('levofloxacin', 'cross-reactivity'),\n ('Test result',\n  'False-positive for HIV in patients who have received betibeglogene autotemcel due to integrated BB305 LVV proviral DNA'),\n 0,\n ('andexanet alfa', 'reversal activity'),\n ('false-positive urinary glucose test using nonenzymatic methods',\n  'false-positive'),\n ('test result', 'false positive'),\n 0,\n ('Uric acid', 'increased'),\n ('ALT', 'interfere'),\n ('aldosterone/renin ratio (ARR)', 'false-positive'),\n 0,\n ('aldosterone (S)', 'increased'),\n ('HIV infection using a PCR-based assay', 'false-positive'),\n ('Test Result', 'Positive'),\n ('Urinary proteins', 'False-positive'),\n ('Blood glucose testing', 'Interference (falsely-elevated)'),\n ('Activated partial thromboplastin time (aPTT)',\n  'Type of reagent used affects results when using OSA to determine factor IX activity'),\n ('levofloxacin', 'positive'),\n (\"Coombs' [direct]\", 'positive'),\n ('Labstix', 'false-positive'),\n 0,\n 0,\n ('direct Coombs test', 'false-positive'),\n ('Glucose-dye-oxidoreductase', 'Falsely elevated blood glucose levels'),\n ('Test Results', ['Potential Underestimation']),\n ('Test Results', ['False-Negative']),\n (\"Coombs' [direct]\", 'positive'),\n ('urinary glucose test using cupric sulfate', 'False-positive'),\n 0,\n 0,\n 0,\n ('CD19+ assay', 'measure B-cell counts'),\n 0,\n ('bivalirudin', ['modification']),\n ('VMA', 'color interference'),\n ('Free Triiodothyronine', 'falsely elevated'),\n ('Test Result', 'false-positive with quinolones; confirmation recommended'),\n ('Test Result', 'may be interfered with by Bisphosphonates'),\n ('Serum concentrations of T4', 'Falsely low'),\n (\"Coombs' test\", 'Positive'),\n ('Transferrin bound iron levels',\n  'may be falsely elevated if assessed within 24 hours of ferric carboxymaltose administration'),\n ('HbA1c',\n  'Erythropoiesis-stimulating agents may artificially lower HbA1c through increased circulation of immature erythrocytes in the peripheral blood stream that have less exposure to glucose (Kobayashi 2016; Rasche 2017).'),\n 0,\n ('BB305 LVV proviral DNA', 'Integrated'),\n (\"urinary glucose test using cupric sulfate (Benedict's solution, Clinitest, Fehling's solution)\",\n  'False-positive'),\n 0,\n ('HPLC assay with solid phase extraction for determination of urinary catecholamines',\n  'does not interact with'),\n ('omeprazole', 'Temporarily stop ≥14 days prior to assessing CgA level'),\n (\"False-positive urinary glucose test using cupric sulfate (Benedict's solution, Clinitest®, Fehling's solution)\",\n  'Positive'),\n ('Test results', ['Potential underestimation'])]"
     },
     "execution_count": 99,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r2"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T08:13:08.019624Z",
     "start_time": "2023-05-10T08:13:07.957106800Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "outputs": [],
   "source": [
    "df_test_interactions_splitted = pd.DataFrame()\n",
    "\n",
    "df_test_interactions_splitted['Test Names 1'] = r1\n",
    "df_test_interactions_splitted['Test Names 2'] = r2\n",
    "df_test_interactions_splitted['Test Names 3'] = r3\n",
    "df_test_interactions_splitted['Test Names 4'] = r4\n",
    "df_test_interactions_splitted['Test Names 5'] = r5\n",
    "df_test_interactions_splitted['Test Names 6'] = r6\n",
    "df_test_interactions_splitted['Test Names 7'] = r7\n",
    "df_test_interactions_splitted['Test Names 8'] = r8"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T08:15:53.402646800Z",
     "start_time": "2023-05-10T08:15:53.371402100Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "outputs": [
    {
     "data": {
      "text/plain": "                                          Test Names 1   \n0        (Direct antiglobulin (Coombs) test, Positive)  \\\n1    {'Wheal and flare reactions to skin test antig...   \n2    (creatinine (Jaffé alkaline picrate reaction),...   \n3    (serum chromogranin A (CgA) levels, falsely el...   \n4    (automated platelet counts, may interfere (pla...   \n..                                                 ...   \n106                               {'uric acid': 'N/A'}   \n107       (urinary metanephrine, May falsely increase)   \n108  (serum chromogranin A (CgA), may falsely eleva...   \n109                (Positive direct Coombs', Positive)   \n110  (Medical test names, [Aminoglycoside serum con...   \n\n                                          Test Names 2   \n0    (Urinary glucose test using cupric sulfate (Be...  \\\n1                                                    0   \n2    (serum methotrexate (dihydrofolate reductase m...   \n3    (neuroendocrine tumor diagnosis, may cause fal...   \n4    (blood samples collection, in tubes containing...   \n..                                                 ...   \n106                                                  0   \n107  (HPLC assay with solid phase extraction for de...   \n108  (omeprazole, Temporarily stop ≥14 days prior t...   \n109  (False-positive urinary glucose test using cup...   \n110        (Test results, [Potential underestimation])   \n\n                                          Test Names 3   \n0    (Serum/urine creatinine with Jaffé reaction as...  \\\n1                                                    0   \n2                                                    0   \n3    (CgA levels assessment, ≥14 days after treatme...   \n4    (platelet count, may be unevaluable or falsely...   \n..                                                 ...   \n106                                                  0   \n107  (aldosterone/renin ratio (ARR), may lead to fa...   \n108                                                  0   \n109  (False-positive serum or urine creatinine with...   \n110                                                  0   \n\n                                          Test Names 4   \n0                                                    0  \\\n1                                                    0   \n2                                                    0   \n3           (CgA levels repeat, if initially elevated)   \n4    (management, Collect blood samples in citrate-...   \n..                                                 ...   \n106                                                  0   \n107                                                  0   \n108                                                  0   \n109                                                  0   \n110                                                  0   \n\n                                          Test Names 5   \n0                                                    0  \\\n1                                                    0   \n2                                                    0   \n3                                                    0   \n4    (run blood samples, within 4 hours of sample c...   \n..                                                 ...   \n106                                                  0   \n107                                                  0   \n108                                                  0   \n109                                                  0   \n110                                                  0   \n\n                                          Test Names 6 Test Names 7   \n0                                                    0            0  \\\n1                                                    0            0   \n2                                                    0            0   \n3                                                    0            0   \n4    (estimate platelet count, through peripheral b...            0   \n..                                                 ...          ...   \n106                                                  0            0   \n107                                                  0            0   \n108                                                  0            0   \n109                                                  0            0   \n110                                                  0            0   \n\n    Test Names 8  \n0              0  \n1              0  \n2              0  \n3              0  \n4              0  \n..           ...  \n106            0  \n107            0  \n108            0  \n109            0  \n110            0  \n\n[111 rows x 8 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Test Names 1</th>\n      <th>Test Names 2</th>\n      <th>Test Names 3</th>\n      <th>Test Names 4</th>\n      <th>Test Names 5</th>\n      <th>Test Names 6</th>\n      <th>Test Names 7</th>\n      <th>Test Names 8</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>(Direct antiglobulin (Coombs) test, Positive)</td>\n      <td>(Urinary glucose test using cupric sulfate (Be...</td>\n      <td>(Serum/urine creatinine with Jaffé reaction as...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>{'Wheal and flare reactions to skin test antig...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>(creatinine (Jaffé alkaline picrate reaction),...</td>\n      <td>(serum methotrexate (dihydrofolate reductase m...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>(serum chromogranin A (CgA) levels, falsely el...</td>\n      <td>(neuroendocrine tumor diagnosis, may cause fal...</td>\n      <td>(CgA levels assessment, ≥14 days after treatme...</td>\n      <td>(CgA levels repeat, if initially elevated)</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>(automated platelet counts, may interfere (pla...</td>\n      <td>(blood samples collection, in tubes containing...</td>\n      <td>(platelet count, may be unevaluable or falsely...</td>\n      <td>(management, Collect blood samples in citrate-...</td>\n      <td>(run blood samples, within 4 hours of sample c...</td>\n      <td>(estimate platelet count, through peripheral b...</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>106</th>\n      <td>{'uric acid': 'N/A'}</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>107</th>\n      <td>(urinary metanephrine, May falsely increase)</td>\n      <td>(HPLC assay with solid phase extraction for de...</td>\n      <td>(aldosterone/renin ratio (ARR), may lead to fa...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>108</th>\n      <td>(serum chromogranin A (CgA), may falsely eleva...</td>\n      <td>(omeprazole, Temporarily stop ≥14 days prior t...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>109</th>\n      <td>(Positive direct Coombs', Positive)</td>\n      <td>(False-positive urinary glucose test using cup...</td>\n      <td>(False-positive serum or urine creatinine with...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>110</th>\n      <td>(Medical test names, [Aminoglycoside serum con...</td>\n      <td>(Test results, [Potential underestimation])</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n  </tbody>\n</table>\n<p>111 rows × 8 columns</p>\n</div>"
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_test_interactions_splitted"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T08:15:56.246590Z",
     "start_time": "2023-05-10T08:15:56.188707100Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "outputs": [],
   "source": [
    "df_test_interactions_splitted.to_excel('Tests Interactions Splitted.xlsx')"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T08:16:18.791365400Z",
     "start_time": "2023-05-10T08:16:18.725913600Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "outputs": [
    {
     "data": {
      "text/plain": "                                          Test Names 1   \n0        (Direct antiglobulin (Coombs) test, Positive)  \\\n1    {'Wheal and flare reactions to skin test antig...   \n2    (creatinine (Jaffé alkaline picrate reaction),...   \n3    (serum chromogranin A (CgA) levels, falsely el...   \n4    (automated platelet counts, may interfere (pla...   \n..                                                 ...   \n106                               {'uric acid': 'N/A'}   \n107       (urinary metanephrine, May falsely increase)   \n108  (serum chromogranin A (CgA), may falsely eleva...   \n109                (Positive direct Coombs', Positive)   \n110  (Medical test names, [Aminoglycoside serum con...   \n\n                                          Test Names 2   \n0    (Urinary glucose test using cupric sulfate (Be...  \\\n1                                                    0   \n2    (serum methotrexate (dihydrofolate reductase m...   \n3    (neuroendocrine tumor diagnosis, may cause fal...   \n4    (blood samples collection, in tubes containing...   \n..                                                 ...   \n106                                                  0   \n107  (HPLC assay with solid phase extraction for de...   \n108  (omeprazole, Temporarily stop ≥14 days prior t...   \n109  (False-positive urinary glucose test using cup...   \n110        (Test results, [Potential underestimation])   \n\n                                          Test Names 3   \n0    (Serum/urine creatinine with Jaffé reaction as...  \\\n1                                                    0   \n2                                                    0   \n3    (CgA levels assessment, ≥14 days after treatme...   \n4    (platelet count, may be unevaluable or falsely...   \n..                                                 ...   \n106                                                  0   \n107  (aldosterone/renin ratio (ARR), may lead to fa...   \n108                                                  0   \n109  (False-positive serum or urine creatinine with...   \n110                                                  0   \n\n                                          Test Names 4   \n0                                                    0  \\\n1                                                    0   \n2                                                    0   \n3           (CgA levels repeat, if initially elevated)   \n4    (management, Collect blood samples in citrate-...   \n..                                                 ...   \n106                                                  0   \n107                                                  0   \n108                                                  0   \n109                                                  0   \n110                                                  0   \n\n                                          Test Names 5   \n0                                                    0  \\\n1                                                    0   \n2                                                    0   \n3                                                    0   \n4    (run blood samples, within 4 hours of sample c...   \n..                                                 ...   \n106                                                  0   \n107                                                  0   \n108                                                  0   \n109                                                  0   \n110                                                  0   \n\n                                          Test Names 6 Test Names 7   \n0                                                    0            0  \\\n1                                                    0            0   \n2                                                    0            0   \n3                                                    0            0   \n4    (estimate platelet count, through peripheral b...            0   \n..                                                 ...          ...   \n106                                                  0            0   \n107                                                  0            0   \n108                                                  0            0   \n109                                                  0            0   \n110                                                  0            0   \n\n    Test Names 8  \n0              0  \n1              0  \n2              0  \n3              0  \n4              0  \n..           ...  \n106            0  \n107            0  \n108            0  \n109            0  \n110            0  \n\n[111 rows x 8 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Test Names 1</th>\n      <th>Test Names 2</th>\n      <th>Test Names 3</th>\n      <th>Test Names 4</th>\n      <th>Test Names 5</th>\n      <th>Test Names 6</th>\n      <th>Test Names 7</th>\n      <th>Test Names 8</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>(Direct antiglobulin (Coombs) test, Positive)</td>\n      <td>(Urinary glucose test using cupric sulfate (Be...</td>\n      <td>(Serum/urine creatinine with Jaffé reaction as...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>{'Wheal and flare reactions to skin test antig...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>(creatinine (Jaffé alkaline picrate reaction),...</td>\n      <td>(serum methotrexate (dihydrofolate reductase m...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>(serum chromogranin A (CgA) levels, falsely el...</td>\n      <td>(neuroendocrine tumor diagnosis, may cause fal...</td>\n      <td>(CgA levels assessment, ≥14 days after treatme...</td>\n      <td>(CgA levels repeat, if initially elevated)</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>(automated platelet counts, may interfere (pla...</td>\n      <td>(blood samples collection, in tubes containing...</td>\n      <td>(platelet count, may be unevaluable or falsely...</td>\n      <td>(management, Collect blood samples in citrate-...</td>\n      <td>(run blood samples, within 4 hours of sample c...</td>\n      <td>(estimate platelet count, through peripheral b...</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>106</th>\n      <td>{'uric acid': 'N/A'}</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>107</th>\n      <td>(urinary metanephrine, May falsely increase)</td>\n      <td>(HPLC assay with solid phase extraction for de...</td>\n      <td>(aldosterone/renin ratio (ARR), may lead to fa...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>108</th>\n      <td>(serum chromogranin A (CgA), may falsely eleva...</td>\n      <td>(omeprazole, Temporarily stop ≥14 days prior t...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>109</th>\n      <td>(Positive direct Coombs', Positive)</td>\n      <td>(False-positive urinary glucose test using cup...</td>\n      <td>(False-positive serum or urine creatinine with...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>110</th>\n      <td>(Medical test names, [Aminoglycoside serum con...</td>\n      <td>(Test results, [Potential underestimation])</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n  </tbody>\n</table>\n<p>111 rows × 8 columns</p>\n</div>"
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_test_interactions_splitted"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2023-05-10T08:16:35.743335900Z",
     "start_time": "2023-05-10T08:16:35.671501800Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [
    "df_test_interactions =pd.read_json('')"
   ],
   "metadata": {
    "collapsed": false
   }
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
